﻿

Science-Based Medicine: Real Medicine A Critical Guide for the Health Practitioner and Consumer. 2025 Edition. 
by Executive Editor Steven Novella. Managing Editor David Gorski. Series Editor Mark Crislip.
Contributions by The writers of the Science Based Medicine blog.
Published by SBM
2025

   Table of Contents
Title Page
Introduction
About the book
INFECTIOUS DISEASES?
The Real ID. Mark Crislip
No, Everything You Thought You Knew About Disease Is Not Wrong | H Hall
The Marshall Protocol. Mark Crislip.
Urinary Tract Infections Cause Depression. Directors Cut.* | M Crislip
The Paddison Program for rheumatoid arthritis: An unproven treatment that provides only the illusion of control | D Gorski
Black mold is the new Candida | S. Gavura
Delusional Parasitosis. Steven Novella.
Morgellon's Itching and the Imaginary Passenger Brake. Wallace Sampson
Parasites. Mark Crislip.
Parasite Cleanse S. Novella
Lice | H Hall
TB Or Not TB? Don’t Rely on a Blood Test | H Hall
LYME
Lyme: Two Worlds Compared and Contrasted | M Crislip
Chronic Lyme Disease – Another Negative Study | S Novella
Chronic Lyme disease: Fake diagnosis, not fake disease | D Gorski
Lemons and Lyme: Bogus tests and dangerous treatments of the Lyme-literati | J Snyder
Lyme Testing | M Crislip
More Lyme ‘Guidelines’ | M Crislip
More Political Science: Proposed laws protect “Lyme literate” doctors from discipline | J Bellamy
Avoid prolonged antibiotics for “Chronic Lyme” | S Gavura
Another “Chronic Lyme” VIP disciplined by NY medical authorities: Bernard Raxlen | J Bellamy
“Chronic Lyme” VIP Daniel Cameron disciplined by New York medical authorities | J Bellamy
Jarisch-Herxheimer and Lyme disease | S Novella
A Review of Under Our Skin, A Cult Classic | B MacBeth
Warts | M Crislip
Should We Fear the Monkeypox? | S Novella
A Pox on All Our Houses | M Crislip
Are We Ready for Mpox | S Novella
Conspiracy theories about monkeypox: Déjà vu all over again or same as it ever was? | D Gorski
New CDC Data Confirms Continued Rise in Sexually Transmitted Diseases | C Jones
Medical Misinformation Falsely Links a Serious Infection to Leftover Chinese Food | C Jones
Mouse Model of Sepsis Challenged | S Novella
Some Sepsis Stuff | M Crislip
Madonna !?! | M Crislip
The Tuskegee Syphilis Experiment: A Fiasco with a Silver Lining | H Hall
ANTIBIOTICS
Antibiotics for Low Back Pain | H Hall
No, Purell Does Not Breed Super-Anything | A Wegman
Why Antibiotic Use Scares Me | J Horton
If you feel better, should you stop taking your antibiotics? | S Gavura
I’ve been prescribed an antibiotic. Should I take a probiotic? | S Gavura
Overprescribing Antibiotics | S Novella
New Tools Against Antibiotic Resistance | S Novella
Phage Therapy and Antibiotic Resistance | S Novella
Using Bacteria To Fight Bacteria | S Novella
Using Evolutionary Principles to Reduce Antibiotic Resistance | S Novella
There is really nothing super about Antibiotic Resistant Gonorrhea | C Jones
Antibiotics vs. the Microbiome | H Hall
The Microbial Metagenome. Mark Crislip.
Meet Your Microbes: uBiome Offers New Service | H Hall
Yet another plague panic | M Crislip
Live Blood Analysis: The Modern Auguries. Mark Crislip
Honey. Mark Crislip
Hi Ho Silver. Mark Crislip
1799 | M Crislip
Jurassic Farce | M Crislip
Zoonotic Spillover Is A Problem | S Novella
EBOLA
Ebola outbreaks: Science versus fear mongering and quackery | D Gorski
Ebola conspiracy theories: Same as it ever was | D Gorski
Conspiracy theories and Ebola virus transmission | D Gorski
Is the Ebola Crisis a Reason to Skip RCTs? | H Hall
Using the fear of Ebola to promote the placebo legislation that is “right to try” | D Gorski
The Latest Ebola Outbreak | S Novella
Ebola: Science Is Making Progress | H Hall
Ebola SCAMs | M Crislip
Keep An Eye On This Ebola Outbreak | S Novella
Elephants, Herpes, and Protests: A Zoo Tragedy Distorted | G Bishop
Curing Hepatitis C: A Success Story and a Price Tag | H Hall
Buzzword Medicine – Anti-Proinflammation | S Novella
Legionnaires’ Disease: The Other Disneyland Outbreak | C Jones
Worms, Germs, and Dirt: What Can They Teach Us About Allergies and Autoimmune Diseases? | H Hall
The Application of Science | M Crislip
IMMUNITY
780.6. What is a fever? | M Crislip
Boost Your Immune System? | M Crislip
More Boosting the Immune System | M Crislip
Tattoos Won’t Boost Your Immune System | C Jones
Tattoos Still Won’t Boost Your Immune System | C Jones
Nobel Prize in Medicine: Peripheral Immune Tolerance | S Novella
You can’t beat the common cold, and that’s a fact | J Snyder
The (Cold) Drugs Don’t Work | S Gavura
The New Cough and Cold Products for Children: Evidence is Optional and Science is Marketing | S Gavura
Decongestant doesn’t work, concludes FDA advisory committee | S Gavura
Medicine Must-Haves: A Pharmacist’s Guide to Your College Student’s First Aid Kit | S Gavura
HIV
More HIV Nonsense in Africa | S Novella
Science vs HIV | S Novella
PreP for HIV/AIDS | H Hall
There’s No Vaccine for HIV/AIDS, But There’s Truvada | H Hall
Second Patient Cured of HIV Still Clear | S Novella
XMRV Chronic Fatigue Syndrome Update | S Novella
IOM Recommends Replacing CFS with SEID | H Hall
Rituximab for Chronic Fatigue Syndrome: Jumping the Gun | H Hall
Chronic Fatigue Syndrome: Rituximab Revisited | H Hall
Hepatitis C Vaccine Fails Testing | H Hall
Ivermectin to Control Malaria — A Cluster-Randomized Trial | T Noonan
Biohacking Backfires: When Self-Tracking Can Harm | S Gavura
“Gain of Function” Research Is Misunderstood – And That Is A Problem | H Miller
Science-Based Medicine Reviews: Real Medicine
A Critical Guide for the Health Practitioner and Consumer 
2024 Edition

Executive Editor Steven Novella MD
Managing Editor David Gorski MD PhD
Series Editor Mark Crislip MD

   Introduction
Steven Novella
The world of health care is becoming an increasingly complex and challenging place. The internet is changing the way we generate and access information, and health information is one of the most popular uses of the internet. It represents an unprecedented democratization of information and opinion. 
While there are many advantages and benefits to such information access, there are also many challenges to health professionals, regulators, academics, and consumers. There is a proliferation of health related products and services, with many provocative health claims. Regulations are generally not keeping up, and often have been watered down, in the face of this onslaught of claims and products. 
The consumer is left with an overwhelming array of health claims, many of which challenge and even directly oppose the traditional experts and institutions. 
The mission of Science-Based Medicine (SBM) is to be a source of reliable information and analysis to help navigate the wild west of health information on the internet and elsewhere. The authors who contribute to this series of e-books are all physicians and other health care professionals who have a great deal of experience educating the public about complex medical issues. We especially take on controversial issues and try to expose pseudoscience and fraud wherever possible.
The Philosophy of Science-Based Medicine
The philosophy of SBM, at its core, is simple: Safe and effective health care is critical to everyone’s quality of life; so much so that it is generally considered a basic human right. Therefore, health care products and services that work and are safe are better than those that do not work or are unsafe. 
The best method for determining which interventions and health products are safe and effective is, without question, good science. Therefore it is in everyone’s best interest for health care to be systematically evaluated by the best science available.
Too often the nature of science itself is misunderstood or misrepresented to the public. Science is not an arcane and privileged discipline. By its very nature it is meant to be transparent and public. Science is nothing more than a systematic and careful use of evidence and logic to evaluate factual claims. And good science possesses certain virtues that are not unique to science but generic to all intellectual endeavors: fairly accounting for all available evidence, using valid and internally consistent logic, using unambiguous concepts and language, proper use of statistics, being quantitatively precise and accurate, and above all being honest.
And yet there are numerous and powerful influences in society that strongly appose the scientific basis of medicine. Driven by some combination of ideology or the desire for profit they wish to eliminate standards of science in health care, or (often under the guise of “health care freedom”) create a double standard in which unscientific methods and products can thrive unchecked. Others simply lack the training or knowledge to achieve minimal standards of quality for scientific medicine. And even the best traditions of scientific medicine can benefit from more critical analysis.
Recognition of the need for careful scientific analysis in medicine partly stems from a recognition that it is very difficult (almost impossible) to reliably assess treatments anecdotally. Human perception, memory, and cognition are prone to a host of flaws, weaknesses, and biases that will tend to mislead us, especially towards conclusions that we wish to be true. Placebo effects, confirmation bias, and simple statistics can make any intervention seem effective, even when they are worthless or harmful. 
Science-Based Medicine vs Evidence-Based Medicine
Within the practice of medicine there is already a recognition of the need to raise the standards of evidence and the availability of the best evidence to the practitioner and the consumer – formalized in the movement known as evidence-based medicine (EBM). 
EBM is a vital and positive influence on the practice of medicine, but it has its limitations. EBM tends to focus on clinical trial results to the exclusion of scientific plausibility. The focus on trial results (which, in the EBM lexicon, is what is meant by “evidence”) has its utility, but fails to properly deal with medical modalities that are highly implausible, or seem to defy well-established findings in science.
All of science describes the same reality, and therefore it must (if it is functioning properly) all be mutually compatible. Collectively, science builds one cumulative model of the natural world. This means we can make rational judgments about what is likely to be true based upon what is already well established. This does not necessarily equate to rejecting new ideas out-of-hand, but rather to adjusting the threshold of evidence required to establish a new claim based upon the prior scientific plausibility of the new claim. Failure to do so leads to conclusions and recommendations that are not reliable, and therefore medical practices that are probably not safe and effective.
The SBM Series
This is why the authors of this series strongly advocate for science based medicine – the use of the best scientific evidence available, in the light of our cumulative scientific knowledge from all relevant disciplines, in evaluating health claims, practices, and products. 
Some of the articles here will analyze individual studies, and explore the strengths and weaknesses of their methods, separating what the study really tells us from how it may be represented in the media. Other articles will summarize what many studies tell us about a specific medical question. 
We will also explore health information on the internet, separating out which information is reliable from that which is misleading, erroneous, or possibly even fraudulent. Likewise we will critique mainstream media coverage of health topics, giving the reader specific tools for to critically analyze health information for themselves.
Other articles will explore topics related to health regulation and academia. Regulations have struggled to keep up with the rapidly changing health care market place, with critical gaps that leave the health care consumer responsible for their own protection. Academic institutions themselves, long the defenders of high standards of scholarship in all fields, including medicine, have been infiltrated by promoters of pseudoscientific belief systems. The result is that there is no longer any single reliable guarantee of scientific integrity. 
The SBM series of e-books is organized by topic, such as acupuncture, chiropractic, homeopathy, and many others. The books are collections of essays, not intended to be a systematic reference, but rather to explore the various scientific issues related to each topic. The goal is to give the reader critical thinking skills and a deeper understanding of, not just the current findings of science, but the process of science, specifically how it relates to health care and the topic of each book. 
Science-based medicine can serve as your pocket guide through the wilderness of health information.

As of 2025, there are over 5000 essays on the Science Based Medicine website. I do no know about you, but I find it difficult to find any post I wrote, much less one written by another contributor. 

So I have updated the books and include almost all the articles through 2025. The volumes are

CAM Concepts
Chiropractic
COVID 
Critical Thinking
Diet and Nutrition
Ethics and CAM
Herbs, Supplements, and Diet
Homeopathy
Infections and Immunity
Law and CAM
Media and Internet
Medicine, Public Health, Dentistry and Pediatrics
Miscellaneous CAM
Naturopathy
Neurology and Psychiatry
Placebo
Quackademic Medicine
Regulation. FDA and FTC
SBM or EBM
Stem Cells, Genetics, AI and Gender
Supplements, Vitamins and Herbs
Vaccine & Anivax
Vaccines and Autism
Vaccines and Preventable Infections

The articles are roughly organized by publication date and topic. Many articles will be in multiple volumes as an essay of, for example, chiropractic and law will be found in both the chiropractic volume and the law volume.

You may find the organization a bit odd. I do. But 4700 plus articles are difficult to organize and I have more to do in my retirement than work of these volumes.

Still, if you find I have missed a nentry or some glaring error, drop me a note and I will fix it for the next edition.

About the authors
Steven P. Novella, MD – Founder and Executive Editor Science Based Medicine.
Founder and currently Executive Editor of Science-Based Medicine Steven Novella, MD.
David H. Gorski, MD, PhD – Managing Editor. Science Based Medicine.
Mark A. Crislip, MD. Editor, Science Based Medicine Guides. 
He did he editing of all the volumes so is to blame for any mistakes.
As to all the other contributors, if you are interested click on the ‘Link’ at top of each essay to go the SBM site, where further information about each author can be found.
A Note On References

The chapters in this book were originally blog entries at ScienceBasedMedicine.org.
Blog and web pages lend themselves to hyperlinks to sources and references that are tedious to translate into footnotes for this ebook.
Under the title of each essay is a hyperlink, cleverly titled ‘Link’, to the original blog entry with all the hyperlinks and references, as well as the comments to the blogs, which often have interesting and thoughtful insights by our readers, as well as some curious comments by the not so thoughtful.
Graphs, tables and links to videos are not in included these essays due to issues of copyright and permission. However, thanks to the ‘Link’, the graphics are a click away.
Thanks for reading the site.
Mark Crislip 




   Infectious Diseases?

   The Real ID
Mark Crislip
Link
Stein: When we just saw that man, I think it was Mr. [PZ] Myers, talking about how great scientists were, I was thinking to myself the last time any of my relatives saw scientists telling them what to do they were telling them to go to the showers to get gassed.Stein (speaking about the Holocaust): …that was horrifying beyond words, and that’s where science — in my opinion, this is just an opinion — that’s where science leads you.]
Crouch: That’s right.
Stein: … Love of God and compassion and empathy leads you to a very glorious place, and science leads you to killing people.
I am a full time Infectious Disease physician. In the short hand of the medical field, I am an ID doc. Recently, saying I do ID is kind of like having last name like Himmler. No relation, but a vague discomfiture that I might be misrecognized as something else.
My ID, the real ID, along with medicine, is a branch of science (I always hear Mangus Pyke in the Thomas Dolby song when I type the word) with a long history, of, well, saving lives. Lots of lives. Millions and millions of lives. And relieving suffering. The simplest of things have been responsible for the long and reasonably healthy lives we get to have here in the industrialized world.
The Science-Based Medicine Blog deals with what Merlin Mann refers to as first world problems. The fine points of botanicals and prostatism or whether the placebo effect is the cause of the response to acupuncture. Interesting though these topics can be to some, when it comes to the overall health of most of us in the first world the main triumphs of science (Or is Ducks Breath I hear? “I have a masters degree in Science”) occurred over a century or two ago. The science of 200 years ago, by the standards of today, was simple, with simple results, but lead to remarkable advances in longevity and health.
Simple interventions. I always say the three reasons we get to live to be a burden on our children are clean water, good nutrition, vaccines, and antibiotics. And no one expects the Spanish Inquisition. Whether it was 400 years ago or this year, the application of science has saved lives and relieved suffering, or, at least, help us understand, sometimes imperfectly, how best to live a healthy life. And in the future our best chance to survive is through science.
Clean Water
Cholera. Due to the organism Vibrio cholera. It makes a toxin that causes a massive diarrhea. I still doubt the veracity of proponents of transcendental meditation who claim they can levitate. However, that may be possible with the severe diarrhea of cholera. Patients can lose a liter of water an hour and rapidly die of dehydration. Historical mortality rates have been enormous.
Examples of mortality from cholera (From Wikipedia) :
* 1829-1851 – Second cholera pandemic reached Europe, London and Paris in 1832. In London, the disease claimed 6,536 victims; in Paris, 20,000 succumbed (out of a population of 650,000) with about 100,000 deaths in all of France.
* 1849 – Second major outbreak in Paris. In London, it was the worst outbreak in the city’s history, claiming 14,137 lives, over twice as many as the 1832 c outbreak. In 1849 cholera claimed 5,308 lives in the port city of Liverpool, England, and 1,834 in Hull, England.
Cholera spread throughout the Mississippi river system killing over 4,500 in St. Louis, and over 3,000 in New Orleans as well as thousands in New York.
* 1852-1860 – Third cholera pandemic mainly affected Russia, with over a million deaths. In 1853-4, London’s epidemic claimed 10,738 lives.
* 1854 – Outbreak of cholera in Chicago took the lives of 5.5% of the population (about 3,500 people).[19] The Soho outbreak in London ended after removal of the handle of the Broad Street pump by a committee instigated to action by John Snow.[21]
* 1866 – Outbreak in North America. In London, a localized epidemic in the East End claimed 5,596 lives just as London was completing its major sewage and water treatment systems–the East End was not quite complete.
* 1881-1896 – Fifth cholera pandemic ; The 1892 outbreak in Hamburg, Germany was the only major European outbreak; about 8,600 people died in Hamburg
* 1899-1923 – Sixth cholera pandemic had little effect in Europe because of advances in public health, but major Russian cities were particularly hard hit by cholera deaths.
* January 1991 to September 1994 – Outbreak in South America. Beginning in Peru there were 1.04 million identified cases and almost 10,000 deaths.
This small slice of Cholera deaths adds up to 173,749 deaths. Thats only a few cities over a short period of time. Millions have died in Russia, India and China over the centuries from the disease, whose death rates were 25 to 50%.
Cholera is rarely seen in the industrialized world, and mortality rates from the disease are 2-3% with simple, optimized rehydration therapy. Therapy, by the way, that was identified by scientists (5).
Why has cholera faded in much of the world?
“Love of God and compassion and empathy.” I don’t think so. Could it have been………..science (Imagine Church Lady here)?
The science of epidemiology we use today to investigate and identify the cause of Infectious Disease outbreaks started with the Cholera epidemic in London in 1854.
John Snow was a physician who thought that cholera was spread by contaminated water, rather than the by the inhalation of poisonous vapors, the accepted medical opinion of the time. During the outbreak he took the simple (to us) expedient of plotting the deaths from cholera based on where the patients lived. The closer they were to a water pump, the higher the death rates. So what did they do? Offer ” love of God and compassion and empathy?” Nope. They did what I believe is referred to as a scientific experiment. They took off the pump handle and the death rates from cholera fell dramatically. Remember, this was before bacteria were known. Even without knowing about the Vibrio bacillus, the power of the scientific method allowed people to understand disease transmission, make an intervention, and prevent people from dying.
Dr. Snow’s map.
It was the beginning of epidemiology. Applying and expanding the concepts started by Dr. Snow has saved countless lives. Pick a disease. How do we know how it is spread and how to stop the spread? The science of epidemiology. Infections have a wide variety mechanisms of spread: Coughing, sex, mosquito bites, direct contact, blood. Who knows what infection you would get if you did all the above at once. It has been the science of careful epidemiology that has identified the source of these infections and allowed us to break the chain of transmission.
New sources and mechanisms of spread are discovered yearly. There was a recent outbreak investigated by the CDC of norovirus in an elementary school where disease transmission was traced in part to contaminated keyboards and computer mice (6).
When a new epidemic hits, be it avian flu or something unexpected, it will be the science of epidemiology and scientists that will decrease the morbidity and mortality of the disease. It will be science that will be saving lives.
Unfortunately, 1/3 of people still have no access to clean drinking water and an estimated 2 to 5 million people die every year from drinking contaminated water (WHO estimates). At the low estimate, that’s six people every minute. Next time you turn on your tap for a glass of water, say a toast to Dr. Snow for the safe water.
Diet
In the US the problem is excessive nutrition. Occasionally, in the alcoholic, nutritional deficiency is an issue, but in my hospital too much rather than too few calories is the issue.
Good nutrition is important for health, and eating a balanced diet can ensure we get sufficient vitamins to stay healthy. How do we know what vitamins we need? The “Love of God and compassion…………..” I know, I know. I’ll stop. I am sure you get the point.
Vitamin C deficiency leads to scurvy, an unpleasant disease with an unpleasant death. Vitamin C is required to make collagen. Without it you cannot make your supporting tissues and there would be nothing to augment your lips. Your soft tissues fall apart and you bleed and painfully die.
Vitamin C is easy enough to find in the diet: fresh fruits and vegetables are the key.
Tell that to the British Navy. While out at sea conquering the world and making sure the sun never set, their sailors came down with scurvy. Sailing ships, in the era before food preservation, were not noted for having fresh fruits and vegetables on the menu. Think of travel in the 1700′s next time you complain about airline food.
In 1747 James Lind did a simple experiment.
“Lind thought that scurvy was due to putrefaction of the body which could be prevented by acids; that is why he chose to experiment with dietary supplements of acidic quality. In his experiment he divided twelve scorbutic sailors into six groups. They all received the same diet, and in addition group one was given a quart of cider daily, group two twenty-five drops of elixir of vitriol, group three six spoonful of vinegar, group four half a pint of seawater, group five received two oranges and one lemon and the last group a spicy paste plus a drink of barley water. The treatment of group five stopped after six days when they ran out of fruit, but by that time one sailor was fit for duty and the other had almost recovered. Apart from that, only group one also showed some effect of its treatment. (Wikipedia)”
He found out that lemons and oranges (why were the British not referred to as Lemonies or Orangies?) prevented scurvy. Like cholera, he had no understanding of the biology of scurvy, but the power of the scientific method is such that if the experiment is done right, the results can still be meaningful. It was the first randomized controlled study in history. But it started medical science down the path of increasingly complex and sophisticated clinical studies to tease out the effects of therapies on diseases.
The importance of good nutrition and vitamins is well established, the uselessness of extra therapeutic doses (aka supplements), especially when used as antioxidants, is increasingly being established.
A recent JAMA (1) looked at
“5442 women who were US health professionals aged 42 years or older, with either a history of CVD or 3 or more coronary risk factors, were enrolled in a randomized, double-blind, placebo-controlled trial to receive a combination pill containing folic acid, vitamin B6, and vitamin B12 or a matching placebo, and were treated for 7.3 years from April 1998 through July 2005.” to see if they had a reduction in cardiovascular events.
A wee bit more complicated than Lind’s study. The results?
“After 7.3 years of treatment and follow-up, a combination pill of folic acid, vitamin B6, and vitamin B12 did not reduce a combined end point of total cardiovascular events among high-risk women, despite significant homocysteine lowering.”
When used as antioxidants, these vitamins did not alter rates of stroke and heart attack, a result supported by Cochran reviews (2). So if you are taking vitamins as an antioxidant, you can stop. But do not come after my beer or chocolate, although future studies may show their uselessness as antioxidants and I will be forced to enjoy them only for the pleasure they provide.
Vaccines
Smallpox. Bad disease. And it was only a ‘’small’ pox. Like evolution is only a ‘theory’. 20-60% of people who contracted smallpox died. It has killed millions upon millions since it came into human populations around 10,000 BC.
Smallpox killed an estimated 400,000 Europeans each year during the 18th century. That’s 45 people an hour, every hour, for 100 years.
During the 20th century, it is estimated that smallpox killed 300–500 million people. That one disease killed more than twice the number of people killed in wars during the same time (7). In 1967, the World Health Organization estimated that smallpox killed two million people.
That’s just a small sample of the mortality from small pox, from times and places where the data has been available. In most places, through most of of time, millions died unknown and unregistered.
Smallpox is almost gone now, existing in few freezers and, given that we know the genome, can be reconstructed anytime. I guess those scientists may kill us all in the future after all.
We don’t have smallpox because of vaccines.
It started with the simple experiment by Jenner in 1796. He noted that people who developed cowpox did not get smallpox. So he took the fluid from the lesion of a milkmaid with cowpox and infected the most courageous man in history, a farmer named Phipps, who developed cowpox. Then a few weeks later he repeated the process with smallpox. Jenner must have been one convincing talker to get Mr. Phipps to take the smallpox. Jenner later went into multilevel marketing and Farmer Phipps did not get smallpox.
At one time I would have said that this study would not have passed an Institutional Review Board as ethical, but after reading the blog entries here on the Gonzales pancreatic cancer trial at Columbia University, I bet it could have been done at Columbia as long as it was funded by NCCAM.
The number of vaccines keep on growing and continue to decrease morbidity and mortality from communicable illnesses. There are many factors that contribute to spread and deaths from infection, like good nutrition and good hygiene. But do not underestimate the benefit of vaccines. A recent JAMA looked at the effects of vaccines on mortality and morbidity in the US
“…before and after widespread implementation of national vaccine recommendations for 13 vaccine-preventable diseases for which recommendations were in place prior to 2005. A greater than 92% decline in cases and a 99% or greater decline in deaths due to diseases prevented by vaccines recommended before 1980 were shown for diphtheria, mumps, pertussis, and tetanus. Endemic transmission of poliovirus and measles and rubella viruses has been eliminated in the United States; smallpox has been eradicated worldwide. Declines were 80% or greater for cases and deaths of most vaccine-preventable diseases targeted since 1980 including hepatitis A, acute hepatitis B, Hib, and varicella. Declines in cases and deaths of invasive S pneumoniae were 34% and 25%, respectively. (3)”
A. Maze. Ing.
It is incomprehensible the number of people who have gone on to live long lives thanks to vaccines. The most recent vaccine is the HPV, which will prevent death from cervical and throat cancer.
If the past predicts the future, and in infectious diseases it often does, if we cannot eradicate a disease it will return. There will be anther influenza pandemic like 1918 -1919 that killed about 6% of the world, about 10x what were killed in the trenches of WWI in 4 years.
And when it comes our best hope for preventing disease will be an effective vaccine.
Clean water. Good nutrition. Vaccines.
A few of the benefits that science has given us that will allow most of us to grow old enough to be screwed by Medicare.
As an aside, it should be noted that these basic foundations of science-based medicine were simple experiments. If you look over the history of science, all the basic studies that set the fields in motion were simple, but well done, studies that can easily be reproduced by high school or grade school students. Or even 10 year olds.
Simple experiments. After all the millions sent down the rathole of alternative medicine by the NCCAM, there has yet to be a single, clear cut study that demonstrates the plausibility of the science behind their interventions or a single clear cut study to show efficacy.
However a 10 year old, with a simple study, can show that the underlying premise of Therapeutic Touch, that human energy fields can be felt and manipulated, is nonsense (4). Maybe the NACCM needs some smart 10 year olds to devise some simple experiments for them.
So when I hear Ben Stein, a Columbia (Hmmmm. Columbia again. Is a pattern emerging?) educated lawyer, I think, no way is he that stupid. No one can be that willfully ignorant.
Then it hit me when I read “http://scienceblogs.com/evolutionblog/2008/05/what_i_really_think.php”
It’s obvious. Stein is doing performance art. It’s a put on. He is pulling a Borat. He is the Sacha Baron Cohen of the Intelligent Design crowd.
It is the ONLY possible explanation.
You wait. Someday the truth will be known about Ben Stein and we will all laugh at being taken in by his elaborate hoax.
References
(1) Effect of Folic Acid and B Vitamins on Risk of Cardiovascular Events and Total Mortality Among Women at High Risk for Cardiovascular Disease: A Randomized Trial. Christine M. Albert; Nancy R. Cook; J. Michael Gaziano; Elaine Zaharris; Jean MacFadyen; Eleanor Danielson; Julie E. Buring; JoAnn E. MansonJAMA. 2008;299(17):2027-2036.
(2) Bjelakovic G, Nikolova D, Gluud LL, Simonetti RG, Gluud C. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database of Systematic Reviews 2008, Issue 2. Art. No.: CD007176. DOI: 10.1002/14651858.CD007176
(3) Historical Comparisons of Morbidity and Mortality for Vaccine-Preventable Diseases in the United StatesSandra W. Roush, MT, MPH; Trudy V. Murphy, MD; and the Vaccine-Preventable Disease Table Working GroupJAMA. 2007;298(18):2155-2163.
(4) A Close Look at Therapeutic Touch. Linda Rosa, BSN, RN; Emily Rosa; Larry Sarner; Stephen Barrett, MD. JAMA. 1998;279:1005-1010.
(5) Amylase-Resistant Starch plus Oral Rehydration Solution for Cholera NEJ, Volume 342:308-313 February 3, 2000 Number 5
(6) Norovirus Outbreak in an Elementary School — District of Columbia, February 2007. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5651a2.htm
Deaths from war are subject to wide variations. My source: http://users.erols.com/mwhite28/warstat8.htm

No, Everything You Thought You Knew About Disease Is Not Wrong
The authors of this book are not doctors or scientists, but they try to convince readers that science-based medicine gets it all wrong, that germs don’t cause disease, and that drugs and vaccines can’t possibly work. No, the book gets it all wrong.
Harriet Hall on June 2, 2020
Link

The book What Really Makes You Ill?: Why Everything You Thought You Knew About Disease Is Wrong, by Dawn Lester and David Parker has been featured on conspiracy podcasts and shows like Crrow777 and it’s getting a lot of attention. I’ve always been willing to follow the evidence and admit I was wrong about something; and if everything I thought I knew about disease was wrong, I needed to correct my errors, so I struggled through the whole 1,030 pages. I’m willing to follow the evidence, but this book contained no actual evidence for me to follow. It failed to convince me that science-based medicine is wrong.
Unequaled chutzpah
The authors have no background in science or medicine. Their backgrounds are in accountancy and electrical engineering. They say those fields require an aptitude for logic, and they claim that their freedom from the dogma and biases of “medical science” (the quotation marks are theirs) enabled them to follow the evidence with open minds. What chutzpah! Their minds must have been so open that their brains fell out. Instead of asking what was true, they started with a preconceived belief that they already “knew” the truth. Their “research” was classic confirmation bias: they simply located everything they could find that questioned the dominant paradigm. They were “enabled” to mistake opinion for evidence, to cherry pick from the writings of quacks and other questionable sources, to make obvious errors of fact and logic, and to reach conclusions no reasonable person could agree with. They say, “Unthinking respect for authority is the greatest enemy of truth,” but they demonstrate an unquestioning respect for people who are not authorities.
Their starting point was their belief that germ theory is a myth. Yes, they are germ theory denialists. They say the germ theory remains unproven and there is overwhelming evidence that it is a fallacy. They say no original scientific evidence definitively proves that any “germ” causes any specific disease: no so-called infectious organism has ever met Koch’s stringent postulates, the four criteria needed to prove a causative relationship between a microbe and a disease. They claim that toxins in our environment and in our food are what really makes us ill. They even deny that specific diseases exist.
They say Paracelsus’ idea that the dose makes the poison was wrong. Since we know that very tiny amounts of hormones produce effects in the human body, they assume that infinitesimal amounts of any substance must have toxic effects, and when people are exposed to multiple natural toxins and manmade products, the effects must add up. They are chemophobes, assuming that every chemical is a poison to be avoided. They believe Multiple Chemical Sensitivity is a real disease.
They say the claim that everything is made of chemicals is misleading, because matter is also electrical in nature. They believe all electromagnetic fields are harmful, whether from cell phones or home appliances. They believe EMF causes cancer. They believe EMF hypersensitivity is a real disease. They don’t mention any of the scientific studies showing that the symptoms are due to the nocebo effect.
They say no virus causes any disease. They say all medicines, in any dose, are poisons, as are all vaccines.
They quote Stephen Sinatra, one of the authors of the book Earthing, which I reviewed unfavorably for Skeptic magazine : “Emerging science reveals that direct contact with the ground allows you to receive an energy infusion.” No, it doesn’t!
They repeatedly cite Death by Modern Medicine by Carolyn Dean, the MD and ND whose book on magnesium I reviewed last week. They accept everything she says as gospel truth, even though she was declared unfit to practice medicine and was stripped of her license.
They believe Fereydoon Batmanghelidj’s pronouncements on water. I don’t: see my SBM article.
They complain that drugs have not been tested in combination with each of the other drugs a patient might conceivably be taking. As I said in a previous article, that’s impossible. The number of studies needed would far exceed the number of people in the world.
A few of their many errors
They say neutrons have positive and negative charges which balance each other. Wrong! Neutrons have no charge.
In their discussion of drug testing, they say Phase III clinical trials are done on normal, asymptomatic subjects. Wrong! In both Phase II and Phase III trials they test patients who have the disease the drug is intended to treat.
They say virtually all the kids responsible for school shootings were on SSRI medications; they weren’t.
They say fully half of prescription drugs are pulled from the market due to side effects. That’s false. The FDA says only 3 out of the 222 drugs they approved between 2001 and 2010 were later withdrawn from the market.
They say the active ingredient in aspirin is salicylic acid. It isn’t. It’s acetylsalicylic acid.
They adopt the strategies of evolution denialists
People who argue against evolution seem to think if they can identify a single missing link, that will disprove the whole edifice of evolution. Or if they can find two scientists whose words seem to contradict each other. Or if there is any legitimate controversy about some tiny detail. Both the Theory of Evolution and Germ Theory are correctly called “theories” in the strict scientific sense, because they comprehensively explain all the pertinent facts, they are supported by overwhelming evidence, and they are so well established that no new evidence is likely to alter them. Rejecting a scientific theory requires denial and perversity, traits Lester and Parker demonstrate in abundance.
They point out that medical explanations for diseases “contain many anomalies, inconsistencies, and contradictions and present a number of aspects that remain poorly understood.” They have assiduously accumulated statements from anywhere and everywhere that they perceive as questioning the dominant paradigm. They crow about things like the WHO fact sheet that says, “The fundamental causes of asthma are not completely understood.” They quote the CDC: “Experts don’t know the cause of many forms of arthritis.”
As if statements like that disproved the Germ Theory!
Anti-vax arguments
They oppose vaccination. Of course they do. They repeat most of the usual anti-vax arguments and misinformation, but they go even further. They say vaccines can’t possibly work because they’re based on a false theory. They say, “It is clear from this discussion that no disease is caused by a virus.” They seem to think a “discussion” of opinions, rather than science, is the way to determine the truth.
Where’s the evidence?
They don’t trust science because they think it has been corrupted by vested interests. They believe patient anecdotes about alleged adverse effects of statins, rather than the evidence of controlled studies. They claim that Andrew Wakefield and others who have dared to question mainstream ideas were unfairly persecuted.
Here’s an example of what constitutes “evidence” in their world. They say that in her 1957 book The Poisoned Needle Eleanor McBean quoted a Dr. Laurie as saying “I am thoroughly convinced that the increase in cancer is due to vaccination.” A random person’s unsubstantiated opinion. How can they imagine this would mean more to us than all the scientific studies? Occasionally they do mention a controlled clinical study, but they ignore all the other studies that got the opposite results.
They claim to have expertise in logic, but their words demonstrate logical fallacies and false dichotomies. Their defective reasoning produces non-sequiturs like “Phosphorus is a proven neurotoxin. It should be noted that the definition of polio includes references to effects on the central nervous system.” (Yes, so what?)
I previously mentioned their acceptance of Carolyn Dean and Fereydoon Batmanghelidj. They also quote Peter Duesberg, an AIDS denialist. They think Florence Nightingale’s casual observations in the Crimea were evidence that one disease could morph into another. They quote John Tilden, a “drugless doctor” who died in1941, who claimed “Measles is the manner in which a child’s body throws off toxemia.” They cite the infamous Gary Null, who is notoriously hostile to evidence-based medicine; Dr. Robert Mendelsohn, whose book Confessions of a Medical Heretic calls bottle-feeding of babies “the granddaddy of all junk food;” Devra Davis, who opposes cell phones and has been accused of doing “junk science;” and many others whose names will be familiar to readers of SBM, such as Vandana Shiva, Betty Martini, Stephen Sinatra, T. Colin Campbell, Viera Scheibner, Joel Fuhrman, and many others. Nowhere do they mention real experts like Siddhartha Muherjee, the author of The Emperor of All Maladies, who could have readily corrected most of their misinformed ideas about cancer.
They call Pasteur a plagiarist and imposter who deliberately deceived the public. They say Semmelweis was wrong: the unsanitary surgeons didn’t transmit germs to their patients but poisoned them with “noxious matter” from autopsies.
Questionable opinions
The book is full of questionable opinions not backed up by evidence. Here is just a sampling of them:
    • Malaria is caused by unhealthy living conditions, not by Plasmodium.
    • “Antibiotics should never be used.”
    • Gulf War Syndrome was proven to be caused by chemical exposures and vaccine overload.
    • Diseases are not transmissible between people.
    • The Black Death was caused by toxic chemicals in comet debris.
    • “There are no separate and distinct disease entities with distinct causes.”
    • Humans are not natural omnivores.
    • Neurosyphilis was actually mercury poisoning.
    • “Pharmaceutical drugs can neither prevent nor alleviate disease.” (What about insulin?)
    • They address 5G, fracking, phthalates, bisphenol A, and fluoride, blaming them for causing illness.
    • Their rant on animal experimentation covers all the usual points but adds germ theory denial.
    • They question climate change and believe chemtrail conspiracies,
    • “No infection can cause a birth defect.”
Conclusion: Wrong, wrong, wrong!
This book is wrong, wrong, wrong! They don’t seem to understand science, how it works, and why it is so important. They rely on opinions rather than on evidence. If you don’t think “some random scientist reportedly said” is evidence, if you value science, this book is not for you.

   The Marshall Protocol
Mark Crislip
Link
While there are many taxonomies of alternative medicines, one thing almost all alternative therapies have in common is they are originally the de novo discovery of one lone individual. Working outside of the mainstream, they are the gadflies who see farther because those around them are midgets.
Hanneman conceives of homeopathy, the treatment of all disease.
Palmer conceives the cause of all disease and its treatment in chiropractic
Mikao Usui, while having a mid-life crisis, conceives Reiki.
Virgin births all. These pioneers boldly go where no man has gone before.
Others have been less acclaimed after seeking out new life. An example is Virginia Livingston, MD, the discoverer of the cause of all cancer (1). She discovered a bacterium, the cause of cancer, she called Progenitor cryptocides, which, unfortunately only she could grow. Her therapies include an autogenous ‘vaccine” made from your own urine, which will probably preclude widespread use even in alternative therapies circles. I wonder if Jenny would object to vaccines if there were naturally derived from the patients urine?
Discovering a new form of pathogenic microbiology that no one else can see or grow is not uncommon, since people seem to be unable to recognise artifact on slides, be it Oscillococcinum being seen by Joseph Roy 200 years ago or Virginia Livingston in the 1960’s. Sometimes I regret the discovery of H. pylori as a cause of gastritis as it gives the alternative microbiologists a medical Galileo to point at. H. pylori is used as an example, erroneously, of a bacteria causing disease that was laughed at by the medical establishment (Parenthetically, as my flawed memory has it, while I was an Infectious Disease Fellow the data for H. pylori came trickling in. I remember discussing the papers with one of my attendings who was an expert in GI infections. We all thought is was an interesting hypothesis and waited further data with interest. I cannot remember anyone dismissing the idea out of hand with derisive laughter. But then, I remain convinced that infections are the cause of all disease, at least the diseases that matter).
A letter from a reader lead me another lone reseacher who has discovered the cause and treatment of many, if not all, diseases. So may I introduce to you, Trevor Marshall, the developer of the Marshall Protocol. (As I have said many time, I want something in medicine named after me, and it is not the glove breaking during an exam. “Damn, I just had a Crislip. I need to go and clean my nails.” If Swan or Groshong can get some silly little catheter named after them, well, I should be good for some eponym). You have not heard of Trevor Marshall? Often the fate of originality is to languish in obscurity.
The Marshall Protocol has all the characteristics of modern alternative therapy: a single discoverer, a hitherto undiscovered biology, an unproven therapeutic intervention and one of the most aggravating issues in alternative medicines: Taking a scientific truth the size of a molehill and transmogrifying it into a Cascade Range of exaggerated disease etiology and treatment. Unlike most alternaive proponents, however, as best as I can tell Dr Marshall does not seem to be in the business of making a business from his discovery, although he does have patent applications for his protocol.
Dr Marshall is a PhD in electrical engineering and was diagnosed years ago with sarcoidosis. It was his diagnosis with what is often a fatal disease that lead to his insights into diseases. One cannot help but think of Linus Pauling and his vitamin C epiphany after almost dying of kidney failure. Staring into the eyes of your own mortality almost always leads to personal epiphanies. Most people learn to appreciate the little things in life they had hitherto ignored. Others aim higher.
Sarcoid is an interesting disease whose etiology is unknown but is characterized by non-caseating granulomas. Granulomas are an immunologic response to infections, often fungal or mycobacterial, and I will not be surprised if some day an infectious cause of sarcoid is discovered. Same, I will bet, for Crohns, another disease of uncertain origin that has granulomas. For as of today, no definite infection has been found to cause sarcoid or Crohns.
However, Dr. Marshall was intrigued by studies that demonstrated Rickettsia DNA in two patients with sarcoid and by the fact that his disease was worsened by sunlight. He then developed an hypothesis, unproven, but interesting, as to the cause of many chronic illnesses. And from there he developed a protocol to treat diseases.
Marshall suggests that autoimmune diseases are due to a correctable defect in innate immunity from a dysregulation of vitamin D. This immunologic defect allows L-form (cell wall deficient) bacteria, to proliferate. In an interview he points to ‘bacteria” on electron micrographs that are living happily in white cells. How does he know they are bacteria 100 times smaller than usual? Can he grow them? No. It appears that they are bacteria because, well, they look like bacteria. To him. Not to me. But underlying all of the diseases treated by the Marshall protoall are due to colonies of
“intraphagocytic, metagenomic microbiota… The term intraphagocytic refers to the fact that these bacteria have developed the ability to remain alive and proliferate undetected inside the cytoplasm of the cells they infect. These cells include macrophages, the very cells of the immune system that the body uses to kill invading pathogens…The term metagenomic indicates that there is a tremendous number of different species of these chronic bacterial forms. Finally, the term microbiota refers to the fact that these bacteria are also hypothesized to sustain themselves by grouping into communities called biofilms. The bacteria inside a biofilm produce a protective matrix that allows them to more effectively evade the immune system and develop resistance to antibiotics.”
It is nice that at least they use the term hypothesis, although redundant, should also include the adjectives untested and unproven.
He refers to these infections as TH-1 infections, “after T-helper Type 1 (Th1) immune response. The T-helper Type 1 (Th1) immune response is usually defined as one which generates significant quantities of the cytokine Interferon-gamma (3).” The Th1 is the humoral immune system, Th2 is the B cell, or antibody wing of the immune system. Many infections are attacked with both Th1 and Th2 and to call pathogens Th1 is false dichotomy and a term only used by Dr. Marshall et. al. It does sound nice and sciency, although no one in the closed minded field of infectious diseases has ever used the term Th-1 infections around me that I can remember.
These bacteria then interfere with the vitamin D receptor to shut down the immunologic modulation of vitamin D.
“Recent molecular modeling research (which has been confirmed by a large amount of clinical data) has shown that levels of 25-D over 20 ng/ml can bind and inactivate the VDR, which subsequently shuts down the innate immune system. Certain species of bacteria also produce substances that can bind and inactivate the VDR in a manner similar to 25-D. Consequently, people who are infected with the Th1 pathogens and consuming vitamin D are no longer able to produce the AMPs or turn on the innate immune response. This allows their bacteria to proliferate and spread. (5)”
Bacteria and Vitamin D act together to shut down the immune system and the bacteria take off.
Vitamin D is an important immunomodulator and a pubmed search will reveal an a growing and interesting literature that vitamin D deficiency, increases, note increases, the risk of a variety of infections. There is a concomitant SCAM literature to suggest that all you need to treat influenza and other infections is to increase your vitamin D intake. As found in the Weekly World er, I mean, the Natural News, taking vitamin D helps treat or prevents cancer, stroke, psoriasis, schizophrenia, and depression (8). Who are you gonna believe? One (or both) of these approaches should be wrong, although I suppose that influenza is a Th-2 pathogen and as such doesn’t count.
From this untested hypothesis, there is a therapy.
1) Kill the bacteria with long term (years) of antibiotics like doxycycline like minocycline. This is to eradicate the supposed L forms found in the granuloma. Unfortunately, the L forms, or even pathogens, have not yet been discovered in most of the diseases treated by the Marshall Protocol. And when bacteria have been found in rheumatoid arthritis or sarcoidosis, the studies have not been replicated, which is most annoying.
2) Use of angiotensin receptor antagonists. They recommend olmesartan which is said to be able able to bind to and activate the vitamin d receptor and block vitamin D effects.
This has never been shown to occur either in the test tube or in humans or animals. The data to support this, and please read it slowly so it sinks in, is based on a computer model (3). Computer simulations, not experiments. As the FDA has said “The FDA-approved prescribing information for Valsartan states “Valsartan does not bind to or block other hormone receptors or ion channels known to be important in cardiovascular regulation (3).” Again, as a closed minded arrogant tool of the medical industrial complex, I worry about going straight from computer models to treating patients. Wouldn’t do it with an airplane, wouldn’t do it with a medication.
3) Avoid vitamin D. This is interesting. Vitamin D does more than build strong bones and has wide ranging effects on immune regulation. Given the growing literature demonstrating the a deficiency of vitamin D increases risks for a variety of infections, from viral to tuberculosis, I am uncertain of the wisdom of suggesting this intervention without supporting clinical trials. I would worry more if there is a history of osteoporosis in the family.
Some collagen vascular diseases, like lupus, worsen as vitamin d levels decline. Multiple sclerosis is improved with vitamin D. A recent review suggests “Epidemiological evidence indicates a significant association between vitamin D deficiency and an increased incidence of several autoimmune diseases (4).”
Sarcoid has dysregulation of vitamin D with increased levels in the blood, the vitamin D being made in the granulomas. Maybe avoiding vitamin D in sarcoid is not completely without reason, but I would not extrapolate to other diseases that have nothing in common except for unproven Th-1 pathogens.
Generally speaking the problem for patients, especially in the northern latitudes, are diseases made worse by vitamin D deficiencies.
What diseases are treated with this protocol?
“Th1 inflammatory diseases and symptoms currently being treated with the Marshall Protocol include:
ALS (Lou Gehrig’s), Ankylosing Spondylitis, Asperger’s, Back pain, Barrett’s esophagus, Bipolar disorder, Candidiasis, Cardiac Arrythmia, Celiac disease, CFS / CFIDS / ME, Chronic Lyme/Borreliosis, Crohn’s Disease, Diabetes insipidus, Diabetes type I, Diabetes type II, Dementia, Depression, Epilepsy, FM (Fibromyalgia), Gastroesophageal reflux disease, Hashimoto’s Thyroiditis, IBS (Irritable Bowel Syndrome), Interstitial cystitis (IC), Inflammatory bowel disease, Irritable bowel syndrome, Kidney stones, Lofgren’s syndrome, Lupus In ‘Overlap’ With Other Connective Tissue Diseases, Mania, MCS (Multiple Chemical Sensitivity), Migraine headache, Morgellon’s, Multiple Sclerosis, Myasthenia gravis, Neuropathy, OCD(Obsessive Compulsive Disorder), Osteoarthritis, Panic attacks, Parkinsons, Pervasive Developmental Disorders- Not Otherwise Specified, POTS (Postural Orthostatic Tachycardia Syndrome), Prostatitis, Psoriasis, Psoriatic arthritis, Raynaud’s syndrome/phenomenon, Reactive Arthritis (Reiter Syndrome), Restless leg syndrome, RSD (Reflex Sympathetic Dystrophy), Rheumatoid Arthritis, Sarcoidosis, Scleroderma, Sinusitis, Seasonal affective disease (SAD), Sjogren’s, Ulcerative colitis, Uveitis, Vertigo , Other Th1 diseases which should respond to the Marshall Protocol: Alzheimer’s, Anorexia Nervosa, Bulbous pemphigus, Cystic fibrosis, Macular degeneration, Polymyalgia rhuematica, Polymyositis, Schizophrenia (5)”
That’s a good list. Back pain, mania, osteoarthritis, vertigo, and kidney stones all have the same pathogenesis and treatment. I went to medical school for what? And it is good to see a treatment for Morgellon’s.
And there may be no end to diseases that could fall to the Marshall protocoll:
“I disagree that Th1 patients each have different illnesses. I have seen no data to confirm this. Everything I see is that all the Th1 diagnoses spring from a common pathogenesis, a special adaptation of intra-phagocytic bacteria which allows them to evade phagocytosis by stimulating a Th1 response in the parasitized phagocytes.
“I personally believe that ALL the Th1 diseases result from the same bacterial pathogenesis. This belief is grounded in my understanding of how the bacteria directly drive the phagocytic biochemistry, causing the Th1 cytokine release.
“IMO, it is important for everybody to stop thinking about these Th1 syndromes as being separate and discrete diagnoses. IMO, all Th1 illness has a common pathogenesis, only the mix of symptoms varies from person to person, depending on bacterial species present, and the sequence of infection/coinfection.
“We are not all different. Th1 disease overrides ALL the issues of diet, location, exposure to pathogens, etc. (My bold) We can see that by standing back and looking at ALL the folks on the Marshall Protocol. There are more similarities than differences, and it does not help recovery to focus on perceived differences. (7)”
So what do I make of the Marshall Protocal?
Unproven. Based of hypothesis that are almost certainly not true. Potentially harmful if it induces side effects from unneeded antibiotic uses or, more worrisome, from vitamin deficiency.
Notes
(1) http://www.rense.com/general72/cancer.htm
(2) Waterhouse, J.; Perez, T.; Albert, P.; “VDR Receptor Competence Induces recovery from Chronic Autoimmune Disease.” 6th International Congress on Autoimmunity. Porto, Portugal. 2008 Sept 10-14. Retrieved 2008-12-31 from http://AutoimmunityResearch.org/transcripts/ICA2008_Transcript_TomPerez.pdf
(3) http://www.tbiomed.com/content/3/1/1#IDA0SVWF
(4) Nat Clin Pract Rheumatol. 2008 Aug;4(8):404-12. Control of autoimmune diseases by the vitamin D endocrine system.
(5) http://www.marshallprotocol.com/forum32/1263.html
(6) http://www.marshallprotocol.com/forum2/1071.html
(7) http://www.marshallprotocol.com/forum32/1263.html
(8) http://www.naturalnews.com/003069.html

Urinary Tract Infections Cause Depression. Directors Cut.*
Mark Crislip on January 24, 2014
Link
As some may know I am infectious disease doctor. Urinary tract infections (UTI) butter my bread. Figuratively speaking. There is an enormous amount known about the pathophysiology of UTI’s. It is both a common and complex problem. But for all our knowledge, chronic and recurrent UTI’s remain a vexing issue for the patient and the doctor.
One reason people develop recurrent UTI’s is not because of altered chi along meridians altered by needles stuck in the skin distant from the bladder. That would be ridiculous. I like reasoning from basic principles. Given what we know about anatomy, physiology and microbiology, how might acupuncture interfere with the development of a urinary tract infection? Would it prevent colonization with pathogenic E. coli? Prevent retrograde travel of bacteria up the urethra into the bladder? Stop E. coli from binding to uroepithelial cells? Have a bactericidal or bacteriostatic effect?
None of the above seem likely. To my mind, postulating any of the above as a potential mechanism for acupuncture as a preventative for UTI’s would be ludicrous. And spare me your Boosting the Immune System, a concept that exists as a marketing tool, not a useful therapeutic intervention. My boss used to say that many an academic career floundered on attempting to prevent and treat UTI’s using an immune system approach. With some exceptions, and there are always exceptions, recurrent UTI’s in normal humans are usually due to anatomic or microbiological anomalies.
Despite its popularity, it is clear that acupuncture is not based on reality and, like all pseudo-medicine, only has demonstrable efficacy in poorly-designed studies. Acupuncture displays the usual progression of all pseudo-medicines. Increasingly-well-done studies show decreasing effect until a study that removes all bias shows it to be no better than placebo. Which one would expect for an intervention based on fantasy. Prior plausibility (the toy boat of SBM, try saying it three times very fast) would predict that acupuncture is worthless. And that should be acupunctures, all 6 styles are an elaborate ritual with no more likelihood of efficacy than the superstitions in a Budweiser commercial.
Much to my embarrassment, Clinical Infectious Disease (CID), the flagship journal of my specialty, published “Recurrent urinary tract infections among women: comparative effectiveness of 5 prevention and management strategies using a markov chain monte carlo model.” One of the five interventions included in their analysis was acupuncture. Really. They thought a pseudo-medical intervention divorced from reality to be worthy of consideration for the prevention of UTI.
As to be expected, the study generated the usual ‘acupuncture works’ headlines, especially as the analysis suggested acupuncture was second only to antibiotics in preventing UTIs, and better than cranberry pills, estrogens, and symptomatic self-treatment.
Now we get into problems, given my non-statistical brain. What is a markov chain monte carlo model? Fortunately I have a statistician at work who was kind enough to translate statistics into Crislip, a.k.a. dumb it down.
It is a simulation. In this case they simulated 10,000 patients over a year and then summarized what happened on average for each intervention.
Each virtual patient in the model had an assigned probability per day of having a UTI, and there are probabilities for the various interventions being effective. They used an algorithm to determine whether or not a UTI occurs on a given day. That is why “Monte Carlo”: they pick outcomes at random with a certain probability. So if you sample enough virtual patients a UTI will occur roughly the correct percent of the time.
The “Markov Chain” part means that what happened in the past for the virtual patient is irrelevant, all that matters is what state they are in that ‘day’. So it’s a simplifying assumption, which makes evidently makes the simulation much easier.
It is a simulation and, like all simulations, the end results are dependent on how the initial conditions are set.
There is a table of Probability Values for Variables in Model. They have risk reduction probabilities for the interventions evaluated in the simulation:
    • Daily antibiotics/nitrofurantoin, 100 mg once daily, risk reduction 0.86
    • Acupuncture, risk reduction 0.68
    • Estrogen use, risk reduction 0.65
    • Cranberry risk reduction 0.50
I appears to me that the initial conditions are set up to show, as the accompanying editorial says, the ‘surprising’ result that acupuncture was second only to antibiotics in UTI prevention. The order of efficacy that came out of the simulation appears to parallel the order of the initial conditions. Go figure. Again, I am no statistician, correct me if I am wrong.
They derived their probability of risk reduction of 0.68 from two clinical trials. I asked my statistician how that number was derived and he said it was a mystery as he could not tell from the paper and that I should email the authors. As I publish this I have not heard back from the author, who said a week ago they would get back to me. When they do, I will post an addendum.
I would have expected the risk reduction probability of acupuncture to be zero, since there is zero prior plausibility acupuncture would work. It made me curious about the articles that demonstrated efficacy. Both were done by the same authors in Sweden. As we learned from Benveniste and homeopathy studies, the same group doing a study does not a reproduction make.
The most recent study, “Acupuncture Treatment in the Prevention of Uncomplicated Recurrent Lower Urinary Tract Infections in Adult Women”, did not have a sham acupuncture group, so the study is worthless. Equally important is the patients were only followed for 6 months, probably not long enough to decrease normal variability of recurrent UTI’s. What is the natural history of uncomplicated urinary tract infections in women (bold added)?
we observed 51 infection-prone women in a standardized fashion for a median of 9 years. During intervals when patients were not receiving antimicrobial prophylaxis, infections occurred at an average rate of 2.6 per patient-year, but the rate varied widely from patient to patient (range 0.3-7.6 episodes per year). Seventy-three percent of the observed episodes were symptomatic, with an 18:1 ratio of cystitis to pyelonephritis episodes. Infectious episodes were strikingly clustered, and rates of infection decreased in the winter months.
Their microbiologic definition of UTI is probably outdated and would fail to diagnose many UTI’s:
bacteriuria (10^5 or more colony-forming units per milliliter of uropathogen or any amount of Staphylococcus saprophyticus).
As a recent NEJM study, “Voided Midstream Urine Culture and Acute Cystitis in Premenopausal Women”, suggests 10^2 CFU of E. coli is predictive of UTI.
And with a p value of 0.08, it is far from the .005 that would be suggestive.
An earlier study, “Acupuncture in the prophylaxis of recurrent lower urinary tract infection in adult women”, has the same fatal flaws they were to repeat later: inadequate duration of follow up, an inadequate microbiologic definition of UTI (although of course they could not have known), poor statistical validity and very small numbers in each arm of the study (acupuncture (27), sham acupuncture (26), and control (14)).
There was no microbiologic information in the latest study, but the early study reported 5 patients with enterococcus as the pathogen, with the NEJM article suggesting that enterococcus is not a pathogen in this population.
In the latest study no mention was made as to what mechanisms was used to get follow up, in the earlier study it was patient initiated. We have no way of knowing, given the self-limited nature of cystitis, if patients became symptomatic and did not bother to come in or sought care elsewhere.
And, importantly in the first study, no mention was made as to whether blinding to sham or real (as if there is a difference) acupuncture was successful, which the authors recognize was a flaw with plenty of opportunity for the clever Hans effect (unconscious cuing):
The study otherwise mainly applied a single-blind design, since patients were not informed about the type of treatment they were receiving. It is however difficult to ensure that there was no non-verbal communication about treatment type between the acupuncturist and the patient, and patients receiving real acupuncture may have felt an increased anticipation of an effect.
Two profoundly flawed studies from which no valid conclusions can be made about the efficacy of acupuncture, much less an estimated acupuncture risk reduction of 0.68. There was a recent review of UTI prevention in the Journal of Urology with the same conclusion:
Cranberries decreased urinary tract infection recurrence (2 trials, sample size 250, Jadad score 4, RR 0.53, 95% CI 0.33-0.83) as did acupuncture (2 open label trials, sample size 165, Jadad score 2, RR 0.48, 95% CI 0.29-0.79)
This is a classic example of the difference between evidence and science-based medicine. There is evidence for acupuncture that stinks on ice if anyone would take a moment to read the articles. A science-based consideration of reality, anatomy, physiology, microbiology would suggest that any real risk reduction by acupuncture should be zero. Prior plausibility would suggest any positive outcome in an acupuncture study would be a false positive due to methodologic errors in the study. As we have discussed at great length over the years, there is zero reason to suspect any true efficacy of acupuncture beyond study bias and poor methodologies, which were rife in these studies.
That being said, the authors say:
Somewhat surprisingly, we found that acupuncture was the next most effective prevention method. Acupuncture’s high efficacy may be a function of publication bias, as there were fewer studies on acupuncture compared to other management
No. Acupuncture’s high efficacy was a function of profoundly horrible studies and an estimation of risk reduction that is too large by 0.68. No one involved gives the appearance of having read the original papers to see if the estimated risk reduction is reasonable. The editors and reviewing peers evidently did not as well.
It is an oddity of medicine. I would wager that astronomy journals do not publish editorials touting astrology as a solution for difficult problems. Similarly, psychology journals do not look to psi and chemistry journals do not advocate the methods of alchemy. In medicine, the editors have no problem with suggesting nonsense on the basis of GIGO in their journal. The accompanying CID editorial says:
For example, in an individual case, a clinician and patient working together may opt to use acupuncture in combination with cranberry juice and self- directed therapy at the first sign of symptoms.
Did the editorial writer read the paper? The simulation evaluated cranberry pills, not juice. Goodness gracious great balls of fire, an editorial in CID recommending two simultaneous worthless therapies, acupuncture and cranberry juice. I would so love to have the editors and authors come up with a plausible explanation for how acupuncture may work for UTI prevention and why this simulation had any validity as to the efficacy of acupuncture after reading the original papers. I did not go back and read the papers touting cranberry pills, but my father taught me to judge a risk reduction by the company it keeps.
I used to have a slightly smug attitude about CID since it had been the only journal I regularly read that had not published an article erroneously promoting pseudo-medicine based on bad studies. No longer. And to add salt to the wounds, it comes out of the institution where I did my fellowship. When ID falls for pseudo-medicine (because we are the best and brightest in medicine) we are indeed doomed.
I am so bummed. I am going to have to look into treatment for reactive depression. I wonder if acupuncture would work…
——-

The Paddison Program for rheumatoid arthritis: An unproven treatment that provides only the illusion of control
Clint Paddison is an Australian comedian with a science degree who developed rheumatoid arthritis at age 31. He now claims to have controlled it with a diet he developed to alter the gut microbiome. How plausible is his story, and does his Paddison Program work? Answer: Not very and almost certainly no.
David GorskionApril 29, 2019
Tweet

If there’s one thing about blogging, day in and day out, over the course of fourteen and a half years, it’s that sometimes you get stuck for a topic. Back in my early days at my not-so-super-secret other blog, I used to be so obsessive that when that happened I’d find something—anything!—to write about, even the end result ended up being not so good. These days, I’ve mellowed considerably. If I don’t have a topic over there on a given day, I don’t sweat it and instead let the topics come to me. Unfortunately, Science-Based Medicine is different. I’m the editor; I’m scheduled every Monday. Writer’s block is not permitted. Usually it’s not a problem, as I have an idea by Friday or Saturday and my post written by Saturday night or Sunday morning, but yesterday morning arrived, and I had no idea what I was going to write about. Then I saw this:
I don't know anything about it, don't recall anyone chatting about it. Let's call some other skeptic MDs too: @gorskon @palmd @HHSkepDoc @ScienceBasedMed @SBMPediatrics Anyone know what this is about? Science based?
— Dr. mem_somerville | Wossamotta U (@mem_somerville) April 28, 2019
It was almost like firing up the Bat Signal!
Even better, the Paddison Program is a treatment that I don’t recall ever having discussed. A search of SBM and my not-so-secret-other blog turned up no mention of this treatment for rheumatoid arthritis (RA). Google searches turned up nothing but the Paddison Program website and lots of laudatory material about the program. So there it was, a dubious-sounding dietary treatment for RA that I hadn’t heard of before and about which there appeared to be very little, if any skeptical material available on the web. Perfect! Let’s take a look!
The Paddison Program
If you peruse the Paddison Program website, you’ll immediately find a number of red flags for quackery and pseudoscience. The site urges readers to “Get Fast And Dramatic Rheumatoid Arthritis Relief With A Proven Step-By-Step System That Is Recommended By Health Professionals”. The entry page for the website is festooned with little other than testimonials. Clicking on the Get The Paddison Program Now leads to a page urging:
Reverse Rheumatoid Arthritis Symptoms With The Paddison Program And Get Your Life Back.
Join over 10,000 others and have less joint pain, less swelling, more mobility and more energy with this unique program.
There’s also a video of a TEDx Talk by Clint Paddison, the inventor of the Paddison Program. (More on that later.) In addition, there are more testimonials. This time the testimonials go further, with people claiming that the Paddison Program allowed them to get off their methotrexate, sulfasalazine, prednisone, and Humira (adalimumab) for their RA, ankylosing spondylitis, etc. Even worse, there are testimonials from physicians, one of whose name I recognized, Dr. Michael Klaper. You might remember him as Penn Jillette’s water fast guru, and his big thing is to advocate vegan diets and extreme fasting as a treatment for, well, almost everything. As for the others, predictably, they ranged from “integrative medicine” doctors (e.g., Dr. Nina Malek, who’s on faculty at the University of Arizona working for Dr. Andrew Weil) to physicians pushing fad diets (Dr. John McDougall and Dr. Monica Aggarwal) to a “chiropractic neurologist” (Dr. Richard Matthews) who specializes in chronic Lyme disease and “brain fog” and appears to be heavily into unproven treatments based on the “gut microbiome.” (Watching his video was painful.)
It gets worse. The Paddison Program website also features glowing recommendations by naturopaths and other chiropractors. Meanwhile, it states:
The standard approach from Rheumatologists is to ‘hit the disease as hard as possible’ with dangerous pharmaceutical drugs that can have side effects that are as bad as the disease itself.
Whilst we must keep the inflammation as low as possible, we should also be addressing the underlying cause so as to stop the disease progression.
This is done by healing the gut (more on this below).
As if the numerous patient testimonials and recommendations by integrative medicine doctors, naturopaths, chiropractors, and purveyors of fad diets weren’t enough in the way of red flags for quackery, we’re now seeing the claim of “addressing the underlying cause” of a disease that is not the underlying cause (as you will see) and the inflammatory (if you’ll excuse the word—I couldn’t resist) characterization of how doctors do treat the disease. If you’re hearing echoes of how cancer quacks characterize cancer treatment as “cut, poison, burn,” you’re not alone. That’s the first thing I thought reading the website. I got the same vibe reading the next segment:
NSAID‘s (like Advil, Voltaren, Nurofen etc) cause digestive issues, quickly exacerbating RA. Taking these drugs usually worsens RA long term.
NSAID damage is so great that they are often accompanied by Proton Pump Inhibitors (PPI’s) which negative impact gut bacteria, cause more RA symptoms.
Clients on antibiotics for RA usually go backwards long term. I see these patients after treatment and they are some of the most difficult clients to help.
Prednisone is exceptionally bad for leaky gut, osteoporosis, vitamin D absorption and more. Long term use is both dangerous and results in worse RA symptoms.
Studies show that RA Sufferers have low levels of healthy bacteria and an overgrowth of pathogenic “unfriendly” bacteria. The more sever the bacterial overgrowth, the more severe your RA is. This bad bacteria, along with undigested food particles, can get into your bloodstream via a leaky gut. Your body sends in antibodies against these particles and creates circulating immune complexes which can get lodged in the joints triggering inflammation. Chronic acidosis, from poor dietary habits, lowers pH levels in the synovial tissue which promotes inflammation. Associated with RA sufferers is low stomach acid, resulting in undigested proteins. When undigested proteins enter the bloodstream the body can develop molecular mimicry, mistaking your own tissue’s proteins for those entering through the gut wall. Studies show that persons with RA have poor intestinal mucosal lining, often worse than that of people with intestinal disease, and some RA folks are lacking an epithelium altogether. This digestive disaster is exacerbated [sic] by low digestive enzymes, further promoting an under active, highly problematic digestive system that needs a massive overhaul.
Paddison even has a cutesy mnemonic for his program: BLAME (Bacteria, Leaky Gut, Acid, Mucosal Lining, Enzymes).
I’ll examine just what Mr. Paddison’s claims entail after I provide a brief primer on rheumatoid arthritis. Here’s his TEDx Talk video, which I will be discussing along the way:
Basically, the video above is Mr. Paddison’s story of his being diagnosed with RA, how it was treated, and how he came up with his protocol. The idea is that RA sufferers can take control of their disease through dietary interventions that alter their gut microbiota. Unfortunately, it’s the illusion of control.
Rheumatoid arthritis
Most readers of the blog probably know that rheumatoid arthritis (RA) is an autoimmune disease that primarily affects the joints. Indeed, RA is the most common type of autoimmune arthritis. It affects more than 1.3 million Americans, about 75% of whom are women. The disease most often manifests itself between the ages of 30 and 50 but can start at any age. Classic symptoms include joint stiffness that is at its worst in the morning (which Mr. Paddington had and related in his talk, as you’ll see). This is in contrast to osteoarthritis, the stiffness and pain of which are usually not more pronounced in the morning. RA often improves with movement of the joints throughout the day. It also most commonly afflicts the joints of the hands, feet, wrists, elbows, knees and ankles, and the joint effect is usually symmetrical; i.e, if one ankle is affected usually the other will be too. Although there is a familial component, with a family history of RA being able to increase the risk of RA three to five times, most patients with RA do not have a family history. (In his video, Mr. Paddington makes a big deal of his not having a family history of RA, which means, really, little or nothing, contrary to his harping on it.)
Other signs and symptoms of RA include fever, loss of energy, loss of appetite, lumps known as rheumatoid nodules that grow beneath the skin in places such as the elbow and hands. Being an autoimmune disease, RA can affect many other organs besides the joints, including:
    • Kidneys
    • Skin
    • Liver
    • Neurological
    • Eyes
    • Lungs
    • Heart
    • Salivary glands
    • Nerve tissue
    • Bone marrow
    • Blood vessels
RA is diagnosed by a combination of physical examination, radiological imaging, and blood tests. Blood tests include tests to look for specific antibodies, inflammation, and anemia. The most well-known of these is an antibody known as rheumatoid factor, which is found in about 80% of patients with RA in time, but as few as 30% when the arthritis starts. Antibodies to cyclic citrullinated peptides (anti-CCP, for short) are found in 60-70% of patients with RA. Erythrocyte sedimentation rate (ESR), a nonspecific indicator of inflammation, is often elevated as well. Some viral infections can cause symptoms that can be mistaken for RA, and false-positive blood tests can occur, so it’s important to be evaluated by a rheumatologist (which Mr. Paddington was).
RA is treated with a combination of drugs. Steroids are sometimes used initially because of their powerful nonspecific anti-inflammatory activity. The mainstay of RA treatment, though, consists of disease-modifying antirheumatic drugs, commonly abbreviated as DMARDs. Common DMARDs include methotrexate, leflunomide, hydroxychloroquine, and sulfasalazine (Azulfidine). Gold and the antibiotics minocycline, azathioprine, and cyclosporine are also DMARDs, but are rarely prescribed for RA these days because of the advent of biological agents used for more severe disease or disease refractory to DMARDs. These include abatacept (Orencia), adalimumab (Humira), anakinra (Kineret), certolizumab (Cimzia), etanercept (Enbrel), golimumab (Simponi), infliximab (Remicade), rituximab (Rituxan, MabThera), sarilumab (Kevzara), and tocilizumab (Actemra), all monoclonal antibodies against proteins involved in the inflammation of RA. Usually, ultimately a combination of drugs, including nonsteroidal anti-inflammatory drugs (NSAIDS) are used to treat and control RA.
The concept of remission is important, too, because drug-free remission in RA is possible. It could also explain much of Mr. Paddison’s story. You see, Mr. Paddison came up with his protocol because he himself suffered from RA.
The goal in treating RA is to stop the inflammation and achieve remission, even better, drug-free remission.
Clint Paddison’s story versus science
In his TEDx Talk video, Mr. Paddison provides an engaging story of his RA diagnosis, symptoms, and treatment, describing how this led him to his protocol. Annoyingly, he talks about his “discoveries”, and how they might “provide hope” to others with this crippling disease. He begins by describing how, seven years ago, at the age of 31, he woke up with swelling in his fingers. (The talk is five years ago, which means that Mr. Paddison is now 43.) This happened a few times; so he went to see his GP, who examined him, ordered some blood tests, and diagnosed him with RA, referring him to a rheumatologist.
The rheumatologist, apparently, told Mr. Paddison that the standard approach to RA is to take drugs for the rest of your life. (I noticed immediately how Mr. Paddison led with that, given that it’s a standard talking point in alternative medicine testimonials.) The drug the rheumatologist wanted to start him on methotrexate, a DMARD, but he balked, noting, as I mentioned above, that no one in his family had had RA, plus that he was a young, fit guy, a runner, and more. He also noted that he had been working as a standup comedian (great qualification!), leading him to point out that he only worked a couple of nights a week and should be able to “work it out” on his own. Obviously, you and I see deadly hubris here, but apparently Mr. Paddison did not.
I will admit that the next part of the testimonial did surprise me a bit. Mr. Paddison describes going to see every naturopath, homeopath, Chinese herbalist, acupuncturist, and massage therapist that he could and being on up to ten supplements at a time. None of it worked, and his disease had progressed alarmingly after 18 months of this. One of his elbows had such limited range of motion that he needed surgery, a synovectomy, followed by six weeks of rehabilitation, to restore range of motion. His fingers were so swollen that he couldn’t close his hands into fists. He had chest pain that sounded like pulmonary involvement (pain with every breath), in his jaw, and in many other areas of his body, including his left knee, which had swollen enormously. So, yes, the quackery didn’t work.
I felt bad for Mr. Paddison, as he was in rough shape, but hopeful because he decided to go back to his rheumatologist, who put him on methotrexate, which he took for twelve months. Unfortunately, as is often the case, the methotrexate became less effective. The other problem Mr. Paddison had was that he wanted to have children but because methotrexate is mutagenic you can’t have children while on the drug and in fact have to wait six months. This is what inspired him to come up with his treatment. He also discussed how great he had been as an undergraduate science major. Specifically, he studied physics, and bragged about all the science awards he won (1st Class honours, The Macquarie Foundation Science Prize, Australian Institute of Physics prize, NSW Branch, and Semi-Finalist for Young Australian of the Year) and his one peer-reviewed publication, joking, “If I could do all that, I should be able to kick some rheumatoid butt.” Uh, no. Physics is a very different science than biology, and the skills are not necessarily transferrable. It’s also more hubris to think that you can succeed where generations of immunologists and rheumatologists had failed. I don’t care if, as he claims, Mr. Paddington really did spend the equivalent of a second university degree “studying” RA, especially when his research was guided by books by “the only two people who had ever recovered from this disease” and did it through diet.
Mr. Paddison claims that his great insight was what he calls the “cherry incident,” where he ate a bunch of unwashed cherries, got violently ill for 24 hours, and felt much better, including his joint pain. It’s at this point where he got into all sorts of dietary woo, and related that he felt pain whenever he was full but no pain whenever he was empty. Ultimately, he ended up on a raw food diet, then reintroduced some cooked vegetables. He showed a picture of his left hand before and after, claiming there was nothing wrong with his hand in the “after” photo. I’ll admit that the “after” image looks much better, but his middle finger’s proximal interphalangeal joint still looked quite swollen to me.
Now here’s the kicker. He did this for 24 months, during which time he was still taking methotrexate. As he felt better, eventually he got off of his methotrexate. As an aside, one thing I don’t understand at this point is why the rheumatologist apparently never added another drug or switched Mr. Paddington to a biological agent if he was really doing as poorly as he described at the point right before his “cherry incident”. Something sounds a bit fishy in the story there. Normally what you do when one drug isn’t working as well any more is to add or switch to another.
In any event, let’s move on to BLAME-ing the microbiome.
BLAME the microbiome and diet!
Mr. Paddison came up with his BLAME concept based on his experience. It’s very much a “just-so” story to explain how changes in gut microbiome can lead to damage to the intestinal mucosa, which in turn can lead to “leaky gut“, which leads to antigens getting into the bloodstream undigested, which leads to their triggering autoimmunity through molecular mimicry. Similarly, decreased stomach acid contributes, as do decreases in digestive enzymes, because both contribute to proteins making it to the intestine less digested. It all sounds so reasonable, but is there any evidence?
In a word, sort of. Basically what Mr. Paddison is doing is what so many other alternative medicine and diet mavens do. He’s taking correlative data that hasn’t been firmed up and definitively shown to be part of the pathophysiology of a disease, and extrapolating wildly based on it. For instance, research has been published showing differences in gut microbiota between RA patients and normal controls associated with disease and duration. However, there doesn’t appear (yet) to be good evidence that these are not epiphenomena, that they are causative. More importantly, there isn’t a lot of evidence that dietary interventions to alter the symptoms, pathology, or clinical course of RA. In fact, there’s almost no such evidence that I could find. There’s a study here and there suggesting that specific foods or nutrients affect symptoms. Most are observational or negative. In other words, although it’s certainly possible that the gut microbiome affects RA risk and progression and that dietary manipulation might be a useful adjunct treatment, most of what we know now is preliminary and speculative. Indeed, in this recent review, the microbiome is mentioned, but not as a critical new target for intervention.
None of that, of course, stops Mr. Paddison from building a veritable empire selling his dietary intervention program for RA. He hasn’t, as far as I can tell, published anything in the peer-reviewed medical literature on his program, or verified that his intervention has any significant effect on the gut microbiome at all. All he has are anecdotes. Sure, it’s not unreasonable that decreasing stress would be good for RA symptoms. Sure, it’s possible that dietary interventions might have an effect on the disease symptoms and progression. Unfortunately, Mr. Paddison has done none of the hard work to show any of this. He thinks he has, but he hasn’t. Yet, none of this stops him from selling unproven interventions to desperate patients, even though he is not a physician.
How do I explain Mr. Paddison’s recovery, though?
RA remission: Not as uncommon as you think
The first thing that struck me about Mr. Paddison’s story is how long it was. He spent 18 months after his diagnosis pursuing quackery. He spent twelve months on methotrexate before deciding he had to try something different, and it was two years after that before he got off of his methotrexate. All told, that’s four and a half years, by my estimation, three of which he was on a DMARD, methotrexate. During that time, despite Mr. Paddison’s claims of how poorly he was doing, his rheumatologist never switched drugs, which is very odd if he really was doing so poorly on just methotrexate. Again, most RA patients require more than one DMARD; if Mr. Paddison was doing reasonably well on just methotrexate, it suggests milder disease. Of course, we don’t know why he was never switched to another drug. Maybe he refused. On the other hand, if he was so afraid of methotrexate’s effects on his sperm, you’d think that he would have jumped at the chance to try a different drug.
What I suspect is that Mr. Paddison was fortunate enough to go into remission and that his diet probably had little or nothing to do with it. Indeed, a 2017 review article states, notes that “with new treatment strategies drug-free sustained remission is becoming an achievable goal”. It also cited several studies, dating back to the 1990s, that show that drug-free remissions are not uncommon in disease that is successfully managed with DMARDs:
Once a good response on DMARDs and stable remission are achieved, the treatment could be tapered; and once remission is further sustained, the treatment could be stopped.9 Drug-free remission has been described in several patient groups which supports that drug-free remission could truly be achieved.
The approach of benefit/risk assessment of continuation or stopping DMARDs was examined as early as the 1990s in a double-blind placebo-controlled study.10 In this study, RA patients with a good long-term therapeutic response, after median duration of DMARD therapy of 5 years, were randomized to continue therapy, n = 142, or to receive placebo, n = 143. At 52 weeks of follow up, as many as 62% of the patients who were randomized to placebo and 78% of the patients who were randomized to continue therapy did not have a flare, defined as recurrence of synovitis. Side-effects that necessitated dose reduction or discontinuation occurred equally in each group.
This sounds not unlike Mr. Paddison, who was on his methotrexate three years, at which point he appeared to be in remission. Given that he reported that he wasn’t getting better on methotrexate, another possibility is that he might have undergone spontaneous remission, as described in this review:
Spontaneous remission is not uncommon in patients who present with very early arthritis, some of whom may meet criteria for RA over less than a few months. Spontaneous remission is thought of as a “natural remission,” in which disease activity essentially disappears, and medications are no longer required. Spontaneous remission may be seen in 13% to 55% of individuals presenting with undifferentiated arthritis, probably as a result of different underlying etiologies, such as a transient viral infection [32]. About one third of patients with undifferentiated arthritis go on to develop RA. In a study of three cohorts of recent-onset undifferentiated arthritis from the United Kingdom, Germany, and the Netherlands, the severity of morning stiffness and presence of autoantibodies were the strongest predictors of progression to RA [33]. Spontaneous remission can be seen not only in early undifferentiated arthritis but in RA pregnancy and juvenile idiopathic arthritis (JIA) as well.
So, what’s more likely, that Mr. Paddison cured his RA with a diet that altered his microbiome, a diet that he stumbled across through trial and error, or that he was fortunate enough to undergo remission? Barring compelling evidence, I vote for the latter, but leave open the possibility of the former, although I consider that possibility to be highly unlikely.
What Clint Paddison is really selling
Chronic disease is frustrating. Aside from the symptoms and the impact on quality of life, the patient suffering from a chronic disease like RA suffers from a loss of control. What Clint Paddison is selling, above all, is the same thing a lot of quacks sell: The illusion of control. I realized this when I came across this video:
In this video, a woman asks Paddison how she can eliminate random RA flares. Beginning at 0:45, Paddison goes on an extended discussion of why he never uses the term “flare”, because it implies something beyond the patient’s control. He defines a flare as meaning that a disease is out of our control, that it’s random, and that we can’t do anything about it. He then goes on to argue that RA is almost completely within the patient’s control and that “if we apply a consistent pattern of behavior with our foods—our exercises as well—our stress levels, and also supplementation, then we’re going to get the same outcome with our symptoms” and that “the disease responds to influences that are mostly and largely under our control.”
Holy hubris, Batman! No physician goes that far with almost any disease. Also note that the implication is that this woman is having flares because she’s not doing something right; in other words, her symptoms are her fault. It’s the common quack trope that the treatment doesn’t fail the patient, but the patient fails the treatment, and it’s despicable.
Unfortunately, for patients with a chronic disease like RA, that message of taking control is very seductive. Certainly, it’s that very idea of being able to control his disease himself, without the help of doctors, naturopaths, homeopaths, acupuncturists, etc., that led Mr. Paddison down the path to believing he had found the answer to RA when in reality his story of self-recovery due to his own treatment is dodgy at best when examined critically and his treatment is based on ideas that are speculative at best. If you’re an RA patient, run, don’t walk, from Clint Paddison. He was lucky, not good, and now, sadly, he appears to be descending into the role of charlatan. Stick with science-based treatment.

Black mold is the new Candida
How concerned should we be about mold in our homes and environment?
Scott Gavura on January 18, 2024
Link

How concerned should we be about mold in our homes and environment?
With the disintegration of Xitter, I’ve turned my social-media attention to what appears to be far more useful waste of time: Reddit. Reddit is amazing in that there’s a subreddit for every possible topic you can think of. The content is human- and not bot-generated, and the best comments rise to the top – based on reader votes. One of the subreddits that I enjoy following is called Cleaning Tips, which is pretty much exactly as described – people ask for advice on how to clean different objects, and other people comment. Some of the before and after photos are both horrifying and satisfying. One of the major concerns of the community seems to be black mold, something that everyone has likely seen but some people are truly frightened of. I thought it was just odd and didn’t think much about it until one of my regular podcast listens, Unbiased Science dedicated an entire episode to debunking fearmongering about black mold. Listening to it I learned that there’s a growing concern about black mold, fueled by social media. Google searches bear this out. The podcast made me reflect back on earlier in my pharmacy career, when just of school, I learned (acccording to my local pharmacy’s customers) that the root of all illness was just one thing: Candida, a yeast. Is black mold the new Candida?
Old School yeast fears
Concerns about Candida – yeast – seemed common over 20 years ago. Most chronic diseases could be traced back to Candida, patients informed me. And pharmacies did little to dissuade it – some even sold “Candida removal” kits. These didn’t contain antifungal drugs – most were combinations of laxative and purgatives, combined with psyllium and bentonite clay, all promising to sponge up toxins and Candida and restore health. There was a strict diet to be followed, too: No sugar, no bread – anything it was thought the yeast would consume. While you can still find these kits for sale, the enthusiasm for them seems to have waned. Whether consumers have caught on that these kits are useless, or have abandoned them because they don’t actually treat any underlying medical issues, isn’t clear.
New School mold fears
Molds and mold spores are are everywhere – indoors and outdoor. They are carried in the air and on your clothes. When molds encounter excessive moisture, typically in places like bathrooms, they will grow. Many materials inside our home can support mold growth, such as carpets, ceiling tiles, furniture, and drywall.
Moldy environments can cause a variety of health effects, but they are not certain to. Some people are sensitive to molds, and they may describe symptoms like congestion, wheezing and itchy eyes. Those with existing lung diseases, like asthma or chronic obstructive lung disease, may have more severe reactions. For these people, exposure to molds can lead to symptoms such as stuffy nose, wheezing, and red or itchy eyes, or skin. Some occupations may face regular exposure to significant amounts of mold (e.g., farming) and they may also experience more pronounced reactions.
Social media and influences appears to be driving fears about molds. Dave Asprey (the guy who puts butter in his coffee) writes about “mold poisoning” and promotes a long list of supplements to help you “recover” from “mold toxicity”.
Posts on black mold have millions of views on TikTok. Any form of mold, no matter how small, is blamed on any health-related concern. Mold is said to change how you will feel and even how you look. Weight gain is blamed on mold. So is weight loss. Celebrities blame mold for sickening their children. You can even find advice about how to keep mold out of the latest social-media-must-have, the Stanley Quencher.
Understanding molds
Mold is a common term used to describe a visible collection of fungi that develop as multicellular filaments or hyphae, which then come together to form web-like structures. Incredibly, while 100,000 fungi have been identified, the actual diversity of fungi is thought to be at least 7 to 10 times greater. Millions of fungal species have not yet been described and classified.
Fungi in the soil and on plants play crucial roles in breaking down organic matter, making essential nutrients like nitrogen and phosphorus available to other organisms. The survival of many plants relies on mycorrhiza, a symbiotic relationship between a fungus’s mycelium and a plant’s roots, facilitating the supply of water and essential nutrients to the plant.
Yeasts (which are single-celled fungi) and molds are critical to foods like bread and certain cheeses, as well as delicious beverages like beer and wine. They also serve as sources for medications, including antibiotics, immunosuppressants, and the statin drugs.
Both outdoor and indoor environments have microbiomes of molds, with their levels indoors being strongly influenced by their outdoor counterparts. Molds and other fungi are everywhere. They cannot be avoided – they live on our skin and in our mouths – and we are constantly exposed to them.
With molds ubiquitous, our immune system is naturally pretty adept at dealing with them. There are some cases where disease is known to occur. One example would be rare diseases like “farmers’ lung” or “pigeon breeders’ disease”. Infections can also occur in the immunocompromised – think untreated HIV, or patients being treated for some forms of cancer.
Evidence and expert opinion
Exposure to molds and the impact on health and in particular, air quality, have been examined. In 2004 the Institute of Medicine (IOM) found there was sufficient evidence to link indoor exposure to mold with upper respiratory tract (nose and throat) symptoms, cough, and wheezing in otherwise health individuals, with asthma symptoms in people with asthma; and with hypersensitivity pneumonitis (which is a rare immune-mediated condition) in susceptible individuals.
The World Health Organization also has a guideline on indoor air quality. It summarizes the evidence (as of 2009) on problems associated with moisture and exposure to molds. That review concludes that the most common effects are an increase prevalence of respiratory symptoms, allergies and asthma:
Our review of the epidemiological evidence presented in this report, the previous review by the Institute of Medicine and the quantitative meta-analysis of Fisk, Lei-Gomez and Mendell (2007) leads us to conclude that there is sufficient evidence of an association between indoor dampness-related factors and a wide range of respiratory health effects (Table 8), including asthma development, asthma exacerbation, current asthma, respiratory infections, upper respiratory tract symptoms, cough, wheeze and dyspnoea.
The CDC has a page on molds. It says,
Exposure to damp and moldy environments may cause a variety of health effects, or none at all. Some people are sensitive to molds. For these people, exposure to molds can lead to symptoms such as stuffy nose, wheezing, and red or itchy eyes, or skin. Some people, such as those with allergies to molds or with asthma, may have more intense reactions. Severe reactions may occur among workers exposed to large amounts of molds in occupational settings, such as farmers working around moldy hay. Severe reactions may include fever and shortness of breath.
Some molds are “toxigenic”, producing “mycotoxins”. Color is not an indication of how dangerous a mold may be, or if it produces mycotoxins. A review article from 2017, entitled “Mold and Human Health: a Reality Check” published in Clinical Reviews in Allergy and Immunology, provides an overview of concerns about molds and the accumulated evidence. It concludes:
Molds and fungi are ubiquitous and generally live in harmony with human beings. Only rare molds have been associated with human disease. The diseases that molds can cause are restricted to allergies, hypersensitivity pneumonitis and infection. There is no validity to the hype of “toxic black mold” and “mycotoxicosis.” Humans are not exposed to enough mycotoxins to develop illness, unless they ingest toxic quantities of mycotoxins or become exposed to intense organic dust storms.
Are molds the new…Candida? Or gluten?
When I started this post I saw the parallels between fears about black mold and worries about Candida. But there was something in between. Remember several years ago when all sorts of health ills were being blamed on gluten? This wasn’t previously-undiagnosed Celiac disease, or even subtle Irritable Bowel – it was the ascribing of vague health concerns health ills to a bogeyman in our diets. While the craze for gluten-free foods exploded (which was admittedly good for those with Celiac disease), my sense is that most people went back to breads and gave up on cauliflower pizza crust. Today, it looks like mold is that new substance that social media is hypervigilant about.
Like gluten, mold can be be potentially harmful in some circumstances, especially in individuals who may be predisposed. There is no argument from health organizations that mold, when identified in our homes, should be removed. We should look for evidence of mold whenever there is water damage, and clean or remove anything that is moldy. When there is mold growth in our carpets, walls or insulation, the only way to fix it is to remove it. It is also important to regulate moisture and humidity to reduce the likelihood of mold growth. However, it’s worth noting that the CDC does not recommend routine sampling for molds. There’s also no evidence that mold toxins cause diseases in people, so you don’t need to detox after mold exposure – you simply need to reduce your exposure. Unapproved or unvalidated diagnostic studies and treatments based on theoretical infections or suspected toxicity are both useless and potentially costly.
Like much pseudoscience, there is a kernel of truth at the heart of mold fears. Regrettably and also somewhat predictably, mold has become are marketer’s dream and the anxious consumer’s nightmare. I have no doubt that in a few years time, I’ll be describing some new product as “the new black mold”.

   Delusional Parasitosis
Steven Novella
Link
A new study looks into the disorder known as delusional parasitosis, which many dermatologists believe is the true diagnosis behind the controversial disorder called Morgellon’s disease. Morgellons is a controversial disorder because many patients with symptoms believe they are being infected by an unusual organism, causing excessive itching, but no offending organism has been found. Some patients claim they have strange fibers exuding from the sores in their skin.
The term “Morgellons” was coined in 2002 by Mary Leitao, who was trying to find a diagnosis for her son who was suffering from skin lesions. Since then it has become a grassroots diagnosis – used by some patients to describe themselves but not accepted by the medical community.
Most dermatologists, rather, feel that the disorder is actually a manifestation of delusional parasitosis – a mental disorder. This has set up an unnecessarily confrontational situation. And of course, some charlatans are exploiting the situation by taking the side of the patients and offering them their nostrums as a cure.
These situations are always helped, but rarely resolved, by better information. It is in this context that Hylwa et al performed a retrospective analysis of patients diagnosed with delusional parasitosis at the Mayo dermatology clinic. They analyzed records from 108 patients who had either a skin biopsy (80 patients) or presented their own sample (a patient-provided specimen – also 80 patient), or both (52 patients).
They found that in all 108 cases no evidence of infection or infestation was found.
They did find, however, that 48% of biopsies showed dermatitis – inflammation of the skin. This finding has two plausible interpretations. The first is that in some patients with delusional parasitosis, they may have an underlying skin condition that causes non-specific dermatitis (an allergy, for example) and the symptoms of this dermatitis triggers the psychological reaction that results in the belief that they are infested with something foreign. In this case they could be simply misinterpreted their skin sensations. Further the chronic symptoms can cause stress and lack of sleep and result in the anxiety and depression that often accompanies this disorder.
The other plausible interpretation is that the dermatitis is secondary to scratching and perhaps treating the skin with irritating substances intended to treat the problem. The current study is not capable of distinguishing between these two possibilities.
The authors acknowledge the limitations of this study – mainly that it was retrospective. It also needs to be considered that their search criteria was for patients diagnosed with delusional parasitosis – not all patients with unknown or mysterious skin lesions. In that respect the results are not surprising – the diagnosis may result from a negative biopsy or sample analysis, and so of course patients with that diagnosis will have had a negative biopsy.
The authors do not even address the controversy surrounding Morgellons. Rather they are asking if skin biopsy is useful in patients presenting clinically with delusional parasitosis. Again – given the retrospective nature of this study I don’t think it answers that question.
This study does, however, review a large series of cases demonstrating a lack of biopsy or sample analysis findings in patients who fit within the clinical syndrome that is labeled as either Morgellons or delusional parasitosis. It should further be noted that those who claim that Morgellons is a distinct disease caused by a skin infestation cannot point to any objective evidence of an actual infestation to support that claim.
What proponents do have are mysterious fibers sometimes found in the skin lesions of people with this syndrome. The fibers often cannot be specifically identified, or they are identified as foreign fibers consistent with clothing. They usually do not appear to be of organic origin. At best the fibers represent an anomaly, and are not specific evidence of any underlying cause.
What is especially disturbing about the Morgellons phenomenon is the tone of the discussion, the extent to which the controversy has been politicized. Often irrelevant issues are brought to the forefront, such as patient empowerment or medical authority. Not that these issues are not important – they are just not relevant to the real question of what, exactly, is the underlying cause of what is referred to as Morgellons.
Patients who suffer from this syndrome are best served by bringing objective scientific evidence to bear to discover exactly what the cause(s) and best treatments for their symptoms are. But this issue is often derailed by accusations that the medical community is dismissing them and their claims. By grabbing the reigns of diagnosis and treatment such patients are given a false sense of empowerment, but are likely just cutting short earnest attempts to understand and treat their condition.
And of course, good science has to follow the evidence wherever it leads, even if the answer is not what is hoped. The truth does not care what people need or want – it is what it is.
Conclusion
This latest study will likely not change the debate about Morgellons vs delusional parasitosis. Although it should be kept in mind that delusional parasitosis (DP) is a disorder in its own right, and pre-existed any notion of Morgellons. Morgellons is likely just a recent manifestation of DP – a cultural entity spreading mainly on the internet. It should also be noted that DP likely contains two or more subgroups that have distinct causes – such as the two causes of dermatitis I discussed above.
At present there is no compelling evidence that Morgellons exists as a discrete entity separate from DP. The CDC is currently studying the condition (which they are calling unexplained dermopathy) but has not yet made any report of their findings.
My review of the evidence is that it best supports the conclusion that Morgellons is a mostly a psychocultural condition (it may be triggered in cases by an underlying skin condition). It is a combination of a cultural phenomenon spreading mostly online, giving specific manifestation to an underlying psychological condition. I am willing to be convinced that there is a biological process going on, but so far no compelling evidence to support this hypothesis has been put forward.
I also think that specific harm can be done to individuals with this syndrome by the spread of false information. Sufferers can easily be made to settle prematurely on a false conclusion, and in fact can reinforce their delusions if that is ultimate cause of their symptoms. They can be lured away from practical interventions and the medical community to dubious treatments that are, if nothing else, a waste of their resources.
The situation represents a challenge to the medical community. Perhaps the only solution is to explain and promote the scientific approach to diagnosis and treatment.

   Morgellon's Itching and the Imaginary Passenger Brake
Wallace Sampson
Link
The press and government agencies ally to shine a disproportionate amount of publicity on false and improbable medical ideas. (Danger: Congressmen and reporters at work.)
The latest was a press release from either the Centers for Disease Control (and prevention? – I’ll get to the “prevention” part later,) or from Kaiser-Permanente Medical Group. Three Bay Area newspapers carried simultaneous articles. The articles announced a new, $338,000 CDC/Permanente study of something they call “Morgellon’s disease.” I say they call it that because what they are describing is not what was originally described as “Morgellon’s,” but what is most likely a form of somatiform illness – delusional parasitosis, or neurodermatitis.
What is Morgellon’s and why is CDC funding Kaiser/Permanente with $338,000 to study it? I was never taught about anything called Morgellon’s, and althoughI had practiced medicine for forty years, I still had not known of it until several years ago when a group of affected San Francisco patients and R L Stricker MD, were reported as having a number of cases of it.
It turns out that in 2001, a South Carolina biologist named Mary Leitao, mother of a young son who complained of painful, itching skin lesions, somehow found reference to an obscure report of a disorder describd by a person named Morgellon from 17th century France. A drawing from that period or later showed a skin opening with a sizeable wormlike object protruding from it. From the picture, the mother proposed her son had a form of that disorder, and she named it Morgellon’s. No such disorder was known to exist in modern times.
In 2006, newspapers reported that SF’s Dr. Stricker and another physician had accumulated increasing numbers of patients complaining of similar symptoms. The Bay Area, Los Angeles, Florida and a few other areas became centers of these cases, but then reports began coming from UK, Australia, and Canada. No specific diagnosis could be made on these people, whose skin lesions they reported exuded fine threads of black, blue, red, or white material. No constant bacterial cultures were found, but the physicians treated patients with antibiotics, nevertheless. They claim that they found high incidence of antibodies to the bacterial agent of Lyme disease. The sources of the pieces of fine thread could not be identified, but suspicions were that they came from clothing and other materials, rubbed into the breaks in the skin, produced by scratching.
Cases accumulated world-wide, most reports came from English speaking countries. Dermatologists recognized the paients as having “delusional parasitosis,” and treated them with anti-depressants on the assumtion of a somatiform reaction to anxiety or depression.
If this all sounds familiar, it should. A similar phenomenon in the mid-1980s began at South Lake Tahoe when a single internist claimed that scores of people accumulated in his practice, all of whom reported chronic fatigue, mental fogginess, muscle aches, and other symptoms but with no physical findings. (Ask any internist or family practitioner what percent of patients have those symptoms.) That was the germ of the chronic fatigue syndrome epidemic that resulted when millions of people who were feeling tired or depressed suddenly realized they could have a real disease, and bandwaggoned together to form a mass sociogenic illness of unprecedented volume. Newsweek and other news sources reported the problem as a real organic disease, estimating some 2 million cases in ther US alone. Curiously, no such masses accumulated in most other countries. CDC is still “looking into it” spending millions of dollars on what has been historically established as a mass delusion.
The late Stephen Straus made his reputation when assigned to lead the NIH investigation into chronic fatigue, leading to his eventual appointment as the last Director of the National Center for Complementary and Alternative Medicine. (He never solved the “problem” but added to the confusion by finding non-specific blood pressure and other changes in CFS patients.)
A characteristic of episodic, localized sociogenic illesses – sick building syndrome, schoolgirl fainting, etc. – is that they spread by line of sight. Interestingly, this current epidemic spreads locally via a line of sight surrogate – local TV reports and newspaper columns, and that the predominant reported early centers were all in English speaking countries.
The likelihood of “Morgellon’s” being an organic disease – bacterial, viral, or auto-immune – is vanishingly small. Physical symptoms like itching are almost universal, but kept below the horizon of awareness or concern, overwhelmed by the multiplicity of normal external stimuli, and suppressed through consciousness and other mechanisms. All one has to do is to concentrate on them or allow expression through depression or other causes, and they can magnify to frightening degrees. The physician sees nothing but the patient’s depression and concern, the patient rejects attempts at reassurance as disbelief or lack of understanding, accusations of professional neglect and conspiracies accumulate, reinforcing patient mistrust, and on it goes.
But criteria for diagnosis of emotional and psychological conditions are rarely physical or objective, so the CDC and Permanente experts will have severe credibility problems if they try to classify the problems as “functional” or somatiform. This “epidemic” is something best left on a lower key level, examined by physicians and other medical scientists in universities and academic institutions, not by government agencies, under pressure from members of Congress.
Now about that imaginary brake; a new radio commercial states that Mercedes Benz engineers recently experimented and determined that the passenger side “imaginary brake” that the passenger “uses” in certain urgent situations “does not work.” A clever ad, but also a real-life example of how imagination results in real organic responses, in this case motor rather than sensory – but quite real, nevertheless.
On to the prevention business. The CDC taking on this investigation and its probable unresolved ending a decade or more away, as with the NCCAM, gives legitimacy to the false idea that “there might be something there.” This unexpected consequence is likely to cause further spread of this imaginary disease and classic somatiform illness. All parties would benefit from reading Edward Shorter’s “From Paralysis to Fatigue.”

   Parasites
Mark Crislip 
Link
I saw a patient recently for parasites.
I get a sinking feeling when I see that diagnosis on the schedule, as it rarely means a real parasite. The great Pacific NW is mostly parasite free, so either it is a traveler or someone with delusions of parasitism.
The latter comes in two forms: the classic form and Morgellons. Neither are likely to lead to a meaningful patient-doctor interaction, since it usually means conflict between my assessment of the problem and the patients assessment of the problem. There is rarely a middle ground upon which to meet. The most memorable case of delusions of parasitism I have seen was a patient who I saw in clinic who, while we talked, ate a raw garlic clove about every minute.
“Why the garlic?” I asked.
“To keep the parasites at bay,” he told me.
I asked him to describe the parasite. He told me they floated in the air, fell on his skin, and then burrowed in. Then he later plucked them out of his nose.
At this point he took out a large bottle that rattled as he shook it.
“I keep them in here,” he said as he screwed off the lid and dumped about 3 cups with of dried boogers on the exam table.
To my credit I neither screamed nor vomited, although for a year I could not eat garlic. It was during this time I was attacked by a vampire, and joined the ranks of the undead.
I have seen the occasional earthworm thought to be an intestinal parasite. Sometimes people start to pay attention to their stool, often for the first time, and note tube like structures that move in the water. Most likely mucous or undigested fiber wafting in the gentle currents of the toilet water. Doesn’t that sound romantic? The contents of the average stool, like hot dogs and laws, are better left unexamined. In those patients, an examination of the stool for worms and worm eggs is usually unrevealing and makes me glad I am not a microbiology technician.
Morgellons is, as best I can tell, a variant of delusions of parasitism.
Here is a thing about germs in general and parasites specifically: they have patterns and can be seen. There are patterns of disease and patterns of their life cycle. You can tell when a disease is probably delusional because the “organisms” have no understandable pattern in the life cycle, the disease, the physiology, the anatomy or the epidemiology.
And germs can be seen. Well, most germs. Single celled organisms can be tricky and may require special stains to be seen under the microscope. Viruses are, of course, too small to be seen by a lab microscope. But parasites? Worms? These wee beasties are multicellular. They are big. Not a long way to the chemists big, but sizable, not hard to see with a microscope unless they have Romulan cloaking technology.
So what is Morgellons?
Before we continue, I would like to clarify one thing. I see patients self diagnosed with Chronic Candida Syndrome or Morgellons or Chronic Lyme or some other process. I do not doubt these people are ill and have symptoms that can be severe and life altering. What I may disagree with the patient is the reason for these symptoms. As best I can tell none of the above are due to an infectious disease.
Unfortunately when the patient is convinced they have an etiology for their symptoms and I think that their reason is nonsense, it does not lead to a therapeutic physician-patient interaction. I try and phrase it as gently and non-judgmentally as possible, but it rarely leads to a good time in the clinic.
Morgellons has existed as a disease since about 2002 and is an internet phenomena right up there with Rebecca Black. See. For a 54 year old man, I am hip. Morgellons received its name from a paper from 1935 called SIR THOMAS BROWNE AND THE DISEASE CALLED THE MORGELLONS By C.E. KELLETT, M.D., M.R.C.P. and published in Annals of Medical History, n.s., VII (1935), 467-479, where it refers to a disease from the 1600′s (yes 1600′s) described by said Thomas Browne.
“Hairs which have most amused me have not been in the face or head, but on the Back, and not in Men but Children, as I long ago observed in that endemial Distemper of little Children in Languedock, called the Morgellons, wherein they critically break out with harsh Hairs on their Backs, which takes off the unquiet symptoms of the Disease, and delivers them from Coughs and Convulsions.”
Who know what these hairs/worms really were; the 1600′s were not a time noted for its diagnostic accuracy. Unlike the modern disease, it was usually a disease of children and often fatal, so whether these “hairs” had anything to do with the disease or were actual living creatures, one cannot say.
In 1715 when the first microscopist, Leuvenhoeck, took a look at the bristles and thought them “inanimate”, starting a long tradition of looking at the detritus presented by Morgellons patients and seeing nothing. I, for one, always look at the fluff brought in by Morgellons patients and have yet to see anything resembling a living creature. Diseases have come and gone in the past, like the English Sweating Sickness, so maybe there was a plague of virulent hairs (that’s hair not hare, it was not a virulent bunny, for which Hef is undoubtedly grateful), but no longer.
Fast forward 400 years. Round about 2002 this disease was described on the net in regards a child with the symptoms now referred to as Morgellons, and since others have had the disease. It is transmissible as an internet meme, but not spread person to person.
What are the distinguishing characteristics of Morgellons? Here are features as noted from the Morgellons Research Foundation
1. “Filaments” are reported in and on skin lesions and at times extruding from intact-appearing skin. White, blue, red, and black are common among described fiber colors. Size is near microscopic, and good clinical visualization requires 10-30 X. Patients frequently describe ultraviolet light generated fluorescence. They also report black or white granules, similar in size and shape to sand grains, on or in their skin or on clothing. Most clinicians willing to invest in a simple hand held commercial microscope have thus far been able to consistently document the filaments.
2. Movement sensations, both beneath and on the skin surface. Sensations are often described by the patient as intermittently moving, stinging or biting. Involved areas can include any skin region (such as over limbs or trunk), but may be limited to the scalp, nasal passages, ear canals, or face…and curiously, legs below the knees.
3. Skin lesions, both (a) spontaneously appearing and (b) self-generated, often with pain or intense itching. The former (a) may initially appear as “hive-like”, or as “pimple-like” with or without a white center. The latter (b) appear as linear or “picking” excoriations. Even when not self-generated (as in unreachable regions of babies’ skin), lesions often progress to open wounds that heal incompletely (e.g., heal very slowly with discolored epidermis or seal over with a thick gelatinous outer layer.). Evidence of lesions persists visually for years.
4. Musculoskeletal Effects and Pain is usually present, manifest in several ways. Pain distribution is broad, and can include joint(s), muscles, tendons and connective tissue. Both vascular and “pressure” headaches and vertebral pain are particularly common, the latter usually with premature (e.g., age 20) signs of degeneration of both discs and vertebrae.
5. Aerobic limitation is universal and significant enough to interfere with the activities of daily living. Most patients meet the Fukuda Criteria for Chronic Fatigue Syndrome as well (Fukuda, Ann. Int. Med., 1994). Cardiology data and consistently elevated heart rates suggest a persistent myocarditis creating lowered cardiac output that has been partially compensated for by Starling’s Law.
6. Cognitive dysfunction, includes frontal lobe processing signs interfering with logical thinking as well as short-term memory and attention deficit. All are measurable by Standard Psychometric Test batteries.
7. Emotional effects are present in most patients. Character typically includes loss or limitation of boundary control (as in bipolar illness) and intermittent obsessional state. Degree varies greatly from virtually absent to seriously life altering. “
It is the filaments. Over the years I have seen a smattering of Morgellons and they bring in the filaments and I look at them under the microscope. I see hairs, and threads, and non-specific detritus, but never anything that resembles the results of a living creature. I have looked carefully at the skin of these patients, and have never seen an intradermal fiber.
So you can see why I am skeptical that this is anything but a version of delusions of parasitism. In one series of 25 patients
Most patients in this study (23 out of 25) had prior psychiatric diagnoses (most determined by specialists) as follows: 11 out of 25 bipolar disease; 7 out of 25 Adult ADD; 4 out of 25 Obsessive Compulsive Disorder (OCD); and 1 out of 25 Schizophrenia.
The same study had a hodgepodge of lab abnormalities, but there were not compared to matched controls. It may well be that the patients have some underlying inflammatory process that causes skin lesions and a feeling of the creepy crawlies and are misidentifying standard environmental material as associated with the diseases. But I am skeptical.
Against this hypothesis are the case reports where Morgellons is cured with Pimozide, an antipsychotic. Delusions of parasitism is often treated with olanzapine, another antipsychotic, but others have suggested pimozide is superior. Most infections would be unlikely to respond to antipsychotics, but I have never been satisfied with response to treatment as a means for confirming a diagnosis, that is a path better not followed without good reason. In my world docs often think if patients are improving on antibiotics the response is considered evidence of infection. I know better. But given the lack of a demonstrable parasite, a response to psychiatric medications is certainly suggestive.
So response to anti-psychotics would suggest patients with Morgellons could have a psychosis, but I keep in mind it does not necessarily extrapolate to all patients. I try to bear in mind that when patients present with odd symptoms that they attribute to worms and parasites, it may be simple misunderstanding.
As of this entry, no one has fulfilled Kochs postulates with Morgellons.
For those not immersed in infectious diseases, Koccs postulates were a series of criteria to demonstrate the causality of infections, Here there are, with the word filament substituted for microorganisms:
1) The filament must be found in abundance in all organisms suffering from the disease, but should not be found in healthy organisms.
2) The micro filaments must be isolated from a diseased organism and grown in pure culture.
3) The cultured filament should cause disease when introduced into a healthy organism.
4) The filament must be re isolated from the inoculated, diseased experimental host and identified as being identical to the original specific causative agent.
So far proponents of the disease are 0 for 4.
But if this disease is due something that can be visualized with the naked eye or a magnifying glass, it should be simple enough to characterize. Lets say you are a DNP and a member of ILADS. Well, I have to admit that you have lost some credibility with me. But lets say you saw a series of patients with Morgellons and you could see the fibers. There, right there. You can see them. Would you not biopsy the fibers? Would you not try to characterize them? Nope. So aggravating. It boggles the mind that someone could have a diagnostic coup right in front of them and let it pass.
Delusions of parasitism can be nosocomial. Well, not truly delusions, but patients can be convinced they have parasites when, in fact, they do not, and waste serious amounts of time and cash in pursuit of an imaginary diagnoses.
I recently saw a patient who had unexplained abdominal pain for a year and a half. The patient had an extensive evaluation and no explanation for the symptoms, and, looking for answers, eventually wandered into the arms of a naturopath.
One of the shows my eldest liked to watch was I Love the 80′s on VH1. The 80′s was the decade I was in medical school, residency and fellowship. When I watched I Love the 80′s I recognized virtually nothing of popular culture of time. Not the TV shows, the hair styles, the music. Nothing. It really brought home how consuming becoming a doc and a subspecialist is. A decade of my life was spent understanding medicine and infectious diseases. I am not complaining, mind you. There are lots of reasons people go to an alt med provider, but I do not think gullibility is on the list.
The patient with the abdominal pain and their spouse are educated people, why would they see a naturopath?
Looking for answers. Their areas of knowledge are totally removed from medicine and science, and while it is popular to bemoan the science illiteracy of the US population, and it is sorry, if your career arc was law, or finance or auto repair, or stoner at the 7/11, are you going to find time to become literate in medicine? Doubt it. I can’t design a bridge or fly a jet. Why would I expect someone who has mastered these tasks to understand medicine? There are just so many hours in a day to accomplish tasks.
I have, as a further example, zero idea if my mechanic is giving me good diagnostic and repair advice on my car. I have to take everything he says on faith. I have neither the time or inclination to become expert in car repair, and most people do not have the time to become fluent in medicine. Am I gullible? I do not think so.
I had my epiphany years ago when I told a father of a meningitis patient, your daughter has an infection in the fluid that surrounds her brain and he replied, could you phrase that in a way I can understand it? He had no idea of basic brain anatomy or infections, and why would he? So I drew him a picture. It helped.
So anyway, the patient wandered into the lair of a naturopath and was diagnosed with parasites. Now mind you, the patient did not have symptoms that could be reasonably ascribed to parasites or worms, and, more importantly, had no risks for parasites or worms. The industrialized West is reasonably free of worms and their brethren. The naturopath did not do serology or blood work or even a simple stool study looking for the eggs of various worms. It is how I, along with a history and physical looking for the pattern of disease that marks a parasite, come to a diagnosis. No, he or she (I do not remember the pronoun used at the time) proudly used electrodiagnosis.
Proudly. As my patient related it to me, the naturopath, a graduate of Bastyr, (if there is an legitimate opportunity for a deliberate mispronunciation, it is with Bastyr) considered herself to be an expert in parasite treatment and diagnosis.
What is electrodiagnosis you ask?
There are many devices out there, so I do not know precisely which one the patient used.
My patient said they held an electrode in each hand, the naturopathic expert in parasitology twirled a dial, and told them that the reading indicated parasites. Really. I am proud that I did not burst out laughing during the interview, as from my perspective it was a ludicrous joke. But, as I mentioned, not everyone knows what I do, and EEG’s and EKG’s can also diagnoses a variety of medical problems, so why not parasite infestation?
Electrodiagnosis are said to measure disturbances in the body’s flow of “electro-magnetic energy” along “acupuncture meridians” but are expensive galvanometers that measure electrical resistance of the patient’s skin when touched by a probe. Two pseudosciences in one. I have seen better. It is sometimes called electroacupuncture according to Voll, or EAV, and was pulled out of Dr. Volls backside in the 1950′s.
“The basic concept for all of the ElectroDermal screening devices, was the invention of Dr. Reinhardt Voll[1], who in the 1940s, discovered that the electrical resistance of the human body is not homogenous and that meridians existed over the body which may be demonstrated as electrical fields. Furthermore, he showed that the skin is a semi-insulator to the outside environment. By the 1950s Voll had learned that the body had at least 1000 points on the skin which followed the 12 lines of the classical Chinese meridians. Each of these points, Voll[2] called a Measurement Point (MP). Working with an engineer, Fritz Werner, Voll created an instrument to measure the skin resistance at each of the acupuncture points, patterned after a technique called Galvanic Skin Resistance (GSR). This was named Point Testing. In 1953, Voll had established the procedure that became known as Electro-Acupuncture according to Voll.”
There is zero validity to making any diagnosis this way. Except, of course, the E-Meter of Scientology. I wouldn’t want to cross the them there Scientologists. Oh no, uh uh. No way. E-meter forever. But those other electronic diagnostic devices? Pure bunkum. I could not say it better than Quackwatch:
“The devices are used to diagnose nonexistent health problems, select inappropriate treatment, and defraud insurance companies. The practitioners who use them are either delusional, dishonest, or both.”
That the American Association of Naturopathic Physicians has a position statement on electrodiagnosis that considers it experimental is another sign that naturopaths have no business taking care of people. To quote their position paper
“There are three levels of electro-diagnosis:
a. Meridian testing: Readings are interpreted in indicate strength of specific meridians, organ strength or physiologic function.
b. Remedy testing: Variations in readings are interpreted when remedies are given to the patient either orally, to hold or put on a “testing plate” wired to the electrodiagnostic equipment. Interpretations may include sensitivities, nutritional enhancement, or improved function.
c. Energy medicines: Electrodiagnostic equipment interprets information and manufactures an energy medicine which is given to the patient to take orally.
THEREFORE IT IS THE POSITION OF THE AANP THAT:
It is appropriate that the naturopathic profession pursue scientific research regarding the reproducibility and reliability .”
There is nothing on the Pubmeds on the validity of electrodiagnosis, and, on basic principals and prior probability, to suspect that electrodiagnosis would have any utility in the diagnosis of parasites or anything other disease.
Despite this, my patient received prolonged courses of mebendazole, thiabendazole and praziquantel, all at half doses, and all out of pocket.
Uncertain of which parasite to kill, the naturopath tried to kill them all with under-dosed medications. Good thing, come to think of it, that he did not use his infernal contraption to diagnose cancer, who knows how many anticancer treatments would have been prescribed.
And what is an energy medication and how does one manufacture them? Besides a triple shot of espresso? The principals of EAV have been expanded for
“BioScan (remote DNA resonant testing) – This procedure utilizes extremely sensitive EAV computerized equipment to accurately measure stressors in the body. It bombards the clients sample DNA (usually hair) with up to 10,000 frequencies to locate bacteria, viruses, pesticides, heavy metals, industrial pollutants, chemicals, parasites, foods, allergies, dental materials, trees, weeds, pollens, inhalants, molds, yeast, fungus and many other substances that poison the environment today. These stressors and related deficiencies are identified in print form for the client along with the organs and glands affected by the stressors. Supplements are suggested that resonate with the test subject and homeopathics are customized to support the body to remove the stressors and return to homeostasis.”
Only 275 dollars, plus 5 dollars shipping and handling. And they recommend a minimum of 4 evaluations.
Try as I might, I cannot write a satisfying concluding paragraph to this entry, so I will just stop.

   Parasite Cleanse
Link
Steven Novella on March 13, 2024
Tik Tok is a cesspool of wellness pseudoscience and misinformation. All of social media has the potential to spread misinformation without any filter, but for some reason Tik Tok has become the preferred platform for the most outrageous claims and nonsense.
A recent trend on Tik Tok (and within the wellness community generally) is the parasite cleanse. The idea is that many people are walking around with GI parasites and don’t know it, and so a regular parasite cleanse should be part of a healthy routine. These claims are false and potentially dangerous.
Parasites are organisms that live on or inside other organisms as part of their lifecycle. They can exist chronically without causing an acute infection. Gastrointestinal parasites, like worms, can cause gas, diarrhea, bloating, stomach pains, fatigue and weight loss. Of course, a lot of other things can cause these symptoms as well.
This creates a perfect setup for a typical wellness scam – scare people into thinking they may have some otherwise rare or fake illness, then sell them a snake oil treatment for said illness. It’s best (for cash flow) if the treatment has to be done on a routine basis indefinitely.
While parasitic infections are a real thing, they are extremely rare in industrialized nations. We have the privilege of being able to easily prevent such infections – don’t eat raw or undercooked meat, and don’t drink “raw” water or untreated water. That’s pretty much it, and it’s really easy if you live in the US. Traveling to parts of the world where parasites are endemic and with poor hygiene is the main risk factor for people living in developed nations for getting parasites. It’s also possible if you eat food you hunted without preparing it or inspecting it properly, or if you camp and drink untreated spring water.
For most people it is not something you have to worry about. In the rare event that you may somehow contract a parasite, this is a serious medical condition and requires real medical treatment with medication. A “cleanse” won’t be enough if you actually have a parasite. See your medical doctor.
Here is just one example from Tik Tok – fearmongering over a case where someone had parasite eggs in their brain presenting as a “migraine”. First, anyone with a new headache is likely to get imaging, which can easily make the diagnosis, as it did in this case. Treatment with actual medicine is then required.
But the Tik Tok producer uses this case to claim that everyone should do a parasite cleanse multiple times a year. That would not have helped or prevented the parasite infection in this case. The parasite cleanses that are out there are generally not effective. Some include simple dietary restrictions, which may be benign, but can risk poor nutrition in extreme cases. In the case of an actual GI parasite, which includes weight loss as a symptoms, dietary restrictions may exacerbate the weight loss resulting in worse outcomes. The idea is to “starve the parasite” but that would not prevent or eliminate a parasite infection.
There are also many herbal concoctions promoted as parasite cleanses, with the most common ingredient being wormwood, which contains artemisia. Artemisia does have some anti-parasitic (helminthic specifically) activity, but when given as an herb suffers all the limitations of this approach. As this study demonstrates, for example, in vitro effects do not always translate in vivo. This means that because an herb or derivative kills parasites in a Petri dish, that does not mean it will have any such effect when taken orally. There are issues with bioavailability, half-life, and distribution, for example.
Further, there are over 500 species of wormwood, with highly variable amounts of specific constituents, which can also vary considerably by season, part, method of collection and preparation. This is a problem generally with herbal products, there is no consistency. If you have an actual parasitic infection, then you want to take a purified drug with known properties and amounts in a dose proven to be safe and effective.
Some herbal parasite cleanses also cause diarrhea, which is meant to create the impression that they are working. But this can be a dangerous side effect. Also, again, if you had an actual GI parasite, taking a drug that causes diarrhea would be counterproductive.
Artemisia in wormwood has also been shown to cause liver toxicity. Remember – herbal products are drugs, they are just poorly regulated drugs. They can have all the common toxicity and interactions that pharmaceuticals have, and liver toxicity is very common.
Good medicine is all about carefully considering risks vs benefit. The potential benefit of a routine parasite cleanse is negligible, because the risk of actually having a parasite for those living in developed nations is incredibly low. You are far better just not engaging in risky activity. The parasite cleanses out there also have unproven efficacy, with good reason to think that they are likely ineffective. They also carry some risk of direct harm through toxicity.
There is also the potential of indirect harm, through generating a false sense of security, delaying proper medical care, or diverting people from a proper medical evaluation.
A good rule of thumb is not to listen to wellness influencers on Tik Tok – which has risk massively in excess of any potential benefit.

Lice
Harriet Hall on May 6, 2014
Link
If you have children, there’s a good chance you’ve had experience with head lice. Head lice affects as many as 12 million people in the US each year, mostly children. Compared to other health conditions, it is a trivial problem; but it is common and annoying. It can cause itching, notes sent home from school, and often a strong “yuck” reaction. Fortunately, several effective treatments are available, including enough “natural” options to please any critic of Big Pharma.

The critter
Pediculosis humanus var capitis is a bloodsucking parasitic insect specific to humans. It is 2.5-3 mm long and flattish. It can’t jump or fly or even walk efficiently, but is easily transferred, usually by head-to-head contact with an infected person or less often with an infected person’s headgear, comb, towel, or other object. Infestation is not a sign of poor hygiene. Lice bite and suck blood 4-5 times daily, injecting an anti-coagulant in their saliva. Mommy lice live for up to 3 months and lay up to 300 eggs at a rate of 3-4 a day. They glue the eggs individually to a hair shaft, usually close to the scalp but in warm climates as far as 6 inches from the scalp. They hatch in 6-10 days, after which the empty egg cases move further and further from the scalp as the hair grows out. The diagnosis can be made by seeing live, moving lice and finding nits (the egg or young lice) on the hair. The best place to look for them is behind the ear and at the nape of the neck. Nits can be confused with dandruff and debris, but these can usually be brushed away while nits remain firmly stuck to the hair shaft. Nits alone are not enough to make the diagnosis of active infestation. They may be either alive or dead: empty or nonviable egg cases may still be present long after the infestation has resolved.
Non-drug treatments
Combing . Removal by wet combing with a fine-toothed lice comb every 3 days for at least 2 weeks produces reported cure rates of 47-75%. Downside: time-consuming, especially if hair is long and thick. Upside: no risks, quality time with kids, satisfies primate grooming urges (chimps pick lice for social bonding and they eat what they find). Shaving the head also reliably removes lice, but it is a rather drastic solution that few people would choose.
Desiccation. Hot air kills both lice and eggs. A study of hot air devices found that the LouseBuster was the most effective: a single 30 minute session was well-tolerated and essentially 100% effective. Only one treatment is needed, and the lice aren’t likely to develop resistance. The device is expensive and requires special training; using a regular blow dryer is not recommended because it can propel live lice airborne to infest other people.
Suffocation. If you can block its air intake, the critter dies. Nuvo lotion was 95% effective in a study that was questioned because it was non-randomized, uncontrolled, unblinded, and had other design flaws. It turns out the doctor who headed the research was re-packaging Cetaphil Skin Cleanser and selling a $10 product under a new name (Nuvo) for $285. That means he’s sneaky, but it doesn’t mean it doesn’t work. More studies are needed.
Home remedy suffocants have included Vaseline, mayonnaise, olive oil, and almond oil. Vaseline and mayonnaise are no longer recommended because they are messy and hard to wash out. Essential oils have also been used, including tea tree oil, lavender oil, neem oil, clove oil, eucalyptus oil, aniseed oil, cinnamon leaf oil, red thyme oil, peppermint oils, and nutmeg oil. There have been a few promising pilot studies of some of these treatments, but the studies have not been replicated; the research is far from conclusive and success rates have been as low as 3.3%.
Drug treatments
Most effective drugs are neurotoxic, designed to paralyze and kill the lice. They do not reliably destroy the eggs, so repeat treatment is typically needed after 7-10 days. Available neurotoxic options include ivermectin, lindane, malathion, permethrin, and pyrethrins. Since 2006 a prescription suffocant, 5% benzyl alcohol lotion, has also been available. The drug of choice today is permethrin; lindane is discouraged because of neurotoxicity concerns but is a good second-line choice in areas where lice have become resistant to permethrin and pyrethrins.
Permethrin (Nix). Generally recommended as a first-line treatment, permethrin is a synthetic version of a natural insecticide that is more effective and less allergenic than natural pyrethrins. Advantages: the most studied pediculicide and the least toxic, reported side effects are mild (itching, redness, and swelling), low cost: $8-9. Disadvantage: resistance is increasing and treatment failures are becoming more common. For treatment failures with 1% permethrin, using a 5% solution and leaving it on the hair overnight under a shower cap may be effective.
Pyrethrins with piperonyl butoxide shampoo (Rid). A natural extract from chrysanthemum flowers, pyrethrins are less effective and more allergenic than permethrin. Advantages: sold over-the-counter, no prescription required, low cost ($5-6). Disadvantage: treatment failures are common.
Benzoyl alcohol 5% lotion (Ulesfia). This is a suffocant that is applied to dry hair, left on for 10 minutes, then rinsed; the treatment must be repeated after a week. Advantages: approved for children 6 months and older, OK for pregnant or lactating women, two double-blind studies showed it to be 75% effective, resistance is unlikely to develop. Disadvantages: not as effective as some other treatments, and higher cost than permethrin ($60).
Malathion (Ovide). An irreversible cholinesterase inhibitor, malathion is the fastest-killing, most effective head lice treatment ever marketed. Advantages: safe and effective, kills eggs, resistance has been reported in other countries but not yet in the US. Disadvantages: not recommended for children under 6 or for women who are pregnant or nursing, long application time (8-12 hours), objectionable odor, flammability, high cost ($150). An earlier version was removed from the US market by the manufacturer but a new formulation was reintroduced and approved by the FDA in 1999.
Lindane (Kwell). An organochlorine insecticide similar to DDT, lindane is stored in fat and nerve tissue. There are concerns about contamination of drinking water, rivers, and lakes, with hazards to fish and wildlife. The FDA issued a public health advisory about the risk of neurotoxicity and seizures, and lindane is banned in California. It is a shampoo applied to dry hair for 4 minutes as a single application; it costs $136. The Medical Letter cautions against its use because there are safer alternatives. It is usually safe when used as directed, but seizures and deaths have occurred with overuse, misuse, or accidental ingestion, and in rare cases death has reportedly followed a single application according to directions. It should be used with caution by those who might be more susceptible to side effects, including infants, children, women who are pregnant or breast-feeding, people who weigh less than 110 pounds, HIV-positive patients, the elderly, and patients with skin conditions like atopic dermatitis or psoriasis. It is contraindicated in premature infants and patients with seizure disorders.
Ivermectin lotion. Two double-blind studies showed this was 76% and 71% effective. It is not recommended for children under 33 lbs. or for women who are pregnant or nursing. Side effects include dizziness and itching. It costs $260.
Ivermectin pills. The pill form of ivermectin is not FDA approved for head lice, although it has been reported to be 95% effective and has been used successfully when all other therapies have failed. The tablets are taken as a single dose repeated after a week. The cost is around $10.
Spinosad (Natroba). A new neurotoxic drug approved by FDA in 2011, spinosad provokes hyperexcitation and eventually paralyzes the lice and kills them. Two comparative trials showed it was twice as effective as permethrin, and it is safe. Side effects are mild and infrequent: irritation at the application site, eye redness, dry skin, etc. It is approved for age 4 and up. It is expensive ($240) but it usually requires only one application and does not require nit combing.
Comparing effectiveness
It’s hard to draw any firm conclusions about the relative effectiveness of different treatments. Comparing results from different studies is problematic. Different endpoints are used. The incidence of treatment-resistant lice varies with geographic location. Home treatments may not be administered uniformly. Did they follow instructions precisely? Did they leave the product on for the recommended time? Did they comb out all the nits? Did the study measure clinical cure or death of lice?
Back to school
Some schools have had no-nit policies where a child couldn’t return to school until all nits were removed. International guidelines say these policies are unjust and should be discontinued because they are based on misinformation rather than on objective science. Dead nits remain after effective treatment, so finding nits in the hair doesn’t mean the child can infect others.
Conclusion
Head lice are more of an annoyance than a health problem. There is a wide choice of treatments to fit every budget, philosophy, and personal preference. Permethrin is a safe, effective first choice; other remedies can be used if treatment with permethrin fails. Even the most potentially toxic product is seldom hazardous when used as directed. The hot air treatment is a new but very promising non-drug option; I’m staying tuned.

TB Or Not TB? Don’t Rely on a Blood Test
TB can’t be diagnosed with a blood test.
Harriet Hall on August 9, 2022
Link

Tuberculosis has been infecting humans since prehistoric times. It’s still with us. It usually can be cured today with good medical care but is still a serious problem in much of the world, especially among underprivileged socioeconomic groups and some ethnic populations. It kills 1.5 million people every year, and it’s getting more prevalent because of multi-drug-resistant strains and the interaction with HIV infections. Around 80% of people test positive by skin test in third-world countries, compared to 5-10% of people in the US. If you’re old enough, you may remember getting a tine test in school. A device with multiple short needles coated with TB antigens was pressed into the arm. It had to be read 48-72 hours later by measuring the size of the largest area of induration. It was recommended for testing children because it was easy to use, but it was difficult to control the amount of antigen injected. The Mantoux test, with a single injection, is preferred today, but it also requires a return visit to have it read. Skin tests are also known as PPD tests, for purified protein derivative.
TB has three clinical forms: latent (meaning that they have small numbers of TB bacteria in the body that are alive but inactive and haven’t made them sick or caused any symptoms), pulmonary, and extra-pulmonary and remains a disease difficult to diagnose accurately.
Today there are blood tests for TB. Wouldn’t it be great if a simple blood test could reliably diagnose active TB, with no need for a return visit? Unfortunately, it doesn’t work that way. Many techniques have been tried to diagnose TB, since cultures, the gold standard, are slow and can be unreliable. One test that has gone by the wayside is serology, looking for an antibody response to TB.
In July 2011 the World Health Organization (WHO) issued a warning calling for an end to the practice of doing serologic blood tests for active TB, calling it bad practice because the currently available serologic blood tests are "inconsistent, imprecise and put patients’ lives in danger". False positive results can occur because other organisms share the same antigens and the antibodies they produce can be confused with antibodies to TB. The blood tests can have false-negative results that falsely reassure patients that they are disease-free, meaning that infected patients will not be treated. After a rigorous review of the data, the WHO found "overwhelming evidence that the blood tests produced an unacceptable level of false results".
However, new technologies have advanced the diagnosis of latent TB and are of some utility in the complex diagnose of active TB. The two blood tests available in the US that have been approved by the FDA are:
    • QuantiFERON®-TB Gold In-Tube test (QFT-GIT)
    • T-SPOT®.TB test (T-Spot)
These are Interferon Gamma Release Assay, or IGRAs. The patients lymphocytes are incubated with TB antigens and controls. If the patient has latent or active TB, the lymphocytes will release interferon and the increase in interferon is the marker for TB. The IGRA is of more utility for diagnosing latent, rather than active, TB.
These tests are preferred to skin tests for people who have received BCG vaccine, but false-positive and false-negative results are both possible. The other advantage of an IGRA over a skin test is that it requires only a single visit.
Bacillus Calmette–Guérin (BCG) vaccine
A vaccine for TB has been available for almost a century. It is widely used around the world where it is often given to infants at birth. It doesn’t prevent TB but only reduces the risk. Its efficacy may be as low as 19%. It seems to have its greatest effect in preventing miliary tuberculosis or tuberculosis meningitis. It has never been used in the US where the prevalence of TB is low and where the preferred approach has been to detect and treat latent infections. People who were vaccinated with BCG vaccine can have positive skin tests afterwards, but that doesn’t mean they have active TB. However, many never develop a positive PPD or revert to negative after the BCG.
Neither the skin tests nor the IGRAs are sufficient to diagnose a person with active TB. A positive test might mean they could have active TB, but it might just indicate they have latent TB. People with latent TB are not contagious. About one in ten will later develop active TB. The risk of progression to active disease can be reduced by treating them with various short courses of anti-tuberculosis drugs. The risk is not totally eliminated. It is increased if their immune system becomes weakened or compromised in some way, for instance by HIV infection or by chemotherapy. According to the CDC:
A positive TB skin test or TB blood test only tells that a person has been infected with TB bacteria. It does not tell whether the person has latent TB infection or has progressed to TB disease. Other tests, such as a chest x-ray and a sample of sputum, are needed to see whether the person has TB disease.
While PCR to diagnose TB has been problematic, cell free DNA assays show great promise in diagnosing a host of infectious diseases, including TB, with a simple blood draw.
Conclusion: Don’t try to diagnose active tuberculosis with IGRAs
The advice of the WHO should be followed for TB serology. The currently available IGRAs are not sufficient by themselves for a diagnosis of active TB. IGRAs are the best test for latent TB and are part of the diagnostic armamentarium for trying to determine if the patient has active TB. Definitive diagnosis requires follow-up with other tests such as chest x-rays, sputum cultures and perhaps cell free DNA assays. At best, an IGRA might be used to help identify those who need more definitive testing. At worst, it is a waste of money and can misinform through false results.

LYME

Lyme: Two Worlds Compared and Contrasted
Mark Crislip on March 20, 2015
Link


The practice of infectious disease (ID) is both easy and difficult. If you read my ID blog on Medscape you are aware of my trials and tribulations in diagnosing and treating infections.
ID is easy since, at least in theory, diseases have patterns and an infecting organism has a predictable epidemiology and life cycle. So if you can recognize the pattern and relate it to the life cycle and exposure history, you can often make a diagnosis before the cultures come back.
My favorite story is the time I was asked to see a young girl with endocarditis. The history was she had a week of fevers, headache and myalgia that went away for five days, returned for a week, went away for five days and returned yet again.
So I asked her “How was your vacation at Black Butte?”
The look of astonishment on her face as she asked how I knew she had been to Black Butte was so satisfying.
But the pattern was relapsing fever and Black Butte is where all the relapsing fever in Oregon is located. And sure enough, her smear had Borrelia. A course of antibiotics and the spirochete was dead and gone.
However, my son says all I ever do is say “Get cultures and start vancomycin.” How hard is that?
ID is hard because in practice patients do not read the textbooks and do not always present with the correct signs and symptoms. If you have an uncommon infection with an uncommon presentation it can be difficult to diagnose. I get a fair number of these in consultation and syphilis has been the tricky one the last few years. While there is the classic progression from primary to secondary to latent to tertiary, patients often have peculiar manifestations that bypass the classic findings and are sometimes hesitant to mention risk factors.
Once you make the diagnosis of syphilis, you give a course of antibiotics and the spirochete is dead and gone.
Relapsing fever and syphilis are two spirochetal illnesses that can be both straightforward and difficult. Both have well-understood pathophysiology but that doesn’t mean that they are easy to diagnose.
Lyme is also a simple and complex diseases. Caused by the spirochete Borrelia burgdorferi (as least in the US; there are other Borrelia in Europe that cause Lyme and worldwide there at least 36 Borrelia species) its epidemiology, pathophysiology, and treatment are well understood. Like all infections, it can be tricky and present atypically, but the science is clear: there is no chronic Lyme disease that is amenable to long term antibiotics.
Let me mention here, not that it will make any difference, that I do not deny the symptoms and suffering of patients with the “diagnosis” of chronic Lyme. They are often quite ill with something that is not, however, from Lyme.
Unfortunately, in public discourse science and reality do not necessarily triumph over pseudo-science. Last year, New York passed a bill to allow:
rogue doctors [to] be able to shill their non-evidence-based treatments without worrying about intervention.
the bill:
prohibits the state Office of Professional Medical Conduct from investigating a licensed physician based solely upon the recommendation or provision of a treatment that is not universally accepted by the medical profession.
Those protections include, but are not limited to, treatments for Lyme disease and other tick-borne illnesses.
A similar bill is now before the Oregon Legislature, House Bill 916. A public hearing on the bill will be held on Monday, March 30th. I have no doubt that similar bills will be appearing in legislatures throughout the US. They may be there now, unbeknownst to you. I only discovered the Oregon bill by serendipity.
The bill, sponsored by the Oregon Lyme Disease Network, says:
SECTION 1. (1) The Oregon Medical Board and the Oregon State Board of Nursing shall each adopt rules regarding the diagnosis and treatment of Lyme disease.
(2) The rules adopted under this section must:
(a) Permit professionals regulated by the boards to diagnose and treat, in manners consistent with the standards of care guidelines developed by the International Lyme and Associated Diseases Society, Lyme disease and associated viral, bacterial and parasitic diseases;
and
(b) Establish disciplinary procedures that consider as a mitigating factor whether, in diagnosing or treating Lyme disease or associated diseases, a professional who is facing discipline followed evidence-based diagnosis and treatment guidelines not recognized by the boards.
There are two sets of Lyme Treatment Guidelines. One is from the Infectious Disease Society of America and is about to undergo an update from the 2006 guidelines. The guidelines suggest (note the not):
Selected antimicrobials, drug regimens, or other modalities not recommended for the treatment of Lyme disease.
    • Doses of antimicrobials far in excess of those provided in tables 2 and 3
    • Multiple, repeated courses of antimicrobials for the same episode of Lyme disease or a duration of antimicrobial therapy prolonged far in excess of that shown in table 3
    • Combination antimicrobial therapy
    • Pulsed-dosing (i.e., antibiotic therapy on some days but not on other days)
    • First-generation cephalosporins, benzathine penicillin G, fluoroquinolones, carbapenems, vancomycin, metronidazole, tinidazole, trimethoprim-sulfamethoxazole, amantadine, ketolides, isoniazid, or fluconazole
    • Empirical antibabesiosis therapy in the absence of documentation of active babesiosis
    • Anti-Bartonella therapies
    • Hyperbaric oxygen therapy
    • Fever therapy (with or without malaria induction)
    • Intravenous immunoglobulin
    • Ozone
    • Cholestyramine
    • Intravenous hydrogen peroxide
    • Vitamins or nutritional managements
    • Magnesium or bismuth injections
I suspect, given the creativity of those who treat chronic Lyme, that this list will grow in the next version of the guidelines. These are the kinds of pseudo-therapies, and there are many more, that the people with the pseudo-diagnosis of chronic Lyme undergo. All useless, all costly, and, occasionally, fatal. Key in the IDSA guidelines is the avoidance of long term and repeat courses of intravenous antibiotics.
Long term antibiotics are not benign. Besides allergic and other side effects, secondary infections of the intravenous catheters can and has killed people.
A 30-year-old woman died as a result of a large Candida parapsilosis septic thrombus located on the tip of a Groshong catheter. The catheter had been in place for 28 months for administration of a 27 month course of intravenous cefotaxime for an unsubstantiated diagnosis of chronic Lyme disease.
I keep thinking the 27 months is a typo, but it is neither a typo nor atypical in the chronic Lyme world. Twenty five years of infection control has only served to emphasize that unnecessary intravenous catheters can only cause harm and one of the keystones of non-standard chronic Lyme therapy is prolonged intravenous antibiotics.
The other Lyme treatment guideline is from ILADS, The International Lyme and Associated Disease Society. They differ from the IDSA, as noted by ILADS:
The ILADS panel recommendations differ from those of the IDSA. Different guideline panels reviewing the same evidence can develop disparate recommendations that reflect the underlying values of the panel members, which may result in conflicting guidelines. The IOM explains that conflicting guidelines most often result ‘when evidence is weak; developers differ in their approach to evidence reviews (systematic vs non-systematic), evidence synthesis or interpretation and/or developers have varying assumptions about intervention benefits and harms. Conflicting guidelines exist for over 25 conditions and there is no current system for reconciling conflicting guidelines.
It may be more than a simple difference of opinion. But I would note that every recommendation in the ILADS guidelines is based on:
very low-quality evidence.
There are multiple differences in the two approaches to Lyme. First is the belief (belief is what you have when you lack data), unsupported by the preponderance of the scientific medical literature, that Lyme persists despite adequate treatment.
The other major issues concern treatment. ILADS supports prolonged intravenous therapy for Lyme, re-treatment for patients with persisting symptoms after treatment and the use of adjunctive therapies including treatments of co-infections. All are not supported by Lyme literature.
ILADS suggests repeat courses of intravenous antibiotics for patients who remain symptomatic; IDSA does not and the best studies to date supports the IDSA approach:
There is considerable impairment of health-related quality of life among patients with persistent symptoms despite previous antibiotic treatment for acute Lyme disease. However, in these two trials, treatment with intravenous and oral antibiotics for 90 days did not improve symptoms more than placebo.
This is because antibiotics are effective in killing off Lyme:
There continues to be no evidence that viable B. burgdorferi persist in humans after conventional treatment with antimicrobials.
Most studies looking for living B.burgdorferi after treatment have failed and those that do have severe flaws. Antibiotics eradicate the organism and in animal models, where they can culture the entire mouse, 5 days of antibiotics is enough to kill off all the Lyme:
Our findings further document the effectiveness of antibiotic therapy in eradicating cultivable cells of B. burgdorferi, irrespective of tissue or organ site.
The organism does not hide out, protected in some organs, as some believe. As the 2014 NEJM review succinctly puts it:
Several carefully conducted, placebo-controlled, randomized trials of prolonged antimicrobial treatment in patients with persistent subjective symptoms after treatment for Lyme disease have shown a minimal benefit or none and a substantial risk of adverse effects. Consequently, prolonged antimicrobial treatment for subjective symptoms is not recommended in patients whose objective signs of Lyme disease have resolved in response to conventional therapy. Consideration of other causes of persistent symptoms is warranted. In most of these patients, nonspecific symptoms resolve over time without additional antimicrobial treatment.
When it comes to adjunctive therapies, ILADS is less proscriptive than the IDSA:
ILADS agrees that first-generation cephalosporins, intravenous hydrogen peroxide and bismuth injections are not recommended. However, ILADS has concluded that it is premature to exclude other potentially beneficial therapies based on the evidence to date. Therefore, ILADS contends that the use of such agents should not be precluded until studies have demonstrated their ineffectiveness in the treatment of Lyme disease.
A real difference in approach to treatment. Given the potential dangers in all medical interventions, therapies should be precluded until studies have demonstrated their effectiveness in the treatment of Lyme disease.
Lyme diagnosis is also mentioned in the Oregon bill, although the ILADS guidelines do not address issues related to the diagnosis of Lyme. Lyme is classically diagnosed by a two-step procedure: a screening ELISA followed by a confirmatory Western Blot, although the ELISA for antibodies against the C6 peptide may be helpful.
There are laboratories, in my experience evidently beloved by naturopaths, that use unvalidated and unreliable non-standard tests, of which there are many. This is because:
in the mid–1970s, the FDA began exempting certain diagnostic tests from its approval process. Many of these tests — developed, manufactured, and offered by a single lab, such as in a hospital — were variations on common tests, low-risk, or devised for rare diseases and could not be adequately validated.
And Lyme testing has proliferated with all the subsequent false positives in patients and resultant un-needed therapies. Patients often do not realize that when a lab is CLIA certified it means little as to the validity of the testing offered, just as a restaurant being certified as sanitary says nothing about the quality of the cooking.
The FDA recognizes this is a problem with many kinds of tests:
The US Food and Drug Administration, responding to growing concerns that a host of diagnostic tests for illnesses from cancer to Lyme disease may be inaccurately identifying conditions, announced Thursday that it intends to regulate many of the tests.
and there are new guidelines for these tests that may result in less unreliable testing.
I heard a story at a meeting that a company developed a Lyme test and everyone tested positive. Rather than recognize a flawed test, they concluded everyone had Lyme. Probably apocryphal, but the mindset of the Lyme world is often:
No Lyme test has no false negatives, but it is important to understand that there is no such thing as a false positive.
Also popular in the nonstandard Lyme world is treating co-infections. I once had a patient tell me she also had a Babesia infection as well as Lyme, diagnosed at one of the creative Lyme labs by a naturopath. The accompanying photomicrograph had an arrow pointing to…a platelet clump misidentified as Babesia. While there is occasionally more than one infection spread with a tick bite, it is not common:
Often, the controversial diagnosis of chronic Lyme disease is given to patients with prolonged, medically unexplained physical symptoms. Many such patients also are treated for chronic coinfections with Babesia, Anaplasma, or Bartonella in the absence of typical presentations, objective clinical findings, or laboratory confirmation of active infection…The medical literature does not support the diagnosis of chronic, atypical tick-borne coinfections in patients with chronic, nonspecific illnesses.
The ILADS guidelines mention:
A survey of 3090 patients diagnosed with Lyme disease found that laboratory confirmed cases of babesiosis and anaplasmosis were reported by 32.3 and 4.8% of respondents, respectively
Although given that this is a survey, we have no idea as to the rigor with which these diagnoses were made; they may have had misidentified platelet clumps.
This bill is especially worrisome when combined with HB 3301 that designates naturopaths as “primary care” providers. Not only will this bill remove consumer protections from providers of questionable therapies, it has the potential to expand the ability for pseudo-doctors with no standards to provide pseudo-therapies for pseudo-diseases.
The reason that the ILADS approach is not embraced by other organizations such as the IDSA is that their recommendations are not based on the best understanding of the treatment and diagnosis of Lyme and they ignore or rationalize away high quality evidence.
The IDSA is often vilified for supporting the best data and science. When not supported by the science, organizations often resort to the law, a poor way to adjudicate medicine and science; House Bill 916 is no different in that respect to attempts to legislate the value of pi.
Removing consumer protections and institutionalizing substandard medical care will not benefit the health of Oregonians, will lead to the protection of those practicing substandard medicine, and will protect those practicing substandard medicine from being held accountable for their practice.
As an aside, I will mention that I have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed above. The odd thing about the world of pseudo-medicine is that most of the time we are accused of being big pharma shills, prescribing vaccines willy-nilly to line the pockets of our masters. Except for Lyme where we are accused of being insurance company shills, not willy-nilly prescribing antibiotics to line the pockets of our masters. Can’t win for trying.
More information on the status House Bill 916 as well as Oregonians for Science-Based Medicine, part of the Society for Science-Based Medicine.
Other Lyme posts
    • Political Science: Chronic Lyme Disease
    • Lemons and Lyme: Bogus tests and dangerous treatments of the Lyme-literati
    • Does Everybody Have Chronic Lyme Disease? Does Anyone?
    • Connecticut Legislature Intrudes on Debate Over Chronic Lyme Disease
    • Lyme disease—who is credible?

Chronic Lyme Disease – Another Negative Study
Steven Novella on April 6, 2016
Link


While Lyme disease itself is a real and often serious infectious illness, the existence and proper treatment of so-called chronic Lyme disease is dubious, and some would say controversial. However, like many controversies we cover, the science itself is not very controversial, but the topic is made so by a persistent minority of outliers who refuse to accept the scientific consensus.
The issue has been raised yet again by a study published recently in The New England Journal of Medicine: “Randomized Trial of Longer-Term Therapy for Symptoms Attributed to Lyme Disease.” The study was negative, but I will get into the details below.
Lyme disease
Lyme is an infection caused by the bacteria Borrelia burgdorferi, and related species. In Europe the infecting species are B. afzelii and B. garinii. These bacteria are spirochetes, which refers to their spiral shape. They are related to the bacterium which causes syphilis, Treponema pallidum, which is also a spirochete.
Syphilis and Lyme both have three stages of illness – a primary infection, secondary symptoms, and then a persistent tertiary syndrome. With Lyme disease, stage 1 involves local infection, including headache, fever, chills, and local arthritis. Stage 2 is disseminated Lyme, including the classic target- or bullseye-shaped rash at the site of the bite, pain, weakness, fatigue, and diffuse arthritis. Stage 3 is persistent late stage infection, and includes ongoing stage 2 symptoms, heart involvement, and neurological involvement.
As you might suspect, treating the infection early is important and most effective. The bacterium is sensitive to a number of antibiotics. Doxycycline is an oral antibiotic most often given in the early stages. Tertiary Lyme often requires IV antibiotics.
Lyme can be diagnosed by a combination of presenting with the classic clinical features, and a positive antibody titer, which can be confirmed with a western blot test. Antibodies can show an acute infection, or can have a profile that reflects a past infection.
Chronic Lyme disease
Fortunately, most patients will recover from Lyme disease after an appropriate course of antibiotics. The evidence shows that antibiotics are capable of eradicating the infection, and there is no evidence that the spirochete can evade treatment by hiding out somewhere in the body, going dormant, or resisting the antibiotics.
However, 10-20% of patients diagnosed and treated for Lyme disease will continue to have chronic symptoms of fatigue, muscle aches, poor sleep, and cognitive fog. Experts believe in some cases this may be due to a post-Lyme syndrome – the effects of inflammation or perhaps an activation of the immune system. There is also the possibility that symptoms in some cases are not due to the infection itself but to another cause, which may or may not have been triggered by the infection. Possibilities include disturbed sleep, deconditioning, and depression.
There are also patients who never had confirmed Lyme disease but have a similar syndrome of pain, fatigue, poor sleep, and mental fog.
This is where the controversy comes in – there are some patients and practitioners (who sometimes call themselves “Lyme literate MDs”) who believe that these chronic symptoms are due to persistent infection with the Lyme bacteria, and that the proper treatment is recurrent and long term treatments with antibiotics, often intravenous (IV).
Their only real source of evidence for this claim is the apparent response of such patients to courses of antibiotics, and the only real published evidence is case reports and case series or uncontrolled studies. However, responses are subjective and temporary, and often patients require ongoing treatment. This has all the hallmarks of a placebo response.
Physicians and scientists skeptical of this claim (myself included) will point to the fact that patients with alleged chronic Lyme disease are often seronegative (they don’t have antibodies, or their antibodies reflect only past infection), and often lack classic clinical features of Lyme disease.
In other words, chronic Lyme advocates are claiming that their patients have seronegative, atypical, treatment-resistant Lyme disease. That is a lot of special pleading, very much like Sagan’s invisible, floating, heatless, noncorporeal dragon. The more parsimonious interpretation is that these patients do not have Lyme disease.
This is a critical distinction for two reasons. The first is that treatment with antibiotics, especially IV antibiotics, is not benign. There is tremendous potential for complications.
The second is that these patients, if they don’t have chronic Lyme disease, have something else which is being missed because they and their practitioner are distracted by the false diagnosis. This is a missed opportunity to treat the real cause of their symptoms. If there is no treatable cause, it is then better to focus on symptom management and quality of life, rather than chase a fictitious infection.
Treatment trials
Initial research trying to settle the question of whether or not chronic Lyme disease is a real entity focused on trying to find evidence for persistence of the spirochete in patients with symptoms diagnosed as chronic Lyme. Such efforts failed, but did not settle the controversy. Proponents of chronic Lyme just special-pleaded away this negative evidence.
Research efforts then shifted to seeing if such patient responded to courses of antibiotics, with double-blind placebo controlled trials. This is often a good strategy to addressing such questions, because it cuts right to the clinical management question – do these patients benefit from courses of antibiotics?
A 2013 systematic review of the major clinical trials of antibiotic use for patients with alleged chronic Lyme disease concluded:
On the basis of this analysis, the conclusion that there is a meaningful clinical benefit to be gained from retreatment of such patients with parenteral antibiotic therapy cannot be justified.
A 2015 review also concluded:
Prolonged courses of antibiotics neither prevent nor ameliorate these symptoms and are associated with considerable harm.
This brings us to the current study. I found the trial design to be a little unusual, but was justified as trying to replicate how chronic Lyme is often treated in real practice. The study occurred in Europe, and therefore involved the European Borrelia species which causes a slightly different clinical picture than the North American variant.
Enrolled patients did not need to have confirmed prior Lyme disease, so they could include both subjects with post-Lyme symptoms and subjects who never had Lyme. All subjects were given a course of IV antibiotics, ceftriaxone, for two weeks, followed by either placebo or a longer course of oral antibiotics (doxycycline and clarithromycin with hydroxychloroquine.)
The study showed no difference between the treatment and placebo groups, demonstrating that long term antibiotics are ineffective.
In an accompanying editorial, experts who were not part of the study concluded:
Critics may rightly say that this trial does not truly capture with certainty the consequences of bona fide Lyme disease. However, studies with more stringent inclusion criteria have already been conducted, and the approach used by Berende and colleagues probably reflects the common practice in ambulatory care settings, in which patient presentations of fatigue or nonspecific pain prompt serologic checks for Lyme disease, despite evidence suggesting that these tests will not identify a probable cause or result in a treatment benefit.
Conclusion: Where are we now?
If you look at the totality of scientific evidence, it does not support the existence of chronic Lyme disease or the approach of treating patients with long term or recurrent courses of antibiotics.
Patients who end up with this diagnosis tend to have non-specific symptoms that could have many causes, and lack a clinical picture specific to Lyme. They also lack serological proof of active Lyme (although may have had past Lyme). Most significantly, they do not respond to antibiotics in rigorous clinical trials.
Proponents of chronic Lyme essentially just dismiss the scientific evidence, and instead resort to anecdotal evidence of a subjective response to treatment in some patients.
As would be expected, when a group has a persistent belief that experts reject due to lack of scientific evidence, or even evidence of lack of efficacy, conspiracy theories proliferate. In this case the usual “Big Pharma” conspiracy won’t work, because the treatment being offered is pharmaceuticals. So a new enemy was invented, insurance companies. They were made the bogeyman for not wanting to pay for multiple courses of IV antibiotics.
The Infectious Disease Society of America (IDSA), a professional organization of experts who reject the claims made for chronic Lyme (and have been sued for holding that opinion), are also accused of being in on the conspiracy. What possible motive would an infectious disease society have for denying that a common illness is caused by an infectious illness?
This just shows how versatile conspiracy theories are. Villains and motives can be made up as needed out of whole cloth, without any burden of logic or consistency.
Unfortunately, gullible (or perhaps cynical) legislators have fallen for the conspiracy theory. In 2009, for example, my own state of Connecticut passed a law shielding health care providers who treat chronic Lyme with long term antibiotics from being held to any standard of care. Insurance companies and the IDSA were specifically pointed to as perpetrating a conspiracy against such providers.
At the time I argued that it is a folly for legislators to decide on what the standard of care is, let alone enshrine it into law. The standard of care is a moving target that shifts with the scientific evidence. Here we are, 7 years later, and the scientific evidence has only moved more in the direction of rejecting chronic antibiotic treatment for alleged chronic Lyme. There is no lobby, however, to get CT legislators to reconsider their past mistakes on this issue – which is precisely why you shouldn’t calcify a particular practice into law.

Chronic Lyme disease: Fake diagnosis, not fake disease
Believe it or not, an encounter on Twitter actually changed Dr. Gorski’s mind. Chronic Lyme disease is a fake diagnosis, not a fake disease.
David Gorski on May 20, 2019
Link

Today, I’d like to do something a bit different than what I usually do, and that’s to take a step back and discuss how an experience in the weeds on Twitter last week led me to start to think about a term that we frequently use or, more specifically, rethink that term. The term to which I refer is “fake disease,” and my rethinking started innocently enough, with me doing what I do sometimes on Twitter: responding to the promotion of quackery by—who else?—Dr. Mehmet Oz:
So @DrOz is promoting chronic Lyme disease quackery. Why not? He promotes pretty much every ornery major firm of quackery.
Chronic Lyme disease is a fake disease, and long term antibiotics do more harm than good. https://t.co/erLyWNp0sW
— David Gorski, MD, PhD (@gorskon) May 15, 2019
Yes, big surprise, last week Dr. Oz was promoting the quackery that are treatments for chronic Lyme disease. I’ll elaborate a bit more in a moment, but for the moment it suffices to point out that we refer to chronic Lyme disease as a “fake disease” because there is no evidence that the symptoms patients diagnosed with chronic Lyme disease suffer are, in fact, due to the tick-borne spirochete that causes acute Lyme disease. What chronic Lyme disease advocates and “Lyme literate” doctors claim is that the symptoms these patients experience are due to chronic persistent infection with B. burgdorferi or other Borrelia species of bacteria that can cause Lyme disease, and that long term antibiotics (as in months or even years of antibiotics) is the treatment. As we’ve pointed out time and time again, though, there is no evidence that chronic Lyme disease/infection exists, and several randomized clinical trials that show very clearly that long term antibiotics do not help and can cause harm. It is, of course, not surprising that prolonged courses of antibiotics can cause harm. They decimate the normal flora of the colon and other niches where bacteria live on the body while selecting for resistant bacteria.
That’s why the CDC, the NIH, the Infectious Diseases Society of America (IDSA), the American Academy of Pediatrics, the American College of Physicians, and the American Academy of Neurology all reject the notion that “chronic Lyme disease” is a scientifically and medically valid diagnosis and that long-term antibiotics are an appropriate treatment. Over a dozen international organizations, like the Canadian Public Health Network, and the European Federation of Neurological Societies, concur.
With that knowledge in the back of my head, I didn’t really think that my Tweet would garner much, if any, reaction, as it just didn’t seem too controversial to me. Then Dr. Jen Gunter retweeted it, which exposed it to a much larger audience than I’m accustomed to. Twitter, being Twitter, this predictably led to a lot of angry people Tweeting at me or subtweeting my original Tweet. Here are some examples:
Bit by a tick at 7 yrs. old. Despite tx & other antibiotics over the decades for infections & post surgery protocols I tested CDC positive for Lyme 40 yrs later! I have Post-Treatment Lyme disease syndrome, NOT a FAKE disease.
— Leslie B (@ruready1st) May 17, 2019
And the worlds flat….oh and HIV is fake!!!😂 If you cant keep up with advancements in your field then get out!!!
— J.A.C (@ottyjac) May 16, 2019
Someday you will find out you are as wrong about this as the medical community was when they vehemently denied that ulcers could be caused by bacteria. Because of faulty testing guidelines, Lyme goes undiagnosed and untreated for far too long, at which point it becomes chronic.
— Betsy Cahoon (@SwimBikeRowMom) May 17, 2019
This is what I like to refer to the fallacy of future vindication.
You all laugh and poke fun of lyme. My whole family has it and yes we got tested and for me I tested years after treating and was still positive….if it's fake how is it possible?
— Zimbur (@Zimbur1) May 17, 2019
Yes! This charlatan promotes the fraud, corruption & collusion that keeps shrinking our pool of lyme literate doctors, specialists & treatments. Anxiety, depression, PTSD caused by denial/delay of even inadequate treatment, not Lyme/TBD's infections. Pain, inflammation etc igored
— terri scofield (@terriscofield) May 17, 2019
You sir, are profoundly ignorant. I’ve had Chronic Lyme Disease for 14 years now, and have seen my live spirochetes under a medical microscope. You may want to actually listen to the thousands of patients with this disease, and doctors who have experience in treating it.
— Julie Passetto (@poetgirl2) May 17, 2019
DANGEROUS SHILL ALERT. https://t.co/QYi3MBdD6f
— Dana Parish (@danaparish) May 16, 2019
I do so love the “pharma shill gambit,” but let’s continue:
If tests weren’t so flawed, fraud and failing then more Chronic Lyme disease patients would pop up. You’re inconsiderate for a doctor and pretty uneducated. You lack compassionate care. I feel bad for your patients, who almost all have given you a bad review.
— Holly Lyme 13 (@13Lyme) May 16, 2019
Yes, I do have bad reviews on those doctor review sites, but I haven’t been able to find one of them that, as far as I can tell, was actually one of my patients. Why do I say that? Simple. There are various “tells” and dead giveaways, such as mentioning that I mentioned my blog to them. Basically, I never discuss my blog with patients unless the patient brings it up first, and when that happens I only do it reluctantly. I also can’t help but note that posting bad reviews on doctor review sites is a tactic of the antivaccine movement to harass and intimidate doctors who speak out against their pseudoscience.
In any event, you get the idea. A lot of chronic Lyme disease patients were very unhappy at my characterization of chronic Lyme disease as a “fake disease”. Many of them viewed the term “fake disease” as a direct attack on them, an insinuation that they were hypochondriacs or that their symptoms weren’t real. In the intense world of Twitter, where it’s frequently “Tweet first and ask questions later” and the pithy, biting comment is valued more than it should be, it’s easy to fall into the trap of going for memorable sarcasm, and I appear to have done that. After all, far be it for me (or, I daresay, any of the bloggers here at SBM) to deny that patients with chronic Lyme disease experience symptoms ranging from mild to severely debilitating. The message that we as advocates of science-based medicine trying to promote is that, whatever is causing those symptoms, it’s not what “Lyme literate” doctors claim it is. It’s not persistent infection with B. burgdorferi or other Lyme-associated spirochetes after the initial Lyme infection is treated with antibiotics, and treating people with long term antibiotics for months or even years does not help them and can definitely hurt them.
That’s why I’ve reconsidered and will no longer use the term “fake disease” to describe quack diagnoses like chronic Lyme disease. Instead, henceforth I will use the term “fake diagnosis” or “quack diagnosis” to describe these terms. Now, I can hear the more “militant” and “reason-based” of you out there making like Picard in a facepalm meme and asking, “What the heck is the difference?” Certainly, that’s your prerogative, and—who knows?—you might even be right. But hear me out before dismissing me as going all wobbly.
What is “chronic Lyme disease”?
It’s probably worthwhile here to discuss Lyme disease and its treatment. Lyme disease, as you probably know, is the most common tick-borne infection in the Northern Hemisphere. In the US, it is caused by B. burgdorferi, while in Europe multiple spirochetes (e.g., B. afzelii, B. garinii, B. burgdorferi) can cause it. Lyme disease is a complex infection and has a number of objective signs after one is bitten by a tick harboring Lyme-causing spirochetes, the most common of which is erythema migrans, which is seen early in the infection in about 80% of Lyme disease cases and sometimes called a “bull’s eye rash” because that’s what it often looks like. Even if it doesn’t look like that, it’s still a characteristic expanding rash. Other early symptoms can include fever, fatigue, and headache, while more advanced symptoms can include neurologic symptoms, joint pain and stiffness, severe headaches with neck stiffness, and cardiac symptoms such as palpitations. All of these symptoms usually respond well to conventional antibiotic therapy. However, as noted in a New England Journal of Medicine (NEJM) Current Concepts article:
Despite resolution of the objective manifestations of infection after antibiotic treatment, a minority of patients have fatigue, musculoskeletal pain, difficulties with concentration or short-term memory, or all of these symptoms. In this article, we refer to these usually mild and self-limiting subjective symptoms as “post–Lyme disease symptoms,” and if they last longer than 6 months, we call them “post–Lyme disease syndrome.”
It’s true. There is a subset of patients who’ve been treated for properly diagnosed Lyme disease who still have symptoms that persist months or years after treatment, perhaps 10-20% who will develop chronic symptoms of fatigue, muscle aches, poor sleep, and cognitive fog, hence the term post-Lyme disease syndrome. What cause of these symptoms remains poorly understood. Perhaps they’re sequelae of inflammation or an activation of the immune system, or perhaps they’re due to another cause that was triggered by the acute infection. We don’t know yet. What we do know is that there is no convincing evidence that these symptoms are due to persistent B. burgdorferi infection or that long term antibiotics are required to eradicate the disease. Sure, “Lyme literate” doctors point to anecdotes of sometimes-dramatic improvement after long term antibiotics, but anecdotes are one of the lowest forms of medical/scientific evidence, and multiple well-designed clinical trials have failed to demonstrate that longer courses of antibiotics relieve these patients’ symptoms.
The article also echoes the CDC and NIH in pointing out that many patients diagnosed with “chronic Lyme disease” have no evidence of having or ever having had Lyme disease in the first place:
The diagnosis of chronic Lyme disease and its treatment differ substantively from the diagnosis and treatment of recognized infectious diseases. The diagnosis is often based solely on clinical judgment rather than on well-defined clinical criteria and validated laboratory studies, and it is often made regardless of whether patients have been in areas where Lyme disease is endemic.6,7 Although proponents of the chronic Lyme disease diagnosis believe that patients are persistently infected with B. burgdorferi, they do not require objective clinical or laboratory evidence of infection as a diagnostic criterion.
Thus, for “Lyme-literate” MDs, naturopaths, chiropractors, and all manner of other dubious practitioners, “chronic Lyme disease” is a wastebasket diagnosis that “Lyme literate” doctors use for patients with unexplained chronic symptoms. The symptoms are real, hence my objection to the term “fake disease”, but the diagnosis is not based on science or any conventionally accepted reproducible diagnostic criteria. Yes, the NIH notes that there are studies showing that “B. burgdorferi may persist in animals after antibiotic therapy”, including in mice and nonhuman primates, but in the nonhuman primates the NIH noted that it was “not possible to culture these bacteria and it is not clear whether they are infectious.” Not surprisingly, “Lyme-literate” doctors point to these studies as evidence that chronic Lyme disease is a real entity caused by persistent infection with B. burgdorferi. Unfortunately, randomized clinical trials are where the rubber hits the road, and if chronic antibiotic therapy doesn’t improve the symptoms of patients diagnosed with post–Lyme disease symptoms or syndrome, it’s unlikely that the persistence of the Lyme spirochete is the cause of those symptoms, even if someday scientists demonstrate the persistence of B. burgdorferi in humans after standard treatment for Lyme disease.
Fake diagnoses: Beyond chronic Lyme disease
In light of my discussion above, I note that, yes, I’m aware that symptoms do not a disease make. How often do you or I have a headache that goes away, aches and pains, or unexplained fatigue that resolves, none of which are associated with a definable disease? It’s called living and getting older. We all experience these things from time to time, some of us more than others. I’m also aware that, although it might seem deceptively straightforward at first glance, defining just what a “disease” is can be devilishly tricky. I’m not going to go into the weeds of that discussion right here, other than to note that defining a disease is often the necessary first step to determining how to treat it. That’s why it’s so important to note that these patients with chronic symptoms have been labeled as having a disease. Whether the definition of that disease is supportable by science or not doesn’t matter in terms of the explanatory power that it has for the patient. The label assures them that someone is taking their symptoms seriously, as does the treatment associated with the label. That’s why so many of them react so strongly to an attack on their fake diagnosis as a fake disease.
I like the term fake diagnosis more than fake disease, because it’s such a generalizable term in pseudomedicine. I bet that, if you just took a minute to think about it, you could name quite a few other fake diagnoses. If you think about it more, you’ll realize that these fake diagnoses are applied to patients with real symptoms that are as yet unexplained. In my experience having studied these things for nearly two decades, I’ve concluded that, in addition to chronic Lyme disease, the most common fake diagnoses used by quacks include adrenal fatigue; chronic candidiasis; heavy metal toxicity (I still can’t believe that no one’s named a rock band after this); electromagnetic hypersensitivity (sometimes called EMF or Wi-Fi allergy); or deficiency of a nutrient or nutrients, my favorite example being orthomolecular medicine, a whole pseudomedical specialty constructed around testing as many nutrient levels as possible and then massively supplementing any “deficiencies,” whether the deficiency is real or not, whether it needs supplementing or not.
Like chronic Lyme disease, these diagnoses are vaguely and poorly defined, such that basically any patient with any set of puzzling and persistent symptoms can be shoehorned into one of these diagnoses. All of these conditions allow quacks to provide the illusion of “treating the cause, not the symptoms” and to exercise “individualization” of treatment so extreme that they can basically do whatever they want or, as I like to say, make it up as they go along. That same fetish towards “individualization” makes patients feel special and cared for more than a cold, standardized diagnosis and science-based, sometimes algorithmic, treatment or, even worse, lack of a definable diagnosis to explain their symptoms.
What’s the harm of fake diagnoses? Plenty!
What’s the harm of these fake diagnoses? you might ask. Plenty! First and foremost, the problem with placing a fake diagnosis on a set of symptoms that a patient is experiencing is that it can forestall proper medical investigation that might find the real cause of the patient’s symptoms. Indeed, in response to one of my Tweets, just such a patient stepped forward:
Agreed! https://t.co/KVNRL5KMpG
— It's Training Cats and Dogs🐱🐶 (@AbbyHartman) May 16, 2019
Her essay, Lyme Warrior No More, is well worth reading. Here’s a relevant excerpt:
For nearly 11 years, I told people I had chronic Lyme disease. It wasn’t true. Then I told people I had Post Treatment Lyme Disease Syndrome, but that can’t be true anymore, either. The one thing I know for sure is that I was a victim of “chronic Lyme” treatment. This consisted of false diagnoses, long-term antibiotics, and other inappropriate drugs and supplements, all based on dangerous pseudoscience.
People who identify as having chronic Lyme usually become entrenched in a cult-like support group community both online and in real life. These Lyme groups are echo-chambers for pseudoscience. They convince followers that they must see self-appointed and often secret “Lyme-literate doctors” (LLMDs) who will treat them for chronic infection. These groups empower their marginalized members with validation, support, and the ability to even treat themselves by comparing notes when there is no access to a LLMD. Their multiple conspiracy theories mirror those of the anti-vaccine community in many ways, and both movements overlap. As it is with cults, it doesn’t matter who you are or how educated you are, anyone can get sucked in. However, this community is disproportionately female. I suspect one reason is that more women report not being taken seriously by doctors, and perhaps many women have little choice but to look to the fringes for help out of desperation. Once you’re marginalized, vulnerable, desperately ill, entrenched in online pseudoscience and conspiracy theory echo chambers, and wooed by the nicest quacks you’ll ever meet, you’re a Lyme Warrior. If you or someone you love is a Lyme Warrior, then please learn from my mistakes.
Her doubts finally started to lead to her leaving the world of chronic Lyme disease quackery when she was told that her son had “congenital Lyme” based on his chronic pain and testing positive for Lyme by a “Lyme literate doctor’s” standards even though he tested negative by CDC standards:
After a few rough nights, I told my husband I was thinking about treating our son for Lyme, but I wasn’t sure if that was the right thing to do– I just couldn’t watch him suffer anymore. My husband had more doubts than me. He wondered if my son was mimicking my own illness he’d been witness to instead of it really being real. I wondered this, too. We decided to wait and talk to Dr. Anderson more. Dr. Anderson did a fantastic job of convincing me with perfect patience and compassion that congenital Lyme is pseudoscience. He also went out of his way to research for over a year until he finally figured out that my son had joints that grossly hyperextended (future contortionist?), which could cause this amount of pain and nightly pattern of pain while growing. Physical therapy was the answer. His pain stopped. Aszani Stoddard, on the other hand, was trying to convince me to treat him and referred me to a Lyme-literate nurse practictioner who treats children at Newbridge Clinic. I declined. She even appealed to my duty to protect my son from medical neglect. This was when I found myself Googling “is chronic Lyme disease real?” in earnest.
The result was that she found Lymescience.org, which led her to question her “Lyme literate doctors” even more and:
I reached out to friends, family, and even veterinarian coworkers with extensive knowledge about Lyme in dogs. I was shocked to learn that some people close to me knew this was quackery and didn’t speak up before I did, even feigning support. This was more upsetting to me than if they had argued with me about my illness really being Lyme, which feels like gaslighting for sick people. I watched my son get back to normal with no Lyme treatment. I felt myself getting better off antibiotics. I spoke with others online who are victims of chronic Lyme treatment. I left my integrative medicine doctor and found a traditional MD. I was no longer a Lyme Warrior.
My new doctor has never heard of the cult of chronic Lyme and stared at me in shock when I told her my story. She thinks my mysterious illness is partly damage done, and she is properly appalled that people think chronic Lyme is a real thing. I trust her to tell me the truth, even if it’s not what I want to hear, and I trust she’ll do it compassionately. When you’ve lost everything to illness, you build up a network of support in which to survive it. People who leave the chronic Lyme cult are often still ill, but now they’re without support to boot. They are even attacked by other Lyme Warriors for speaking out. Honestly, if my speaking out means I might indirectly save even one child from harm, then it is worth it. Being able to eat gluten again isn’t so bad, either.
Indeed. I realize that it must be horrible for these patients who have unexplained symptoms. There’s no doubt that we in medicine need to do better by these patients. However subjecting them to quackery is not the answer.
There are other stories of just this sort of phenomenon. Worse, the cult of chronic Lyme and “Lyme literate” doctors has political power. They’ve not only persuaded state legislators in some states to introduce bills mandating insurance coverage for long term antibiotics for chronic Lyme disease (and in some cases, like Massachusetts, passing them into law, legislators there overrode a veto by the governor so that insurers would have to pay for long-term antibiotic treatment) and protecting “Lyme literate” doctors from sanctions.
Fake diagnosis, not fake disease
This brings us back to the concept of referring to entities like chronic Lyme disease or adrenal fatigue as fake diagnoses or quack diagnoses rather than as fake diseases. I realize that some might view this as a minor matter, a quibble, but as a physician I do not. We at SBM started and continue this blog in order to protect patients from unscientific, ineffective, and potentially harmful medicine. Given that, I, at least, do not want to do anything that patients, even erroneously, interpret as attacks on them. It’s become clear to me that they do interpret the term “fake disease” that way. The term “fake diagnosis” or “quack diagnosis” however, directs the charge of fakery right where it belongs, at the quacks making the bogus diagnosis. The symptoms these patients experience are real. The diagnoses used by quacks to describe these symptoms are not.
I’m under no illusion that a simple change in terminology will lead patients with fake diagnoses to be less hostile to science-based medicine. Nor am I under any illusion that medicine does anywhere near as good a job as it should deal with chronic symptoms that don’t fit easily into a specific disease. On the other hand, language matters, and there is utility in trying to be as clear as possible. Using the term “fake diagnosis” or “quack diagnosis” does help to remind me (and, I hope, others) to take the patient’s complaints and symptoms seriously even if I can’t explain them now and to put the blame for quackery where it belongs, on the quacks, by reminding myself (and, I hope, others) that it’s the quacks who make the fake diagnoses, not the patients and that the answer to helping poorly-understood symptoms is not pseudoscience.

Lemons and Lyme: Bogus tests and dangerous treatments of the Lyme-literati
John Snyder on July 18, 2014
Link
It’s that time of year when every day I can expect to see at least one patient with a concern about Lyme disease. In Lyme-endemic regions such as Western Massachusetts, where I practice pediatrics, summer brings a steady stream of children to my office with either the classic Lyme rash (erythema chronicum migrans, or ECM), an embedded tick, a history of a tick bite, or non-specific signs or symptoms that may or may not be due to Lyme disease. Sometimes the diagnosis is relatively straightforward. A child is brought in after a parent has pulled off an engorged deer tick, and there is a classic, enlarging ECM rash at the site of the bite. More often the presentation is less clear, requiring detective work and science-based reasoning to make an informed decision and a diagnostic and therapeutic plan based on the best available evidence. Depending on the story, the plan may include immediate treatment without any testing (as in the straightforward case described above), immediate testing without treatment pending test results, or waiting as we watch and see how a rash progresses before doing anything. An example of this latter course of action would be when a patient comes in with a pink swelling at the site of a new tick bite. In this case, it may not be clear if the swelling is a Lyme rash or simply a local reaction to the bite, a much more common occurrence. The classic ECM rash (an enlarging, red, circular, bull’s-eye rash at or near a tick bite) typically develops 1-2 weeks after a tick bite, but can occur anywhere from 3-30 days later. It then expands and darkens over another 1-3 weeks before fading. This classic rash is not the most common rash of Lyme disease, however, as it occurs in only about 30% of cases. Instead, the rash may be uniformly pink or red (or even darker in the center) without the target-like appearance, or may be a linear rash, expanding outward from the tick bite site. In the case of a patient who comes in with a vague, pink swelling within a day few days of a tick bite, we will typically wait and see what happens to the rash. If it is a local reaction, it will likely resolve within another few days. With Lyme disease, the rash will continue to enlarge and declare itself as an ECM rash. Another unclear and not uncommon situation is when a patient comes in with non-specific symptoms such as fatigue, musculoskeletal pains, and headache. If warranted by the history and the physical exam, we may in this case order Lyme testing. This may not give us an answer even if the patient has Lyme disease, because results are often negative in the first few weeks of the disease. In this case, if symptoms persist or evolve, we will repeat the testing in another few weeks at which point true Lyme disease will test positive and can then be treated. The good news is that the treatment of Lyme disease, particularly in the early, localized phase of the disease, is extremely safe and effective with a 14-day course of antibiotics. The testing is also relatively straightforward, with very good sensitivity and specificity when performed correctly. And this is where the bad news comes…
Lyme-literate doctors
Though providers who choose to practice a science-based approach to caring for their patients stick to the CDC-recommended testing protocol, created using the best evidence, there are many so-called “Lyme literate” providers who stray from the evidence-based path to offer up a potpourri of unapproved, non-recommended, and expensive tests to their patients. The purpose of these tests is without a doubt to detect cases of Lyme disease that other, presumably Lyme-illiterate providers missed due to their “close-mindedness” to these superior tests. Before we discuss these maverick, enlightened providers further, let’s review the tests that are currently recommended by the CDC and the best available evidence.
The CDC has set forth a relatively simple protocol for the use of laboratory testing to confirm a suspected case of Lyme disease. The current, science-based consensus on laboratory diagnostic testing for Lyme disease comes from the Second National Conference on Serologic Diagnosis of Lyme Disease, which convened in 1994. Based on the best available evidence, the Conference recommended a two-step testing protocol using a single blood sample.
Step I: ELISAIn step I, an enzyme-linked immunosorbent assay (ELISA) is used to detect antibodies to a wide assortment of antigens from B. burgdorfori, the Lyme organism. If this test is negative, it is likely that either the patient does not have Lyme disease, or that the test was performed too early in the course of the illness (the first 3-4 weeks). In this case, the test should be repeated in a few weeks, assuming the diagnosis is still being considered due to persistent signs or symptoms. If, on the other hand, the result of step I is positive or equivocal, a more definitive and specific test is performed.
Step II: Western BlotIf Step I is positive or equivocal, we move to step II, the Western blot (WB) test. This looks for antibodies to specific Lyme proteins that have been separated based on their molecular weights. These separated proteins are then exposed to the patient’s blood sample. If the patient has antibodies to these proteins, they bind to them and are visible as bands on the WB. A specific pattern of positive bands of sufficient intensity are required to be present for the WB to be interpreted as positive.
When performed correctly, this test is considered highly specific for Lyme disease. When well-trained individuals at certified labs perform the correct FDA-approved tests in appropriate circumstances, and when providers interpret the results correctly, Lyme disease testing can be a reliable way to confirm or rule out the disease with a high degree of validity. Unfortunately, this does not always occur.
Confirmation bias and the Lyme-literati
Individuals who believe they have Lyme disease that was missed by their own providers will sometimes seek out so-called “Lyme-literate” providers; I’ll call them Lymlits. Often these individuals believe they are suffering from chronic Lyme disease (a non-entity discussed elsewhere), and are hoping to confirm this diagnosis. Lymlits provide the confirmation bias these patients are looking for. They quickly empathize with these patients and offer what they claim to be a more informed approach to their diagnosis and treatment. Like all alternative medicine providers (and make no mistake, that is exactly what we are talking about here), they are quick to cast the patient’s more conventional provider as shackled by convention, or to Big Government or Big Pharma. Often they claim a more holistic approach as well, infusing other sCAM modalities or spiritualism into the mix. Again, like many sCAM providers, they claim special knowledge and insights not available to or ignored by conventional providers. To the sCAM-credulous, the Lymlits represent an open, understanding ear and long-sought answers to their problems.
The websites of Lymlit providers clearly pander to the fears, anxieties, and preconceptions of their clients. Often they contain entire sections devoted to the “problem” of undiagnosed (but not over-diagnosed) Lyme disease, and how the Lymlits can help uncover the diagnosis and provide the correct (often dangerously incorrect) treatment. The patients I see at my practice who have bought into a wide variety of woo diagnoses and treatments have often been seen by providers of the Northampton Wellness Center, and the over-diagnosis and treatment of Lyme disease is no exception. Their services are so typical of this this kind of practice that I will use them as an example. A quick perusal of their website’s Lyme disease section should be of concern to anyone who cares about the practice of EBM and SBM. Like many sCAM practitioners, this group does not serve as primary care providers but rather as “consultants”. This is a misnomer, however, as they are rarely consulted by science-based providers. Rather, patients typically self-refer. Using a “holistic” approach, they claim the ability to help patients with chronic illness who have not been helped by their conventional providers. What they offer is reassurance that they have come to the right place, that they will get the answers they are looking for, and receive treatments not available through most providers. Ironically, their diagnostic tests and treatment modalities are usually described with terms borrowed from true science, and are often claimed to be evidence-based as well. The Northampton Wellness Center’s website seems to do everything possible to reaffirm people’s fears about their chronic or undiagnosed Lyme disease. It explains why the organism is so tricky to diagnose and treat (it really isn’t), and how they can do so safely, effectively, and often “naturally” and “holistically”. They hype the existence and importance of biofilms, co-infections, weakened immune systems, and heavy metals in the pathogenesis of Lyme disease, and explain how they can help diagnose and fix these problems. And unsurprisingly, the Northampton Wellness Center website has the clear red-flag seen on many other sCAM practice websites – the ubiquitous web store. These stores typically hawk all manner of supplements, potions, and snake oils to treat your every ailment. I couldn’t access the Northampton Wellness Center’s web store without being a patient, so I don’t know exactly what they offer the chronic Lyme sufferer. Perhaps most alarmingly, Lymlits like those at the Northampton Wellness Center hype unapproved and non-recommended laboratory tests for diagnosing Lyme disease in their patients. One example is an extended, purportedly-superior Western blot assay. According to their website:
Unfortunately, most laboratories leave out the most specific bands, 31 and 34, on their Western Blot assays. If we use a special laboratory and get a positive band 31 result, we can confirm that this is truly related to the Lyme organism by doing a “31 kDa epitope” test, to make sure it is not positive from a cross-reaction, which could occur from having a chronic viral infection.
Without getting too deep into the weeds here, the Internet is rife with conspiracy theories about why the CDC would fail to include the 31 kDa band in the group of bands required to be present for a positive Western blot interpretation. At the heart of the conspiracy is the belief that this band, which represents OspA, the outer surface protein of B. burgdorferi, was left out because OspA was the main component of a Lyme vaccine (Lymrix) which is no longer available but was given to nearly 2 million people before it was taken off the market. The allegation is that the band was not included because people who had received Lymerix would likely test falsely positive. Given the limited number of individuals vaccinated with Lymerix, this seems an unlikely explanation. Another allegation is that the CDC and FDA do not want people to be diagnosed with Lyme disease as a result of a conspiracy involving the insurance industry. However, as explained by Halperin et al. in the book Lyme disease: an evidence-based approach, the explanation is much more mundane (and rational) than this:
the bands selected for use in the Western blot were chosen not because they are unique to B. burgdorferi but rather on the basis of statistical considerations that included an analysis of those combinations of bands that provided the best predictive values for well-characterized specimens known to have been obtained from individuals with and without Lyme disease
In other words, though OspA is a relatively specific marker for infection with B. burgdorfori, in the assessment of actual patients it was not found to be among the group of bands which best distinguished Lyme disease patients from controls.
They go on to add that that:
laboratories using criteria other than these must establish the validity of their own criteria based on equally rigorous scientific assessments.
Scientists are actively working on better, more sensitive and specific diagnostic tests for Lyme disease. But it will take reproducible and validated results to move these tests forward. Not the direct marketing of unsupported tests to Lymlits by specialty labs. Other examples of unapproved and non-recommended tests discussed on the Northampton Wellness Center website and recommended by many Lymlits include dot-blot testing, PCR, and T-lymphocyte response assays. The CDC clearly states that none of these tests are sufficiently reliable for diagnosing Lyme disease. In 2005, the CDC became so concerned about the proliferation of non-validated and potentially dangerous tests for Lyme disease, that it issued an alert in its Morbidity and Mortality Weekly Report (MMWR). In April of this year, the CDC issued yet another warning about a new laboratory-developed culture method that has been made available commercially. Again, the CDC has warned that the results of these types of “home-brewed” tests should not be relied upon. According to the warning:
Published methods and results for this laboratory-developed test have been reviewed by CDC. The review raised serious concerns about false-positive results caused by laboratory contamination and the potential for misdiagnosis.
The CDC’s warnings are justified. While Lymlits claim these specialized tests are better able to detect Lyme disease than those used by conventional practices, what they do, in fact, is produce a predictable increase in false-positive results. Thus, by pretending to have superior testing options than those provided by the patient’s primary care provider, Lymlits provide patients with the elusive Lyme disease diagnosis they are searching for, and then offer unnecessary treatments for a non-existent infection. Ignoring the science-based treatment recommendations of the Infectious Disease Society of America (IDSA), Lymlits often recommend dangerously long, sometimes intravenous courses of antibiotics, in addition to myriad other potentially dangerous sCAM modalities for the treatment of these questionable infections. Additionally, the misdiagnosis of Lyme disease in these individuals potentially delays the diagnosis of other, real conditions, which then go untreated.
Ironically, Lyme advocates and Lyme-conspiracy proponents were at the forefront of the manufactroversy surrounding the demise of Lymerix, the first FDA-approved Lyme vaccine. Although Lymerix, whose main component was the OspA protein, was not the most effective vaccine (with an efficacy rate <80%), it was still a cost-effective preventative strategy for people at risk in endemic areas. Unfortunately a slew of adverse events reported soon after the vaccine was licensed, combined with an irresponsible (but predictable) media storm, put a chill on the use of the vaccine, eventually leading to its economic failure and being pulled from the market. Pre- and post-marketing studies involving large numbers of patients failed to link any significant adverse events to Lymerix beyond the usual injection site redness and swelling and occasionally fever seen with other vaccines. There was some evidence that a small subset of people with the HLA-DRB1*0401 genotype might be at risk for developing an autoimmune reactive arthritis in response to the vaccine, though the data was inconclusive and did not prove causality. Still these concerns, combined with the spreading fear of unsupported adverse events and the ensuing media frenzy was enough to put an end to the vaccine, a vaccine that could have led to the prevention of many cases of Lyme disease.
Conclusion: Lymlit tests are not supported by good evidence
Lymlit doctors claim they are providing their patients with a service that most others are either unwilling or lacking the knowledge to provide. They balk at the argument that these tests are not supported by sufficient evidence of validity, citing junk science, data from the proprietary labs themselves, or anecdote to support their position. These arguments are often shrouded in conspiracy theory, invoking closed-door sessions in which physicians and scientists do the bidding of Big Pharma or the insurance industry. So-called Lyme advocacy organizations have evolved to support individuals who believe they have chronic Lyme disease or Lyme disease undiagnosed by their doctors. While research is underway to develop even more sensitive and specific tests for diagnosing Lyme disease, the current strategy recommended by the CDC is the best we have to date. Unfortunately, as long as there are providers willing to pander to conspiracy theorists and to patients looking to confirm their fears, people will continue to be needlessly treated, and our societal approach to science will move further back in time.

Lyme Testing
Mark Crislip on January 8, 2016
Link


I hate those oh hell moments. I was up way too late last night, but who can pass up the opportunity to see Patti Smith playing Horses (and more) for the 40th anniversary of the album. Only 44? Behind the Eagles? No way. I would nudge it up a few more spaces. Hard to believe I was 18 when that album came out. Horses is one of the few albums that made the transition from vinyl to CD. It was a tremendous show, and at 69 Patt performs with the energy and passion of a 29 year old. And she sure can spit. I had the evening off, so food and drinks at Swine until well past midnight. First time my wife and I closed a bar. I am too old for this.
But as I was blearily drinking my a.m. coffee on a dreary PDX morning, I opened the browser to SBM and there was a post by Jann. Oh hell. That means I have a post due tomorrow and I had lost track of the time over the holidays. I thought my next post was next Friday. Oh. Hell. So unlike most posts which I write over a week, this one was done in about 4 hours. And I am sure it will show.
How do you diagnose an infection?
Not always so simple. You always start with a history and, for infectious diseases, an exposure history is paramount. People get what they are exposed to, so you want to know travel, animals, diet, water, sex etc. If you have ridden a horse to have sex in an Indian lake while drinking raw milk (not really an unusual history in my practice; people do the darndest things) you have exposure risks for a variety of infections. If you have not left the Willamette Valley it is unlikely that the cause of the illness is malaria, although you always have to consider that the infection came to the patient rather than the other way around.
A panoply of bacteria
In Oregon it is also unlikely that the cause of your symptoms is Lyme, as we do not have much Borrelia in the state. Yet there are many symptomatic people who have a positive blood test for Lyme. Having a positive blood test for a disease is a very powerful confirmation that you have a disease, right? Well, yes and no. Like much of medicine, it is not as straight forward as one would like.
First, Borellia. In the US, Lyme is due to Borrelia burgdorferi. In Europe there are Borrelia burgdorferi, Borrelia afzelii, and Borrelia garinii. And there are the relapsing fever Borrelia, B. recurrentis, B. hermsii, B. parkeri, or B. miyamotoi, the last probably more common than suspected. And there are other spirochetes, like syphilis and leptospirosis, in family. Spirochetes are a large phylum of what I think are particularly evil appearing organisms. They just look pathogenic and I can always imagine them corkscrewing into tissues to cause disease.
The gold standard in ID for diagnosis is culture. If you can grow the organism then you have the diagnosis. Usually. Again it depends. The world is a remarkably filthy place and sometimes the cultures are contaminated. And more aggravating are negative cultures. There are a variety of reasons that cultures can be negative, but the main one is that we simply cannot grow the vast majority of microorganisms from people or the environment. Some organisms, such as Borrelia, are too difficult to grow outside of specialty labs.
When you can’t grow an organism you have to rely on less accurate methods of diagnosis. Some diseases, like syphilis and extrapulmonary tuberculosis, remain very difficult to rule in or out with confidence, despite plaguing humans for millennia.
Lyme testing: Do little but dab it
For US Lyme we rely on indirect, two-step testing to determine if the disease is present; first is a screening ELISA followed by a confirmatory western blot. The test we use was validated in patients with culture-proven Lyme, so we know what the false positive and negative rates are, the sensitivity and specificity.
The ELISA is a screening test and, like many screening tests in ID, are designed to be overly sensitive. You don’t want to miss a real case of Lyme but it is at the cost of having a positive test that due to other processes. Remember all those spirochetes mentioned above? They, and other infections, can lead to a positive Lyme ELISA. The ELIZA is sensitive, but it is not specific. It will pick up Lyme, but a lot of other diseases as well.
To get a more specific answer, you do a western blot. The western blot has two flavors, the IgM (for acute disease) and the IgG (for more prolonged disease). IgM is the first antibody to respond to infection, lasting a couple of months and eventually supplanted by IgG, which is lifelong. The current testing may occasionally give a positive that is actually from infection due to B. miyamoitoi in the US, but for spirochetes, there is not a lot of data, but most will have a negative western blot.
So a positive standard two step Lyme test says you have (or had if it was treated) Lyme disease. But that is the problem with serology – it does not say if you have active disease or reinfection. That is where risk and symptoms come to play.
The diversity of species
But what about European Lyme? Is the Borrelia in Europe the same as in the US? Doubt it. Organisms separated by geography will diverge. It has happened with histoplasmosis, coccidiomycosis and Plasmodium ovale to name but a few. They may look the same and act the same but genetically they are different. The same applies to US and European Borellia; they are different enough that it affects testing. The US two-step test was developed against a US strain of Borrelia and is probably not optimal for the diagnosis of European Lyme. A better test if you can’t fly back to Germany is probably the C6 ELISA, and that may be a sufficient screening test that does not need a confirmatory Western blot.
It is an interesting question whether the genetic diversity of Borrelia as you get further away from the NE epicenter may alter the sensitivity of Lyme testing if using tests developed in the US. There are also issues in the future with genetic drift due to climate change and the movement of the animal reservoirs, the natural evolution of the organism, and the discovery of other Borrelia that could affect the epidemiology and testing for Lyme. As of now, these do not appear to be issues and the standard testing remains both sensitive and specific for diagnosing Lyme.
All this testing is under the assumption that there is a reasonable pretest probability that the patient could have Lyme. If the pretest probability is low, as in Oregon, any positive test in a patient with no risk and atypical symptoms is likely a false positive:
Predictive value is determined both by test characteristics (sensitivity and specificity) and, importantly, by the population in which it is used. The practice of testing patients with a low likelihood of Lyme disease can generate more false-positive results than true-positive results, resulting in misdiagnosis and thereby harming ill people…However, when the pretest probability is low, most positive test results are false positives (67%).
That is a tough concept for doctors and patients to wrap their heads around with any type of testing. The test is positive; it must be due to disease.
What about other Lyme tests?
With little oversight, laboratories can develop their own tests and offer them to patients. The questions are whether they are accurate, and what they were validated against, so you know what the true sensitivity and specificity is. Many of the alternative tests for Lyme have no documented validation, so their sensitivity and specificity is not known. And some labs have their own unvalidated interpretation of the standard two step. Any indirect test for infection has to be validated against a population with known disease, patients with positive cultures, to be of use.
The specialty labs for Lyme testing have been evaluated and found to be wanting, with false positive rates approaching 50% depending on the lab. With the Lyme specialty laboratories:
…one could claim that their methods provided greater sensitivity. However, this increase in sensitivity came at what can only be considered an unacceptable price, a steep decrease in specificity: 15 of 40 (37.5%) of the normal healthy controls met their IgM criteria, 11 of the 40 (27.5%) met their IgG criteria, and 23 of the 40 healthy controls (57.5%) met one or the other.
Widespread testing for Lyme in populations at little risk for the disease offers little benefit:
With 20%–25% of the population having nonspecific complaints, the positive predictive value of a positive serology using CDC criteria, IgG only for complaints of >4 weeks, is extremely poor. It is certainly not diagnostic. For serologies with specificities like those of reported for Lyme specialty laboratory B, a “positive” serology in this patient population has such a low positive predictive value that it has virtually no value. Simply stated, basing a diagnosis of LD or any other tick-borne infectious disease on the presence of ≥1 of these common vague symptoms is unjustified.
These unvalidated tests are one of the reasons why the FDA is in investigating the process by which these labs offer their tests.
And, interestingly, those with false positive Lyme serologies get labeled as chronic Lyme disease but their clinical presentation is identical to patients diagnosed with chronic fatigue syndrome (now called systemic exertion intolerance disease, abbreviated SEID). Whatever the etiology of SEID is, it is a debilitating illness and sloppy diagnostic testing will result in patients being funneled into the black hole of chronic Lyme treatment instead of, hopefully, the more fruitful future of SEID research.
Alternative tests: More “science fiction” than science
Other diagnostic tests not to be used for Lyme:
    • Capture assays for antigens in urine
    • Culture, immunofluorescence staining, or cell sorting of cell wall-deficient or cystic forms of B. burgdorferi
    • Lymphocyte transformation tests
    • Quantitative CD57 lymphocyte assays
    • “Reverse western blots”
    • In-house criteria for interpretation of immunoblots
    • Measurements of antibodies in joint fluid (synovial fluid)
    • IgM or IgG tests without a previous ELISA/EIA/IFA
And, unfortunately, the PCR is of little use.
Of course it’s really all just a conspiracy!
There does need to be better Lyme testing. As a practicing ID doctor, tests like these are an indirect means of diagnosing disease; while very good, they are still far from ideal. I am sure there will be no CDC-supported test that will satisfy those who believe in chronic Lyme disease. In that universe there are no false positive tests, only false negatives, and the CDC and FDA are in a conspiracy to cover up the truth about Lyme.
For Lyme, and many other infections, diagnosing a disease is not based on a test in isolation. It depends on the risks, the symptoms, and the operative characteristics of the test. No specific risks, no characteristic symptoms, and a positive result from an unvalidated test, is not the way to diagnose Lyme.

More Lyme ‘Guidelines’
Mark Crislip on October 2, 2015
Link


I noted with understanding that the Doubtful News can’t take it anymore. The relentless tsunami sewage slurry of pseudo-science (who says I can’t alliterate?) has worn her down. She is:
currently experiencing a phase in which I can’t seem to bring myself to promote another ridiculous story in the media about a haunted location, scary sounds from the sky, or the latest outrage fueled by ancient superstition. You might call that… jaded. It’s been over four years now of nearly daily effort to keep track of the weird world of woo. It can wear one down when virtually or literally the same thing appears and reappears over and over as if it hasn’t already been passed around a million times.
I sympathize. I have had a touch of SCAM ennui of late. It is a bit due to the repetitiveness of the SCAMs. I still find the variations on the theme of pseudo-sciences curious. It is like infectious diseases where every case has unique and subtle diversity so no two SCAMs are the same. But there are almost 4,000 clinical trials on acupuncture and I would wager that they all have several of the same half-dozen fatal errors. It is like hand hygiene at work. We have known for, oh what, 160 years, that hand hygiene prevents the spread of disease but people still can’t do it right. We know how to do a good clinical trial but the SCAMsters just can’t seem to figure it out.
The ennui is not the seeming futility of the endeavor. I have always been comfortable with futility, secure, as an example, in the knowledge that someday I will be consumed by the bacteria I spent a career killing. Unless, of course, they get me cremated right away. I keep looking for a motto for the SfSBM; I am attracted to “Sisyphus had it easy.”
The painful necessities of Lyme literacy
There are some topics I feel an obligation to cover, a necessity that is hard to tackle with enthusiasm, like taking out the trash. But after six years of writing for this blog I fear I am running out of ways to discuss SCAMs in novel ways. Simply rolling my eyes and making a gagging motion is hardly a sufficient blog entry, which was my initial response to “Evidence assessments and guideline recommendations in Lyme disease: the clinical management of known tick bites, erythema migrans rashes and persistent disease” over at the National Guideline Clearinghouse (NGC). Not unlike Publishers Clearing House, the NGC are not responsible for the content of the product they offer as long as the guidelines meet their criteria, but I doubt they are going to send me a big check.
Some of those criteria include:
A description of study selection that includes the number of studies identified, the number of studies included, and a summary of inclusion and exclusion criteria.
A synthesis of evidence from the selected studies, e.g., a detailed description or evidence tables.
A summary of the evidence synthesis (see 3d above) included in the guideline that relates the evidence to the recommendations, e.g., a descriptive summary or summary tables.
I am reminded of several posts ago where I discussed how the system was gamed to allow a naturopathic clinic to be a center of excellence. I have filed a Freedom of Information request for more information on that farce. I get the hint that these Lyme guidelines are the same. This guideline is like that curious incident of the dog in the night-time; it is what is not mentioned that is interesting.
An update and a downvote
There are numerous issues with the International Lyme and Associated Disease Society (ILADS) guidelines, some of which I have discussed in the past. One problem I have as I write this is that the Infectious Disease Society of America (IDSA) guidelines are being updated with an expected release date in the fall of 2016. So we have at least a year to wait before we have a more reality-based approach to Lyme disease.
Time and energy preclude addressing every part of even this brief guideline. I hope that when the IDSA releases their guidelines they will also do a compare and contrast with ILADS. But I will not hold my breath. When it has come to Lyme and vaccination the IDSA has not been on the front lines of defending science against pseudo-science.
So I will focus on one section, the need for retreatment of Lyme:
…in the panel’s judgment, antibiotic retreatment will prove to be appropriate for the majority of patients who remain ill. Prior to instituting antibiotic retreatment, the original Lyme disease diagnosis should be reassessed and clinicians should evaluate the patient for other potential causes of persistent disease manifestations. The presence of other tick-borne illnesses should be investigated if that had not already been done. Additionally, clinicians and their patients should jointly define what constitutes an adequate therapeutic trial for this particular set of circumstances.
When antibiotic retreatment is undertaken, clinicians should initiate treatment with 4 to 6 weeks of the selected antibiotic; this time span is well within the treatment duration parameters of the retreatment trials. Variations in patient-specific details and the limitations of the evidence imply that the proposed duration is a starting point and clinicians may, in a variety of circumstances, need to select therapeutic regimens of longer duration.
What do you call a recommendation based on very low quality data? Belief. Belief is what you do in the absence of data. Like most the ILADS recommendations, the recommendations, often strong recommendations, are based on low-quality data. But more than basing their suggestions on low quality data, they ignore the fact that there is data that contradicts their position.
There are clinical trials that address the issue of re-treating Lyme. Like all clinical trials, you can find issues in study design when you read them carefully. But they say more or less the same thing: treating patients with persisting symptoms of Lyme has no long-lasting effects:
    • “A randomized, placebo-controlled trial of repeated IV antibiotic therapy for Lyme encephalopathy“:
IV ceftriaxone therapy results in short-term cognitive improvement for patients with post-treatment Lyme encephalopathy, but relapse in cognition occurs after the antibiotic is discontinued.
    • “Study and treatment of post Lyme disease (STOP-LD): a randomized double masked clinical trial“:
Because fatigue (a nonspecific symptom) was the only outcome that improved and because treatment was associated with adverse events, this study does not support the use of additional antibiotic therapy with parenteral ceftriaxone in post-treatment, persistently fatigued patients with PLS.
    • “Two controlled trials of antibiotic treatment in patients with persistent symptoms and a history of Lyme disease“:
There is considerable impairment of health-related quality of life among patients with persistent symptoms despite previous antibiotic treatment for acute Lyme disease. However, in these two trials, treatment with intravenous and oral antibiotics for 90 days did not improve symptoms more than placebo.
You can quibble over issues in these studies. I can with every clinical trial. But all the information points in the same direction: there are no persisting symptoms after treatment for Lyme that are amenable to further antibiotic therapy. And it is better data than that used to support retreatment.
I love killing microscopic corkscrews
As an ID doc who spends a lot of time with hard-to-kill organisms, spirochetes are refreshingly susceptible to antibiotics and die with ease. I am well aware of the various arguments to suggest that Lyme has developed ways to avoid being killed by antibiotics. That would be a blog entry in itself, but I have read the papers and find them less than compelling and, when considering the biology of spirochetes, probably not even wrong. I have suspected that the complete lack of response to even months-long courses of IV antibiotics is a strong clinical suggestion that there is nothing there to kill. Patient being treated for chronic Lyme just never seem to get better with ILADS-based therapies.
Don’t trust the antitrust
In 2006 there was an antitrust investigation by the Connecticut Attorney General that cost the IDSA money they could ill afford. They settled and as part of the settlement the IDSA agreed:
to convene a Review Panel whose task would be to determine whether or not the 2006 Lyme Guidelines were based on sound medical/scientific evidence and whether or not these guidelines required change or revision.
I will also mention with no irony that one of the complaints about the IDSA guidelines was that those who were involved with their production were compromised by ties with industry, and biased against chronic Lyme and its treatment. The National Guidelines Clearinghouse document was written in part by the President of ILADS, the organization that is the biggest proponent for the long term treatment of Lyme. Oh no, no bias here. Keep on moving.
And now the big reveal!
Here now are the results of that IDSA review:
2006 RecommendationTo date, there is no convincing biologic evidence for the existence of symptomatic chronic B. burgdorferi infection among patients after receipt of recommended treatment regimens for Lyme disease.
Panel Determination/Discussion – The Review Panel determined that this recommendation is medically/scientifically justified in light of all of the evidence and information provided (7-1).
2006 RecommendationAntibiotic therapy has not proven to be useful and is not recommended for patients with chronic (>6 months) subjective symptoms after recommended treatment regimens for Lyme disease (E-I).
Panel Determination/Discussion – The Review Panel determined that this recommendation is medically/scientifically justified in light of all of the evidence and information provided (8-0)
And they further noted on review:
     1.  The prospective, controlled clinical trials for extended antibiotic treatment of Lyme disease have demonstrated considerable risk of harm, including potentially life- threatening adverse events.
     2.  Prospective, controlled clinical trials have demonstrated little benefit from prolonged antibiotic therapy. Nearly all primary outcome measures have failed to demonstrate a benefit to prolonged antibiotic therapy. Statistically significant improvements in treatment groups were not demonstrated across studies, were nonspecific, were of unclear clinical importance, and in one case, not sustained at the end of the trial.
     3.  The risk/benefit ratio from prolonged antibiotic therapy strongly discourages prolonged antibiotic courses for Lyme disease.
Emphasis in original, citations removed. The NGC guidelines not only use weak data, they ignore the data that doesn’t fit their world view. I suspect next they will run for President of the United States.

More Political Science: Proposed laws protect “Lyme literate” doctors from discipline
“Lyme literate” doctors are scamming patients out of thousands of dollars with needless long-term antibiotics based on a fake diagnosis of “chronic Lyme.” So why are state legislators trying to protect these doctors from discipline and make insurers pay for unnecessary treatments?
Jann Bellamy on March 15, 2018
Link


In yet another example of the ubiquitous practice of Legislative Alchemy, bills are pending in several state legislatures this year giving sustenance to the fake diagnosis of “chronic Lyme” disease and its treatment with unorthodox and potentially dangerous means. The most troublesome bills protect so-called “Lyme literate” physicians and other practitioners from discipline for substandard practice. “Chronic Lyme” patients want to protect their doctors from what they see as persecution by the medical establishment, even as these same patients are being fleeced out of thousands of dollars for unproven treatments. Other bills force insurers to pay for discredited treatments for “chronic Lyme” or require that burdensome and misleading disclosures be given to patients about Lyme disease.
Before we get to the specifics of these proposals, a brief refresher on “chronic Lyme” and “Lyme literate” physicians, a subject we’ve covered covered many times on SBM.
Lyme literacy
Lyme disease is an infectious disease transmitted by a tick bite. Its symptoms are a rash, fever, headache and fatigue, although not all symptoms may appear. According to the Infectious Diseases Society of America (IDSA), it is diagnosed by medical history, physical exam, and sometimes a blood test. Treatment with a short course of antibiotics usually eliminates the symptoms, but delayed treatment can result in more serious problems.
“Chronic Lyme” is not recognized as a disease in the medical community. Its symptoms are, well, pretty much anything. One description from a post by Harriet Hall:
[Chronic] Lyme is a multi-systemic illness, and may affect every part of the body causing fatigue, stiff neck, headaches, light and sound sensitivity, tinnitus (ringing in the ears), anemia, dizziness, joint and muscle pain, brain fog, tingling, numbness and burning sensations of the extremities, memory and concentration problems, difficulties with sleep (both falling asleep and frequent awakening), chest pain and palpitations and/or psychiatric symptoms like depression and anxiety.
As Dr. Hall correctly notes, “that pretty much covers everyone.”
A new term, post-treatment Lyme disease syndrome, has been coined for those who had Lyme disease but whose symptoms remain, although there is no good evidence that these symptoms can be attributed to persistent Lyme infection. There is no scientific controversy, however, that “chronic Lyme” disease, as applied to patients with nonspecific symptoms who show no objective evidence that they have been infected with Lyme disease, is a fabricated diagnosis. (As are the newer, move-the-goalposts putative infections to which “Lyme literate” doctors attribute “chronic Lyme.”) It is these patients who have been victimized by “Lyme literate” physicians and alternative medicine practitioners.
As you would expect in cases where a collection of vague symptoms have been bootstrapped into a disease (e.g., chronic candidiasis, adrenal fatigue) there are also a number of bogus diagnostic techniques and worthless quack treatments available. The main treatment is long-term antibiotics, for which there is no evidence of effectiveness but serious risks. (Also, here and here.)
The CDC, the Infectious Diseases Society of America (IDSA), the American Academy of Pediatrics, the American College of Physicians, the Medical Letter, and the American Academy of Neurology all reject the notion that “chronic Lyme” exists and that long-term antibiotics are an appropriate treatment. Over a dozen international organizations, like the Canadian Public Health Network and the European Federation of Neurological Societies, agree.
That has not stopped “Lyme literate” doctors from banding together to form the International Lyme and Associated Diseases Society (ILADS) and issuing their own guidelines for the diagnosis and treatment of “chronic Lyme,” guidelines based on very low levels of evidence that are accepted only by themselves and, in contrast to the IDSA guidelines, no other professional medical organization. ILADS teaches physicians and other practitioners how to become “Lyme literate.” ILADS, again in contrast to IDSA, is not an ACCME-accredited provider of continuing medical education and, to my knowledge, none of its courses qualify for continuing medical education credit. Nor are ILADS guidelines taught as appropriate in any medical school, residency or fellowship program.
Making a fake diagnosis and treating the patient with unnecessary long-term antibiotics can put a “Lyme literate” doctor on the state medical board’s radar, especially when patients are harmed by the treatment or there is a failure to diagnose the patient’s real condition, such as Parkinson’s disease. Hence, the need to protect the “Lyme literate” from prosecution. This effort is assisted by a small but vocal contingent of patients who see their “Lyme literate” doctors as saviors and flood medical boards with letters of support. These same patients, armed with anecdotes of their supposed cures, petition their legislators for protection of what they deem persecution of their physicians.
Maryland: All in on “chronic Lyme”
In 2016, the Maryland legislature passed a bill substituting its healthcare advice for that of physicians. The law requires labs to tell patients that current tests for Lyme are “problematic,” that a negative test does not mean they don’t have Lyme disease, and that they should contact a health care provider if they continue to exhibit “unexplained symptoms” to “inquire about the appropriateness of retesting or initial or additional treatment.”
The IDSA opposes this type of notice as “non-evidence based.” That being the case, I question the constitutionality of the law because:
the First Amendment prohibits the government from compelling people [including physicians] to make false or misleading statements or to express the government’s point of view as their own.
At the time, Delegate Kathy Afzali, a co-sponsor of the bill, whose background is in theater and real estate, said it was only the first of a series of bills she hoped to get through the legislature:
The question is, what is the proper treatment for the disease [sic] There’s many different schools of thought. We want to be able to pass legislation that helps these patients who have long-term treatment for Lyme.
Even though there are not “many different schools of thought,” true to her word, Delegate Afzali and 38 of her fellow Delegates are sponsoring a bill (House Bill 880) in this legislative session forcing insurers to pay for long-term antibiotic treatment of “chronic Lyme” disease, which includes a clinical diagnosis that does not meet the CDC’s criteria:
but presents other acute, persistent, or chronic signs or symptoms of Lyme disease as determined by a licensed physician, whether that diagnosis is based on knowledge obtained through medical history and physical examination only or in conjunction with testing.
In other words, if the “Lyme literate” physician says it’s Lyme, it’s Lyme, and the health insurer must provide coverage for:
the full length of the long-term antibiotic treatment to be administered in the manner prescribed . . . [The insurer] may not impose a quantitative limitation on the long-term antibiotic treatment . . . [and] may not deny coverage . . . solely because the treatment may be categorized as unproven, experimental, or investigational in nature.
In sum, Maryland legislators, including the Senators who support a companion bill (Senate Bill 793) are willing to put the force of law behind a fake diagnosis, as well as unproven treatments for the fake diagnosis, and make everyone (though the shared cost of insurance) pay for it. This won’t be the first time. In 2016, Massachusetts legislators were so enamored of a similar bill that they overrode Governor Baker’s veto so insurers would have to pay for long-term antibiotic treatment.
Sadly, testimony in favor of the bills only serves to demonstrate just how badly “Lyme literate” physicians are scamming patients. In one media report, a mother said she had taken her daughter to 51 doctors before she was “properly diagnosed” with “chronic Lyme.” One legislator told a reporter that people were being bankrupted paying for long-term treatment. That’s unsurprising, considering media reports that “chronic Lyme” treatment can cost $10,000 to $35,000. (After one of my posts on the discipline of a “Lyme literate” physician by a state medical board, I received a thank-you email from a parent who had been scammed out of $30,000 for a child’s treatment.) In contrast, the cost of the IDSA-recommended treatment for Lyme disease with antibiotics is about $40 and is covered by most insurance. Fortunately, good citizens with no connection to the insurance industry showed up as well (although in far fewer numbers) to testify against these bills.
But that’s not the worst “chronic Lyme” bill pending in Maryland. That honor goes to House Bill 1266 and its companion Senate Bill 950. These would protect not only “Lyme literate” physicians from disciplinary action by the medical board, but “Lyme literate” chiropractors and naturopaths as well – anyone, in fact, who is licensed under the state’s health practitioner licensing statutes. Typical of the ill-advised state laws protecting quacks in general, the bills allow a “Lyme literate” practitioner to avoid the constraints of evidence-based medicine as long as he or she makes a few disclosures. The bills’ saving grace may be that they are so poorly drafted that the quack practitioner won’t be able to figure out how to comply, thus forgoing the proposed law’s protection.
“Lyme literate” practitioners could not be disciplined:
solely because of the . . . practitioner’s diagnostic evaluation, testing, or treatment of Lyme disease or another tick-borne disease in a patient if [he] . . . discloses to the patient
that the evaluation, test or treatment:
    • is integrative, complementary, alternative, nontraditional or nonconventional, but none of these terms is defined;
    • has risks and benefits, and what they are, and its FDA “status;”
    • may not be widely recognized in the medical profession and “subject to disagreement among qualified medical experts.”
If the patient has a “potentially significant medical condition” and hasn’t yet had a “conventional diagnosis or treatment,” she must be told of medical specialties that may provide her with other options. All patients must be told of “significant known risks of deferring widely accepted treatments, if any, for the patient’s condition.”
This last bit really got me confused. If the practitioner thinks the patient has “chronic Lyme,” does that mean no other specialties could provide her with other options, because no other specialties believe in its existence? Or, on the other hand, is the “Lyme literate” practitioner going to be forced to consider that she may have a “conventional” disease or condition and not “chronic Lyme,” in which case, how is he going to justify his ruling out that condition in favor of “chronic Lyme?” And when determining the risks of deferring accepted treatments for the patient’s condition, do we pretend the condition is “chronic Lyme” or are we talking about the patient’s real condition?
In any event, none of this exempts the practitioner from discipline if the evaluation, testing or treatment has a “significant safety risk greater than the conventional methods” and the risk is not outweighed by the potential benefits. By “conventional” medical standards, this would seem to rule out long-term antibiotics in every case. But, having been legislatively forced to accept the existence of “chronic Lyme,” do we also have to accept the benefits of long-term antibiotics claimed by “Lyme literate” practitioners, or are we allowed to point out that several clinical trials showed that they provide no benefit?
In other words, once pseudoscience is made into fact by this bit of Legislative Alchemy, will the medical board prosecutors be allowed to rely on science at all in making their case? Just how far does the medical board have to go in pretending to believe in a fake diagnosis and its attendant “treatment?”
While passing a law shielding substandard practice is ill-advised and will make prosecution more difficult, fortunately it is not an absolute bar to prosecution. In 2014, New York passed a similar bill. Yet, 2017, two leading lights of ILADS were successfully prosecuted by that state’s medical authorities using the clever strategy of avoiding the “chronic Lyme” issue altogether and simply focusing on the atrociously bad medical care these two delivered. After all, if a physician is willing to ignore efficacy and safety to the point of prescribing long-term antibiotics for a fake diagnosis, it is unlikely he or she is otherwise meeting the standard of care in his overall treatment of patients. One particular requirement that tripped up these “Lyme literate” physicians was failure to keep adequate medical records, such as documenting a rationale for treatment.
The “Lyme literate” cabal seems to have learned from its substantial experience in disciplinary proceedings. Maryland’s proposed legislation also protects them from being disciplined for record-keeping and, much more broadly, all other regulatory requirements, “for acts or omissions that arise from professional differences of opinion” if the practitioner has acted in good faith to comply with the intent of the requirements. It is interesting to note that only “chronic Lyme” practitioners are legislatively blessed with this particular good faith exception.
Finally, if the medical, chiropractic or other healthcare practitioner board uses a system of peer review in standard of care cases, these bills ensure that at least one member of the review panel include a practitioner with “demonstrated training, competence, and experience in the same methods” as the licensee facing discipline, thereby insuring that quacks will be protected by other quacks.
Pennsylvania, Indiana and Illinois
Similar bills are pending in Pennsylvania, Indiana, and Illinois, although none is as complicated, or provides as much protection for “Lyme literate” practitioners, as Maryland’s.
Pennsylvania House Bill 174 begins with a swipe at the IDSA, noting that there are “multiple” diagnostic and treatment guidelines for Lyme disease but the National Guideline Clearinghouse maintains only the ILADS guidelines, having removed the IDSA guidelines because of their being “outdated and not in compliance with current standards.” (In fact, the IDSA is reviewing the evidence and developing new guidelines.) The bill fails to note the very low level of evidence that support the ILADS guidelines.
HB 174 forces insurers to cover antibiotic treatment for Lyme and related tick-borne illnesses even if the treatment is “unproven, experimental or investigational” for whatever “duration the health care practitioner determines appropriate for the patient” for controlling both the patient’s [presumed] infection or symptoms. It also provides immunity to physicians, nurse practitioners and physician’s assistants from disciplinary action “solely for” diagnosing Lyme disease or prescribing long-term antibiotic therapy as long as the diagnosis, treatment plan and ongoing monitoring has been documented in the patient’s records.
HB 174 passed in the House and has moved to the Senate for consideration. A similar bill, Senate Bill 100, is also pending there.
Indiana’s Senate Bill 284 manages to combine these provisions (which are almost identical to Pennsylvania’s) as well as those similar to Maryland’s law requiring that patients be told that standard lab tests for Lyme are “problematic” and “often result in false negative and false positive results” and that, if the patient’s results are negative, it doesn’t necessarily mean he doesn’t have Lyme disease. If he continues to have symptoms, according to the mandated statement, he should consult a health care provider about retesting “or additional treatment.” Even though this sort information isn’t back by good evidence, it is the perfect segue into the “Lyme literate” physician’s office, who will happily offer unvalidated testing and “additional treatment.”
Finally, in Illinois, House Bill 4515, also prohibits the medical board from disciplining physicians who diagnose and treat “chronic Lyme.” The physician must have examined the patient, gotten informed consent, provide a “medical reason” for the treatment, informed the patient of “other treatment options” and his or her credentials, and make a medical judgment based on “a thorough review of all available clinical information on Lyme disease.” Of course, “Lyme literate” physicians already rationalize their way through all of these steps to a diagnosis of “chronic Lyme,” so how much protection this offers patients is questionable. On the other hand, patients can be comforted by the fact that the legislation requires the physician to determine:
the treatment will not, in the opinion of the [physician], result in the direct and proximate death of or serious bodily injury to the patient.
Indirect causation of death and minor bodily injury are apparently ok and no risk-benefit analysis appears to be required.
You can gauge the passion behind HB 4515 by what the Illinois General Assembly calls “witness slips,” indicating pro and con stances on the bill. There are 286 witness slips in favor of the bill and only one opponent, the Illinois Department of Financial and Professional Regulation, upon whose unfortunate shoulders will fall the task of trying to discipline “Lyme literate” physicians after the legislature ties one hand behind its back.
You can check on the status of bills mentioned in this post by clicking on the links, which will take you to the states’ legislatures’ websites. The website Lyme Science has a list of all state “chronic Lyme” bills with summaries and links to bills and other helpful information. (Yes, there are more, although none, as of this date, protecting “Lyme literate” practitioners from prosecution.) To oppose these efforts, check out the American Lyme Disease Foundation’s excellent list of questions and answers exposing common misinformation about Lyme disease. The IDSA also has helpful materials on its website, especially its Lyme Disease and State Policy Primer for State Legislators.
Don’t just complain about quackery. Do something about it.

Avoid prolonged antibiotics for “Chronic Lyme”
There is no evidence to suggest that “chronic Lyme” exists, or that long-term antibiotics are required to treat it.
Scott Gavura on April 18, 2019
Link


Lyme disease is a real and growing concern in much of North America. The spirochete Borellia burgdorferi was only discovered in 1982, and today, Lyme is the most common vector-borne disease in the United States. While Lyme disease is treatable, some people have prolonged or non-specific symptoms that they may attribute to Lyme disease, sometimes on the basis of nonstandard/unorthodox testing or diagnostic criteria. While the debilitating symptoms may be real, the relationship to Lyme disease is not. There is no evidence that “Chronic Lyme” exists, but there are repeated reports of signs and symptoms that are regularly attributed, incorrectly, to Lyme infections.
Along with the emergence of “Chronic Lyme” have been self-identified experts in treating these symptoms, often with a variety of unproven treatments, of which long-term antibiotic therapy is the most common recommendation. There is no evidence that long-term antibiotics are evidence-based, appropriate, or effective. Recently the Association of Medical Microbiology and Infectious Disease Canada has put out a position statement on the diagnosis and treatment of people with persistent symptoms attributed to Lyme disease. The position statement outlines why unproven, unorthodox treatments like long-term antibiotics are more likely to harm, rather than help, patients.
What is Lyme disease?
Lyme disease is a bacterial infection spread by ticks. Its name comes from Lyme, Connecticut, where a cluster of cases called “Lyme Arthritis” were reported in 1977. While it’s highly prevalent in New England, Lyme disease has been reported in every state, and its reach continues to grow. Several species of the Borrelia bacterial family have been found to cause Lyme disease, but B. burgdorferi is the primary cause in North America. Lyme disease is carried by various Ixodes ticks, which vary based on geography. Ticks contract B. burgdorferi from a blood meal from an infected host – usually a mouse, but it can be any rodent, and also birds. Infected ticks reside on shrubs or grass (peaking in June of each year), and will attach to mammals when they detect warmth and carbon dioxide. It’s preferably the white-tailed deer, but increasingly, a human. They can attach to any part of the body, but it is locations like the back, armpits and scalp where they may not be noticed for a few days – which is when infection can occur. This image from the CDC gives a good illustration of the circle of (a tick’s) life:Ticks must be attached for 36-48 hours before a transmission of B. burgdorferi occurs. Infections can be divided into three phases:
    • Early localized infection appears as a rash (often in the form of a series of concentric rings, or “bull’s eye rash”) and what feels like a viral illness (fatigue, headache, aches, and sometimes fever). It can occur in about 80% of those infected, usually within a month of infection.
    • Early disseminated infection occurs weeks to months after the initial infection. It can include neurologic (e.g., meningitis), and cardiac complications. This may be the first sign of infection in some.
    • Late disease occurs months to years after the initial infection. Arthritis is the most common sign, but there may be neurologic signs as well.
Lyme is diagnosed based on signs and symptoms, plus a history of possible exposure to ticks. Laboratory testing may also be used. Treatment of Lyme disease depends on when it was detected and how it has manifested. Treatment is usually weeks of antibiotics and other therapies when more serious complications are present. When treated early, Lyme responds well to antibiotics, and a full recovery can be expected.
Treating after treatment
Some people with Lyme disease report symptoms after treatment that are attributed to the infection (and some people with no history or signs of infection also report similar symptoms). There is no evidence to demonstrate that B. burgdorferi infections cause chronic occult infections after standard treatments endorsed by the Infectious Disease Society of America (IDSA), AMMI Canada, the CDC, or, in the UK, the National Institutes for Health and Care Excellence. The cause of these symptoms may not be clear, and may be non-specific (e.g., fatigue, pain, difficulty concentrating.) While it is important that these symptoms receive proper investigations, there is a lack of evidence supporting the use of long-term antibiotics.
Unorthodox and unproven testing and diagnostics are commonly used by practitioners to arrive at a diagnosis of “chronic Lyme”. The AMMI notes the following:
Concordant with the NICE guidelines (2018), AMMI Canada recommends that Lyme disease testing be done in accredited laboratories that participate in proficiency programs and use validated methods (“Validation should include published evidence on the test methodology, its relation to Lyme disease and independent reports of performance”) (NICE 2018). Given the high rate of false positive results (some as high as 50%) (Fallon et al, 2014), the use of laboratories that do not use FDA or Health Canada approved tests or use alternative interpretive criteria is not recommended.
Alternative and unproven testing methods are necessary to propagate the “chronic Lyme” diagnosis in order to explain away the negative results of conventional, established testing. As Steven Novella noted in 2017,
Patients with alleged chronic Lyme may have negative blood tests for Lyme, but that’s OK because the antibody titers and Western blot tests are not 100%. They may also not have all the classic symptoms of Lyme, but a long list of non-specific symptoms that do not point specifically at an infection or Lyme. They also are not cured by a single round of antibiotics, but that is because, it is argued, they have treatment-resistant strains of the Lyme spirochete.
In essence the argument is that chronic Lyme disease represents an atypical presentation of seronegative treatment-resistant Lyme. That is what we call special pleading – inventing a specific explanation for each instance of evidence (or lack of evidence) that would seem to falsify a hypothesis.
Long-term antibiotics do not benefit and may harm
In addition to the cost and ineffectiveness of long-term antibiotics, many patients experience adverse effects. The AMMI notes:
Well-designed studies have shown that long-term antibiotic treatment –beyond standard recommended treatment– is of no more benefit to the patient than a placebo, but caused significant adverse events in up to 26% of participants including Clostridioides difficile, intravenous catheter site infections (when intravenous catheters are used for medication delivery),and significant allergic reactions (Patel et al., 2000; Fallon et al., 2008; Holzbaueret al., 2010; Klempner et al., 2013; De Wilde et al., 2017; Marzec et al., 2017).
The AMMI points to a program at BC Women’s Hospital, the Complex Chronic Diseases Program, as a model approach to helping patients manage debilitating symptoms. That program offers group-based education, and self management support, in addition to medical consultation for myalgic encephalomyelitis/chronic fatigue syndrome, fibromyalgia, and symptoms attributed to chronic Lyme. They do not offer long-term antibiotics.
The AMMI has published a fact sheet on Lyme that answers common questions about the disease and its treatment.
Conclusion
People who believe they have “chronic Lyme” are suffering and deserve compassionate treatment. But giving medicine not based in evidence is magical thinking, not good science. Regrettably, practitioners that do believe they are treating “chronic Lyme” continue to propagate erroneous information and offer dubious treatments despite good evidence they are ineffective. Multiple organizations in Canada, the United States and worldwide caution against the indiscriminate use of intravenous antibiotics for the treatment of symptoms attributed to Lyme disease.

Another “Chronic Lyme” VIP disciplined by NY medical authorities: Bernard Raxlen
Another “Lyme literate” NY physician is on probation and under orders to clean up his act. Will other physicians treating “chronic Lyme” take note?
Jann Bellamy on November 9, 2017
Link

Bernard Raxlen, MD, who devotes more than 90% of his practice to the treatment of so-called “chronic Lyme” disease, is on a three-year probation imposed by the New York State Board for Professional Medical Conduct (BPMC). Raxlen agreed to probation and a lengthy list of practice requirements last month following allegations, filed in September, of negligence, incompetence, gross negligence, gross incompetence, and failure to maintain adequate patient records. In doing so, he becomes the second “Lyme literate” VIP disciplined by the NY medical authorities this year. Based on similar charges of professional misconduct, David Cameron, MD, was also put on probation with numerous practice restrictions in June.
Who is Bernard Raxlen, MD?
Raxlen is a psychiatrist and solo “chronic Lyme” practitioner in New York City who says he’s “successfully treated” over 3,500 cases of tick-borne disease in the past 15 years. (He named his practice “Lyme Resource Medical of New York.”) He touts a “total comprehensive treatment program which utilizes both oral and intravenous (IV) antibiotic treatment.” It doesn’t come cheap, either. An initial visit with Raxlen costs $1,200 with follow-up visits between $600 and $700. A PICC-line insertion (presumably for long-term antibiotics) is $750 and a “nutritional IV” is $150. He does not accept public or private insurance.
Raxlen has a history of disciplinary actions against him in two states stretching back almost 20 years. In Connecticut, where he was formerly licensed, he was reprimanded and paid a total of $35,000 in civil penalties in two cases arising out of his refusal to provide patient records to the Health Department and insurance companies, even though patients had signed releases. He was also disciplined for inappropriate prescribing and failing to maintain malpractice insurance. Because these infractions constituted professional misconduct in New York as well, he was subject to two disciplinary actions in that state, resulting in censure, reprimand and a $2,500 fine.
According to the Chicago Tribune, Raxlen had other professional misconduct charges brought against him by Connecticut authorities but they were ultimately dropped. The Tribune reported that, in one case, Raxlen was charged with telling a patient with Lou Gehrig’s disease (ALS) that she had Lyme disease and treating her with an illegal drug from Germany. He told the reporter that the relationship between ALS and Lyme was “unclear,” even though ALS experts concluded that there was no evidence of a connection.
Per his New York State Department of Health physician profile (just type his name into the search engine), Raxlen completed residency training in psychiatry and lists his specialty as psychiatry, but he is not board certified in any specialty. He did not train in internal medicine, family medicine or pediatrics (although he treats pediatric patients), specialties that normally treat routine Lyme infections. Nor did he train in infectious diseases, experts to whom patients with more complicated cases of Lyme would normally be referred by other practitioners.
Yet, he is described by the International Lyme and Associated Disease Society (ILADS) as a “leader in Lyme disease treatment and research.” In fact, he is a founding member of ILADS, former Secretary of the Board, and has taught a number of ILADS courses. He was a co-author of the original ILADS guidelines for the treatment of tick-borne diseases. Despite their troubling disciplinary status, both he and David Cameron are scheduled to speak at the ILADS Annual Scientific Conference, which starts today in Boston.
How can this be? How can one be a leading light in ILADS with a disciplinary history like Raxlen’s and no graduate medical education in infectious diseases?
“Lyme literate” physicians like Raxlen have fabricated a disease they call “chronic Lyme,” which they regularly “diagnose” and treat with long-term antibiotics, sometimes for months to years. Board-certified infectious diseases doctors and other “conventional” physicians all agree that “chronic Lyme” is not a valid diagnosis and rely on well-conducted trials showing that long-term antibiotics do not substantially improve the outcome for patients diagnosed with so-called “chronic Lyme.” Long-term antibiotics can, in fact, result in serious harm, including death, a subject our good friend Orac covered recently over on Respectful Insolence. Orac’s post nicely summarizes the differences between real Lyme disease and “chronic Lyme,” “a prototypical fake medical diagnosis,” and the dangers of long-term antibiotics, as have posts on SBM, here, here, here, and here.
The CDC, the Infectious Diseases Society of America (IDSA), the American Academy of Pediatrics, the American College of Physicians, the Medical Letter and the American Academy of Neurology all reject the notion that “chronic Lyme” exists and that long-term antibiotics are an appropriate treatment. There is something called “post-treatment Lyme disease syndrome,” but responsible medical authorities do not equate this syndrome with the nebulous symptoms and unvalidated lab tests of “chronic Lyme” and specifically reject the utility long-term antibiotic treatment based on well-conducted clinical trials. None of this is to say that patients who’ve been told they have “chronic Lyme” are not truly suffering, a fact that makes “Lyme literate” practices all the more reprehensible.
None of this stopped “Lyme literate” doctors from banding together to form ILADS and issuing their own guidelines for the diagnosis and treatment of “chronic Lyme,” guidelines based on very low levels of evidence that are accepted only by themselves and, in contrast to the IDSA guidelines, no other professional medical organization. ILADS teaches physicians and other practitioners how to become “Lyme literate.” ILADS, again in contrast to IDSA, is not an ACCME-accredited provider of continuing medical education although, for some inexplicable reason, the Westchester [County, NY] Medical Society has teamed up with ILADS and is using its accrediting authority to grant CME credit for some of the talks (also here) at the ILADS Scientific Conference.
Despite the lack of evidence that “chronic Lyme” is a valid diagnosis, and the lack of efficacy as well as the risks of long-term antibiotic treatment, ILADS healthcare providers currently treat more than 100,000 patients with “chronic Lyme” and tick-borne diseases in the USA and around the world. Given media reports that patients can spend $10,000 to $35,000 for treatment, “Lyme literacy” translates into millions of dollars for practitioners.
While it may be profitable, “Lyme literate” doctors risk running afoul of state medical boards. Raxlen is just one among ILADS-trained, “Lyme literate” physicians who have had their medical practices questioned by their peers, up to and including discipline imposed by state authorities (also, here and here).
With that background, let’s look at the allegations against Raxlen and the terms of his probation.
The BPMC v. Raxlen
New York’s medical misconduct procedures do not require the physician charged to stipulate to any particular acts of misconduct as a condition of settling his case. The physician can, as Raxlen did here, simply state he is unable to “successfully defend against at least one of the acts of misconduct alleged” and agree to the imposition of sanctions. This means the allegations in the state’s Statement of Charges were never proven, as it was unnecessary to reach a decision on the factual issues once Raxlen agreed to a settlement. However, per the Office of Professional Medical Conduct’s (OPMC) standard procedures, the allegations were based on expert review of Raxlen’s patients’ records and they remain uncontested by him.
The allegations of misconduct arise out of Raxlen’s care of eight patients. As is typical of “chronic Lyme” diagnosis and treatment, patients (whose identities are protected) presented with a variety of disparate symptoms, such as:
    • Patient A: freezing, burning, air hunger, weakness, fatigue, neck pain and intestinal pain.
    • Patient E: fatigue, migraines, neck pain, joint pain, numbness and tingling, irritability, sound, light and temperature sensitivity and nonrestorative sleep.
    • Patient G: back pain, abdominal pain, feet pain, extremity weakness, anxiety, depression and mood swings.
    • Patient H (who got the Hickman catheter and numerous antibiotics mentioned below): mouth, teeth and jaw pain, confusion, forgetfulness, irritability and mood swings.
Diagnosis and treatment of “chronic Lyme” is never mentioned, a wise decision on the part of the BPMC prosecutors in light of the ill-conceived New York law protecting “Lyme literate” doctors from prosecution
based solely upon the recommendation or provision of a treatment modality by a licensee that is not universally accepted by the medical profession, including but not limited to, varying modalities used in the treatment of lyme disease and other tick-borne diseases.
Instead, the BPMC focused on the fact that Raxlen had failed in the most basic tenets of good medical care, although the fingerprints of “chronic Lyme” diagnosis and treatment, such as failure to consider alternative diagnoses, prescribing IV antibiotics and using a Hickman catheter, are all over the charges. The charges included:
    • Repeatedly failing to perform or note in the patient’s chart a comprehensive history and appropriate physical exam, including (despite his being a psychiatrist) a psychiatric history, neuropsychological testing and mental health status exam.
    • Failing to construct a differential diagnosis and pursue a thorough diagnostic evaluation prior to instituting a treatment plan.
    • Inappropriate prescribing, including prescribing Rifampin for a patient on Tamoxifen and prescribing addictive medications prior to a making a diagnosis and without considering non-addictive treatment.
    • Inappropriately relying on Applied Kinesiology (which is quackery) to formulate a diagnosis.
    • Placement of a Hickman catheter without medical necessity.
    • Inappropriately administering antibiotics, including intravenous Invanz, Clindamycin, Flagyl, Rifampin, Minocycline, Mepron, Plaquenil and Bactrim, all of these for one patient.
    • Failure to present or note in the patient’s chart potential risks, benefits, side effects and safe use of prescribed medications.
    • Failure to appropriately identify, address, and/or follow-up on potential side effects.
    • Treating inappropriately with an ongoing and/or escalating medication regimen without appropriate physical exams and clinical reassessment for consideration of alternative diagnoses and treatment.
    • Poor record-keeping.
These allegations resulted in charges of negligence, incompetence, gross negligence, gross incompetence, and failure to maintain adequate patient records. As noted, Raxlen agreed to a three-year probation in addition to the imposition of conditions on his practice. He must, among other things:
    • Communicate to patients the nature of his medical role, whether it be a primary care physician responsible for the patient’s general medical condition, or for a defined or limited purpose, and/or as a practitioner of a particular medical specialty.
    • Obtain written informed consent addressing all aspects of treatment and document same, including documentation of all discussions with the patient about the nature and scope of his evaluation and treatment and the patient’s need to pursue “conventional medical care elsewhere.”
    • Document all histories and physicals.
    • Refer patients to primary care physicians, specialists or consultants for further evaluation and/or treatment where medically warranted and provide these physicians with all relevant patient information.
    • Cooperate fully with the state in enforcing the Consent Order and timely respond to all state requests for written periodic verification of his compliance and all documents.
What now?
Based on a birthdate of 1938 in his state physician profile, Raxlen is either already, or soon will be, 79 years old. One wonders whether he will continue his practice in face of these new sanctions, although his website is still trying to attract patients.
Sadly, the “chronic Lyme” lobby responsible for passing the law protecting “Lyme literate” doctors has its sights set on even greater rewards. Several bills are pending in the NY legislature which would force insurers to cover “chronic Lyme” treatment (Assembly Bill 114, Senate Bill 4713, Senate Bill 670). Other bills give them the opportunity to argue in yet another venue for insurance coverage. (Assembly Bill 4863, Senate Bill 2168, Assembly Bill 6927).
In any event, it is commendable that the Board for Professional Medical Conduct has not let New York’s unfortunate law get in the way of its prosecuting physicians who take advantage of patients with a diagnosis of “chronic Lyme,” no matter how they frame the specific charges. With two leading NY “Lyme literate” physicians now on probation and under strict orders to clean up their acts, it remains to be seen what effect this might have on other “Lyme literate” doctors in the state.

“Chronic Lyme” VIP Daniel Cameron disciplined by New York medical authorities
“Chronic Lyme” guru Daniel Cameron, MD, has been put on 3-year probation by New York medical authorities. Will fellow “Lyme literate” doctors take note?
Jann Bellamy on June 22, 2017
Link

The medical practice of “Lyme literate” guru Daniel Cameron, MD, will be closely supervised by the authorities during a three-year probation imposed last week by the New York State Board for Professional Medical Conduct (BPMC). The order was based on professional misconduct charges filed against Cameron earlier this year.
Cameron agreed to the imposition of sanctions during administrative proceedings on the charges and a consent order was entered by the BPMC based on his concession. He stipulated that
he could not successfully defend against at least one of the acts of misconduct alleged. Those allegations included practicing the profession of medicine with negligence on more than one occasion, incompetence on more than one occasion, gross negligence, gross incompetence, and/or failing to maintain accurate patient medical records.
Who is Daniel Cameron, MD?
Cameron is a solo practitioner in Mt. Kisco, NY, and board certified in internal medicine, but not fellowship-trained in infectious diseases and not board-certified in that sub-specialty. He also holds an MPH and describes himself as epidemiologist. According to his website, he:
is a nationally recognized leader for his expertise in the diagnosis and treatment of Lyme disease and other tick-borne illnesses.
That is partially true. He is a “recognized leader” among those who consider “chronic Lyme” a real disease and who treat it with long-term antibiotics, sometimes for months to years. He is not a “recognized leader” among board-certified infectious diseases doctors and other experts who agree that “chronic Lyme” is not a real disease and who rely on well-conducted trials showing that long-term antibiotics do not substantially improve the outcome for patients diagnosed with so-called “chronic Lyme.” Long-term antibiotics can, in fact, result in serious harm, including death, a subject our good friend Orac covered just yesterday over on Respectful Insolence. The CDC, the Infectious Diseases Society of America (IDSA), the American Academy of Pediatrics, the American College of Physicians, the Medical Letter and the American Academy of Neurology all reject the notion that “chronic Lyme” exists and that long-term antibiotics are an appropriate treatment.
(Orac’s post nicely summarizes the differences between real Lyme disease and “chronic Lyme,” “a prototypical fake medical diagnosis,” and the dangers of long-term antibiotics, as have posts on SBM, here, here, here, and here.)
That has not stopped “Lyme literate” doctors from banding together to form the International Lyme and Associated Diseases Society (ILADS) and issuing their own guidelines for the diagnosis and treatment of “chronic Lyme,” guidelines based on very low levels of evidence that are accepted only by themselves and, in contrast to the IDSA guidelines, no other professional medical organization. ILADS teaches physicians and other practitioners how to become “Lyme literate,” although there is precious little information about the courses on the ILADS website. ILADS, again in contrast to IDSA, is not an ACCME-accredited provider of continuing medical education and, to my knowledge, none of its courses qualify for continuing medical education credit. Nor are ILADS guidelines taught as appropriate in any medical school, residency or fellowship program.
Unfortunately, according to Cameron,
ILADS healthcare providers currently serve more than 100,000 patients with Lyme and associated tick-borne diseases in the USA and around the world.
Cameron is a leading light among the “Lyme literate.” He is the past president of ILADS and is the lead author of both the original ILADS guidelines and its 2014 update. He has testified before several state legislatures promoting the protection of “Lyme literate” doctors from prosecution by state medical boards, including the legislature in New York, where such a bill became law. He also makes presentations to Lyme support groups, spreading the gospel of “chronic Lyme.”
He has written a number of articles in the medical literature promoting the notion that “chronic Lyme” exists and that long-term antibiotics are an appropriate treatment, including two in the bottom-feeder journal, Medical Hypotheses, known for its publication of pseudoscientific papers.
His bibliography includes a letter to the editor of the New England Journal of Medicine, complaining about an article by infectious diseases experts rejecting “chronic Lyme” as a valid diagnosis and its “treatment” with long-term antibiotics. The evidence, Cameron claimed, is actually in “clinical equipoise.” This drew a sharp rebuke from the article’s authors:
The term ‘clinical equipoise,’ used by Cameron, is difficult to justify in view of the published reports of five double-blind, randomized, placebo-controlled clinical trials that have convincingly demonstrated that antibiotic treatment of post–Lyme disease symptoms is not in the best interests of patients. Our article summarizes the consensus among clinicians who practice evidence-based medicine . . .
The direct implication being, of course, that Cameron is not one “among clinicians who practice evidence-based medicine.”
Cameron, for his part, brushes off the expert opinion of infectious diseases doctors versus “chronic Lyme” pseudoscience manufactroversy as simply “different points of view:”
Only by airing these different points of view will the medical and scientific community reach a better understanding of controversial topics such as treatment of chronic Lyme disease. Meanwhile, physicians must be able to exercise their clinical judgment and patients should be provided with treatment options.
With that, let’s turn to how, in the view of the New York state medical authorities, Cameron exercised his “clinical judgment” and provided patients with “treatment options.”
“Clinical judgment” and “treatment options”
Apparently, New York’s medical misconduct procedures do not require the physician charged to stipulate to any particular acts of misconduct as a condition of settling his case. Rather, as noted, Cameron simply stated he was unable to “successfully defend against at least one of the acts of misconduct alleged” and agreed to the imposition of sanctions. This means the allegations in the state’s Statement of Charges were never proven, as it was unnecessary to reach a decision on the factual issues once Cameron decided to settle. However, per the Office of Professional Medical Conduct’s (OPMC) standard procedures, the allegations in the Statement of Charges were based on expert review of Cameron’s patients’ records and they remain uncontested by Cameron.
The state’s allegations were based on Cameron’s care of seven patients. According to the Statement of Charges, some of his more egregious actions include:
    • Continuing to prescribe narcotics to a patient diagnosed with bipolar disorder and narcotic abuse for two years after the patient had moved to another state.
    • Failing to follow up on previous diagnostic tests and symptoms indicative of multiple sclerosis, “thereby depriving the patient of an accurate diagnosis and years of effective therapy for her progressive disease.”
    • Failing to appropriately and timely evaluate a patient, who suffered from Parkinson’s disease, when she complained of pain associated with a PICC line inserted at Cameron’s direction for parenteral antibiotics, which itself was done without an appropriate physical examination or “clinical re-assessments for consideration of any alternative diagnoses and/or treatment.”
    • Failing to consider “other infections or inflammatory processes” in a patient with a recent termination of pregnancy and diverticulitis, who had abnormal lab results, including abnormal liver function tests and an elevated sedimentation rate, and failure to order a CT scan of the abdomen and pelvis as well as additional blood testing.
The state wisely avoided specifically challenging Cameron’s diagnosis of his patients with “chronic Lyme” or his treating “chronic Lyme” with long-term antibiotics. In fact, the term is never mentioned. In doing so, it circumvented the quagmire of arguing over “different points of view” and concentrated on the fact that Cameron quite simply failed his patients by giving them substandard care, “chronic Lyme” or no “chronic Lyme.” This strategy also avoided any shield which might have been provided by New York’s foolish law aimed at protecting “Lyme literate” doctors.
Yet the fingerprints of “chronic Lyme” diagnosis and treatment show through loud and clear in the state’s case. For each and every patient, Cameron was charged with:
    • Repeatedly failing to take and/or note an adequate history of present illness.
    • Repeatedly failing to perform and/or note an appropriate physical examination.
    • Failing to appropriately construct a differential diagnosis and pursue a through diagnostic evaluation.
    • Failing to maintain records accurately reflecting care and treatment rendered to the patient.
For six of the seven, he was charged with:
Treating patients inappropriately with an ongoing and escalating antibiotic regimen without appropriate sequential physical examinations and clinical reassessments for consideration of any alternative diagnoses and/or treatment.
And for four of them, according to the state, Cameron failed to follow up in a timely fashion when the patient developed possible adverse reactions to therapy.
Two of the patients who presented with complaints of fatigue and pain had previous diagnoses and treatment for Lyme disease, 9 and 16 years earlier, fitting the “Lyme literate” notion that their current complaints are most certainly sequelae to inadequately-treated Lyme and cannot be attributed to other causes.
Reading between the lines, Cameron had only one tool, a hammer, so he saw every problem as a nail. The possibility that the patient might be suffering from something other than “chronic Lyme” was tossed aside via inadequate physical exams and medical records, failing to consider other diagnoses, and bulldozing ahead with inappropriate long-term antibiotics, adverse consequences be damned.
Of course, if you think about it, substandard care and “Lyme literacy” would appear to go hand-in-hand. It is hard to imagine the “Lyme literate” doctor, who routinely ignores medical science in favor of unvalidated testing, makes repeated diagnoses of a fake disease, and orders unwarranted long-term antibiotics, otherwise delivering standard-of-care medical practice. As with the Cameron case, this offers a way forward to state medical boards hamstrung by laws designed to protect the misconduct that is “chronic Lyme” from disciplinary action.
Terms of three-year probation
In entering into his probationary period, Cameron is in the company of other “Lyme literate” doctors who have had their medical practices questioned by their peers, up to and including discipline imposed by medical regulators (also, here and here).
Hopefully, Cameron will be hard-pressed to continue his usual M.O. under the terms of the Board’s Consent Order. He has agreed to practice medicine only when monitored by a licensed physician (a “practice monitor”) who must be “board certified in an appropriate specialty considering [Cameron’s] specialty of practice, who is familiar with the diagnostic and treatment modalities practiced and offered by [him].”
The practice monitor can see all of Cameron’s records and must visit his office “on a random unannounced basis at least monthly” and examine no fewer than 20 records. The monitor’s review is to determine whether Cameron’s medical practice “is prudent and competent.” Any perceived deviation from prudent care or refusal to cooperate must be reported to the OPMC within 24 hours. The monitor must also report to the OPMC quarterly and Cameron must pay the expenses of monitoring.
Cameron gets to propose his own monitor to the OPMC. This, coupled with the language about familiarity with Cameron’s “diagnostic and treatment modalities,” leaves some concern that a fellow traveler would be put in charge. The fact that the OPMC must approve the monitor, plus the broad authority given to the OPMC in the Consent Order to look at his records and otherwise investigate what he is up to, somewhat allays those concerns.
He must also, among other things:
    • Obtain written informed consent from each patient “specifically addressing all aspects of treatment” and provide the OPMC with copies of his consent forms.
    • Fully document all discussions with patients concerning his evaluation and treatment “and of the patient’s need to pursue conventional medical care elsewhere, if indicated.” This is of some concern as well, as it implies Cameron is free to provide unconventional medical care as long as he tells the patient she needs the conventional kind.
    • Obtain and review medical records from physicians who previously or are currently treating his patients and refer patients to other physicians for further evaluation and treatment “where medically warranted and beyond the scope of [Cameron’s] role with regard to the patient.”
    • Maintain at least $2 million per occurrence/$6 million per policy year limit medical malpractice insurance.
    • Complete CME courses as directed by OPMC.
But, Legislative Alchemy
Whether Cameron’s case will prove to be a cautionary tale for other “Lyme literate” doctors remains to be seen. Even as one branch of state government successfully prosecutes a “Lyme literate” doctor, another branch, the legislature, is considering forcing insurers to cover treatment of “chronic Lyme,” the subject of no less than three bills now pending. (Assembly Bill 114, Senate Bill 4713, Senate Bill 670). Three other bills are sympathetic to the cause in that they will give “chronic Lyme” advocates yet another venue to argue for insurance coverage. (Assembly Bill 4863, Senate Bill 2168, Assembly Bill 6927). Pseudoscience, it seems, is endemic in the state of New York.

Jarisch-Herxheimer and Lyme disease
When patients diagnosed with chronic Lyme are treated, no matter what happens as a response to the treatment is considered by believers to be evidence in support of the diagnosis. If they get better, then that is evidence that the treatment is working. If they get worse, then that is evidence that the treatment is working and they are experiencing the JHR (or “herxing” as the community calls it). If nothing happens, they just need more treatment. No matter what happens or doesn’t happen, it’s chronic Lyme.
Steven Novella on October 25, 2017
Link
In one of my favorite lines from Full Metal Jacket a solider notes, “Anyone that runs, is a VC. Anyone that stands still, is a well-disciplined VC!” Or if you prefer, from The Simpsons, Chief Wiggum observes about the ghost cars that he believes haunts the highway near Springfield, “They always come out at night, except during the day.”
These lines are funny because we immediately recognize the flawed logic. They are blatant examples of, “Heads I win, tails you lose.” In scientific terms, no matter what the outcome it is evidence that supports the original hypothesis, rendering the hypothesis unfalsifiable. And yet, as obvious and funny as these examples are, it is easy to make the same mistake ourselves in perhaps less obvious fashion.
Let us take, for example, the Jarisch-Herxheimer reaction (JHR) and its relation to alleged chronic Lyme disease. For background, the JHR was first described by Austrian dermatologist Adolf Jarisch (1895) and German dermatologist Karl Herxheimer (1902). They described a reaction to mercury in treating syphilis, in which the patients would have an exacerbation of their symptoms beginning 1-3 hours after treatment, lasting for about a day. Jarisch hypothesized that the mercury was killing off the syphilis spirochetes in large numbers, and the lysed bacteria were releasing endotoxins which were causing the symptoms.
This is almost exactly right. The reaction, it has recently be discovered, is caused more by nonendotoxin pyrogen and spirochetal lipoproteins which stimulate the immune system, including inflammatory cytokines and tumor necrosis factor. The reaction has also been observed in Lyme disease, which is also caused by a spirochete, and in several other bacterial infections.
Symptoms of JHR include fever, chills (often to the point of rigors), worsening skin rash, and may include hypotension, tachycardia, hyperventilation, flushing, and myalgia (muscle pain). In rare severe cases reactions can include meningitis, alterations in consciousness, seizures, and strokes. Death is very rare, except in young children or those who are already in compromised health. 
How does all this relate to unfalsifiable hypotheses and the discipline of possible VC? The issue involves how to interpret symptoms occurring during treatment for alleged chronic Lyme disease. But some further background is necessary. I have already reviewed the issue of Chronic Lyme, so see that article for details, but here is the very quick overview: Lyme disease is a real thing, and infection with a spirochete bacteria that causes a primary, secondary, and possibly tertiary infection if left untreated. Patient with tertiary Lyme can have neurological involvement, including symptoms of meningitis, nerve or spinal cord inflammation, in addition to systemic symptoms. The bacteria is killed off by standard antibiotic treatment, but may require IV antibiotics for tertiary Lyme.
All of this is non-controversial and well-established. However, there is a dubious claim that some patients can have chronic Lyme disease which can survive even IV antibiotic treatment. Treatment reduces the symptoms, but the infection remains chronic and cannot easily be eradicated. The problem with this hypothesis is that proponents have rendered it unfalsifiable by explaining away negative evidence. Patients with alleged chronic Lyme may have negative blood tests for Lyme, but that’s OK because the antibody titers and Western blot tests are not 100%. They may also not have all the classic symptoms of Lyme, but a long list of non-specific symptoms that do not point specifically at an infection or Lyme. They also are not cured by a single round of antibiotics, but that is because, it is argued, they have treatment-resistant strains of the Lyme spirochete.
In essence the argument is that chronic Lyme disease represents an atypical presentation of seronegative treatment-resistant Lyme. That is what we call special pleading – inventing a specific explanation for each instance of evidence (or lack of evidence) that would seem to falsify a hypothesis.
None of this means that patients who are diagnosed with chronic Lyme are not sick. The probably just don’t have a chronic Lyme infection. This is critical because if they are being wrongly diagnosed with a dubious entity then their real diagnosis is being missed, and they may be subjected to multiple rounds of long term IV antibiotics, which is not without risks, to say the least.
Finally we get to the connection to the flawed logic referred to at the top of this article. When patients diagnosed with chronic Lyme are treated, no matter what happens as a response to the treatment is considered by believers to be evidence in support of the diagnosis. If they get better, then that is evidence that the treatment is working. If they get worse, then that is evidence that the treatment is working and they are experiencing the JHR (or “herxing” as the community calls it). If nothing happens, they just need more treatment. No matter what happens or doesn’t happen, it’s chronic Lyme.
Further, just as the symptoms that are used as evidence for chronic Lyme don’t match the actual symptoms of documented Lyme disease, “herxing” after treatment for alleged chronic Lyme can also be highly variable. Here is one chronic Lyme disease site’s description of the JHR:
A Herxheimer Reaction usually causes near-immediate physical symptoms such brain fog, pain, fatigue, and just an overall lack of motivation or passion for anything, but one that lasts for days on end can begin to influence the mentality of a person enduring that Herxheimer Reaction.
You will notice that this does not resemble, except very superficially, the classic description of the JHR. There is no mention of fever, chills, rigor, or hypotension. Instead we get a list of typical non-specific symptoms – similar to the symptoms that lead to the diagnosis of chronic Lyme in the first place. The symptoms can also last for weeks, and fluctuate with good days and bad days. This also does not fit the known pathophysiology of the JHR, which results from starting treatment when there are large numbers of spirochetes that all die and lyse over a short period of time.
Further, I have to note the inherent contradiction here. The JHR results from killing large numbers of spirochetes, and yet chronic Lyme is premised on the existence of treatment-resistant Borrelia burgdorferi (the spirochete that causes Lyme) that can survive antibiotic treatment. You would think that a treatment-resistant strain wouldn’t die off so effectively as to cause a JHR. You can invent an explanation for this as well (a hidden reservoir of the bacteria survives to spread again), but this amounts to more special pleading as there is no evidence for any such explanation nor a reason why it would differ from all our current research into the life cycle of Borrelia burgdorferi.
In science, and in medicine specifically, we have to be careful about the criteria we use to validate or falsify our hypotheses. This is not just in research, but in treating patients as well. We need to decide ahead of time what objective criteria we will use to determine outcomes. It is easy to fall into the trap of ad hoc or post hoc reasoning – interpreting outcomes after the fact. We are great at making everything appear to make sense – just as astrologers are very creative in explaining how behavior, personality, and events are consistent with astrological charts, but only after the fact. They are abysmal at actually making predictions.
Medicine becomes astrology unless we use evidence to decide how we will interpret future data, such as a response to treatment. Related to this is the need to think of signs and symptoms in terms of how predictive they are, not just how typical they are. The predictive value of specific signs relates to how specific they are to one or a category of diagnostic entities. For example, fever may be typical of a specific infection, but it is not very predictive by itself of that one infection because fever can occur in hundreds of entities. This is precisely why we frequently criticize the reliance on non-specific symptoms to allegedly establish the existence of scientifically dubious conditions.
Finally, I want to emphasize that Lyme disease is real, and the JHR is also real and may occur in response to antibiotic treatment for Lyme disease. However, it is a fairly specific reaction in terms of time frame and symptoms, varying mostly in severity. Proponents of chronic Lyme disease, however, rely on a broadening of the possible symptoms, natural history, response to treatment, and reaction to laboratory tests to maintain belief in this entity. They also have to deny the various studies which show a lack of response to treatment for alleged chronic Lyme. Similarly they have taken the concept of the JHR and then applied it to any worsening of symptoms that happens after any treatment for alleged chronic Lyme. This is used to further validate a dubious diagnosis, and to keep patients invested in getting a treatment which the evidence shows not only doesn’t work but may be giving them side effects.

A Review of Under Our Skin, A Cult Classic
Under Our Skin is a propaganda film attempting to sell viewers dangerous treatments for ‘chronic Lyme disease’, a rejected diagnosis not recognized by any legitimate medical organization.
Braden MacBeth on April 8, 2019
Link

[Editor’s note: Dr. Gorski will be absent for another week, so in his stead we present another post from Braden MacBeth.]
Under Our Skin is a documentary about Lyme disease, a tick-borne illness mostly relegated to the northeastern US. It was released in 2009 and received mostly positive reviews from critics. Having watched the film, I don’t really understand why. Under Our Skin exists to sell viewers on unnecessary and dangerous long-term antibiotic therapies, and the existence of chronic Lyme disease.
Lyme disease is boring
Under Our Skin tries to make Lyme disease seem like the most terrifying illness anyone could ever get, and that ticks are going to take over the universe or something. The filmmakers grossly exaggerate the severity of Lyme disease, and the intensity of the required treatment.
Lyme disease is not that scary
The filmmakers try to make Lyme disease seem like it’s as debilitating and dangerous as cancer or something. While the symptoms of Lyme disease can be pretty nasty, it’s still pretty tame compared to the ailments you could possibly suffer from. Early symptoms of infection include: fever, chills, headache, fatigue, muscle and joint aches, and swollen lymph nodes. If left untreated, symptoms can get markedly worse but it’s still very treatable. Lyme disease can be treated easily with a course oral antibiotics and symptoms will resolve quickly in the vast majority of cases. A very small number of patients may still experience minor symptoms following antibiotic treatment up to 6 months, however I am unable to find a study in any credible journal that symptoms will persist beyond that. A study in Pediatrics studied long-term neuropsychological outcomes of children who had facial palsy as a result of Lyme disease, and found that “The neuropsychologic and health outcomes of children with facial nerve palsy attributable to Lyme disease 7 to 161 months earlier are comparable to those who did not have Lyme disease”. Another study published in JAMA also found that the frequency of symptoms following Lyme disease treatment occurred no more often than in the group that never had Lyme disease in the first place.
Lyme disease doesn’t do that
Under Our Skin makes numerous outlandish statements about the possible effects of Lyme disease, none of which are true. According to one “Lyme Literate MD”:
At this point I’ve had many women who’ve gotten pregnant, who’ve lost the baby or they give birth to a baby who has Lyme. The babies don’t have– the developmental growth may be off. Their IQ may be lower. They may develop seizures. They may have other neurological problems because it was not known that the mother has Lyme.
There is no evidence to suggest this is the case, and it’s been studied to a rather large extent. One study tested 2,000 mothers for Lyme disease at their first prenatal visit and at delivery, and found that there was no risk of fetal death, prematurity, or congenital malformations associated with having Lyme disease at the time of conception or during pregnancy. There is no evidence that Lyme disease during pregnancy results in a child having a lower IQ, or has led to the development of neurological problems in children. Furthermore, there is no evidence that a mother with Lyme disease can pass it on to her child.
Chronic Lyme disease is fake
Under Our Skin heavily promotes the idea that Lyme disease can turn into a chronic, persistent infection that requires the long-term use of antibiotics. The Infectious Disease Society of America (ISDA) held a special review panel about their Lyme treatment guidelines in 2006 and unanimously concluded that there is no existing evidence of a chronic Lyme infection and attempting to treat it can be dangerous. A good portion of the film is dedicated to trying to disprove the findings of scientists using anecdotes and conspiracy theories. Chronic Lyme advocates even managed to convince a Connecticut attorney general to investigate the ISDA for possible conflicts of interests on the part of the those who wrote the ISDA guidelines. In 2010, another board review was conducted of the 2006 guidelines, and the guidelines were upheld unanimously.
There are a large number of “medical” organizations that solely exist to try to legitimize chronic Lyme disease as a diagnosis, based on weak scientific evidence. These organizations also work tirelessly to lobby for legislation that prevents medical board sanctions against doctors who use long-term antibiotic therapies to treat “chronic Lyme”. Also on their agenda is forcing insurance companies to pay for long-term antibiotic treatments. In Pennsylvania, ILADS (a Lyme Literate organization) is currently trying to pass legislation that would force physicians to complete two hours of Lyme disease CME and require that they include input from ILADS in creating the Lyme disease CME requirements. There is an overwhelming scientific consensus that long-term antibiotic therapies provide no benefit for Lyme disease. Dr. Lipson covered the investigation by the Connecticut attorney general in 2009, and the fight is still ongoing.
Lyme Disease probably won’t kill you but quack treatments just might
Under Our Skin tries to claim that Lyme disease can be deadly, when that isn’t really true. Lyme disease is one of the least deadly illnesses in existence, since 1985 only 9 deaths have been recorded out of over a million cases. Assuming that there were 30,000 cases every year from 1985 to 2019, your chances of dying if you get Lyme disease are .00091%. Despite no real evidence of long-term negative effects or high chances of death, the documentary advocates risky antibiotic treatments from “Lyme Literate” MDs. A number of the LLMDs in the film have been sanctioned by their state medical boards for prescribing unnecessary long-term antibiotic therapies for the treatment of Lyme disease.
Early on in the film it shows a woman who believes she has chronic Lyme disease meeting with an LLMD. He said that she would need 6 to 8 months of antibiotic therapy and he will need to put a catheter in. He was, of course, referring to a peripherally inserted central catheter (PICC line). Apparently in the chronic Lyme community the use of PICC lines to administer antibiotics over a long period time is quite common. There are even stories online of children having PICC lines inserted and administering IV antibiotics themselves. There is no reason to have a PICC line inserted for the treatment of Lyme disease as IV antibiotics are rarely recommended. There are many risks associated with long term antibiotic use in general, especially when you’re giving those antibiotics through a PICC line. You don’t have to look hard to find stories of people dying because of various complications of PICC lines or long-term antibiotic use for the treatment of “chronic Lyme disease”. The CDC published a report of three patients dying from infections resulting from a PICC line inserted to give antibiotics over a long period of time to treat “chronic Lyme disease”. To reiterate, the evidence shows that there is no benefit from the use of antibiotics for longer than the recommended guidelines. The CDC’s states in their report:
These cases highlight the severity and scope of adverse effects that can be caused by the use of unproven treatments for chronic Lyme disease. In addition to the dangers associated with inappropriate antibiotic use, such as selection of antibiotic-resistant bacteria, these treatments can lead to injuries related to unnecessary procedures, bacteremia and resulting metastatic infection, venous thromboses, and missed opportunities to diagnose and treat the actual underlying cause of the patient’s symptoms. Patients and their health care providers need to be aware of the risks associated with treatments for chronic Lyme disease.
The many amazing moments of Under Our Skin
Under Our Skin features many unforgettable and hilarious moments and it would be irresponsible for me not share them with you.
World’s strangest conspiracy theory?
Under Our Skin presents the most ridiculous conspiracy theory I have ever heard. The major conspiracy theory is that the CDC, and physicians in academia, are conspiring to suppress the severity of Lyme disease and keep patients from expensive treatments. According to the “science writer” on-screen (anyone can call themselves that), it was a perfect storm of a couple different events starting with:
1980, the United States said it was okay for government institutions and universities to patent and profit from live organisms. So the Lyme disease organism was discovered in 1981, and all of a sudden there was the equivalent of an Oklahoma land grab, people looking under their microscopes, patenting pieces of the organism, so the people that are credited for being the Lyme disease experts no longer shared information about a new, really dangerous pathogen.
The ruling she is presumably referring to is Diamond v. Chakrabaty in 1980, which did not rule that universities and government institutions could patent and profit from live organisms. The ruling allowed genetically modified organisms to be patented, but does not extend to “newly discovered products of nature”. This well established in many cases long before this ruling such as in the Supreme Court case Funk Brothers Seed Co. V. Kalo Inoculant Co. where the court stated:
Their qualities are the work of nature. Those qualities are of course not patentable. For patents cannot issue for the discovery of the phenomena of nature. See Le Roy v. Tatham, 14 How. 156, 175. The qualities of these bacteria, like the heat of the sun, electricity, or the qualities of metals, are part of the storehouse of knowledge of all men. They are manifestations of laws of nature, free to all men and reserved exclusively to none.
Basically, what she is claiming is utter nonsense and reflects flagrant dishonesty or ignorance of even basic legal concepts. It gets better:
The other thing was the rise of managed care. Insurance companies and HMOs realized that if they can get researchers in universities to define diseases and write guidelines for diseases a certain way, then they could help manage the escalating medical costs.
Her argument almost seems reasonable if you don’t think about it in the slightest. There are researchers, universities, and government health organizations researching diseases around the world, the US insurance companies paid all of them off? It would take a massive amount of money to pay off people who have it pretty good already, and researchers would incur a huge amount of risk in participating in a scheme like this. If someone working for the NIH or CDC did what she’s suggesting, they would almost certainly be charged with fraud, and their careers would certainly be over if caught. Lyme disease occurs in other nations too, what do they recommend? The European Center for Disease control also says that Lyme disease should be treated with appropriate antibiotics for a few weeks. Are they on a US insurance company’s payroll too?
Now for my favorite part of this conspiracy:
really what this means is, the people who protected public health, so, like, the CDC, and the NIH and universities. Who didn’t have any commercial interests, all of a sudden, they were partners with big pharma.
Here’s the problem, the NIH and CDC don’t really have financial interests. They work for the United States government, they’re bankrolled by an organization that literally prints money. This is by far the weirdest conspiracy theory I have ever heard.
Lyme disease basement research/Lyme disease causes everything guy
About 15 minutes into the film we are introduced to Dr. Alan MacDonald, who researches Lyme disease on his own time, in his basement, with his little Maltese dog named Travis. According to him the view that the bacteria that causes Lyme disease doesn’t stay around in the body very long will be disproven. To date, there is no evidence that symptoms following antibiotic treatment for Lyme disease are the result of a persistent bacterial infection. He also believes that the Lyme disease bacteria is responsible for Alzheimer, Lou Gehrig disease, Parkinson disease, and multiple sclerosis, because he was able to find the DNA of the spirochete that causes Lyme disease in 7 out of 10 brain DNA samples. His reasoning is that if a spirochete like syphilis can cause dementia, then the Borrelia spirochete could also do that. The problem with his theory is that Lyme disease is pretty rare in most parts of the world, and many parts of the world will never see a case of Lyme disease, while the diseases he believes Lyme disease cause are common throughout the world.
Anecdotes vs. evidence
Under Our Skin, like all quack documentaries, is filled with testimonials. The problem with testimonials is that most people are poor historians and couldn’t present their own medical history accurately if they tried. They could also be actors or just mistaken, lying about or exaggerating their symptoms. Under Our Skin is different from most quack documentaries because they actually have testimonials from experts which always come before or after showing someone giving a ridiculous opinion or anecdote with no evidence to back it up. Just to give you an idea of how ridiculous it gets: they show an interview with a researcher stating that the scientific evidence shows there is no benefit to long-term antibiotic treatment. They follow it up with an anecdote from a LLMD’s secretary who claims that patients who received long-term antibiotics seemed to be doing better afterwards. Another absurd example is when they try to prove that Lyme disease is everywhere by filming one woman driving in her car and pointing at houses claiming that the person who lived there had Lyme disease. I have no idea how anyone is supposed to take the testimonials in the film seriously.
Conclusion: A cult classic
Under Our Skin is a documentary designed to sell viewers on a fake illness that supposedly comes from a real illness. Dr. Lipson’s post back in 2009 examining a study that surveyed households a month after viewing the film suggests it might actually be successful. Throughout researching this article, I have tried to identify anything about Lyme disease that makes it something you should actually worry about over any other illness. Lyme disease is uncommon even where it’s the most prevalent, and the only hard part about treating it is finding a pen to write ‘Doxycycline’ on a prescription pad. Lyme disease is the most overhyped illness of all time. The horror stories you hear about it are a million times worse than it actually is. It’s a bacterial infection that causes temporary neurological symptoms and can be treated with oral antibiotics; that’s it.
The story of how Lyme developed a reputation of being this incredibly dangerous disease that you should be terrified of is far more interesting than the disease itself. There is no such thing as ‘chronic Lyme’ but there is an online cult obsessed with it. I’m being quite serious when I use the term ‘cult’, as I think it’s accurate to call online chronic Lyme support groups cults. However, chronic Lyme cults differ from how we would usually define a cult in a few key ways. Chronic Lyme cults (CLCs) differ from normal cults in that they don’t form around a charismatic leader, however believers flock around doctors they consider to be heroes. The last thirty minutes of the film are dedicated to portraying “LLMDs” as heroes standing up against the medical establishment to protect their patients. The reality is that these physicians practice substandard medicine to treat Lyme disease or are administering dangerous treatments to patients for a condition that does not exist. Practitioners in the film were reported by other physicians for following unusual practices in treating Lyme disease because they were following unusual practices in treating Lyme disease. The evidence shows that there is no benefit to long courses of IV antibiotics to treat Lyme disease. Furthermore, practitioners being sanctioned for substandard practices in the treatment of Lyme disease is not going to make physicians practicing competent medicine afraid to treat patients with Lyme disease (which the film argues.
An article in the Psychiatric Times on the nature of cults provides a list of traits of people who are most prone to join cults, some of which are particularly applicable. One of these traits is a low tolerance of ambiguity, and the film’s many testimonials showcase this. One woman’s son was born with an unspecified neurodegenerative condition, she claims that she had Lyme disease when she was pregnant and that her son was born with Lyme disease and that was the cause of his condition. While it’s a sad state of affairs, there is no evidence that being treated for or having Lyme disease during pregnancy will result in any neurodegenerative conditions in children. Many CLC websites promote the idea that Lyme disease causes or mimics the symptoms of autism. There is no evidence that Lyme disease causes or mimics the symptoms of autism, and research has shown there is no correlation. These people want a reason for why something terrible has happened to them that science might not have a great answer for, and ‘chronic Lyme’ gives them a simple, digestible answer.
The most notable characteristic of cults also exhibited by the chronic Lyme cults is how they treat critics and non-believers. The chronic Lyme disease cult is very passionate and has a long history of protesting the investigation of doctors treating Lyme outside established guidelines, and harassing doctors who do not want to incorporate pseudoscientific treatments into their practices. Whenever a “Lyme Literate” physician is investigated by the medical boards or taken to trial for questionable practices, a chronic Lyme cult protest can always be found. Researchers and physicians who speak out against chronic Lyme are often the target of harassment campaigns in the form of baseless complaints to the board of medicine, death threats, protesting their place of work, and libelous online blogs. One physician received 11 complaints to the board of medicine shortly after speaking out against the use of long-term antibiotics to treat the illness, and simply stating that there is no evidence that chronic Lyme disease exists. All of the complaints were dismissed, and his record is still spotless, but it made him deeply afraid to even talk to the media. One of his colleagues wrote to the medical board stating:
“A complaint campaign to the board is just the latest escalation in a guerrilla war against physicians, scientists and federal officials who are not inclined to view Lyme borreliosis as the Fifth Horseman.” Since the campaign, Steere’s friends say that he has grown more and more depressed, though he wouldn’t say so publicly. “This is criminal what is being done.”
However, the chronic Lyme cult would not stop in their attempt to harass him, the director of the Lyme Disease Coalition said: “There will be a day of reckoning”.
It’s easy to see hardcore believers of chronic Lyme as mentally ill given their actions, but it’s important to remember that they’re also victims of an incredibly successful health misinformation campaign. There is more inaccurate information about Lyme disease on the internet than accurate information. When searching “Lyme Disease” online, the first result that isn’t from the CDC, Mayo, or WebMD is a link to LymeDisease.org. Surely you would think that LymeDisease.org is a credible source of Lyme information…right? Not quite. There are Lyme Disease support groups, Lyme disease organizations, and articles in The New York Times talking about the “Lyme Controversy”, all of which promote the idea that Lyme disease is a life-altering, possibly chronic condition. There are Lyme disease support groups in Australia, when there is no evidence that Lyme disease even occurs in Australia.
People who claim to suffer from chronic Lyme disease may not be suffering anything related to Lyme disease but they can still have real illnesses. They can be suffering from an untreated illness, such as one man who was treated for ‘chronic Lyme’ that actually had a brain tumor that would’ve been treatable without surgery if found sooner. It’s likely that people claiming to suffer from chronic Lyme have somatic symptom disorder. According to the APA: “Somatic symptom disorder involves a person having a significant focus on physical symptoms, such as pain, weakness or shortness of breath, that results in major distress and/or problems functioning. The individual has excessive thoughts, feelings and behaviors relating to the physical symptoms. The physical symptoms may or may not be associated with a diagnosed medical condition”. The more I check the research against the claims of the documentary, the weirder this documentary appears to me. Under Our Skin is a very strange film for an audience who in all likelihood, already has their minds made up. This documentary is as educational as the information videos on the Scientology YouTube channel and I would advise steering clear.

Warts
Mark Crislip on February 22, 2013
Link
As this is published I am finishing the last day of a 12 day stretch covering my partner while he is off trying to get MDRTB and typhoid fever. He is in India. I may have to autoclave him when he returns before I let him in the hospital. Double the work means double the fun, but free time goes down by the power. Same thing happens with the kids. If you have two kids, the work squares, three kids, the work cubes. A linear change in one domain leads to exponential change in other domains. I am sure that phenomena has a name that one of our readers will know.
I lack the mad typing skills of other contributors and it usually takes me at least a week to carefully construct the spelling errors and grammatical faux paux for which I am justly famous. And then I have to come up with content to surround the faulty English. This week I have little time and so a ‘fun’ post.
When I make rounds it is not unusual for people to ask questions about their health and their family. I learned long ago to ask why they want an answer to a particular question so I do not inadvertently offend a colleague. When I offend I like to be advertent. Years ago I was asked what I thought of hyperbaric oxygen, and I replied that it is great for the bends but otherwise mostly serves to enrich the hyperbaric doctors. Why do you ask? I am the new director of the hyperbaric program, was the reply. Open mouth and insert foot.
So recently a nurse asked me if duct tape would remove warts. Wary, I asked why, and she showed me a huge wart on her hand. I have used duct tape for many purposes; few home repairs cannot be (temporarily) accomplished with duct tape. But treating warts? Do you use the tape as a way to yank the wart out by its roots? Got me. I gave my best Gallic shrug and went looking for information.
Warts, and from here on I am referring to common warts on the hand, are due to a virus, the papilloma virus. Or so I was taught. For the first two years I took the bus to medical school and occasionally someone would see I was reading a medical text and strike up a conversation. This usually occurred on the trip to school. After gross anatomy lab, the last class of the day, I usually sat alone, I assume the result of my smell. Preserved cadavers have a penetrating fragrance that saturates the skin and hair and will drive away even urine stained crazies.
Once it was a student at the naturopathic school who noted that, contrary to what I was taught, warts are actually the result of the body walling off toxins and expelling them. I remember thinking at time, this is a loon, and the last thing you do is egg-on a loon when you can’t run away. So I smiled grimly, made non-committal grunts and was relieved when he got off the bus. Turns out he wasn’t a loon, but was repeating the teaching of his school. It is the school that has the loons.
Naturopaths believe that such symptoms as warts are the result of toxins in the body, and an immune system that is not running efficiently. They may prescribe treatments such as colonic irrigation, alongside a program of healthy eating to raise the general level of health. A naturopath may suggest a paste made with vitamin C, applied to the wart daily for a period of a few weeks.
Remember, these folks want to be primary care docs: have a wart, get a colonic.
Determining effective treatments for warts is problematic since the natural history for warts is to go away. In a study that is slightly creepy, but how it was done back in the day, they found:
The natural history of warts was recorded by examining 1,000 institutionalized mentally defective children for 2 years. Treatment of warts was withheld. We found: (1) The overall incidence increased from 18% to 25% in 2 years. (2) The dynamic aspect of warts was reflected by the fact that two-thirds of the original lesions in 168 cases involuted within 2 years. (3) Involution occurred almost twice as often in boys as girls.
That is the only study of the natural history of warts I can find. 2/3 will go away in two years. So if you get two years of colonics you can credit the colonic with the resolution of the warts.
And the Cochrane reviews notes
In 21 trials with placebo groups that used participants as the unit of analysis, the average cure rate of placebo preparations was 27% (range 0 to 73%) after an average period of 15 weeks (range 4 to 24 weeks).
Warts are a self-limited disease.
There are many popular remedies for warts. Pick a SCAM, it has been used on warts. Some allege benefit, some do not. My wife, who grew up in rural Minnesota, swears by milkweed. She is anecdote central for the efficacy of milkweed. Warts melt away with application of the milkweed milk. There was one clinical trial out of India that evaluated milkweed and it did not work.
There are over 140 types of milkweed, and in Minnesota it is Asclepias syriaca, not the Asclepius curussavica tested in India, so the best you can say is one down, 139 to go. Besides, I am not going to cross my wife on the efficacy of milkweed, although I would on vaccines if needed.
Of the popular cures for warts my favorites are from Mark Twain:
Aha! Talk about trying to cure warts with spunk-water such a blame fool way as that! Why, that ain’t a-going to do any good. You got to go all by yourself, to the middle of the woods, where you know there’s a spunk-water stump, and just as it’s midnight you back up against the stump and jam your hand in and say:
‘Barley-corn, barley-corn, injun-meal shorts,Spunk-water, spunk-water, swaller these warts,’and then walk away quick, eleven steps, with your eyes shut, and then turn around three times and walk home without speaking to anybody. Because if you speak the charm’s busted.”“Well, that sounds like a good way; but that ain’t the way Bob Tanner done.”
“No, sir, you can bet he didn’t, becuz he’s the wartiest boy in this town; and he wouldn’t have a wart on him if he’d knowed how to work spunk-water. I’ve took off thousands of warts off of my hands that way, Huck. I play with frogs so much that I’ve always got considerable many warts. Sometimes I take ’em off with a bean.”
“Yes, bean’s good. I’ve done that.”
“Have you? What’s your way?”
“You take and split the bean, and cut the wart so as to get some blood, and then you put the blood on one piece of the bean and take and dig a hole and bury it ’bout midnight at the crossroads in the dark of the moon, and then you burn up the rest of the bean. You see that piece that’s got the blood on it will keep drawing and drawing, trying to fetch the other piece to it, and so that helps the blood to draw the wart, and pretty soon off she comes.”
“Yes, that’s it, Huck — that’s it; though when you’re burying it if you say ‘Down bean; off wart; come no more to bother me!’ it’s better. That’s the way Joe Harper does, and he’s been nearly to Coonville and most everywheres. But say — how do you cure ’em with dead cats?”
“Why, you take your cat and go and get in the graveyard ‘long about midnight when somebody that was wicked has been buried; and when it’s midnight a devil will come, or maybe two or three, but you can’t see ’em, you can only hear something like the wind, or maybe hear ’em talk; and when they’re taking that feller away, you heave your cat after ’em and say, ‘Devil follow corpse, cat follow devil, warts follow cat, I’m done with ye!’ That’ll fetch any wart.”
Although the final cure does run risk of witnessing a murder and all the adventures that follow.
There is an interesting and variable literature on hypnosis curing warts that someday I would like to review but I know so little about hypnosis and this is not the time or place. Warts have a more supernatural/mind-body reputation to their treatment than most common ailments. Although I had always been told that people could hypnotize away warts on one side of the body only, what literature I could find suggests it is not true. Bummer. One of my favorite myths. I will feel the need to start a sentence with actually next time the topic comes up.
I received an interesting email from a colleague, Dr. Robinson, with this approach to warts:
Burkhart freezes them first. Then he adds a yeast extract and several liquids, including the juice from a Asian blistering beetle – not sold in the United States.
But here, Burkhart plumbs the darker methodology. At 33, dressed in a bow tie, the Chapel Hill physician hardly looks the part of wart shaman. Spend 20 minutes in his Southern Village office, and you get the feeling he could smile the warts off your finger.
He’s eradicated more than 100 of the little devils, mostly from children. He’s tackled the common sort that pop up around the eyes, the stubborn variety that sprout around fingernails and, once, an irritating growth from a football player’s foot.
But he’s willing to dive into weird practices, or at least the pages of long-forgotten Advanced Dermatology Therapy, published in 1987 by fellow Toledo native Dr. Walter B. Shelley.
Borrowing the late Shelley’s technique, Burkhart wraps the offending growth in silk tape and asks the patient to describe its mood. Angry wart? He draws an angry face on the bandage. Sad wart? He draws a sad face. Next, he offers the patient an exotic coin. He carries them in a Ziploc bag: Norwegian kroner and Argentine pesos. One coin equals the price of one wart. If the growth returns, he expects his coin back. But so far, after probably 100 wart exorcisms, he’s never needed a refund.
Finally, he tells patients to remove the bandage at the stroke of midnight. If that’s too late for a patient, he offers bedtime as a substitute.
I get the feeling that Burkhart is having fun with the wart therapy, since he is treating children, and it is part of the art of medicine that I can appreciate and admire. But it still has the odd vibe that hypnosis adds to wart therapy.
I have to stay on topic. The topic is duct tape. Squirrel.
There are a surprising number of hits when searching the topic on PubMed.
The mechanism by which duct tape is alleged to work is the Goldfinger effect: by occluding the area it is denied oxygen and dies. Warts are supplied from the inside, as are people, and neither warts nor Jill Masterson will die as a result of being covered with duct tape or paint.
There are clinical trials for duct tape. Duct tape does not work in adults:
There were no statistically significant differences in the proportions of patients with resolution of the target wart (8 [21%] of 39 patients in the treatment group vs 9 [22%] of 41 in the control group). Of patients with complete resolution, 6 (75%) in the treatment group and 3 (33%) in the control group had recurrence of the target wart by the sixth month.
But warts are usually more difficult to treat in adults, so how about kids? Nope.
Duct tape applied to the wart or placebo, a corn pad (protection ring for clavi), applied around the wart for 1 night a week. Both treatments were applied for a period of 6 weeks. Patients were blinded to the hypothesis of the study.MAIN OUTCOME MEASUREMENT:Complete resolution of the treated wart.RESULTS:After 6 weeks, the wart had disappeared in 16% of the children in the duct tape group compared with 6% in the placebo group (P = .12). The estimated effect of duct tape compared with placebo on diameter reduction of the treated wart was 1.0 mm (P = .02, 95% confidence interval, -1.7 to -0.1). After 6 weeks, in 7 children (21%) in the duct tape group, a surrounding wart had disappeared compared with 9 children (27%) in the placebo group (P = .79). Fifteen percent of the children in the duct tape group reported adverse effects such as erythema, eczema, and wounds compared with 0 in the placebo group (P = .14).CONCLUSION:In a 6-week trial, duct tape had a modest but nonsignificant effect on wart resolution and diameter reduction when compared with placebo in a cohort of primary school children.
At least no better than placebo, but better than cryotherapy:
INTERVENTION:Patients were randomized using computer-generated codes to receive either cryotherapy (liquid nitrogen applied to each wart for 10 seconds every 2-3 weeks) for a maximum of 6 treatments or duct tape occlusion (applied directly to the wart) for a maximum of 2 months. Patients had their warts measured at baseline and with return visits.MAIN OUTCOME MEASURE:Complete resolution of the wart being studied.RESULTS:Of the 51 patients completing the study, 26 (51%) were treated with duct tape, and 25 (49%) were treated with cryotherapy. Twenty-two patients (85%) in the duct tape arm vs 15 patients (60%) enrolled in the cryotherapy arm had complete resolution of their warts (P =.05 by chi(2) analysis). The majority of warts that responded to either therapy did so within the first month of treatment.CONCLUSION:Duct tape occlusion therapy was significantly more effective than cryotherapy for treatment of the common wart.
Although when you read the wart treatment literature there is great variability in all the responses to all the therapies depending in part how long you follow them.
The Cochrane reviews only found two duct tape studies, as did I, and suggest that most therapies for warts are of minimal efficacy over doing nothing. Systematic reviews suggest that best therapy is not still known for warts.
Overall, trials comparing cryotherapy with placebo showed no significant difference in effectiveness, but the same was also true for trials comparing cryotherapy with [salicylic acid]. Only one trial showed cryotherapy to be better than both SA and placebo, and this was only for hand warts. Adverse effects, such as pain, blistering, and scarring, were not consistently reported but are probably more common with cryotherapy. None of the other reviewed treatments appeared safer or more effective than SA and cryotherapy. Two trials of clear duct tape demonstrated no advantage over placebo.
It appears duct tape does nothing and other therapies little more. Me? I’m sticking with the dead cat in the cemetery. Anything that involves a dead cat is good by definition.

Should We Fear the Monkeypox?
A recent outbreak of monkeypox is likely containable, but people are understandably concerned.
Steven Novella on May 25, 2022
Link
The notion that we will have to live with COVID as a new human pathogen is perhaps just sinking in to the general population. If you want an update, check out Mark Crislip’s new post (it’s great to have Mark back at SBM – his dry humor was missed). I have long resigned myself to the notion that we are basically never going to get back to the pre-COVID normal. Likely, routine masks are now the new normal in health care. During my career once a new infectious precaution is added it never goes away.
It is possible that humanity will also have to get used to the idea of not just living with COVID, but living in a world in which pandemics happen with increasing frequency. I don’t think it will be another century before the next COVID, and there are much worse things than COVID lingering on the edges of civilization, waiting for their chance. COVID should be a wake-up call, and in an even semi-rational world would lead to a much more robust international effort to limit zoonosis (infections spreading from animals to humans), rapidly responding to novel outbreaks, and vaccinating everyone.
Speaking of which, you may have seen reports that a new virus is being reported in different parts of the world, the monkeypox. The World Health Organization (WHO) recently reported 250 confirmed cases in 16 different countries. This includes (as of May 23) 20 confirmed cases in the UK, with one confirmed and four suspected cases in the US. Pre-COVID an outbreak like this would barely register. Now, outbreaks understandably make people a little twitchy. I remember in February 2020 the “voices of reason” were saying about COVID (myself included) that we should be concerned, but it’s too early to panic. I don’t know if in retrospect that struck the right tone (without Monday morning quarterbacking), but it feels like we are in the same place now with the monkeypox.
Any new zoonotic outbreak should be taken seriously, and is cause of concern, but we cannot panic every time it happens. It would help if we could all feel confident that those in charge will respond appropriately, and they will tell us if we need to take any precautions. Right now the WHO is not recommending any lockdowns or special measures. They are characterizing these outbreaks as “containable”. That’s reassuring, but let’s take a look at monkeypox to hopefully have a better idea how concerned we should be.
The monkeypox is not new, it is a known virus closely related to smallpox. Smallpox was a scourge of humanity declared eradicated from the world in 1980, due to a robust vaccination campaign. Monkeypox is a virus, a member of the Orthopoxvirus genus in the family Poxviridae – the same genus as smallpox. As the name implies, it is zoonotic, transmitting from animals to humans. It is less contagious than smallpox and causes less severe illness, typically a rash, fever, and inflamed lymph nodes lasting 2-4 weeks. The fatality rate depends on the strain, and ranges from 0-10%, with the WHO stating 3-6% on average. While that may be relatively low, it is still concerning, especially if one of the more virulent strains breaks out.
Monkeypox was first identified in the Congo in 1970, and most outbreaks since then have been in Africa. This is why the recent outbreaks have perked the interest of experts, as it is spreading outside its usual range. Another cause of concern is that, as we all learned from tracking COVID, the reports of confirmed cases is likely a couple weeks behind reality. So by the time we know of outbreaks in other countries, the virus has likely already spread even farther.
There is good and bad news on the vaccine font. The good news is that the smallpox vaccine conveys about 85% coverage of the monkeypox. So we already have effective vaccines and many people are vaccinated. However, the bad news is that if you are under age 45 you are likely not vaccinated because smallpox was eradicated. But, more good news, Moderna (one of the mRNA companies) is already working on a specific monkeypox vaccine.
Monkeypox is spread mostly through direct physical contact with bodily fluids, but also through contact with contaminated surfaces, and through droplets. A 2013 study also found that aerosolized monkeypox can remain infective for up to 90 hours, but this may not be a significant mode of transmission. It seems, therefore, that masking, avoiding physical contact, cleaning surfaces, and social distancing can be highly effective, and is partly why the WHO feels recent outbreaks can be contained. This can also be combined with contact tracing.
Given all this, should we fear the monkeypox? Yes and no. Right now outbreaks are limited and containment is possible. We have methods of preventing and treating monkeypox. This is exactly the scenario for which we need a robust international rapid-response capability, to nip these outbreaks in the bud before they become epidemics or pandemics. But we need to keep our eye on the situation, because we also know how quickly they can get out of control. Outbreaks like this have always been going on the background, while the general public is mostly unaware or pays little attention. The main difference now is that we are paying attention.
I also firmly believe that COVID should have taught us that we need to radically change the conversation around vaccines, and if we needed it the monkeypox may be a potent reminder. Vaccines are our best defense against a world in which viruses and other agents are constantly evolving in order to exploit a large human population with frequent global travel. The world is essentially a petri dish for infections, and we have also made ourselves more vulnerable by getting too cozy with wildlife populations. We need the protection that only vaccines can provide.
Tolerance for anti-vaccine lies and propaganda needs to be a thing of the past. We need to aggressively marginalize and counter antivaccination views. This also needs to be paired with far greater vaccine requirements. While I don’t agree with forced vaccination (which is likely not feasible in any case), it is completely reasonable (given the reality I outlined above) to make it very difficult to live in this world as someone who refuses to do their common sense duty to protect themselves and others with vaccination. It’s your choice, but now you have to stay over there away from everyone else (metaphorically speaking). Clearly such regulations need to be on the federal level (and when it comes to travel on an international level) – universality is the whole point.
Either that or we need to accept the fact that we live in pandemic world.

A Pox on All Our Houses
‘Tis but thy name that is my enemy;Thou art thyself, though not a Monkeypox.What’s Monkeypox? It is nor hand, nor foot,Nor arm, nor face, nor any other partBelonging to a man. O, be some other name!What’s in a name? That which we call an orthopoxvirusBy any other name would sicken as much;So Monkeypox would, were he not Monkeypox call’d,Retain that dear perfection which he owesWithout that title. Monkeypox, mutate,And for that name which is no part of theeTake all myself.
Juliet is just asking to be patient zero.
Mark Crislip on June 16, 2022
Link

They tell us thatWe lost our tailsEvolving upFrom little snailsI say it’s allJust wind in sails
Are we not men?We are Citrate!Are we not men?D-E-V-O
…
Monkey men allIn business suitsTeachers and criticsAll dance the poot
Are we not men?We are Megaplates!Are we not men?D-E-V-O
…
Are we not men?We are Devo!
We must repeatD-E-V-O
Homo Jocko by Devo. Sort of. That brings back memories. Saw Devo back in medical school. When I was in medical school, not Devo. Fun show. My brother bought an Energy Dome Hat, since, unfortunately, lost.
Monkeypox. I know Dr. Novella discussed the pox lately, but I feel like a little idle speculation on the topic. Emphasis on speculation. Monkeypox, chickenpox, smallpox. Ever wonder that the Great Pox was? Syphilis. So horrible it was worse than the Small Pox. From reports, syphilis was quite the disease when it hit Europe in the 15th century, different clinically and more virulent than the three stages of Lues we have today. Why the difference? Did the spirochete evolve? Did we evolve? Some combination? No one knows.
The standard model is that the Old World gave smallpox to the New and the New World returned the favor with the great pox. Or was syphilis circulating in Europe before Columbus and took an evolutionary jump into virulence? It might be the case.
The researchers managed to recover and sequence Treponemal DNA from four samples and compared the sequences with a modern syphilis strain…the diversity of strains around the time of Columbus’s crossing offers additional evidence that the pathogen had already made a home in Europe.
Syphilis or a pox, understanding infectious diseases is, at its core, applied evolution.1
As an aside, I have always liked the word pox and it is a shame that pox is not more widely used. Medicine has a lot of archaic language that we are poorer for no longer using. And I thought it was “a pox on both your houses”, and had this whole Romeo and Juliet theme plotted when I discovered it was “A plague o’ both your houses! They have made worms’ meat of me”, a quote worthy of any of the plagues of the last 40 years. With over a million dead, COVID-45 has been making worms’ meat of far too many.
An ID consultation has, at its heart, three components: what infection does the patient have, why do they have that infection, and how best to treat it. It is the “why” that is usually the most enjoyable to tease out of the case and the most interesting. Why at the molecular level, the human level, and the societal level. ID docs, as I have said before, are the only truly holistic doctors.
Infections first have to spread. There are three ways to acquire infections: eat it, touch it, or breathe it. If you are a splitter, you could say food or water are subsets of eating and sex as a subset of touching, and breathing has the spectrum from droplets to aerosols. And there are all the odd ways of getting infections: injection drugs or insect bites or transfusions; all subsets of touch. But I will be a lumper for simplicity’s sake.
Then organisms have to adhere to something. The pathogen has to stick to a cell, a protein, a sugar, a receptor. Without binding to something, gaining some toe hold, infections cannot start. I find the adherence of pathogens endlessly interesting. Which is part of why I am never invited to parties. I spent three years of my life trying, and failing, to determine how Candida adhered to endothelial cells. I may have been the world’s worst bench researcher.
COVID has its ACE 2 receptors. HIV, its CD4/Chemokine receptors. Interestingly, these receptors have high density on foreskins which is part of why circumcision is one way to decrease HIV spread. Influenza starts by binding to sugar residues that are common in the upper airway of humans. The good news is that bird flu binds to different sugars, which humans do not have. The bad news? Bird flu is three mutations, or an unfortunate recombination, away from being able to use human upper airway sugars. S. bovis has enhanced ability to adhere to the matrix of bowel cancer which is why bacteremia with that organism warrants an evaluation for gastrointestinal malignancy.
And on and on. Each organism has its preferred binding site, its staging site, from which it can launch its invasion.
Of course, there is the yin of receptors to the yang of pathogen binding. We are all different, a mass of polymorphisms and inherited genetic quirks that may increase or decrease a pathogen’s ability to adhere to us. Most of the polymorphisms that show up in my feeds concern the immune system, but my favorite, and yes I have favorites,2 is mutant snot. If you have the wrong snot, you are at increased risk for invasive Meningococcal disease. Or as a scientist would put it,
A mutation in SPLUNC1 affecting mucosal attachment, biofilm formation, and invasion of mucosal epithelial cells is a new genetic cause of meningococcal disease.
The last stage of infection is the land rush. Pathogens want a wide-open vista with no competition that they can fill with their progeny. Competition comes in many forms: other organisms, immunity, cilia, diarrhea, cough. Get rid on the right type of competition and the organism can spread quickly and widely.
Spread, adhere, land rush.
How would that apply to monkeypox?
Monkeypox is spread by contact and droplets, with perhaps a bit of aerosols. Like smallpox. This is always a question from an infection control perspective. Spread by contact and droplet is the predominant method of spread. But there are always unique circumstances, often human behaviors, that will aid in the spread of disease by both its common route and by less common routes. Want to increase the transmission TB? Hotbox. Transmit more hepatitis C? Invent syringes and needles. Etc. Human behavior can lead to surprising ways to aid pathogen spread.
The smartest (see first footnote) way a pathogen can spread is to be a sexually transmitted disease. Sex brings close contact and is face to face as well as face to many other areas. Humans tend towards polymorphous perversity, although Freud is a crock. I prefer the idea that for humans there is nothing unnatural– just untried. Humans tend to try every possible behavior and with that behavior comes the potential for disease spread. Monkeypox, while not a true STD (yet), is apparently latching on to that method to help spread. But as noted above, sex is just a very intimate form of contact spread.
Being an STD is smart for many reasons. One is that I have noticed that people tend to repeat sexual contacts, giving a pathogen many opportunities to spread. Symptomatic pox may occur in and around an orifice that is not being examined by the afflicted and may not be noticed during passion in a darkened environment. Finally, people will often have sex even if they are not feeling well, i.e., when they are infectious. In the old days before the cause of AIDS was known (let alone HAART), and currently, people continue to have sex while symptomatic for HIV. And one of the risks for acquiring HIV is the presence of a genital ulcer. It was no surprise that that circumcision may have initially increased the acquisition to HIV because the patients did not wait until healed to have sex. I suspect that the presence of the pox, like that of an ulcer or circumcision scab, will not deter many people from having sex.
I have a memory from high school of a Lenny Bruce bit where he is in the ER with his leg cut off and he expresses a willingness to have sex at that moment. I can’t find the bit on the web, so maybe it is a false memory. But the concept is valid.
So if monkeypox is trying to go down the STD its route, this is a wise choice from a transmission perspective.
What about initial binding? For smallpox all I can find is:
The virus binds to host cell receptors via hemagglutinin antigens expressed on its outer surface. The exact mechanism of entry is not yet known.
And unlikely to be known. At least I hope no one is currently doing smallpox transmission studies.
For other pox viruses?
In general, poxviruses show species specificities that range from narrow to broad, but we still know little about the fundamental mechanisms that mediate the host tropism of individual poxviruses. Even if variola virus never again infects humans, there are other poxviruses that can cause serious human disease.
For monkeypox:
The genomes of monkeypox and variola viruses are about 96% similar in the central regions but differ in the terminal regions, the place where most of the virulence and host-range genes are located. Phylogenetic analysis has shown that the variola and monkeypox viruses have a common ancestor but have not evolved one from the other.
Monkeypox and smallpox seem different enough that the former is unlikly to take over the space once occupied by the latter. But there is always the worry given its “wide tissue tropism” that it could settle into humans to become the new syphilis. That would not surprise me.
And for that initial adherence:
…for poxviruses, no specific host-cell receptors have been identified…Therefore, poxviruses can probably bind to and enter a wide range of mammalian cells, but the ability of a given poxvirus to fully complete the replication cycle varies markedly between cells of different lineages or species origins.
So I can’t really glean from the basic starting point of infections for monkeypox if there is a potential for enhanced pathogenicity by increasing adherence in humans. Time will tell, as time is wont to do. But we do know that monkeypox can infect human cells, so it is already halfway there.
Many of the articles mention that DNA viruses do not mutate with the abandon of RNA viruses. I somehow do not find that reassuring. Monkeypox is mutating, as it should:
The genomes from the current outbreak share 40-some mutations with each other that distinguish them from their closest relatives…
Although the significance of these mutations is uncertain.
I keep two studies always in my mind when it comes to organisms mutating for increased fitness in a new environment. The first was by Richard Lenski who grew:
E. coli continuously for about twenty years in his Michigan State lab. For the fast-growing bug, that’s over 40,000 generations!
After 30,000 generations the organisms developed the ability to metabolize citrate as an energy source:
The major point Lenski emphasizes in the paper is the historical contingency of the new ability. It took trillions of cells and 30,000 generations to develop it, and only one of a dozen lines of cells did so. What’s more, Lenski carefully went back to cells from the same line he had frozen away after evolving for fewer generations and showed that, for the most part, only cells that had evolved at least 20,000 generations could give rise to the citrate-using mutation. From this he deduced that a previous, lucky mutation had arisen in the one line, a mutation which was needed before a second mutation could give rise to the new ability. The other lines of cells hadn’t acquired the first, necessarily, lucky, “potentiating” mutation, so they couldn’t go on to develop the second mutation that allows citrate use.
The other study is the megaplate. I will pause here while you watch the video. It’s only two minutes long and it’s the whole picture/thousand words thing. Or maybe video/thousand words. Back? Cool, huh? And scary.
My take home? Humans are citrate. Humans are a megaplate. Since monkeypox has found a nice home in humans, I will not be surprised if it rearranges itself, and us, to make itself more comfortable. Cable. A good chair. High-speed internet. Why wouldn’t it? All it will need is time and replication.
Vaccinia is still circulating in South and Central America in humans and cows. What happens if a monkey pox and a vaccinia infect the same human?
Recombination between co-infecting poxviruses provides an important mechanism for generating the genetic diversity that underpins evolution.
Or monkeypox jumps into US rodents? Congress would be doomed. And it would become endemic in parts of the US. Given:
In New York City, the rat population is about 25% the size of human population – that’s about 2 million rats!
Then ratpox would be a better term for the virus; I hope WHO is paying attention. Or maybe Cagneypox.
Probably nothing will happen. But. To paraphrase the Borg:
We are the microorganisms. Lower your immunity and surrender your cells. We will add your biological and technological distinctiveness to our own. Your biochemistry will adapt to service us. Resistance is futile.
Smallpox vaccination stopped in the US in 1972 and every year since has added a new cohort of monkeypox-susceptible humans. Humans are Oklahoma circa 1889, the monkeypox are lined up waiting to grab their acreage.
So will monkeypox settle into humans for the long haul? It seems a reasonable possibility. HIV did it. COVID-45 did it. Hell, measles did it, by way of rinderpest from cows, about 900 years ago.
Given a chance, it’s what pathogens do.

1 Throughout the essay I am going to use language that will drive real evolutionists crazy, with adjectives that suggest organisms have evolutionary agency. I know they don’t. Maybe it’s sloppy, but I lean towards the colloquial and away from the formal. The Oregon way, where formal dress is tucking your tee shirt into your hiking pants.
2 Part of that whole “not invited to parties” thing.

Are We Ready for Mpox
Steven Novella on August 28, 2024
Link

Are we ready for the next potential pandemic? It seems like we are just get over COVID and already we have to worry about the next one. We first covered the monkey pox (now mpox) in 2022. Since then it has continued to be a concern. Where do our efforts to contain this infection stand?
To recap, the disease mpox is the result of a viral infection with the monkeypox virus. This is a virus closely related to smallpox – a member of the Orthopoxvirus genus in the family Poxviridae – the same genus as smallpox. It also causes a similar infection with fever, a pox-like rash, and inflamed lymph nodes. It is spread mainly through direct contact and bodily fluids, although can be spread from contaminated objects, and can be airborne (although this is not a major route of infection).
Monkeypox is a zoonotic virus, meaning that it has animal reservoirs and can spread from animals to humans, mostly rodents, monkeys, and small mammals. There are two clades of the virus. Clade I is endemic in central Africa, causes a more severe illness with fatality rates up to 10%, but recently has been in the 2-3% range. Clade II is endemic in West Africa and is less severe, with a <1% fatality rate.
Clade II (IIb to be precise) is what caused the global outbreak in 2022 that we previously wrote about. This caused 95,000 cases in 115 non-endemic countries, including the US. There are still new cases of mpox in the US in 2024, although trailing off with no new cases reported in the last month.
Now we are facing a potential outbreak of Clade I mpox. The WHO on August 14th declared a Public Health Emergency of International Concern regarding the growing number of cases in endemic and non-endemic countries in Africa. There have also been cases in Sweden and Thailand in people with recent travel to Africa. The concern is that this can cause a global outbreak similar to the 2022 Clade II outbreak, but with the more severe strain with higher mortality.
One big advantage we did not have in the early days of COVID is that we already have an effective vaccine against mpox, the JYNNEOS vaccine. This is indicated for the prevention of both smallpox and mpox. The CDC has already distributed over 1 million doses in the US to people who are considered at risk. There is not enough vaccine for the general population, and a full population rollout is likely not necessary.
The concern right now, however, is that there is not enough vaccine to fully control the disease spread in Africa. This is part of what has the WHO concerned, cases of clade I are increasing, spreading to non-endemic countries, and there isn’t enough vaccine to stop it. The US and other countries are donating doses of vaccine, personnel, and funding for efforts to treat the disease in Africa, but so far it is not enough. There simply is not enough vaccine manufactured at this time. There are plans to ramp up production, but that takes time.
The risk of a clade I mpox outbreak brings home a couple of realities. First, we now have to accept that we live in a world with a baseline high risk of zoonotic infections spreading to the human population. The primary reason for this is the increasing human population and corresponding land use. This overlap in human and animal populations will increase significantly over the next 50 years.
It is also important that we recognize that disease outbreaks in any part of the world can potentially affect everyone. A virus that spread in a meat market in Wuhan China became a massive worldwide pandemic killing millions. Now we have a virus endemic only in central and west Africa but with the potential to cause worldwide outbreaks. This means that it is in our and everyone’s interest to have a rapid and definitive response to infectious disease outbreaks wherever they may occur. Not only is this the right thing to do from a humanitarian perspective, but by treating outbreaks abroad we prevent outbreaks domestically.
We are being caught a little flat-footed again with the mpox outbreak, although our response is better than in the early days of COVID. We also have an effective vaccine, and so it is worth investing resources in getting this vaccine to everyone who needs it. Our goal should be not just containment, but elimination of the virus in Africa to prevent further outbreaks.
It may already be too late. Monkeypox will be difficult to eliminate and may be impossible to eradicate because it has animal reservoirs. This is something else we need to prevent – allowing the virus to establish new endemic animal reservoirs.
We may simply need to invest far more resources into surveillance and response to potential zoonotic diseases. There are many potential agents out there. There continues, for example, to be outbreaks of ebola, which can have up to a 50% fatality rate. The largest outbreak so far was the 2014-2016 outbreaks, but there have continued to be smaller one through 2023.
Because the world is now so interconnected, all it would take is for an outbreak to hit even a moderate-sized city, or any city with significant international travel, for an outbreak to become an epidemic or even pandemic. We are all in this boat together, and so we need to have a rapid and robust response to infectious disease outbreaks wherever they occur in the world. The mpox is just the latest reminder of this reality.

Conspiracy theories about monkeypox: Déjà vu all over again or same as it ever was?
Last Thursday, the Biden administration officially declared monkeypox to be a national public health emergency. Unsurprisingly, conspiracy theories abound, many of them recycled from COVID-19 and older antivax conspiracy theories.
David Gorski on August 8, 2022
Link

Last Thursday, the Biden administration officially declared the rapidly growing monkeypox outbreak to be a national public health emergency (PHE). It’s a declaration that the virus represents a significant risk to Americans and frees up resources to address that threat:
The declaration by Xavier Becerra, President Biden’s health secretary, marks just the fifth such national emergency since 2001, and comes as the country remains in a state of emergency over the coronavirus pandemic. The World Health Organization declared a global health emergency over the outbreak late last month.
Mr. Becerra’s announcement, at an afternoon news briefing where he was joined by a raft of other top health officials, gives federal agencies power to quickly direct money toward developing and evaluating vaccines and drugs, to gain access to emergency funding and to hire additional workers to help manage the outbreak, which began in May.
Currently, there have been over 6,000 cases of monkeypox reported in the US, and it’s hard not to get a feeling of, as Yogi Berra’s delightfully twisted term described, déjà vu all over again, after the declaration by the World Health Organization (WHO) that COVID-19 had become a pandemic nearly two and a half years ago. What do I mean? You’d think that after all this time dealing with the COVID-19 pandemic the US would be prepared if another pathogen arose with the potential to become pandemic itself, but the response to the monkeypox outbreak has thus far shattered that expectation, as this New York Times article suggests:
Supplies of the monkeypox vaccine, called Jynneos, have been severely constrained, and the administration has been criticized for moving too slowly to expand the number of doses. Less than a decade ago, the United States had 20 million Jynneos doses; by May, the vast majority of them had expired.
In echoes of the early coronavirus response, tests have been difficult to obtain, surveillance has been spotty and it has been challenging to get an accurate count of cases. The administration has also been faulted for not doing enough to educate people in the L.G.B.T.Q. community, who are at high risk, before gay pride celebrations in June.
“We have 5 percent of the world’s population and 25 percent of the world’s cases,” said Dr. Carlos del Rio, an infectious disease physician at Emory University in Atlanta. “That, to me, honestly, is a failure. We were caught sleeping at the wheel.”
Of course, monkeypox is a different disease than COVID-19. Whereas COVID-19 was a brand new disease caused by a new coronavirus to which the population was immunologically naive, monkeypox has been around for a while. Even so, back in May, when the first cases in the US were making the news, Dr. Novella expressed much the same sentiment as I am now:
Now, outbreaks understandably make people a little twitchy. I remember in February 2020 the “voices of reason” were saying about COVID (myself included) that we should be concerned, but it’s too early to panic. I don’t know if in retrospect that struck the right tone (without Monday morning quarterbacking), but it feels like we are in the same place now with the monkeypox.
However we deal with monkeypox (and right now I’m not particularly optimistic about our government response), the disease, showing up so soon after COVID-19 while the COVID-19 pandemic is still raging, provides an excellent “teachable” moment about conspiracy theories and antivaccine misinformation. Why? Because the very same conspiracy theories that arose about COVID-19 (in some cases slightly modified) are showing up about monkeypox, thus demonstrating that truly there is, as I like to say, nothing new under the sun in terms of conspiracy theories about disease outbreaks and vaccines.
First, however, what is monkeypox?
Monkeypox
As I mentioned, in contrast to COVID-19, monkeypox is not a new disease. It’s been around for a while and is relatively known. The monkeypox virus itself is a member of the Orthopoxvirus genus in the family Poxviridae, the same genus as the smallpox virus, to which it is closely related. Fortunately, monkeypox is less contagious and produces less serious disease than smallpox, which, before vaccination eliminated it in the 1970s, had long been a scourge of humanity, with traces of smallpox having been found in the head of the 3,000 year old mummy of Pharaoh Ramses V. For example, smallpox killed roughly one-third of those infected with it and often left survivors with horrible scars from the “pox” lesions on the skin that were characteristic of the disease. Since the eradication of smallpox was officially declared in 1980, monkeypox has emerged as the most important orthopoxvirus for public health.
In terms of symptoms, monkeypox causes fever, headache, lymphadenopathy, and then the characteristic “pox” rash with skin eruptions, which can number from a few to thousands, to the point that in especially severe cases sections of skin can slough off. The overall disease course usually lasts between 2-4 weeks, with poorer outcomes in those with underlying immune deficiencies, and potential complications include secondary infections, bronchopneumonia, sepsis, encephalitis, and infection of the cornea with ensuing loss of vision. The WHO reports that in modern times the case fatality ratio is around 3-6%.
A zoonotic disease, monkeypox can infect a number of animal species besides monkeys and human, including rope squirrels, tree squirrels, Gambian pouched rats, dormice, non-human primates and other species. Before the current outbreak, the disease had been mostly confined to central and West Africa, with a history dating back to 1970:
Human monkeypox was first identified in humans in 1970 in the Democratic Republic of the Congo in a 9-month-old boy in a region where smallpox had been eliminated in 1968. Since then, most cases have been reported from rural, rainforest regions of the Congo Basin, particularly in the Democratic Republic of the Congo and human cases have increasingly been reported from across central and west Africa.
Since 1970, human cases of monkeypox have been reported in 11 African countries: Benin, Cameroon, the Central African Republic, the Democratic Republic of the Congo, Gabon, Cote d’Ivoire, Liberia, Nigeria, the Republic of the Congo, Sierra Leone and South Sudan. The true burden of monkeypox is not known. For example, in 1996–97, an outbreak was reported in the Democratic Republic of the Congo with a lower case fatality ratio and a higher attack rate than usual. A concurrent outbreak of chickenpox (caused by the varicella virus, which is not an orthopoxvirus) and monkeypox was found, which could explain real or apparent changes in transmission dynamics in this case. Since 2017, Nigeria has experienced a large outbreak, with over 500 suspected cases and over 200 confirmed cases and a case fatality ratio of approximately 3%. Cases continue to be reported until today.
However, the disease has been found outside of Africa dating back two decades, as in 2003 the first outbreak in the US occurred and was linked to contact with infected pet prairie dogs. Monkeypox has also been reported in travelers from Africa to Israel, the United Kingdom, and Singapore before the most recent outbreak.
As far as transmission, fortunately monkeypox is far less transmissible than SARS-CoV-2, the coronavirus that causes COVID-19, is. Its mode of transmission is also different in that its primary mode of spread appears not to be respiratory but rather, as the WHO notes, “through close contact with respiratory secretions, skin lesions of an infected person or recently contaminated objects.” In the current outbreak, sexual contact, particularly sex between males, is the primary mode of transmission:
“Right now, about 98% of monkeypox cases are in queer and gay folks and our sexual networks. Of course, that includes trans and non-binary folks,” says Joseph Osmundson, a biologist at New York University who identifies as queer and is helping to lead the effort to stop the outbreak.
Sexual contact is not the only way monkeypox is spread, points out infectious disease doctor Susan McLellan at the University of Texas Medical Branch in Galveston, Texas. But she agrees with Osmundson: It is by far the most likely way in this current outbreak, so far.
“Epidemiological data for the outbreak in Western Europe and the United States makes that clear,” she says. “We’re not detecting many cases in kids and individuals who aren’t sexually active. We’re detecting cases mostly in individuals from networks with a lot of sexual encounters.”
As several scientists have pointed out, although its mode of transmission is primarily through sex, monkeypox as it is spreading now is not just a sexually transmitted disease. It’s possible to get the disease through other means, such as face-to-face interactions and touching contaminated objects, but these routes of transmission are very rare and likely require quite prolonged contact.
Fortunately, those of us old enough to have been vaccinated against smallpox likely have some protection, and there is a vaccine against monkeypox. Unfortunately, that vaccine is not yet nearly as widely available as it should be.
On to the conspiracy theories…
Lab leak
As I pointed out when COVID-19 first hit, every time there is an outbreak of a new disease (or even a not-so-new disease), conspiracy theories declaring the outbreak to have been due to release from a laboratory, either accidental or intentional, of the pathogen responsible arise. These conspiracy theories arose for HIV/AIDS, Ebola, and the H1N1 pandemic, among others, and they appeared with a vengeance after COVID-19.
Indeed, I love to point out that the very first “lab leak” conspiracy theory that I encountered about COVID-19 came from James Lyons-Weiler in February 2020. Lyons-Weiler appeared on Del Bigtree’s video show and claimed to have “broken the coronavirus code”. In brief, he reported that he had found in the just-published nucleotide sequence of SARS-CoV-2 sequences from an artificial plasmid commonly used in molecular biology research to express protein from genes and to transfer genes from one vector to another. Naturally, because he is an antivaxxer, Lyons-Weiler claimed that this sequence came from a failed effort to make a vaccine against the original SARS virus that caused a major outbreak in 2002, thus letting him conveniently link a conspiracy theory that the coronavirus had been “engineered” in a lab with a chance to blame vaccines for the virus. If true, obviously, that would be strong evidence that SARS-CoV-2 had been engineered. However, for someone who before turning antivax crank had run bioinformatics core facilities Lyons-Weiler made a lot of rookie mistakes, and his analysis did not show what he claimed that it did, as I described in gory detail. Unfortunately, “lab leak” conspiracy theories about the origins of SARS-CoV-2 still proliferate and have been weaponized to great effect by conspiracy theorists, even though recent evidence strongly suggests a natural origin for the virus.
It should therefore be no surprise at all that soon after monkeypox started making the news conspiracy theorists claimed that it had escaped from a laboratory. They even blame the Wuhan Institute of Virology, just as “lab leak” conspiracy theorists blame the same institute for COVID-19 using similar distortions of science, with Tweets like this:
BOMBSHELL REPORT: Wuhan Lab was EXPERIMENTING WITH MONKEYPOX Last Year – Published Research Report in International Journal in February 2022…
— Chuck Callesto (@ChuckCallesto) May 23, 2022
For instance, two weeks ago The Jimmy Dore Show aired a segment titled “Wuhan Lab Was Experimenting On Monkeypox Before Outbreak“, while John Campbell, someone who seemed semi-reasonable early on in the pandemic but long ago turned into a total COVID-19 crank, had posted a YouTube video about how the NIH and the WIV had been working on monkeypox, pointing to this NIH grant and a recent paper, “Efficient assembly of a large fragment of monkeypox virus genome as a qPCR template using dual-selection based transformation-associated recombination“.
As described at FactCheck.org:
Jimmy Dore, a frequent purveyor of misinformation on “The Jimmy Dore Show” on YouTube, produced a segment on July 20 with the headline, “Wuhan Lab Was Experimenting On Monkeypox Before Outbreak.”
During the segment, Dore showed a video of Dr. John Campbell, a retired nurse educator, discussing monkeypox and the Chinese study.
Campbell says in the video that the National Institute of Health and the Wuhan Institute of Virology were conducting experiments with monkeypox prior to the outbreak and misleadingly suggests viewers may “draw some parallels” between the origins of the monkeypox outbreak and the origins of SARS-CoV-2.
After playing a clip of Campbell saying the NIH and the Wuhan Institute had been studying monkeypox before the outbreak, Dore asked, “What are the odds of that?”
Dore continued, “whenever there’s a new outbreak now, 50/50 chance it was started in the Wuhan Lab funded by Dr. Fauci and the NIH,” referring to Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases.
Kurt Metzger, a comedian and Dore’s partner on the show, added, “not even a different virology lab accident, the same one.”
As I like to say, humans are pattern-forming animals, and we’re especially good at imputing causation from a pattern when that causation agrees with what we already believe.
I looked up the study, and—surprise!—it shows nothing like what Dore and Campbell claim that it shows. First of all, the scientists didn’t create a whole monkeypox genome, only a portion of it and then only to use to test a method known as “transformation-associated recombination”, which is used to assemble large pieces of DNA. Also, the monkeypox sequence used to assemble the partial genome is different from that of the monkeypox virus now circulating. The current outbreak is due to the West African clade virus while the viral sequence used in the research belongs to the Congo Basin clade.
Unsurprisingly, with the war in Ukraine raging, conspiracy theorists promoting pro-Russian narratives claiming that Ukraine had a number of bioweapon labs quickly pivoted to claiming that monkeypox had escaped from a Ukrainian lab, with headlines like “ECDC Bombshell: ‘Monkeypox Outbreak Appears To Have Leaked From Ukraine Lab’” and Tweets like this:
A Russian-Chinese joint task force has been tasked with establishing: where it originated, whether it is detectable in research conducted by the US in Ukraine, Georgia; whether there is a link to biological research conducted by the US on smallpox in Ukraine.
— Dr. Ben Braddock (@GraduatedBen) May 21, 2022
There is, of course, as usual zero evidence to support this claim, which is based on an anonymous source claiming knowledge of what the European Centers For Disease Control has concluded. Let’s just put it this way:
Richard Ebright, board of governors professor of chemistry and chemical biology at Rutgers University in New Jersey and a figure who has voiced lots of support for the COVID lab leak theory, echoed the point. “All indications are that the monkeypox outbreak involves a natural monkeypox virus,” he told Newsweek.
I’ve tangled with Ebright on Twitter before over lab leak conspiracy theories about SARs-CoV-2, and he’s a total conspiracy theorist. If he thinks your claim of a lab leak origin for monkeypox is nonsense, you’ve really wandered far into conspiracyland. The Ukrainian “lab leak” conspiracy theory is totally fake news, even more ridiculous than the claim that monkeypox came from WIV.
Same as it ever was, though. There is nothing new under the sun, including…
Plandemic 2.0: Monkeypox edition
Early in the COVID-19 pandemic, a “documentary” called Plandemic went viral. Its primary claim was of a massive conspiracy theory in which the entire pandemic was actually planned—”Plandemic”, get it?—all in order for the “global elite” to enslave us all with vaccines and pharmaceuticals. It was followed by Plandemic 2, in which Mikki Willis wove a conspiracy theory implicating an October 2019 pandemic preparation exercise held by Johns Hopkins University’s Center for Health Security in partnership with the World Economic Forum and the Bill & Melinda Gates Foundation that had envisioned a pandemic due to a fast-spreading coronavirus. The whole narrative involved linking together disparate events in a misleading manner to imply an overarching conspiracy that the current coronavirus pandemic had been planned.
In some cases, the “plandemic” conspiracy theory got really wild. In one version, it involved aliens teaming up with the global elite to release a two-stage “bioweapon” (COVID-19 and the vaccine, naturally) to cause global depopulation to about 10% of the current number of humans alive on the planet, all so that the aliens and elite could profit. I kid you not.
Cue May 2022 and monkeypox in the NY Post:
An eerily accurate simulation exercise at the Munich Security Conference in March 2021 centered on a monkeypox outbreak – and had the rare and potentially deadly “hypothetical” disease starting exactly when the real one did.
The Nuclear Threat Initiative (NTI), a non-profit founded by US media mogul Ted Turner and former Democratic Sen. Sam Nunn, gathered a panel of 19 experts — including government officials from the US and China, representatives from the World Health Organization and the UN, and researchers from the Bill and Melinda Gates Foundation and major pharma companies — to game out responses to a “12 Monkeys”-like bioterror attack.
The fictional scenario, sponsored by Facebook co-founder Dustin Moskovitz and his Open Philanthropies non-profit, hinged on the secret release of a lab-enhanced monkeypox virus that eventually killed 271 million people in a worldwide 19-month pandemic.
Sound familiar? It involves a lot of the same players, in particular including—of course!—Bill Gates. The main twist is that this conspiracy theory seems to have originated (or at least spread widely) in China on its social media platform Weibo before making the jump to the West, likely as a response to all the lab leak conspiracy theories about COVID-19 and the WIV:
A 2021 report on biosecurity preparedness planning by a US non-government organization, Nuclear Threat Initiative, which included a scenario of a monkeypox pandemic, has been taken out of context to suggest that the US government knew the outbreak was coming.
Nationalist influencer Shu Chang, who has 6.41 million Weibo followers, deliberately misconstrued the report and posted that it showed “a plan by the US to leak bioengineered monkeypox virus.”
There is, of course, no evidence that this exercise is any indication that the monkeypox outbreak was planned any more than the Johns Hopkins University/Gates Foundation exercise in 2019 was evidence that the COVID-19 pandemic was planned. Health experts and authorities plan for pandemics, and when they do they pick scenarios that seem plausible and likely. Given the SARS outbreak 20 years ago, in 2019 a coronavirus seemed most likely as the next big pathogen to cause a pandemic. Monkeypox has been simmering for years and in 2021 seemed like the next viral threat:
“The risks posed by monkeypox”, according to the NTI, “have been well documented for years” and cases have been on the increase, making it an obvious virus to choose for this workshop.
Outbreaks of infection are a fact of life, so an organisation predicting and planning for them is not in itself suspicious.
Same as it ever was…again.
But…it’s the vaccines!
Going back to James Lyons-Weiler and his attempt to blame COVID-19 on a failed attempt to develop a SARS vaccine, I also can’t help but add that the very earliest COVID-19 conspiracy theory I encountered, way back in January 2020, was that COVID-19 arose in Wuhan because the Chinese had ordered more influenza vaccines in fall 2019 than they normally would. This conspiracy theory then mutated into a version in which the flu vaccine was falsely blamed for increasing one’s chances of getting COVID-19, a claim that persists.
Fast forward to spring and summer 2022, when, to the surprise of no one who has paid attention to antivaccine conspiracy theories over the years, COVID-19 vaccines are being blamed for the monkeypox outbreak, because of course they are. This conspiracy theory tends to take one of two flavors. The first is a claim that the chimpanzee adenovirus vector used in the AstraZeneca COVID-19 vaccine is how monkeypox arose. The second is a more general claim not unlike the conspiracy theories about the flu vaccine and COVID-19 that COVID-19 vaccines weaken the immune system to make people susceptible to monkey pox.
Examples of the first can easily be found on social media:
Who is surprised that after millions of people have been injected with genetically modified chimp virus, there is now an outbreak of monkeypox?
— David Kurten (@davidkurten) May 20, 2022
"The AstraZeneca vaccine uses a chimpanzee adenovirus vaccine vector" Makes you wonder doesn't it.🤔🤔🤔🤔
— Goldie Hawn (@GoldieH34757900) May 21, 2022
Molecular biologists, virologists, and others with significant knowledge of molecular biology and virology are likely cringing at how obviously these claims are nonsense (as did I). However, the percentage of the population with sufficient scientific knowledge to immediately recognize these memes and posts as utter bullshit (there is no other word) is, alas, small. So they sound credible. Adenovirus and monkeypox are not just different viruses, they’re very different viruses, and the one used for vaccines is genetically engineered so that it is unable to replicate. Adenovirus-based vaccines use the virus as a tool to induce cells to make the desired antigen, in the case of COVID-19 vaccines the SARS-CoV-2 spike protein. The only viral proteins made are those absolutely necessary for the vector to serve its purpose of entering cells and forcing them to make the protein from the DNA code inserted into the virus’ genome. Also, not all of the adenovirus-based vaccines use the chimpanzee version of the adenovirus.
Finally, I particularly like this statement in a more general debunking of this claim:
Meedan added: “It should be noted that chimpanzees are not monkeys.”
Chimpanzees are from a group of primates known as great apes, see here.
The second version of blaming monkeypox on COVID-19 vaccines posits an immune suppression due to the vaccine that supposedly laid the groundwork for monkeypox to flourish. More recently, antivaxxers have also tried to blame COVID-19 vaccines for polio, but that’s a secondary claim:
"It is well established the mRNA vaccines affect the natural immune system. A monkey pox outbreak following massive covid vaccination: *Is not a coincidenceDr Shapira 'suggested that the monkeypox outbreak was connected to mRNA vaccines." https://t.co/NGMwGAjwGl
— Ruth Stewart (@RuthSte67917853) August 7, 2022
What if monkey pox is a reaction to the covid vaccine 😅
— BlammySosa (@blammysosa) August 7, 2022
Antivaxxer Robert F. Kennedy, Jr. is pushing this narrative on his Children’s Health Defense website:
Twitter last week censored Shmuel Shapira, M.D., MPH, for suggesting a connection between the monkeypox outbreak and mRNA COVID-19 vaccines, according to a Kanekoa’s Newsletter Substack post published Wednesday.
Shapira, who said he was injured after receiving his third dose of the Pfizer COVID-19 vaccine, said Twitter demanded he remove a tweet that said:
Monkey pox cases were rare for years. During the last years a single case was documented in Israel. It is well established the mRNA vaccines affect the natural immune system. A monkey pox outbreak following massive covid vaccination: *Is not a coincidence.
Shapira is a full professor of medical administration at Hebrew University and served as director of Israel’s Institute for Biological Research from 2013-2021.
Again, none of this should come as any surprise to anyone who’s followed the antivaccine movement for a long time. The claim that vaccines either suppress the immune system or cause autoimmune disease by cranking it up too much—antivaxxers can never make up their minds and craft their narrative depending on what they want to blame vaccines for—are oldie-moldy vaccine tropes.
It turns out that a lot of those claiming that monkeypox arose because COVID-19 vaccines had suppressed the immune systems of those who got them tend to cite two recent papers, one in The Lancet and one in Food and Chemical Toxicology, which they misrepresent as evidence that COVID-19 vaccines cause immunosuppression. The second one is easy to deal with. It’s by Stephanie Seneff, Greg Nigh, Anthony M. Kyriakopoulos, and Peter A. McCullough, and I discussed it in great detail when it was published in April, also noting that Seneff has been an antivax conspiracy theorist for a long time and that McCullough went full COVID-19 and antivax conspiracy theorist early in the pandemic. Both have been featured multiple times in this very blog, with Seneff having achieved her prominence back in 2015 when she predicted that GMOs would render half of all children autistic by 2025, which is now less than two and a half years away. (Early in the pandemic, she even blamed e-cigs and biofuels for COVID-19.) Let’s just say that that review article was an excellent example of Gish galloping and the use of a scientific review article published in a dodgy journal as antivax disinformation.
The first article was indeed published in The Lancet and is a retrospective cohort study from Sweden published in February. Its conclusion was that COVID-19 vaccine effectiveness waned over several months but that effectiveness against severe COVID-19 was better maintained. That’s it. It said nothing about immunosuppression due to the vaccine at all, but that didn’t stop Tucker Carlson from finding a comment that falsely claimed that the study did show immunosuppression from the vaccine:
Carlson cited a comment a Japanese physician, Dr. Kenji Yamamoto, published in a different journal, which claimed the Lancet paper “showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals.”
After suggesting that the Lancet paper hid “a major finding,” Carlson pointed to one piece of data in table 3 of the paper for viewers to check themselves. “Among people around the age of 80 who have been double vaccinated — that would include people like Joe Biden — the per capita rate of medical incidences, including hospitalizations or death, is nearly twice as high as the rate of serious incidence for the unvaccinated,” he said.
Carlson added that the Lancet paper “also includes a chart showing negative vaccine efficacy for all ages after eight months for all participants in the study.”
Carlson, however, is distorting cherry-picked data from the paper.
“The paper we have published [does] not show any of the claims” Carlson made, lead author Dr. Peter Nordström told us in an email, because they were not statistically significant. The findings that are statistically significant and the conclusions of the paper are “presented in the summary of the paper,” he added.
Also:
As for the Japanese physician who claimed the Lancet data “showed that immune function among vaccinated individuals 8 months after the administration of two doses of COVID-19 vaccine was lower than that among the unvaccinated individuals,” Jewell said he found nothing to support that in the Lancet paper, as it also appears to be an erroneous interpretation of figure 2.
Yamamoto’s comment shows a misunderstanding of the figure, and it also incorrectly generalizes a specific and expected decline in immunity to the coronavirus over time following vaccination with a general decline in immunity to all things. There is no evidence of that in the Lancet paper, nor anywhere else.
This is, of course, a typical antivax technique. They love to cherry pick one line of one figure or table in a paper, especially when it’s unadjusted data, and misrepresent it to mean what they want it to mean.
Again, same as it ever was.
There is nothing new under the sun
I had thought about taking just one of the conspiracy theories about monkeypox and doing a deep dive into it, explaining in my usual painful level of detail why it’s a conspiracy theory. However, as I tried to decide which one to examine, it occurred to me that monkeypox is, as I said at the beginning of this post, an excellent “teachable moment” to explain again how there is nothing new under the sun in the world of disease and antivaccine conspiracy theories. Just as COVID-19 conspiracy theories were rehashed and repurposed versions of older antivax conspiracy theories, monkeypox conspiracy theories are so rehashed from COVID-19 conspiracy theories that in many cases they’re the same damned conspiracy theory.
The point is this. Once you start seeing the patterns, you’ll recognize the conspiracy theories. There is nothing new under the sun in antivax conspiracy land (or any conspiracyland, for that matter). It is, as David Byrne once sang, the “same as it ever was” and Yogi Berra once described as “déjà vu all over again”. What’s different is that these conspiracy theories have far more power and influence than ever before.



New CDC Data Confirms Continued Rise in Sexually Transmitted Diseases
A new batch of CDC data on chlamydia, gonorrhea, and syphilis from 2020 has dropped and it doesn’t look good.
Clay Jones on April 15, 2022
Link

It is currently STD Awareness Week at the CDC (how do you celebrate?), and just as they are attempting to spread the word about screening, testing, and treatment of sexually transmitted infections, the latest batch of numbers has confirmed what many in the medical community had feared. Despite a noteworthy, but not unexpected, decline in reported cases of syphilis, gonorrhea, and chlamydia in the early months of the pandemic, the final tally for 2020 is significantly higher than what we saw in 2019, though there is some important nuance that I’ll discuss shortly. This includes a significant increase in cases of congenital syphilis, which I wrote about last October.
Why do the new CDC numbers focus on these three particular sexually transmitted diseases in the new report? Why not HIV or HPV? What about Hepatitis B and C? No respect for chancroid, the most common cause of genital ulcers in the world? It isn’t that the CDC doesn’t care about the others. Chlamydia, gonorrhea, and syphilis are the three notifiable sexually transmitted diseases for which there is a current 5-year-plan (2019-2023) for federally funded control programs:
This NOFO supports strategies and activities to: eliminate congenital syphilis; prevent antibiotic resistant gonorrhea; reduce primary and secondary syphilis; prevent STD-related pelvic inflammatory disease, ectopic pregnancy, and infertility; address STD-related outbreaks; and reduce STD-related health disparities. Priority populations for this NOFO include adolescents and young adults, men who have sex with men, and pregnant women.
Syphilis and gonorrhea and chlamydia, oh my!
In addition to syphilis in adults and babies, 2019 also wasn’t a great year for gonorrhea or chlamydia. In total, there were roughly 2.5 million cases of these infections reported that year. Though there were about 160,000 fewer total cases, with the difference coming from a significant drop in the total reported cases of chlamydia, the reality is that 2020 was worse across the board. The dip in chlamydia is an illusion.
Chlamydia, which is the most commonly reported STD, is not the most prevalent. That would be HPV, a vaccine-preventable viral infection linked to genital warts and cervical cancer that is not a nationally reportable diagnosis. But like HPV, chlamydia tends to be asymptomatic for long periods of time. In fact, 70% of women and 50% of men who are diagnosed with chlamydia have no symptoms at all at the time and are picked up through screening efforts. Though these asymptomatic infections can resolve without treatment, diagnosing and treating chlamydia can prevent pelvic inflammatory disease, infertility, ectopic pregnancy, and chronic pelvic pain in many patients. This also limits spread to sexual partners.
There were roughly 1.6 million cases of chlamydia reported in 2020, which was down about 13% from 2019. But this is not a cause for celebration. Rather, it’s a predictable decrease caused by a plummet in the screening of asymptomatic people during the early months of pandemic. Reported cases of chlamydia have been steadily rising for years and this is an outlier and not the start of a new trend, despite the CDC’s efforts.
In 2019, 616,000 cases of gonorrhea were reported. In 2020, this increased by about 10% to roughly 678,000 cases. Primary and secondary syphilis, which are the stages when the infection is easily spread from person to person through intimate contact, increased by about 7% in 2020 with 41,655 reported cases. Congenital syphilis, which puts children at risk for debilitating sequelae and even death, increased by 15% with 2,148 cases and 149 deaths, continuing the alarming trend I discussed in that October post.
So 2020 was not a very good year, pretty much for anybody or anything. And to make matters even worse, the 2020 numbers are absolutely a massive undercount of the actual prevalence of these sexually transmitted diseases in the United States, and not just chlamydia. Oh, and the preliminary data from 2021 is not reassuring. We continue to move in the wrong direction.
The role of the pandemic in STD diagnosis and treatment
As I mentioned above, the drop in chlamydia cases seen in 2020 almost certainly does not represent a true decrease but an interruption in typical screening practices for a variety of pandemic related reasons. Millions of people did not receive appropriate healthcare because of closures and delays while trying to limit spread of SARS-CoV-2. Adding to this, routine screening tests were often delayed even when patients were able to be seen via telemedicine.
The percentage of chlamydia cases diagnosed in symptomatic people likely rose dramatically in 2020, because that’s who was more likely to seek care despite COVID fears. Many of these people, most of them women, were likely at the point of severe symptoms and may have even needed surgical management by the time they went to the emergency department. These delays likely will result in an ultimate diagnosis of infertility in some of them.
The pandemic wouldn’t have only made it more difficulty to diagnose and manage patients with chlamydia. In fact, prior to when efforts to curb the spread of SARS-CoV-2 began ramping up in the Spring of 2020, the numbers of reported cases of gonorrhea, syphilis, and chlamydia were all on track to surpass 2019. And they all plummeted during March and April. The CDC lists three primary factors in the Spring reduction in reported cases:
Reduced screening: Many healthcare clinics either closed entirely or limited in-person visits to symptomatic patients only…Additionally, decreased routine healthcare visits, increased unemployment and loss of health insurance, as well as STD test kit and laboratory supply shortages, may have reduced screening during the pandemic.
Limited resources: STD program resources shifted to help control the spread of COVID-19. Many jurisdictions redirected staff from routine STD surveillance and control efforts to COVID-19 activities. The observed drop in reported cases may reflect challenges in maintaining key STD activities, including case investigation, partner services, and case reporting.
Social distancing measures: Because COVID-19 can spread during sexual contact, social distancing measures were used to mitigate disease. These measures may have influenced sexual behaviors by limiting sexual activity or the number of new sexual partners, thus reducing the spread of STDs. The fear of being exposed to COVID-19 and limited access to public transportation also may have affected sexual behaviors and led to people with STD symptoms delaying care.
These issues didn’t suddenly resolve later in 2020, though the initial fear to varying degrees across the country despite continued outbreaks and records for cases being set left and right. Some parts of the country, particularly the Northeast, were more focused on pandemic precautions than others. This is a complex problem with many variables, in particular the fact that states less likely to have taken the pandemic seriously also tend to be states that already had more problems with poverty, education, healthcare disparities, social safety nets, and so on. I’m talking about the South, of course, and I’m fighting hard against my nature to not make any comments about competent political leadership, or the lack thereof. Oops, I guess I lost that battle. The food is good though.
I don’t think it’s a significant stretch to expect to see less of a decrease in STD cases in areas that in general were less likely to have experienced widespread and intense limitations in services and public fear of COVID-19. Again, I’m not making any bold claims about what these numbers mean, but the Northeast did have a 20% decrease in chlamydia cases in 2020 compared to a drop of only 7% in the South. In addition to this, the Northeast had an increase in gonorrhea cases of 5% compared to the South’s 15%. To finish this little experiment up, I found that the Northeast had an increase in primary and secondary syphilis cases of 7% while the South increased by 9%.
So it is certainly true that the South had more STD cases reported than the Northeast in 2020. The South also saw larger increases in gonorrhea and syphilis cases, and a smaller decrease in chlamydia cases, than the Northeast compared to 2019 numbers. But the South has pretty much always had a bigger problem with STDs. One could argue though, in this specific situation, that in 2020 the Northeast ended up with a higher percentage of untreated people who would have normally been diagnosed had it not been for a raging pandemic. Also that the food is terrible.
Not surprisingly, healthcare disparities were evident in the STD data from 2020, with just over half of all reported cases being diagnosed in people ages 15 to 24. Also not unexpected, sadly, were racial disparities. For example, a third of cases involved non-Hispanic Black people, which is wildly disproportionate to their 12% of the total population. In their report, the CDC focuses on social and economic factors like poverty and access to adequate healthcare as the cause for worse health outcomes in these populations. As with COVID-19, a lot of people are being ignored and are shouldering an unfair percentage of the burden.
Conclusion: The worst is probably yet to come
As I mentioned above, the data from 2021 looks bad. Things are going to get worse before they get better. If they get better. It’s great that the CDC is throwing money at this problem, but it will take more than that. Much of the underlying issue comes down to weaknesses and biases inherent in the healthcare system. Hell, in the very fabric of American society. This crap has been baked into it from the very beginning so it will take a lot of work and time to set things right.

Medical Misinformation Falsely Links a Serious Infection to Leftover Chinese Food
A young man contracted a dangerous infection that was newsworthy, because it could have been prevented by a safe vaccine, but it had absolutely nothing to do with leftover Chinese food despite what is being promoted by a viral YouTube video and several news articles.
Clay Jones on March 4, 2022
Link

In March of 2021, The New England Journal of Medicine published a case report from a team of doctors at Massachusetts General Hospital involving a 19-year-old man with meningococcemia, one of the most historically infamous infectious diseases. I am not at all exaggerating when I say that this disease, caused by systemic infection with the bacterium Neisseria meningitidis, strikes fear in the hearts of medical professionals at the mere consideration of the possibility of its diagnosis in a febrile and ill-appearing patient. It is, and again I am quite serious here, an infection that is known for its ability to cause catastrophic injury and even death in a matter of hours.
The case report discussed the initial presentation of this unfortunate young man whose condition rapidly deteriorated from nausea and abdominal pain to fever and severe diffuse muscle ache, then to respiratory failure, hypotensive shock, multiple organ failure, and a disseminated coagulopathy that would ultimately result in the loss of both legs below the knees and parts of all 10 fingers. He progressed from feeling fine to suffering severe illness over just 15 hours, and then became profoundly critically ill requiring maximal intensive care over only an additional 4 hours. Thanks to the amazing skill of the pediatric intensive care team, a couple of which I’ve worked with personally since moving to Boston in 2013, and the progress medical science has made in developing life saving pharmacotherapies, the patient survived and was able to be discharged home after a lengthy stay in the hospital.
What does this have to do with leftover Chinese food? To be frank, not a damn thing. But that didn’t stop this ridiculous idea from going viral when a popular medical YouTuber posted a video dramatizing the case report last week that blamed food poisoning for the patient’s illness.
The video, which involves actors portraying the patient and his roommate, uses a lot of generic stock images and video as well as heavy handed narration that I suppose is meant to add a sense of drama. Unfortunately, it also contains a number of assumptions about the events leading up to the patient’s initial evaluation at a community emergency department that are presented as established facts of the case. It all comes across as manipulative and geared towards getting the maximum amount of views rather than actually educating the viewers. The video was then featured by numerous news outlets, such as the New York Post, and the inaccurate assumption that the patient’s infection came from contaminated food was parroted over and over again.
It is true that the authors of the report mentioned, as part of a thorough discussion of the events preceding the patient’s illness, that he had eaten a meal consisting of rice, chicken, and lo mein that was leftover from the night before. They also wrote that the patient’s roommate had eaten the same meal the night before. The roommate had an isolated episode of nausea and vomiting but did not otherwise become ill. At no additional point in the report, in particular during the discussion of the potential causes of his clinical presentation and abnormal lab results, did the meal come up again. This is because it is irrelevant to meningococcal disease.
Despite this absence of concern from the MGH PICU team regarding the meal consumed prior to the patient becoming ill, which again is because meningococcal disease is not a foodborne illness and there has never been a documented case of Neisseria meningitidis being spread this way, Bernard Hsu, the pharmacologist and clinical adjunct professor at the University of Illinois, claimed it was the source of the infection in his viral video. The video, which has been viewed more 1.5 million times (Hsu has nearly 2.5 million subscribers) is terrible for numerous subjective reasons in my opinion, some of which I have already mentioned, but I’ll stick to an objective assessment of this one huge error for this post. But first, a brief primer on meningococcal disease epidemiology.
Meningococcal disease 101
As I stated in no uncertain terms above, infection with Neisseria meningitidis is serious, even more so when it results in meningitis, an infection and associated inflammation of the protective membrane covering the brain and spinal cord. Prior to the development of effective antibiotics and modern intensive care modalities, this condition was almost always fatal. Even with early diagnosis and the best medical care in the world, death is still common and surviving patients often suffer significant long-term disability.
Historically, and sadly also currently in certain regions of the world such as Sub-Saharan Africa, epidemics of meningococcal disease have occurred. In regions privileged enough to have access to the marvelously safe and successful vaccines that significantly reduce the risk of infection from serogroups most likely to cause invasive disease, epidemics are rare. In the United States, the incidence of meningococcal disease has plummeted since the mid-1990s, especially since routine vaccination of adolescents began in 2005. Currently this disease is seen in .11 out of 100,000 people, which represents a roughly 75% decrease over the past 20+ years.
While epidemics of meningococcal disease resulted in cases in patients of all ages, there are certain groups that are at higher risk even in regions where these epidemics are rare. This is because Neisseria meningitidis, a bacteria that only infects humans, is endemic. This means that it is out there, among us, silently colonizing our nasopharyngeal tissue and jumping from person to person, pretty much causing disease whenever it feels like it.
At any given time, 5-10% of the general population and as many as 35% of older teens are colonized. Most people clear the bacteria, never having known it was there, but it may hang out in our nasal passages and throats for weeks to years first. Before being cleared, a colonized individual may spread it to others, but this only happens with close, typically intimate contact. So you are not going to become infected and colonized by simply talking to someone or even being near them for significant periods of time. You really need to swap spit, by kissing or sharing objects that one might insert into the oral cavity for example, be on the receiving end of a juicy coughing fit, or spend a lot of time in very close contact.
The folks who are most at risk tend to be teens and young adults living together, in particular college students in dorms and soldiers in army barracks, and children under two years of age, likely because they like to slobber all over each other. Smoking is another risk factor for colonization. Once colonized, most people never get sick and those who do mostly just have some serious bad luck. People with certain immune deficiencies are at increased risk of disease, however, as are people taking certain immune modulating medications. Another independent risk factors for developing meningococcal disease is a recent respiratory illness.
About the case report and the leftover lo mein…
So what happened to the 19-year-old patient in the case report? How did he develop meningococcal disease and is it possible that the lo mein was to blame? No, no it wasn’t.
Again, this bacteria is not spread by food. It just isn’t. There have been zero reported cases of this. Neisseria meningitidis only lives in humans and is susceptible to desiccation on surfaces that significantly decreases its ability to survive and cause infection. This is why it takes sustained close contact with other humans to spread, and this typically comes from lots of kissing or inhaling droplets from a cough, although it is possible that repeatedly sharing a toothbrush in close temporal proximity could do it.
The meal so hyped by the professor that should have known better and in all those news articles was a red herring that had nothing to do with the patient’s illness. Based on our understanding of meningococcal disease, he was almost certainly colonized with the bacteria. He is an adolescent smoker with a roommate, after all, so he’s pretty high risk for it. As I mentioned earlier, just based on his age alone there was a roughly 35% chance. Add in the other risk factors and it was likely much higher.
Even if, for argument’s sake here, he somehow became infected with Neisseria meningitidis because of the leftover food, it still wouldn’t make sense given the rapid onset of his symptoms. During epidemics of this disease, when large numbers of people are becoming ill and we know it isn’t just colonized people with bad luck, illness typically takes 2-3 days to set in, and it can take up to 10 days. It would be very unlikely to be exposed and then become deathly ill all in less than a day.
The patient’s initial symptoms of nausea and vomiting with associated abdominal pain may have been consistent with possible food poisoning, but that is also a classic early presentation of meningococcal disease. The authors of the report knew that by the time he presented for medical care, and began to rapidly deteriorate, his illness was not at all related to any recent meal. Again, that’s why it wasn’t included in the discussion of his disease process in the body of the report.
Conclusion: Be wary of viral videos and lazy journalism when it comes to medical information
Bernard Hsu really has no excuse for the massive error in his popular YouTube video. He is a highly trained pharmacologist with access to experts and expert resources. My hunch is that visions of virality clouded his judgement and confirmation bias impaired his research. I haven’t watched any of his other videos, and to be honest I don’t plan on it, but I hope they are of better quality considering the large number of people he reaches with them.
The lazy journalism, which not coincidentally wasn’t produced by any dedicated science or medical writers, is an even bigger problem. Simply parroting the views seen on a YouTube video is highly irresponsible and can even be harmful when it spreads medical misinformation. Maybe this particular example isn’t likely to result in any risky lifestyle changes, but I’m confident that readers of SBM can easily think of several that have. But millions of people potentially avoiding eating Chinese food, take out in general, or even leftovers, could have economic downsides. We have also seen significant increases in anti-Asian hate crimes during the pandemic and this is the last thing they need.
There is at least a silver lining to all of this. In Hsu’s video, and even in the many poorly written news articles, the fact that there is a vaccine that protects people at risk from such a severe outcome was mentioned. Unfortunately, the young adult discussed in the NEJM case report had not taken advantage of them, having only received the first dose of the two recommended vaccine series. Hopefully people will be inspired to take advantage of these lifesaving medical marvels and get themselves or their kids vaccinated.

Mouse Model of Sepsis Challenged
Steven Novella on February 13, 2013
Link
A recent study published in the Proceedings of the National Academy of Sciences calls into question the standard mouse model of sepsis, trauma, and infection. The research is an excellent example of how proper science investigates its own methods.
Mouse and other animal models are essential to biomedical research. The goal is to find a specific animal model of a human disease and then conduct preliminary research on the animal model in order to determine which research is promising enough to study in humans. There are also non-animal assays and “test tube” type research that is used to screen potential treatments, but scientists still prefer a good animal model.
It is also understood that animal models are imperfect – mice are not humans, after all. Animal research is therefore not a substitute for human research. I and other SBM authors have regularly criticized proponents of dubious treatments who make clinical claims based upon preliminary animal research. Until something is studied in humans, we cannot make any reliable claims about its safety and efficacy in people.
I would also point out that it is highly problematic to discuss the utility of animal models in general. Each animal model needs to be considered by itself, in terms of how predictive it is, and for what. For example, there are SOD1 mice who have a mutation that causes familial ALS (FALS). This mouse model has served as a screen for many potential ALS treatments. It turns out that the SOD1 mouse is an excellent animal model for SOD1 FALS in humans. This is not surprising considering that it is the same mutation. However, the SOD1 mouse model of ALS is much less predictive for sporadic ALS. Most of the drugs that look promising in the SOD1 model have not shown a significant clinical effect in humans with sporadic ALS (only one drug has actually made it through FDA approval: riluzole).
The question investigated by the authors of the current study is this – how good is the current mouse model of sepsis (infection in the blood), trauma, and other infections? The deeper question is – how similar is the mouse immune system to the human immune system.
The authors first questioned the mouse model after studying the pattern of gene activation in patients suffering from these three conditions, each of which cause inflammatory stress on the body. They found that the pattern of genetic response was similar across all these conditions, pointing to a common inflammatory response to stress. Their research was criticized, however, for not including mouse data to back it up. So they conducted follow up research looking at the pattern of gene activation to these stress conditions in mice.
What they found surprised them – mice had a different pattern of genetic activation in each of the three conditions, and all of them were different from the response found in humans. In other words, the mouse immune system responds differently to various kinds of stress than the human immune system.
The authors were quick to recognize the implications of their findings: the mouse model of inflammatory stress reactions is likely worthless or even misleading. According to their research, it should not be used as a preliminary indicator of human research into these conditions.
The data seems fairly robust and the conclusions valid. We still need time for the study to be digested by the scientific community, and perhaps for some follow up research to be conducted, but even with this one study it seems that researchers should think carefully about using mice to research potential treatments in these conditions.
Media reporting about this research was generally good, probably because the story is pretty juicy as it is, but as usually ramped up the drama a notch or two. It is common for researchers themselves to overestimate the importance and impact of their own research. Often they exaggerate prior ignorance and resistance to their findings in order to magnify the apparent effect of their new findings. The media will tend to focus on this aspect of a science new story, ramping up the drama even further.
The New York Time reporting on this study falls into this pattern, in my opinion. The author, Gina Kolata, makes it seem like the authors of the current study are the first to challenge the mouse model of inflammation, and were met with irrational resistance. She offers as evidence the fact that it took the authors a year to get past peer-review and that they were turned down by Nature and Science before being published by PNAS.
This is not unusual at all, however. Taking a year to get published is actually pretty good, and no one should cry about being turned down by two top-tier journals before being published in a third. This is not a sign of resistance, but more like standard procedure.
Further, there are previously published articles also expressing skepticism of the mouse model. This 2012 editorial, published in Nature Medicine and not by one of the authors of the current study, has the title: Rodent model of sepsis found shockingly lacking. This examination from 2008 also concludes that “Based on these criteria, the ideal model of sepsis does not exist.” This review concluded that there is utility to animal models, but they have significant weaknesses that need to be understood.
None of this is to imply that the current study is not an advance – the data on differences in genetic activation is very useful and does change the overall assessment of the utility of mouse models of inflammatory stress such as sepsis. I disagree with the impression given in reporting, however, that this notion comes out of the blue, is fundamentally different than prior attitudes, and was met with unwarranted resistance.
Conclusion
Animal models of disease are a vital technology to biomedical research, but they are a highly variable and problematic technology. This is well known to researchers, however, who seem to spend a sufficient amount of time questioning and studying the animal models themselves.
The current research appears to be a significant blow to the current mouse models of inflammatory stress, but also contains a wealth of information about which genes becomes active in humans and mice in response to such stress. This potentially can lead to other useful models or biomarkers, and also to new treatments in this very challenging area of medicine.

Some Sepsis Stuff
Sepsis interventions. Some don’t work and some don’t work.
Mark Crislip on October 20, 2022
Link

Sepsis. Bad stuff. Sepsis is when an infection, and occasionally other medical conditions, set off a cascade of out of control inflammation, damaging or destroying any number of organs and often leading to death.
As I said, bad stuff. Sepsis, in all its manifestations, has been one of the mainstays of my practice. Sepsis can be transient and respond rapidly to antibiotics and modern ICU supportive care. It can also be a relentless crash and burn, a rapid and uncontrolled spiral into death.
I have seen a few young meningococcal patients who were fine at breakfast and dead by dinner. Bad stuff.
For whatever reason, patients have recently been made aware of sepsis. For the past few years, it has not been unusual to have been asked by families if the patient was septic.
We have improved the management of sepsis over the years, mostly as we are better and more aggressive at supporting failing organs. But the basic approach has been the same for the 36 years I have been in infectious diseases: antibiotics, supportive care, and a gobbet of good luck.
Why some die and some survive is often a mystery. There is always variation in both the infecting organism and the host. All E. coli are not the same, for example, where different strains infecting identical mice will have different mortality rates. Conversely, the same E. coli strain will have different mortality rates in different strains of mice.
There are innumerable variations in the immune system that increase or decrease the risk of acquiring or dying from a variety of infections. My personal favorite is how variations in snot can increase the risk of meningococcal disease. As the Bard said, “The Sepsis, dear Brutus, is not in our stars / But in ourselves”. I will be long retired (3 months, 9 days, 2 hours, 11 minutes as I write this, but who is counting?) before we can scan the genome of a patient with a tricorder and point to the polymorphism that increased, or decreased, the chance of infection and death.
Vitamin C
Every once in a while a patient does survive sepsis who really should not have. It always fries my bacon when the family credits God with the save. They have no idea of the work and training the ICU team had accomplished to produce the ‘miracle’. Give credit where credit is due.
I have been around long enough to see many an adjunctive therapy come and go for sepsis. Xigris, steroids, and others. It is common in the ICU, perhaps more often for processes in which our interventions often fail and death is common, for doctors to glom onto therapies that appear to work based on suboptimal trials.
I have referred to it in the past as medical cold fusion: an effect that makes little sense, if any, when compared to known reality. What follows is a flurry of explanations about how the effect could be the real deal, some enthusiastic embracing of the intervention, slow discouragement, finally ending in better clinical trials that show, nope, the intervention did not do anything at all.
Sherman, set the Wayback machine to March 31, 2017, when you will find my last entry of the first series of my SBM bloggin’, “Vitamin C and Sepsis. All Sound and Fury? Much Ado About Nothing?”
At the time I was, for lack of a better word, skeptical (me? Hardly.) that intravenous vitamin C and thiamine were actually effective in decreasing mortality in sepsis. But I noted at the time:
Never go in against vitamin C when death is on the line!
So the study was grudgingly embraced by our intensivists. For a while. You could not tell at the time if the intervention made any impact on outcomes. It did drive up the price of both IV vitamin C and thiamine. A lot. And then there were more clinical trials.
What had been impressive was the decrease in mortality in the vitamin C/thiamin study I evaluated last decade. From 40% to 8.5%. I mean, wow. That seemed too good to be true. And you know what follows. Was that result replicated?
Of course not. Based on eleven studies:
In this meta-analysis, the use of IV high-dose vitamin C in patients with sepsis was not associated with lower short-term mortality.
And:
A total of 17 studies including 3133 patients fulfilled the predefined criteria and were analyzed. Pooled analysis indicated no mortality reduction in patients treated with vitamin C when compared to reference.
So another one bites the dust.
There were a few minor potential beneficial effects, which often show up in these studies. And they are likely meaningless, the usual background noise seen in complex medical interventions that looks promising in subgroup analysis or secondary endpoints. It’s usually crap:
…although it was associated with significantly shorter duration of vasopressor use and greater decline in the Sequential Organ Failure Assessment score at 72–96 hours.
And:
…subgroup analyses revealed an improved survival if vitamin C treatment was applied for 3–4 days
Subgroup analysis is a Latin term used by statisticians for ‘likely bullshit’. Subgroup analysis invariably leads to nothing in later studies. I long ago learned to ignore subgroup analysis.
It was noted that:
…interestingly, six studies reported no adverse events related to the intervention, while three studies documented more frequent adverse events in patients treated with intravenous vitamin C (hypernatremia n= 24, hospital-acquired infections n= 14, hyperglycemia n= 13, gastrointestinal bleeding n= 3, and fluid overload n= 1).
Interesting? Naw. The usual noise in clinical trials.
Perhaps more interesting was the NEJM trial, published after the above meta-analyses:
In adults with sepsis receiving vasopressor therapy in the ICU, those who received intravenous vitamin C had a higher risk of death or persistent organ dysfunction at 28 days than those who received a placebo.
Oops. The numbers:
At day 28, 191 of 429 patients (44.5%) in the vitamin C group had died or had persistent organ dysfunction, as compared with 167 of 434 patients (38.5%) in the placebo group (risk ratio, 1.21; 95% confidence interval [CI], 1.04 to 1.40; P=0.01).
I have been convinced that a p needs to be at least .005 to perhaps represent a ‘real’ effect. So really? Vitamin C was no different than placebo. All the effects, good and bad, noted in these trials are, I would bet, just noise. More sound and fury, signifying nothing.
I mean, they didn’t even bother to collect “information regarding specific pathogens and the appropriateness of antimicrobial therapy”.
And that is a finding across all the studies that I could hunt down. No one cared about the microbiology, the source of infection, the host (for example, while transplant patients have more bacteremia, they may die less often) or the appropriateness of antibiotics. All of which make a difference in outcomes.
From the perspective of an ID doc, it renders all the studies of marginal applicability. Not all sepsis is the same, a concept apparently only an ID doc cares about. Perhaps why every study has demonstrated that ID involvement with infections of all kinds, including sepsis, improves outcomes: less morbidity and mortality. Odd how having someone who actually knows that they are doing improves care. Of course, since most of these studies were done by self-serving ID docs, well, go to Midas, get a muffler.
But it probably doesn’t matter. Vitamin C has a long history of no practical benefit for any process outside of scurvy, because there is no reason it should. Add sepsis to that list.
NRLM
As mentioned above, having healthcare providers who know what they are doing improves care. What a concept. It makes me wonder how the opposite end of the spectrum impacts healthcare. Not just knowing nothing about diseases but having your medical approach is based on the nonsensical ravings of a lunatic mind (NRLM) cannot be good.
Great Britain at one time had 5 homeopathic hospitals, one as recently as 2018. I cannot tell if these institutions operated like real hospitals or not.
The Bristol Homeopathic Hospital continued to provide a full range of services.
Whatever those services that might cover. I can’t imagine presenting at a homeopathic hospital with sepsis where all they had to offer is nothing.
No one would rely solely on homeopathy for sepsis, or so one would hope. Homeopathy has been used as an adjunctive therapy, with no benefit. Much to my surprise, I discussed homeopathy and sepsis in 2009. The things I have done for which I have no memory. Sigh.
Despite being an “excellent piece of work on the role of homeopathy in critically ill patients“, at least according to a homeopath, there has been little research since I wrote that blog entry.
Part of the problem is the inability of septic patients to provide the bizarrely detailed and pointless history that guides the selection of homeopathic nostrums. Fear not. There is now, in caps:
…the Protocol for Objective Homeopathic Semiology for patients with an altered state of consciousness.
The Protocol is available online, but I will confess after reading the paper upon which it is based, I have no clue how one would apply it. The author’s website, in Portuguese, has no explanation I can find. “[S]eeking the actual characteristic symptomatic totality, with the hierarchization of homeopathic symptoms” is, I fear, beyond me.
The author goes on to demonstrate how the protocol was applied to a series (three) of septic patients:
Choice of patients for homeopathic intervention was based upon recognition that they were not responding satisfactorily to conventional treatment as judged by the attending ICU medical team.
This was followed by the application of 5 drops of a 30 C or 200 C homeopathic nostrum. A perforated gastric ulcer, a meningococcemia, and a pneumonia, all of whom survived. The conclusion?
The practice of homeopathy may effectively be extended beyond treating chronic cases toward the less familiar but highly important frontiers on the verge of life and death.
They actually thought homeopathy added to care of the patients. I keep wondering why the practice of homeopathy is not considered a DSM-IV delusional illness. NRLM indeed.
Acupuncture
One meta-analysis notes:
Acupuncture has been used for various diseases, including severe infection, in China for more than 2,000 years.
That is true. There are multiple reports of infection and sepsis caused by acupunc… oh wait. This is acupuncture used to TREAT infection and sepsis. That’s different. Nevermind.
Supposedly,
Previous studies reported that acupuncture at Zusanli (ST36) might be effective in treating sepsis
The point is just below the knee and lateral.
It is quite the point, stimulation of which has wide-ranging effects besides treating sepsis. In animal models,
…acupuncture at ST36 could be useful in reducing sepsis-induced injuries in heat, lung, kidney, liver, gastrointestinal tract, and immune system. Moreover, its potential mechanisms for antisepsis might include decreasing oxidative stress and inflammation, improving microcirculatory disturbance, and maintaining immune balance during sepsis.
I mean wow, truly the wonder drug that works wonders despite:
Poor methodological quality and publication bias exist.
How about in humans? And here we have a problem. I can’t access most of the original data from the review “Efficacy and safety of acupuncture as a complementary therapy for sepsis: a systematic review and meta-analysis” that purports to show a mortality benefit to adding acupuncture to standard care.
All the studies are from China, and as a result, are unfortunately suspect as has been mentioned before. As is always the case, a were included in the review, so there was no one acupuncture intervention that ‘worked’ – it is the concept that is effective.
The same issue, by the way, was in the meta-analysis that demonstrated decreased mortality in sepsis with Traditional Chinese Pseudo-Medicine: each trial in the series had a different treatment intervention but the collected data showed:
Addition of TCM has better effects in participants with sepsis.
It just does not matter the specific form of TCPM. I find that so…weird that these meta-analyses include very different interventions as if they were all the same. Meta-analyses are supposed to compare apple and apples, not dog shit and cow pies.
For the acupuncture trials:
Most included studies had an unclear risk or high risk of bias in allocation concealment and blinding of participants. In addition, included studies were mostly small sample single-center RCTs. Therefore, the degree of certainty around our findings is low to very low.
My certainty is high that acupuncture does nothing for any process so why would it alter the course of sepsis?
I went through the bibliography seeing if I could glean much from the titles and abstracts. Nope. More than a few dead links. None of the articles appeared to be evaluating mortality as a primary outcome, mostly looking at lab parameters or effects on the GI tract, such as “Electroacupuncture Improves Intestinal Dysfunction in Septic Patients: A Randomized Controlled Trial“, which found:
However, there were no significant differences in the days on MV, length of stay in ICU, and 28d mortality between two groups ( P>0.05).
And Yang et al., noted in the references, demonstrated that:
There was no significant difference of mortality in the 28th day between the two groups, with 5 deaths of 29 patients in the intervention group (17.2%) and 9 of 29 in the control group (31.0%).
But not included in the mortality section of the meta-analysis. Odd.
So in the end I can’t make detailed analysis of the meta-analysis, but that always begs the question: why bother to apply the concepts of reality to fiction?
Because it is what we do at SBM.

Madonna !?!
Remembering the old days of Madonna, courting, and naloxone use.
Mark Crislip on July 18, 2023
Tweet

Something in the way endorphins won’t let me beI don’t want to be your patientSo naloxone, won’t you set me free?
Stop playing with my heartFinish what you startWhen you make my blood pressure come downIf you want me, let me knowBaby, let it showNaloxone, don’t you fool around
Just try to understand(Understand)I’ve given all I can‘Cause you got the best of me
BorderlineFeels like I’m going to lose my BPYou just keep on pushing my BP over the borderlineBorderlineFeels like I’m going to lose my BPYou just keep on pushing my BP over the borderline
Borderline
I write the first of this draft of this entry on 8th of July for a July 18th publish date. Information may evolve, and everything you are about to read is a crock. As French manga might say, Sailor Vee.
My wife and I are at that stage in life where we read feed headlines to each other in the morning over coffee. My parents would read newspaper headlines to us, but newspapers are not what they once were.
“Madonna got naloxone,” she said. “Pulled her back from the dead.”
Say what?

Madonna was not in my feeds. I was surprised to find she was newsworthy but I am far removed from popular culture. Madonna, along with Purple Rain and She Bop, were the soundtrack of the courtship of my wife. Somehow Madonna got old. She is 64, less than a year from Medicare, and just a year younger than me. Everyone is getting old. We are going to see Neil Young Monday, which is yesterday, and he’s 77!
It is a popular pastime in Infectious Diseases to speculate on the illnesses of the rich and famous. Did Lincoln have aortic insufficiency from syphilis or was it just Marfans? Did Alexander the Great die of an amoebic liver abscess rupture? In that tradition, I will yammer on a bit about Madonna.
The details of her illness are, of course, vague. As they always are on the web. Somehow the information I would want, like the name of the bacteria, are never mentioned.
An elderly woman is found down, lifeless!, is revived, is found to have a “severe bacterial infection”, spends a few days in the ICU and is soon sent home to recover.
A very common clinical scenario, and, common things being common, I would bet on E. coli urosepsis. Infections with an easily controlled source get better very fast, and really, that would only be urosepsis. Modern ICU care snatches people back from the brink of septic death every day. Maybe Madonna had some other bacteria or infection, but there is a lack of clinical information for further pointless speculation. Hopefully, we will never know. But the damage has been done. Google News knows I have clicked on Madonna. My feeds are doomed.
It is the use of naloxone (brand name Narcan) that got my attention. Today, naloxone is primarily used to reverse the effects of narcotic overdose. It is an opioid antagonist and binds to opioid receptors to reverse the effects of opioids such as heroin. It doesn’t last long, a 30-60 minute half-life, and I have seen people revived then lapse back into methadone (8-59-hour half-life) coma over the course of a couple hours. I wonder how often those who get a dose in the community for a fentayl ( half-lives 3 to 7 hours) overdose and refuse further care wander off to die a few hours later.
Why was the naloxone given to Madonna? Again, the reports are not clear. I assume she was found down and they have her a snort (naloxone comes as a nasal spray) just in case it was an opiate overdose. The emergency tech would have no way of knowing if was an overdose or not, so safe is better than sorry.
Evidently, the naloxone was the wonder drug that worked wonders and brought her back from the borders of Tartarus.
It also brought back memories. Watching her Borderline video on MTV with my then girlfriend, now wife. The ice collecting on the windows during call nights at Hennepin County Hospital, where I met my wife to be. True story of our first meeting. I was post call, trying and failing to put a central line in a demented patient, so I called for help from a nurse. As the nurse entered the room, I hit the subclavian, passed the catheter, and I could now go home and sleep. I turned to the nurse, who I had never seen before, and said, “Thanks. You brought me good luck. Will you marry me?” The rest is history. I digress. As ususal.
And I remember giving naloxone for sepsis.
Back in the day there was a brief flurry of interest in giving naloxone as it improved blood pressure in sepsis.
When you are dying of sepsis, the body releases endogenous morphine aka endorphins that help perpetuate low blood pressure. I figure it is nature’s way of letting you die comfortably. Naloxone blocks endorphins. If you search the PubMeds for naloxone and sepsis, you will find a series of articles in the 1980s showing transient benefit from naloxone for raising blood pressure in sepsis. And, I suppose, making your death from sepsis more unpleasant. Waking up to your unexpected impending demise might transiently raise the blood pressure. Panic does that.
Naloxone had salubrious effects on a variety of parameters I spent much of my internship in the ICU measuring. I don’t think I have seen a Swan Ganz catheter in the ICU for decades.
… a moderate nonsignificant increase in cardiac index, pulmonary capillary wedge pressure, and systemic vascular resistance.
The use of naloxone was based on animal studies and care reports and we gave all our septic patients continuous infusions of naloxone. I cannot remember if it helped or not.
The use of naloxone went nowhere as although it improved blood pressure, it did not change the outcome. Patients still died at the same rates. Two placebo-controlled studies were the steak (sic) in the heart of naloxone use for sepsis.
Mean systolic blood pressure rose by 13.3% in the naloxone group and 11.3% in the placebo group. Two-way analysis of variance for repeated measures of blood pressure, obtained over 30 min periods before and after treatment, revealed no significant difference (p greater than 0.10) between treatment groups.Survival rates in the two groups at 48 h and 7 days after the start of treatment were similar. Naloxone, 0.4 to 1.2 mg intravenously, was no better than placebo in ameliorating hypotension in septic shock..
and
Five (46%) of 11 patients in the naloxone group and one (9%) of the other 11 patients in the placebo group responded clinically. The MAP among the five responders increased from 62 +/- 5 to 89 +/- 4 mm Hg within 20 min of naloxone treatment (p less than .01). This favorable hemodynamic response was sustained throughout the patients’ clinical course. In contrast, the MAP did not change significantly in the nonresponders who received naloxone, nor did it change in the placebo group. More patients in the naloxone group than in the placebo group received steroids concurrently. Survival rate was 100% in those who responded to naloxone clinically. However, overall survival rate in each group was essentially the same. No adverse effects were observed, except for mild agitation in some of the patients receiving naloxone. We conclude that naloxone infusion is clinically efficacious in improving the hemodynamic profile of a subgroup of patients with severe early hyperdynamic septic shock, but does not appear to improve the overall survival rate.
Although as house staff, we somewhat cynically said it was our job to make sure patients died with normal numbers.
Of course, no therapy every truly dies in medicine. Someone always reinvents the wheel. In 2010, nalmefene, an opiate antagonist, was used in sepsis with the same results.
Based on the conventional anti-shock therapy, early use of nalmefene can improve the hemodynamics, which is conducive to ameliorate septic shock, however, there is no significant effect on 28-day mortality.
So, is there some doc in NYC who still believes in naloxone for sepsis? The lifestyles of the rich and famous often includes more medical care than us regular folks receive, although more is not always better. I don’t think so. Naloxone for sepsis may be passe, but I do not doubt Madonna got a blood pressure boost from naloxone for worries of opiate overdose as she was heading to the hospital and it may have been of transient benefit. But it was the ICU care that saved her.

The Tuskegee Syphilis Experiment: A Fiasco with a Silver Lining
The Tuskegee syphilis experiment studied black men with advanced syphilis for 40 years. Patients were lied to and prevented from getting treatment. A black mark in the history of American medicine, it led to important reforms.
Harriet Hall on March 5, 2019
Link


The Tuskegee experiment was one of the most regrettable incidents in the history of medicine in the U.S. Conducted by the U.S. Public Health Service, it started in 1932 as a six-month study of the natural course of untreated syphilis in 399 black men and 201 controls. It took on a life of its own, lasted forty years, and was only terminated in 1972 after whistleblowers sparked a public outcry.
Patients who could have been cured were denied effective treatment and most of them suffered the complications of advanced syphilis and died before their time. 40 of their wives contracted syphilis, and 19 children were born with congenital syphilis.
The doctors were accused of racism and genocide. They were compared to the Nazi doctors whose unethical experiments cruelly tortured and killed prisoners in Hitler’s concentration camps. Many myths were circulated. It was widely believed that the doctors injected patients with syphilis; they did not. It was assumed that doctors told patients they had syphilis; they did not. It was widely believed that no treatment was given; in reality, most patients did receive some treatment, although it was inadequate. It was often believed that both men and women were enrolled; but the study was restricted to black males who had advanced syphilis and were in a specific age group, excluding younger men. The reasoning was that it was important to know when patients contracted the disease; men usually had an identifiable, memorable skin lesion, while women often did not. And they needed to be able to follow patients who had been infected long enough to develop late complications.
When I first heard of the Tuskegee study, I was appalled. I couldn’t imagine what those doctors were thinking, or how they could sleep at night after participating in such an unethical experiment. As I learned more, especially from reading the book Bad Blood by James H. Jones, I realized the truth was far more nuanced than I had realized. I now have a better understanding of what those doctors were doing and thinking; I don’t condone their actions, but I can cut them some slack because I know they were heavily influenced by peer pressure and by the social milieu of their time.
To set the scene
Racial prejudice was rampant, and segregation was in full force. The study subjects were all black and impoverished; the researchers were all white and well-to-do. Conventional wisdom held that blacks were inferior in various ways. The high incidence of syphilis in blacks was attributed to physical inferiority and sexual promiscuity. The effects of abject poverty and ignorance were confused with intrinsic racial traits. Doctors believed that diseases had different effects in patients of different races. They thought blacks were more likely to suffer cardiovascular complications of syphilis and whites more likely to have central nervous system complications.
A study in Oslo, Norway, had examined the natural course of untreated syphilis in white males, but it was a retrospective study pieced together from information about patients who, for whatever reason, had not been treated. The U.S. Public Health Service researchers thought there would be value in prospectively following black males who were diagnosed with syphilis but not treated. Macon County, Alabama, was a convenient place for such a study, with a rural population of isolated, uneducated, illiterate, ignorant, malnourished, desperately poor black sharecroppers who had no access to medical care; many of them had never been seen by a doctor in their entire life. They didn’t know what syphilis was, and the researchers didn’t explain; they just told them the test showed they had “bad blood”. They were promised treatment for their bad blood, free medical care for minor ailments, free transportation to appointments, free meals on study days, and free burial insurance. Since they had no other way to afford medical care or burial insurance, they could hardly refuse. They were initially told the study would last six months and would provide treatment.
As time passed, the researchers lied to subjects repeatedly. They gave them token placebos (aspirin and iron tonics) and let them believe they were getting effective treatment (some subjects had never taken an aspirin before, and they were impressed when it relieved their headaches). They went to great lengths to prevent them from getting effective treatment outside the program. They got permission for autopsies by calling them “surgeries” and making them a requirement for receiving funeral benefits.
They wanted to gather data with spinal taps, but they knew patients often had serious side effects like prolonged incapacitating headaches, and they were afraid the word would get around and other patients would refuse. So they found a way to process a large number of patients at once before the word could spread, and they cynically enticed patients in with a deceptive letter that said “Last Chance for Special Free Treatment”. Some patients didn’t realize that the purpose of the spinal tap was diagnostic; they believed their spine was being injected with curative medication.
Contemporary treatment for syphilis
Apparently the original plan was to treat everyone who tested positive with the standard anti-syphilis drug, Salvarsan, an arsenic-based drug, along with mercury. But the study was only supposed to last for six to eight months, and effective treatment required a full year. The injections were painful, and the treatments were toxic. The side effects were so bad that some doctors discouraged treatment, arguing that the treatment was worse than the disease. Due to the Great Depression, private funding for treatment medications was withdrawn; but the study was continued as an observational study of untreated patients. The partially treated patients were considered untreated for the purpose of the study. So it was never really a valid study of untreated patients; it was hopelessly contaminated by partially treated patients. It never even had a formal study protocol, and it didn’t have an appropriate control group. When subjects in the control group developed syphilis during the study, they were simply transferred to the syphilis group.
When a safer, more effective treatment, penicillin, came along in 1943, it was never offered to study participants; they weren’t even told it existed. Some researchers argued against it to maintain the “untreated” integrity of the study, and some argued that it was new and was not really a good treatment; it might do more harm than good to patients with advanced disease. Some argued that withholding treatment did not injure the participants, because if the study had not existed, the patients would not have had any kind of medical care.
Nurse Eunice Rivers
A black registered nurse, Eunice Rivers (later Eunice Rivers Laurie), played an essential part in getting the study done. She gained the confidence of patients, knew how to talk to them, became friends with them, visited them at home, provided transportation in her own car, and worked hard to locate patients when the researchers lost track of them. She never questioned the study. She believed a nurse’s duty was to not ask questions and to simply carry out the doctor’s orders.
When interviewed years later, she refused to believe the patients had been harmed. She felt it was best to withhold treatment in the 1930s because there were bad reactions and some patients would have died. She wasn’t so sure about the wisdom of withholding penicillin when it became available, even though withholding it was illegal: it violated state laws and the federal Henderson Act of 1943 which required testing and treatment of venereal disease. But when asked what mistakes had been made, her main concern was the lack of informed consent: it bothered her that the doctors never told the patients they had syphilis.
Similarly, the doctors who participated in the program felt they were simple clinicians who were not qualified to evaluate the scientific merits of a study that the expert scientists had said was important and necessary. They simply did what they were directed to do.
Compensation
The victims received a formal apology from President Clinton on behalf of the United States in 1997. The researchers themselves never expressed contrition; they insisted they had acted in good faith. The 74 participants who were still alive were offered free medical care and burial stipends. A lawsuit was settled out of court for $10 million.
Lessons learned
The Tuskegee experiment was a terrible fiasco, but there was a silver lining: one good thing did come out of it. Nothing of scientific value was learned from the study. Nothing that would “prevent, find, or cure a single case”. But there was one very valuable, important result. Due to the public outrage, laws were passed to protect the rights of human subjects in research studies. Today human studies must be approved by Institutional Review Boards. Subjects cannot be denied effective treatment. They must understand the purpose of the study and they must give informed consent. Protection is not perfect, and there will still be abuses, but hopefully none as egregious as the infamous Tuskegee experiment.

ANTIBIOTICS

Antibiotics for Low Back Pain
Harriet Hall on May 14, 2013
Link
Low back pain is a particularly frustrating condition that is common, poorly understood, and difficult to treat. Could a long course of antibiotics be the answer for some patients? A recent study from Denmark suggests that it might be: “Antibiotic treatment in patients with chronic low back pain and vertebral bone edema (Modic type 1 changes): a double-blind randomized clinical controlled trial of efficacy” by Albert, Sorensen, Christensen and Manniche. Is this a crazy idea like long-term antibiotics for “chronic Lyme disease” or will it pan out like antibiotic eradication of H. pylori in patients with ulcers? Time will tell. This was a rigorous, well-done study, but we can never rely on the results of a single study until it is replicated or confirmed elsewhere.
BackgroundModic type 1 changes represent edema in the bone and can be seen only on MRI. They are present in 6% of the general population and 35-40% of the low back pain population. Infection is one of the hypothetical causes of bone edema, and several studies have found bacteria in material removed during disc surgery. Low virulence anaerobic organisms (Proprionibacterium acnes and Corynebacterium propinquum) were found in 53% of patients in one study. Another study found bacteria in 37% of disc material from patients with herniated discs and 0% of disc material from patients with other spinal disorders. It is thought that these skin and mouth organisms spread to the disc during normal bacteremias as a result of neovascularization associated with disc disease; the Modic changes may be a side effect manifested in the adjacent bone rather than a bone infection per se.
An uncontrolled pilot study of 32 patients had shown promising results with antibiotic treatment. This new double blind study confirmed those preliminary results.
Study MethodsSubjects were 162 chronic back pain patients recruited from spine centers. They had to have MRI-confirmed disc herniation within the previous 6-24 months, with Modic type 1 changes on MRI. Subjects had had either conservative or surgical treatment; patients with and without sciatica and neuropathic pain were included. Randomization and blinding were rigorous. The placebo was a calcium carbonate pill indistinguishable from the active treatment. The antibiotic, amoxicillin-clavulanate (500mg/125mg), was given 3 times a day for 100 days, consistent with the recommendations of infectious disease experts based on bacterial culture results of previous studies. There were 4 treatment groups: single and double dose antibiotics, single and double dose placebos. MRIs, symptom questionnaires, clinical exams, and blood tests were done at baseline, at end of treatment, and at a 12-month follow-up.
ResultsThe antibiotic group improved on the primary outcome measures of disease-specific disability and lumbar pain, and also on the secondary outcome measures of global perceived effect, leg pain, hours of LBP during the last 4 weeks, the EQ-5D Thermometer (a measure of quality-adjusted health status), days with sick leave, bothersomeness, constant pain, MRI Modic grading, and physical exam measures (i.e. pain with Valsalva maneuver). Improvement in all these factors was clinically as well as statistically significant at p levels from .05 to .0001. Pain relief was gradual, beginning at 6-8 weeks and sometimes continuing long after the end of the treatment period. On MRI there was a significant decrease in the volume of Modic-1 findings in the antibiotic group but no reduction in the placebo group. Side effects (mostly gastrointestinal) were reported by 65% in the antibiotic group and 23% in the placebo group. There were 13 dropouts in the antibiotic group (only 4 of these were due to side effects) and 5 in the placebo group (due to no shows and new disc herniations). There was a trend towards a dose-response relationship with double-dose antibiotics being more effective (not statistically significant).
DiscussionThe authors point out that the improvements in this group of traditionally resistant chronic low back pain patients with this protocol were substantially greater than those described with other treatments. They felt the course of improvement was consistent with slow resolution of anaerobic infection in poorly vascularized tissue followed by gradual healing. They stressed that their findings applied only to this specific group of patients with disc herniation and Modic-1 changes on MRI, not to all patients with back pain. They also stressed that high-dose long-term antibiotics should not be prescribed without careful consideration because of the risks to individuals and to the community (antibiotic resistance).
ConclusionThis study is encouraging but far from definitive. It might justify antibiotics for patients with chronic low back pain and Modic-1 MRI changes following a herniated disc when they have failed to respond to all other treatment options. This was a well-designed study, carefully carried out, with a credible rationale, impressive results, and a cautious interpretation. This is how science should be done.
The authors cautioned:
We rely on our fellow colleagues to use clear evidence-based criteria and to avoid excessive antibiotic use.
Back pain is a frustrating problem, and patients who learn about these results may ask for a trial of antibiotics even if they don’t fit the criteria of the study. That would not be justified and might be expected to do more harm than good. Chronic low back pain is a mixed bag with various etiologies, and it must be stressed that this study addressed only one very limited sub-group of back pain patients. That said, it is a ray of hope for those patients, and I hope it will be confirmed.

No, Purell Does Not Breed Super-Anything
Adam Wegman on November 28, 2015
Link


Recently, I was sitting in a meeting and reached for the dispenser of Purell hand sanitizer sitting on the conference room table. A colleague of mine gave a small, rueful shake of her head to the person on her other side. Apparently I had erred. I asked what was the matter, and got a brief answer to the effect of “because superbugs.” We exchanged nothing more about it; the interaction was over before the alcohol had dried from my hands.
I wouldn’t have thought anything of such an interaction with anyone else, but my colleague is a PhD student in immunology, six years older and more schooled than I, doing her doctoral research in a lab run by a physician-scientist — a specialist in infectious disease, no less. A touch ironic.
And so I noticed a need for some mythbusting: alcohol-based hand sanitizers do not breed resistant bacteria.
Superbugs: whence they come
Antibiotics breed resistant bacteria. I’ll leave the topic of antibiotic stewardship out of this post — suffice to say that antibiotic use and the resultant resistant microbes are a serious problem — but I’ll explain how alcohol-based sanitizers do not breed “superbugs,” either bacteria or viruses. I’ll then touch on the hygiene hypothesis as it pertains to personal hygiene.
First, bacteria. Antibiotics have specific mechanisms of action by which they weaken or kill bacteria. Take penicillin and its derivatives (β-lactam antibiotics) as a classic example: they inhibit the synthesis of the peptidoglycan wall of gram-positive bacteria at the final transpeptidation step. This in turn renders the bacteria fragile and vulnerable to physical and osmotic stress, as well as unable to divide. This inhibition process requires high molecular precision.
This specificity is what characterizes antibiotics’ function. It is also what creates a selection pressure for bacteria to evolve to survive what was previously toxic to them. We tend to think of evolution as a process taking place over millions of years, but it’s faster for microorganisms — a lot faster. The vast numbers of bacteria, their short time of replication, and their capacity for horizontal gene exchange, accelerate their evolution when they are in the presence of an environmental pressure such as an antibiotic.
These factors create the dangerous potential for evolution of bacteria into resistant strains. Over time, and with improper use, antibiotics can breed superbugs.
Why you shouldn’t worry about (alcohol-based) sanitizers breeding resistant bacteria
What, then, separates Purell from penicillin? The answer lies in the mechanism of action of ethanol — a type of alcohol, and the active ingredient in Purell and similar products.
(It is important to note that I have deliberately specified alcohol-based hand sanitizers in this post. They are by far the most common kind of instant sanitizer. Other active ingredients, like triclosan, may promote resistance, because they have different mechanisms of action.)
While antibiotics target very specific cellular processes, ethanol is a nonspecific bactericidal agent. It disrupts several bacterial functions at once, “caus[ing] membrane damage and rapid denaturation of proteins, with subsequent interference with metabolism and cell lysis.”
This is not something that can be evaded as simply as activating a specific gene and secreting β-lactamase to destroy the antibiotic, for example. Tolerance to the action of ethanol would take much longer to evolve, and would be comparable to the organism becoming an extremophile.
Moreover, antibiotics are administered over the course of days or weeks (or even months) and therefore represent a sustained environmental pressure against which bacteria can evolve. By contrast, alcohol in hand sanitizers is present for about twenty seconds and is gone — there’s no continuous stress against which the bacteria are being selected. Further, because of the very brief exposure, there is no opportunity for the bacteria to replicate in the presence of ethanol — and therefore a negligible selection pressure over time.
Alcohol hand sanitizers and viruses
Next, viruses. The ethanol in hand sanitizers is effective against some viruses, for the same main reason: overwhelming force. Ethanol can denature the protein coat of some (not all) viruses, or break down the outer lipid envelope (depending on the type of virus in question).
There’s another reason, quite different from the case of bacteria: viruses are obligate intracellular parasites that need to be inside a cell to replicate. Viruses on the surface of the skin aren’t even replicating, and therefore a denaturant such as alcohol doesn’t constitute a selection pressure. No evolution, no resistant organisms!
And so, just as they don’t breed resistant bacteria, alcohol-based sanitizers don’t breed resistant viruses. (And neither do antibiotics, as those are ineffective against viruses and wouldn’t create any selection pressure either.) Alcohol hand sanitizers are second only to hand washing (which is sometimes absolutely necessary), and nonetheless represent an important and convenient approach to curtailing contagion, especially in hospital environments.
But there’s another reason some people object to hand sanitizers.
The hygiene hypothesis
We can kill bacteria and viruses with sanitizers, and it does not breed resistant strains…but should we? The hygiene hypothesis — the idea that we need microorganisms — is another concern that often comes up along with the worries about superbugs. Basically, the rationale is that nuking microganism populations could have unfortunate unintended consequences for human health, even if it doesn’t breed superbugs (Harriet Hall has discussed the hygiene hypothesis previously, reviewing a book about it in the process).
There have been questions raised about the hygiene hypothesis concerning hand sanitizers and personal hygiene in general. The hygiene hypothesis has gone through several redefinitions since its 1989 introduction by David Strachan, but can be broadly described as the “potential beneficial role of microbial exposures for the development of asthma, allergies and autoimmune disorders.” The logic is that exposure to antigens (through infection by bacteria, or helminths – parasitic worms) hones the specificity of the immune system, reducing the incidence of autoimmune events.
The hygiene hypothesis is, by definition, not a scientific theory — it is still being evaluated, reformulated, and appended. This summary does a good job of listing some of the gaps and inconsistencies in the hypothesis, some of which include:
    • “…numerous unknown mechanisms and inconclusive findings to date…”
    • “The potential role of viruses has not been explored…”
    • “There is large uncertainty with respect to the potential beneficial effects of probiotics…”
    • “…we still do not know whether prenatal or postnatal exposures matter”; and
    • “…the use of comparative animal models has not sufficiently been explored…”
I don’t mean to cast doubt on the entire idea. The hygiene hypothesis is not pseudoscience. It shows all of the makings of a genuine (if fledgling) scientific idea: plausible mechanisms, explanatory potential, initial validating evidence, reasoned challenges, careful review, and much more to be discovered. What this early-stage status means is that scientific medicine cannot recommend specific actions at this time.
A thorough (if somewhat aged) 2006 review is cautious: “the relationship of the hypothesis to hygiene practice is not proven,” and recommends further study. The authors of this summary succinctly write: “We consider it too early to provide recommendations on an individual level with respect to personal hygiene.” A 2015 paper specific to asthma and allergies concluded: “…neither personal nor home cleanliness was associated with a risk for asthma and allergies. Other microbial components in house dust not affected by personal hygiene are likely to play a role.”
The hygiene hypothesis and hand sanitizers
Concerning the hygiene hypothesis at large, the body of evidence is growing. However, it has not converged on an interpretation — there aren’t enough consistent data to recommend specific interventions. There have been isolated studies, mostly epidemiological or in mouse models, with helminths (parasitic worms) and a few species of bacteria. But there are a prodigious number of “microbial exposures” which might have a potential effect on “allergies and autoimmune disorders,” and the research thus far has explored only a fraction of these.
What we do know doesn’t boil down to advice regarding exposure to pathogens or about personal hygiene. This includes any recommendation for or against using alcohol-based hand sanitizers.
Even if the body of evidence grows large and cohesive and suggestive enough to promote the hygiene hypothesis to a theory, there are still a number of important questions and considerations. For example: is it just antigen exposure that is needed, or is the full-blown infection required to hone the immune system? If it’s the former, then one could reasonably hope for a “vaccine” of sorts that would contain the relevant antigens to coach the immune system (although we well know that many have issues with vaccines). If, however, a true infection is required, it becomes quite a murky question about how prophylactic microbial exposure would be reliably and ethically obtained. In any case, wherever this fledgling area of research leads, it’s sure to be interesting.
Alcohol hand sanitizers have no known downside
Ethanol-based hand sanitizers are a safe and practical approach to personal hand hygiene. While they can’t replace hand washing, use of such products should not be discouraged for fear of breeding microorganisms — because they just don’t.
Fears of unintended health consequences based on the hygiene hypothesis are premature. Although the hygiene hypothesis is a fascinating and potentially promising scientific idea, it is not coherent or complete enough to make specific recommendations about personal hygiene. As such, nothing in the hygiene hypothesis should deter use of ethanol-based sanitizers at this time.
While it is possible that sanitizers have unknown health consequences, it’s a certainty that not using them has consequences.

Why Antibiotic Use Scares Me
Joshua Horton on March 20, 2016
Link

Editor’s note: Today we present a guest post from fourth-year medical student Joshua Horton, about the looming problem of antibiotic resistance. Welcome!

I read a study recently that alarmed me: acute bronchitis is a condition that rarely requires antibiotics, but three quarters of patients presenting with this condition receive a prescription for antibiotics. Even more worrisome, this statistic has not changed in 20 years. To those of us on the cusp of a career in medicine – I am a fourth year medical student – this is terrifying because we are going to have to deal with the consequences. Antibiotic overuse leads to:
    • Increased morbidity and mortality for patients infected with resistant bugs
    • Unnecessary and exorbitant healthcare expenditures
    • The potential to cultivate multi-resistant bacteria that could spread to pandemic proportions
We still take them for granted, but antibiotics are a finite resource. Each time we breed a bug that is resistant to a particular drug, we are forced to relinquish that gun from our armamentarium. With fiscal impetus for pharma to develop new antibiotics waning, we may have reached a point of no return. That’s why this study scared me. Hopefully, clever techniques based on behavioral theory designed to reduce antibiotic prescribing may pull us back from that edge – read on to learn more.
We have known about the problem of antibiotic overuse and how to control it for a while, but the response has been slow. Experts, including Otto Cars (sweet name, man) of Uppsala University in Sweden, believe that the lack of morbidity and mortality data associated with antibiotic resistance prevents politicians and public health workers from reacting robustly. We all know how efficient and reliable political and public policy change can be. In the meantime, what about the ground level? Antibiotic resistance can be tied to the misuse and overuse of antibiotics by both patients and physicians. What are we doing wrong?

The physician and antibiotic resistance
According to a recent systematic review, the majority of physicians have “heard about antibiotic resistance, believe it is a serious problem, believe that using too many antibiotics is the main cause, and know some of the evidence-based strategies to reduce it.” Sounds great, right? Unfortunately, most deflect responsibility.
More physicians attributed resistance to a being a “global problem,” due to patient factors, or emanating from other countries or healthcare settings than said it was a problem for their own practice. Further, they considered resistance to be a “low priority and a distant consequence of antibiotic prescribing.” (I have to be honest: this was also my opinion before getting into the later years of medical school and becoming familiar with the literature.) And when patients insist on antibiotics in situations when they are not indicated, physicians will often relent under this social pressure for fear of dissatisfying or even losing the patient. I would hope this could be a prime opportunity to educate the patient, rather than caving to the pressure.
For now, doctors are (still) prescribing far too many antibiotics.
The patient and antibiotic resistance
Another review, this time on patient perceptions of antibiotic resistance, compiled studies from Europe, Asia, and North America. If you are familiar with this topic or sniffed out the theme, you can predict the next part. While most patients had heard of antibiotic resistance (some even knew strategies to reduce it), they “largely attributed its development to the actions of others” and thought changes in physician behavior were the key to its reduction.
There is a culture of “not my problem.” But I think with that mindset, soon enough it will be everyone’s problem.
Humans are not inherently altruistic, at least not to a significant degree (except maybe to their kin – Richard Dawkins has some profound thoughts on this, check out chapter 6 of The Selfish Gene). It is, therefore, unrealistic to expect a patient to “suffer through an illness” sans treatment simply for the ideological goal of preventing global resistance, when (in their mind) antibiotics would cure them. It may work better to educate the patient regarding the risk of becoming a long-term carrier of resistant bugs and the risk to themselves of more severe infection with these bugs.
Despite this talk of physician- and patient-specific misconceptions and failures regarding antibiotic use, much of the problem arises outside of this doctor-patient contract. At home, patients are their own doctors and the opportunity for education and intervention is lost. This is where much of the consumer-created damage leading to antibiotic resistance occurs. Patients feel better and stop their antibiotic course halfway through. Patients suffering from a simple common cold prescribe themselves their sister-in-law’s expired Z-Pak. Patients take expired drugs or reduced doses.
There is a significant knowledge barrier between patients and the responsible use of antibiotics. And that barrier is larger in some places than others.
The world and antibiotic resistance
We are only as strong as our weakest link. It’s important to study public knowledge of antibiotic resistance in developed countries with healthcare systems, but the ultimate multi-resistant bug could come from anywhere in the world.
In November, the World Health Organization (WHO) published findings of a large global survey assessing the understanding of antibiotic resistance among subsets of the world population. Twelve countries were surveyed, chosen to encompass varying income levels, populations, and preexisting knowledge of antibiotic resistance (Nigeria, South Africa, Barbados, Mexico, India, Indonesia, Egypt, Sudan, Russian Federation, Serbia, China and Vietnam). Surveys were conducted online or face-to-face and nearly 10,000 (n=9,772) response sets were recorded. The key findings, as listed in the report, were:
     1.  65% of respondents had taken antibiotics within the last six months
     2.  Antibiotic use was higher in poorer countries
     3.  72% acknowledge that many infections are becoming resistant to antibiotics
     4.  25% think it’s okay to use antibiotics from a friend or family member
     5.  43% think it’s okay to re-use antibiotics that helped them in the past
     6.  32% say they should stop taking antibiotics when they feel better, rather than finish the course (especially in Sudan, Egypt, and China)
     7.  64% reported that cold and flu should be treated with antibiotics
     8.  57% think there is nothing people like them can do to help prevent resistance
     9.  76% believe “resistance” means that their body is becoming resistant to the drug
Obviously there is much work to be done! As in the other studies quoted above, most people can identify that antibiotic resistance is a problem and are aware of some basic prevention (e.g. hand-washing). However, there’s not much understanding around the world of any more than that: what resistance actually is, how it develops, and what can be done to prevent it. Echoing many of the studies coming before, this report makes some general recommendations to develop a “better understanding of why antibiotics are being used without having been prescribed” and to increase public education about “which conditions can be treated with antibiotics, why we should limit intake of antibiotics, and the importance of finishing the prescribed course.”

A significant limitation of this report was the fact that only two countries per WHO region were included, therefore it was not a supremely representative sample of the individual regions or the global population. Closed-ended questions were also used in the survey, which allowed for only a limited knowledge of the patient’s actual understanding. Finally, as with all survey-based studies, there is a risk of response bias (potentially social desirability bias).
The official conclusions
Through the implementation of evidence-based approaches to public education and proper antibiotic use, there is significant potential for practice improvement. According to the WHO report, physicians should be frugal with antibiotic prescription, become familiar with resistance patterns, and take care to prescribe only drugs indicated for the suspected bug.
Patients, in addition to employing proper hygiene and infection-prevention measures, should follow antibiotic dosing and course instructions precisely, never sharing antibiotics or stopping a course early (even if they are feeling better).
From a systems perspective, improvements in resistance tracking and research into new diagnostic tools and medications are sorely needed.
Is that all?
The next steps
I am finding my fourth year of medical school to be an interesting time. About to begin my training in my chosen specialty within medicine – with all of the required (and graded) courses behind me – I am struggling to strike a balance between the diligent, hard-working version of myself that got me through the difficult years of medical school and the happy-go-lucky version of myself that doesn’t want to be on campus unless absolutely necessary. It’s the medical school version of the “senioritis” people describe feeling in their last semester of high school or college.
However, it was in one of my recent fits of diligence (while reviewing the literature for an unrelated project) that I came across the study I kicked off this post with. It would have been easy to stop there (especially with my self-motivation at an all-time low), but something about the topic really got under my skin. So, doctors should prescribe fewer antibiotics and patients should use them as prescribed. Great. But…um…what is actually being done to create these changes? Anything? It doesn’t seem there’s been much progress. And I’m going to be a doctor soon, so can we get our asses in gear?
Behavioral modification
Lucky for me, while working on revisions for this piece, the latest issue of the Journal of the American Medical Association (JAMA) landed in my inbox. In it, a report by researchers from Harvard and UCLA details the findings of a study comparing various behavioral modification techniques for inappropriate antibiotic prescribing by primary care physicians. Physicians who wrote an prescription for antibiotics to treat an acute respiratory infections encountered one of three prompts while updating their patient’s electronic medical record:
     1.  Suggested alternatives: upon signing the prescription, a “pop-up” appeared within the electronic medical record with a statement along the lines of, “antibiotics are not generally recommended for this condition” and alternative treatment strategies were suggested.
     2.  Accountable justification: upon signing the prescription, the physician would be required to enter a free-text justification for writing the prescription, which would be recorded in the patient’s chart.
     3.  Peer comparison (my money is on this one; most doctors are, after all, competitive creatures at their core): physicians received an email message informing them that they were a “top performer” (in the top decile of appropriate antibiotic use) or “not a top performer” (if they found themselves in the bottom decile).
Forty-seven primary care practices in Boston and Los Angeles comprising 248 physicians were randomized to encounter various combinations of these interventions and then their prescription patterns were followed for 18 months. The first interesting finding from this study was that the negative controls (those encountering none of the interventions) decreased their antibiotic use by 11%. As the authors point out, this is likely due to the Hawthorne effect: the tendency to change behaviors while participating in a study just due to the fact that one knows their actions are being scrutinized. I bring this up mostly to illustrate the importance of being judicious when reading scientific evidence, even the most well-controlled studies in the highest-impact journals. Most SBM readers will be aware of this, but extraneous effects such as these are rampant in scientific research and the implications must be considered. In this case, the Hawthorne effect is not necessarily a limitation, but it may have dampened the effect size of the interventions.
These were the results, in terms of rate of inappropriate antibiotic prescription:
     1.  Suggested alternatives: 22.1% pre-intervention to 6.1% post-intervention (16% drop)
     2.  Accountable justification: 23.2% to 5.2 % (18% drop)
     3.  Peer comparison: 19.9% to 3.7% (16.2% drop)
Only the drops observed in strategies #2 and #3 were found to be statistically significant compared to the amount that the control group rates reduced. No combination of techniques was better or worse than any single technique. Importantly, an increase in complications or return visits stemming from reduced antibiotic prescription for acute respiratory infection was not observed – reducing antibiotic prescriptions did not seem to result in worse outcomes.
As Jeffrey Gerber alludes to in his editorial discussion of this study in the same issue of JAMA, these interventions have two major strengths. First, while antibiotic stewardship programs are now common in hospitals, antibiotic usage trends are not currently monitored in the outpatient setting. This study did just that. The methods employed by the researchers could serve as a model for future tracking systems in the outpatient setting. Second, and more immediately salient, the interventions are simple: they do not create significant waste (time, money, or resources) within the system and could be easily implemented across all electronic medical record systems.
Of course, the study was limited in a couple areas: namely that the sample sizes were relatively low and the physician practices received monetary compensation for their participation, which Dr. Gerber believes may limit the generalizability of the results.
One more interesting finding of the study: the only intervention that was not found to be statistically significant (#1, suggested alternatives) was also the only one that did not involve a social component. Just food for thought.
This has not been an exhaustive account of the literature on this topic, just some recent, relevant data to pique your interest and hopefully light a fire under those of you in a position to incite change. As I write this final paragraph, I am on a flight to my final residency interview of what has been a grueling interview season (at one point, I had six interviews in seven days in cities scattered across the country). Thinking about transitioning from this to the next step in my training, I also think about what the landscape of antibiotic usage and resistance will look like in my practice in the decades to come. I wanted to become a doctor to help people, and at the beginning of my first year of medical school, I pledged an oath to “Do No Harm.” But we are doing harm. Giving a patient an antibiotic for a viral sinus infection in order to pacify them today is putting the patient sitting across from me in my office 20 years from now in harm’s way. What am I going to give them when we have used up all of our antibiotic options or when they have a bug that is resistant to even our biggest guns? We know that change is needed and, increasingly, we are developing the tools to enact that change. So what are we waiting for?

If you feel better, should you stop taking your antibiotics?
A recent paper suggests that patients would be better off stopping antibiotics when they feel better, instead of completing the entire amount prescribed. Could this approach reduce antibiotic overuse and the risk of widespread resistance?
Scott Gavura on September 21, 2017
Link

A recent paper in the BMJ argues that there is little scientific evidence to suggest that completing a prescribed course of antibiotics has any impact on antibiotic resistance, and that health professionals should stop giving this message. Martin Llewelyn and colleagues state:
Public communication about antibiotics often emphasises that patients who fail to complete prescribed antibiotic courses put themselves and others at risk of antibiotic resistance. For example, in materials supporting Antibiotic Awareness Week 2016 WHO advised patients to “always complete the full prescription, even if you feel better, because stopping treatment early promotes the growth of drug-resistant bacteria.” Similar advice appears in national campaigns in Australia, Canada, the United States, and Europe. And in the United Kingdom it is included as fact in the curriculum for secondary school children. However, the idea that stopping antibiotic treatment early encourages antibiotic resistance is not supported by evidence, while taking antibiotics for longer than necessary increases the risk of resistance.
This is a narrative review and not a systematic review of the literature. It is intended to promote a particular perspective, and the authors make the following arguments:
    • Concerns that too little antibiotics could lead to the survival or “selection” of resistant bacteria can be traced back to the discovery of antibiotics. However, there is a lack of evidence to show that failing to complete a course of antibiotics leads to resistance in that bacteria.
    • Antibiotic resistance that develops spontaneously during treatment, and may be selected for is called “target selection”. It can occur with infections like malaria, HIV, tuberculosis and gonorrhoea. Appropriate dosing and often combinations of antibiotics are necessary when treating these infections to ensure resistance does not develop. However, most of the bacterial species that pose public health threats due to widespread resistance did not develop resistance this way.
    • Taking antibiotics for any reason means that antibiotic-sensitive species and strains will be replaced by resistant species already present. The longer the treatment, they argue, the greater the antibiotic exposure, and the greater likelihood of the replacement of antibiotic-sensitive bacteria with residual, resistant bacteria.
    • Antibiotics are typically prescribed for set durations (e.g., 7 days of amoxicillin). There is a lack of evidence to show that the currently accepted durations are the minimum required. Historically, courses of antibiotics were based on fears of undertreatment, and less about overuse.
    • The idea that there should be standard course of antibiotics hasn’t been shown to be valid, owing to different patient and disease factors. Stopping antibiotics based on factors like fever resolution may be superior – and need to be tested.
    • While there have been substantive efforts to reduce the initiation of antibiotics (e.g., Choosing Wisely), little has been done to reduce overuse once prescribed.
    • The “complete your antibiotics” message has persisted and while it is simple, it is not supported by evidence.
    • Research is needed to determine the most appropriate messages, such as “stop when you feel better”.
The media uptake to this opinion paper was quite remarkable – there were dozens of stories, suggesting, “Why you may not need all those days of antibiotics“, “Some Doctors Now Say to Stop Antibiotics When You Feel Better“, and “The Common Wisdom on Antibiotics Is Wrong“. But is it really wrong, and should prescribing and use change?
From one non-evidence-based recommendation, to another?
Let’s look at the areas of agreement, first. The standard advice to “complete your antibiotics to prevent resistance” is not based on scientific evidence. The idea that excessive antibiotics can be harmful is not a new idea. There is absolutely a downside to antibiotics – they can cause adverse effects, sometimes severe, and minimizing the duration of therapy can reduce the risk of harms. Where shorter courses of therapy have been shown to be effective, they can (and should) be recommended and used.
But should patients simply stop antibiotics when they “feel better”? While the authors of the paper noted that this approach also required research, it’s the main message that almost all of the media coverage focused on. And it’s a potentially dangerous message to amplify, as there is no convincing evidence that this approach is any better than the conventional one. For example, what does “feel better” mean? To one person, it might mean a fever breaking. To another, it might mean complete resolution of symptoms and a return to normal function. And in some cases, what might look like signs of infection can persist long after antibiotics can be appropriately discontinued. And this type of rule would be even more difficult to apply in young children, who may not be able to express their feelings of wellness. We need evidence for any stopping rule for each type of infection and antibiotic used. And until we have evidence to suggest that arbitrary and potentially subjective stopping rules are better for patients, we could be making matters worse.
Another consideration: What would become of unfinished prescriptions of antibiotics? While some people will return unused and expired prescriptions to pharmacies (most pharmacies will accept and dispose of them safely), others may keep the remainder of a prescription for future use, or, even worse, possible use by others. A “stop when you feel better” direction could lead to more inappropriate use, not less.
More evidence on duration of treatment is needed
        ◦ Given the frequency with which we use antibiotics, and the justified concerns about growing rates of antibiotic resistance, we need more evidence to inform decision-making, and we need better adherence to the evidence that actually exists. If one in three antibiotic prescriptions are unnecessary, then let’s focus on stopping them before we start. Where there is evidence that shorter courses of antibiotics are as effective as longer ones, then we need to ensure that physicians are prescribing according to best practices. And where we don’t actually know the optimal duration of therapy, then we need research to answer those questions. Before we recommend a “stop when you feel better” approach to antibiotics, we need evidence that we’re not doing more harm than good.

I’ve been prescribed an antibiotic. Should I take a probiotic?
Scott Gavura on July 18, 2013
Link
We are not one organism, we are many organisms. And when we disturb the relationship with our symbiotic partners, we can suffer unpleasant and sometimes life-threatening consequences. One of the most fascinating areas of medical research is the study of how our bodies interact with the the various organisms that we carry around, on us and in us. A focus is the gastrointestinal tract, particularly how the composition and function of those organisms contribute to what we think of as “normal” function, and how they can affect our risk for obesity and disease. My favorite analogy is from SBM’s own Mark Crislip who likened it to a “metaphorical rainforest” giving a vivid mental image of the of the number of species (thousands) in our guts, and the complexity of that ecology. If the gastrointestinal tract is a rainforest, then antibiotics are the metaphorical clear cutters, wiping out some of the normal bacteria, and creating the conditions where unwanted bacteria can grow.
Antibiotics are among the most useful (if not the most useful) classes of drugs in widespread use today. They’re also among the most widely prescribed, and both antibiotic overuse and their addition to animal feed present real dangers to their ongoing effectiveness. Their popularity stems in part from their effectiveness, but also from the perception that they are safe. And, in general, a course of most antibiotics is usually well tolerated. Among the side effects, diarrhea is common (with an incidence of 5% to 39%). It’s due in part to the antibiotic killing off our normal “good” bacteria, which can significantly change the most prevalent species. In some cases, “bad” bacteria can surge as a result. Clostridium difficile infection is pretty much the worst gastrointestinal consequence of antibiotic therapy. It isn’t just a cause of antibiotic-induced diarrhea, “C. diff” infections are virulent and vicious, spreading easily, especially among hospitalized patients, causing widespread misery and even killing.
Probiotics are some of the more interesting of the “complementary and alternative” products out there, because they’re among the more plausible. Probiotics are bacteria and yeast that are administered to replace the bacteria killed by other means, with the goal of reducing the risk of diarrhea and the chance of serious infections from pathogens like C. diff. But plausible doesn’t mean valid – remember the idea that antioxidant vitamins would be beneficial? Or preventing arrhythmias would reduce mortality? Science has repeatedly shown the hazards of making assumptions of benefit in the absence of clear evidence. Given the complexity of the body’s ecosystem, it’s reasonable to be skeptical of the concept of probiotics. Again, Crislip’s analogy of probiotics to be akin to “planting corn in a rainforest” is one that I use a lot. Plausibility is one thing, a demonstrable effect is another. For that, we need to see the evidence.
Proponents of probiotics liken their effect to some sort of bacterial and mycological panacea, providing benefits that range from nonspecific (“wellness”) to promising (prevention of respiratory tract infections) to the somewhat more established uses, like the prevention of antibiotic-associated diarrhea (AAD). To keep the topic focused, I’ll consider a typical use: starting a probiotic when you start an antibiotic, with the goal of preventing diarrhea. For the sake of simplicity and to make this relevant, let’s assume you’re not hospitalized, nor do you have any underlying gastrointestinal disease, like Crohn’s. Let’s assume you’ve been prescribed oral antibiotics for an infection that’s usually treated at home, such as a urinary tract infections, a skin or soft tissue infections, or a lung or other respiratory tract infection. Is the use of a probiotic a good investment for you?
The evidence
Reviewing trials with probiotics is complicated by an array of studies, endpoints, prior antibiotics, patient populations, and the quality of the studies. The result is a number of endpoints that a few authors have attempted to systematically evaluate with meta-analyses. Admittedly a meta-analysis is not the ideal tool under these circumstances, but it does give a sense of the overall evidence base.
Hempel’s meta-analysis, published in 2012, is the most recent review. It looked at 82 studies and combined the results of 63 RCTs, giving a sample set of almost 12,000 patients taking antibiotics, comparing probiotics to placebo or no therapy. Probiotic species included Lactobacillus, Bifidobacterium, and the yeast Saccharomyces. The overall findings were impressive. Those taking probiotics had a 42 percent lower risk antibiotic-associated diarrhea. Based on this analysis, 13 people who would otherwise experience AAD need to take probiotics to prevent one. So it’s not a panacea, but as interventions go, this is a good number needed to treat (NNT). Subgroup analysis, including an analysis of the highest-quality trials, didn’t change the effect size significantly – the effect was also consistent in both adults and kids, though it was non-significant in seniors. Of the studies that collected adverse event information (23) none were noted, which is reassuring but makes me skeptical that this information was collected accurately. It should be noted that most trials were sponsored by manufacturers, introducing an additional potential bias in the individual studies that would be reflected in these results.
Hempel’s review is not the first meta-analysis of probiotics for AAD. Its conclusions are broadly in line with Sazawal, D’Souza, Van Niel, Szajewska and McFarland. There is also the 2011 Cochrane review by Johnston that looked specifically at probiotics to prevent AAD in children, selecting 16 trials of over 3400 patients. Despite the numerous data quality issues, it concluded that there is likely a beneficial effect from probiotics, but the overall quality of the evidence for the primary endpoint (incidence of diarrhea) was low. It calculated an NNT of 7, even more impressive than Hempel’s review. Again, no serious side effects were associated with probiotics. The review called for more studies to better establish the appropriate probiotic species, dose, duration and side effect profile.
The other recent meta-analysis is from Videlock in 2012, pulling together 34 studies with over 4000 patients. Species included Lactobacillus, Enterococcus, Streptococcus, and the yeast Saccharomyces. It estimated the overall relative risk of diarrhea when taking probiotics to be 0.53 (95% CI 0.44-0.63), suggesting an NNT of 8 (95% CI 7-11). Both of these estimates are difficult to interpret given the diversity of trials and endpoints in the included studies. Problems in the analysis included the suggestion that the results are positively biased because of negative trial bias. Side effects were not notable. Overall, positive findings but the limitations in the data suggest that we need to accept these estimates of efficacy with some caution.
When probiotics are given specifically to prevent C. diff infections (versus just diarrhea) the Hempel analysis suggests that there is expected to be a net benefit. A 2013 Cochrane review by Goldenberg suggets that probiotics can reduce the risk of infection by 64%. There are also reviews by Ritchie and Bradley that suggest a net benefit. Again, the merits really depend on the likelihood of a C. diff infection, which is relatively unlikely in the otherwise healthy, unhospitalized person.
Guidelines, position statements, and regulators
The Australian not-for-profit NPS Medwise says the following about probiotics and antibiotics:
There is not enough evidence to determine the following about probiotics:
    • The minimum dose that is effective for preventing antibiotic-associated diarrhoea
    • How well they work for different age groups
    • Whether they prevent diarrhoea caused by Clostridium difficile (which can lead to more serious complications)
    • How different probiotics compare in effectiveness and safety
    • The best length of time to take them for
    • Whether the effect of a probiotic differs depending on the type of antibiotic taken or for how long the antibiotic is taken.
The Canadian Pediatric Society’s guideline has a nice compilation of the data, and suggests the following in its 2012 guideline:
Keeping in mind that the effect of probiotics is both strain- and disease-specific, physicians should consider recommending probiotics to prevent antibiotic-associated diarrhea.
The European Food Safety Authority has reviewed many probiotic products for treatment claims made by manufacturers. A review of any of their evaluations illustrates the problems with the individual trials that make up the probiotic evidence base. Reviews point out methodological weaknesses that preclude conclusions about cause and effect. They also criticize manufacturers for not demonstrating that the product they are selling is identical to the product studied in their clinical trials, which is a necessity if manufacturers want to infer efficacy from these studies.
Risks
Given the diversity of products studied, patient populations and the underlying quality of the data, it’s difficult to make a single statement about the potential harms. However, it is reassuring that there is little evidence in the literature to suggest that probiotics are harmful. The exception seems to be those with weakened or compromised immune systems, where serious cases of infection have been observed. And once you have antibiotic-associated diarrhea, the case that can be made for probiotics is less clear.
The weak regulatory structure for probiotics makes quality control more questionable that you would find for prescription drugs. The degree to which consumers can expect a reliable product is not clear. Analyses have shown that labels may be inaccurate with respect to types and quantities of species included. Variations from the label have been observed in other studies, too. This may introduce the risk of an infection from an undesirable species.
Discussion
On balance, probiotics have a good safety record and clinical trials of moderate quality suggest that they may reduce the risks of antibiotic-induced diarrhea. Whether or not probiotics should be recommended routinely is still a matter of debate. There is still a lack of information about the most effective species, the optimal dose, and the timing of product. While there remains contradictory data, there seems to be enough evidence to suggest that there is a net beneficial effect. No standard doses exist, nor does the optimal duration of treatment, though most studies evaluated supplementation during the duration of the antibiotic therapy.
I haven’t covered specific brands of probiotics at all in this post. (Some are discussed in Dr. Crislip’s post.) Frustratingly there is a lack of good data to help distinguish which brands and species of probiotics are demonstrably and reliably effective, or if one is superior to another. There is no head-to-head data to compare formulations. There are many claims that the multi-species formulas are superior, but this hasn’t been clearly shown to be the case. Yogurt is often suggested as a source of healthy bacteria. However, the probiotics used to ferment milk (L. bulgaricus and S. thermophilus) are not believed to survive the trip through the gastrointestinal tract. Acid-resistant probiotics (e.g., L. acidophilus) added to yogurt can make the product an effective probiotic source. Depending on where you live you may also see yogurt-like fermented dairy products such as DanActive and Bio-K Plus in your grocery store, created to provide a source of probiotics.
Costs vary dramatically. A Canadian review noted the 14 day costs of probiotics with the best evidence for C. diff prevention ranges from $13 (for Bio-K+) to $112 (for VSL#3).
Importantly and probably most frustratingly, the lowered safety and quality bar in place for “supplements” regulated (I use that term loosely) under the DSHEA makes it difficult to identify a preferred product. It’s not clear that what’s on the label is actually on the bottle, especially when it comes to live bacterial cultures. Even industry insiders note the problems with the manufacturing quality of these products.
Conclusion
There’s reasonably good evidence that probiotics, when taken with antibiotics, will reduce the risk of antibiotic-associated diarrhea. There is still much to be learned about how these products can be used most effectively, which means it’s unlikely we will see routine use recommended for some time. However, the reassuring lack of side effects, and potential to reduce potentially serious complications of antibiotic treatment, suggests that probiotics may become a valuable addition to antibiotic therapy.

Overprescribing Antibiotics
Steven Novella on May 4, 2016
Link


Recently I had a cutaneous abscess which was treated (quite painfully) with incision and drainage. My doctor told me that antibiotics were not strictly necessary, but I could have them if I wanted. The idea of any treatment that could resolve the abscess more quickly was appealing, but I did not want to contribute to the unnecessary use of antibiotics so I declined.
The use of antibiotics in cutaneous abscess is not straightforward, as there are indications – signs of systemic infection, failure to resolve quickly with just I&D, or in immunocompromised patients. Antibiotics may also reduce the risk of recurrence. These are, after all, bacterial infections.
If I were not very familiar with the issue of antibiotic overuse and emerging resistance I probably would have caved and accepted the antibiotics, and I suspect most patients do. Many patients probably request antibiotics or at least ask about them. I declined, and everything turned out fine. 
The numbers
It has been known for a long time that antibiotics are prescribed more than they should, including to patients who likely have a viral illness which does not respond to antibiotics. Further, this contributes to antibiotic resistance, which is a serious problem. Some experts are warning that we are heading toward a post-antibiotic era.
A recently published study in JAMA, “Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011,” is the largest survey of antibiotic use in the ambulatory (outpatient) setting to date. They estimated the number of antibiotic prescriptions that should be written per 1,000 people in the population and compared this to the number of antibiotic prescriptions that were written per 1,000 people. They found:
In the United States in 2010-2011, there was an estimated annual antibiotic prescription rate per 1000 population of 506, but only an estimated 353 antibiotic prescriptions were likely appropriate, supporting the need for establishing a goal for outpatient antibiotic stewardship.
That means that 153 out of 506 antibiotic prescriptions, or 30%, were likely unnecessary.
Sinusitis was the most common diagnosis treated with antibiotics in the outpatient setting, followed by otitis media and pharyngitis. Upper respiratory infections, also including colds and flus, were the most common type of infection treated with antibiotics, but antibiotic use was only appropriate in about half of cases.
Upper respiratory infections are usually caused by viruses, which do not respond to antibiotics, which are only active against bacteria. However, sometimes such infections can be caused by bacteria. This is often a bacterial superinfection – fighting off the viral illness leaves the tissue more vulnerable, allowing for bacteria to establish a second infection.
Why are antibiotics overprescribed?
Human behavior is always complex and it is difficult to tease out various factors. The question of why doctors are prescribing antibiotics when they shouldn’t is no exception.
When doctors are asked their most common response is that they are pressured by patients and parents of sick children to prescribe them. Other factors have also been suggested, however.
Patient education can be time consuming, and writing a prescription may be the pathway of least resistance for a busy practitioner. We also live in a time of waning trust in professionals. The old paternalistic model is dead. Now everyone feels it is appropriate to question experts, especially when it comes to their own health. This is reasonable to an extent, but it makes it more difficult for a physician to refuse a request by a patient who feels that they “know their own body” and what they need.
Even experienced doctors may also doubt themselves. We also live in an era of defensive medicine, in which a doctor may not wish to risk a complication, especially if they are going against the strong desires of their patient. This situation feels like a lawsuit waiting to happen.
By contrast, the risk of antibiotic resistance is diffuse and distant. Human psychology favors avoiding the immediate direct risk for the delayed indirect risk with diffuse responsibility.
It also should be recognized that it takes much more expertise to feel comfortable not doing something than it does to do something. Knowing when a treatment or diagnostic study is not necessary requires more knowledge and experience then knowing how to use the treatment or study. For this reason, increasing expertise tends to be associated with fewer interventions and more efficient practices.
I point this out because it is important to recognize that reducing inappropriate antibiotic prescriptions requires more than basic competence. It requires confident expertise and adequate support.
Related to this is the difference between analytical and intuitive thinking styles in medical practice. An intuitive style might be: this patient looks really sick and in my experience they are going to end up needing antibiotic, so I will give them a prescription now. An analytical approach would be: only a small percentage of patients with acute sinusitis statistically will require antibiotics, so regardless of my personal feelings and experience, I will practice according to published evidence-based guidelines.
Most physicians use a combination of analytical and intuitive thinking styles in practice, but it can be difficult for physicians, and especially so for patients, to do not what feels right, but what is dictated by cold hard numbers.
Where do we go from here?
Clearly overprescribing antibiotics is still a huge problem and needs to be addressed more aggressively. Physician education has been the primary mechanism of addressing this problem, and will likely remain the cornerstone of such efforts.
Physician education, at least as currently practiced, is apparently not enough, however. Physicians need to be educated not only about the evidence-based guideline of when and when not to prescribe antibiotics, but also how to feel confident in their decisions, and how to deal with patients who ask about, request, or even demand antibiotics.
Patient education is also critical. Public education about the problems of antibiotic overuse is underway, but given the recent data probably needs to increase.
Individual prescribers could also benefit from a support structure, in their practice or institution. This can include reviews of prescribing practices, educational material for patients, and feedback to improve prescribing practices.
We will never reduce inappropriate antibiotic prescriptions to zero. Medicine is too complicated, and there are many gray zones requiring judgement calls. Also, medical best practices often include a little buffer – you need to have a certain negative rate to make sure you are capturing all the positives. So, you may need to prescribe antibiotics to some patients who may not have needed them to make sure everyone who does need antibiotics gets them.
But clearly 30% is too high. Something like 5-10% is probably a realistic and appropriate goal.
The needs of the patient versus the needs of society
The final tricky part about this issue is that of the needs of the patient vs the needs of society. Physicians are trained, and our ethics demand, that we think first of the patient in front of us. We are their health advocate. We consider the risks vs benefits to that patient of any intervention.
In the case of antibiotics, however, we are being forced to consider the risks to society as a whole, which does also include the risk of future patients. A physician, therefore, might feel that the risk of unnecessary antibiotic use to their patient is small, while the risk of delayed treatment, if it turns out to be a bacterial infection, could be quite high. This calculation favors prescribing antibiotics liberally.
We are now being forced to consider, however, the long term effects to society in terms of antibiotic resistance. This means we have to perhaps accept a small increase in risk for the patient in front of us (at least it may feel this way, even if it is not strictly true) to avoid a very bad long term outcome.
To optimize success, I think it’s necessary for the physician and the patient to be partners. They both have to be on the same page, understanding the importance of following strict guidelines when it comes to antibiotic use. This is a societal problem, and fixing it has to be a societal effort.

New Tools Against Antibiotic Resistance
Antibiotic resistance is a serious problem that may lead to a post-antibiotic era. However, there are potential solutions that deserve research priority.
Steven Novella on November 22, 2017
Link

Scientists are often placed in the role of Cassandra – because of their expertise and knowledge they may see potential serious problems on the horizon, but may also find it challenging to convince the general public. Sometimes they are working uphill against vested interests. Often scientists will warn against possible problems that they then work to prevent, and when successful it seems like their warnings were unwarranted. Or they may simply be calling for preparation for a possible event, like an epidemic, that still probably won’t occur but you should be prepared ahead of time in case it does.
Also, as science communicators we don’t want to overhype potential problems. It can be a delicate balance. With all that in mind, it is probably difficult to overstate the potential risk of antibiotic resistance. This is one of those looming issues that I genuinely worry about, but gets too little attention, if anything, in the media. It is also a manageable problem – there are things we can do to mitigate antibiotic resistance, if we take the issue seriously enough.
The World Health Organization summarizes the problem in stark terms:
Antibiotic resistance is rising to dangerously high levels in all parts of the world. New resistance mechanisms are emerging and spreading globally, threatening our ability to treat common infectious diseases. A growing list of infections – such as pneumonia, tuberculosis, blood poisoning, gonorrhoea, and foodborne diseases – are becoming harder, and sometimes impossible, to treat as antibiotics become less effective.
Where antibiotics can be bought for human or animal use without a prescription, the emergence and spread of resistance is made worse. Similarly, in countries without standard treatment guidelines, antibiotics are often over-prescribed by health workers and veterinarians and over-used by the public.
Without urgent action, we are heading for a post-antibiotic era, in which common infections and minor injuries can once again kill.
I don’t think they are overstating the problem.
The cause of antibiotic resistance is fairly easy to understand. Bacteria reproduce very quickly in large numbers. When someone takes an antibiotic, that provides a selective pressure towards resistance. If any individual bacterium has a gene which provides resistance to the mechanism of that antibiotic it will tend to survive the treatment and then reproduce a new generation of resistant bacteria.
Bacteria also have the ability to swap genes, so that genes are not just passed from parent to offspring, but horizontally to other bacteria in a process called conjugation. Bacteria may contain plasmids, which are loops of DNA. Those plasmids can be copied from one bacterium to another. A plasmid may contain one or even multiple genes that confer resistance – and so in one conjugation event a bacterium may receive resistance to multiple antibiotics.
The existence of bacterial plasmids with multiple resistant genes is a problem, because if they are exposed to one of the antibiotics to which they are resistant, that will favor the proliferation of the bacteria with plasmids that confer multiple resistance.
There is one potential bright spot in all this. Genes that confer antibiotic resistance often come at a price. They may make it more difficult for the bacteria to reproduce, or force them to expend more energy. That is why they don’t have the feature in the first place. The selective pressure of antibiotics is necessary to favor the more costly feature. The hope is that in the absence of selective pressure from antibiotic, the resistant features will tend to fade away.
However, a new study suggests that this may not always be the case. Researchers looked at costly antibiotic resistance features in various strains of E. coli. They followed them for over a month and found that strains were able to maintain even costly antibiotic resistance in the absence of antibiotics if they contained plasmids. The key is the conjugation rate – how frequently do bacteria exchange plasmids? The research found that, at least in these strains, the rate was high enough to maintain antibiotic resistance even in the absence of antibiotics.
This research suggests that limiting antibiotic use may not be enough to reverse existing antibiotic resistance. Of course, limiting use is essential to slowing the development and spread of resistance. This is the primary mechanism by which the medical community is trying to combat resistance, but even here we are not doing enough. Antibiotics are still massively overprescribed. Some countries allow for over-the-counter antibiotic use, and it is common for the public to take them for viral illnesses. Antibiotics are also heavily used in the farming industry.
Even if we achieved our goal to properly limit antibiotic use, and educated practitioners to optimally prescribe antibiotics, the current research suggests this may not be enough to reverse some types of resistance. However, the same research suggests there may be more active interventions that will.
There are potential drugs that can limit conjugation or induce bacteria to lose their plasmids. For example, a 2015 study identified features of synthetic fatty acids that were effective conjugation inhibitors. This would limit the horizontal spread of plasmids among bacteria, and therefore limit the spread of resistance.
Another approach is to prevent plasmid replication. Researchers are looking at ways to exploit the existing compatibility system in bacteria toward this end. Since bacteria are so promiscuous with their genes, they need mechanisms to know when plasmids are incompatible with their other DNA. You could essentially trick a bacterium into thinking its plasmid is incompatible, and therefore when the bacteria reproduces it will not replicate the plasmid. The plasmid will therefore be lost to the next generation. These treatments would not just limit the spread of resistance, but cause a population of bacteria to lose their resistance.
What all of this research suggests is that we should not only be researching novel antibiotic mechanisms, we should be investing in research into drugs that inhibit plasmid conjugation and induce plasmid loss. These treatments can reduce the spread of resistance, and even potentially reverse resistance. Such treatments could be given alongside antibiotic regimens, or used in farming or similar contexts to limit the development of resistance.
My hope is that this type of research will eventually lead to a situation in which all those scientists and science-communicators who warned about the coming post-antibiotic era will look like Cassandras. Rather than getting the credit for identifying and then preventing a major problem, people will either forget them or falsely think the warnings were overhyped to begin with. But I will take that fate if it means avoiding a post-antibiotic era.

Phage Therapy and Antibiotic Resistance
We are potentially seeing the rebirth of phage therapy for bacterial infections, but we can’t skip the science.
Steven Novella on February 24, 2021
Link

Imagine if we had a self-replicating programmable smart bomb that could target specific pathogenic bacteria and kill them, while being entirely safe for the host. It turns out, such a thing exists – they are viruses that evolved to kill bacteria, and they are called bacteriophages. Bacteriophages were first discovered in 1896, and they were an early rival to antibiotics for the treatment of bacterial infections. In the former Soviet Union, Poland, and other Eastern countries there was extensive research into so-called “phage therapy” but in the West antibiotics won out and phage therapy never caught on.
But now phage therapy is gaining a second look, because a century later we have produced a dangerous level of antibiotic resistance. To some extent we may be coming to the end of the antibiotic era, as more and more multi-resistant strains of pathogenic bacteria emerge. This is a serious health problem that requires a multi-pronged solution. First, we need to minimize the emergence of resistance through best practices – not overusing antibiotics, using narrow rather than broad-spectrum antibiotics when able, and optimally completing antibiotic courses.
In addition we need to develop new classes of antibiotics that work through novel mechanisms. There may come a time when we need to retire classes of antibiotics, to allow for resistance to wane while we depend on other classes. Perhaps we can come to a sustainable long-term cycle.
Another possible solution is to take an entirely different approach to treating bacterial infections, and that’s where phage therapy comes in. The history of phage therapy is interesting, and there are a few lessons in there. Part of the reason phage therapy did not gain acceptance in the West is because the research was flawed. One early proponent, d’Herelle, did not use control groups in his clinical trials. He gave all the subjects phage therapy. This is a critical point for SBM – we often point out that, if the remarkable claims being made for a dubious treatment were in fact true, the proponents would be doing a disservice to humanity by not doing proper research to adequately prove it. The history of phage therapy, to some extent, bears out this concern.
But also it seems that the technology of the time was perhaps not quite ready for phage therapy. There were problems with purification, and contaminants could cause side effects at bad as the infection itself. Like antibiotics, some phages are lytic (they kill the bacteria) and some are not. Some early research unknowingly did not use lytic phages. It was also difficult to maintain stable lines of therapeutic phages.
The time, however, may be ripe for phage therapy. The technology to develop, quality control, and mass-produce biologics has evolved considerably, and the old problems that plagued phage therapy are entirely solvable. I liken this to the competition between electric and internal combustion engines. The gasoline engine won out a century ago, partly because of quirky contingency, but also partly because battery technology was very primitive. But now, with Li-Ion batteries, the time for electric vehicles is here. The same may be true for phage therapy.
In fact, with advances in genetic engineering, using a therapy that is potentially genetically programmable may allow for the rapid development of specific phages for specific infections. This is similar to the emergence of mRNA vaccines – once we develop the mRNA vaccine platform, new vaccines can be designed in a matter of days, because we are getting really good at engineering and making mRNA.
Where does the research stand? Some of the basic research is having to be repeated and updated, including preclinical and animal research. There are also some good clinical studies which support the safety and efficacy of phage therapy for specific infections. For example, a review of phage therapy for joint and bone infections concluded:
Together, the reports identified by this review suggest that appropriately purified phages represent a safe and highly efficacious treatment option for complex and intractable bone and joint infections.
Another review of phage therapy for superficial infections concluded:
This review strongly suggests that the use of purified phage to treat superficial bacterial infections can be highly effective and, by various routes of administration, is safe and without adverse effects.
A recent study also shows that using phage therapy in combination with antibiotics can be highly effective. The key is this:
We characterized two bacteriophages, ΦFG02 and ΦCO01, against clinical isolates of Acinetobacter baumannii and established that the bacterial capsule is the receptor for these phages.
The phages bind to the bacterial capsule in order to gain entry and kill the bacteria. Some of the bacteria did evolve resistance to the phage, however. They did so with loss-of-function mutations to genes responsible for the capsule. The bacteria without a capsule had no receptor site for the phage, so they were resistant. However, the capsule is what provides resistance to beta-lactam antibiotics, so those same bacteria were now susceptible to those antibiotics. The obvious conclusion here is that a combination of antibiotics and phage therapy can be very potent, because it would be extremely difficult for any bacterium to evolve resistance to both. This is the advantage of having different treatments that use wildly different mechanisms.
Conclusion: The end of antibiotics and the rebirth of phages?
At the same time that the antibiotic era is running into serious problems because of antibiotic resistance, we may be at the dawn of the era of phage therapy for bacterial infections. But phage therapy is actually over a century old, so what we are seeing is the rebirth of phage therapy with far more advanced technology for biologics in general, and genetic manipulation specifically. Further, the combination of antibiotic and phage therapy may be particularly potent.
But the history of phage therapy also tells us that we cannot get so caught up in the hype that we skip over careful and rigorous clinical research.

Using Bacteria To Fight Bacteria
New research explores the possibility of using modified bacteria to fight the thorny problem of biofilms.
Steven Novella on October 6, 2021
Link

One of the major challenges facing modern medicine is the coming “post-antibiotic” era, in which we face numerous pathogens resistant to all available antibiotics. We are essentially engaged in an evolutionary war against pathogenic microbes, and by all accounts they are winning. We can delay the emergence of antibiotic resistance with best practices, but not prevent it entirely. We can also develop novel antibiotics, but the release of antibiotics using new mechanisms that can evade resistance has been extremely slow.
Clearly, while we do need to slow the emergence of resistance and develop new antibiotics, we also need to develop entirely new approaches to treating bacterial infections. I previously discussed here using viral phages as living weapons to attack infecting bacteria. This is a promising, but still experimental, approach.
Researchers are now also exploring the possibility of using bacteria themselves as weapons against bacterial infections. This may seem counterintuitive, likely because we tend to think of bacteria as germs, capable of causing infection. However, much less than 1% of all bacterial species can cause infections in humans (the estimate can vary widely, however, because the estimate of how many bacterial species exist varies considerably). Many bacterial species live in helpful symbiosis with humans, helping us digest our food and acting as part of our immune system (hence the whole notion of probiotics).
It is therefore not farfetched that we would be able to genetically engineer a bacterial species to help fight off antibiotic-resistant infections. This approach is also made more plausible by the rapid and incredible advances that are being made in genetic engineering technology. A recent study demonstrates the potential of this approach.
Victoria Garrido et al, publishing in Molecular Systems Biology, focused their sights on bacterial biofilms on implanted medical devices. Biofilms are notoriously antibiotic resistant, because they form sheets or films of bacteria that block access from either antibodies or antibiotics. They form an “exopolysaccharide matrix that adheres to a surface” and shields the bacteria within. A biofilm can be 1,000 times more resistant to an antibiotic than free-floating bacteria. There are multiple mechanisms of this resistance, including that biofilms can use efflux pumps to remove antibiotics from their environment. Often an implanted device that becomes colonized with a biofilm of bacteria simply has to be removed. Biofilms are also common, accounting for about 80% of bacterial infections.
There are many approaches to treating and preventing biofilms, including coating devices with surfaces resistant to adhesion or with embedded antibiotics, using electricity or ultrasound to break up biofilms so that antibiotics can get at them, or using enzymes or other antimicrobial proteins that dissolve the biofilm.
The researchers decided to use the enzyme approach, because while it can be effective it is limited by toxicity to host tissue. Their idea was to engineer a bacterial species to produce and release enzymes right on the biofilm. They decided to use Mycoplasma pneumoniae as the starting species, because it has a unique genetic code that limits horizontal gene transfer to other bacterial species. First they removed genes which give M. pneumonia the ability to cause infection, rendering it harmless. They then added genes to increase its ability to secrete enzymes. And finally they gave it the ability to produce two specific enzymes, one that is capable of dissolving biofilms and the other bacteriocidal against Staph aureus.
They tested their modified bacteria in vitro, and then both in vivo and ex vivo in mice (on catheters which developed S. aureus biofilms). They found that their attenuated M. pneumonia bacterium was safe and did not cause infection itself. Further, it was able to disrupt the biofilms and kill the S. aureus. The authors report that their treatment was 82% effective in removing the biofilms.
This is obviously a pre-clinical trial, but it is a compelling proof of concept. The researchers need to figure out how to mass produce their modified bacteria for further study. They are also planning on starting a clinical trial in 2023. Even in the best-case scenario we would likely not see such treatments in the clinic until the end of the decade. Often new technologies like this take 10-20 years to make their way into clinic use, and that’s if all goes well.
We are starting to see research into a number of “live” biological agents (viruses are only sort-of alive) to address the growing problem of antibiotic resistance and emerging infections. This is precisely what we need, entirely new approaches to fighting pathogens. The pharmacological approach may be playing itself out due to the emergence of resistance. Using viral phages and modified bacteria are promising technologies, made possible by incredible advances in genetic engineering.
These basic technologies also go beyond treating infections. The technology displayed in this research essentially is a bacterial delivery system – modified bacteria that are not capable of producing infection or transferring their genes to other bacteria, and can be used to produce and deliver protein payloads. Once a basic platform is perfected and proven safe, it can be modified for a long list of possible therapeutic interventions.
The one caveat to all of this is the fact that these therapeutic agents are self-replicating. The bar for proving safety is therefore incredibly high. We learned from our early attempts at using viral vectors for gene therapy that such agents can be risky. It took about 20 years longer than we initially thought, but eventually we developed safe viral vectors. It would therefore not surprise me if this research likewise takes longer than we currently think, or hope. We are not, however, in the same position we were in the 1990s. Biotechnology has advanced considerably, so it would also not surprise me if the time horizon for developing new genetically modified therapeutic agents is getting shorter.
        ◦ Hopefully we’ll be unleashing these new microbial armies against human infections sooner rather than later.

Using Evolutionary Principles to Reduce Antibiotic Resistance
We need to harness all options to delay the inevitable emergence of antibiotic resistance.
Steven Novella on September 1, 2021
Link

Antibiotic resistance is an enormous and challenging problem for science and medicine. It needs to be a focus of research in order to minimize the development of resistance, but right now we are losing this battle. Since bacterial resistance is essentially an evolutionary process, we may be able to exploit evolutionary principles to minimize it.
The “golden age” of antibiotics lasted only from the 1930s to the 1960s, a very brief window. Since then the pace of bacterial resistance to antibiotics has been faster than the pace of development of new antibiotics. We have therefore been slowly sliding into bacterial resistance for the last 60 years. Resistance emerges when a specific species of infectious bacteria evolve a trait that allows them to bypass the mechanism by which an individual or class of antibiotics work. This happens at a rapid pace because of the number of bacteria that reproduce even in a single individual with an infection is very high, so the opportunity for mutations is also high. Further, the presence of antibiotics provides a selective pressure, favoring those with genes for resistance.
Bacteria pose a further challenge, because bacteria can exchange genes in packages called plasmids, even between different bacterial species. This means that once a gene that provides antibiotic resistance is out there, it can spread horizontally and confer resistance to other bacteria. Plasmids can even contain many resistance genes at the same time. The catalogue of all bacterial genes that confer resistance is called the “resistome” and currently includes about 20,000 resistance genes. There are also about 1,400 microbial species (including viruses, bacteria, fungi, protozoa and helminths) that infect humans. According to the CDC, in the US there are about 2.8 million infections each year with a resistant bacteria, causing 35,000 deaths.
This is also a global problem (which we should all be aware of, especially in the middle of a pandemic). A resistance gene that emerges in a distant corner of the world can find its way around the globe. This means that the entire world needs to observe best practices. Of course, this is not happening. In some countries people can purchase antibiotics over the counter, without a prescription. As many as half of antibiotic prescriptions may also be unnecessary.
While we are still struggling to enforce basic good practices to reduce antibiotic resistance, researchers are looking to tweak those best practices. At the very least, physicians who prescribe antibiotics should be doing so not only responsibly, but optimally. Since the emergence of resistance is an evolutionary problem, we may be able to exploit evolutionary principles to help minimize it (notice how I never say “eliminate” resistance – that is not even an option with current technology).
One of the evolutionary principles that has emerged in recent years is the sequential use of heterogenous, rather than homogenous, antibiotics. This involves using multiple antibiotics, either together or in series, that use completely different mechanisms of action. This reduces the probability that a single bacterium will be able to resist all of the antibiotics, so it will still be affected. The probability of simultaneously developing multiple resistances is a lot lower than evolving a single resistance.
A recent study, however, shows that there may be a lot of complexity to this basic principle. They show that sequential use of homogenous antibiotics of the same class can be effective. They tested different heterogenous and homogenous series of antibiotics and found:
To our surprise, we found that fast switching between only β-lactam antibiotics resulted in increased extinction of bacterial populations. We demonstrate that extinction is favored by low rates of spontaneous resistance emergence and low levels of spontaneous cross-resistance among the antibiotics in sequence.
In other words, if you use antibiotics that have an inherently low rate of spontaneous resistance emergence, you can still rapidly switch between antibiotics of the same class and this will increase killing of the bacteria. You can also use antibiotics that have a low rate of cross-resistance, meaning that resistance to one does not necessarily confer resistance to the other. This is an interesting result, because it’s surprising, but it remains to be seen if this will usefully inform prescribing practices.
The more important point is that prescribing patterns optimized to minimize resistance can be highly complex. Perhaps we should not be leaving this up to individual prescribers.
The end game
In just a few decades since the introduction of antibiotics, resistant strains started to appear, and now they pose a serious health threat. Where will this all lead? Some experts fear we will enter a post-antibiotic era, with most infections being entirely resistant to antibiotics. In fact, it is reasonable to argue that this outcome is inevitable. The only real question is how long it will take, not if it will occur. The more optimistic view is that we will be able to identify new antibiotics fast enough to indefinitely stave off the post-antibiotic crisis. It’s simply true that this is not happening now. If anything, resistance is accelerating, while the emergence of new antibiotics is slowing.
For the medium-term the goal is to accelerate the research of new antibiotics, while slowing the emergence of resistance. This will take a coordinated global effort. Unfortunately, such an effort is unlikely to be robust enough to work (a reality that applies to many urgent global problems). In addition to the WHO’s list of best practices, we will likely need a fundamental rethink about how antibiotics are used.
For example, hospital prescriptions of antibiotics usually do undergo some expert review, but arguably this process could be more ubiquitous. Perhaps it will also need to extend to out-of-hospital prescriptions. This would be logistically challenging with existing infrastructure, and may require new mechanisms entirely. For example, we could theoretically leverage artificial intelligence algorithms to optimize antibiotic prescribing – take it entirely out of the hands of human prescribers who have no hope of tracking all the data necessary to make the optimal decision. There are also some common sense systematic changes we can make, such as an international ban on OTC availability of antibiotics. We may further need to take specific antibiotics out of rotation at times in order to allow resistance to fade. Vaccines, of course, can play a critical role in preventing infections in the first place.
I think it’s unlikely that anything close to what is truly required will happen (but we can always hope). Antibiotic resistance requires a centralized global response that coordinates all antibiotic use. Antibiotics need to be thought of as a precious limited resource. Every use brings us one step closer to a post-antibiotic world of extensive resistance. I know there is great resistance to the notion of any kind of “centralized global control” but we just have to recognize that without it, worsening antibiotic resistance is inevitable. We are collectively mostly ignoring this problem while it slowly advances.
        ◦ There is still the hope that we will technology our way out of this problem, although we cannot rely upon quirky scientific breakthroughs that haven’t happened yet. We may develop entirely non-antibiotic mechanisms for treating bacterial infections. Engineered bacteriophage viruses, for example, may be one option. Antibacterial nanotechnology would be nice. Generations, however, may live in a post-antibiotic world before such transformational technology emerges. Even if we are techno-optimists, it is in our best interest to slow down bacterial resistance as much as possible. We need to buy time for these new technologies to emerge.

There is really nothing super about Antibiotic Resistant Gonorrhea
Reports out of Massachusetts are raising concerns of a highly resistant strain of gonorrhea being seen for the first time in the United States. Are we close to living in a reality where there are no more effective treatments for this nasty, and potentially deadly, infection?
Clay Jones on February 3, 2023
Link

Unlike killer bees in the 1970s, Y2K at the turn of the century, and numerous fear fads spread via social media over the past several years, the potential appearance of so-called “super gonorrhea” has been a legitimate concern for doctors in the United States since the 1990s. Sadly, it appears that time is close at hand. At least it sure looks that way according to a number of recent news reports.
But what is super gonorrhea, and is it something that we should all be worried about? Are there any effective treatments left? Is it time to make a run for our emergency apocalypse bunkers hidden deep in the Black Hills of South Dakota? The answer to all of these questions is an unqualified yes. Fly, you fools!
What is super gonorrhea?
Back on January 19th, Massachusetts health authorities announced the identification of a “concerning gonorrhea strain” found in two unrelated individuals diagnosed with the infection. The bacteria in each case showed signs of resistance or reduced response to 6 of the 7 antibiotics tracked for resistance by state and federal surveillance programs, the first time this has been observed in the United States. Both patients were still able to be successfully cured using an antibiotic named ceftriaxone, which has been the standard first line treatment for gonorrhea for several years, but don’t let that reassure you too much.
Ceftriaxone is an injectable (IM/IV) broad spectrum antibiotic in the cephalosporin class, and It is one of the most important drugs currently in our armamentarium when treating a wide variety of serious bacterial infections, including meningitis, pneumonia, soft tissue infections, and urinary tract infections. Since 2012, it has been recommended as the first line treatment for gonorrhea because of rising resistance to other choices that could be taken orally. Unfortunately, the strain of bacteria in the recent Massachusetts cases was found to have the penA60 allele, a mutation in the penA gene associated with resistance to ceftriaxone.
The two Massachusetts isolates mark only the 2nd and 3rd time that the penA60 allele has been seen in the United States, though it has been identified in several other countries around the world. In the first case, seen in Nevada, the strain of gonorrhea was sensitive to several other antibiotics. These recent cases were not.
Ceftriaxone worked this time, but there was a reduced response that could quickly evolve in to full resistance. In susceptibility testing, the only antibiotic without any reduced gonorrhea murderability, at least in a Petri dish, was gentamicin. This particular drug has a worse safety profile, though I would still consider it pretty safe in most cases, but isn’t as effective in treating all types of gonorrhea infections as ceftriaxone.
How worried do we need to be?
Well, it depends. If you don’t plan on ever contracting gonorrhea, and take well established precautions, you are probably going to be fine. I’m not sure how many people actually plan to get gonorrhea, though. Certainly some people take a riskier approach to life than I would recommend.
Gonorrhea is an incredibly common infection, second only to chlamydia among reported sexually transmitted infections, and it effects people from all walks of life. Even children aren’t spared from it. Newborns acquire the infection when passing through infected fluids during a vaginal delivery and can develop vision-threatening eye infections, arthritis, meningitis, and even sepsis. Some younger children become infected during acts of sexual abuse. And sexually active older kids also encounter gonorrhea the old fashioned way.
Most gonorrhea infections are mild or even asymptomatic. When symptomatic, most men and women have inflammation in the genitourinary tract, but the throat and rectum are other common locations. Infection in women can spread to the uterus and ovaries leading to infertility. In some cases the bacteria can disseminate throughout the body, causing inflammation of the joints and skin in particular. Systemic disease can even be fatal.
Like all sexually transmitted infections, gonorrhea is on the rise. In Massachusetts, confirmed cases have gone up by more than 300% since 2009. In total across the country, there has been a 131% increase, with nearly 700,000 cases reported in 2021. According to Massachusetts authorities, the two patients with the highly resistant strain were not linked in any way. And because one of them had no history of travel to regions where this strain is known to exist, it is likely that others are infected with it and spreading it right now.
Losing ceftriaxone as an effective treatment for gonorrhea would be really bad. Some patients would still be curable using older treatment strategies, but there would be many treatment failures. If this new (to us) strain takes hold, our options would become even more limited, and with a few strokes of genetic bad luck there may be no options left at all. Numbers of gonorrhea cases would skyrocket since treatment prevents spread, and a lot of people would suffer.
Through the efforts of CDC and FDA fast track programs, there are two new antibiotics currently in phase 3 trials that look promising. There is also some hope that a vaccine could be developed considering that the bacteria that causes gonorrhea shares 80-90% of its DNA with Neisseria meningitidis, a common and vaccine-preventable cause of meningitis. But we can’t count on these to be available anytime soon. So, in the meantime, be careful out there.

Antibiotics vs. the Microbiome
Harriet Hall on August 12, 2014
Link
In 1850, one in four American babies died before their first birthday, and people of all ages died of bacterial infections that could have been successfully treated today with antibiotics. Unfortunately, treatments that have effects usually have side effects, and we are seeing problems due to the overuse of antibiotics. They are given to people with viral infections for which they are useless and to food animals to improve their growth. As a result, antibiotic-resistant organisms are evolving and the development of new antibiotics is not keeping up with the threat. This is common knowledge, but we’re starting to realize that there may be other problems with antibiotics even when they are used correctly to save lives.
The rates of obesity, diabetes, asthma, food allergies, hay fever, eczema, inflammatory bowel disease, celiac disease, acid reflux disease, and esophageal cancer are all on the rise. Martin Blaser, MD, director of the Human Microbiome Program at NYU, thinks antibiotics may be to blame, either as a causal or a contributing factor. In his book Missing Microbes: How the Overuse of Antibiotics Is Fueling Our Modern Plagues, he describes some of the fascinating research he and others have been doing to elucidate the role of the more than 100 trillion microbes that live on and in each of us, and the possibility that antibiotics may have a causal role in several of the so-called diseases of civilization.
H. pylori
I learned a new word from the book: amphibiosis, the condition in which two life-forms create relationships that are either symbiotic or parasitic, depending on context. You have probably heard of Helicobacter pylori, the bacteria that earned Drs. Barry Marshall and Robin Warren a Nobel Prize in 2005 for finding it in the stomach and discovering its connection to gastritis, ulcers, and stomach cancers. We think of it as a pathologic organism that we should eliminate with antibiotics. Dr. Blaser argues that along with the harms it causes, it protects its hosts from a number of diseases.
That may sound like a crazy idea, but he provides a lot of surprising supporting evidence, as well as insights from evolutionary theory. Genetic studies have shown that humans have carried H. pylori for 100,000 years. We can trace human migration patterns with different strains: pure East-Asian strains can be found deep in the Amazon jungles while European strains predominate in South American coastal cities. Until recently it colonized virtually all children early in life; today, only 6% of American children harbor it. Nearly all adults in Africa, Asia and Latin American carry the bacteria, but only half of adults in Australia do. The reason for its declining prevalence can be explained in one word: transmission. Sanitation is better, families are smaller so kids are less likely to pick it up from siblings, and antibiotics destroy bacteria.
We are just beginning to appreciate the importance of the microbiome, the mixture of microbes that help keep us healthy. Babies get their first dose of microbes as they pass through the birth canal. Babies born by C-section are not colonized by their mother’s vaginal lactobacilli, and their microbiome only gradually comes to resemble that of vaginally born babies over the next several months. We don’t know how much this matters, but it’s certainly worth thinking about. The C-section rate varies geographically from 4% in some parts of Sweden to 80% in Rome.
H. pylori stimulates a profusion of lymphocytes and macrophages in the stomach. This is diagnosed as gastritis, but Blaser argues that maybe we should think of it as a normal immune response that attacks some pathogens and improves the ecology of the stomach for friendly microbes. The increase in T-cells is protective against diseases like asthma, especially early in life.
Carriers of H.pylori are 6 times more likely to develop stomach cancer as non-carriers, and carrying the cagA-positive strain doubles the risk.
Non-carriers have higher levels of stomach acid, have more heartburn, and are 8 times more likely to develop gastroesophageal reflux disease (GERD).
Carriers are 30-40% less likely to have asthma and are also less likely to have hay fever and skin allergies.
H. pylori affects the regulation of the hormones ghrelin and leptin. Farm animals are given antibiotics because they promote growth. Subtherapeutic antibiotic treatment (STAT) alters bacterial diversity, converts indigestible food in the intestine to useable calories, and increases body fat; and the effect is synergistic with a high-fat diet. Transferring the STAT microbiome to germ-free mice makes them fat. Studies in mice have shown that even brief exposures to antibiotics early in life can contribute to lifelong obesity. Children who got antibiotics in the first 6 months of life were fatter. And C-section births were associated with childhood obesity.
Antibiotics and C-sections
There is evidence that antibiotics early in life and C-sections increase the incidence and progression of diabetes. Patients who recently developed celiac disease are 40% more likely to have been prescribed antibiotics in the preceding months. Children who develop inflammatory bowel disease (IBD) are 84% more likely to have received antibiotics. Victims of Salmonella infections were more than 5 times as likely to have taken antibiotics in the previous month. Blaser speculates that antibiotic use might also be a contributory factor in conditions as diverse as nut allergies and autism.
Babies in the US routinely get antibiotics on the first day of life to prevent devastating gonorrheal eye infections, but the risk is low today. In Sweden, they are not treated, and there is no effect on the rate of infection. Perhaps we should reconsider.
Blaser says our microbiome evolved for good reasons and tampering with it is potentially dangerous. He is enthusiastic about the prospects of increasing our understanding of all those critters that live inside us, but he recognizes the limits of our current knowledge. He is skeptical of claims for probiotics and prebiotics, but he does support more rational antibiotic use and efforts like the Antibiotics Are Not Automatic campaign that has reduced the prescriptions of antibiotics by 26% in France.
Conclusion
Blaser’s book is well-written, explains the science clearly for the average reader, and includes fascinating stories and facts. This is exciting stuff! I wish I could be alive 100 years from now to see how research into the microbiome will change the practice of medicine.

   The Microbial Metagenome
Mark Crislip
Link
First some background. I was first directed to the Marshall protocol by a reader who wondered about the information the found on the web. So I went to the web and looked at the available information, much as any patient would, and discussed what I found there.
I have subsequently been lead to believe that none of the information on the website http://www.marshallprotocol.com can be considered up to date or accurate. As as result of, I have told that my post is chockablock with errors, although, outside of writing doxycycline where I should have put minocycline, I am left in the dark as to exactly what my errors are. I am told that it is my responsibility to locate the errors in the last post, yet I can find none when compared to the website.
However, to remedy the deficiency of having reviewed inaccurate and out of date material, I have been sent 6 articles that I am informed represent the state of the art in understanding the science behind the Marshall protocol. Ah, the peer reviewed medical literature. An opportunity to carefully read and critique new ideas. It is one of the reasons people publish: to see if their ideas can withstand the scrutiny of others.
Several of these papers concern Vitamin D, the Vitamin D receptor, and olmesartan which I will review, perhaps, another time. I don’t find them a compelling read, but it not an area about which I have more than a standard medical knowledge. The other papers concern the role of infection in autoimmune diseases, which I will discuss here. It is easier as an infectious disease doctor to read this literature as I am, as least as far as the American Board on Internal Medicine is concerned, a specialist in the field. Alternatively, I am a closed minded tool of the medical industrial complex who only seeks to push his own twisted, narrow agenda at the expense of suffering patients (1). We can’t all be perfect.
The main article, which was published in July of this year, is “Autoimmune disease in the era of the metagenome (2)” will be discussed along with several (2, 3) references that are, as of the writing of this post, not yet published. For the clarity, footnotes in ‘()’ are mine, footnotes in ‘[]” are from the referenced material. I added any bold face type.
The article starts with an interesting sentence.
“According to the NIH, a mere 10% of the cells that comprise the organism known as Homo sapiens are human cells. The remaining 90% are bacterial in origin. Thus, Homo sapiens is best described as a superorganism in which a large number of different organisms coexist as one (1).”
That is certainly a curious way to think about the microbial ecosystem we carry around with us. It is true that there are 10 to 100 times more bacteria on us than there are cells that make us up (for the sake of clarity, bacteria on the skin and in the GI tract I will refer to as on us even though from one perspective the bacteria in our gastrointestinal tract are in us. Prepositions can be imprecise. But the GI tract is contiguous with the environment, so I will use the word on. To be in us, the bacteria will have had to breech the cells that line us and be in the blood, the cytoplasm, the nucleus, the interstitial spaces, etc.).
We are covered in bacteria and carry a complex ecosystem that we are just beginning to understand and of which we can grow or, by molecular techniques, identify a minority. However those cells are not us. While we do have some interaction with these bacteria, they are not the cells that make us. It would be the same as saying that the cells of the fleas on a dog are part of what constitutes a dog or the cells of a monkey in a tree are part of what constitutes a tree. There is self, and there is not-self, and our bacteria are not-self. Our genome is what we pass on to our children with reproduction. So the opening sentence does not inspire confidence in the authors understanding of what constitutes being human. From my understanding of human-microbial interaction the opening sentence is wrong.
“Medicine is now comfortable with the bacterial populations that exist in the gut and areas of the body in contact with the external environment, such as the mouth, ears, nose and skin. Yet, components of the human microbiota also likely persist in many other body tissues, including those which become inflamed in autoimmune disease [5] (1).”
Reference 5 is a video of a lecture of one of the authors which is a keynote address summarizing the ideas found in the articles discussed here. You evaluate a review by the quality of the arguments and the quality of the referenced material. It has more credence if the information is based on first class, reproduced research in high impact journals. Linking to your own lectures? Well, no so much. I should put up YouTube video of me reading this blog and link to it as proof of the assertions in this entry as I suppose an on line video constitutes now constitutes valid, scholarly reference material. See. It’s on the interwebs, so it must be true.
What they appears to be saying is the complex microbiology found on us is also to be be found in us, in our cells and tissues, and are involved in the pathogenesis of autoimmune diseases. We shall see.
They continue with
“Such bacteria can persist inside the very cells of the immune system that are supposed to kill them [6], or in bioﬁlm communities in which they are protected from the immune response by a self-created polymeric matrix [7].”
The reference in regards to persisting bacteria is scanning electron microscopy (EM) of white cells in three patients with eye disease and the alleged pathogens were never shown as living organisms nor have the findings of the paper ever been reproduced or verified by others. Dr. Witosko, the author of reference 6, published a number of studies in the 1980′s where he found what he considered to be mycoplasms in several diseases, the proof of an infection being based on EM and response to antibiotics. Unfortunately since that time, his findings have not been confirmed by other researchers. Searching Pubmed for mycoplasms and uveitis, sarcoid, Crohn’s and JRA yield next to nothing. If the primary references to support your hypothesis, at least the ones that are not internet videos, are one off’s, never reproduced or verified, then the foundation upon which your are building your argument may be less than solid.
Bacteria can persist for short times in phagocytic cells during acute infections. However, extrapolating from this paper to bacteria living for years in phagocytes for the lifetime of the patient with an autoimmune disease is a leap across the Grand Canyon of medical hypothesis. Biofilms are important in persisting infections associated with prosthetic material and osteomyelitis but the role of biofilms in other diseases not associated with inert material is uncertain.
So they are building an argument for disease pathogenesis, based in large part on examples and parallel, for infections due to colonies of as of yet undiscovered organisms that evade the immune system and live in biofilms.
Because some organisms cannot be isolated, ours exist and cannot be isolated.
Because some organisms can evade the immune system, ours evade the immune system.
Because some organisms live in biofilms, ours live in biofilms.
The next paragraph concerns the easy exchange of bacterial DNA and how calling an organism E. coli may by old fashioned. I am sympathetic to this view of bacteria, because at one level, given their ability to exchange and utilize DNA, bacteria are a metagenome and our classification of bacteria can be imprecise. I tend to think of bacterial identification as probability functions rather than an absolute characteristic. They are fuzzy, and not in a good way.
“Due to their small size, hundreds, or even thousands, of bacterial cells can ﬁt inside a human cell [6]. The combined genetic contributions of these microbes inevitably provide myriad gene products not encoded by our own relatively small genomes. This means that the human genome is only one of the many genomes that affect Homo sapiens function. In reality, the organism we call Homo sapiens is controlled by a metagenome, a tremendous number of different genomes working in parallel. “
Sorry, this seems ludicrous to me. Sure. We have covered with millions of bacterial genes and in some places there is an ongoing interaction between the bacteria and us. But to suggest that these genes in bacteria are part of our genes and controlling us is an unwarranted extrapolation and, in my understanding, more science fiction than science fact. And just because thousands of bacteria could fit into a cell it doesn’t mean they do. One would think, given the last 50 years of light and other forms of microscopy and the ongoing search for infectious etiologies of most autoimmune diseases (a search that keeps coming up negative) that someone, some time, would have noticed huge numbers of bacteria stuffed into cells. And that such findings would be easily reproduced by others. Curiously, that hasn’t happened. So if the bacteria don’t seem to fit, we must acquit…. sorry for that one.
Then another odd example:
“Bacterial gene products can be very similar to our own. For example, the metabolism of glucose-6-phosphate by both the human body and E.coli is nearly identical, so that remarkably similar metabolites are produced by both species [11]. With this in mind, the interaction between an E.coli genome and the human genome, as they exchange nutrition and toxins, increases the complexity of transcription and translation for both species.”
Thanks to evolution, we do share many common metabolic pathways with many bacteria; it is why some antibiotics will affect human cells and some anticancer drugs will affect bacteria. However, the role of the interaction of bacterial metabolic products, out side of locally, is currently speculative in disease. They then mention that in a test tube system that probiotic bacteria grown in skim milk make enzymes that inhibit angiotensin 1 converting enzyme. How this is relevant to human systems requires another huge leap. It is always a question whether test tube examples have clinical relevance. In this case, unlikely, as we are not skim milk and the bacterial strains in probiotics are usually different than the strains found in us. Possible, but I would not generate a treatment plan based on it.
The authors then give examples of how two genes are altered by bacteria in the test tube: one up regulated, one down regulated. No argument here. When infected the body responds in a variety of ways. Genes get up regulated and down regulated. It is always a question whether these test tube phenomena are of clinical relevance or if they are lost in the complex human metabolic system. Often these effects are the equivalent of tossing a rock in the Oregon ocean and to increase the size of the waves in Hawaii. The effects are too small to be noticed, butterflies and hurricanes not withstanding.
Then the move on to capnine:
“Created by the gliding bacteria that are present in bioﬁlm, the sulfonolipid Capnine provides a speciﬁc example of how a bacterial metabolite could manipulate human gene expression in order to dramatically alter the progression of autoimmune and other chronic diseases.Capnine has the capacity to disrupt transcription by the VDR, one of the body’s most proliﬁc nuclear receptors [15].”
Note could, not does. And the proof? The reference is from a paper that is from computer modeling of the interaction of capnine and the VDR. Again with the computer modeling. No real data to show an interaction of this molecule and the VDR. No data to show that this molecule has ever been found outside of biofilm where it could have pharmacologic effects. Going from computer modeling to disease pathogenesis and treatment is another huge stretch. As a clinician I am not impressed. Computer models are interesting but have to be compared to that pesky reality before they can be taken seriously. It is a shame that one cannot jump straight from the computer model to real life, as I would love a computer model that would makes me a Powerball winner.
“Thus, if Capnine was deregulating the VDR, it would greatly hamper the innate immune response. VDR dysfunction would cause the active vitamin D metabolite 1,25-D to rise to excessively high levels where it could inhibit expression by the bulk of the body’s other nuclear receptors -including alpha thyroid, the glucocorticoid receptor, and the androgen receptor [20]. This would result in hormonal imbalances and also interfere with expression of the dozens of other AmPs expressed by these receptors. In vivo, the microbiota appears to gradually shut down the innate immune response over a person’s lifetime, resulting in the increased accumulation of chronic bacteria and other pathogens [21]. “
If wishes were horses, Beggars would ride: If turnips were watches, I would wear one by my side. If capnine was pathogenic, Bacteria would more than glide.
All an unproven speculation presented as fact, all following from could and if. There is no in vitro or in vivo data to suggest that capnine is involved in anything but the production of biofilms. Reference 21 leads to a speculative review that will be discussed later, not original research. But none of this is based on original research in real biologic systems. The shutting down of the immune system by bacteria, while stated as fact, is yet more unproven speculation.
“Eventually, genes from the accumulating microbial metagenome may determine a clinical disease symptomatology such as an autoimmune diagnosis, or simply drive the inﬂammation associated with the aches and pains of aging [5]. This accumulation is an extremely logical evolutionary survival mechanism. Components of the human microbiome have evolved to dysregulate the VDR receptor that would otherwise activate a potent immune response against its presence.”
No. Most bacteria in our microbial metagenome are simply not pathogenic and lack the capacity to invade and cause disease. Bacteria need to have the capacity to cause disease, and most do not. They live outside of us, on us, and in symbiosis with us. Even if you wipe out most of the immune system with chemotherapy or AIDS and patients become ill with their own bacteria invading, the number of pathogens in these patients is limited relative to the number of bacteria they have. Of our thousand bacterial species, I only have to worry about a couple dozen. Of the millions of microbial species in the world, less than a thousand have the ability to infect humans. Most bacteria simply can’t cause disease. They do not need to have evolved to dysregulate the Vitamin D receptor to survive. Unless, of course, they are forming large, unseen, intracellular colonies, which as best as I can tell, they do not.
“As Royston Goodacre comments in Journal of Nutrition, we are born with a genome that, aside from the genes of species that can survive in the womb and endometrium [22], is largely human. But we inevitably die with a genome that is at least 90% bacteria.”
Nonsense. The genome that is on us is not the genome that is in us. Our genome, what makes us human, is what we pass on with reproduction and those genes are most certainly not bacterial in origin. I suppose under this paradigm, that if you were to drown in a sewage pit, then you would die with an even greater genome.
They move on to discuss antibody production as a result of infection with the metagenome.
“Yet now that Homo sapiens is understood to be the product of multiple genomes, it is equally possible that the antibodies observed in autoimmune disease result from alteration of human genes and gene products by the bacterial metagenome.”
If we take one unsupported hypothesis as true then anther unsupported hypothesis is equally true. We are not the product of multiple genomes, that is hyperbole. But if you repeat something frequently enough, maybe it will be considered true despite a lack of evidence. Works for politicians. Are they saying that the metagenome alters our genes to cause disease? That the bacteria lead to genetic mutations? They are not talking natural selection here.
They are saying that the DNA is altered by the bacteria. News to me, and, if true, leads to a new understanding of disease pathophysiology. It is only “equally possible,” although I would classify that speculation as extremely unlikely.
Next is a discussion of how the bacterial flora varies in time and in location and as a result the products of that bacterial flora will change with time. No argument here, the ongoing ebb and flow of out bacterial flora is just beginning to be elucidated. How this alters disease manifestation is hinted at in the text, but I infer that different microbiota in people will lead to different autoimmune diseases. Which would be good excuse for the not finding a consistent pathogen causing a given disease in each patient. Each patient has a different microbial metagenome causing their sarcoid or RA or whatever disease is present. I admit to being wedded to the idea that one bug causes one disease. For over a century that concept, at the core of Koch’s postulates (5), have helped to discover the cause of everything from AIDS to Zygomycetes. If inference is true, it may make the pathophysiology espoused in this paper unable to be tested or falsified. It would also make the it impossible to isolate the infecting organisms and test it to see what is the optimal antibiotic to be used to kill it. A clinician could never say that the patient DIDN’T have a disease, which is often important information to give a patient.
Then they move on to where and how the microbiota cause disease:
“Persistent bacteria including Francisella tularensis [25], Mycobacterium tuberculosis [26], Rickettsia massiliae [27], Brucella spp. [28], Listeria monocytogenes [29], Salmonella typhimurium [30] and others, use a variety of mechanisms to evade the immune response and survive inside macrophages and other phagocytic cells.”
It is the rare pathogen that survives, usually for a relatively short time, in the cytoplasm of cells. Eventually it either kills the host in relatively short order or is cured. Chronic infection of cells is not the norm of these organisms, although extracellular persistent infections can occur. As will be discussed later, it is postulated that cell wall deficient organisms persist in the cytoplasm to cause autoimmune disease. What is curious about the organisms above is that is the mechanisms by which these organisms evade the immune system are often part of, well, er, the cell wall. Often what allows bacteria to evade the immune system and survive intracellularly is due to constituents on the cell wall and I would suppose that cell wall deficient organisms would lack that mechanism.
“Furthermore, various species of bacteria have been detected inside the cells of patients with juvenile rheumatoid arthritis [31],sarcoidosis [6], and other inflammatory diseases [32].”
The search for a reproducible infection in these and other autoimmune diseases continues and I will not be surprised if one day one or more microbes are found at the center of a sarcoid granuloma. Or in a JRA joint. But the consistent, reproducible demonstration of an infectious agent in any of these autoimmune diseases is still pending. When they discover an infectious cause of some of these autoimmune diseases, it will probably be one lone organism, not a colony. If it takes a village of bacteria to cause a metropolis of diseases, that would be a novel pathophysiology.
“This suggests that disease-causing microbiota largely persist in the cytoplasm of nucleated cells, where it has access to both the DNA transcription and protein translation machinery of Homo sapiens. “
Really? It does? If so, where are they? Colonies of bacteria should be seen by light or electron microscopy and yet for 100 years these bacteria have evaded detection. Romulan cloaking technology is probably beyond their capacity. It might be suggested, but it has never been noticed. There are the occasional reports of quasi bacterial products found in the cells on EM, never reproduced, never confirmed by alternative techniques. Just where are they in all the specimens in all the pathology labs all over the world? It should be easy enough to find the microbiota, should they not?
“Microorganisms are also capable of integrating their DNA with our own [36]. This results in alteration of the human DNA by the microbiota over time, potentially leading to genetic mutations associated with autoimmune diagnoses. Genetic haplotypes observed in autoimmune disease frequently have very low statistical significance, as would be expected based on knowledge that the metabolome varies from population to population and individual to individual. In addition, host DNA repair mechanisms are susceptible to modification by the products of the metabolome. In fact, bacteria may hijack DNA repair mechanisms to generate genetic diversity without losing genomic stability [37, 38].”
The microorganisms referred to is a herpes virus, and there are a few viruses, herpes and retrovirus, that can insert its DNA into ours. The paper refers to bacteria as the constituents of the microbiota and then they switch to a virus and do not bother to mention it. That is disingenuous at best and misleading to anyone who did not bother to go to the footnotes. This kind of scholarship is not reassuring to the reader. However, higher organisms (bacteria, mycoplasma etc) do not put their DNA into ours. There is zero data to suggest that the accumulation of bacterial DNA in humans accounts for autoimmune disease. This is stated as if it were fact, when it is closer to science fiction. Reference 37 is in an insect and reference 39 is computer modeling. Quite a leap from a bug and a PC to the cause of human disease.
So what do we have?
Humans have in them colonies of unseen and undiscovered bacteria that persist undetected in the cytoplasm and alter our genome in ways as of yet proven to suppresses the immune system by way of uncharacterized and unproven metabolites interacting with the Vitamin D receptor to cause a wide variety of autoimmune diseases ranging from sarcoid to diabetes. Hey, I’m convinced. Nothing like lots of speculation and extrapolation from primary sources that are poor in quality and never reproduced or validated by alternative lines of data, and are unsupported by primary in vivo or in vitro studies.
Maybe the reader can see why I am less than enamored of the validity of the pathophysiology noted above. I read dozens of papers a month to keep up in my field. This one is not going to rank high of the compelling review list.
So how does that translate into treating infections? For that we must turn to “Reversing Bacteria-Induced Vitamin D Receptor Dysfunction is Key to Autoimmune Disease. (2)”, which is in press. Sorry. I have a copy and you do not.
Here is the basic hypothesis from the introduction:
“An intraphagocytic bacterial microbiota is proposed to be the primary cause of VDR dysfunction. Because the VDR is key to the innate immune response, its dysfunction would lead to chronic infections with a wide range of pathogens, leading to inflammation and frequent elevation in autoimmune disease markers.”
The first part of the article is a review of the same issue discussed above. Intracytoplamsic colonization of colonies of bacteria make products that interfere with the VDR. No new data, no primary research, many of the same references. I am again going to focus on the infectious disease aspect of the paper, rather than the vitamin D.
“The use of pulsed, subinhibitory, bacteriostatic antibiotics is an important part of this approach. Research indicates that most standard antibiotic protocols used so far to treat chronic inflammatory diseases are ineffective, and so new ways of using antibiotics are called for to deal with the relative treatment resistance of the bacteria involved.”
I read this and my jaw dropped. I promised myself not to be snotty when I evaluated these papers, but such statements really do deserve ridicule. Maybe they are ineffective because the disease do not have infectious etiology? Maybe? The new ways of giving antibiotics? Dose them so that they cannot be effective.
In the practice of infectious diseases when patients do not respond to therapy, there can be a multitude of reasons for the failure. One is that the patient does not have an infection. Another is that the organism is resistant to the antibiotics being used. In the context of the e pathophysiology of the paper, what they say is that since standard antibiotics at standard doses do not work, they will give the same antibiotic, but dosed intermittently and in small amounts, or in such a way that it should have no effect on the infecting organism.
Your infection is not getting better, so we will continue the antibiotic that is not working, but we will give you less of it. That would only make sense to a homeopath but if I were to treat infections this way we would have no shortage of cases for morgue conference. However, novel infections get novel therapies, right?
That’s assuming that bacteria are involved, which as we have noted, while interesting, is far from proved. Antibiotics are presumed not to work against the bacteria in autoimmune disease as the bacteria are cell wall deficient and the antibiotics are dosed too high.
The first part I understand. If there are indeed L forms persisting in the cytoplasm, which have never been demonstrated definitively in autoimmune diseases, then cell wall active agents will not work. Which is why the tetracycline class (minocycline) and macrolides are used against these bugs.
There is a long history in infectious disease of the concept of the minimal inhibition concentration. It takes many more than one antibiotic molecule to inhibit an organism. How many depends on the antibiotic and the organism, but is takes hundreds of antibiotic molecules to have an effect on a bacterium. If you fall below the MIC, the organism still grows, although perhaps more slowly. Using subtherapeutic concentrations of antibiotics are the quick and easy way to develop resistance to the antibiotics. What doesn’t kill it makes it stronger. Currently for most infections you give maximal dose for as short a period of time to maximize killing and minimize the development of resistance. The opposite of what is suggested in this paper. Of course I am biased by 60 years of the successful treatment of infectious diseases and am stuck in my ways.
“The survival of “persister” cells when constant dosages are used means that pulsed antibiotics are likely to be more effective.[18] The ability of bacteriostatic antibiotics to be effective at low dosage levels has been documented.[37]“
To date, there is not an infection treated with pulsed antibiotics. Intermittent antibiotics helps breed resistance. Reference 37 does not concern the ability of low doses of antibiotics to be effective against bacteria, it is an article about the effect on antibiotics on the phagocytosis of bacteria, the ability of cells to ingest bacteria. In the context of the paper, this appears to be a misrepresentation of primary sources. Since the alleged bacteria in autoimmune disease are already intracellular, one wonders about the relevance of this reference as it applies to the use of antibiotics as proposed in this paper.
“The existence of communities of multiple bacterial species, like those occurring in biofilms, means that combinations of antibiotics are likely to be necessary to fully target all species. Thus, there is increasing support for the use of pulsed, low dosages of combinations o bacteriostatic antibiotics.”
Where are these biofilms? In the cells? Extracellular? Never quite certain where the biofilm is in the context of autoimmune diseases. Where are the multiple bacterial species? One does not necessarily need multiple antibiotics just because there are multiple species of bacteria. Often the judicious and rational use of antibiotics allows one to kill multiple organisms with one antibiotic. Rather than delaying the development of resistance in bacteria (bacteria, not mycobacteria, so do not use Tb as an example of why I am wrong), multiply antibiotics may intensify the evolutionary pressure on bacteria to become resistant. There is no support outside the extrapolations of this paper for the use of pulsed, low dose combination antibiotics in any disease that I treat (and cure) for a living.
“The waxing and waning of symptoms that typically follows each of the pulsed antibiotic doses supports the model’s contention that bacteria are involved in autoimmune disease. The fact that these immunopathological responses decline over time, as the patient improves during treatment, provides evidence of disease reversal.”
This is the most risible statement in the paper. An equally unjustified conclusion from a similar paper:
“Perez showed that 81% of a group of 54 patients representing 20 different autoimmune diagnoses reported continual improvement after treatment durations of 18-53 months with aVDR agonist and antibiotics – further pointing to bacteria as a causative agent in autoimmune disease.[21] (4)”
Here is the reasoning: we dose antibiotics in a manner that should have no effect on bacteria (pulsed and subinhbitory).
We therefore conclude that because the ineffectively dosed antibiotics are having an effect, the diseases have an infectious etiology.
That’s a clinical paradox that would shut down an M-5 multitronic unit.
I emphasize with the residents that unless you have firm evidence of infection (culture, serology, PCR etc), response to therapy is not a good way to prove an infectious disease etiology. If they were to make such a suggestion, I would pat them on the head, smile patronizingly and point out that there are four solutions to an alleged antibiotic response:
The patient improved because they had in infection that responded to antibiotics.
The patient improved because they had a self limited infection and the antibiotics did nothing. Treating a viral pneumonia with ampicillin as an example.
The patient improved because they had a non infectious disease and the antibiotics did nothing. They received antibiotics for their stasis changes in their legs misdiagnosed as cellulitis but responded to elevation.
The patient improved because they had a non infectious disease that responded to the antibiotics.
It is the last that makes the treatment success problematic to prove. I used to think that the immunomodulatory effects of antibiotics and other agents were too minor to be of clinical importance. Now I am not so sure. The association of NSAID use and the development of group A streptococcus necrotizing fascitis and the possible decreased mortality with infections in patients who are on statins are non-antibiotic examples of possibly clinically relevant effects of minor immunomodulation.
Both the tetracycline and the macrolide classes of antibiotics are immunomodulatory, and several recent studies have demonstrated decreased mortality for infections resistant to macrolides that are treated with adjunctive macrolides. An animal model suggests that the decrease in mortality from macolides is due to a decrease in cytokines. The minor immunomodulatory effects may, much to my surprise, be clinically relevant.
So assuming that tetracycline and macrolide antibiotics are indeed effective in decreasing the symptoms of autoimmune diseases, in the absence of a well defined infection, you cannot know for sure of the result is from the antimicrobial drug treating an infection or the result of an immunomodulatory drug altering immune function. I bet, since they are dosed at levels to low to be effective against bacteria, that it is the latter that will be the mechanism of action, if, indeed, they are demonstrated in clinical trials to be effective.
“Diseases responding to treatment include systemic lupus erythematosus, rheumatoid arthritis, scleroderma, Sjogren’s syndrome, autoimmune thyroid disease, psoriasis, ankylosing spondylitis, Reiter’s syndrome, type I and II diabetes mellitus and uveitis8 and sarcoidosis. [3] Fibromyalgia, though not generally established as an autoimmune disease, has also responded favorably to this approach.”
If there is a recurrent theme in this blog, it is the difficulty of assigning causality to therapeutic interventions, especially when the underlying treatment has no or unproven biologic plausibility. The acupuncturists say their interventions are effective and that chi exists because of anecdotes of efficacy and poorly controlled studies. Yet when rigorous trials are done, acupuncture is no better than twirling toothpicks on the skin. The plural of anecdote is anecdotes, not data. With diseases that can naturally wax and wane there is always a question of true causality with anecdotal information. Until you do a placebo controlled trial, anecdotal evidence may be interesting but is not definitive.
So perhaps you can see why, as an infectious disease doctor, I am less than convinced about the infectious diseases component of the pathogenesis of autoimmune diseases as presented in these papers.
No reproducible, credible evidence that colonies of organisms and their biofilms exist inside of human cells.
No evidence outside of in silico (I love that term. It means computer modeling, but suggests parallel validity with in vivo and in vitro) data to suggest that bacteria make molecules to alter the VDR to suppress immune function.
No controlled trials to suggest that patients are having a response to the antibiotics due its antimicrobial, rather than immunomodulatory, effects. 
Antibiotics are used in a manner that has a long history of being ineffective and aids in the development of resistance.
Lots of extrapolation, hypothesis and anecdote. To me it is all, as Shakespeare might say, all sound and fury, signifying nothing.
All aspects of the pathophysiology are amenable to testing, so I could easily be proven wrong. I can easily imagine a clinical trial that would prove or disprove the therapies independent of the theory behind it. It could be that they have the right therapeutic idea for all the wrong reasons. It wouldn’t be the first time in medicine. Take a well defined population of sarcoid or another illness. 4 treatment groups: 2 placebos, one placebo plus antibiotics, one placebo plus olmesartan and both antibiotics and olmesartan. Everyone blinded. It also makes me wonder: what research would the proponents consider valid in falsifying the pathyphysiology and treatment in the Marshall protocol?
Much is made by the fact that these articles are peer reviewed. After reading the papers closely, what peers and what they were reviewing, I am uncertain. Perhaps spelling and punctuation? They didn’t pay a whole lot of critical attention to the arguments or the references. Certainly, peer reviewed does not mean true; much of the published literature in medicine is subsequently shown to be incorrect. It is good to have speculative ideas published, it drives innovation. To use speculative ideas as the basis of a complex treatment protocol is not, to mind, the safe and prudent practice of medicine. I have in my mind a factoid, and I am not sure where I read it, it so it may be in error, that if you have no data to support a therapeutic intervention, the odds are you will do more harm than good. I heard that, I think, as a resident almost 25 years ago and could be misremembering, but I am sure the commentators will set me straight.
“It should be noted that the immunopathological reactions resulting from this approach are sometimes strong enough to be life-threatening in patients with more advanced disease.[3]“
It is good to note that you may be killing people with an intervention. The ethics of almost killing people with unproven treatments is problematic. The ethical guidelines for doing research are found in the Declaration of Helsinki, I will quote from the Wikpedia summary, which I sure will lead to derision.
“Research should be based on a thorough knowledge of the scientific background (Article 11), a careful assessment of risks and benefits (Articles 16, 17), have a reasonable likelihood of benefit to the population studied (Article 19) and be conducted by suitably trained investigators (Article 15) using approved protocols, subject to independent ethical review and oversight by a properly convened committee (Article 13). The protocol should address the ethical issues and indicate that it is in compliance with the Declaration (Article 14). Studies should be discontinued if the available information indicates that the original considerations are no longer satisfied (Article 17). Information regarding the study should be publicly available (Article 16). Ethical publications extend to publication of the results and consideration of any potential conflict of interest (Article 27). Experimental investigations should always be compared against the best methods, but under certain circumstances a placebo or no treatment group may be utilized (Article 29). The interests of the subject after the study is completed should be part of the overall ethical assessment, including assuring their access to the best proven care (Article 30). Wherever possible unproven methods should be tested in the context of research where there is reasonable belief of possible benefit (Article 32).”
I am not so certain that these (nonbinding) guidelines are being adhered to. But if you are almost killing people, it really behooves the proponents to subject the therapies to careful clinical trials to make sure the potential for death is worth the benefit.
Which brings us to China, an internationally recognized center of human rights and ethics. A press release has noted that the Marshall protocol is to be used in the biggest hospital in China. Bigger, of course, is always synonymous with quality. What is being done in China is not clear: a clinic to make money and turn out more anecdotes? Like the fake stem cell clinics? Or is a protocol finally to be put to the test with a placebo control blinded trial in a well defined patient population. If the former, well, I can go to Mexico for a cheaper alternative. If the latter, I look forward to eating my words when a well done clinical trial demonstrates the efficacy of the Marshall protocol.
References
(1) For the record, I have not talked to a drug rep not accepted anything, not even pizza at a conference, for over 25 years. I am, however, the Head of the Vitamin D subcommittee of the trilateral commission.
(2) Autoimmune disease in the era of the metagenome
Amy D. Proal, Paul J. Albert, Trevor G. Marshall
Autoimmunity Reviews. Jul;8(8):677-81. Epub 2009 Feb 13.
(3) Reversing Bacteria-Induced Vitamin D Receptor Dysfunction is Key to Autoimmune Disease
Joyce C. Waterhouse, Thomas H. Perez, Paul J. Albert, 
in press.
(4) Dysregulation of the Vitamin D Nuclear Receptor may contribute to the higher prevalence of some autoimmune diseases in women
Amy D. Proal, Paul J. Albert, Trevor G. Marshall, 
in press.
(5) From Wikipedia
Koch’s postulates are:
1. The microorganism must be found in abundance in all organisms suffering from the disease, but should not be found in healthy animals.
2. The microorganism must be isolated from a diseased organism and grown in pure culture.
3. The cultured microorganism should cause disease when introduced into a healthy organism.
4. The microorganism must be reisolated from the inoculated, diseased experimental host and identified as being identical to the original specific causative agent.
There are ethical and practical limitations to these postulates, but they serve as a reasonable starting point for determining causality.

Meet Your Microbes: uBiome Offers New Service
Harriet Hall on June 25, 2013
Link
We are not alone. Walt Whitman didn’t know how right he was when he said, “I contain multitudes.” The microbes on and in our bodies outnumber our own cells 10:1. Perhaps that creeps you out. Perhaps that makes you curious to know just who all these billions of creatures are that are using your body for a home and a transportation device.
For just $89 you can learn what’s in your gut, nose, mouth, skin, genitals…or sample anything!
The offer comes from uBiome, a “citizen science startup” that has scientific goals somewhere down the line, but for the moment is happy to just provide a personal service, to sequence your microbiome and tell you how you compare to others. The current utility of this offering is questionable. It’s just not ready for prime time.
You are urged to become a “citizen scientist” by contributing your microbiome information to a huge database of other contributors. You get a sample kit, swipe a sample swab across the appropriate area, and mail it back to them. You also fill out an online survey that asks questions about your health, lifestyle, demographics, social connections, and more. You can see how you compare to others, and eventually the data may be used to explore questions about the influence of the microbiome on health.
The choices
     1.  For $89 you can choose to sample your mouth, nose, genitals, or gut.
     2.  For $159 you can sample your mouth and gut.
     3.  For $399 you can sample all 4 of these sites, plus a 5th site behind the ear.
These tests provide a snapshot at one point in time. Your microbial flora will change over time, providing a reason to repeat testing and continue to generate income for the company.
For $229 you can sample your gut bacteria 3 different times, perhaps to gauge the effect of antibiotics or the response to probiotics or changes in diet.
The process
It would be too expensive to do full sequencing. What they are doing is called 16S sequencing, measuring a ribosomal gene in bacterial DNA. They are able to filter out genetic material from humans and other organisms and classify bacteria at the genus level. 16S sequencing is an accepted method of identifying bacteria, but it is problematic. The sequences in some databases are inaccurate, there is no consensus quantitative definition of genus or species, and microheterogeneity within a species is common. False positives occur. In some cases no identification is possible; 14% of bacteria can only be identified by genus. And that can make a BIG difference. Streptococcus is a genus that includes various species, some of which are harmless skin flora, one of which causes strep throat and scarlet fever, and one of which (Strep. pneumoniae) is the target of an immunization, the pneumonia vaccine. Staphylococcus can be the harmless skin dweller Staphylococcus epidermidis or the killer methicillin-resistant Staphylococcus aureus (MRSA). If I were carrying MRSA, I’d like to know about it, but telling me I have bacteria of the genus Staphylococcus would be meaningless, since we all carry some species of that genus.
16S testing can only hope to identify bacteria that carry those ribosomal genes. It can’t identify other microbes we carry, like Archaea, yeast, fungi, and protists.
IRB approval
The website says they have received Institutional Review Board approval to perform research studies. Customers who want to participate will sign a consent form. No consent form is required for the basic service of microbiome compositional analysis and interpretation for private individuals.
“Ethical shenanigans”?
Blogger Melissa Bates is worried about what she calls “ethical shenanigans.” Her concerns:
     1.  Participation requires the payment of a fee
     2.  There is no clear statement about what will be done with the data or samples.
     3.  There is no apparent plan for how your identity will be protected.
     4.  It’s not clear what conflicts the major players in the project might have.
     5.  The benefits you’ll receive are grossly over-stated. They do state that it is not a diagnostic test, but they recommend discussing results with your doctor and say the information may be useful in treating difficult disease.
     6.  There’s no statement as to what your risks of participation are.
     7.  Children are included, but it’s not apparent how they are protected.
After responses from the company and other bloggers, Bates wrote some final thoughts:
We can now safely say based on statements left here and at Comradde Physioprof’s blog that uBiome has not received IRB approval for their project, despite having made what I believe to be grossly over-stated claims about the applicability of their data to human disease and the fact that they have already collected money from their subjects and are in possession of potentially identifying data from their future subjects. That makes this “ethical shenanigans.” I believe that this is made more egregious by the fact that they used their university affiliations to “sell” their donors/subjects on the fact that they could complete their study as they described.
What do we know about the microbiome?
We have just begun to dip our toes into this unexplored ocean. We have learned that certain gut bacteria may be related to obesity and that Clostridium difficile infections can be successfully treated with fecal transplants. It has been speculated that bacteria might be implicated in diseases like autism, depression, multiple sclerosis, etc. A company official told The Guardian:
We are doing exploratory science, and hope to discover correlations that will be useful in understanding health and disease, new bacteria that have not been previously studied, and other knowledge.
The Human Microbiome Project at the NIH, characterized as a feasibility study, is attempting to establish a database by more systematic, conventional scientific methods.
Problems with this kind of research
    • It’s unsystematic.
    • Only those who have the money and interest will be tested; this will not be a random sample of the population and could skew results in unforeseen ways.
    • One-time sampling is not representative of the individual’s life history; it could easily miss microbes present earlier in time that triggered a given disease, or it could identify microbes that were only present transiently and were insignificant.
    • It’s the mother of all fishing expeditions. They are bound to find correlations galore just because of the mass of data, but correlation is not causation. Further studies will be required to tease out meaningful data from the noise and look for evidence of causation.
    • It is inevitable that false conclusions will be drawn prematurely.
    • It will raise a lot of new questions, which is a good thing; but it can’t provide any answers.
Problems with individual testing
We don’t know what constitutes a desirable microbiome. Efforts to increase the population of one microbe might benefit you in one way while harming you in another. We don’t begin to understand all the permutations and the ways in which bacteria influence each other. It’s an incredibly complex ecosystem, a web where tweaking on one part might drastically warp other parts. You can test your microbiome before and after starting a diet, and you may see some changes; but how will you interpret what the changes mean? You won’t know whether the changes were due to your diet or to some other factor.
Comparison with genome testing
Personal genome testing is being offered to the general population by numerous companies. It doesn’t sequence the entire genome, but only SNPs (single nucleotide polymorphisms). The company 23andMe advertises that on average, one person in five develops diabetes by age 79, and that variations in your DNA that they test for might raise your risk to one in three. That’s not particularly helpful. Diabetes is multifactorial. Genes are not destiny. Having the associated genes doesn’t mean those genes will be expressed, and it doesn’t tell us how other genes or environmental factors might affect gene expression. Even if you are only at average risk, you ought to already be making appropriate lifestyle choices like exercise and weight control; you shouldn’t need whatever additional motivation the knowledge of a slightly higher risk might provide. They test for a rare mutation that is associated with a nearly 60% lifetime risk of Parkinson’s disease, but if you have that mutation there is nothing you can do to reduce your risk, and there is a 40% chance you won’t get the disease anyway. BRCA1 is a highly significant mutation, with a risk of breast cancer as high as 87%, and we have an effective way to reduce that risk. That was the reason Angelina Jolie decided to have both breasts removed. If she had relied on direct-to-consumer genomic testing, they wouldn’t have detected that risk: because of patent protection, there is only one company that can test for BRCA1.
Direct-to-consumer genomic testing promises much but delivers little. It isn’t good for much. uBiome is good for even less.
Conclusion
As a scientific endeavor, uBiome is questionable. As a personal medical test, it is essentially meaningless at our current state of knowledge. Just because we can test something doesn’t mean we should, and it doesn’t mean we will be able to understand the test results, much less do anything about them to improve our health. Biome testing is simply TMI (too much information).

Yet another plague panic
Mark Crislip on August 8, 2014
Tweet
Case #3 from the 1976 Ebola outbreak in Zaire; picture by Dr. Lyle Conrad, Centers for Disease Control – Centers for Disease Control and Prevention’s Public Health Image Library (PHIL), with identification number #7042.
This image is in the public domain and thus free of any copyright restrictions. As a matter of courtesy the CDC requests that the content provider be credited and notified in any public or private usage of this image. Taken from the Wikimedia Commons.
Thirty plus years in medicine has given me some perspective as has infectious diseases (ID). One of the almost TNTC cool things about ID is that infections, unlike the diseases of modernity, have been plaguing humans since before we were humans.
There is a sense, a usually unvoiced assumption, on the part of many people that we are supposed to be healthy, that our default mode is good health and that with the proper diet and attitude we could obtain the health that was ours before the fall.
I think not. I see no perfection in any human, except maybe my wife who would achieve perfection if only she liked beer and steak.
We are a hodgepodge of anatomic and physiologic compromises that allowed us to spread across the world. But if you like to read history, you realize that most of the time we died like flies from infections, trauma and other medical problems. The variations that allowed us to survive malaria or tuberculosis led to sickle crises and the metabolic syndrome. Even with evolution no good mutation ever goes unpunished.
And, immunologically, we are perhaps as individual as snowflakes. We currently lack the cost-effective technology to check for the many polymorphisms that increase or decrease our odds for infection. Just have the wrong form of snot and it increases your risk for meningitis. Who knows what genetic variations are lurking to increase (or decrease) the risk of disease?
So I do not see the baseline for animals as healthy, just healthy enough to survive and reproduce and there is not a lot that can be done to be healthy beyond the simple basics: don’t be fat, eat a reasonable diet, exercise, avoid too much alcohol and any tobacco. No matter what you do you will get old and sick and die, but if you were lucky enough to get the right genes (please, let me have my mother’s not my father’s) you may get a reasonably healthy life.
Men at some time are masters of their fates: The fault, dear Brutus, is not in our stars, But in ourselves
I also expect infections, new and old, to sweep across the world. It happens all the time. There was no AIDS when I started medical school. West Nile Virus was not in the US until about 1999. Since then West Nile has spread across the US to all lower 48 except Oregon. We still have had very little local transmission of West Nile in Oregon. I credit the hops. H1N1 influenza had not been seen for 50 years but it came back like gangbusters in 2009.
Infections spread across the world all the time. It may be birds (West Nile) or planes (SARS) or boats. Bubonic plague was unknown in the West until steam ships brought to San Francisco in 1900, and then plague spread across the west.
There are many factors that can contribute to outbreaks and the spread of infectious diseases. You need susceptible hosts, you need an infectious organism, and you need an efficient mode of transmission.
The best ways for infections to spread are coughing and sex. Avoid sex with someone who is coughing I always say. The nice thing about sex as method of spread is that the organism does not have to be present in high amounts or be very infectious since sex appears to be a past time that people enjoy repeating. Most people with herpes, as an example, are never symptomatic and secrete small amounts of virus all the time.
HIV has been interesting. In the old days, before we knew about HTLV-3, we only knew the risks for HIV, one of which was having many sexual partners. It was not uncommon for patients to report Wilt Chamberlin numbers for their sexual contacts. That has changed and there is some suggestion that as the number of partners has declined along with an increase safer sex, HIV may have become more virulent. With less opportunity to be passed on, only the more infectious/virulent strains survive, although HIV maintains the same mode of transmission.
Every couple of years there is a new infection that gets everyone worried. HIV, SARS, West Nile, Legionella, MERS –CoV have been the worries in my time.
Now Ebola is the current infection most in the news with 1,700 cases and 930 deaths as of today. It took six months to cause that many cases in an area with a population of around 20,000,000. And this in an area with a horrible infrastructure for both health care and infection control. While a ghastly outbreak, Ebola does not appear to be particularly infectious or pose much of a pandemic risk.
Compare that with H1N1:
From 12 April 2009 to 10 April 2010, we estimate that approximately 60.8 million cases (range: 43.3-89.3 million), 274,304 hospitalizations (195,086-402,719), and 12,469 deaths (8868-18,306) occurred in the United States due to pH1N1.
and perhaps 250,000 deaths worldwide. Ebola, from an epidemic potential viewpoint, appears to be trivial. It looks to be one of many localized outbreaks of awful diseases in the world that are common and may be increasing in the future.
Ebola is spread by direct contact with blood or secretions from the infected person and as such should, in areas with resources, be controlled with aggressive infection control procedures. Based on what is known to date, I do not worry overmuch about the spread of Ebola in the US. Direct contact is not a very efficient way to transmit infections, especially infections that are rapidly fatal. Most infections routinely spread by direct contact are relatively indolent. Maybe I am overly sanguine, but I do not see much to worry about with Ebola from either an epidemic potential or having patients brought to the US.
Thirty year of following infection control procedures and I have yet to catch an infection from a patient. I remember at the start of the AIDS epidemic there were those who refused to care for AIDS patients due to worries of catching the disease. It never worried me since I knew the modes of transmission and I did not partake of those behaviors. That said, I still remember the first AIDS patient I took care of, before we knew about HTLV-3, offering me a chocolate from the box at his bedside while declaring he would have to “spit in my mouth” to pass on AIDS. While I had no problem touching the patient, shaking hands and doing an exam, I politely declined the chocolate. I would eat one today however, as long as it didn’t have walnuts.
It is curious that people worry about Ebola, yet little is said about Dengue, another very common hemorrhagic fever that is at our doorstep.
The World Health Organization (WHO) estimates that 50 to 100 million infections occur yearly including 500,000 DHF cases and 22,000 deaths.
Dengue has the most efficient mechanism for infection spread known: mosquitos. I have seen it estimated that half of all human deaths are due to infections spread by mosquitos. Dengue is present throughout Central and South America and the mosquitos that spread the infection, Aedes aegypti and Aedes albopictus are ubiquitous in the Southern half of the US (and, sadly, Oregon). 40% of people who have never left Brownsville Texas (and who would not want to leave Brownsville Texas?), have serologic evidence of Dengue. There has been an outbreak in the Florida Keys and where there is Dengue, there follows Yellow fever.
Both diseases have the potential to spread (or re-occur as in the case of Yellow fever, which caused considerable morbidity and mortality in the 17th and 18th century US) with global warming and the potential northern spread of the mosquito vector. No one seems worried about these two infections, but instead fret about Ebola, some of it totally wackaloon.
There are many infections to worry about, with potential for local outbreaks, epidemics and pandemics. But that has always has been the case. The best we can do for most infections is a holding action, keeping them at bay with public health measures such as vaccines and potable water. Unfortunately, I doubt we will ever repeat the successes such as the eradication of smallpox and rinderpest and many of the predicted short term changes (the next 1,000 years or so) would likely increase the spread of many infections.
These infections do offer opportunities for those in the world of pseudo-medicine. For some, like the Natural News, perhaps alternative medicine is preferred term, because it suggests the alternate universe, the one where Spock has a goatee, and not the real world in which I live.
Although homeopaths have weighed in on the appropriate magic water to be used to treat Ebola, evidently homeopaths are not heading for Africa to prove the efficacy of their therapy and there will be scant opportunity for them to use their magic in the US or Europe to treat Ebola.
Homeopaths love to credit the proof their superior therapeutics to the cholera outbreaks in London in the 19th Century. Given the purging and bleeding that were the standard medical therapy at the time, the nothing of homeopathy was likely better than the dangerous interventions of the time.
There have not been many epidemics this century for which homeopathy could test their mettle. H1N1 hit hard and fast and to judge from the few papers on homeopathic treatment, it can be judged as hit or miss. Or perhaps miss and miss, give the quality of homeopathic research that resulted from the H1N1 epidemic.
We may be primed for a new epidemic in the US: chikungunya. It is in the Caribbean where it is going gangbusters: in 8 months over 500,000 cases.
Six out of 10 cases have been reported from the Dominican Republic, which tallied 307,933 cases in Epidemiological Week 31, up 26,000 cases from last week. In addition to the DR, Guadaloupe reported 71,000 cases, Haiti reported nearly 65,000 and Martinique recorded 54,000. The French side of St. Martin, where the epidemic began has reported 4,500 cases.
Now that is an epidemic. Spread by mosquitos, almost everyone who gets the virus has symptoms: fevers, muscle and joint pain, rash and headache, often quite severe. Death is rare.
There are now a few cases of chikungunya transmitted in the US, and once it gains a toehold it should spread fast. It took West Nile less than a decade to cross the US, although it had help from birds. Perhaps it will hit the poor disproportionately since they do not have air conditioning to keep themselves cool and away from mosquitos.
Homeopaths have treatments for chikungunya, although they retain their usual inability to understand the difficulties in assigning causality to events when treating a process that by its nature is self-limited.
We are probably on the cusp of millions of cases of chikungunya in the US. Given that there is no specific treatment or prevention (besides avoiding mosquito bites) for chikungunya and 70-90% of those infected will become ill, it is perfect opportunity for homeopathy, and the other pseudo-medicines, to put up or shut up. An epidemic is probably coming for which medicine only has supportive care, the perfect opportunity for pseudo-medicines to demonstrate their superior effectiveness with modern methods.
Somehow I suspect it will not happen.
P.S.Idle thoughts. I have asked psychiatrists why practicing homeopathy does not meet the criteria for delusional disorder. I always get a blank look. I am not a fan of the DSM, mostly as one past girlfriend or another has used it in attempt to classify me and I am well aware of the sordid history of using psychiatry as a means to suppress those whose opinions are unpopular. The latter is certainly not appropriate.
It seems to fit and homeopaths are a danger to others, since they act on their delusions. Probably a weakness in the DSM rather than homeopaths.
It remains one of the curiosities of human culture and medicine. People can believe in and practice medical systems that are totally divorced from reality with an acceptance found in no other profession. Weird.

   Live Blood Analysis: The Modern Auguries
Mark Crislip
Link
I saw a patient last week who was self referred. He had been seeing a DC/ND for a variety of symptoms that turned out to be asthma. Not that the DC/ND made that diagnosis. His DC/ND diagnosed him with an infection, based on live blood analysis, and offered the patient a colonic detox as a cure. My patient thought he should get a second opinion before he submitted to a cleansing enema, always a good policy
Live blood analysis to diagnose an infection. I had never heard of the technique, but thanks to the google and the interwebs, I was soon immersed in the field.
In live blood analysis, the “physician” takes a drop of the patients blood and examines it under a high power phase contrast or a darkfield microscope. Changes in the constituents of the blood are noted and linked to a variety of ills.
It is an impressive and expensive system: microscopes and various support equipment start at around $5000 (3). However, live blood analysis has the opportunity to be lucrative in the right hands as the patient often gets weekly analysis to see how the interventions (usually supplements sold by the blood analyst) are working. Evidently in the hands of a skilled snake oil salesman, an income of $100,000 a year to more can be generated (8).
Live blood analysis is one of these alternative methodologies that has a hint of legitimacy that is extrapolated far out of proportion to its validity.
Phase contrast and darkfield microscopes are used in medicine, in my world primarily to look for syphilis. As a rule, most pathologic changes in the blood are best seen when various stains are applied to the blood sample. Most commonly a Wright”s stain is used on blood cells, because many diagnostic features are invisible on phase contrast. There are many different stains used in the pathology laboratory to help identify what you are observing under the microscope. Using different stains on microbial specimens can help categorize organisms before they can grow. It is not either-or, both phase contrast and other modalities are used in clinical medicine. More practical clinical information is derived from light microscopy on stained specimens.
An evaluation of the cells of the blood can give hints to the presence or cause of many diseases, from vitamin deficiencies to infection to leukemia. The CBC (complete blood count) with or without a differential (the types of cells seen) is part of any initial evaluation of ill patients.
With live blood analysis, practitioners take the seed of truth that the evaluation of the blood constituents can give valuable information and grow a forrest of fantasy and magic. It is something to behold.
Besides live blood, some practitioners also practice dry blood analysis, where they examine clot to look for patterns that are allegedly indicative of diseases.
Let’s evaluate each diagnosis made on live blood analysis. Note the key feature of each alleged diagnosis. The problem lies in diet, and supplements are the solution to the problem, which, it just so happens, are sold by the live blood analyst. Curious that while I am alleged to be a shill of big pharma, I do not get dime one from any supplements or other products sold in my office because I don’t sell stuff to my patients. Any alternative provider who makes part of their living from selling supplements has far more conflict of interest than most physicians.
Someone may argue that I am an Infectious Disease doctor, what do I know about blood analysis. I also showed these photographs to a hematopathologist and a hematologist. It was refreshing how they laughed and laughed and laughed at the descriptions I showed them of live blood analysis.
Live blood analysis evidently began with Gunther Enderlein at the turn of the last century. He was in the Bechamp school of disease etiology and his concepts are unintelligible in the context of modern biology and physiology. Enderlein placed blood under a darkflield microscope and interpreted the artifacts he saw as quasi-life forms, which he called protits, symbionts or endobionts, that could transform into pathogens (11). Only Live Blood analysts can see these forms. As one site says “Enderlein’s “Endobiont” only had meanings to dark field microscopists following his teaching (10).” There is large inter-operator variability in analyzing live blood and no two live blood analysts see the same pathologic changes on the same slide (7). Live blood analysis is the N-Ray of microscopy.
Overtime live blood analysis expanded to include multiple diet related diagnosis, and is sometimes called nutritional blood analysis, the better, I suppose, to sell expensive supplements.
Here is where I apologize.
It appears that copyright laws prevent me from showing specific examples to blood analysis, so I add the link instead. Lots of clicking back and forth, I know, but I do respect intellectual property, although to apply the word “intellectual” to live blood analysis is akin to calling a naturopath a doctor. Lets say I respect their property. These photographs are widely reproduced on the net, but I am uncertain as to who, if anyone, owns the copyright, so I will be careful. There is evidently one lawyer for every 265 Americans.
Rouleau (http://www.healthsystem.virginia.edu/internet/hematology/HessEDD/BenignHematologicDisorders/redbloodcelldisorders/rouleaux.cfm)
In real medicine rouleau is an anomaly seen with paraproteinemias such as multiple myeloma. The extra proteins in the blood alter the charge on red cells, causing them to stack like coins.
In the world of live blood analysis, the are more causes:
“Often poor protein digestion. The pancreas may be off. Excess dietary protein, poor assimilation. Eating too much animal protein. Blood too toxic (altered blood pH) from stress, coffee, cigarettes, meat, etc. Dehydration, not drinking enough water (2).” None of these issues is known to cause rouleau formation. However, it you have multiple myeloma and you see a live blood analyst, the chance of having a serious and important diagnosis misdiagnosed and incorrectly treated is high.
Other photos here: http://healthenlightenment.com/live-blood-cell-analysis.shtml
RBC Aggregation http://www.betterblood.net/gallery.htm
“The loss of the negative surface charge; this is a more disorganizing symptom where plasma acids act as molecular glue, causing RBCs to stick together (0).”
The “Live Blood Analysis Diploma Course (1)” says it is due to “ingestion of high fat meals, high blood cholesterol levels, and blood fat chemistry imbalances.”
No. That is not the cause of red cell aggregation outside of Dr. Young, the acid maven. There are no plasma acids that act as a molecular glue. Diet does not make red cells stick together, unless you dine on Elmer’s.
Protein Linkage http://www.betterblood.net/gallery.htm
“Over acidity and blood pH imbalance. The diet is high in strong acids from proteins and carbohydrates. (0)” Perhaps “digestive insufficiency, excess protein consumption, imbalanced electrolytes, and inability to assimilate lipids or toxicity (1). ” A pathologic finding due to an excess and an insufficiency.
This is a made up nonsense. Blood pH is constant at 7.4 and varies not at all except under severe metabolic derangements like diabetic ketoacidosis and sepsis.
Macrocytes, Microcytes http://www.betterblood.net/gallery.htm
“Ingestion of an excessive amount of over acidic food and drinks which causes a deficiency of sodium bicarbonate in the alkalophile glands (4).”
Macrocytes are most often due to B12 or folate deficiency, although there are other causes like AZT and hypothyroidism. Microcytes are most often due to iron deficiency and can be a marker of bowel cancer. Microcytes and macrocytes on a smear can represent serious underlying diseases, but are not due to “a deficiency of sodium bicarbonate in the alkalophile glands. ” Missing the real cause of these abnormalities could prove fatal, which, with their erroneous understanding of blood cell morphology, live blood analysts would be prone to do.
Echinocytes http://www.betterblood.net/gallery.htm
“Latent tissue acidosis in the extra cellular fluid and the body’s inability to remove acid waste build up in the blood causing the cells to break down (0).”
No, latent tissue acidosis is not the cause of echinocytes. These are pathologic and a marker of liver disease.
Fibrous Thallus http://www.betterblood.net/gallery.htm
“Indicates a nationalization of bacteria, yeast/fungus, mold, and their acid wastes and acid crystals lying in a dormant/inactive state (0).” Sounds worrisome. Biomedx says “The presence of large numbers of protoplast structures in peripheral blood is an unfavorable sign. Some authors propose they are a collection of progenitor cryptocides (Livingston-Wheeler). Progenitor meaning existing across millennia at the beginning, cryptocides meaning cellular killer. Protoplasts are thought to be related with infectious disease or neoplastic activity and or L-form bacteria. They are thought to be viral in origin (5).” Try as I might, I cannot understand what any of this means.
When you look at the photograph, what is seen is artifact of the slide, not a constituent of blood. Schmutz. Slides are not pristine and stray bits of cloth, cells and environmental dirt is common on the cells. A skilled microscopist understands the difference between artifact and real pathology. The patient, however, does not, and if I were not knowledgeable about cellular morphology I would be most impressed to see a large fibrous thallus in my blood. The explanation of fibrous thallus is nonsensical pseudoscientific gibberish.
Fibrin Spicules http://www.betterblood.net/gallery.htm
“Involved in clotting to prevent internal bleeding. There is usually an increase during detoxification with the complete program and effective diet because the body is pulling acids stored in the connective tissues back into bloodstream for elimination (1).”
Glass is good at causing fibrin to precipitate out of blood, so occasionally you will see clot on the slide. Some of the photos in the net are artifact, some are fibrin, and all are the normal response to blood on glass. Again, the explanation is nonsense.
Mold http://www.betterblood.net/gallery.htm
“Yeast overgrowth, collection of yeast, bacterial, fungus, mold. very toxic. Indicated in advanced stages of latent tissue acidosis. Highly disruptive to normal blood circulation (0).”
You never see mould in the blood in people who are not in the ICU dying of sepsis and profound immunocompromise.
These are not mold, they are artifacts on the slide.
Target Cells http://www.betterblood.net/gallery.htm
“Fermenting RBCs; White spots or white yeast forms inside RBCs; Indicates the diet is too high in carbohydrates/simple sugars; sugar intolerance and/or imbalance; endocrine system/ pancreas stress (0).”
Red cells do not ferment and yeast do not live in red cells. This is fiction.
Yeast http://www.betterblood.net/gallery2.htm
“Born out of RBCs due to blood pH Imbalance from latent tissue acidosis; diet too high in protein, carbohydrates/ sugars; may be caused by excess antibiotic use, hormonal therapy, steroid use; fungal outfection (0)”
This is artifact, not yeasts. Yeasts can only been seen in people dying of overwhelming sepsis from profound neutropenia. Yeasts are not “born out of RBC’s.” More nonsense.
Platelets http://www.betterblood.net/gallery2.htm
“High counts are due to latent tissue acidosis and excess acids in the bloodstream not being eliminated through the urinary tract causing RBCs to biologically transform giving birth to “filthy, dirty, platelets.”
Red blood cells do not biologically transform into platelets, much less filthy dirty ones.
Rod Forms http://www.betterblood.net/gallery2.htm
“Bacterial forms born out of RBCs and found in the blood when there is latent tissue acidosis which alters the blood pH; due to acidic diet, emotional or physical stress, low nascent oxygen (O1); waste products of bacteria and yeast/ fungus (0). ”
Bacteria are not born out of red blood cells. More fiction and fantasy. The rod forms, like the L forms seen in some slides, are artifacts. The rods are many times larger than any known bacteria.
Anesthetized WBC”s http://www.betterblood.net/gallery2.htm
“Indicates recent consumption of excess sugars/ carbohydrates or proteins; WBCs are paralyzed by the acids (acetyl aldehyde, ethanol alcohol, lactic, nitric, uric, sulfuric, and phosphoric) for up to 5 hours (0).”
White cells cannot be anesthetized, although I can be when reading these sites. The photo to me and others appears to be a normal cell. Of course, if you can diagnosis a normal cell as paralyzed by a dietary lack, then everyone can benefit from supplements.
Basophiles http://www.betterblood.net/gallery2.htm
“Perceived to be related to allergies and/or sensitivities to foods or the environment; exotoxic and mycotoxic reactions; histaminea. Alergic reactions to dairy (0).”
The only way you can diagnose a basophile is by staining it.
Crystals http://www.betterblood.net/gallery2.htm
“Crystals are observed when there is excess acidity. It is the body’s preservation mechanism to buffer acidity and create a solid form which is less toxic than the liquid acids. Crystal are perceived to be he signature of the microzyma fermenting sugar, protein or fat (0).”
Making more stuff up. I feel like there should be a midget shouting “Boss, Boss, Da live blood, the live blood” as they only place such physiology exists is on fantasy island.
The crystals on every live blood site are artifact not of blood, but of schmutz on the slide. One practitioner noted some of the crystals looked like glass, but were in cholesterol. No, it was glass, a by-product of making the slides from glass. Microzyma are not the small empress of Oz, but the imaginary micro organisms of Bechamp and are artifacts of darkfield microscopy.
Black Crystals http://www.betterblood.net/gallery2.htm
More schmutz/artifact on the slide.
“Tobacco, marijuana; chemical, recreational and prescription drugs. Brown is also associate with the fermentation of protein (0).”
I can imagine some gullible person losing a job because of drug use found on live blood analysis. If companies will use handwriting analysis or, in Japan, blood type as a basis for hiring and firing, live blood analysis will be next.
Cholesterol http://www.betterblood.net/gallery2.htm
More schmutz on the slide. You cannot see cholesterol on a blood smear.
“Usually indicates high blood pressure, arterial sclerosis, high cholesterol. Diet is too high in animal source proteins. Dehydration, acidosis (0).”
Taking the blood pressure usually indicates high blood pressure. It is a simple enough diagnostic procedure and more reliable than looking at live blood. Similarly, a fasting lipid panel may be the more accurate way to diagnosis hypercholesterolemia.
In summary, virtually every diagnosis in live blood analysis is nonsense and much of the alleged pathology is either normal or artifact on the slide. The alleged pathophysiology is also nonsense; they just make this stuff up.
Live blood analysts tend to make up words and processes that sound scientific and cromulous (6): several sites refer to seeing orimbryonic bacteria, but the google cannot find a definition. This pseudoscientific jargon and imaginary physiology combined with the a microscope and a view of their own blood, which most people have never seen, gives the live blood analysis proponents the trappings of real science. A nickel says they wear white coats.
There is no validity behind almost all of the claims made by the practitioners. The one study that looked at the ability for blinded live blood analyzers to make the same diagnosis demonstrated that no two viewers saw the same thing (7). The one diagnostic trial of live blood analysis demonstrated that practitioners were unable to accurately diagnose patients with known metastatic cancer (9).
Many of the web sites show before and after slides to demonstrate the benefits of the detox or supplements or diet have had on the blood. It all depends on what microscopic field on a given slide you choose to present. If you were to show the front of my scalp as the before and the back as the after, you would conclude that something made my hair grow in the interim.
Live blood analysis is a remarkable the combination of artifacts being diagnosed as pathology combined with an imaginary pathophysiology that is completely divorced from reality. It is microscopic paradolia, with the practitioners seeing their own imagining in the structures on the slides. When I was a child, before I learned to cursive writing, I would make squiggles on paper occasionally crossing a ‘t’ and dotting an ‘i’. It was gibberish but I called it real writing. I didn’t realize I was in training to be a live blood analyst.
Live blood analysis does not resemble most alternative medicine modalities, but is more akin to high tech reading of tea leaves or the entrails of pig to divine the future. It is the cargo cult of quackery, with the trappings of science but none of the substance.
Notes
0) http://www.betterblood.net/gallery.htm
1) www.collegenaturalmedicine.com/images/LBA/LBACOURSES/interpretng%20blood%20morphologies-8-1.pdf
2) http://biomedx.com/microscopes/training/LB1.html
3) http://biomedx.com/microscopes/systems/pricing.html
4) “alkalophile glands” appears to be an invention of Dr. Young, a major shill for acids as the cause of every diseases. As he says “alkalophile glands that need these quick bases in order to build up their strong sodium bicarbonate secretions. These glands and organs are the stomach, pancreas, Brunner”s glands (between the pylorus and the junctions of the bile and pancreatic ducts) Lieberkuhn”s glands in the liver and its bile with its strong acid binding capabilities which it has to produce.” http://articlesofhealth.blogspot.com/2008/10/get-off-your-fat-acid.html
5) http://biomedx.com/microscopes/training/LB6.html
6) Thanks Steve.
7) Altern Ther Health Med. 2006 Jul-Aug;12(4):36-41. Reliability of Enderlein’s darkfield analysis of live blood.
CONTEXT: In 1925, the German zoologist Günther Enderlein, PhD, published a concept of microbial life cycles. His observations of live blood using darkfield microscopy revealed structures and phenomena that had not yet been described. Although very little research has been conducted to explain the phenomena Dr. Enderlein observed, the diagnostic test is still used in complementary and alternative medicine.
OBJECTIVE: To test the interobserver reliability and test-retest reliability of 2 experienced darkfield specialists who had undergone comparable training in Enderlein blood analysis.
SETTING: Inpatient clinic for internal medicine and geriatrics.
METHODS: Both observers assessed 48 capillary blood samples from 24 patients with diabetes. The observers were mutually blind and assessed their findings according to a specific item randomization list that allowed observers to specify whether Enderlein structures were visible or not.
RESULTS: The interobserver reliability for the visibility of various structures was kappa = .35 (95% CI: .27-.43), the test-retest reliability was kappa = .44 (95% CI: .36-.53).
CONCLUSIONS: This pilot study indicates that Enderlein darkfield analysis is very difficult to standardize and that the reliability of the diagnostic test is low.
PMID: 16862741
http://www.quackwatch.com/01QuackeryRelatedTopics/Tests/livecell.html
(8) http://www.quackwatch.com/01QuackeryRelatedTopics/Tests/livecell2.htm
(9) Forsch Komplementarmed Klass Naturheilkd. 2005 Jun;12(3):148-51. Epub 2005 Jun 23. [Does dark field microscopy according to Enderlein allow for cancer diagnosis? A prospective study]
BACKGROUND: Dark field microscopy according to Enderlin claims to be able to detect forthcoming or beginning cancer at an early stage through minute abnormalities in the blood. In Germany and the USA, this method is used by an increasing number of physicians and health practitioners (non-medically qualified complementary practitioners), because this easy test seems to give important information about patients’ health status.
OBJECTIVE: Can dark field microscopy reliably detect cancer?
MATERIALS AND METHODS: In the course of a prospective study on iridology, blood samples were drawn for dark field microscopy in 110 patients. A health practitioner with several years of training in the field carried out the examination without prior information about the patients. RESULTS: Out of 12 patients with present tumor metastasis as confirmed by radiological methods (CT, MRI or ultra-sound) 3 were correctly identified. Analysis of sensitivity (0.25), specificity (0.64), positive (0.09) and negative (0.85) predictive values revealed unsatisfactory results.
CONCLUSION: Dark field microscopy does not seem to reliably detect the presence of cancer. Clinical use of the method can therefore not be recommended until future studies are conducted.
(10) http://www.drseeger.com/endobiontprion.html
(11) A miniature form of Venom.

   Honey
Mark Crislip 
Link
I cram for TAM, and, combined with other commitments, not the least of which is that it is finally sunny and warm in Portland, after a year that has resembled All the Summer in a Day, which leads to a relatively short post. There are just so many hours in a day and if possible those days need to be spent in the sun.
In my first year in practice I was sitting on a nursing station writing a note when a patient started howling in pain. Further investigation revealed that the patient had a chronic, open surgical wound and the (old) surgeon had ordered sugar poured into the wound as part of wound care. The cafeteria mistakenly sent up salt, and a metaphor became reality. It did pique my interest in both sugar and honey for wound care, an area where you have to be careful not to fall prey to all the errors in CAM thinking: a reliance on anecdotes, using suboptimal studies as evidence, mistaking a gobbet of basic science as a meaningful clinical application, and not realizing the warping effect of confirmation bias.
That being said, I have suggested honey and sugar for years for patients, and many patients with prior refractory wounds had healing. And what are the three most dangerous words in medicine? In my experience. I have recommended honey less in the era of the wound vac, but there are not an insignificant number of people with insufficient financial resources who cannot afford even simple wound care supplies. Many of the ointments, creams and special bandages for wound care costs too much. Patients also like honey as it is natural (people do love to fall for the naturalistic fallacy) and inexpensive, and I always tell patients that the data is iffy, but not stupid.
Wound itself is mostly a combination of tradition and hype. One doc learned from his attending who learned from their attending, in a line that stretches back to the first barber-surgeon. I was told as a medical student, never put in a wound what you wouldn’t put in your eye, which seemed to be a good guiding principle, although it is expensive to pack a wound with soft contact lenses. New products, often combinations of old treatments, come out monthly with flashy brochures and little good data.
“There is a lack of large, high-quality published RCTs evaluating debridement per se, or comparing different methods of debridement for surgical wounds, to guide clinical decision-making. ”
So I rely on basic principals. Keep the wound clean, keep the new tissue from drying out, remove the dead meat, and keep the bacteria at bay, and do not let your pet lick it are more or less guiding rules in wound care. That, and no matter what you do, most people will heal. My rule remains: take credit for success, blame nursing when things go wrong. That’s ‘humor’ for the sarcasm impaired.
What is the rationale for sugar and honey for wounds and burns?
Basic Biologic Plausibility
The first is mechanism of action is primarily mechanical. The high osmolality of sugar and honey prevents bacterial overgrowth. Food can be preserved in sugar (jam is a good example) so the honey and sugar can prevent or decrease bacterial colonization of wounds. Honey has a low pH and contains hydrogen peroxide, both of which are antibacterial, but I doubt clinical relevance of the latter. And there may be bee and flower constituents that aid in antibacterial properties, although again I wonder about clinical relevance. Also, sugar and honey do not damage new tissues and when the honey is washed off, it painlessly removes the dead tissues with it, so it is good for debridement.
Honey, and to make sure you can charge a premium amount call it medical grade honey, can kill bacteria and decrease skin colonization. Avoid raw honey, as it can contain C. botulinum and has been the source of botulism in children. I don’t expect it would be of much use on facial wrinkles
At least from a basic science perspective, honey and sugar have mechanical, perhaps biochemical, and certainly financial, reasons it could be beneficial in wound care.
Clinical trials
So how are the clinical trials? There are lots of poor quality studies. Almost 400 references if you are in the mood for cherry picking. The preponderance of the poor quality studies points to benefit.
For burns?
“Available evidence indicates markedly greater efficacy of honey compared with alternative dressing treatments for superficial or partial thickness burns, although the limitations of the studies included in the meta-analysis restrict the clinical application of these findings.”
and
“Honey may improve healing times in mild to moderate superficial and partial thickness burns compared with some conventional dressings”
For Wounds?
From the ever helpful and potentially flawed Cochrane reviews:
“Honey dressings as an adjuvant to compression do not significantly increase leg ulcer healing at 12 weeks. There is insufficient evidence to guide clinical practice in other areas.”
and as they note
“The poor quality of most of the trial reports means the results should be interpreted with caution.”
So be it. I have read many of the 400 references over the years, and the sense is that honey is of some value in wound care.
There is even less information of granulated sugar, where it looks encouraging and has been used to treat mediastinitis , diabetic foot ulcers and sloughing wounds.
Of course, honey is not the end all and bee all of treating soft tissue infections. Depending on the process, surgery and antibiotics will do far more to resolve the infection and promote healing, espcially for acute and/or acutely infected wounds. Relying on only natural products has lead to one death in a complimentary practitioner who treated himself with honey:
“a minor injury became infected with gangrene, the judge was told. He died, aged 52, in April 2007. Instead (of standard care) he used honey and magnesium sulphate.”’
The doctor who treats themself has a fool for a patient and an idiot for a doctor.
So in the end, do I recommend honey and sugar? Yes. The literature is interesting and I give patients a long list of caveats. It is maybe sort of probably useful in patients with chronic wounds who cannot afford other interventions. In my experience it always works. Back to TAM.

   Hi Ho Silver
Mark Crislip
Link
I was making rounds at the hospital and, for some strange reason, I was being asked about influenza. No, this is not going to be an entry on influenza. But I was asked if there was anything besides the vaccines that can prevent influenza. Masks and good hand washing will help, I said.
Anything else?
A nurse suggested colloidal silver.
I said there was nothing to colloidal silver. With what I would describe as a withering look, she opined that not only had she never had the flu because she took colloidal silver, but that she has a friend whose tumor has been in remission for 6 years because of colloidal silver. She had to respond to an alarm and I had to move on to the next patient, so we yet had an opportunity to converse further on the topic. Which is good because it occurred to be I did not know much about colloidal silver beyond the fact it can turn you blue. So this entry in my attempt to prepare for my next discussion with a colloidal silver proponent.
Silver is an antiseptic, not an antibiotic. It has the advantage of most antiseptics in that organisms do not easily become resistant. It does kill a large number of pathogens and is used clinically. Silver is impregnated into catheters to prevent infections. Silver nitrate has been put in the eyes of newborns to prevent gonorrhea.
Various formulations of silver have been tried to aid wound healing, with little effect and Silvadene, silver sulfadiazine, has long been used to treat burns, although its efficacy, when compared to everything from honey to aloe, is often found wanting. So there is variable clinical data to perhaps supporting use of some forms of silver to treat or prevent some infections. I will admit to an affinity to suggesting honey and or sugar for chronic wounds; that should be a topic for another post. There are also uses of silver for water purification. So there are legitimate reasons to use silver as an antiseptic.
Ancient wisdom is always a guide for therapy. Cupping. Bleeding. Purging. Popular therapies back in the day. Silver containers was used by ancients to keep water and other fluids fresh. I cannot find independent verification of this fact, perhaps they kept water in silver because silver is pretty and rare and good for demonstrating wealth, and we are attributing its antiseptic properties retroactively. Nor can I find independent verification that Royals were called blue bloods due to chronic silver exposure from their eating utensils. Odd that colloidal silver sites would mention this, since it is evidence of toxicities they deny occurs in other sections of the same websites. The use of apocryphal information appears to be standard in the colloidal silver ‘literature’. It is rare to have so little verifiable information about a treatment.
As I have discussed before, users of alternative therapies are not comfortable with nuance and subtlety, and, I think, prefer black and white binary approaches. Mercury in one form is toxic, so all forms of mercury are toxic. Some forms of silver are beneficial, so all forms of silver of benefit, including colloidal silver. The inability to deal with shades of gray is a hallmark of many forms of alternative therapy.
As best I can tell, silver was used as a medicine for years by grinding it up and suspending it in water. The problem is that the silver is not dissolved but is a suspension and it rapidly settles out of solution. What people were looking for at the turn of the century was a way to keep the silver in suspension. Colloids occur when one substance is evenly distributed in another without being dissolved, like antibodies or albumin in blood. Or fat in milk. Proteins like albumin have the advantage of binding metals like silver and allow them to stay in suspension for long periods of time.
“The broader commercial definition of “colloidal silver” includes products that contain various concentrations of ionic silver, silver colloids, ionic silver compounds or bound proteins in purified water. Colloidal silver with concentrations of 30 parts per million (ppm) or less are typically manufactured using an electrolysis process, whereas colloidal silver with higher concentrations of 50 ppm or more are usually silver compounds that have been bound with a protein.”
In the form of colloidal silver it is ingested for various alleged health benefits, especially to treat infections.
How many infections? “Colloidal Silver safely kills over 650 disease-causing bacteria, viruses, fungi, parasites, and molds, has no negative side-effects.” 650! Wow! Where does that number come from? It, evidently was pulled out of thin air in a 1976 Science Digest article entitled “Our mightiest germ fighter”
which was a discussion of of of not colloidal silver, but silver sulfadiazine, aka silvadene and other topical uses of silver.
And nowhere in the article is 650 validated. It was a number that appears to have been invented by the headline writer. Not that Science Digest is peer reviewed journal and has to reference their headline. But that 650 has taken on a life of its own. Like 98.6 being normal body temperature. Many of the colloidal silver sites trumpet this on their websites (43,000 Google hits for “Colloidal Silver kills over 650″ as a search term.” 650 is so sciency, even if made up.
Could silver kill 650 various and sundry organisms? I would not be surprised if it were the right concentration. Silver is toxic to cells, so it should kill germs. And it does. Like mercury or gold. In its elemental form they are toxic and will kill living things at the right concentration. As will isopropal alcohol; ingestion may not be such a good idea. Many chemicals can kill a wide variety of bacteria in the test tube. The question is whether they have the same effects in humans and or animals.
If you look on Pubmed for the antimicrobial effects of colloidal silver, I find nothing. No test tube studies, no animal models, no case reports, no clinical trials. As far as the medical industrial complex is concerned there is, outside of toxicities, no supporting data of any kind for the use of colloidal silver. The interwebs does allow access to susceptibility tests of colloidal silver that are published by the companies that make colloidal silver products. However, conflict of interest is not part of the alt med world, so we do not need to worry about their validity. Sarcasm aside, the studies are growth of bacteria in various concentrations of colloidal silver products and as the concentrations increase, the bacteria die more rapidly. That’s the usual dose-effect of a poison. They also tout that bacteria can’t become resistant to silver. Always a mistake, for to misquote the Borg, resistance is inevitable as E. coli has demonstrated.
So there is no data to support silver to treat infections. What about cancer? It is suggested, with often identical wording on website after website, that “Dr. Bjorn Nordstrom, of the Karolinska Institute, Sweden, has used Silver in his cancer cure method, for many years. This brought rapid remission in patients given up on by other doctors.” I do not know who was first with this sentence so I am uncertain whom to credit with the first use of this phrase.
But here is the weird thing. Although Dr. Nordstom is credited with the same breakthrough with exactly the same sentence in site after site, I can find no English language reference that confirms there is a Bjorn Nordstrom or any details as to how he uses silver for a cancer cure. Dr Nordstum has not published on Pubmed. The only reference on the interwebs to a Dr Nordstom is in Swedish. If someone can translate http://www.cancerochallergifonden.se/priset1998.html we may find out more. The Swedish word for silver, silvret, is not on the page. I suspect, from reading the Swedish, he may be married to Betty Crocker.
So for what diseases is there evidence for which colloidal silver is efficacious? Well, nothing. Pubmed is silent on taking colloidal silver to benefit any disease, infection or otherwise. There are no clinical trials to show efficacy. Nothing.
There is, however, little to suspect that colloidal silver, taken orally, would be of benefit. There are not even basic pharmacokinetic studies to show how much of a given colloidal silver preparation is absorbed. Nothing. We know it is absorbed, as there are multiple cases of argyria reported in the literature. Argyria is where the silver gets irreversibly into the skin and you turn not silver but blue or blue gray. It is an unusual side effect, but the only documented effect of prolonged ingestion colloidal silver.
If you Google colloidal silver, you will find multiple sites where you can purchase various formulations of colloidal silver with variable concentrations of silver. All of the purveyors of these substances agree that theirs is the one true formulation for silver and that the others are flawed with the wrong size of silver molecule or the wrong preparation. Which one is truly the true silver colloid? All. Or none I would suppose.
One seller (many of these people really need a web designer) sells increasing concentrations of colloidal sliver, with the higher concentrations for the most cost (1500 dollars for 6 bottles) to treat ” Severe Infections and Life and Death Infections Ebola, Dengue Fever, Malaria, SARS, West Nile at a dose of 1-3 tablespoon (15-45 cc) every 4 hours”.
There appears to be as many silver formulations as there are silver sellers, and if you are a do it yourself kind of person, you can make your own colloidal silver.
What perpetuates the use of colloidal silver are testimonials, like the nurse who suggested silver to prevent H1N1. The interwebs are filled with unsubstantiated testimonials, for common infections and unusual infections, with one gentleman crediting colloidal silver, rather than the vancomycin and gentamyin, for the cure of his subdural empyema (pus between the brain and skull).
The FDA, with little effect to judge from the interwebs, has declared that colloidal silver is neither safe nor effective and, as an unclassified drug, cannot be sold for medical reasons.
Even the National Center for Complementary and Alternative Medicine, who rarely finds anything alternative therapy without some caveat to support its use, says:
“* Silver has no known function in the body
* Silver is not an essential mineral supplement or a cure-all and should not be promoted as such
* Claims that there can be a “deficiency” of silver in the body and that such a deficiency can lead to disease are unfounded
* Claims made about the effectiveness of colloidal silver products for numerous diseases are unsupported scientifically
* Colloidal silver products can have serious side effects
* Laboratory analysis has shown that the amounts of silver in supplements vary greatly, which can pose risks to the consumer.”
Of course, this review leaves me with blanks in my SBM gun. I have no data to say there is no reason to use colloidal silver. To combat the testimonials I have, well, nothing. No science and no substance. It is the Oakland of alternative medicine. Except for toxicity, all the supporting data I can find, history, 650 germs killed, Dr. Bjorn Nordstrom, the testimonials, and the formulations of colloidal silver are based on unverifiable information or apparently made up. It is a house of silver cards. However, if the Blue Man Group is looking for members, I know a potential source that will save on makeup costs.

1799
Mark Crislip on May 20, 2025
Link
“Give me your E. coli, your polio, your huddled Tuberculosis yearning to kill free.”
Statue of Liberty, 2025
Originally I was not going to write a post this month. As this goes live, I am in Adelaide on a trip down under. When I was young, aka in my 50s, I would try and write a blog entry while traveling. It is amazing how concentration and stamina fade in the 60s. My age, not the decade. I figured, given other commitments and encroaching decrepitude, that I would not have the wherewithal to churn one of these out.
Then my feeds noted there was an E. coli outbreak in 15 states that killed one and sickened at least 88. The CDC told no one. Holy Bad Word. So what follows is a quick one (while I am away).
As regular readers know, I was an infectious disease doctor for 36 years if you include my fellowship. For most of my career, I was the only ID doc for 3 or 4 hospitals, where I saw all the consults and was in charge of infection control for 2 hospital systems and, for a year, and LTAC.
Just me. All by my lonesome. The buck stopped with me. And you cannot practice medicine alone.
For years our Saturday night tradition is to watch Noir Alley on TCM. Most of the movies are from the late 1940s and 50s. I am always amused when a doctor is needed in these old movies, be it for a gun-shot wound or to deliver a baby. Do they go to the hospital or ER? Nope. Someone goes to the doctor’s house, usually late at night, where he is awakened, along with his long-suffering but understanding wife in curlers. After a brief push back at the late hour, he grabs his black bag and, kissing his wife, he is off to attend to whatever medical problem the script has thrown his way. And he always takes care of the problem.

Although I have a Zaphod Beebleox level of self-regard, there were many situations in my practice that occurred where I needed advice. I had my boss, who was one of the best clinicians I have ever known. And there were other ID docs in town who I could talk to at conference. But they all had the same problem I did. They lived and practiced in Portland.
Portland, and the Pacific NW is the best part of the US, if not the world. That is an absolute truth. Except for infectious diseases. You are not going to see a lot of tropical illnesses nor have experience with outbreaks of odd organisms. So who do you call?
The county and state public health departments and the CDC. I could always rely on them for the experience and expertise I lacked. For 30 plus years, they had my back and helped with the odd and unusual cases that are part of ID.
Experts that were only found only in the government played an important role in allowing me to provide the best care I could for complex and unusual cases. Now with the CDC being gutted and local public health always underfunded, I thought I would take a stroll (with a walker) down memory lane and reminisce about the role of government in helping a lowly ID doc practicing just to the left of the middle of nowhere.
Even though the song says, you don’t know what you’ve got till it’s gone, I always valued the giverment. Could not have done it without them.
County Health
Tuberculosis. Just common enough, I would see a case or two a year. Uncommon and variable in presentation where you can develop an extensive experience. Tb is almost always in patients with little to no support, financial or social. Combine that with its interactivity, potentially toxic medications, unpredictable antibiotic susceptibilities and an often horrible death (two of my Tb deaths were due to ruptured Rasmussen aneurysm, they drowned in their own blood, the rest died of refractory miliary disease), it is nice to have experienced help. Measles is bad enough. We don’t want a return of TB.
Tuberculosis, also known as “consumption”, “phthisis”, or the “white plague”, was the cause of more deaths in industrialized countries than any other disease during the 19th and early 20th centuries. By the late 19th century, 70 to 90% of the urban populations of Europe and North America were infected with the TB bacillus, and about 80% of those individuals who developed active tuberculosis died of it.
I called county health with every active case. Not only to reassure me that I was indeed doing right by the patient, they provided medications and, most importantly, made sure the patient was kept in proper isolation and took their medications properly. County health is involved with treating and controlling many other infections, such as syphilis and AIDS, but for my practice their help in TB was invaluable.
TB care has been gutted thanks to foreign aid cutbacks and people are dying as a result. Infections do not give a rat\u2019s ass about borders and Tb anywhere is a plane trip away from Tb in your city. Tb antibiotic resistance is a nightmare, and cutbacks are helping to ensure we will be seeing more Tb.
State Health
Rabies. People get bit by the damnedest things: not just dogs and cats, but squirrels, raccoons, opossums, and damn near anything that has teeth. And bats end up in the damnedest places. I was watching a Jack the Ripper movie one summer and right at the most tense part of the movie a bat flew into the living room. I shrieked. I have had bats in the house several times over the years. Always scares the hell out of me. What do you do with a bat exposure? What do you do with the patient done gets bit? Call the State. They know which animals are a rabies worry and who needs rabies prophylaxis.
It is critical to have an organization, like State Public Health, who tracks unusual infections. I estimated that there are around 1500 pathogens I needed to know. You can’t test for all of them. Well, given the newer diagnostic technologies, that may no longer be the case. And pathogens move around, either from human intervention or due to climate change. As a clinician it is invaluable to know what pathogens are where. Otherwise, how would you know that Cryptococcus in invading the great Pacific NW? Of that West Nile, Hanta and Lyme are very rare? Not now, anyway. State Public Health departments are invaluable.
And the State was someone to call when something odd would occur. If I saw a small cluster, say two or three cases, of invasive Group A Streptococcus or infections after a tattoo. Trust me, you don’t want a tattoo infection. I had someone to call to investigate. An ounce of prevention and all that
CDC
I live in Portland, Oregon. The best Portland. Again, another fact, not opinion. Not much in the way of parasites in this part of the world. Almost every worm I have been asked to identify has been an earthworm. But people do travel and can bring home some unusual diseases. Like Malaria. It’s a difficult pathogen that kills over 600,000 people a year worldwide, but the US sees 1500 cases a year. Hard to gain a lot of clinical experience in Portland. Antibiotic resistance is common and increasing in the various malaria species around the world. Thank Febris for the CDC. Experts are available 24/7 to help with diagnosis and appropriate therapy. The last thing you want as a clinician is a patient dying because of a lack of experience. With the CDC at your back, that was never the case.
Other rare parasites I saw over the years that the CDC was incredibly helpful were Leshmania and Trypanosoma. The only place for proper diagnosis and access to medications is the CDC. You might think, I don’t need to worry. These are a few of the many infections coming north with climate change that no wall will ever stop. As an example
The southern half of the United States contains enzootic cycles of T. cruzi, involving 11 recognized triatomine vector species. The greatest vector diversity and density occur in the western United States, where woodrats are the most common reservoir; other rodents, raccoons, skunks, and coyotes are also infected with T. cruzi. In the eastern United States, the prevalence of T. cruzi is highest in raccoons, opossums, armadillos, and skunks.
Brucella: an important disease of swine and of economic importance. Pig farms, and other animals, need to be Brucella free. So imagine you have a patient who buys a local pig for a pig roast, slaughters it, becomes ill and is diagnosed with Brucella? All sorts of potential ramifications for the pig farms and feral pigs. The CDC was involved and, long story short, it was genetically identical to the stains in Tonga, where he had been borne It was reactivation Brucella, not a new infection.
Brucella suis infection was diagnosed in a man from Tonga, Polynesia, who had butchered swine in Oregon, USA. Although the US commercial swine herd is designated brucellosis-free, exposure history suggested infection from commercial pigs. We used whole-genome sequencing to determine that the man was infected in Tonga, averting a field investigation.
Outbreaks: Legionella, Flu, HIV, Food-borne illnesses, West Nile Hanta, Mpox, Nagleria, Avian Flu, and on and on. The CDC and the MMWR are invaluable for information on what infections are happening where and why. As a clinician, you rely on the CDC is a resource of epidemiological data without which you could not practice ID. I mean, how else would I know that castrating sheep with your teeth was a risk for Campylobacter?
During June, both patients had participated in a multiday event to castrate and dock tails of 1,600 lambs. Both men reported having used their teeth to castrate some of the lambs. Among the 12 persons who participated in the event, the patients are the only two known to have used their teeth to castrate lambs. During the multiday event, a few lambs reportedly had a mild diarrheal illness.
As a result and because of the County, State and National Public Health departments, docs practicing anywhere in the world with a computer can have state-of-the-art access to the best information on the diagnosis and treatment of infections.
The government, combined with PubMed, truly transformed how I practiced ID because it gave me knowledge and access to expertise that would otherwise have been unavailable.
I cannot imagine providing care to the odd cases that came my way without their help. But that looks to be a real possibility going forward. Invaluable knowledge and expertise is being shed at the CDC and Co., like a cybertruck panal.
People do the damnedest things and acquire infections as a result. Not that we are going necessarily find out moving forward. For example, they are stopping testing for infections in raw milk, a most excellent way to transmit a variety of infections. They are going to stop looking for Salmonella in chicken.
Don’t ask, don’t tell is not the best approach to infectious diseases. Come September, when vaccines will be found to cause autism (and you know that’s coming), combined with a lack of infection epidemiology and prevention, I will have retired too soon to see some great pathology. I always said that ID was like birding, only interesting, in that you could have a life list of diseases. Some, like measles, smallpox and plague, you did not want to see. But the opportunity to see so many preventable infections. Ah. Love me my infectious diseases.
From an ID perspective, we are heading for wide open borders, no walls, no border patrol, providing both an all-you-can-eat and a get-out-of-jail-free card to the most prolific of killers of history, and letting them party likes it’s 1799.
I was dreamin’ when I wrote this
Forgive me if it goes astray
But when I woke up this mornin’
Could’ve sworn it was judgment day
The sky was all purple
There were people runnin’ everywhere
Tryin’ to run from the infections
You know Kennedy didn’t even care
Say say
Two-thousand-twenty-five party over
Oops out of time
So tonight germs gonna party like it’s 1799
(I was dreaming’ when I wrote this)
(So sue me if I go too fast)
(Life is just a party, and parties weren’t meant to last)
Infections all around us, my mind says prepare to fight
So if I gotta die I’m gonna listen to my body tonight
Yeah


Jurassic Farce
Mark Crislip on August 10, 2012
Link
It feels like I live in the real world example of Ray Bradbury’s All the Summer in a Day but for the last two weeks we have had sun and heat and it has been glorious. I get Christmas and Thanksgiving and New Years as vacation, but who needs that? I need July and August to live the vida loca in the Oregon summer. Who wants to blog when I can be outside, at concerts, golfing, hiking and…
Yes Dr. Gorski. I did agree to write an entry every other Friday. Yes Dr. Gorski. I know you have the documentation. Yes Dr. Gorski, I do not want any of that information made public. No one needs to know that I wanted to be a naturopath when I was young. Sigh. Yes, Sir, I will get to blogging. Damn those youthful indiscretions. Let’s see how little I can do and meet my obligations with the powers that be.
My professional career is based upon inflicting death, and in my time I  have obliterated uncountable numbers of unicellular organisms. If there were such a thing as Karma, I would certainly return in the next life as a rabbit in a syphilis lab. But there isn’t, and I can kill and kill with a clean soul. There is no guilt or hesitation in killing unicellular life, or even multi-cellular life, as long as it cannot be seen without a microscope. I start to get a wee bit squeamish as soon as I can see a life form. I tend to not kill bugs or animals, unless, of course, they can be eaten. If it tastes good, all bets are off. But as a tree hugger, I tend to look upon killing wildlife and extinctions as a bad thing.
Well, maybe. I am glad that smallpox and rinderpest are no more, but they are viri* and not really life. I would not be saddened to see the end of polio, measles, or many of the other diseases that plague mankind. Extinction of organisms whose sole ‘purpose’ is to sicken and kill humans would be, I would think, a good thing. As life gets more complicated, the unease with extermination grows. Except for the dogs in my neighborhood, but that is really irresponsible dog owners (a redundant phrase) and not the barking vermin.
Mosquitoes have been a bane on humans since the beginning of time. It has been estimated that half of everyone who ever died has died of malaria. There are the other mosquito borne infections that kill and sicken: West Nile, Yellow Fever, Dengue, the various hemorrhagic fevers. I think mosquito borne illnesses have left more evolutionary footprints in our DNA than any other illness, from sickle cell disease to G-6-PD deficiency. And wildlife, without ready access to netting and DEET, suffers more. The world would be a better place without those blood sucking insects.
Well maybe. Bug Girl was kind enough to point me to an article that suggests that, unfortunately, mosquitoes, even the blood sucking mosquitos, may have an important niche in the ecosystem as food, if not as blood suckers. I will mention here a bit of skeptical heresy, but I was never that enthralled with Cosmos. Most science shows elicit ‘a tell me something I don’t know’ response. My PBS epiphanies were Shock of the New (an art show?!?) and Connections. Actions always have unintended consequences and mosquitoes probably have many under-recognized connections with their environment. No good deed goes unpunished, so getting rid of all 3500 species of mosquitoes would undoubtedly be a bad thing, but controlling or eradicating the few that are responsible for so much human death and disease would be a net benefit.  In medicine sometimes there are no good solutions, just the least bad solution.  What is worse?  A million humans dead a year or the end of Aedes aegypti? As the experiment with DDT demonstrated, eradication of mosquitoes is probably impossible, but control? Probably.
Dengue, along with other infections, is coming north. Dengue has been reported in the Florida Keys and at least 40% of people in Brownsville Texas are seropositive for dengue.  It is one of many infections that may  infect or reinfest the US as the world warms. If we could control mosquitos, we could decrease the chances of the spread of dengue and other infections.
There have been some clever approaches to the control of infections. Mansonella perstans, a parasite that causes filariasis, can be controlled by killing bacterial endosymbionts found in their gut with doxycycline. Another way to control infection spread is the use of mutant mosquitos. One slick approach is to release sterile males into the environment. If the females mate with the sterile males, then they lay sterile eggs. They used to release irradiated mosquitoes, but now they render the males sterile with genetic modifications. It is, by the way, very difficult to perform vasectomies on mosquitoes.
The nice thing about mosquitoes is they are homebodies, staying close to where they are were born. If you release a swarm of  of sterile males into a local environment, the females mate with sterile males and viola, no children. And the effects are limited to the local environment. Sound like a good approach for other species as well.
It appears to work. When sterile males are mixed with a wild population, there is an 80% drop in the mosquito population. That can only be a good thing.
To my mind it is the perfect way to control mosquitos: no spraying of chemicals, no side effects and, perhaps unfortunately, no permanent eradication of the mosquitoes. And since it is a local application of sterile males (only females, by the way, feed on blood)  there is little impact on wild populations, where the bugs can breed to be a continued food supply and repopulate human habits, requiring repeat treatments. Good for bottom line.
They want to try this approach in Florida and, what a surprise, over 100,000 people have signed a petition to prevent the release of the GM mosquitos. Why?
First, people do not want to be guinea pigs, from what I am not certain.
“”Have there been studies of what can happen if someone is bit by one of these mosquitoes?” said Key West realtor Mila de Mier. “Are we the subjects, the guinea pigs of this experiment?””
Male Aedes aegypti mosquitoes, which is what is modified,  do not bite, only females. Unless they are making homosexual mosquitoes as part of a government conspiracy. That would be just like the government. So there should be no bites from gm mosquitoes.
Of course there is always the worry about being bitten by a mutant insect. Think Peter Parker, although Bug Girl has written the definitive essay on what should happen if you are bitten by a radioactive spider. Imagine what would happen if you were bitten by a genetically modified gay male mosquitoes. It makes web shooters pale into insignificance.
The other worry is ‘a Jurassic Park event happening in the Keys.“ In Jurassic Park the dino DNA was extracted from a preserved mosquito and cloned to make new dinos. So a Jurassic Park event would be what: someone would clone the DNA from the blood in the gut of a mosquito to make what? More Floridians? With a Presidential election coming up, that is scary indeed with packs of voters unable to read a ballot or punch out a chad.
There is also the worry about the environmental impact of killing off large amounts of mosquitos, and that could be a real concern. That, to my mind, is the tricky one, and it is an interesting calculus: how much animal life are you willing to kill to decrease human suffering and death? But that is a political-ethical, not a scientific, question.
The science of sterile mosquitos would point to a safe and clever way to decrease the vector of many of the infections that kill and sicken humans with little downside.
The drive against the GM mosquitoes seems based on fear of government, fear of science and fear of biting gay mosquitos and a lack of understanding of the biology of mosquitoes and an appreciation of how rapidly infections can spread in a community if they can gain a proboscis hold. It looks like the ethic of the Natural News is more widespread than I had suspected.
I write this essay on my front porch and I have to stop now and then to slap a mosquito. We have yet to have West Nile in Oregon, and I have been predicting a small epidemic for about 5 years now. Still hasn’t happened, and I am uncertain why. I like to credit the superior beer for keeping the virus and mosquitoes at bay. Perhaps those in the Keys should make note.
Can I go back to playing Dr. Gorski? Please?
    • * the plural of Elvis is Elvi, so the plural of virus is viri. What is the pleural of empyema?

Zoonotic Spillover Is A Problem
Steven Novella on March 25, 2026
Link

Recently I gave the latest update on the origins of SARS-CoV-2 – bottom line, it was very likely a zoonotic spillover event and not a lab leak. Following that, I interviewed a researcher, Dr. Andersen, who is an expert on the origins of epidemics/pandemics and has researched this very question. He reinforced the spillover hypothesis, indicated he had considered the lab leak hypothesis early on but it was quickly shown to be highly unlikely.
More important than that, however, was the discussion about why a zoonotic spillover was so likely, and why, if anything, we are more vulnerable to another such event today. Far from learning from the COVID pandemic how to reduce the chance and prepare for the next inevitable such event, COVID has caused “pandemic fatigue” and left us worse prepared than we were. Further, it’s unlikely to be a century until the next such pandemic.
A zoonotic spillover event refers to an infectious agent, usually a virus, that is endemic in an animal population that crosses over into the human population. Viruses evolve and adapt, and therefore a species that is not adapted to humans with a very limited (but non-zero) ability to infect a human can evolve in a human host to become more infectious and virile. When a virus gains the ability to transmit from human to human, we consider that as spilling over into the human population. That is what happened with COVID.
The chances of this happening are proportional to the number of viruses circulating in animals that are in close proximity to humans. The Huanan seafood market in Wuhan China was the perfect setup for this to happen. In this market there is a vast trade in wildlife and farmed animals for human consumption. The supply chain of these animals could not be more risky if it were designed to maximize the spread of viruses.
Every step in the chain – commercial breeding, transport, buying, selling, storage, processing, and killing – puts animals from diverse taxa in close proximity to each other. Often these are animals that would not be in close contact in the wild. The conditions are often unsanitary, the animals are stressed, and they attract rodents that contribute to the circulation of disease. In this environment animals that perhaps had few or no viruses in the wild acquire multiple viruses. This not only magnifies their spread, it allows for recombination – for different viruses to combine, gaining different abilities that expand their ability to infect and spread.
Amanda Fine, WCS Health Program Associate Director, Asia, and a co-author of a study on origins of COVID, said: “Wildlife supply chains, and the conditions the animals experience while in the supply chain, appear to greatly amplify the prevalence of coronaviruses. In addition, we documented exposure of rodents on wildlife farms to both bat and bird coronaviruses. These high prevalence rates and diversity of coronaviruses, added to the species mixing we see in the wildlife trade, create more opportunities for coronavirus recombination events as well as spillover.”
The same is true not just of coronaviruses, but of many virus types. We then take these now virus-ridden stressed animals, we pack them into a market in the middle of an urban center that we further pack with humans. So if a virus does jump to a human, there will be plenty of other people around to spread the new virus to.
Even though China continues to deny that SARS-CoV-2 originated in the Wuhan market, there have been steps to improve conditions. This includes the proposal of a classification system of wet markets to quantify their risk and to highlight the steps necessary to reduce this risk. The authors write:
“We identify six key risk factors of wet markets that can affect human health: (1) presence of high disease-risk animal taxa, (2) presence of live animals, (3) hygiene conditions, (4) market size, (5) animal density and interspecies mixing, and (6) the length and breadth of animal supply chains.”
In 2020 China quickly closed the Huanan wet market, and it remained closed. They also tightened restrictions and monitoring of other wet markets and officially banned the illegal trade of wild animals. It is too early to tell how much this has helped. The wild animal market was a critical part of the food chain in that part of the world, and cannot instantly be replaced. Also, demand for wild animals is still driven by Traditional Chinese Medicine (TCM). Much of the market has simply shifted to a black market trade, which uses the internet to conceal its activity. There is also a problem of laundering – of selling wild animal products as if they are legal and farmed.
According to the most extensive recent study on the topic:
“The annual value of the illegal trade in wildlife in Southeast Asia has been estimated at USD 8–11 billion and likely exceeds that. The annual wildlife farming industry in China was valued at USD 74 billion.”
This is a critical food source, and you cannot simply take it away overnight. It is also a huge industry that will not quietly go away. The best option might be to carefully regulate it to improve conditions and reduce the chance of spillover events. Banning the trade and pushing it underground may actually worsen conditions and make it more difficult to monitor and evaluate them.
At least there was an immediate reaction after COVID to improve conditions in China, but it remains to be seen how the international wild meat market reacts and adapts, and what the net effect will be. These markets are also only part of the problem – humans are increasingly pushing their living spaces into wild spaces, putting them at increasing proximity to wild animals. These animals also have diminishing wild spaces (through deforestation, climate change, urban spread and other factors), and so they are increasingly encroaching into human spaces to find food. And the legal market of domestic animals also often packs many animals into small spaces, making the spread of disease more likely.
The conditions still exist for zoonotic spillover events to happen, despite some efforts to address the worst conditions. In fact, recent studies find the risk is increasing, and historically has been increasing by about 5% per year. A more comprehensive global effort is needed to reverse this trend.


Ebloa


Ebola outbreaks: Science versus fear mongering and quackery
David Gorski on August 4, 2014
Link
“Ebola virus particles” by Thomas W. Geisbert, Boston University School of Medicine – PLoS Pathogens, November 2008 doi:10.1371/journal.ppat.1000225. Licensed under CC BY 2.5 via Wikimedia Commons.
Without a doubt the big medical story of the last week or so has been the ongoing outbreak of Ebola virus disease in West Africa, the most deadly in history thus far. Indeed, as of this writing, according to a table of known Ebola outbreaks since 1976 at Wikipedia, in Guinea, Sierra Leone, and Liberia, the three nations affected thus far, there have been 1,440 cases and 826 deaths. Worse, the World Health Organization (WHO) is reporting that it is spreading faster in Africa than efforts to control it. In particular, late last week it was announced that two Americans who had been infected with Ebola were going to be flown back to the US, specifically to Emory University, for treatment, a development that ramped up the fear and misinformation about Ebola virus to even greater heights than it had already attained, which, unfortunately, were already pretty high. Indeed, the ever-reliably-histrionic Mike Adams of NaturalNews.com wrote a typically hysterical article “Infected Ebola patient being flown to Atlanta: Are health authorities risking a U.S. outbreak?” On Saturday, we learned that Dr. Kent Brantly, an aide worker for Samaritan’s Purse, a Christian charity run by Franklin Graham, son of the well-known preacher, Billy Graham, who had been evacuated from Liberia aboard a private air ambulance, had arrived in Georgia.
This latest development inspired medical “experts,” such as Donald Trump, to stoke fear based on the arrival of two infected Americans in the US. For instance, last Friday, after it was first announced that the Ebola-infected Americans would be flown back to the US, Trump tweeted:
Stop the EBOLA patients from entering the U.S. Treat them, at the highest level, over there. THE UNITED STATES HAS ENOUGH PROBLEMS!
— Donald J. Trump (@realDonaldTrump) August 1, 2014
One is tempted to add that ignorant Twitter tirades by billionaires with far more money than sense are also one of the “enough problems” that the US has. After all, besides having embraced conspiracy theories like “birtherism,” Trump has been a raving antivaccinist since at least 2007. So, right there, you know that Trump’s knowledge of medicine is—shall we say?—lacking, to put it kindly. None of that stopped him from following up with more fear mongering:
The U.S. cannot allow EBOLA infected people back. People that go to far away places to help out are great-but must suffer the consequences!
— Donald J. Trump (@realDonaldTrump) August 2, 2014
And:
The U.S. must immediately stop all flights from EBOLA infected countries or the plague will start and spread inside our "borders." Act fast!
— Donald J. Trump (@realDonaldTrump) August 2, 2014
And:
The fact that we are taking the Ebola patients, while others from the area are fleeing to the United States, is absolutely CRAZY-Stupid pols
— Donald J. Trump (@realDonaldTrump) August 2, 2014
Trump also re-Tweeted a bunch of equally overheated Tweets about the topic, and meanwhile WorldNetDaily is stoking fears of illegal immigrants massing at our southern border to bring in Ebola and other diseases, bolstered by Dave Hodges and the president of the American Association of Physicians and Surgeons (remember the AAPS?), Dr. Jane Orient, who are claiming that “100,000 West Africans are in Central America, have been taught to speak Spanish and are coming across our Southern border” carrying Ebola, naturally. These claims are based on anonymous and unverifiable “sources.” All of this is why now seems an opportune time to discuss the Ebola outbreak from a science-based perspective and whether or not bringing back these two Ebola patients is such a huge mistake that, if Mike Adams and Donald Trump (and several others) are to be believed, will endanger this country with the possibility of an Ebola epidemic. The time is all the more appropriate, given that, as they all too frequently do, quacks are promoting their remedies as cures for Ebola. So what is the situation, really?
What is Ebola virus disease?
The disease caused by Ebola virus belongs to a class of diseases known as viral hemorrhagic fevers. It’s a diverse group of diseases caused by Ebola virus that range in severity from relatively mild to exceedingly deadly, but all share in common the tendency of being complicated by disseminated intravascular coagulation (DIC), which eats up clotting factors and results in an increased susceptibility to bleeding. Other hemorrhagic fevers include dengue, yellow fever, Marburg virus, Lass fever, and more. There are five classes of viruses, all RNA viruses, that can cause hemorrhagic fever; of these, the Ebola virus belongs to the family Filoviridae, because the viruses form filaments, as you can see from the photo of an Ebola virus at the beginning of this post, and uses negative-sense single-stranded RNA as its genetic material, which is used both to produce more viral protein and to produce an antisense template to produce more viral RNA. The virus was discovered in 1976 and has caused sporadic outbreaks since then. It’s diagnosed by a combination of history (particularly of travel to areas where the disease is found) and clinical history, but definitive diagnosis is made using either enzyme-linked immunoassay (ELISA) for viral proteins or reverse transcriptase polymerase chain reaction (RT-PCR) for the viral RNA.
There are five subtypes of Ebola virus:
    • Ebola-Zaire
    • Ebola-Sudan
    • Ebola-Ivory Coast
    • Ebola-Bundibugyo
    • Ebola-Reston
Ebola-Reston, which is found in the Philippines, doesn’t cause human disease, but all the others, which are found in Africa, do. Of these, the Zaire strain of Ebola is the most deadly, with a greater than 90% case fatality rate. It is the most feared of all the strains of Ebola virus, and quite rightly so. However, it should be remembered that the figure of 90% fatality is the case fatality rate with essentially no treatment. With modern medical care, the case fatality rate, even for Ebola-Zaire is more like 56%, which is still quite bad. In this specific outbreak, thus far the case fatality rate is around 57%.
After infection, symptoms usually begin within 5-10 days. Early signs and symptoms are very much like influenza or other flu-like illnesses and include fever and chills, headache, joint and muscle aches, and weakness. With progression, additional symptoms can include a maculopapular rash, cough, nausea and vomiting, and abdominal pain. The bleeding that gives hemorrhagic fevers their name can, in the case of Ebola disease, manifest itself many ways, including bleeding from the eyes, hematemesis (vomiting blood), hemoptysis (coughing up blood), melena (dark blood in the stool from upper GI bleeding), hematochezia (red blood in the stool), bleeding from orifices (such as ears, mouth, and nose), and internal bleeding. As the disease progresses, multiple organ failure can occur, contributing to death:
Those who survive can suffer long-term complications, such as hepatitis, fatigue, headaches, and testicular inflammation.
Worse, Ebola is a master of evading the immune system:
The Ebola virus is also a master of evading the body’s natural defenses: It blocks the signaling to cells called neutrophils, which are white blood cells that are in charge of raising the alarm for the immune system to come and attack. In fact, Ebola will infect immune cells and travel in those cells to other parts of the body — including the liver, kidney, spleen and brain.
Each time one of the cells is infected with the Ebola virus and bursts, spilling out its contents, the damage and presence of the virus particles activates molecules called cytokines. In a healthy body, these cytokines are responsible for provoking an inflammatory response so that the body knows it’s being attacked. But in the case of an Ebola patient, “it’s such an overwhelming release [of cytokines], that’s what’s causing the flu-like symptoms” that are the first sign of Ebola, Bhadelia said.
Yes, Ebola is a very, very bad disease. Worse, there’s not much that even modern science-based medicine can do to treat the virus specifically. Basically, the treatment consists of supportive care: Fluid resuscitation to prevent dehydration, transfusion as needed to replace blood loss; treat the DIC with clotting factor replacement, and respiratory and cardiovascular support if needed. It’s true that there are experimental drugs that has shown promise in preclinical models, and the search for an Ebola vaccine has been put on the fast track, but as of now there is no approved treatment or vaccine for Ebola.
So should we be bringing victims to the US for treatment?
Treat in Africa or treat in the US?
So are the concerns of Donald Trump and Mike Adams justified? One of the two Americans infected with Ebola (Dr. Kent Brantly) is already here. The second, Nancy Writebol, will leave Africa tomorrow. In considering whether bringing these patients back home is so dangerous that it shouldn’t have been done, it’s important to consider two things: how Ebola is transmitted and existing isolation protocols.
Ebola virus, although contagious, is not nearly as contagious as, for example, influenza or measles, both of which are easily spread through the air. Ebola, by comparison, is transmitted through contact with body fluids (blood, saliva, semen, vomit, urine, or feces) in much the same way HIV or hepatitis B is. Although transmission through aerosol has been demonstrated in the laboratory between pigs and primates, it has never been conclusively demonstrated to happen from human to human and the evidence is fairly compelling that it does not. True, the virus, from what I’ve found in my research, persists on surfaces for days, and only 1-10 virus particles are needed to initiate infection. Most people acquire the virus through contact with the blood or bodily fluids of the infected (as in blood from an infected person coming into contact with the mucus membranes of the mouth or eye or with an open cut) or through nosocomial transmission (accidental needle sticks with a syringe containing infected blood, for instance). In Africa, given how poor the countries suffering outbreaks tend to be, the nosocomial route is prominent, because of reuse and improper sterilization of syringes, needles, or other medical equipment contaminated with these fluids. Also in Africa, a common means of acquiring the virus is preparing the bodies of the dead for funerals.
Dr. Bruce Ribner, one of the doctors who will be caring for Ebola patients described the situation nicely:
Ebola isn’t “some mystical pathogen (with) some bizarre mode of transmission,” the doctor noted, adding that it is transmitted similarly to illnesses like SARS or HIV.
So, if patients are brought to the US (as one has already been as of this writing), it’s not as though American hospitals don’t have considerable experience with universal blood and bodily fluid precautions, and it’s not as though they don’t properly sterilize instruments and equipment between uses. In other words, there’s nothing unique about Ebola virus in terms of transmission. No one’s saying the risk is zero, but it’s incredibly low, the blatherings and bloviations of ignorant gasbags like Donald Trump on Twitter notwithstanding. One also notes that the CDC has stocks of the virus, which it studies, which means that Ebola virus is already on US soil (in various universities, an Army facility, and the CDC) and Canadian soil, along with patient blood samples from Africans infected with the various forms of Ebola. As a real infectious disease expert, Tara Smith, pointed out, not only is Ebola already in the US, but US health officials have already dealt with cases and small outbreaks of related hemorrhagic fevers, such as Lassa fever and Marburg.
Moreover, Emory University is better equipped than most hospitals to deal with such patients:
Emory University Hospital, which is slated to care for the patients, has a specially designed wing separate from the rest of the hospital that was created to treat people infected by bioterrorism attacks or pandemics.
But Dr. William Schaffner, an infectious disease specialist and professor of preventive medicine at Vanderbilt University, says almost any American hospital is equipped to take care of an Ebola patient without endangering staff or the public.
Infectious patients are put in an isolation room, and health workers have to put on protective gear before entering the room. They remove the gear when leaving. It is put in red infectious disease waste bags, which are burned.
Even though Ebola isn’t spread through the air, the CDC says that patients probably will be put in negative-pressure rooms that isolate air so it can’t circulate through the building. Those are typically used with patients with active tuberculosis, which is airborne.
It’s also noted that it isn’t the precautions that might fail, but the humans doing the precautions, as Schaffner noted that they were “busy” or “because familiarity breeds if not contempt then casualness.” This was learned in Toronto dealing with the SARS outbreak when hospital workers dealing with SARS patients became infected. Posting monitors outside the patients’ rooms to make sure personnel followed the precautions eliminated any further cases. Emory did the same thing when patients with suspected Middle East Respiratory Syndrome (MERS) were admitted, and, given the level of fear over Ebola virus, you can be quite sure that anal sphincters will be even tighter this time. Moreover, given that, as far as has been ascertained, Ebola does not spread through the air as SARS and MERS do, the likelihood of nosocomial transmission to a health care worker is minimal, particularly given that any staff in contact with Ebola victims will almost certainly be carefully monitored for any signs of viral infection and rapidly quarantined if they exhibit them. Again, the likelihood of an outbreak in the US due to these patients is not zero, but it’s very close.
So, when faced with Americans infected with Ebola virus in Third World hospitals lacking the resources to provide optimal treatment, the options are to send sufficient medical equipment and staff there to take care of them in Africa or to bring the patients back. By far, the most efficient and economical solution is to bring the patients back to the US, and the risk is minimal. However, fear of contagion remains a powerful force, as noted by Dr. Michael Osterholm, director of the Center for Infectious Disease Research and Policy at the University of Minnesota:
Osterholm said he’s been getting calls from editors and reporters in the United States asking why the sick patients are being brought here. “Their reaction to the virus on the fear and panic side is no different than what you see in Africa,” Osterholm says.
“We’re being critical of the West African population for not understanding,” Osterholm says. “I’m thinking, ‘Oh my God, the U.S. senior media doesn’t get it.'”
Or a conspiracy-minded billionaire with bad hair.
It also helps to put Ebola in perspective. Since 1976, Ebola has infected fewer than 5,000 people and killed fewer than 3,000. That’s in Africa, where over 1 billion people live. By contrast, poor, “boring” measles still kills 122,000 people every year and killed over 2 million a year in 1980, before widespread vaccination campaigns. According to the WHO, in 2012, malaria caused an estimated 627,000 deaths, mostly among African children. Also according to the WHO, since the beginning of the AIDS epidemic (which dates back almost as far as the discovery of the Ebola virus), HIV has infected over 75 million and killed 36 million, with approximately 35 million currently living with the infection. None of this means that we shouldn’t take Ebola seriously or that much larger outbreaks couldn’t happen. Nor does noting this difference minimize the deaths of people infected with the disease. We should note from these observations and others, however, that Ebola is unlikely to reach such numbers because it is simply not infectious enough and Ebola outbreaks tend to “burn themselves out” because, unlike HIV or measles (which are also transmissible human-to-human), Ebola virus disease is so rapidly fatal.
In other words, Ebola is a horrible disease, but because it’s so horrible it’s unlikely to kill as many people as diseases we already know about. And it’s not nearly as dramatic as people think. Tara Smith interviewed representatives of Doctors Without Borders several years ago, and this is what one physician, Armand Sprecher, told her:
As for the disease, it is not as bloody and dramatic as in the movies or books. The patients mostly look sick and weak. If there is blood, it is not a lot, usually in the vomit or diarrhea, occasionally from the gums or nose. The transmission is rather ordinary, just contact with infected body fluids. It does not occur because of mere proximity or via an airborne route (as in Outbreak if I recall correctly). The outbreak control organizations in the movies have no problem implementing their solutions once these have been found. In reality, we know what needs to be done, the problem is getting it to happen. This is why community relations are such an issue, where they are not such a problem in the movies.
“Getting it done” is much easier in the US and other developed nations than it is in Africa.
Enter the quacks
Unfortunately, there is no effective treatment for Ebola virus disease yet. All doctors can do right now is to isolate the patient to prevent others from being infected and to support the patient’s physiology with fluids, antibiotics for secondary infections, and blood products to combat the DIC until the patient either manages to clear the infection or dies. There are experimental drugs being tested against Ebola. (David Kroll has nicely summarized the current state of research and development of Ebola drugs, and there is an antibody-based treatment being tested.) Also, there is no vaccine, although efforts to develop one have been fast tracked. The problem in human testing of such a virus, of course, is that Ebola outbreaks are sporadic and difficult to predict. By the time human tests are ready, this latest outbreak could be over, and scientists would have to wait for the next one to test the vaccine. Worse, the economics of developing effective treatments or vaccines against Ebola are prohibitive.
Not surprisingly (or maybe surprisingly, I don’t know), antivaccine activists are already afraid of an Ebola vaccine, even though one hasn’t been approved yet and is unlikely to be for quite some time:
I actually agree with the last commenter. If you’re a nurse and antivaccine, you’re in the wrong career. Please, for the good of your patients, change careers. Seriously, how can you be a nurse and be antivaccine? In any case, resisting the vaccination of healthcare personnel against Ebola is a problem for the future, after such a vaccine has been developed. Meanwhile, in Africa itself, faith healing is being promoted by at least one Nigerian pastor, Ituah Ighodalo, as a means of curing Ebola, including laying on hands, which is a great way to infect oneself with the virus if those hands happen to come into contact with any bodily fluids of the sick and then happen to touch a mucus membrane.
Here in the “developed” world, we have similar claims being made, for instance, in this article entitled Can Gingko and Turmeric Help Stop Ebola? I could have saved them the trouble and said “almost certainly not,” but the author of this article insists on all sorts of handwaving about JAK-STAT signaling p38 MAP kinase and the effect of Gingko and Tumeric on these pathways. It might be worth a detailed deconstruction elsewhere. For now, let’s just say it’s “speculative,” to put it kindly. The editors of Inside Surgery should really know better. Or maybe not. I saw another article on Inside Surgery entitled Can Rife Therapy Help Stop Ebola Disease? Then I saw that the editor of Inside Surgery, L. “Skip” Marcucci, MD, has completed “a fellowship in Integrative Medicine at the University of Arizona” and that he’s also “a formally trained medical acupuncturist.” Well, OK, then. That explains a lot. It also rather saddens me to see an article on a website called Inside Surgery that is not too different from this article by Mike Adams about “natural” cures for Ebola (one of which is based on traditional Chinese medicine).
And that doesn’t even count this amazing bit of pseudoscientific nonsense from Robert F. Cathcart III, MD, who touts himself as an allergist and practitioner of orthomolecular medicine. If you know anything about orthomolecular medicine, you know what’s coming next. Yes, according to Cathcart:
Note that the 2005 epidemic in Angola which was first referred to as an Ebola like virus has now been called the Marburg Virus. It does not make a difference from the point of view of treatment with massive doses of intravenous sodium ascorbate. Both diseases kill by way of free radicals which can be neutralized by massive doses of sodium ascorbate intravenously.
[…]
It does not take a genius to figure out that with the increased bowel tolerance to oral ascorbic acid somewhat proportional to the toxicity of the disease that the most serious infectious diseases would rapidly exhaust all the bodies vitamin C, acute induced scurvy, and cause bleeding all over the body and finally free radical deaths.
That’s right. Cathcart claims that Ebola kills by “free radicals,” which exhaust the body’s supply of vitamin C and induce scurvy, resulting in bleeding. Never mind that Cathcart’s view of the pathophysiology of Ebola virus disease and reality are related only by coincidence, and not even very much then.
As if claims for all sorts of herbal and vitamin treatments for Ebola virus disease weren’t bad enough, there are Kelly and Nate Bailey, the makers of dōTERRA® Essential Oils, who say right on their website:
The reason doctors can’t do anything for viruses is because viruses live inside of your cell’s walls, and medicine particles can’t penetrate those walls. Essential oils, however, have super tiny particles and a makeup that allows them to pass through with no problem! They go in, kill the virus while also stopping the viral cells from duplicating, and all the while boost the immune system so the body can continue to fight for itself. We’ve found that we can kill viral infections in 12-48 hours, depending on how quickly we start using oils.
One notes that doctors can do something for certain viruses, just not this particular virus—yet, hopefully. None of this stops them from playing the martyr from the inevitable charges of quackery that will fly:
Again, I expect an outlash from the western medicine community, and those indignant that I would write about using essential oils against such a ruthless virus. I’m okay with that, because my mission since beginning to share about essential oils is to provide hope where there is none, and to empower people to not let life and illnesses happen to them, but rather arm themselves with the tools to do something.
That’s nice. Actually the “outrage” comes about because the Baileys are peddling quackery that will not help patients with Ebola and capitalizing on the fear of Ebola inspired by the current outbreak to sell essential oils through what sure looks like a multilevel marketing system. They are, however, as nothing compared to what practitioners of The One Quackery To Rule Them All, homeopathy, are doing. Yes, homeopaths are claiming they can cure Ebola.
Given the symptoms of Ebola virus disease, here’s what two homeopaths have proposed as a homeopathic remedy for Ebola:
Dr. Gail Derin studied the symptoms of Ebola Zaire, the most deadly of the three that can infect human beings. Dr. Vickie Menear, M.D. and homeopath, found that the remedy that most closely fit the symptoms of the 1914 “flu” virus, Crolatus horridus, also fits the Ebola virus nearly 95% symptom-wise! Thanks go to these doctors for coming up with the following remedies:
1. Crolatus horridus (rattlesnake venom) 2. Bothrops (yellow viper) 3. Lachesis (bushmaster snake) 4. Phosphorus 5. Merc. cor.
If you are not in the U.S., you must locate your closed homeopathic practitioner and ask him or her to order these remedies for you from Hahnemann Pharmacy, (510) 327-3003 (Albany, California, a suburb of Oakland). If your country’s laws allow you to call a homeopathic pharmacy directly, do so. In any case be sure to find a homeopathic practitioner you can work with. Do not try to take care of yourself without the further education and experience that a homeopath can give you.
You know what they call an Ebola victim foolish enough to rely on these five homeopathic remedies to treat his disease, whether administered by a “real” homeopath or not? Almost certainly dead, that’s what! (Well, at least with a 90% certainty, given that homeopathy is the equivalent of no treatment.) Unfortunately, Derin and Menear are not the only homeopaths recommending this nonsense. Homeopathy has been proposed by clueless homeopaths as a valid means of combatting bioterrorism, chief among the bioterrorism agents being Ebola. For instance, homeopath Joetta Calabrese has suggested:
In the case of Ebola, no conventional treatment or vaccine is available. Fortunately for us, homeopathy has great renown for its healing ability in epidemics.
No. Really. No, it doesn’t, except among homeopaths. Among those health care practitioners rooted in science, not so much. Calabrese proposes a variant of Derin and Menear’s delusional treatment:
If a person is infected, the remedies most commonly used would be the following. One dose every hour, but as the severity of the symptoms decrease, frequency is reduced. If no improvement is seen after 6 doses, a new remedy ought to be considered.
Crotalus horridus 30C – Is to be considered for when there is difficulty swallowing due to spasms and constriction of the throat, dark purplish blood, edema with purplish, mottled skin.
Bothrops 30C – Is the remedy to think of when nervous trembling, difficulty articulating speech, sluggishness, swollen puffy face, black vomiting are present
Lachesis mutus 30C ,– when there’s delirium with trembling and confusion, hemorrhaging in any area, consider this remedy. Often, the person cannot bear tight or constricting clothing or bandages and feels better from heat and worse on the left side.
Mercurius corrosivus 30C, – For copious bleeding, better when lying on the back with the knees bent up, delirium, headache with burning cheeks, photophobia, black swollen lip, metallic, bitter or salt taste in mouth.
Secale cornutum 30c,– For thin, slow, painless oozing dark hemorrhage with offensive odor, cold skin and tingling in the limbs. The individual wants to be uncovered and feels WORSE from motion.
Echinacea 30C – For when there’s sepsis or blood poisoning, fetid smelling discharges and enlarged lymph nodes.
Homeopathy is an ideal medical stratagem for survivalists, homesteaders and anyone wanting to be self-reliant in any situation.
I thought this might be a joke, but it’s not. All you have to do is to peruse the rest of Calabrese’s website to realize that she actually believes these things. Calabrese also pimps her forthcoming book, The Survivalist Guide to Homeopathy. In any event, all of these remedies, being 30C dilutions, are nothing more than water, likely soaked into sugar pills. I still can’t figure out why homeopaths take their water, press it into sugar pills, and then let them dry out. Why not just administer the water with a bit of salt? In that case, it might at least have a chance to contribute to the rehydration of a vomiting and bleeding patient.
Of course, these recommendations aren’t just the delusional ravings of pseudoscience-believing homeopaths? (Well, actually, they are.) Homeopaths try to show there’s “science” behind them. For example, there’s even a paper in the British Journal of Homeopathy (OK, so it’s not actually science) entitled “Sicarus (Six-Eyed Crab Spider): A homeopathic treatment for Ebola haemorrhagic fever and disseminated intravascular coagulation?” Shockingly, I found this ridiculous paper hosted on a personal page on the Indiana University website. In any case, it’s not just Ebola. Homeopaths are deluded enough to think that they can treat potential bioterrorism agents such as anthrax (Anthracinum and Arsenicum album), smallpox (Variolinum, Malandrinum, Sarsparilla, Thuja, Baptisia (Pestinum and Crotalus horridus for hemorrhagic plague; Lachesis, Arsenicum album for bubonic plague; Phosophorus for pneumonic plague), and Botulism (Botulinum and Gelsemium, Arsenicum album, Belladonna Alternate).
Meanwhile, on Twitter, the homeopathy supporters were out in force, and the WHO tweeted:
There is no evidence base that #homeopathy can cure #Ebola. Severely ill patients require intensive supportive care http://t.co/itpATExjBk
— WHO (@WHO) July 31, 2014
It’s sad and also evidence of how loudly homeopaths have been making the claim that homeopathy can cure Ebola virus disease that the WHO felt obligated to state this simple fact. Not surprisingly, the WHO got responses like:
@Skepticat_UK @WHO Applied Research in Evidence-based Homeopathy for 29 medical conditions http://t.co/7SK8Gc26g3
— EvidenceBased Hpathy (@DrNancyMalik) July 31, 2014
And:
WHO on Ebola "No specific treatment is available" and no comments about #homeopathy pro or con. http://t.co/hzDvGhEtzD
— Laurie J. Willberg (@LaurieJWillberg) August 1, 2014
This response from Laurie J. Wilberg, who was told that the burden of proof is not on homeopathy critics, says it all:
#homeopathy @BrownBagPantry The burden of proof concept is a legal one: the accuser needs to prove their case, as in malpractise.
— Laurie J. Willberg (@LaurieJWillberg) August 2, 2014
Once again, homeopaths get a basic concept of science and medicine wrong. Science is not the legal system. It is thus not up to skeptics to prove that homeopathy doesn’t work. It’s up to homeopaths to prove it does. Indeed, it’s tempting to propose that a homeopath infect himself with the blood of an Ebola victim, wait until the flu-like symptoms start, and then cure himself with homeopathy. I say “tempting” because I won’t really propose it. Some homeopath might actually try it. So if you’re a homeopath reading this, please don’t do something like that. And, if you’re in Africa (or anywhere else) and are unfortunate enough to be infected, please, please, please, please, don’t rely on homeopathy or other quackery for your treatment. If you want to quadruple your chances of surviving (10% chance of survival to over a 40% chance), don’t do it. Seek the best science-based medical care you can find.
Conclusions
This is the largest Ebola virus disease outbreak recorded thus far. Because Ebola virus (particularly the Zaire strain) produces such a nasty disease that kills more than 50% of those infected, even when optimal medical care is available, and over 90% of the untreated, it’s natural that fear and misinformation are running rampant, be they peddled by faith healers, homeopaths, or rich old guys with bad hair and an overinflated opinion of their own knowledge. It’s important for us to remember here in the US that the likelihood of an outbreak due to bringing back two patients with Ebola virus disease is incredibly small, and that conditions here in the US and other developed nations are such that it is unlikely that such an outbreak, even in the unlikely event that it happened, would spread very far, given the differences in medical care, availability of resources, and differences in funeral practices. That’s not to say we shouldn’t be vigilant, but there is really nothing particularly unusual about Ebola virus other than the rapid onset and severity of the disease it causes.
As for Africa, the problem is, as is usually the case in poor and less developed countries, resources. Doctors Without Borders/Médecins Sans Frontières are stepping up efforts to bring real medical care to the victims in Africa, constructing a clinic that looks like this:
But:
Already stretched beyond capacity in Guinea and Sierra Leone, MSF is able to provide only limited technical support to the Liberian Ministry of Health. MSF has set up an Ebola treatment center in Foya, in Lofa county in northern Liberia, where cases have been increasing since the end of May. After the initial set up, MSF handed over the management of the center to nongovernmental organization Samaritan’s Purse on July 8.
WHO is also contributing, as is Samaritan’s Purse. If there’s one thing that’s sure, more resources and more effort on the part of developed nations will be required to bring these outbreaks under control and save as many lives as possible. If there’s another thing that’s sure, it will require science-based medicine, not quackery like homeopathy, to succeed.

Ebola conspiracy theories: Same as it ever was
David Gorski on October 18, 2014
Link
Does anyone remember the H1N1 influenza pandemic? As hard as it is to believe, that was five years ago. One thing I remember about the whole thing is just how crazy both the antivaccine movement and conspiracy theorists (but I repeat myself) went attacking reasonable public health campaigns to vaccinate people against H1N1. It was truly an eye-opener, surpassing even what I expected based on my then-five-year experience dealing with the antivaccine movement and quacks. Besides the usual antivaccine paranoia that misrepresented and demonized the vaccine as, alternately, ineffective, full of “toxins,” a mass depopulation plot, and many other equally ridiculous fever dream nonsense, there was the quackery. One I remember quite well was the one where it was claimed that baking soda would cure H1N1. Then there was one of the usual suspects, colloidal silver, being sold as a treatment for H1N1. Then who could forget the story of Desiree Jennings, the young woman who claimed to have developed dystonia from the H1N1 vaccine but was a fraud? Truly, pandemics bring out the crazy, particularly the conspiracy theories, such as the one claiming that the H1N1 pandemic was a socialist plot by President Obama to poison Wall Street executives, which was truly weapons-grade conspiracy mongering stupidity. Oh, wait. That last one was a joke. It’s so hard to tell sometimes with these things.
Yes, pandemics and epidemics do bring out the worst in people in many ways, but particularly in terms of losing critical-thinking abilities. This time around, five years later, it’s Ebola virus disease. To the average person, Ebola is way more scary than H1N1, even though H1N1, given its mode of transmission, had the potential to potentially kill far more people. Now that cases of Ebola virus disease have been reported in the US, the panic has been cranked up to 10 in certain quarters, even though the risk of an outbreak in the US comparable to what is happening in West Africa is minimal. We’ve seen quackery, too, such as homeopaths seriously claiming that they can treat it and quacks advocating high-dose vitamin C to “cure” Ebola. The über-quack Mike Adams is selling a “natural biopreparedness” kit to combat Ebola and pandemics, while the FDA is hard-pressed to track down all the quacks, such as hawkers of “essential oils,” who—of course!—also think that their wares can cure Ebola.
Now, given how afraid everyone is of Ebola, not entirely without some justification (it is a horrible disease, after all, and it is spread by contact with blood and bodily fluids; taking reasonable precautions is prudent), you’d think that everyone could and would get behind the fast-track development of vaccines against the disease. Given that Ebola is a virus and a successful antiviral treatment tends to be considerably more difficult to develop than a successful antibiotic, a vaccine likely represents the best hope for rapidly bringing the current epidemic under control with as little loss of life as possible. Certainly if such a vaccine were to be developed, as it likely will be relatively soon (at least in terms of drug or vaccine development time, given the urgency now that wasn’t there before), you’d think that a vaccine would be welcomed with open arms. And when it comes to most people, at least not antivaccine activists, you’d be right. However…take a look at this video by Barbara Loe Fisher, Grande Dame of the antivaccine movement and founder of the Orwellian-named National Vaccine Information Center (NVIC):
First, we have a highly cherry-picked timeline designed to make the US and CDC look as incompetent as possible, as Fisher asks a series of “Why?” questions, some semi-reasonable, some pure fear mongering. Then comes the kicker. Near the end of the video, Fisher asks (at the 9:00 mark or so):
And why are experimental Ebola vaccines being fast tracked into human trials and promoted as the final solution rather than ramping up testing and production of the experimental ZPapp drug that has already saved the lives of several Ebola-infected Americans?
I wonder what this “ZPapp” drug is. I’ve never heard of it before. I’m guessing that Fisher means ZMapp. Barbara, Barbara, Barbara. How are we supposed take you the least bit seriously if you can’t even get the name of the main experimental drug currently being tested against Ebola right? Then there’s Fisher’s choice of words to describe experimental vaccines: Final solution. Freudian slip much, Barbara? One wonders if she could be more obvious in her biases against vaccines. In any case, contrary to what Fisher claims it isn’t clear whether ZMapp actually did save the lives of those Americans who survived Ebola. It might have. It might not have. It might have been that those patients would have recovered anyway with supportive care alone. Indeed, at least one patient that I’ve read about received the drug but died anyway. That’s why we need more data and a clinical trial to tell if ZMapp is as effective as we all hope it is, based on preclinical studies in primates. As for “ramping up production,” it’s not as though ramping up production of an experimental drug is as easy as just turning a switch, as I discussed in the context of discussing misguided “right to try” laws. This drug is a humanized monoclonal antibody (like Avastin and Herceptin, for instance). Making such drugs is difficult, expensive, and can’t easily just be “ramped up” instantly.
Of course, to Fisher, this emphasis by public health officials on fast tracking an Ebola vaccine can’t be because it would be a powerful tool in our arsenal to halt the spread of Ebola. Oh, no. it can only mean one thing:
A logical conclusion is that some people in industry, the government, and the World Health Organization did not want the Ebola outbreak to be confined to several nations in Africa because that would fail to create a lucrative global market for mandated use of fast tracked Ebola vaccines by every one of the seven billion human beings living on this planet. Will there be an Ebola outbreak in America? Ask the CDC, WHO, DOD, NIH, and Congress. Learn more about Ebola and Ebola vaccines at NVIC.org. It’s your health, your family, your choice.
Notice how it never occurs to Fisher that the best way to stop an outbreak of an infectious disease is through prevention (i.e., a vaccine, in addition to other public health measures designed to slow the spread of the disease). This is particularly true when the disease in question is a viral disease for which an effective drug is difficult to make. In any case, this is a common theme through the latest crop of Ebola conspiracy theories coming from antivaccine loons like Fisher: The claim, implication, or insinuation that the government either created or at least sustained (and took advantage of) the current Ebola outbreak in order to create a market for vaccines for its pharma overlords, although some variants, as we will see, postulate that the reason for starting and sustaining the epidemic is to create a lucrative market for ZMapp, whose early development was—of course!—funded in part by the U.S. Department of Defense.
Fisher is not alone in promoting paranoid conspiracy theories. All over Twitter and other social media, there are exchanges like this:
@KaiHolloway I cant see any other agenda for the Ebola Feargasm on M$M…fuck I hope im wrong..
— Paul Schmidt (@psc96180_pablo) October 15, 2014
The replies were equally unhinged:
@psc96180_pablo me too brother, but we have seen it coming… as a human being we are entitled to defend our selves. this is fkn bollox!
— no one special (@KaiHolloway) October 15, 2014
That’s right. According to antivaccinationists, the real reason for the Ebola “feargasm” is to promote a toxic mass vaccination program because…well, just because apparently the government wants to poison us in order to…well, I must confess that I really can’t follow the “logic” of this particular conspiracy theory, such as it is. Such is the nature of the conspiracy theories springing up among antivaccinationists about the latest Ebola outbreak. Why would the government want to kill thousands, possibly hundreds of thousands if the epidemic gets out of control in Africa? Antivaccine conspiracy theorists honestly seem to think that the Ebola outbreak is being used as a pretext for mass vaccination programs, rather than proposals for vaccines flowing from the understandable desire of public health officials in the US, Africa, and the rest of the world to stop mass suffering and death as rapidly as possible. Not surprisingly, the paranoia and conspiracy theories are eerily similar to the ones that sprang up five years ago in response to the H1N1 pandemic and the mass vaccination programs instituted by the US and other nations to try to forestall its worst effects.
In fact, the conspiracy theories get even loonier than that. For one thing, there are idiots like Larry Klayman claiming that President Obama actually wants Ebola to become established in the US because he wants to infect white people and make the US more like his “home” in Africa. I kid you not.
However, it is the antivaccine movement that’s really jumped into the Ebola conspiracy-theory pond feet first. Remember the whole “CDC whistleblower” conspiracy theory? It broke on a waiting online world like a massive fart only less than two months ago, back in August. It began when biochemical engineer turned “vaccine expert,” epidemiologist, and, of course, mercury militia member published a truly awful “re-analysis” of a decade-old study (DeStefano et al) that failed to find a correlation between age at MMR vaccination and risk of autism in a case control study. Basically, his “re-analysis” proved Andrew Wakefield wrong in that it found no increased risk of autism attributable to MMR vaccination in all but a very small subgroup in the study, African-American boys, and the numbers for that group were so suspect that virtually everyone with any knowledge of statistics, epidemiology, or experimental design highly doubted they were anything other than an anomaly. Unfortunately, it did spark a ridiculous campaign on the part of the antivaccine fringe, who saw this as “smoking gun proof” of their central conspiracy theory that the CDC covered up The Truth that vaccines cause autism, because, it turns out, a CDC psychologist named William Thompson, who was a co-author on DeStefano et al, had been feeding Brian Hooker information out of some sort of misguided “guilt” over a decade-old scientific disagreement he lost over how to analyze the data. Naturally, there was no evidence presented that the CDC did anything wrong other than the cherry-picked and highly edited quotes and snippets of text from Thompson provided by Andrew Wakefield and Brian Hooker, the latter of whom had recorded Thompson without his knowledge for months, but that didn’t stop the antivaccine movement from going full mental jacket over this affair.
So, now that they’ve failed to get any traction on the “CDC whistleblower” issue in the mainstream press other than a smackdown by MSNBC’s Ronan Farrow, who made one of the “thinking moms” named Lisa Goes look even more ignorant than usual, angering the “media editor” of the antivaccine crank blog Age of Autism, how do antivaccinationists explain their failure to get any significant attention despite a whole lot of trying? My explanation is that most reporters know cranks as cranky as this when they see them and, probably more importantly, that Andrew Wakefield is so disgraced and so toxic that his involvement in the story basically killed any opportunity antivaccinationists might have had to get even a bottom feeding “mainstream media” outlet interested in the story. One antivaccinationist’s explanation is that, obviously, Ebola’s the result of a plot to keep the mainstream media from reporting on the “CDC whistleblower” affair:
How is it we suddenly have an Ebola “outbreak” and it is coming to the USA too?The Ebola outbreak is quite a coincidence – senior CDC scientist Dr Thompson has been talking with Dr Hooker for 10 months about the CDC knowing the MMR vaccine causes autism. The Ebola “problem” was introduced gently to the US public earlier in the year.
Now we have an Ebola “outbreak” in the west just when Hooker’s paper has been published and the admissions about the CDC knowing the MMR vaccine causes Autism issue are breaking news which the mainstream media refuse to report.
And today’s news of a “vaccine” will of course be certain to ensure editors will publish nothing about MMR vaccine causing autism.
Of course to test a new vaccine and a new drug one needs a clinical trial. But people tend not to get Ebola – it has been pretty quiet for a very long time – until now.
And suddenly they ship the sick people off to the USA with all the attendant risks of spreading the disease instead of treating them where they got sick.Seems a gift for WHO and the CDC but who wrapped it and how long ago?
Because, obviously, the CDC and US government are so nefarious and clever that they foresaw many months ago that in August the whole “CDC whistleblower” thing would blow up, which is why they got an Ebola epidemic in Africa going with enough lead time so that the number of fatalities would be percolating along at the same time, timing it even more ingeniously so that the fear of the disease would be reaching a fever pitch right around the same time those poor, intrepid antivaccinationists were trying to get the attention of the media. Damn, I wish our government functioned so efficiently and with such purpose! Obviously, it doesn’t. But it’s still a hell of a conspiracy theory. Well, not really.
That doesn’t stop the “Vaccine Information Network” from asking Ebola: yet another fake pandemic set up to poison us with drugs and vaccines? The cranks at the VIN do realize that usually when the title of an article is in the form of a question, the answer to that question is, “No,” don’t they? Apparently not, because clearly Jon Rappoport (remember him?) believes that it is. And guess what? He even likens it to H1N1 in this interview:
Q: What is the major psychological factor at work here?A: Above all else, it is people making an automatic connection between their own frightening image of Ebola and the statement, “So-and-so is sick.”
Q: “Sick” doesn’t automatically = Ebola?A: That’s right, even when an authority says some person is sick and in the hospital and has Ebola.
Q: Is the Ebola epidemic a fraud, in the same way that Swine Flu was a fraud?A: In the summer of 2009, the CDC stopped counting cases of Swine Flu in the US.
Q: Why?A: Because lab tests on samples taken from likely and diagnosed Swine Flu cases showed no presence of the Swine Flu virus or any other kind of flu virus.
Q: So the CDC was caught with its pants down.A: Around its ankles. It was claiming tens of thousands of Americans had Swine Flu, when that wasn’t the case at all. So why should we believe them now, when they say, “The patient was tested and he has Ebola.” The CDC is Fraud Central.
Q: Where is the fraud now, when it comes to counting Ebola cases and labeling people with the Ebola diagnosis?A: The diagnostic tests being run on patients—the antibody and PCR tests are most frequently used—are utterly unreliable and useless.
Q: Therefore, many, many people could be labeled “Ebola,” when that is not the case at all?A: Correct.
Q: But people are sick and dying.A: People are always sick and dying. You can find them anywhere you look. That doesn’t mean they’re Ebola cases.
Q: In other words, medical authorities can place a kind of theoretical grid over sick and dying people and reinterpret them as “Ebola.”A: Exactly. The map can be drawn in any number of ways.
Got that? Back in 2009, apparently (if you believe Rappoport), it wasn’t H1N1 that was sickening people, and now in 2014 it’s not Ebola that is killing people in West Africa and has infected a handful of people in the US. What is the cause? According to Rappoport, it’s not the virus. Basically, it’s protein-calorie malnutrition, hunger, starvation, extreme poverty, contaminated water supplies, overall lack of basic sanitation, a decade of horrific war, toxic medical drugs, prior toxic vaccine campaigns, and the like that cause destruction of immune systems, leading to:
Then, any germ that sweeps through the population, a germ that would ordinarily be defeated, instead kills many people. Why? Because the immune system is too weak to respond. With healthy and strong immune systems, the germs would have no significant effect.
This is, of course, utter BS. Rappoport, as usual, argues by assertion and doesn’t know what he’s talking about. It’s amazing how constant the forms of infectious disease denialism are. Just like HIV/AIDS denialism blamed “lifestyle” and immune compromise due to drugs, anal sex, and “lifestyle,” claiming that AIDS is not caused by HIV, Ebola virus denialism claims that what is being diagnosed as Ebola is in fact not due to Ebola but to “toxins,” malnutrition, and, of course, vaccines. Notice the striking similarity to HIV/AIDS denialism claims. One wonders why, if these conspiracy theorists truly believe that a normal healthy immune system in a person living a healthy lifestyle and eating the “right” foods can ward off Ebola, they don’t immediately head over to West Africa to help out in the relief efforts! (Actually, I ask the same question about Homeopaths Without Borders. Why don’t they head over to Africa and help out?)
Delusions upon delusions, to Rappoport, the whole thing is a plot to drive demand for products made by big pharma, such as vaccines. Naturally, as with all good disease conspiracies, Rappoport drives it with claims that the case numbers are being “manipulated,” labeling the Ebola outbreak as a “hoax,” claims that the tests are “unreliable” (they’re not; while it’s true that early in the course of symptomatic Ebola infection the disease resembles a lot of other viral diseases, there are a number of sensitive and accurate diagnostic tests, including PCR, ELISA, and, ultimately, virus isolation); and claims from the inventor of PCR, Kary Mullis, from whom Rappoport cites a 1996 quote claiming that “quantitative PCR is an oxymoron.” It’s not; I’ve been doing highly accurate quantitative real time PCR in my lab for 14 years now, and it’s a routine technique in molecular biology labs. In 1996, reliable quantitative PCR hadn’t been perfected yet, but today it’s a routine, every-day test.
Of course, it’s not just the CDC, at least not according to Yoichi Shimatsu, but it’s apparently the UN, too. According to the Shimatsu, Ebola outbreaks coincided with vaccination campaigns by World Health Organization (WHO) and the UN children’s agency UNICEF. To others, however, the Ebola outbreak is not so much a plot to enrich big pharma but rather US-sponsored bioterror. At least, so sayeth someone calling himself Prof. Jason Kissner. Kissner, it turns out, is a criminologist and a birther, but with a twist. While he accepts that President Obama was born in Hawaii, but claims that he holds dual citizenship as an Indonesian. In fact, Kissner is all over the conspiracy sites, and his arguments about Ebola are no more coherent than his arguments about the President’s birth certificate. He also thinks that the “the racial “dialogue we’ve been hectored about for several decades is in reality no ‘dialogue’ at all; it is a monologue imposed by the powerful in order to decimate the values and individuality of the powerless.” After worrying about whether the virus responsible for the current outbreak might have gone airborne, he goes on to invent a conspiracy theory in which the current outbreak is due to a bioengineered variant of Ebola that’s more contagious than previous strains. He bases this almost entirely on an article in the New England Journal of Medicine from April about the emergence of the Zaire strain of Ebola in Guinea, which notes that the Guinea strain in West Africa is distinct:
According to the initial epidemiologic investigation, the suspected first case of the outbreak was a 2-year-old child who died in Meliandou in Guéckédou prefecture on December 6, 2013 (Figure 2). A second investigation confirmed the origin of the outbreak in Meliandou but revealed a somewhat different timing of the early events (including the death of Patient S1 at the end of December and the deaths of Patients S2, S3, and S4 in January). Patient S14, a health care worker from Guéckédou with suspected disease, seems to have triggered the spread of the virus to Macenta, Nzérékoré, and Kissidougou in February 2014. As the virus spread, 13 of the confirmed cases could be linked to four clusters: the Baladou district of Guéckédou, the Farako district of Guéckédou, Macenta, and Kissidougou. Eventually, all clusters were linked with several deaths in the villages of Meliandou and Dawa between December 2013 and March 2014.
In a nutshell, both the Shimatsu conspiracy theory and Kissner’s conspiracy theory rely on an appeal to incredulity. Just because Kissner and Shiamatsu can’t believe that Ebola could remain dormant for years and then reemerge to cause this outbreak, to them something else must be going on. For instance, Shimatsu writes:
The mystery at the heart of the ebola outbreak is how the 1995 Zaire (ZEBOV) strain, which originated in Central Africa some 4,000 km to the east in Congolese (Zairean) provinces of Central Africa, managed to suddenly resurface now a decade later in Guinea, West Africa.
Kissner’s contribution to this argument from incredulity is that he can’t believe that the distinct strain of Ebola could have arisen naturally and then found its way from Zaire all the way to West Africa without human intervention. I bet you can guess what that intervention is:
And, we seem to have a single introduction of the Guinea (West African) Ebola variant into the human population. Thus, we seem not to have, for example, something along the lines of multiple bites of humans by supposedly Guinea variant Ebola infected fruit bats.
Finally, the Western Africa Ebola outbreak does not appear to be traceable to Central Africa or anywhere else, and so we still do not know how Ebola got to West Africa.
To Kissner, this of course means that it must have been US bioterrorism that introduced this “new” Ebola strain into the human population in Guinea in order to…what? Why? To Kissner, it’s all about the experimental Ebola drug ZMapp, which was only identified as a potential Ebola drug candidate in January 2014:
Does “ZMapp was first identified as a drug candidate in January 2014” mean that ZMappwas [sic] designed from the ground up, pretty much when the outbreak began, with the specific purpose of treating the Guinea Ebola variant (see above for timing of the outbreak)? Or, does it mean that ZMapp was repurposed in some way to grapple with the Guinea variant? Or does it perhaps mean something else entirely?
That “something else entirely” to Kissner is that the makers of ZMapp knew about the new Guinea variant and designed ZMapp to combat it. Apparently Kissner has never heard of crossreactivity of antibodies. Or perhaps he has but just doesn’t believe it:
Perhaps Mapp had been in the process of designing ZMapp so that it could successfully attack already extant Ebola variants, and whatever properties made it effective against those already extant variants also transferred to the novel Guinea variant?
Maybe.
But if that is so, ZMapp should prove successful against variants of Ebola other than the Guinea variant. Will it?
If it doesn’t prove successful against variants of Ebola other than the Guinea variant, I do not see how one can logically avoid the conclusion that the West African rooted, Guinea variant of Ebola amounts to U.S. government linked bioterror.
Unless, of course, one is willing to invoke what amounts to a miraculous stroke of luck consisting in the design of a solution that successfully attacks something that’s never been seen before and was not anticipated—even though the solution fails against related versions of the same problem.
In closing, please note that the U.S. act of bioterror explanation economically accounts for all three U.S. lies discussed in the article. It explains why the U.S. government is lying about the airborne status of Ebola, why the U.S. government/MSM hybrid is in no hurry to disclose the geographical and virological novelties of the Guinea variant, and, finally, why the U.S. government, out of one side of its mouth, wants to act like its “miracle experimental drug” had to be pried out of its greedy and comprehensive regulatory hands.
“Economically accounts for”? You keep using that phrase, Mr. Kissner. I do not think it means what you think it means.
That’s one hell of a plot, isn’t it? Of course, ZMapp has been under development at least since 2012 and the antibody cocktail against Ebola virus used went through at least three distinct iterations, its latest composition having been arrived at in early 2014 based on testing in rhesus macaque primates. I suppose that means that those nefarious Department of Defense funders who helped fund the drug and Leaf Biopharmaceutical Inc., the company currently developing ZMapp, must have planned even further ahead than even Kissner could know. Or maybe there’s just good crossreactivity of this antibody cocktail to multiple strains of Ebola.
Shimatsu disagrees. Although his logical fallacy is also an appeal to personal incredulity, unlike Kissner, he thinks it’s all due to the UN vaccine programs:
The reason for suspecting a vaccine campaign rather than an individual carrier is due to the fact that the ebola contagion did not start at a single geographic center and then spread outward along the roads. Instead. Simultaneous [sic] outbreaks of multiple cases occurred in widely separated parts of rural Guinea, indicating a highly organized effort to infect residents in different locations in the same time-frame.
But how and why? Shimatsu has a ready answer:
Repeated dosages of potent toxins on populations with poor health, which no public-health agency in the Western world dares attempt inside its own borders, can have harmful side effects, especially on children. The casualties of vaccination have gone unreported by the media and buried under official cover-ups. Even worse, vaccine programs could well have been used to conceal human testing of antibodies that originated in biological warfare labs for the purpose of mass murder of entire nations.
Yes, according to Shimatsu, the MSF, UNICEF, WHO, CDC, NIH, USAMRIID and, as Shimatsu puts it, the “rest of the alphabet soup of the hypocritical oafs of pharmaco-witchcraft” are all just that evil.
Throughout history, infectious disease has brought out the best and worst in humanity. The best, like Doctors Without Borders, go selflessly straight into the hearts of epidemics in order to treat the ill, try to prevent further spread of the disease, and alleviate suffering wherever they can. The worst, like antivaccinationists and conspiracy theorists like Kissner and Shimatsu, try to deny the cause of the disease in favor of conspiracy theories that demonize the very organizations trying to help its victims and companies trying to make vaccines to prevent it and drugs to treat it. Every misstep of the CDC and other health authorities is magnified and taken advantage of by antivaccinationists to make the non sequitur claim that, if the CDC makes mistakes handing the Ebola outbreak it must be wrong when, based on existing science, it correctly states that vaccines do not cause autism.
What’s really depressing is that, at the heart of these conspiracy theories is a belief that public health officials, doctors, governments, the UN and WHO, and pharmaceutical companies are so irredeemably evil that they would willingly start an outbreak of a deadly disease like Ebola in impoverished African nations, but, realizing that no one cares about Africans that much, make sure it spreads to the US to cause a panic, and then let the disease kill many thousands, all in order to create a market for drugs and vaccines. Oh, and those drugs and vaccines are toxic. Truly, the delusional nature of such conspiracy theories is depressing to behold.

Conspiracy theories and Ebola virus transmission
David Gorski on November 3, 2014
Link

Yesterday, I spiffed up a post that some of you might have seen, describing how a particular medical conspiracy theory has dire consequences in terms of promoting non-science-based medical policy. Specifically, I referred to how the myth that there are all sorts of “cures” for deadly and even terminal diseases that are being kept from you by an overweening fascistic FDA’s insistence on its approval process is an important driving force behind ill-advised “right to try” legislation that’s passed in four states and likely to pass in Arizona by referendum tomorrow. I’m not exaggerating, either. If you have the stomach to delve into the deeper, darker recesses of alternative medicine and conspiracy theory websites, you’ll find words far worse than that used to describe the FDA, such as this little gem from everyone’s favorite über-quack Mike Adams basically portraying the FDA as Adolf Hitler. Even more “mainstream” advocates, such as Reason.com’s Ronald Bailey and Nick Gillespie, are not above using a version of this myth stripped of the worst of its conspiracy mongering for public consumption, claiming that the FDA is killing you.
Unfortunately, this sort of medical conspiracy theory is very common. Like all conspiracy theories, medical conspiracy theories tend to involve “someone” hiding something from the public. I like to refer to this as the fallacy of “secret knowledge.” That “someone” hiding the “secret knowledge” is usually the government, big pharma, or other ill-defined nefarious forces. The “secret knowledge” being hidden comes invariably in one of two flavors. Either “they” are hiding cures for all sorts of diseases that conventional medicine can’t cure, or “they” are hiding evidence of harm due to something in medicine. Although examples of the former are common, such as the “hidden cure for cancer,” it is examples of the latter that seem to be even more common, in particular the myth that vaccines cause autism and all sorts of diseases and conditions, that genetically modified organisms (GMOs) are dangerous, or that radiation from cell phones causes cancer. In these latter examples, invariably the motivation is either financial (big pharma profits), ideological (control, although descriptions of how hiding this knowledge results in control are often sketchy at best), or even some seriously out there claims, such as the sometimes invoked story about how mass vaccination programs are about “population control” or even “depopulation.” Either way, “The Truth” needs to be hidden from the population, lest they panic and revolt.
Indeed, in the case of the antivaccine movement, the belief that the CDC is “hiding” the true harms of vaccines (such as that they can cause autism) has been called the central conspiracy theory of the movement. It’s not surprising, then, that antivaccinationists have tried to claim that vaccines are responsible for the initial Ebola outbreaks in West Africa. These conspiracy theories have profound effects dealing with health emergencies. In particular, the idea that the CDC is “hiding” something can undermine trust and facilitate the spread of misinformation. That’s just what happened last week.
The CDC “admits”…nothing new!
Just last week, there was an example of just how pernicious these beliefs can be in the middle of an outbreak of a disease as deadly as Ebola. This example came in the form of a news story/meme that popped up first in the fever swamps of conspiracy and quackery sites like NaturalNews.com and then found its way into more “mainstream” outlets. Perhaps the reason that the story gained traction last week is that it happened as news stories were circulating about a Maine nurse named Kaci Hickox, who had treated Ebola patients in West Africa. When she returned a week and a half ago, arriving first in Newark, she was quarantined in appalling conditions in a tent with no heat, even though she showed no symptoms other than a one-time low grade fever on forehead scanning on arrival, has been completely asymptomatic since, and ultimately tested negative for Ebola. Ultimately, having been accused of playing politics with fear of Ebola (which he clearly was), NJ Governor Chris Christie was forced to relent, and Hickox went home to Maine, where a similar scenario played out, this time with Maine Governor Paul R. LePage, in the heat of a tight re-election race, equally shamelessly played for politics by pushing for an in-home quarantine for the full 21-day incubation period, even though it was not medically indicated. Meanwhile, the online opprobrium against Hickox, where demands that she be arrested were common, was depressing to behold. Apparently we’ve learned nothing since the Black Plague. At least then there was the excuse that people had little or no idea what caused the plague.
I had to admire Hickox in a way for defying Maine’s governor and ignoring the quarantine order, but on the other hand I was concerned that there is such a thing as being too bold in this case and questioned whether so blatantly flouting the governor by going out in public was particularly wise. I say that not because I thought that her quarantine was medically indicated, but more because I was worried that someone, out of fear of Ebola, would kill her if he saw her out in public. In any case, ultimately, Judge Charles C. LaVerdiere, the chief judge for the Maine District Courts, struck down the quarantine as not being reasonably based in science and instead ordered the much more reasonable and science-based condition that Hickox submit to daily monitoring for symptoms, to coordinate her travel with public health officials, and to notify them immediately if symptoms appear, stating that she “currently does not show symptoms of Ebola and is therefore not infectious.”
Into this background started appearing stories, first in places like NaturalNews.com, then in the New York Post, claiming that the CDC “knew” or “admitted” that Ebola could be spread by air. Part of the conspiracy of “secret knowledge” invariably involves that knowledge being inadvertently revealed somehow, either through an inadvertent admission or some other way. Clearly, the “secret knowledge” here was that, contrary to what scientists have been saying all along that Ebola is spread by contact with infected bodily fluids in much the same way HIV and hepatitis B are, in reality you could catch it just by being in the same room as someone with Ebola. This is the sort of story I’m talking about in the NY POST, “CDC admits droplets from a sneeze could spread Ebola“:
Ebola is a lot easier to catch than health officials have admitted — and can be contracted by contact with a doorknob contaminated by a sneeze from an infected person an hour or more before, experts told The Post Tuesday.
“If you are sniffling and sneezing, you produce microorganisms that can get on stuff in a room. If people touch them, they could be” infected, said Dr. Meryl Nass, of the Institute for Public Accuracy in Washington, DC.
Nass pointed to a poster the Centers for Disease Control and Prevention quietly released on its Web site saying the deadly virus can be spread through “droplets.”
“Droplet spread happens when germs traveling inside droplets that are coughed or sneezed from a sick person enter the eyes, nose or mouth of another person,” the poster states.
Nass slammed the contradiction.
“The CDC said it doesn’t spread at all by air, then Friday they came out with this poster,” she said. “They admit that these particles or droplets may land on objects such as doorknobs and that Ebola can be transmitted that way.”
First off, let’s just say that Dr. Nass is not exactly a reliable source. For example, she’s been known to show up on quack websites like Mercola.com spouting antivaccine tropes, to write a letter asking for help to the antivaccine website Vaccination News, and to write a great deal about mass vaccination programs, particularly anthrax vaccines in the military, viewing it as a cause of Gulf War syndrome. Indeed, she has her very own page on that granddaddy of conspiracy sites, Whale.to and did this video for Gary Null:
It’s a video full of conspiracy mongering against the CDC, insinuations that Gardasil is killing girls, and claims that recent litigation “reduced” the ability of victims of vaccine injury to claim compensation. Making a newbie (or antivaccine) mistake, she takes claims made to the Vaccine Adverse Effects Reporting System (VAERS) at face value, even though it’s been described many times why VAERS is not a good measure of the true frequency of adverse events related to vaccines and is heavily influenced by litigation and publicity. Regular readers will recognize the misinformation and tropes, so much so that I had a hard time listening to the entire 15 minutes of the video.
But what about the poster to which Dr. Nass pointed as evidence that the CDC was “admitting” that Ebola could be spread through the air? Clearly, she’s been getting her information from people like Mike Adams and sites like NaturalNews.com, where Adams ran a story on Friday entitled “Schizophrenic CDC pulls document admitting Ebola can spread via sneezes and doorknobs; see the original here“:
Just days after admitted it lied about how Ebola spreads and finally admitting the virus can spread through aerosolized particles propelled via sneezing or coughing, the CDC yanked its document off the web.
It replaced it with a new PDF that’s almost entirely empty, except for the statement “Fact sheet is being updated and is currently unavailable.” You can see that file at this CDC link.
As the editor of Natural News, I anticipated the CDC doing this, so I saved off a copy of the original PDF on Natural News servers, which you can access at the following link: http://www.naturalnews.com/files/infections-…
“Ebola is spread through droplets” – admitted but now scrubbed
As you can see in the original document the CDC has now buried, it admitted “Ebola is spread through droplets,” and stated “Droplet spread happens when germs traveling inside droplets that are coughed or sneezed from a sick person enter the eyes, nose, or mouth of another person.”
The document also stated “Droplets can contaminate objects like doorknobs” and explained “A person might also get infected by touching a surface or object that has germs on it and then touching their mouth or nose.”
This is a classic example of confusing the colloquial definition of a term with the scientific definition of a term, in much the same way creationists think that a scientific theory is just a “hunch” or a “guess” because that’s what most people mean when they say theory. To explain what is really going on here, let’s look at the actual original poster, taken from NaturalNews.com and other websites that have “saved” it to prevent the CDC from going back on what it said (click for full PDF):
Then there’s the changed poster, dated November 1. Adams claims that the CDC link went to an empty document, but in reality the document is there. Perhaps he clicked on it while the document was being revised. Either way, here it is (click for full PDF):
On the surface, this sounds as though Nass and Adams might have a point, that Ebola can be spread by air, but they don’t. Their contention rests on the colloquial idea of what it means to be spread through the air. If someone sneezes a wet sneeze right in someone else’s face, to the average lay person that suggests that the droplets can be spread through the air. However, that’s not what epidemiologists and infectious disease specialists mean when they state that a disease can be spread through the air. Similarly, when they say that disease can be spread through “droplets,” they are not saying that the disease is “airborne” or can be spread through the air. To help explain the difference, I’m going to steal shamelessly from a post by colleague of mine (well, posts actually), Tara Smith, as well as posts to which she’s linked, such as one from Virology Down Under and this one from Pathogen Perspectives. You don’t need to click those links if you don’t want to, but I highly recommend that you do because they are excellent discussions.
To understand where Nass and Adams go wrong, it’s necessary to understand what infectious disease experts mean when they speak of droplets. As Heather Lander explains, bodily secretions that make it into the air from various orifices are called “droplets” and classified based on their size and the distance they can travel. The smaller the droplet, the longer it can stay suspended in the air and the farther it can travel. Not coincidently, the smaller the droplet, the deeper into the respiratory tract it can travel upon inhalation. Now here’s where this is relevant:
Teeny-tiny droplets (less than 5 microns) are generally referred to as “aerosols” and can be generated by a cough, a sneeze, exhaling, talking, vomiting, diarrhea, passing gas etc. Aerosols can also be generated mechanically by things like flushing a toilet, mopping, or rinsing out a bloody wash cloth. When aerosols are infectious, they transmit disease when they are inhaled by an organism and its called “aerosol transmission”. When droplets are larger than 10 microns they are called “large-droplets” and if infectious, they transmit disease by inhalation if the organism being infected is close enough to inhale the particles before they settle out of the air. They can also transmit virus if someone gets showered with droplets from, for example, a sneeze, or touching a droplet that is on the surface of an object(fomite) or someone’s skin and it’s called “large-droplet transmission”.
If you want to get more specific, this article will do it for you. Basically, by definition, aerosols are suspensions in the air small enough that they remain airborne for prolonged periods of time because of their low settling density. The article reports that for spherical particles of unit density, settling times for a 3 meter fall are 10 seconds for 100 μm, 4 minutes for 20 μm, 17 minutes for 10 μm, 62 minutes for 5 μm. Particles with a diameter less than 3 μm in essence do not settle. So for a disease to be truly airborne, it has to produce aerosols that hang in the air for a long time, such that prolonged contact (or even any direct contact at all) with the infected individual isn’t necessary for disease transmission. Also affecting this equation is how far these tiny particles can get into the lung. Particles greater than 6 μm tend to be trapped in the upper respiratory tract, while essentially no deposition of particles into the lower respiratory tract occurs for particles greater than 20 μm. To sum it up, a good rule of thumb is that particles in the micron or submicron range will behave as aerosols and particles greater than 10 to 20 μm will settle rapidly, won’t be deposited in the lower respiratory tract, and are called large droplets.
It’s a bit more complicated than that, too:
Whether propelled by sneezing, coughing, talking, splashing, flushing or some other process, aerosols (an over-arching term) include a range of particle sizes. Those droplets larger than 5-10 millionths of a meter (a micron [µm]; about 1/10 the width of a human hair), fall to the ground within seconds or impact on another surface, without evaporating (see Figure). The smaller droplets that remain suspended in the air evaporate very quickly (< 1/10 sec in dry air), leaving behind particles consisting of proteins, salts and other things left after the water is removed, including suspended viruses and bacteria. These leftovers, which may be more like a gel, depending on the humidity, are called droplet nuclei. They can remain airborne for hours and, if unimpeded, travel wherever the wind blows them. Coughs, sneezes and toilet flushes generate both droplets and droplet nuclei. Droplets smaller than 5-10µm almost always dry fast enough to form droplet nuclei without falling to the ground, and it is usual for scientists to refer to these as being in the airborne size range. It is only the droplet nuclei that are capable of riding the air currents through a hospital, shopping centre or office building.
This applies to basically all infectious diseases. Now, here’s where the confusion leading to articles like the NY POST article comes from. When infectious disease experts say that a virus is “airborne,” they have a very specific meaning. What they are saying is that the virus is capable of aerosol transmission via inhalation, even when not in close proximity to the source of the aerosol. In other words, if someone with measles (a very highly infectious virus that can be transmitted through the air), coughs up droplets in a room and then leaves the room and then you enter the room, you can breathe in the measles aerosol and will be very likely to contract measles if you haven’t been vaccinated.
The case is different for Ebola virus. As described and documented here, here, and here, for whatever reason, under as natural conditions, airborne droplet nuclei (the very tiniest droplets, the ones that can stay airborne indefinitely or for long periods of time) containing Ebola are not infectious. Whether it’s because the virus doesn’t like being dried down or primates don’t produce enough virus in saliva and mucus coughed up is not clear, but as described by VDU, there may be some Ebola virus in droplet nuclei – but it has never been shown to cause disease, even when that route has been specifically looked for in the same household as a cause of Ebola. Consequently, although Ebola virus-containing fluids are definitely infectious and can transmit Ebola virus disease, they are not considered airborne. Indeed, if Ebola were airborne, the casualties in this latest outbreak would have been far, far higher than the already high numbers we are seeing.
Now that you know this terminology, you should be able to see that there is nothing “nefarious” in either the first or second CDC poster, nor is there any “admission” that Ebola can be transmitted by air. The CDC has been consistent in stating that Ebola can be transmitted by droplets; it’s just that what is meant by that was not well understood. Perhaps that’s why the CDC decided to update the poster, to try to address the misunderstandings. As Tara Smith points out, it appears that the CDC just did a minor redesign of the poster, making some minor wording changes. The old poster stated that Ebola is not transmitted via the airborne route, and the new poster says the same thing. The original poster states that “if a germ is airborne, direct contact with the infected person is NOT needed for someone else to get sick,” in contrast to droplet transmission, which “happens when germs traveling inside droplets that are coughed or sneezed from a sick person enter the eyes, nose, or mouth of another person. Droplets travel short distances, less than 3 feet (1 meter) from one person to another.” The new poster states, “To get Ebola, you have to directly get body fluids (blood, diarrhea, sweat, vomit, urine, semen, breast milk) from someone who is sick with Ebola in your mouth, nose, eyes or through a break in your skin or through sexual contact.”
To repeat (because it’s so important), in other words, droplet transmission is not the same thing as airborne transmission. Airborne transmission can occur in places where the infected patient has been, even if it were hours ago, while droplet transmission requires being close to the infected patient. Yes, if an Ebola patient projectile vomits on you or bleeds on you, you will have Ebola virus on you that could infect you. Contrary to something like measles, just walking into an area of a building where an Ebola patient has passed through before is not going to result in your catching Ebola. Droplet transmission is still direct contact.
Finally, the NY POST and NaturalNews.com articles conflate droplet transmission with transmission by fomites (objects on which infected fluids wind up). Fomite transmission, however, is not thought to be a major source of Ebola transmission. As Smith puts it, it’s theoretically possible, but the object would have to be “heavily contaminated by a person late in the disease.”
How conspiracy theories harm
I can picture what some of you might be thinking: That’s mighty confusing. Some people would likely be confused even if Mike Adams weren’t spreading misinformation with an eye to selling Pandemic Protection Kits for “natural biopreparedness” and news organizations weren’t treating the story in a sensationalistic fashion. While that’s probably true, think of how much more difficult it is for health authorities to explain these things in a way that lay people understand, given all the medical conspiracy theories out there. For instance, as discussed by Steve and others a recent survey/study in JAMA Internal Medicine , 69% of respondents had heard the myth that the CDC and doctors know that vaccines cause autism and other neurological disorders; 20% agree; and 36% are neutral, neither agreeing nor disagreeing. That means two thirds of the population has heard this myth and over half don’t disagree with it. Similar numbers for the myth that the FDA is deliberately preventing people from getting natural cures for cancer and other diseases are 63% heard before; 37% agreeing; and 31% neutral. This means that well over half of the population don’t disagree that the FDA is trying to keep “natural cures” for cancer away from the population.
Is it any surprise that a population with such a high prevalence of belief in ideas that the CDC and FDA are hiding The Truth about vaccines and natural cures from the people and a high level of distrust in health authorities would be far more likely to latch onto the sort of fear mongering that people like Adams and Nass provide? When it comes to trying to explain complex concepts such as the difference between droplet and airborne transmission of disease to people holding such views (or at least being open to such conspiracy theories), is it any wonder that they’re easily confused? Even if the CDC and other health authorities communicated perfectly and didn’t make occasional mistakes along the way (as all humans do), there would likely be confusion. Add belief in conspiracy theories in which the CDC is believed to be hiding something, and those mistakes become magnified—or even spun as evidence supporting the “cover up” postulated by the conspiracy theory. Every inconsistent message is jumped on. Every message containing erroneous information is viewed as undeniable proof of either malice or incompetence.
None of this excuses conspiracy cranks like Mike Adams for spreading misinformation about Ebola in the first place. Indeed, the existence of cranks like Adams cynically spreading misinformation and sensationalistic journalists spreading, well, sensationalism mandate a response. However, even in the absence of cranks, there would likely be some confusion, given that lay people (and even most doctors) are not fully familiar with these definitions. Adams and Nass play on this ignorance to stoke fear, uncertainty, and doubt about the CDC.
Even the bloggers at Virology Down Under admit how hard it is, even under ideal circumstances, to communicate science-based information about Ebola transmission. First, they point out that, although airborne transmission has been engineered to occur in the laboratory using idealized conditions and very high amounts of virus, there is no evidence that it has ever occurred outside of a laboratory. They then discuss “messaging the masses”:
Leaving aside other issues around acquiring a rare disease like Ebola when outside of the current outbreak region, the case definitions and risk assessments have raised confusion. There are questions around how otherwise apparently well-protected healthcare workers in West Africa are acquiring an EBOV. For a virus described as spreading only through direct contact, recommendations for the use of masks, implying airborne spread to many, fuel such questions. In fact, face protection is recommended to prevent infectious droplets landing on vulnerable membranes (mouth and eyes).
It’s important to pass a message that is correct, but also to ensure distrust does not result from a public reading apparently contradictory literature. Such distrust and real concern have been rampant among a hyperactive #ebola social media. Simple, clear phrases like “ebolaviruses cannot be caught from around a corner” (h/t @Epidemino), may help uncomplicate the communication lines. And it works on Twitter.
In another post, virologist Ian MacKay has even solicited ideas for better ways to communicate these concepts to the general public in an accurate, but clear and understandable, fashion:
So the problem is trying to define a name for that other process that can simply and clearly describe infectious disease transmission of viruses & bacteria that are propelled from/by the sick person, across the gap between them and an uninfected person, measurably infecting the recipient. The name should make clear that it is a different process to the one that sees a person get sick by inhaling infectious viruses or bacteria held aloft by the air, in a cloud, made by a previously ill person, that has been hanging around for perhaps an hour or more. That one is an airborne route of transmission.
It is an excellent question. Not being a virologist or infectious disease expert, I’m not sure I have a good answer. I do know, however, that that answer must include language that can be used to counter the pernicious effects of the widespread belief in medical conspiracy theories. Absent such conspiracy theories, it would be hard to imagine why the CDC (or any other governmental authority) would want to hide evidence of airborne transmission, just as it would be hard to imagine any reason why the FDA would want to hide “natural cures” or the CDC hide harmful effects of vaccines and keep vaccinating. With such conspiracy theories as prevalent as they are, the jobs of Mike Adams and those like him are made much easier.

Is the Ebola Crisis a Reason to Skip RCTs?
Harriet Hall on January 6, 2015
Link


In a recent “Perspective” article in The New England Journal of Medicine, three physicians (Drs. Cox, Borio, and Temple) make a strong case for not letting the rush to save Ebola patients tempt us to deviate from good science and skip the randomized controlled trial (RCT). Their arguments cut to the essence of the scientific approach to medicine, and they deserve careful consideration.
Ebola is uniquely scary
Ebola is the kind of threat that really gets our attention. The virus was first identified in 1976, and prior to 2013 there were several small outbreaks in Africa with death rates as high as 90%. This time the death rates are lower, but the numbers are much greater. It has spread to several African countries, and a few cases have even reached the US and Europe due to infected travelers and health care workers. We face a risk that Ebola may become endemic, smoldering along as a constant presence in Africa.
There is no known effective treatment. Fear of Ebola has sparked bizarre conspiracy theories and claims of “natural” cures and prevention kits from homeopaths, alternative medicine advocates like Mercola, and purveyors of remedies like colloidal silver and essential oils. These have been covered on SBM here, here, and here. 
Treatment approaches
The current approach consists of early identification, isolation, rigorous infection control protocols with space-suit-like personal protective equipment for health care providers, supportive care with intravenous fluids, and conventional treatments for symptoms and complications. The death rate is lower where good medical care is readily available. As of 31 December 2014, the WHO announced there had been 20,206 reported cases with 7,905 reported deaths, for an overall fatality rate of 39%. But the reported case fatality rate in the three intense-transmission countries among all cases for whom a definitive outcome is known is 71%, and the numbers are uncertain because under-reporting continues to be a challenge.
A number of experimental treatments have been tried or are being considered. Several patients have been given serum transfusions from recovered patients to passively supply them with antibodies to the virus. ZMapp, a combination of monoclonal antibodies, has been used to treat 7 individuals; some of them recovered, some did not. Several anti-viral drugs are under development, and certain selective estrogen receptor molecules and ion channel blockers have also shown promise in vitro.
In the face of such a deadly threat, it seems like we can’t afford to sit back and wait for the results of randomized controlled trials (RCTs) published in peer-reviewed journals. We are tempted to try any reasonable-sounding experimental treatment before the results of clinical trials are in. Some of these experimental treatments might be unsafe and ineffective, but we know Ebola is definitely unsafe and deadly. The doctors who gave their critically-ill patients serum transfusions or ZMapp did exactly what most of us would have done in the same circumstances. But was it really the best thing to do?
The need for RCTs
If we give patients ZMapp without a control group and some of them recover, how are we to know whether ZMapp contributed to their recovery? Some have argued that we wouldn’t want to deny treatment to a control group, and that we can compare the recovery rate with ZMapp to the historical recovery rate without it. That approach is particularly problematic with Ebola, since the historical recovery rate is so variable and so dependent on differences in supportive treatment and other confounding factors. As Cox, et al. point out, “the historical case fatality rates are irrelevant if current study patients receive better supportive care.”
They argue that allowing patients access to investigational drugs outside of properly-designed randomized controlled trials can have tragic consequences. Using no controls or only historical controls might lead to rejection of treatments that have real but modest benefits, or it might lead to widespread adoption of a treatment that is useless or even harmful. And there are ethical considerations. Limited supplies of investigational drugs have been given to favored Western health care workers instead of being equitably distributed to all candidates.
RCTs tend to be slow and cumbersome, but there are ways to streamline the process. They explain:
…advances in trial design can and should be incorporated into Ebola RCTs. For example, such trials should include ongoing monitoring of results (e.g., group-sequential designs), adaptive elements, and other trial efficiencies to reduce the time required to identify an effective treatment, particularly a very effective treatment. If one investigational drug clearly shows benefit, trials should incorporate it into the new standard of care for all treatment groups thereafter. Then a regimen adding a different investigational therapy to the new standard of care could be compared with the new standard of care alone. If multiple investigational drugs are simultaneously available for clinical testing, an RCT could include more than one drug and a shared control group. Trials could be designed to assess effects on survival (recovery from disease) as the most important and measurable end point…
Scientists at the National Institutes of Health, in collaboration with the Food and Drug Administration, the Biomedical Advanced Research and Development Authority, the Department of Defense, and clinicians caring for patients with EVD in the United States, are leading efforts to develop and implement such trials.
This is a principle that applies to all new treatments in mainstream medicine as well as to the treatments offered by so-called “alternative” medicine and “integrative” medicine. A single anecdote about a single patient tells us nothing, and an uncontrolled study is little better than a collection of anecdotes or testimonials. Anything can seem to work in an uncontrolled study; we have seen many examples of studies with apparently positive results even for things as ridiculous as homeopathy, therapeutic touch, and retroactive prayer.
It has been argued that patients should have ready access to untested and experimental treatments, and that they have the right to try anything they want, especially when their life is at stake and there is no treatment available that has been tested and proven effective. In some cases, trying an untested treatment might very well help the individual patient; but if the treatment is really effective, providing it outside of controlled trials tends only to slow the progress of science and delay the day when that treatment will be proven effective and added to the armamentarium of conventional medicine so that it can benefit all patients. We need to determine whether a treatment works or doesn’t work, and there is only one way to do that: using scientific methodology.
Conclusion
From bloodletting for fevers to internal mammary artery ligation surgery for heart disease, the history of medicine is littered with treatments that were believed to work until they were discredited by rigorously-controlled studies. Randomized controlled trials are the most reliable way to determine whether any new treatment is safe and effective. It is tempting to bypass them and offer experimental treatments to desperately-ill Ebola patients outside of a properly designed RCT. We would be wise to resist that temptation and to insist on enrolling patients in a proper clinical study.
Please don’t misunderstand. I am not saying we shouldn’t use untested treatments in a last-resort situation. I am not saying that access to experimental treatments should be restricted. I am only saying that when experimental treatments are used, they should be used as part of a well-designed clinical trial so that we can learn something from the experience. I recognize that enrollment in a clinical trial is not always feasible, but it is a worthy goal. As a society, we should aspire to take whatever actions are necessary to develop and fund such trials for as many patients as possible.

Using the fear of Ebola to promote the placebo legislation that is “right to try”
Libertarians and free market fundamentalists generally detest the FDA and want to dramatically decrease its power in the belief that the free market can guarantee the safety of drugs better than a government agency that requires strong scientific evidence of efficacy and safety before approval. Not surprisingly, they’re at it again, this time in the service of promoting “right-to-try” laws and using the fear of Ebola to argue for a weakening of FDA regulatory standards and to falsely claim that the FDA’s caution kills more people than it saves.
David Gorski on November 2, 2014
Link


Perhaps the most pervasive medical conspiracy theory of all involves stories that there exist out there all sorts of fantastic cures for cancer and other deadly diseases but you can’t have them because (1) “they” don’t want you to know about them (as I like to call it, the Kevin Trudeau approach) and/or (2) the evil jackbooted thugs of the FDA are so close-minded and blinded by science that they crush any attempt to market such drugs and, under the most charitable assessment under this myth, dramatically slow down the approval of such cures. The first version usually involves “natural” cures or various other alternative medicine cures that are being “suppressed” by the FDA, FTC, state medical boards, and various other entities, usually at the behest of their pharma overlords. The second version is less extreme but no less fantasy-based. It tends to be tightly associated with libertarian and small government fantasists and a loose movement in medicine with similar beliefs known as the “health freedom” movement, whose members posit that, if only the heavy hand of government were removed and the jack-booted thugs of the FDA reined in, free market innovation would flourish, and the cures so long suppressed by an overweening and oppressive regulatory apparatus would burst the floodgates. Under this views, these cures, long held back by the dam of the FDA, would flow immediately to the people, and there would be much rejoicing. (Funny how it didn’t work out that way before the Pure Food and Drug Act of 1906.) Of course, I can’t help but note that in general, in this latter idea, these fantastical benefits seem to be reserved only for those who have the cash, because, well, the free market fixes everything. At least, that seems to be the belief system at the heart of many of these conspiracy theories.
The idea that the FDA is keeping cures from desperate terminally ill people, either intentionally or unintentionally, through its insistence on a rigorous, science-based approval process in which drugs are taken through preclinical work, phase 1, phase 2, and phase 3 testing before approval is one of the major driving beliefs commonly used to justify so-called “right-to-try” laws. These bills have been infiltrating state houses like so much kudzu, and the Ebola outbreak has only added fuel to the fire based on the accelerated use of ZMapp, a humanized monoclonal antibody against the Ebola virus, in some patients even though it hadn’t been tested in humans yet (more on that later). Already four of these laws have been passed (in Colorado, Missouri, Louisiana, and now Michigan) with a referendum in Arizona almost certain to pass next week to bring the total to five states with such laws. Basically, these laws, as I’ve described, claim to allow access to experimental drugs to terminally ill patients with a couple of major conditions: First, that the drug has passed phase I clinical trials and second that the patient has exhausted all approved therapies. As I’ve explained before more than once, first when the law hit the news big time in Arizona and then when a right-to-try bill was introduced into the legislature here in Michigan, they do nothing of the sort and are being promoted based on a huge amount of misinformation detailed in the links earlier. First, having passed phase 1 does not mean a drug is safe, but right-to-try advocates, particularly the main group spearheading these laws, the Goldwater Institute, make that claim incessantly. Second, they vastly overstate the likelihood that a given experimental drug will help a given patient. The list goes on.
Unfortunately, two weeks ago, the cruel sham that was the Michigan right-to-try bill was passed into law and signed by Governor Rick Snyder. It’s rather interesting how this came about. Senator John Pappageorge introduced Senate Bill 991 in the Michigan Senate over the summer. There was very little news coverage, which I considered odd, given the heavy news coverage of right-to-try bills in other states. In fact, I only happened to hear that the Michigan right-to-try bill had even been introduced into the Senate when a colleague whose job in part happens to involve dealing with the legislature gave me a heads up. I also learned from asking around that, in addition to home grown patient advocates supporting the bill, there was a flack from the Goldwater Institute flown in to testify and that no one from Michigan universities or academic medical centers was particularly eager to testify against the bill due to the expected backlash.
As I’ve said many times before, both in posts about right to try and about Stanislaw Burzynski, I can totally understand the patient impetus for these laws, given that I have had family members with terminal illnesses. Unfortunately, however, forces like the Goldwater Institute are taking advantage of the very human desire not to die and not to be forced to watch one’s loved ones die, all in order to push bad legislation. Indeed, the Goldwater Institute uses terminally ill patients desperate for their lives in much the same way Stanislaw Burzynski uses them: As shields and weapons in their battle against the FDA and state medical boards. That’s why, as I’ve morbidly joked before, being against right-to-try in the eye of the public is not unlike being against Mom, apple pie, the American flag, and puppies, hence the reluctance of even doctors doing clinical trials to publicly voice opposition. The most predictable attack against anyone who dares to publicly oppose these bills has been to portray opponents as not just callous, but as practically twirling their mustaches with delight and cackling evilly while watching terminally ill patients die without hope. (I exaggerate—but only slightly.) Few are the physicians and scientists (and even fewer still the medical centers and universities) who want to risk being portrayed that way, and one person who did testify against the bill reported enduring withering looks from patient advocates there to testify for the bill, who, like Burzynski patients and families, really do view opponents of right-to-try as enemies actively seeking to cause harm and to prevent them from saving their lives or the lives of family members.
Before I knew it, Senate Bill 991 had passed overwhelmingly. So, seeing what was coming next, I wrote to my House Representative to urge that he oppose the bill, House Bill 5651. He was receptive and a little surprised that anyone would be against the bill, but he admitted that my arguments made him think. Even so, I was under no illusion that he was likely ever to vote against it. He didn’t. Because it was too late and the law had already been passed by the senate, making writing to my state senator (whom we’ve met before) pointless, I instead wrote his opponent running for his State Senate seat, because (1) she is in the House and could still affect the outcome and (2) perhaps she wanted to hear from someone considering voting for her. I never got a response; so at least in that aspect my Representative did better. At least he listened and responded. None of it, whether it came from me or the feeble opposition, mattered. It is, after all, an election year, and every single one of these legislators, as well as Rick Snyder, are running for election or re-election. On October 1, House Bill 5651 passed the House unanimously and was signed by Governor Rick Snyder on October 17. Interestingly, despite my having tried to pay close attention to news reports and House activity, I only learned of this a week ago, when news stories noted that Snyder had already signed the bill! There was virtually no discussion and very little news coverage. The fix appeared to have been in, as this bill passed with about as close to zero news coverage as I’ve seen for a bill this major in every other state where it’s appeared.
Not surprisingly, “health freedom” advocates and some libertarians are declaring this a big “win” for patients’ rights. It’s nothing of the sort. The flavor of the arguments can best be seen in two articles from Reason.com’s Nick Gillespie, who is clearly clueless about clinical trials. Basically, he took to Reason.com to gloat, referencing an article from over two weeks ago that he entitled “The Upside of Ebola (Yes, There May Actually Be One)“. It’s about as blatant a move to take advantage of the Ebola outbreak to promote bad right-to-try legislation as I’ve ever seen. The subtitle exults:
A rising death toll, mass panic, scary mortality rate—what could possibly be good about the out-of-control epidemic? It may accelerate the adoption of laws giving patients more power.
So let me get this straight. Thousands of people are dying of a horrible disease in Africa while people in the U.S. are freaking out about the possibility of the virus causing outbreaks right here at home, and Gillespie sees these events, apparently more than anything else, as an opportunity to push his libertarian agenda with respect to medicine. No one would be that cynical, would he? Wrong:
Ebola’s arrival and seeming spread in America is causing mass panic, tasteless Internet jokes, and incredibly poorly timed magazine covers. Can anything good come out of the disease, which has no known cure and a terrifying mortality rate of 50 percent?
Yes. To the extent it forces a conversation about the regulations surrounding the development of new drugs and the right of terminal patients to experiment with their own bodies, Ebola in the United States may well accelerate adoption of so-called right-to-try laws. These radical laws allow terminally ill patients access to drugs, devices, and treatments that haven’t yet been fully approved by the Federal Drug Administration and other medical authorities. The patients and their estates agree not to bring legal action against caregivers, pharmaceutical companies, and insurers.
You don’t have to be a doctrinaire libertarian—though it helps—to see the value in letting people with nothing left to lose experiment on themselves. They may get a new lease on life. The rest of us get meaningful information that may speed up the development of the next great medical intervention.
Actually, you do rather have to be a doctrinaire libertarian to have a reality-distortion field as powerful as Nick Gillespie’s to write drivel like this. Ebola and right-to-try laws. Hmmmm. How is one thing not like the other (or not related to the other)? First of all, Gillespie’s rationale is a complete non sequitur, clearly designed to take advantage of the Ebola panic to persuade people that right-to-try laws are a good idea, even though such laws would not have had one whit of an effect on the odd patient in the US who might be infected with Ebola. After all, Ebola, as deadly as it is, is not a terminal illness. With good supportive care, around half, possibly more, survive the disease. Second, I can’t help but note that existing FDA mechanisms got ZMapp to American Ebola patients rather rapidly, even briefly bypassing phase 1 studies, no need for right-to-try laws necessary. But excuse me. What Gillespie says is that Ebola and ZMapp are “forcing a conversation.” I suppose that’s true, but it’s the wrong conversation, a profoundly deceptive conversation, in which an advocate of right-to-try laws shamelessly takes plays on people’s fears of Ebola to promote these bad laws. Claiming that there is “no good argument against right-to-try” (wrong, wrong, wrong, wrong), Gillespie also shamelessly attacks straw men, representing the primary argument against right-to-try as giving patients “false hope.” There are lots of other reasons why these are bad laws.
But Gillespie is just getting warmed up:
But what’s already cruel is the FDA’s drug-testing process. It’s massively expensive and overly long, costing between $800 million and $1 billion to bring a drug to market and taking a decade or more to complete the approval process. There’s every reason to believe that the FDA approval process is killing as many or more people than it saves, especially as the FDA doesn’t allow approvals from Europe and elsewhere to stand in for trials here.
No. Just no. There is not “every reason to believe” anything of the sort. See? Once again, there’s the myth that there are all these fantastic cures out there that the FDA, through its bureaucratic inertia, is keeping from you. I am rather grateful, though, that Gillespie, through his link, makes his intent very clear. The article to which he links is entitled “Kill The FDA (Before It Kills Again).” In the article, referencing the movie Dallas Buyers Club—which I finally saw on cable and was surprised to find that, leaving aside its historical inaccuracies about the AIDS epidemic in the 1980s, taken just as a movie it was at best just OK (I was seriously disappointed)—Gillespie proclaims that the FDA “continues to choke down the supply of life-saving and life-enhancing drugs that will everyone agrees will play a massive role not just in reducing future health care costs but in improving the quality of all our lives.” And what is his rationale? Wrap your mind around this:
As my Reason colleague Ronald Bailey has written, this means the FDA’s caution “may be killing more people than it saves.” How’s that? “If it takes the FDA ten years to approve a drug that saves 20,000 lives per year that means that 200,000 people died in the meantime.”
Completely missing from Bailey’s and Gillespie’s equation is the number of drugs that the FDA doesn’t approve because they don’t show efficacy and safety that could allow even more than those 20,000 people a year to die or even actively kill some of them. As conceded by even Bailey, it was the FDA that prevented, for example, approval of Thalidomide in the US and the rash of birth defects seen elsewhere in the world. Bailey’s argument is, at best, tenuous, at worse misleading. (I favor worst. It’s just plain misleading.) Gillespie notes:
A 2006 Government Accountability Office (GAO) study found that the number of new drug applications submitted to the FDA between 1993 and 2004 increased by just 38 percent despite an increase in research and development of 147 percent. The mismatch, said GAO, was the result of many factors, ranging from basic issues with translating discoveries into usable drugs, patent law, and dubious business decisions by drug makers. But the problems also included “uncertainty regarding regulatory standards for determining whether a drug should be approved as safe and effective,” a reality that almost certainly made pharmaceutical companies more likely to tweak old drugs rather than go all in on new medicines.
Notice how this is another non sequitur applied to right-to-try laws, given that the answer to this problem would be improving regulatory clarity, not passing state-by-state right-to-try laws. Think of it this way: What’s more uncertain? The FDA or having different laws in different states regarding “right to try”? Gillespie’s citing his previous article claiming that the FDA is killing you in an article promoting right-to-try is a very good indication what these laws are really about. Let’s be very, very clear here. They are not about helping patients. That’s how they are sold to desperately ill patients, which is why I must repeat: In reality libertarians like Gillespie and Bailey are using desperately ill patients in the same way that Stanislaw Burzynski uses his patients: As a powerful tool to sway public opinion against the FDA and towards their viewpoint.
There’s a reason that certain aspects of these laws are not as widely emphasized in the PR offensive in favor of right to try. It’s because they are pure “health freedom” and libertarian wingnuttery. For example, if you look at the Goldwater Institute template for right to try laws, which, unfortunately, has been the basis of every right to try law passed and under consideration, you’ll notice a number of highly problematic clauses. As I’ve discussed multiple times, there is the requirement that the drug or device has only passed phase 1 trials, which, given how few drugs that have passed phase 1 actually make it through to approval, is a really low bar, especially since most phase 1 trials involve fewer than around 25 patients.
More disturbing are the financial aspects. The Goldwater Institute legislative language template (to which the Michigan legislation is virtually identical) allows drug companies to charge patients, with no provision to help patients pay for exercising right-to-try. Indeed, it specifically states that the bill “does not require any governmental agency to pay costs associated with the use, care, or treatment of a patient with an investigational drug, biological product, or device” and that insurance companies do not have to pay for costs associated with the use of such therapies. You know what this means? Insurance companies could refuse to pay for care related to complications that might occur because of experimental treatments. You use an experimental drug and suffer a complication? Too bad! Your insurance company can cut you off! Now, it’s unlikely that government entities like Medicare or Medicaid would do that, but insurance companies certainly will.
Basically, what this law says is: If you can afford it yourself, no help, you can have it. If not, you’re S.O.L. As I’ve pointed out, if there’s one thing worse than dying of a terminal illness, it’s suffering unnecessary complications from a drug that is incredibly unlikely to save or significantly prolong your life and bankrupting yourself and family in the process. Right-to-try encourages just that. What’s more compassionate? Attacking the FDA and degrading the approval process that requires drug safety and efficacy while dangling false hope in front of patients or standing up and protecting patients from the harm such a policy could cause? Let’s just put it this way: I predict that Stanislaw Burzynski will soon be sending antineoplastons to patients in right-to-try states if, as he keeps bragging, the FDA has allowed him to reopen his clinical trials. After all, his antineoplastons would qualify just fine under right-to-try laws if they’re back under clinical trial. Indeed, if there’s one thing the decades-long battle between the FDA and Burzynski tells us, it’s that the FDA actually bends over way too far backwards to allow manufacturers of dubious drugs to prove themselves.
Finally, the anti-FDA rhetoric, such as linked to by Gillespie, is a very good indication that the true purpose of right-to-try legislation is to neuter the FDA’s power to control drug approval, thus greatly loosening or even eliminating hurdles to the drug approval process. It is no coincidence that the strongest, richest, and most vocal proponents of these laws are the Goldwater Institute and libertarians like Nick Gillespie and Ronald Bailey, who, not coincidentally, think that the FDA is “killing us.” Those articles are a definite “tell.” It’s also clearly a strategy to get right-to-try passed in as many states as possible and get referendums passed by wide margins to pressure the federal government to weaken the FDA.
In the end, though, right-to-try laws are what I like to call “placebo” laws in that they make people who pass them and support them feel good but don’t actually address the problem that they are supposedly intended to address. Drug approval regulatory authority lies with the FDA; it could completely ignore state right-to-try laws. Even supporters realize this and realize that there will likely lead to a “long, drawn-out court battle over state vs. federal sovereignty.” The FDA also already has a compassionate use program and rarely turns down such requests. Admittedly, the application process is long and probably too onerous, but the answer to that problem is not to pass state right-to-try laws. It’s to address the issue at the federal level. I’ve also said in an interview that, now that my state government has foolishly passed a right-to-try law, one of two things is likely to happen: Either nothing, because federal authority trumps state authority, or disaster for patients, doctors, and, yes, biotech and drug companies. Everybody, myself included, wants to help terminally ill patients. After all, I’ve seen too many of them. Right-to-try and similar misguided efforts, however, are not the way.

The Latest Ebola Outbreak
The second largest Ebola outbreak is underway. This time we have an effective vaccine, but political unrest and distrust of science may be our real vulnerability.
Steven Novella on July 17, 2019
Link

Between 2014-2016 the world saw its largest outbreak of Ebola, affecting 28,616 people mainly in Guinea, Liberia and Sierra Leone, with 11,310 deaths. Prior to that the largest Ebola outbreak killed 280 people in 1976. That’s an increase of about two orders of magnitude. This massive increase shocked the World Health Organization (WHO) and caused a minor panic. Clearly the potential of this virus was underestimated, the response was too slow, and the result was a massive outbreak.
In a sense, with that outbreak we dodged a bullet. The reason Ebola outbreaks have historically been so limited is that the virus is endemic in very rural areas. It took off in 2014-16 because the infection spread to towns, and the higher population density magnified the outbreak. It did not, however, spread into major cities. If that had happened we may have seen the first Ebola epidemic.
We are in the midst of the first Ebola outbreak after the gamechanger in 2014-16. This outbreak is in East Africa, mostly in the Democratic Republic of Congo (DRC). So far there have been 1,600 deaths. What’s interesting is that prior to 2014 this would have been major news, but now it does not seem to be getting the attention it deserves. This outbreak is still about 10 times larger (so far) than all previous outbreaks save for the 2014-16 outbreak. I guess being second best does not garner attention.
We now have recent reports of the first confirmed case of Ebola in Goma, a city of about 2 million people in Eastern DRC on the border with Rwanda. This city is also a major regional transportation hub, and includes an international airport. The WHO believes that this case was quickly contained and do not seem concerned. That’s good, because if Ebola breaks out in a city like Goma that would significantly change the nature of this outbreak, and bring it one step closer to becoming an epidemic.
Last month the WHO reviewed the outbreak and declined to declare a public health emergency of international concern (PHEIC). There are now renewed calls to do just that.
There is some good news in all of this. The 2014-16 outbreak was a wakeup call. It did give a boost to Ebola research, progressing, among other things, the development of a vaccine. That’s right, we now have a vaccine for Ebola, which appears to be about 97.5% effective in the current outbreak. Over 90,000 doses have already been given, but it seems we may now be running low on existing supplies, which could be a challenge if the outbreak suddenly hits a major city. If we need millions of doses on short notice, that would be a problem.
Also, the CDC recently created a synthetic version of the current Ebola strain, which will aid them in doing research. However, this also highlights the fact that outside scientific labs have not been given access to the current outbreak strain for research, which is why they developed a synthetic version.
There are a few lessons from the current Ebola outbreak. First, it reminds us yet again that we now live in a connected world. What happens in East Africa can, potential, affect all of us. Anyone who has played the game Plague, Inc. has a simulated sense of this. Perhaps this game should be offered to all vaccine deniers – see how much easier it is to wipe out all humanity (the goal of the game) without vaccines.
An Ebola outbreak in the DRC is our problem. It is the world’s problem, even before the WHO declares a PHEIC. That’s because the goal should always be to prevent outbreaks from becoming a PHEIC, and once they have, in a sense, we have already failed. Of course, there is a humanitarian reason we should all be concerned, but it is worth noting that we all have a personal stake as well.
This truth extends beyond Ebola. Our population densities and interconnectedness makes us vulnerable to infectious disease. Epidemics and even pandemics are virtually inevitable; it’s more a matter of when and how bad, not if. If not Ebola, it could be the next flu strain, or something like the Zika virus.
One of the things that is making this current outbreak more challenging is the political disruption in the region. There is still a problem with violence, and with distrust of authorities. Many of the people infected with Ebola are too afraid to go to the clinic. Authorities are trying to get people to change their burial customs, which also requires trust. The potential for an epidemic is just one more way in which political unrest in a far corner of the world can affect anyone.
Second, it is amazing to me how quickly we become complacent. Perhaps Ebola outbreaks with thousands or tens of thousands rather than hundreds of death is the new normal. We are psychologically adaptable, which can be a strength, but also leads quickly to complacency. This outbreak is still highly risky and concerning, even if it’s only the second largest in history.
Finally, something which is both good and bad news, is that we have the science to deal with these challenges, if they are properly supported. Perhaps part of the reason for complacency this time around is that the response was more rapid, and we have a vaccine ready to go that is more effective than anything we had in previous outbreaks. If we dodge another bullet with the current outbreak, vaccines will largely get the credit.
However, scientific progress will only save us if it gets the proper support. This means several things, including proper funding, but also proper access to things like the current strain of the virus. This needs to be a global effort, well funded, and politically supported.
But also the general population needs to support the science and its application. This highlights how potentially deadly the anti-vaccine movement can be. There is growing pushback against science, with science denial, conspiracy theories, distrust of experts and institutions, and a proliferation of fake news and misinformation. If vaccines can save us from an Ebola epidemic, than vaccine denial can kill us. Anti-vaccine pseudoscience and fearmongering has already caused a measles resurgence, and prevented the eradication of polio.
If humanity does one day meet its end, I strongly suspect that science-denial and irrationality will have been critical to facilitating our demise.
Update 07/19/2019 – The WHO finally declared the current Ebola outbreak a public health emergency.

Ebola: Science Is Making Progress
Good news! Research on Ebola has identified a 100% effective vaccine and medications that produce a 90% survival rate.
Harriet Hall on August 20, 2019
Link


There have been 24 outbreaks of Ebola virus disease (also known as Ebola hemorrhagic fever) in Africa since 1976. It spreads through contact with infected body fluids. Case fatality rates have ranged from 25-90%, and the only treatment has been supportive care. The largest outbreak killed 11,323 people out of 28,646 infected, a 40% death rate. The current Ebola outbreak is the second-worst ever. 2,800 people have been infected and 1,900 have died (a 68% death rate). The World Health Organization has declared it a public health emergency of international concern.
Experimental treatments
A news release from the National Institutes of Health has just announced the early termination of an Ebola therapeutics trial in the Democratic Republic of the Congo because of favorable results with two of the four investigational agents being tested. These two drugs produced a 90% survival rate when given early in the course of the disease:
One of the drugs, REGN-EB3, is a cocktail of three monoclonal antibodies against Ebola made by Regeneron Pharmaceuticals of Tarrytown, New York. The second, mAB114, is derived from a single antibody recovered from the blood of a person who survived Ebola in the DRC in 1995, and was developed by the US National Institute of Allergy and Infectious Diseases (NIAID).
These two drugs outperformed the two other candidates. 53%of patients who got the anti-viral drug remdesivir died, as did 49% of those who got ZMapp, an antibody treatment that was used in an earlier Ebola outbreak.
Experimental vaccines
At least eight vaccines are in development. There is a handy list on Wikipedia . Most are in Phase I or animal studies, but two have reached the stage of Phase 3 trials. Clinical trials have been expedited due to the emergency. The two vaccines that have been tested in clinical trials have both been shown to be safe and effective: rVSV-ZEBOV and ChAd3-ZEBOV.
rVSV-ZEBOV (recombinant vesicular stomatitis virus – Zaire Ebola virus) is a live, attenuated, recombinant, replication-competent vaccine in which the vesicular stomatitis virus has been genetically engineered to express an Ebola protein, thereby provoking an immune response. It was developed by the Public Health Agency of Canada and is now licensed to Merck. It has been used in outbreaks in Africa. Interim results of an open-label study were published in The Lancet in 2015 and final results were published in 2017. They used a ring vaccination cluster-randomized strategy to vaccinate contacts and contacts of contacts of Ebola cases and compared immediate to delayed (21 days later) vaccination. One dose of vaccine was given by intramuscular injection. Immediate vaccination was 100% effective in preventing the development of the disease from 10 days after vaccination; protection appears not to kick in during the first 9 days. Serious adverse events were rare; only three were judged related to the vaccine and all three recovered with no sequelae. Part way through the trial, preliminary results were so impressive that randomization was stopped and immediate vaccination was offered to all participants. It was thought that the vaccine program had even benefitted non-participants by helping to shorten the outbreak.
In a more recent study in the Democratic Republic of Congo, preliminary results have been reported by the World Health Organization (WHO) on the efficacy of rVSV-ZEBOV-GP (Apparently GP stands for glycoprotein nanoparticle). 93,965 at-risk individuals were vaccinated using a ring vaccination strategy. “The estimated Ebola attack rate for vaccinated individuals was about 0.017%, compared with an estimated 0.656% in unvaccinated individuals. This yields an estimated vaccine efficacy of 97.5%, 95% CI [95.8 – 98.5%].” And no deaths occurred in anyone who developed symptoms 10 or more days after vaccination, for an estimated efficacy in preventing death of 100%. Even those already infected at the time of vaccination had improved survival.
The replication-defective chimpanzee adenovirus 3 (CAd3-ZEBOV) is an experimental vaccine for two Ebola viruses, Ebola virus and Sudan virus. It was genetically engineered by scientists at GlaxoSmithKline from a chimpanzee adenovirus to express Ebola protein. It appeared to be safe and effective in early trials and is currently being tested in Liberia in a three-arm double blind study comparing it to VSV-ZEBOV and placebo. Because of the declining incidence of the disease in Liberia, they have had to expand the trial to other countries. Results are not yet available.
Good news
Ebola is a horrible disease with a high fatality rate. A vaccine that is 100% effective in preventing disease and two medications that produce a 90% survival rate in patients who are already infected? It seems almost too good to be true, but the evidence is convincing. There is a phenomenon known as the decline effect, where studies with initially impressive results tend to be followed by larger, better studies with less impressive results. Because this is a public health emergency, short-cuts have been taken in the usual drug- and vaccine-development procedures, and the treatments have been rushed into use under compassionate use guidelines. It appears that the vaccines have already had an impact in shortening outbreaks, and the treatments have saved lives.
Science works!
This is a great demonstration of science in action. Science-based medicine works! Complementary and alternative medicine can’t offer anything even remotely comparable. The CDC has even had to issue this warning:
Since the outbreak of the Ebola virus in West Africa, the U.S. Food and Drug Administration (FDA) has seen and received consumer complaints about a variety of products claiming to either prevent the Ebola virus or treat the infection. The FDA is advising consumers to be aware of products sold online claiming to prevent or treat the Ebola virus. There are currently no FDA-approved vaccines or drugs to prevent or treat Ebola, and there are no known herbal treatments or other “natural” or “alternative” therapies that prevent or cure this disease.

Ebola SCAMs
Mark Crislip on September 5, 2014
Link

Ebola, like all diseases, is an opportunity for some to offer up curious treatments. Here is a brief budget of Ebola-related SCAM (supplements, complementary and alternative medicine) and a few Dug the Dog digressions.
Homeopathy
Reality seems valueless by comparison with the dreams of fevered imaginations; reality is therefore abandoned. ~ Emile Durkheim. Homeopath?
In its classic form, as promulgated by Hahnemann, homeopathy is divorced from the modern understanding of medical and chemical reality. I can cut Hahnemann a little slack since he came up with his fictions at the end of the 18th century. But I would think that even a modest understanding of chemistry and physiology would suggest that homeopathy is 100% pure bunkum. But homeopaths are nothing if not inventive. Since Hahnemann’s time they have come up with a remarkable number of variations on their nonsense. The motto “you are only limited by your imagination” must have had homeopaths in mind and they have fevered imaginations. Who knows what they could invent if they only had a box. There are nosodes, the homeopaths answer to vaccines. Of course, it is an answer that would be wrong on any reality-based exam. Nosodes are the vaccines of the homeopathic world, only without efficacy. I have written about nosodes in the past.
[A nosode] is a homeopathic remedy prepared from a pathological specimen. The specimen is taken from a diseased animal or person and may consist of saliva, pus, urine, blood, or diseased tissue.
and they are usually diluted to between 30 and 300 C.
Up and Down
Gone in a flash was a Natural News article on a DYI homeopathic treatment for Ebola. A reader (Thank you Jim) saved the recipe and I show it below with the caveat not to try this at home because it is a typical worthless wackaloon homeopathic nostrum attempting to prevent or treat disease and dangerous to make to boot:
How to Make Your Own Ebola Remedy
What you need:
     1.  A face mask and gloves
     2.  Two bottles (50 ml up to 500 ml glass or plastic bottles) with caps
     3.  Clean water (mineral or tap water)
     4.  An Ebola sample: some spit or other disease product, such as blood, from a person infected with Ebola, or who is suspected sick with it. Any small quantity will do, even a pinhead.
     5.  An alcoholic liquid, such as whisky, brandy, rum, etc.
     6.  Half an hour of your time.
Procedure:
     1.  Fill the bottle with water, leaving about 20% space at the top.
     2.  Place the Ebola sample in the water in the bottle.
     3.  Close the top of the bottle with the cap.
     4.  Hold the bottle and strike it hard against a solid surface, such as a large book, 40 times.
     5.  Pour out the contents of the bottle.
     6.  Refill the bottle with water (the fluid remaining on the inside surface of the bottle will serve as the next Ebola sample).
     7.  Repeat steps 3 to 6 a total of 30 times.
Storage:
     1.  Pour the bottle solution into another bottle—your stock bottle.
     2.  Add 10% by volume of the alcoholic liquid (whisky, brandy, etc.) as a preservative.
     3.  Store in a place away from sunlight and electronic equipment.
Using this stock bottle, you can supply the Ebola remedy to as many people you want. With one drop from the stock bottle as an Ebola sample you can produce another stock bottle to give to someone else. Instead of the original Ebola sample you used above to make the original stock bottle, you use a drop from the first stock bottle. This process can be carried out ad infinitum, supplying a whole city, etc., if needed.
Taking Your Home-Made Ebola Remedy
For prevention:
     1.  Place a teaspoonful of your Ebola remedy from the stock bottle into a cup filled with water.
     2.  Stir the water five times with a disposable spoon or stick.
     3.  Take a sip from the cup.
     4.  During the epidemic, take a sip once or twice a day, stirring five times before taking the sip.
     5.  Refill the cup as needed after striking the stock bottle against a hard surface five times.
If you are sick with Ebola:
     1.  Place a teaspoonful of the Ebola remedy from your stock bottle into a cup filled with water.
     2.  Stir the water five times with a disposable spoon or stick.
     3.  Take a sip every 15 minutes, stirring five times each time until you notice improvement, then stop.
     4.  On improving, you can ease off and take the remedy every hour or so, again stirring five times before taking the remedy each time.
It is step 4 in the preparation that is the dicey one. I would think face mask and gloves would be a bit cavalier for infection control, but on par with the understanding of infectious diseases by many pseudo-medical providers. I am not too worried about the final product. If I were washing dishes at home I would probably consider it clean after the third or fourth rinse and shake, although with Ebola I might heat it to 400°F in the oven for an hour. You may think the Natural News was scammed, but this is a standard homeopath approach to nosode production. They suggested the same method for the Ebola nostrum, the Korsakovian, that is used to make Oscillococcinum. If you fret about Ebola being spread as a nosode (and likely only to the fool who went after the original Ebola-containing spit) consider this list of nosodes available on the internet. I’ve underlined the more peculiar.
Anthracinum (Anthrax); Aviare Tuberculinum; Bacillinum; Botulinum; Candida; Canine Dapp (Distemper, Parvo, Parainfluenza); Carcinosinum; Chlorinum; Cholera; Colibacillinum; Derum S”Anguille [sic]; Diphtherinum; Diptherinum; Diptherinum; Diptherotoxinum Dysentery; Eberthinum; E Coli – Bacteria Coli; Enterotoccinum; Epstein Barr Virus; FIP / Feline Infectious Peritonitis; Gonorrhea (also known by Gonotoxinum or Medorrhinum); HIB / Haemophilus Influenza B; Hepatitis A; Hepatitis B; Hepatitis C; HPV / Human Papilloma Virus; Lac Maternum; Leptospirosis / Leptospira Canicola Bacteria; Luesinum; Lyme Tick Bite Balance; Lyssin (also known by Lyssinum or Rabies); Malaria Off; Medorrhinum (also known as Gonorrheal bacteria or Gohorrhea or Gonotoxinum); Mononucleosis; Morbillinum (Measles); Nuclear Radiation; Oscillococcinum (Anas babarie hepatis et cordis) Paratyphoidinum B; Parotidinum (Mumps); Penicillinum; Pertussinum (Whooping Cough); Plague; Pneumococcinum; Polio; Proteus Bulgaris; Proteus Vulgaris; Psorinum; Pyrogenium- sepsis; Radium Bromide; Rubella (German Measles); Rubeola (Measles); Salmonella; Scarlatinum; Secale –Ergot; Serum Anguillar; Staphyloccoccus Aureus; Staphylococcinum; Staphylotoxinum; Streptococcinum; Syphilinum (Luesinum); Tetanotoxinum; Tuberculinum Aviare; Tuberculinum; Tuberculinum Kent; Typhoidinum; Vaccininum / Vaccinotoxinum; Varicella (Chicken Pox) Variolinum (Smallpox); West Nile Virus Complex; X-Ray.
Remember, all of these nostrums supposedly start with an aliquot of an original infected tissue. It is the smallpox that has always given me pause. Just what was the original source material? Do they still have a smallpox sample forgotten in a closet somewhere like the CDC? Are their production facilities rated to handle these pathogens? I would wager no. X-Ray and nuclear radiation always gives me a smile. But they are missing Ebola and HIV. And if you are wondering, as did I, what Derum S”Anguille [sic], it is eel serum. How eel serum, or an X-ray, constitute a nosode eludes me. An HIV nosode is available elsewhere. I also give you:
The Homœopathic Proving of AIDS The nosode prepared from the blood of a man diagnosed as having Acquired Immune Deficiency Syndrome who subsequently died of Syndrome related diseases.
So do you want to take a preparation made from HIV-infected blood or Ebola-infected blood? If you were not convinced of the total lunacy (treated with homeopathic moonlight?) that is homeopathy, read over the site for the HIV nosode. From The School of Homoeopathy in Devon, England no less. The “Ebola Remedy”: part and parcel of the bizarro world that is homeopathy.
But Wait! There’s More!
There are even more creative applications of homeopathy. Like acupuncture, homeopathic variations are remarkable in their number. There are:
“paper remedies,” where the substance and dilution are written on pieces of paper and either pinned to the patients’ clothing, put in their pockets, or placed under glasses of water that are then given to the patients, as well as the use of radionics to prepare remedies. Such practices have been strongly criticised by classical homeopaths as unfounded, speculative, and verging upon magic and superstition.
As if classical homeopathy isn’t unfounded, speculative, and verging upon magic and superstition. LOL. Verging? I leapt in years ago. So pot, kettle, black. Radionics, by the way, is using radio waves to diagnose and treat diseases. It is pure, if expensive, bunkum and one machine does have an Ebola setting. You can make homeopathy remedies as with radionics, although it doesn’t make for nice fingernails. And anything can be turned in to a homeopathic nostrum:
In addition, homeopathic remedies can also be made making use of non-material sources, for instance, electricity, musical frequencies, magnetic fields and even moonlight. In fact, the possibilities are infinite.
Music. Really? I wonder if a Death Grips homeopathic nostrum would cure my headache. There is a Nigerian newspaper with the headline “American doctor proffers technology cure for Ebola.” What is this wonder cure? “You will hear just white noise as the homeopathic remedy energy is played in order to stimulate the body to heal itself.” One sound to be played if exposed, the other if ill for 48 hours. It is based on ‘science‘ as described :
It turns out that the energetic signal in homeopathic remedies can be extracted via a device consisting of a simple coil connected to an amplifier and digitizer, and the resulting signal can be stored on a computer as a .wav file or a MP3 file. This technique was developed originally in the 1990s by Jacques Benveniste, a French researcher doing immunology research. He demonstrated this in repeated laboratory experiments.
And be careful:
In any case, do not play for more than 15 doses. Too many doses may stimulate the body too much.
It is difficult to know what to make of the producer of this product; he does not apparently understand parody (nor maybe do I). One commentator points out the similarity to FSMoSophica, a homeopathy-like use of the Flying Spaghetti monster where they:
…can speak the healing information directly onto raw globules, we will do this by mentioning the latin name of the respective mother tincture. I think that I am going to concentrate on the second method, the speaking method for the final manufactoring process.
to which he replies:
Interesting. Depending on the homeopathic training of the one making the sound, this does fit pendulum prescribing and even radionics. Personally, I do trust signals from reputable pharmacies because their procedures are tried and true for two centuries, methodical, and not dependent on subjectivity of the one creating the frequency. Thank you for your post.
They have been creating quality frequencies since 1814? About 50-100 years before radios and phonographs? Impressive. And pendulum prescribing? What is that? Use a pendulum held over the patient and ask a question, it will move clockwise for yes and counterclockwise for no. Usefull in homeopathic diagnosis and treatment.
To find the appropriate remedy I have made up a list of the most commonly used remedies along with the most common potencies. I have two pages of remedies which cover nearly 80% of the needed remedies. I suspect that with people, the list would be much longer. I first ask if there is a homeopathic remedy suitable for that particular case. If yes, I then ask if it is on my list. If yes, the next question is, “Is it on the first page?”. If no, is it on the second page. If yes, I then ask which letter it starts with. Since you can only get a yes or no, this process is a bit laborious. If the second page begins with Kali Ars., I would ask, “does the name of the remedy start with K?”. If it does not, I ask if the name starts with L and so on until I located the exact remedy. I then ask in the same manner for potency and frequency. If the remedy is not on my list, I then go to a full list of remedies from a textbook or other source and try and locate it there.
I was shocked to find this was subjected to a clinical evaluation and published. I was not surprised to find negative results:
These results, wholly negative, add to doubts whether dowsing in this context can yield objective information.
You think? And of course they threw in the usual caveats so that utilizers of wackaloon diagnostics have an out to continue:
It is acknowledged that the experimental situation may adversely affect dowsing ability and this may be reflected in the study results…The sample was small, and the absence of proof of effect does not mean that there is no effect.
I also found the following interesting: Andrew Vickers helped develop the original idea, he of acupuncture works for pain fame. I suspect that anyone who thinks that dowsing for diagnosis is worthy of a clinical trial has a different idea of reality than I.
Not to be outdone by herbalists with 365 deaths, I guess the homeopaths want in on the action.
Silver and Ebola
Don’t own an mp3 player or have an Internet connection? Don’t have a grand or two for a radionics machine? Well, you could try silver nano particles. Dr. Rima Laibow of the Natural Solutions Foundations suggests “No One Needs to Die From Ebola! ” and has sent an:
Open Letter to Heads of Ebola-Impacted States and World Health Leaders on Ebola Prevention and Treatment
suggesting her product of:
10 PPM Nano silver administered to Ebola victims, contacts and potential contacts, Ebola and other contagious diseases can be eliminated as the deadly scourges that they currently are.
Sounds impressive since it is based on Defence Threat Reduction Agency (DTRA) data that was declassified in 2009. Ohhhhh. Previously secret information. This must be juicy. Silver, like copper and mercury, has broad anti-microbial actions. I still use antimony to treat Leishmaniasis. I prefer less toxic treatments than metals if available and, in the case of silver, a treatment that actually works. According to Dr. Laibow:
10 PPM was by the most effective dose for killing the Ebola virus.
When begs the question of how you ‘kill’ a virus. Laibow also says that the:
DTRA’s research was carried out specifically in the Ebola Virus as well as other deadly hemorrhagic virus.
This statement is based on a government report that appears to be a Powerpoint presentation on the use of silver nano particles against viruses. As best I can tell from the slides (which I assume were used as back up for a lecture, which we do not have) they found the following. Nano silver particles prevented the binding of Ebola-like particles to Vero cells but do not prevent the internalization of Ebola-like particles at concentration between 10 and 50 ug/ml. The site seems to confuse the size of the particles (10 nm) with the concentration (10 PPM). The study used 10 nm particles and larger. The site offers their silver at 10 PPM, parts per million, which is about 10 ug/ml. But in the DTRA study it was the 10 nm size that was most effective as the dose went from 10 to 25 to 50 ug/ml. You have to read it carefully to note that Dr. Laibow seems to not understand that all tens are not the same.
The site suggests 5cc (1 tsp) as the dose for Ebola, up to 12 doses a day of a product “not intended to prevent, treat or cure any disease.” 10 PPM is about 10 ug/ml. So the patient is taking 50 ug. Most people are about 50 L of water. So the silver if 100% absorbed and evenly distributed (not going to happen) would be 50 ug/50,000 ml or 0.001 ug/ml, a wee bit less than the DTRA study by a factor of 10,000. So there was nothing about killing Ebola in the DTRA study. More importantly, they did not even use Ebola, but Ebola-like particles which are all the protein with none of the genome:
Virus-like particles (VLPs) have been generated in insect and mammalian cell expression systems for a number of viruses including rotaviruses, parvoviruses, human papillomavirus, and HIV by ectopic expression of subsets of their respective viral proteins (20–23). These genome-free VLPs are often morphologically similar to the live virus from which they are derived and are highly immunogenic.
The product was being considered for use in Nigeria, whose Health Minister also can’t read. The saddest, and most amusing in a gallows humor kind of way, is that the silver nanoparticles are consistently referred to as an “Experimental Drug” even by the Wall Street Journal. More evidence to suggest that fact checking is a thing of the past for the few remaining newspapers in the US. Somehow I would be skeptical that a website that says:
Chemtrails are part of an aerial spraying program that appears to be a secret government program or series of programs.
And:
I have been identifying publicly the toxic threats presented by prescription drugs and medical vaccines for decades.
And that shaken babies are due to vaccine injury, is going to have a breakthrough experimental treatment for anything.

Keep An Eye On This Ebola Outbreak
Steve Novella on October 14, 2026
Link

Ebola is a deadly disease caused by the orthoebolavirus group of viruses. It is infamous for being extremely deadly, with a mortality rate as high as 80-90%. Luckily, it only spreads by direct contact with body fluids, not through the air. However, it is mainly a problem in sub-Saharan Africa, where the lack of infrastructure and some cultural practices can cause it to spread fast. The virus lives in non-human hosts (so it cannot be eradicated), and occasionally spills over, mostly into rural villages in Africa.
Prior to the 2014-16 outbreak, Ebola outbreaks were measured in the hundreds and mostly were confined to small villages. The largest such outbreak was in 1976, which killed 280 people. Then, in 2014, an Ebola outbreak spread to a larger town, resulting in the largest outbreak to date, with over 28,000 cases and over 11,000 deaths. Then, in the 2018-2020 outbreak, there were 3,481 cases (3,323 confirmed and 158 probable) and 2,299 deaths.
We are now in the middle of the 2026 outbreak in the Democratic Republic of Congo (DRC), which has already caused 9,066 cases and 4,381 deaths. This is therefore the new second-largest outbreak in history. However, you may have noticed that prior outbreaks spanned three years, and we are just in the first year of this outbreak. Further, this one is spreading much faster than previous outbreaks, passing 1,000 cases in 40 days, compared to 235 days for the 2018 outbreak.
Why have the last three Ebola outbreaks been 1-2 orders of magnitude larger than all previous outbreaks? It’s not due to the virus evolving or becoming more virulent. The current variant is Bundibugyo, which is not as deadly as other variants. Although it is a variant for which we do not have a vaccine, we do have a vaccine for the Zaire variant, and there was a 2025 outbreak of this variant with only 64 cases and 45 deaths as a result.
The reason Ebola outbreaks are generally much larger now is due to human factors. Population density in vulnerable areas has increased, as has travel among towns and villages. Further, outbreaks often occur in active combat zones, which causes displaced populations to move around and spread the disease.
Our ability to respond to large Ebola outbreaks has also eroded. Medical infrastructure is weakened in vulnerable areas due largely to political instability. This has also eroded trust in healthcare systems among the populace, which therefore do not follow best practices to limit spread.
After the 2014-16 outbreak, which shocked the medical world due to its unprecedented scale, there was lots of talk about building up our response infrastructure so that the world could collectively respond quickly and decisively to stop other outbreaks before they have a chance to spread widely. It was recognized that every Ebola outbreak is a roll of the dice—if the virus gets into a more populated area or a travel hub, the outbreak can increase by orders of magnitude. The great worry is that one of these outbreaks would become a regional epidemic, and might even become a pandemic. So it is in everyone’s best interest to rapidly stop these small outbreaks, while we also develop vaccines.
We have developed a vaccine for the Zaire variant, and work is in progress on others. But most variants, like the current outbreak, do not have vaccines, and so all we have are traditional containment methods to limit spread.
If someone told me in 2016 that in 2026 we would be less prepared for a massive Ebola outbreak, I would have found that hard to believe. Hadn’t we learned our lesson? Could it be simple stupidity, or had some calamity befallen human civilization, limiting our ability to respond to such an outbreak? Further, between these two times, we suffered an actual pandemic, which claimed over 7 million lives and disrupted world economies. Where is the WHO and the CDC?
Well, here we are. The Trump administration has pulled out of the WHO and has “fed USAID into a woodchipper”. This has gutted the infrastructure we had in place to respond to outbreaks. This lack of infrastructure and networks makes it harder to detect new cases, which means our response to a new outbreak is delayed. The WHO has lost 20% of its workforce, which it uses to back up the fragile health infrastructure in much of sub-Saharan Africa.
The CDC has perhaps been even more affected, as I recently discussed. In the previous large outbreak, the CDC sent 2,000 health workers to help contain the outbreak. This time they sent 100, and their primary goal is to prevent spread to the US, not to contain the outbreak itself.
The US has given over $182 million in assistance. However, you cannot simply throw money at this problem. The money is given to local governments, but the network of experts that we had in place is essentially gone, down the woodchipper with USAID.
The lack of a well-funded and coordinated response, through an established network of experts armed with early detection, is a main reason why this is the fastest-spreading Ebola outbreak in history. This is a human and political failure of epic proportions. It will likely be two more years before we know the full extent of this outbreak, which may eventually take the top spot.
Further, many experts are concerned and are warning that we are less prepared for another pandemic than we were for COVID-19. The usual criticism of preventive measures is that humans tend to be too reactive and insufficiently proactive. It takes a disaster to wake us up and motivate us to take action. But now even that is not working. Our society is collectively so dysfunctional that the net response to a pandemic is to trust institutions less and tear down existing infrastructure.
Of course, this is just the net response, not every individual. There seem to be many people who recognize the folly of what is happening. Those people need to get really politically active if we are going to get back to some measure of sanity before something truly disastrous happens.
You cannot appoint a bunch of cranks and pseudoscientists to key health positions, dismantle existing health infrastructure, wage all-out war against experts and the very notion of expertise, and avoid serious consequences. Generational damage has already been done. What we need is some enlightened outrage and focused efforts to reverse these trends. Otherwise, the fastest-growing Ebola outbreak in history may be the least of our worries.


Elephants, Herpes, and Protests: A Zoo Tragedy Distorted
There has been a recent kerfuffle over the death of a young elephant from elephant endotheliotropic herpesvirus hemorrhagic disease. Was it the zoo’s fault? Probably not.
Greg Bishop on January 18, 2019
Link

A couple of months ago, a young elephant died in a zoo in Oregon. The cause of her death was a viral disease known as elephant endotheliotropic herpesvirus (EEHV) hemorrhagic disease, which is a common cause of young Asian elephant mortality. Undeniably tragic for everyone involved, this high profile death triggered activist demonstrations, who protested the confinement of elephants and in some cases claimed that captivity caused her disease or made her more susceptible to it. In fact, this enigmatic disease has claimed the lives of wild and captive elephants, and it is largely from the captive population of elephants that we know as much about it as we do.
Let’s talk about herpes
The causative agent of EEHV hemorrhagic disease is a herpesvirus. I can hear you snickering in the back, so just be aware that it’s not lack of elephant sex education that causes this, and in fact herpesviruses are extremely common in animals, usually not sexually transmitted, and usually don’t cause significant disease in their hosts. EEHV is an exception to the “harmonious pathogen” rule, however, as it has been documented to cause a lot of elephant deaths.
Herpes viruses in general tend to be strongly associated with a single host species. They may cause mild symptoms in the host (e.g. cold sores in humans are caused by a herpesvirus) but very rarely cause serious disease. But there are some examples of a virus “jumping” into a closely related species and causing disaster. Herpes B virus, for example, is a common host-adapted infection in macaque monkeys that causes minimal symptoms. But if a human is infected through a bite or a scratch, it causes encephalitis and has one of the highest case fatality rates of any known infection. Fortunately it’s relatively rare, but I still cringe when I see people conducting monkey business without protection.
There are an extraordinary number of herpesviruses, and given non-native host disease is so uncommon, when researchers were first trying to figure out why Asian elephants were dying from this virus, they reasonably thought that it was a host-adapted virus from African elephants* housed in the same zoos. Although this was a sound hypothesis at the time, it had yet to be tested, and has been misrepresented ever since. The speculation was enough to be used as “evidence” that housing elephants in artificial conditions (if it’s not clear, African and Asian elephants’ ranges do not overlap in the wild) directly led to the deaths of these young animals.
The Oregon Zoo
Lily’s death was the most recent case of EEHV hemorrhagic disease and the first to occur at the Oregon Zoo, in Portland, Oregon. This zoo is unfortunately no stranger to controversy and has attracted severe criticism from animal rights activists over the years. And yes, it is Portland, which may have a lower protest threshold than say Des Moines, and seems out-there enough to have been a plausible setting for the infamous hoax paper equating dog park behavior to rape culture. All the same, there is a history of controversial incidents at the Oregon Zoo, and this was not the first organized protest in front of its gates. The most prominent group is specifically opposed to the elephant program.
I’d like to briefly dab the distal millimeter of my toe into the firestorm of controversy surrounding elephants in captivity and say this: most modern zoos are deeply dedicated to the humane care of their animals as well as conservation and endangered species survival, while at the same time undeniably the descendants of an exploitative system. Elephants are not endemic to Oregon (for at least the last 15,000 years), and it was not high-minded conservation efforts that brought the original population of most zoo animals to where they have ended up today. That’s not the case nowadays, but it was not that long ago when we practiced some pretty shameful methods of “obtaining” exotic animals. That doesn’t change our responsibility to take care of the animals in modern zoos, or make it any easier to return captive species to the wild. And it doesn’t mean species in the wild can’t benefit from knowledge gained from their captive relatives.
After Lily’s death there were protests at the zoo, and although they were opposing elephant captivity in general, there were some suggestions that the zoo was responsible for the death. Of course, the activists are against captivity, so they’re motivated to assign the blame to the zoo for any negative outcome. According to the activist website Care2.com, “Elephants in captivity are susceptible to life-threatening health problems, like … endotheliotropic herpesvirus”. EEHV, however, has been documented in wild elephants and there is no evidence to suggest that it’s more common in captivity. That’s not to say there aren’t important differences between captive and wild animals (for example, there are a number of diseases in captive black rhinoceros that are virtually unknown in their wild counterparts), but that doesn’t mean that every problem a zoo animal gets is because it’s in a zoo.
One of the main claims still made by activists is that EEHV hemorrhagic disease is the result of unnatural zoo conditions, in which different species are often in close proximity. As stated above, this was the original hypothesis for why a herpesvirus would cause fatal disease in what was suspected to be a non-native host. Research in the last 20 years has since shown that there are more than a dozen subtypes of EEHV and that not only are the most common types responsible for deaths (EEHV1A and EEHV1B) not found in African elephants, but that wild Asian elephants who had never had been near African elephants have died from the disease. It appears that the most fatal subtypes are actually host-adapted to Asian elephants, although no one knows why.
Gaps in knowledge about EEHV
“We don’t know, but we’re working on it” would probably be an appropriate motto for EEHV researchers. There are so many things we don’t know about this significant killer of elephants. That’s not going to satisfy the grieving public or passionate activists after an elephant calf death, but it is the truth. A ton (I’m going to give myself credit for an elephant pun here) of work has been done on this disease over the last 20 or so years since the first cases were described, but the picture appears to be getting more confusing, not less.
Here are some depressing facts we’ve learned about EEHV: It has killed about 20-30% of the captive-born elephant calves born in North American zoos in the last 50 or so years. There have been about 100 cases worldwide, the vast majority in Asian elephant calves (only four cases are known in African elephants), and there are about eight documented survivors. All of the survivors were treated with expensive and sometimes difficult-to-access antiviral drugs, although many of the animals that died were also treated with these drugs, so it’s hard to say if the treatment actually helped or not. Most of the deaths are in animals between 1 and 4 years of age. The epidemiology of this disease has been a tough nut to crack, with almost every individual case caused by a different strain, and no clear reason as to why some individuals are affected and some aren’t. One of the craziest parts of the problem is that this virus is endemic in almost every herd of elephants that’s been examined, so it’s extremely unlikely that we’d be able to eradicate it. It’s been killing young elephants left and right for decades and we don’t understand how it’s transmitted, why it’s so virulent, or how to prevent it. It may have even been a cause of elephant mortality for hundreds if not thousands of years, but we have no idea.
One of the major reasons our knowledge is limited is that we haven’t been able to grow the virus in the lab yet, despite apparently a great deal of effort in doing so. If this hurdle could be crossed, we could make a lot more progress in our understanding of the pathology and treatment of the disease. There have been recent developments in elephant cell culture that might get us closer, and there are a lot of very smart people working very hard on solving the problem.** It’s indisputable that research on captive elephants has shed the most light on the disease. It’s also reasonable to suspect that the only animals who have survived the disease are ones in captive settings that received veterinary care.
Conclusion: Everyone loves elephants, this virus sucks
The trunk and tail of it is that EEHV hemorrhagic disease is one of the most serious threats facing the global Asian elephant population and we know frustratingly little about it. The passions ignited by a high profile animal death in a zoo are understandable but probably misplacing blame in this case. I happen know people in both the “liberate the pachyderms” camp, as well as the “hands-on daily care of individual elephants in zoos” group. The thing they share in common is a deep love of these animals and a desire to protect them. The truth is we know so little about EEHV and what to do about it that it might be a long time before we get any good answers. Captivity has its faults, and there is reason to suspect that many of the “charismatic” species such as elephants and orcas that you can currently see in a zoo will not be on display forever, but there are undeniable scientific benefits that can be gained from non-invasively studying these creatures while they’re in our care.

And after that bummer, allow me to present:

*There are three extant elephant species, two of which are commonly housed in zoos: the African bush elephant (Loxodonta africana), and the Asian elephant (Elephas maximus). The third species, the African forest elephant (Loxodonta cyclotis), is extremely rare to nonexistent in captivity. For super-nerd points, there are 185 known species of extinct elephants.
**Many of whom are at the National Elephant Herpesvirus Laboratory run by the Smithsonian’s National Zoo, although there are a lot of zoo veterinarians and researchers working on this problem.

Curing Hepatitis C: A Success Story and a Price Tag
Previously incurable, hepatitis C now has a treatment. A very, very expensive treatment. But there is hope for acutely and chronically infected people.
Harriet Hall on April 22, 2014
Link
Most people know about hepatitis B; babies get vaccinated for it at birth. But fewer people know about hepatitis C. C is actually more common than B, but most chronically infected people don’t know they have it. You might think ignorance is bliss, but patients who have no symptoms today may have liver cancer or a liver transplant in their future. Until recently, treatment for this stealth disease was disappointing, but according to three recent, large controlled studies published in The New England Journal of Medicine, the virus has been tamed. A short course of a new antiviral drug with few side effects was 99% effective in removing the virus from the blood.
History
In the beginning, there was jaundice. Patients turned yellow, developed flu-like symptoms, and sometimes died. Eventually doctors figured out that jaundice was a sign of liver disease and the condition was named hepatitis; and by the time I graduated from medical school in 1970, scientists had identified two viruses that caused infectious hepatitis: hepatitis A and B. Hepatitis A infection was transmitted by the fecal-oral route, usually by contamination of food; hepatitis B was transmitted by needles and blood products. Prevention was limited to good hygienic practices; treatment of acute hepatitis was limited to bed rest, supportive care, and IV fluids. Contacts could be given gamma globulin. In fulminant cases and chronic hepatitis, steroids were used. No treatment was very effective. Death and cirrhosis often ensued.
Non-C hepatitis today
Fast forward to 2014. Scientists have identified five hepatitis viruses: A, B, C, D, and E, along with numerous serotypes and genotypes. Antigen and antibody tests are available for accurate diagnosis.
Hepatitis A still infects 1.4 million people and kills around 100,000 people around the world every year. There is still no specific treatment available. A vaccine is available, but hygiene, sanitation, and food safety precautions are the mainstays of prevention.
Hepatitis B has infected about a third of the world’s inhabitants, and an estimated 350 million people are chronic carriers. The disease is transmitted through blood, sexual intercourse, semen, saliva, and childbirth. Chronic disease can lead to cirrhosis and causes about half of all liver cancers. The virus was first seen with an electron microscope in 1970, and by the early 1980s its genome had been sequenced. By 1991 an effective vaccine was being recommended for all infants at birth. Early vaccination is important because young children are particularly vulnerable. Only 5% of newborns infected by their mother will clear the infection, and they have a 40% lifetime risk of cirrhosis and liver cancer. Acute infection in older children and adults usually clears spontaneously, but treatment of chronic infection is necessary to prevent cirrhosis and liver cancer. Five antiviral drugs and two immune system modulators (interferons) are available; they don’t cure the infection but they reduce replication and liver damage.
Hepatitis D occurs only in those also infected with HBV, and it increases the risk of complications.
Hepatitis E infects 20 million people a year and causes 57,000 deaths. It’s more common in developing countries, and there are animal reservoirs. Vaccines have been developed but are not licensed in the US due to the low risk of infection in developed countries.
Hepatitis C
Hepatitis C was identified in 1989. It has been found in humans and chimpanzees and is transmitted by intravenous drug use, tattoos, transfusions and other exposures to blood, and by sexual intercourse. Only 15% of patients develop symptoms, but the virus persists in the liver in 85% of those infected; it causes 27% of all cirrhosis cases and 25% of all liver cancers, and is the number one reason for liver transplants. No vaccine is available. More than 3 million Americans are infected, and most of them don’t know it. 75% of cases are in baby boomers, so the CDC recently recommended a one-time screening blood test for those born between 1945 and 1965. Patients with positive tests are monitored with ultrasound, vaccinated against hepatitis A and B, and warned to avoid alcohol and hepatotoxic drugs.
Treatment
The first study of a treatment for hepatitis C was published in 1986, when it was still known only as “non-A non-B hepatitis.” It was a small pilot study (10 patients); treatment with interferon normalized liver function tests, but when treatment was discontinued, patients relapsed. Eventually, an interferon/ribavirin combination became the standard treatment; they were given for 24 or 48 weeks. Cure rates varied from 45% to 80% depending on the HCV genotype. Interferon is contraindicated in patients with certain medical conditions, and serious side effects are common. A systematic review in 2013 showed that a sustained virologic response reduced the risk of liver cancer by 75%. Despite the availability of treatment, the mortality rate from hepatitis C continued to increase until it exceeded the rate for HIV infection.
The new studies
Newer antiviral agents were developed. Three new studies of the combination of ledipasvir and sofosbuvir were published in April of 2014. They were large, randomized open-label studies comparing different antiviral regimens. Placebo controls would have been unethical, since that would have denied subjects the known benefits of treatment.
A four-arm study by Afdhal et al. of 865 previously-untreated patients found high response rates: ledipasvir and sofosbuvir for 12 weeks produced a sustained virologic response in 99% of subjects; for 24 weeks, 98%; with ribavirin added, the rates were 97% after 12 weeks treatment and 99% after 24 weeks.
A similar four-arm study by Afdhal et al. enrolled 404 patients who had already failed treatment with peginterferon and ribavirin. It showed similar results (96-99% response rates).
A study by Kowdley et al. of 647 previously-untreated patients found that 8 weeks treatment with lepipasvir and sofosbuvir was as good as 12 weeks, and adding ribavirin did not improve response.
Virologic response was defined as the absence of quantifiable HCV RNA in serum (less than 25 IU/ml). Side effects were mild, including fatigue, headache, and nausea; no subject in any of these studies had to discontinue treatment because of side effects. The medication was given as a convenient, once-daily pill.
Considering the typical response rates in published studies, these results are astounding. It appears that simply taking a single pill once a day for 8 weeks will safely and effectively protect patients from liver failure and liver cancer. Further studies will be needed to show whether death and transplantation rates will actually decrease, but there is very good reason to expect that they will.
High price tag
There’s only one problem: sofosbuvir pills alone cost $1,000 each, or $84,000 for a 12-week course of treatment; and the addition of ledipasvir will add to the costs. Can society afford the billions of dollars needed to identify and treat everyone at risk? Will we revisit the early days of dialysis when “death panels” rationed treatment and decided which lives were worthy of saving? Today, dialysis is more effective, less expensive, more readily available, and is covered by Medicare for patients of all ages. We solved that problem, and I am optimistic that we will solve the hepatitis C problem as well.
Alternative treatments
Several alternative medicine options have been recommended for the treatment of hepatitis C, including milk thistle, licorice root, ginseng, thymus extract, zinc, SAMe, colloidal silver, probiotics, shisandra, TJ-108 (an herbal mixture used in Japanese Kampo medicine), massage, chiropractic care, and relaxation techniques. The NIH has reviewed the scant available evidence. There is evidence that some of these don’t work, and some of them have not been studied at all. There have been a few mildly positive but questionable studies; but certainly nothing that could even begin to compete with the kind of results achieved in the NEJM studies.
Conclusion: Science works (but does cost money)
The new antiviral treatments for hepatitis C are a great example of science-based medicine in action. We can anticipate that they will save a lot of lives, especially if the economic problems can be overcome.

Buzzword Medicine – Anti-Proinflammation
Does it make sense to simultaneously recommend interventions to suppress and boost the immune system?
Steven Novella on August 11, 2021
Link

Alternative medicine is essentially what you get when you remove science from the equation (at least as a method of determining if an intervention is safe and effective) and emphasize marketing. Pre-FDA, for example, we lived in an era of patent medicine, where marketing was everything and the market was full of useless snake oil with vague or unproven claims. We have partially returned to that world in the post-DSHEA era. Likewise alternative medicine (regardless of the branding de jour) at its core is about eliminating the standard of care or a scientific basis for medicine and letting market forces reign.
In such a world what matters is the narrative, the story are you trying to sell. Narratives, in turn, are supported by basic concepts and buzzwords, which substitute for evidence and careful thought. For example “natural” is a marketing term, based on the appeal to nature narrative which creates a health halo around any product or service that is labeled so. It is not a coherent or internally consistent principle, just a vague sense designed to make people feel good about a product. What, operationally, is “natural”? Why would we think that something evolved in nature is good for us? Nature is generally trying to kill us for its own survival.
I was reminded of all this when I saw an article about the “Naturopathic approach” to COVID-19. The article mostly recommends herbs and supplements, thinly sourced and typically making unsupported clinical claims based on pre-clinical data. As is common they start with some common-sense recommendations, like getting enough sleep, but the core of the article is unsupported herbalism. What struck me is that the recommendations were divided into three categories: “anti-oxidant support” (potentially dangerous), “upregulating the immune system” (what part?), and “anti-inflammatory support” (dubious).
The phrasing here is due to DSHEA, which allows for “structure-function” claims for supplements, but not disease claims. Anyone can claim that anything “supports” a biological function, without the need for evidence. As long as you don’t mention a disease by name, you won’t run afoul of the FDA. But perhaps more interestingly, three of the most common alternative medicine narratives are invoked, even though they are largely contradictory to each other. They nicely represent how a health-halo buzzword is all that matters when it comes to alternative medicine.
Let’s start with anti-oxidant support. The basic idea is that oxidative stress, resulting from metabolism and specifically creating ATP (energy carrying molecules) with oxygen in mitochondria, can cause cell damage. Anti-oxidants chemically neutralize oxygen free radicals and prevent cell damage from oxidative stress. At least, this is the 1980s version of the science. In the last few decades we have learned a few interesting things about the oxidative system.
First, the body makes its own anti-oxidants, and they are orders of magnitude more powerful than anything you can get in a supplement or in food. Therefore, if greater anti-oxidant activity were advantageous, why wouldn’t we have evolved to just make a little more? This question leads to other important facts we learned about oxygen free radicals – they are used by cells for important functions. For example, they are signal molecules that trigger important protective metabolic processes. They are also (and this is important) used by certain cells of the immune system to fight off invaders. Oxidative stress can also damage cells of the immune system, so free radicals are definitely a double-edged sword.
But that is the key – oxygen free radicals exist in a delicate homeostasis with endogenous anti-oxidants. This is a complex system, and there is no reason to think that taking extra (and wimpy) anti-oxidants will somehow improve this balance. In fact, during an infection may be the worst time to take them as they may impair the immune response to the infection. At the same time, the immune response to an active infection can itself cause harm to the body, and sometimes suppressing aspects of the immune system might have more benefit than harm. How do we balance the potential benefit vs harm in any intervention that inhibits immune activity during an infection?
This requires careful study for each individual infection type. It remains to be seen if anti-oxidants are useful in COVID-19, but there is some reason to think that they may be. That is not enough, however. We need rigorous clinical trials. Our track record of predicting whether or not altering immune function will be helpful or harmful is not very good. Immune function is extremely complex, and is a delicate balance of trade-offs. Simple narratives (such as “anti-oxidants good”) are not sufficient.
The same goes for boosting the immune system and anti-inflammatory treatments. Inflammation is also what the immune system does to fight infection, and it can cause damage to the host. Are we boosting the right part of the immune system? Will this unnecessarily cause more damage? If we suppress inflammation, will that worsen the infection? These answers differ for each type of infection.
In COVID-19 it turns out that perhaps the most effective treatment discovered so far is corticosteroids. This is an old-school anti-inflammatory drug. This will worsen some infections, and improve outcomes in others. It was researched in COVID-19 because it was recognized that the worst patient outcomes may be due to “cytokine storm” – a flare of immune activity triggered by severe infection that can be devastating. But not all kinds of anti-inflammatory treatment are the same. The immune system has many components, and if you suppress the wrong one that can hamper defenses against the virus. By the same token, if you increase immune activity you may help fight the virus or increase the risk of cytokine storm or other inflammatory damage.
There is therefore no rationale for simultaneously recommending some interventions that reduce immune activity and other interventions that increase immune activity as blanket recommendations, without evidence for net clinical outcomes from a specific treatment in a specific infection. But researching specific clinical outcomes would be doing science-based medicine, and that is not what alternative medicine is. Alternative medicine is based on marketable buzzwords, applied simplistically, and without proper evidence.

Legionnaires’ Disease: The Other Disneyland Outbreak
As 2017 came to a close, Disneyland again played a role in the outbreak of an infectious disease, this one much more deadly than measles.
Clay Jones on January 12, 2018
Link

Late last year, multiple news outlets covered an outbreak of a serious infectious disease traced to Disneyland. No, it wasn’t another cluster of measles cases, or even of pixie dust-induced lung cancer. This time it was an even deadlier infection, and thankfully one that is much more difficult to catch, known as Legionnaires’ disease.
A total of 15 cases of Legionnaires’ disease were diagnosed during the outbreak, with 11 of the 15 having visited Disneyland from late August through October. The other four cases occurred in people who had been in Anaheim during this window but who had not visited the park. Ten hospitalizations and two deaths occurred, both people who had not been to Disneyland. As would be expected with this condition, the infected skewed older, with the youngest being 52.
According to Disney Parks and Resorts Chief Medical Officer Pamela Hymel, Disneyland was notified of the cluster of cases on October 27th and promptly began investigating their facility. Disneyland has 18 cooling towers in use at the park, and because these types of systems are notorious breeding grounds for the bacteria that causes Legionnaires’ disease they were the focus of testing. Disney found that two of them were contaminated with the pathogenic bacteria.
The two large cooling towers, which could have showered up to a 3 mile area with the potentially deadly bacteria, were shut down immediately and treated. Repeat testing in early November was negative for the bacteria but health officials requested that the towers be kept out of use for a while longer. No follow-up information is available online regarding the outbreak, so it is probably safe to assume that no additional cases have occurred, at least not in Anaheim. Unfortunately, outbreaks are common and, as I’ll get to shortly, appear to be on the rise.
What is Legionnaires’ disease?
Legionnaires’ disease is primarily thought of as a form of community and hospital-acquired pneumonia, although it can present with significant gastrointestinal and neurologic abnormalities. It is caused by infection with Legionella bacteria, named so because it was first identified during a 1976 outbreak of disease at an American Legion convention. Since then, it has increasingly been recognized as one of the more common causes of pneumonia in adults, being diagnosed in about 4% of cases, particularly if they smoke, have chronic lung disease, have had a solid organ transplant, and/or have had significant exposure to contaminated water.
Infection with Legionella is very rare in children. This is because they tend to not smoke but also because healthcare providers don’t typically look for it in kids like they do in adults. In fact, there has been a trend over the past decade of increasing incidence in adults that is at least partially the result of improved diagnostic testing. Rather than having to wait on a culture for several days, there is now widespread availability of rapid urine antigen testing that is highly sensitive and specific. Many hospitals now have protocols where testing for Legionella is performed in all adults admitted for pneumonia
There are no such protocols in pediatric patients. We would only test for the bacteria if there was very high suspicion, such as when treating an immune compromised transplant patient with pneumonia and severe diarrhea. But empiric treatment of community and hospital-acquired pneumonia often includes antibiotics that treat Legionella as well as more common infectious agents, so many adult (and possibly some pediatric) patients have recovered despite a presumed but incorrect diagnosis of a more common type of pneumonia when they actually had Legionnaires’ disease.
One exception to the rarity of pediatric infection with Legionella is something I’ve actually written about on three separate occasions: water birth. Water birth is the absurd and dangerous practice of delivering a baby into water, often at home and without guidance from a trained medical professional. There have been at least three cases, including one death, involving a newborn infection with Legionella when born into contaminated water.
Legionnaires’ disease is considerably more deadly than other common causes of pneumonia, especially if not treated in a timely manner with appropriate antibiotics. When diagnosed quickly and treatment with the right drug initiated early in the course, still up to 5% of patients will die. Delay in appropriate care results in much higher mortality that starts at 10% and rises with the presence and severity of co-morbid conditions. On average, one out of every four patients who acquire the infection while in the hospital does not survive. To put this in perspective, less than one out of every 1,000 patients diagnosed with measles, and who have access to modern medical care, will die.
Legionella and cooling towers
The natural habitat for the bacteria to blame for Legionnaires’ disease is water. This can include lakes, streams, and other sources of “raw water“, but there is typically not a high enough concentration of the bacteria to cause illness. Much higher numbers of the bacteria can be found in contaminated manmade collections of water, such as hot tubs, grocery store mist machines, fountains, and cooling towers. The key growth factors are higher temperature and stagnation, and cooling towers are full of warm water. Unless properly maintained, large amounts of Legionella can leave these towers in the spray of fine mist emerging from the top of the structure and travel a large distance.
Once aerosolized, the bacteria can be inhaled by those nearby. Legionella has also been spread by contaminated drinking water, hospital water supplies used to flush nasogastric tubes, and even damp potting soil. Spikes in incidence have also been associated with significant increases in rain and humidity. But there has never been a proven case of one person spreading Legionella to another, which is a big part of why, thankfully, this more deadly disease is so much less contagious than measles.
Is Legionnaires’ disease on the rise?
Over the past two decades there has been a steady increase in the reported incidence of Legionnaires’ disease in the United States. From 2000 to 2009 the incidence tripled. More recently, there were increases of roughly 8% and 14% from 2015-2016 and 2016-2017 respectively. Many cities are seeing record numbers.
One reason for the increase is almost certainly testing that has improved in both ease and accuracy. This has led to more facilities having protocols where every adult patient diagnosed with pneumonia is tested for Legionella. This is also why the mortality of the disease is actually much lower now than in historical data because a larger number of milder cases are being picked up. Other potential factors are higher temperatures, more flooding, an aging population and infrastructure, and higher population density in many cities.
Conclusion: A nasty disease likely to become more common
Legionella is a nasty bug, and it’s a good thing that it isn’t very easy to catch. It is yet another reason to consider quitting smoking or having your baby on dry land. Although effective treatment is available, the disease it causes is still potentially very deadly when there are delays in appropriate care, which is one more reason not to waste time seeking advice from unqualified pseudomedical professionals.
Don’t be too hard on Disneyland. Contamination of water supplies, such as in cooling towers used to heat and air condition large buildings, is hard to prevent and outbreaks are increasingly going to happen. Protocols for frequent testing of high risk water, and quick action when outbreaks are first noticed, is key to preventing cases and reducing mortality. Unfortunately, unlike with measles there is no vaccine against Legionella.

Worms, Germs, and Dirt: What Can They Teach Us About Allergies and Autoimmune Diseases?
Can infection by bacteria, viruses, and parasites cure us of autoimmune diseases, allergies, and other immune system dysfunctions? There is some preliminary evidence, but the jury is still out on a very complex case.
Harriet Hall on January 29, 2013
Link

Humans evolved in an environment where they were exposed to animals, dirt, and a variety of pathogens and parasites. Our immune systems evolved to cope with that environment. Now most of us live in a different environment, with safe drinking water, flush toilets, food inspection, immunizations, and public sanitation. This means that we are far less likely than our ancestors to die of infectious diseases or to harbor intestinal worms. But it seems that the cleaner we get, the more likely we are to suffer from allergies and autoimmune diseases. One hypothesis is that our immune systems evolved to require early challenges by parasites and pathogens in order to develop properly. A hygienic environment fails to give our immune system the exercise it needs, resulting in imbalances and malfunctions.
The hygiene hypothesis was first proposed to explain observations like these:
    • Hay fever and allergies were less common in large families where children were presumably exposed to more infections through their siblings.
    • Polio attack rates were higher in high socioeconomic groups than in lower ones.
    • Allergies and many other diseases were less common in the developing world.
Investigation of these and other phenomena is contributing to a better understanding of the immune system, which is a good thing. At the same time, it has led some people to deliberately infect themselves with intestinal worms in an attempt to cure their allergies and autoimmune diseases, which may not be such a good thing. These treatments are far from ready for prime time, are risky, and they have a high yuck factor. The very idea of deliberately infecting yourself with worms is unpalatable, and finding wiggly live creatures in your stool or passing a 20 foot tapeworm are not generally considered to be pleasant experiences.
The immune system is an incredibly complicated mesh of many different components that interact with each other. The hygiene controversy focuses on Th1 and Th2. To grossly oversimplify, Th1 responds to intracellular pathogens (bacteria and some viruses) and Th2 responds to multicellular parasites like intestinal worms. They produce different kinds of cytokines, but there is a confusing overlap. Th1 produces inflammation and Th2 suppresses some of that Th1 inflammation and contributes to a pregnant woman’s ability to tolerate the fetus, but it is also involved in producing allergic reactions. Over-activation of either pathway can cause disease, and either pathway can down-regulate the other. Th1 and Th2 were originally thought to act like a seesaw where one goes up as the other goes down; but it turned out not to be that simple. An early hypothesis was that allergies resulted from an imbalance between the two, and that allergen exposure could somehow restore a balance. The subject is complicated. The more I try to understand the details, the more my head hurts. I hope my superficial description hasn’t misrepresented the truth too badly.

In his book An Epidemic of Absence: A New Way of Understanding Allergies, Moises Velasquez-Manoff compiles an impressive array of evolutionary arguments and evidence, everything from epidemiologic studies to personal anecdotes, to support the idea that early exposure to bacteria and parasites would reduce the incidence of allergies and autoimmune diseases, and that exposure after the condition had already developed would reduce symptoms. His book is exhaustive and I found it exhausting to read. It buried me in a mass of repetitious details.
It is an eye-opening book in more ways than one. He describes his own difficult quest to obtain worms to treat himself for his allergies and his alopecia. He has to negotiate with the hookworm underground and travel to Tijuana. He applies the larvae to his forearm and lets them burrow into his skin. Almost immediately, he feels “remarkably crappy.” He gets a headache, a hungover feeling, bloating, cramping, itchy bumps on his arm where the larvae entered, vertigo, cramps, diarrhea. The headaches lingered, but the other symptoms eventually subsided. His skin improved, his hay fever disappeared, and his sinuses were clearer for a while; but then his allergies returned with a vengeance. A stool test showed no whipworms. He assumed they had all died and would have to be replaced with new ones, but he was reluctant to let any more hookworm larvae burrow into his arm and risk experiencing all those unpleasant side effects again. He gave up on the experiment, but later his symptoms cleared again and whipworms showed up again in his stools. It’s far from clear what happened. He likes to think it has something to do with the optimum dose. He says, given his symptoms, that he would never recommend hookworms and would never deliberately administer them to his daughter… unless he was sure that she was destined to develop Crohn’s disease and debilitating allergies. Even then, he couldn’t be confident that the treatment would be effective, and he recognizes that only science can settle the question. He recounts many stories of other people who tried worm therapy and their conflicting results. They tried whipworms, hookworms, and even tapeworms, both from species that infect animals and from those that infect humans. Some people claimed to be cured. Some were improved for a time but symptoms recurred when their worms died and they had to keep infecting themselves with new ones. Some got so sick they had to be de-wormed. Some thought they got results but they also got side effects that they were willing to put up with. As with all testimonials, there is no way to know whether improvements were due to the worms or were coincidental.

Worm therapy is being seriously studied as a treatment for inflammatory bowel disease (Crohn’s disease and ulcerative colitis), celiac disease, and multiple sclerosis. Preliminary results are encouraging, but they are mostly case reports and uncontrolled open label studies. Carefully controlled studies are needed. It’s complicated; for instance, hookworms appear to reduce the risk of asthma but roundworms increase the risk.
Epigenetics and the environment in the womb come into play. Children born to mothers who were exposed to cowshed microbes were less likely to develop allergies. A double-blind randomized controlled study in Uganda showed that deworming pregnant women reduced the odds of her child developing allergic eczema by 82%. One might have expected that would make the child more susceptible, not less. The effects of bacterial exposure are different from those of parasite exposure. It’s complicated.
How ironic that the anti-vaccine folks are worried that vaccines might “overwhelm” the child’s immune system! Far from being overwhelmed, it appears the child’s immune system is not being exercised enough. It apparently needs more practice responding to microbes and parasites in early life in order to avoid allergies and autoimmune diseases in later life.
In a related development, fecal transplants and probiotics are proving to be effective in treating certain health conditions. We have only recently begun to learn about those other organisms that live in our body and outnumber our own cells by ten to one: our microbiome. Our internal and external ecosystems both affect our health. No man is an island.
Conclusion: An interesting, unproven hypothesis
Germs, worms, allergies and autoimmune diseases are all part of a complex web. If we come to understand the complexities, it could well lead to new strategies to prevent or treat allergies, diabetes, and a host of other diseases. But I don’t think we want to return to an unhygienic, parasite-laden environment. And I question the wisdom of deliberately infecting oneself with worms at this point in history, given the present state of knowledge. Not only is the evidence far from conclusive, but worms are yucky.

The Application of Science
Mark Crislip on March 9, 2012
Link
It all seemed so easy
In 2010 an article was published in the New England Journal of Medicine, Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus . Patients were screened for Staphylcoccus aureus ( including MRSA, methicillin resistant Staphylococcus aureus) and those that were positive underwent a 5 day perioperative decontamination procedure with chlorhexidine baths and an antibiotic, mupirocin, in the nose. The results were impressive. Before the intervention the infection rates were 7.7 % and after the intervention it was 3.4 %. That is an impressive drop in surgical infections.
One of the orthopedic groups approached us (us being the hospital administration, pharmacy, nursing and infection control, of which I am Chair) to implement the protocol in their patients, citing a similar study on an orthopedic population. Great. It should be an easy enough intervention. I should have known better, of course, long experience has continually demonstrated that what appears to be simple never is.
First was the question as to whether the study was applicable to our patients. Resources were going to be devoted to an intervention, so going forward we had to demonstrate that the bang would be worth the buck. These are financially lean times, with cutbacks and declining reimbursement, so every expenditure of time and money needs to be justified. In the bizarro accounting of health care, not every hospital administration will include money saved in the evaluation of interventions, only the money spent. I work in a hospital system with a remarkably strong commitment to patient safety and quality, so there was little worry on that point.
Still, our overall surgical infection rates are less than 1%, so we are doing better at baseline than NEJM study were at the end of the intervention. When I see surgical infection rates going from 7.7 % to 3.4 %, I have to wonder if the benefit of the intervention is a surrogate for an issue with deeper problems with infection prevention at the hospital. Maybe there was a a decrease in infections with decolonization because they were sloppy with the compliance with other, more basic, infection prevention strategies. My system has been very aggressive applying SCIP interventions, a series of actions that, when consisting applied, result in a large drop in surgical infections. Perhaps they are sloppy with their SCIP. I have no way of knowing.
Also, I can’t help but think there is a lower limit to the infection rates under which it will be impossible to go. As long as we operate on people we will always have some infections no matter what we do for prevention. One of our surgeons had his only infection for the year in an emergency case on a 450 lb woman with a glucose of 600 and a 2 pack a day habit. Even after a week in the hospital she still had dirt tattooed on her palms and feet. I think zero infections should be our goal; I am not so sure that is realistic given the co-morbidities of some patients. Could we go lower?
I also wondered if we had infections that would be amenable to surgical screening and decolonization. Many of the orthopedic S. aureus infections are presenting late, 4 to 8 weeks post op. Given the virulence of S. aureus, where people usually become symptomatic the day they acquire the bacteria, I suspect the infections we had been seeing in the orthopedic population are being acquired after discharge. If so, we may make no impact on our infections by beating down the S. aureus in the peri-operative period.
Still, we had the occasional S. aureus infection, MRSA and MSSA, Staph colonization is a risk for subsequent infections, and the orthopedic group wanted to do something so it seemed reasonable. I can count on one hand the number of times a surgeon has been the one to ask for help in reducing infection; usually we take suggestions to them. It was an opportunity I didn’t want to miss. We had evidence, science even, to drive change.
At first it was suggested that we not bother to screen, but treat everyone. Everyone has MRSA, right? Wrong. In Washington (in Oregon, we call it Washington, not Washington State) they mandate screening for all ICU admits, and we know that about 20% of patients have S. aureus in their nose, and about 2% have MRSA. With mupirocin resistance already at 14% in some parts of the US and chlorhexidine resistance being described, the last thing I wanted to do was increase the use of these drugs. Resistance, said the Borg, is inevitable, or some such.
Cost-efficacy analysis, which make my head hurt, suggests we should treat everyone but the authors minimize the threat of future antibiotic resistance. In a world that is running out of antibiotics, I cannot be quite so cavalier on the issue. Use it and lose it. We are already sliding into the post antibiotic era, and I don’t want to drive resistance any harder than necessary.
The next step was deciding was how patients would be screened. A nasal swab misses 30% of MRSA carriers, and to maximize the yield would probably require a swab of the nose, throat, skin folds, arm pits and stool. 5 separate swabs would make it cost prohibitive ($120 each) but if you use one swab, in what order do you swab? Always end at the anus, that’s my rule. And the PCR, polymerase chain reaction, is not approved for every body specimen. So in the end we decided that the published data only screened with nasal swabs, so we would as well. We may miss a few MRSA carriers but they would be rare; the perfect is the enemy of the good and reality requires compromise.
The next roadblock was coordination of care. The nasal swab had to be collected within 30 days of the planned surgery. Someone had to note if the swab was positive for MRSA or MSSA, call the patient and the pharmacy for a prescription of chlorhexidine and mupirocin and start the antibiotics a few days before surgery. When 22 in 100 have a positive PCR , initially the test was missed since there was no one person responsible for acting on the result. Most of the people who need a new joint are old and, by definition, not mobile and getting to the pharmacy was limited by both patient mobility and transportation. Getting the prescription to the patient was difficult to do consistently, and transitioning the outpatient prescription to the inpatient setting was equally unreliable. Patients were not bringing in their medications (we did not want duplicate prescriptions) and physicians were not reordering the mupirocin/chlorhexidine, thinking the patients had brought their own.
To compound the problem, many patients had to pay out of pocket for the medications, and there are two formulations of the mupirocin, the much more expensive formulation made for use in the nose. Of course. It is weird how, when nasal mupirocin use started to be common a new, and much more expensive, formulation became available. We elected to go with the less expensive formulation as there is no evidence for increased efficacy of the expensive formulation.
Peri-operatively we had decided to give add, rather than substitute, vancomycin to the usual cefazolin if the patient had MRSA. That was only 2% of the patients, rare enough to be missed. Vancomycin has many characteristics that make it a lousy drug, and I did not want to lose the efficacy of the cefazolin for MSSA. However, initially there was no single person responsible for noting that the patient was MRSA postive and changing the perioperative antibiotics. All too often Vancomycin was either not given, or given too late to have effect. Vancomycin, requiring an hour infusion instead of the IV push of cefazolin, needs more lead time to give and can throw a monkey wrench into the work flow of the OR if a case has to be delayed an hour or more to give an antibiotic.
It took well over six months of trial and error to work out the kinks in the protocol with one orthopedic group to apply the evidence and and get the process to run smoothly. Murphy’s law states that if something can go wrong, it will. I agree with the suggestion that Murphy was an optimist.
Despite all that work, for some patients the process is grinding to a halt from an unexpected source. The swab for Staph costs about 120 dollars, and Medicare, which many joint patients are on, does not pay for screening. For the first several months we (not me) received irate calls from patients about the charge, and now Medicare patients have to sign a waiver when they get tested understanding that the swab will not be covered by insurance and they will be responsible for the cost of the test.
Part of the issue with instituting the protocol is that there is no health care system: one group pays, one group runs the hospital and OR and a third group does the surgery. It would, perhaps, been much smoother to implement if we were in a unified health care system. I dream of universal health care where the system will be totally screwed up in one consistent way, rather than the hundreds of ways it is totally screwed up now. I really want to sit on one of them there death panels.
Has it worked? Too early to say, and I hate to jinx myself, but in the nine months since the protocol was introduced, despite all the glitches, we have had no Staphylococcal infections in that orthopedic group. I am cautiously optimistic the effort has paid off. We hope to spread the protocol to other orthopedic groups and high risk surgeries now that we have worked out the kinks. Of course I expect a whole new collection of complications.
I read papers all the time about this or that intervention improving patient outcomes. Reading the papers it seems ever so simple to apply the results to the real world, but it takes an amazing amount of work by a large number of people to coordinate the care that even a simple intervention can entail. In the end we (mostly everyone else except me) accomplished what we set up to do, only to be stopped short for a large number of patients by Medicare.
This is one of many quality initiatives at my institutions that have resulted in decreased morbidity and mortality. Last time I wrote on the issue I looked to see if there had been similar initiatives in any of the SCAMs. What are chiropractors, acupuncturists, naturopaths and their fellow travelers doing to improve patient care? At the time I had found none. I would have thought chiropractors would be interested since one of the Never Events is “Patient death or serious disability due to spinal manipulative therapy.” In their world a never event never happens, not an event that can haappen but never should. A quick search of the Googles and Pubmeds finds…
Still nothing. Must be nice to be perfect. It results in a lot less work.

IMMUNITY

780.6. What is a fever?
Mark Crislip on December 28, 2012
Link
You can tell what a doctor does for a living by the ICD-9 codes they have memorized. There is an ICD-9 code for nearly every medical condition. Weightlessness is 994.9. Must be there for NASA, I have yet to see a weightless patient. Decapitation by guillotine is E978. There, I suppose, in case Marat returns from the dead. There is an ICD-9 code for the initial visit after being sucked into jet engine (V9733XA) and one for subsequent visits (V9733XD). Why do I suspect V9733XD has yet to be used?
780.6 is my personal favorite. Fever. All my patients have fever and 780.6 was certainly the first ICD-9 code I committed to memory. I have an endless interest in fever and after last Fridays post I thought I would toss in my two cents worth. I will remind my readers that I am an adult ID doctor (who I treat, not necessarily how I behave) and unless specifically mentioned, all that follows applies to those who can legally drink, vote and serve in the military.
98.6 F. It is not normal body temperature. Well it is. But it is not. 98.6 F as average body temperature is an enduring medical myth.
In 1868 Carl Reinhold August Wunderlich published Das Verhalten der Eigenwärme in Krankenheiten (The Course of Temperature in Diseases), then the definitive text on temperature. He was one of the first to recognize fever as a symptom of disease rather than a disease. As only the obsessed of Victorian times seemed to do (see The Professor and the Madman, an account of how the Oxford English Dictionary came into being, as another example) without a spreadsheet or a TI hand calculator he averaged a million observations from 25,000 subjects and came up with 37°C (98.6°F) as the average normal temperature. The book makes me wish I knew German. Well, almost. There is an English translation for the interested.
Because of his book 98.6 became medical dogma, enshrined forever by a red line on a mercury thermometer. My children certainly knew the importance of that red line. If the mercury went past it they did not have to go to school. Ah, mercury thermometers. Endless fun breaking them open as a kid and playing with the mercury. Didn’t do me any harm. Kids today, with their electronic thermometers, will never know the fun for trying to vacuum up mercury spilled into a shag carpet.
While Wunderlich did suggest that 38°C (100.4°F) is the upper limit of normal, his equipment, while the best at the time, fell a wee bit short by modern standards: they were a foot long, took at least 20 minutes to equilibrate and were mis-calibrated by as much as 1.4 to 2.2°C (2.6 to 4.0°F) higher than today’s instruments.
Unfortunately his 400 page epic, while a verbose and interesting read, is based on slightly inaccurate tools. What does modern thermometry have to add?
A 1992 an analysis of 700 baseline oral temperature observations from 148 healthy men and women found
    • There was a range of 35.6°C (96.0°F) to 38.2°C (100.8°F),
    • an overall mean of 36.8 ± 0.4°C (98.2 ± 0.7°F),
    • a median of 36.8°C (98.2°F),
    • a mode of 36.7°C (98.0°F);
The maximal temperature (as reflected by the 99th percentile) varied from a low of 37.2°C (98.9°F) at 6 AM to high of 37.7°C (99.9°F) at 4 PM. So people are 98.6 twice a day: once on the way up and once on the way down.Age did not significantly influence temperature within the age range studied (18 to 40 years) (linear regression, p = 0.99).
Women had a slightly higher average oral temperature than men (36.9°C [98.4°F] versus 36.7°C [98.1°F].Black subjects exhibited a slightly higher mean temperature and slightly lower average diurnal temperature oscillations than white subjects (36.8°C [98.2°F] versus 36.7°C [98.1°F] and 0.51°C [0.93°F] versus 0.61°C [1.09°F], respectively); these differences approached, but did not quite reach, statistical significance (t test, p = 0.06, df = 698).
Oral temperature recordings of smokers did not differ significantly from those of nonsmokers. The two big exceptions being ovulating females (but not ovulating males) will be relatively warmer in the early morning and those who work the night shift, who will have the normal variation shifted by 12 hours.
As best I can tell when I quiz them, most medical students are taught that 98.6 is normal temperature, an observation supported by the literature:
Seventy-five percent of the 268 physicians and physicians-in-training surveyed offered 37 degrees C (98.6 degrees F) as their definition of “normal body temperature.” Only 10 (4%) specified a particular body site (eg, oral or rectal) of temperature measurements in their definition. Although 98% believed that body temperature normally varies during the day, there was not a consensus as to the magnitude of such variability. There was also considerable disagreement as to the specific temperatures defining the lower and upper limits of the febrile range. Subjects exhibited a clear preference for the Fahrenheit scale in their responses
So much for knowing about a so called vital sign. But it could just as likely be that they were given the correct information and it didn’t overwrite a lifetime of misinformation.
Not knowing what normal temperature is does have occasional consequences. Every couple of years I see a patient who takes their temperature in the late afternoon, and what do you know, they have a fever. Their temperature is 99.9. They check the temperature every day and every afternoon it is around 100, so they see their doctor who also thinks it is a fever and they start a FUO (fever of unknown origin) evaluation. Work-up, of course, is negative, so after several thousand dollars, the patient is sent to me and I explain normal physiology to them.
From a practical point of view, I start to worry about people when they have a temperature above 101, especially hospitalized patients if they have more than one elevated temperature. The height of the fever and pattern of the fever is usually of little interest (there are a few exceptions unless you are a homeopath), and there is, to my mind, no such thing as low grade fever. Like pregnancy, where either you are or you are not, either you have an abnormal temperature or you do not. And the occasional person who insists “My normal temperature is 97, so 98.6 is a fever for me”? Nothing in the literature to support the assertion and I wait for the first well patient to consistently have a normal temperature that is lower than the usual variation.
It is quite remarkable how tightly normal temperature is regulated, and 98.2 is the optimal balance between caloric requirements and keeping most germs at bay. Being above ambient temperature is an important defense as most organisms cannot grow well at 98.2, much less 102.
…we present a minimal, parsimonious model to account for the cost of maintaining a high body temperature in mammalian organisms. A body temperature of 36.7°C maximizes fitness by restricting the growth of most fungal species relative to its metabolic cost.
Being warm blooded is important to keep us from becoming compost:
The paucity of fungal diseases in mammals relative to insects, amphibians, and plants is puzzling. We analyzed the thermal tolerance of 4802 fungal strains from 144 genera and found that most cannot grow at mammalian temperatures. Fungi from insects and mammals had greater thermal tolerances than did isolates from soils and plants. Every 1 degrees C increase in the 30 degrees C-40 degrees C range excluded an additional 6% of fungal isolates, implying that fever could significantly increase the thermal exclusion zone.
And may even be part of why we dominate instead of dinosaurs:
Given that most fungal species grow best at ambient temperatures, the high body temperature of endothermic animals must provide a thermal barrier for protection against infection with a large number of fungi. Fungal disease is relatively common in birds but most are caused by only a few thermotolerant species. The relative resistance of endothermic vertebrates to fungal diseases is likely a result of higher body temperatures combined with immune defenses. Protection against fungal diseases could have been a powerful selective mechanism for endothermy in certain vertebrates. Deforestation and proliferation of fungal spores at cretaceous-tertiary boundary suggests that fungal diseases could have contributed to the demise of dinosaurs and the flourishing of mammalian species.
And may be something we should watch so we do not go the way of the dinosaurs:
The relatively high resistance of mammals has been attributed to a combination of a complex immune system and endothermy. Mammals maintain high body temperatures relative to environmental temperatures, creating a thermally restrictive ambient for the majority of fungi. According to this view, protection given by endothermy requires a temperature gradient between those of mammals and the environment. We hypothesize that global warming will increase the prevalence of fungal diseases in mammals by two mechanisms: (i) increasing the geographic range of currently pathogenic species and (ii) selecting for adaptive thermotolerance for species with significant pathogenic potential but currently not pathogenic by virtue of being restricted by mammalian temperatures.
So we probably evolved endothermy in part to keep the microscopic world at bay. We can make it even harder on the organism trying to kill us by increasing our core temperature. Every animal that can raise its temperature will raise its temperature in response to infection, in the case of lizards by moving to environments with increased temperature. Although that is only clinically applicable to Fox News analysts.*
And it is estimated that the febrile response is ancient:
A febrile response has been documented in the Vertebrata, Arthropoda, and Annelida. These observations suggest that the febrile response evolved more than 400,000,000 years ago at about the time evolutionary lines leading to arthropods and annelids diverged.
Although how they estimated that number I am uncertain. I doubt they went back in time and took a rectal temperature in T. tex, since with those forelegs it could not have taken their own oral temperature. Maybe one of Wunderlich’s thermometers would have worked.
There are numerous beneficial physiologic effects that occur as part of the febrile response. Virtually all aspects of the physiologic response to infection are, dare I say it, boosted, and many wings of the immune system function better at higher temperatures.
I feel the naturalistic fallacy creeping over me: fever is an almost universal response to infection that evolved millions of years ago and helps enhance the response to infection. So suppressing a fever during infection should be bad. Right?
This becomes a little less clear cut. There are issues as to how the fever is suppressed: mechanical, such as ice or alcohol baths. Pharmacologic: acetaminophen, steroids, aspirin or nonsteroidal anti-inflammatories, all of which have effects that go beyond suppressing fevers.
What infection is occurring? A response that has evolved as a response to the infections found on the plains of East Africa could be counter productive against diseases of modernity like Pseudomonas sepsis in the ICU or MRSA endocarditis in a heroin user.
All that glitters is not gold, all who wander are not lost, and not all who are febrile are infected. Many pathologic processes will increase temperature, so perhaps it is non-infectious fevers that require antipyretics.
And who is having the fever? An otherwise healthy child? A adult with poor physiologic reserve from congestive heart failure or severe emphysema? Or someone with a new stroke or heart attack?
Which of those factors is involved makes the literature on treating a fever less clear cut, and there is the question as to whether treating fever is of benefit, causes harm, or does nothing. Or are the outcomes even clinically relevant? When you read the literature, depending on the population studied, you can find all manner of interesting consequence of treating fevers.
ICU Fevers
A review suggests
Observational studies on ICU populations have reported associations between fever magnitude and patient mortality. Especially recent findings indicated that infected patients may significantly benefit from temperature elevation, while high fever may be maladaptive for non-infected ones. Aggressive antipyretic treatment of ICU patients has not been followed by decreased mortality in randomized trials. However, fever suppression and return to normothermia improved outcomes of septic shock patients. ”
Aggressive fever treatment with acetomenaphen lowers temperature by a whopping 0.2 degrees C compared with routine fever management. No harm to the patient as a result but another suggests aggressive acetaminophen led to increased mortality in a surgical ICU
And the increase in mortality is a more consistent finding:
For aggressive versus permissive antipyretic treatments, a reduction in mean daily temperatures favoured the aggressive group (MD, -1.09, 95% CI -1.37, -0.81, P<0.001) with a trend towards higher mortality for aggressive treatment (RR, 6.05, 95% CI 0.78, 46.95, P=0.09).”
But it may depend of whether the fever is associated with sepsis or not:
In non-septic patients, high fever (≥39.5°C) independently associated with mortality, without association of administration of NSAIDs or acetaminophen with mortality. In contrast, in septic patients, administration of NSAIDs or acetaminophen independently associated with 28-day mortality, without association of fever with mortality.
As in another study post op fevers worsened outcome in the icu, but
there was a trend toward a protective effect from an infectious etiology of fever.
And whether the fever was prolonged or not:
The mortality in the group with prolonged fever was 62.5% (10/16) compared to 29.6% (16/54) in patients with fever of less than 5 days’ duration, a highly significant difference (p < 0.0001).
Treat a fever in the ICU? Depends. Probably if non-infectious but the effect is not clear cut given the heterogeneity of the patients studied.
Influenza and fevers
In animal models, treatment with antipyretics for influenza infection increases the risk of mortality. There are no randomized placebo-controlled trials of antipyretic use in influenza infection in humans that reported data on mortality and a paucity of clinical data by which to assess their efficacy.
Although there some data to suggest antipyretics prolongs influenza A.
It has been suggested that aspirin was partly responsible for the increased deaths in the 1918 pandemic, although not due to the antipyretic effect:
In 1918, the US Surgeon General, the US Navy, and the Journal of the American Medical Association recommended use of aspirin just before the October death spike. If these recommendations were followed, and if pulmonary edema occurred in 3% of persons, a significant proportion of the deaths may be attributable to aspirin.
The multifactorial effects are one of the problems with pharmacologic interventions. NSAIDs, for example, may make pneumonias worse:
Of the 90 patients included, 32 (36%) had taken NSAIDs prior to hospital referral. Compared with nonexposed patients, they were younger and had fewer comorbidities but similar severity of disease at presentation, despite a longer duration of symptoms before referral. However, they more often developed pleuropulmonary complications, such as pleural empyema and lung cavitation (37.5% vs 7%; P = .0009), and had a trend to more-invasive disease, with a higher frequency of pleural empyema (25% vs 5%, P = .014) and bacteremia, especially in those not having received concomitant antibiotics (69% vs 27%, P = .009).
And aspirin increases mortality in S. pneumoniae infections:
A twofold increased risk of mortality was found with aspirin treatment in animal models of S pneumoniae infection. No relevant human studies were identified
But whether it is due to the effects on fever or other parts of the inflammatory response is unknown.
Antipyretics may make the common cold worse
Sixty healthy volunteers were challenged intranasally with rhinovirus type 2 and randomized to one of four treatment arms: aspirin, acetaminophen, ibuprofen, or placebo. Fifty-six volunteers were successfully infected and shed virus on at least 4 days after challenge. Virus shedding, antibody levels, clinical symptoms and signs, and blood leukocyte levels were carefully monitored. Use of aspirin and acetaminophen was associated with suppression of serum neutralizing antibody response (P less than .05 vs. placebo) and increased nasal symptoms and signs (P less than .05 vs. placebo). A concomitant rise in circulating monocytes suggested that the suppression of antibody response may be mediated through drug effects on monocytes and/or mononuclear phagocytes. There were no significant differences in viral shedding among the four groups, but a trend toward longer duration of virus shedding was observed in the aspirin and acetaminophen groups.
And aspirin prolongs shedding of rhinovirus, although by what mechanism is uncertain.
Fevers and children
Certainly the use of antipyretics can help resolve fever and make the child more comfortable, but is it of benefit in making the child better faster? Probably not. As an example, acetaminophen does not make chickenpox symptoms better and may prolong the disease.
I would advise against this naturopathic treatment of fever unless you want to make sure you sleep alone:
Onions sliced and placed in wool or cotton socks and applied to the feet. It also recommended sliced onions in a bowl by the bed. It is believed that the onions have the capacity to draw out the fever.
This is by no means a comprehensive review of the risk and benefits of treating fever. Outside of comfort to the patient I cannot find a consistant benefit of treating infectious fevers. The preponderance of information suggests treating infectious fevers is almost always detrimental. Whether to treat fever; with chilliness; from putting the hands out of bed or fever; after sexual intercourse, there are no reliable clinical trials for guidance.
While there may be non-infectious reasons to treat a fever, stroke and CNS injury as examples, all the information suggests that treating a fever is probably counterproductive with the caveat in the ICU that the hemodynamic effects of fever may be worse than the potential complications of antipyretics. As in all acute illness, a careful consideration of the risks and benefits of treating a given patients is required, not the automatic attempt to keep everyone euthermic.
That being said, when my boys had fevers as a child and it was my turn to stay home with them, I did not treat the fevers. I think the bulk of data suggests treating fevers is a bad idea and the fevers has the added benefit that the kids were quiet and I could get some work done. Treat the fever and they become too active. Then my wife would take her shift and the kids would get Tylenol.
Peu d’hommes ont esté admirés par leurs domestiques 
Not that my wife is my domestique, but you get my meaning.
——-
*You can fill in the noun of what ever group you most think behaves like a reptile, says the juvenile emotionally immature hateful left wing extremist, or so I have been referred to on iTunes.

Boost Your Immune System?
The immune system is not a muscle, not a rocket, not a pump, not a balloon, nor anything else that can be inflated, expanded, or launched into the stratosphere simply by adding more power.
Mark Crislip on September 25, 2009
Link

This post is a wee bit of a cheat in that it is a rewrite of a Quackcast, but I have three lectures and board certification in the near future, so sometimes you have to cook the wolf.
What does that mean: boost the immune system? Most people apparently think that the immune system is like a muscle, and by working it, giving it supplements and vitamins, the immune system will become stronger. Bigger. More impressive, bulging like Mr. Universe’s bicep. That’s the body part I am thinking about. What they are boosting is vague, on par with chi/qi or innate intelligence. They never really say what is being boosted.
The other popular phrase is “support”. A product supports prostate health, or breast health or supports the immune system. It sounds like the immune system is sagging against gravity due to age and needs a lift.
The immune system, if you are otherwise healthy, cannot be boosted, and doing those things you learned in kindergarten health (reasonable diet, exercise and sleep), will provide the immune system all the boosting or support it needs.
Someone is going to write in and say Americans have a lousy diet and don’t exercise and can benefit from better food and exercise. And that’s true. If you are not taking care of yourself, your immune function can be improved to function better. But if you are at your optimal baseline, you cannot make your immune function better.
The immune system: A really, really, really, really brief primer
What is the immune system? The immune system is a mind boggling complex set of coordinated cells and proteins.
There are antibodies: IgG, IgA, IgM, IgE and IgM, further divided into 5 subtypes of IgG and 2 of IgA, each with a different affinity for different parts of pathogens.
There is complement, a series of proteins that can be activated by two separate pathways and are important in killing some kinds of bacteria and attracting white cells to infection.
There are blood components: Polymorphonuclear leukocytes, also known as white cells. And monocytes. And eosinophils and macrophages. And the lymphocytes oh my, of which there are multiple types and with different functions. Each cell line can have either a specific task or a general task in the attempt to prevent you from dying from infection. If you are infected by a virus, there is one response, a bacterium produces a different response, a parasite, yet another response, and within each response there are subsets of types of response depending on the pathogen and whether or not you have been exposed to the infectious agent in the past.
There are all the proteins and their receptors that regulate the response to infection: chemokines and interferons and interleukins, a hodgepodge of letters and numbers: IL6 and TNF and CCR5 and on and on and on.
There is the Toll system, a wing of the immune system so ancient it is found in plants.
And there all the nonspecific parts of immunity that help prevent infection: platelets and cilia that sweep potential pathogens out and iron metabolism that keeps iron away from bacteria and the list goes on and on and on. The above is the briefest of overviews of the constituents of the immune system. It is almost like saying you have described the works of Shakespeare by noting it contains the words ‘the’, ‘and’, ‘of’, ‘verily’, and ‘forsooth.’ But the purpose of this post is not to describe the immune system in detail as I would soon embarrass myself.
A call for specifics: What are you actually boosting?
So when something allegedly boosts the immune system, I have to ask what part. How? What is it strengthening/boosting/supporting? Antibodies? Complement? White cells? Are the results from test tubes (often meaningless), animal studies, or human studies? And if in human studies, what was the study population? Are the results even meaningful? Or small, barely statistically significant, outcomes in poorly-done studies?
The answer, as we shall see, is usually nothing. It is the usual making a Mt. Everest out of a molehill, and a small molehill at that. If you google the phrase “boost the immune system” you will find over 288,000 pages that give advice on how to give that old immune system a lift. Curiously, a Pubmed search with the same phase yields 1,100 references, most concerning vaccination. If you Pubmed ‘enhanced immune system’ you get 41,000 references mostly concerning immunology. None of the references concern taking a normal person and making the immune system work better than its baseline to prevent or treat infection. I have yet to see a quality clinical study that demonstrates that, in normal, not nutritionally- or otherwise-compromised people, that some intervention can lead to a meaningful increase in immune function and as a result have fewer infections. Maybe such a study exists. I can’t find it. Send me the reference. I suppose the comment section will soon flood me with examples.
If you are normal and in good health, there is nothing you can do to make your baseline better.
Random advice fail
Randomly reading some of the advice on boosting the immune system yields Dr. Phil-level inanities that are trivial yet true. Get a good night’s sleep. Duh. Exercise regularly. Double duh. Avoid being a fat ass couch potato American whose idea of exercise is driving to Burger King for a triple Whopper with extra-large fries. What a concept. Don’t smoke or drink. These sites often intermix common, well-known beneficial lifestyle changes with all sorts of nonsense.
By the way, I need a lifestyle. Best as I can tell, I just have a life. I live it, and someday I won’t. But I need style. That is the problem of being from Portland: no style. It’s the old joke: what’s the difference between yogurt and Portland, Oregon? Yogurt has culture. Sigh.
There are numerous quack nostrums that allegedly boost your immune system. Exactly what is boosted and how is a mystery. Perhaps you are filled with toxins, then any number of detoxification regimens can improve your immune function. How precisely? Another mystery.
All the classic quack interventions: chiropractic, homeopathy, acupuncture, can also boost your immune system by, you know, changing some energy vibration or unblocking something or other. In fact one of the amazing things is that as best I can tell, there is no quack practice that someone, somewhere, will not say boosts your immune system.
People who receive regular chiropractic adjustments have immune system competency that is 200% greater than those who don’t.
Homeopathic remedies stimulate the immune system to assist the body in repairing any imbalances that may have occurred.
The following acupressure points are effective for dealing with a condition that may be caused by a weak immune system. Elegant Mansion (K 27) reinforces immune system functioning by strengthening the respiratory system. Steady, firm pressure on the Sea Of Vitality points (B 23 and B 47) fortifies the immune system, rejuvenates the internal organs, and relieves pain associated with lower back problems. The Sea of Energy (CV 6) tones the abdominal muscles and intestines, and helps fortify the immune, urinary, and reproductive systems. Firm pressure on the Three Mile Point (St 36) immediately boosts the immune system with renewed energy. It helps tone and strengthen the major muscle groups, providing greater endurance. Bigger Stream (K 3) on the inside of the ankle helps balance the kidney meridian and strengthen the immune system. Bigger Rushing (Lv 3) and Crooked Pond (LI 11),ire important points for relieving pain and strengthening the immune system. The Outer Gate point (TW 5) helps to balance the immune system and strengthen the whole body. Hoku (LI 4) is a famous decongestant and anti-inflammatory point; it relieves arthritic pain and strengthens the immune system Last, and most important of all, the Sea of Tranquility (CV 17) governs the body’s resistance to illness and decreases anxiety by regulating the thymus gland. Each of these important points benefits the immune system by enabling the internal organs to function at optimal levels.
I suspect that if one were to do all these interventions as once, your immune system would be raised to such a high level of activation that you would probably spontaneously combust. You heard it here first: the reason for spontaneous combustion is multiple, simultaneous boostings of the immune system.
This kind of nonsense is successful in part because that we all are aware that chance of illness increases with the number of stressors in your life, and the worse your life or lifestyle, the worse you are likely to feel and the more likely you are to have an illness. This phenomenon is real for groups of people. The more stressors, the higher the likelihood something will bad will happen with your life. This effect is harder to quantify for an individual. If you don’t sleep well, eat poorly, don’t exercise, get a divorce and a parent dies, in the next year you are more likely to have a medical problem. I remember toting up my stress score in medical school and based on my number I should have been dead three months earlier.
I would bet that when people turn to these quack nostrums, they do feel better, but not because of the nostrums, but because, for however short a period of time, they are no longer participating in the less than optimal habits that define standard American diet and activity. What they are probably doing is getting back towards a baseline of optimal health, not improving their health past what it is capable of.
I would bet 6 million years of evolution have more or less tuned our immune system to be running optimally, as long as we do the basics of eating well, exercising etc. All the stuff we failed to learn in kindergarten. You can be deficient in vitamins or sleep, etc., which will make you prone to illness, but if you are at baseline, you can’t improve your immune system in any meaningful way.
The sources of boostering
When reading the literature on the immune boosting properties of various products you find there are several kinds of results that they use to justify their claims, all with a thick coating of exaggeration and hyperbole.
The first is just made up. Somebody somewhere decided that this product enhanced immune function. Often the claim is based on ancient wisdom. You know, ancient wisdom, the same ancient wisdom that gave us the flat Earth and slavery and women as inferior, that ancient wisdom. Always a reliable indicator. Most of the time there is no data to support the claims of immune boosting.
Then there are test tube tests for boosting immune system,
The immune system is always looking to distinguish between self and not self. All the cells of your body are labeled with proteins, the major histocompatabilty complex for those of you keeping score, that are, in part, signals to the immune system. This protein on my cell surface identifies me as me to me. And no I am not preparing to sing opera. It tells the immune system, don’t shoot, I’m one of you. Other people’s tissue don’t have the same labels. Bacteria and other pathogens not only lack these signals, they have constituents in their cells that the body has evolved very specific responses against.
For example, E. coli has a toxin, called lipopolysaccaride in its cell walls that the body very specifically recognizes with a wing of the immune system, called the Toll-like receptor. If you incubate immune cells in a test tube with chemicals or non-self life (bacteria, virus, etc.) the cells react. That is what they are supposed to do. In medicine we call it the inflammatory response.
Oh look: Virus. Fungus. New chemical. Is it part of us? Nope. Respond. Kill kill kill. Here is a point I have made in the past. If you take a cell from the immune system and expose it to some chemicals or bacteria, you activate it, you get an inflammatory response. It’s primed. And if you then challenge that activated cell with another pathogen, it will kill that pathogen better than if the cell was not primed. It only works with some pathogens, usually those that are killed by nonspecific cell-medicated immunity.
Listeria and Candida are always popular pathogens that the immune system responds with a nonspecific (i.e. cellular) rather than a specific (i.e. humoral or antibody) response, probably because they are unusual enough pathogens that it made no sense evolutionarily to develop a specific response like we see to more common pathogens.
Some organisms, often unusual ones, are killed with a nonspecific response of the immune system, whereas others, such as viruses, which are killed by very specific antibody, or meningococcus, which really needs complement for optimal killing. This response is used to suggest that the immune system is being boosted and they imply that this boosting is to your benefit. Other test tube studies may show that mediators of inflammation, such as TNF or Il-1 are increased, which is what one would expect if you expose the immune system to a pathogen or a probiotic organism.
The mmmmmeat of the post
Those who say that that their product, for example probiotics, boost the immune system, point to studies such as these that show that in response to bacteria, cells of the immune system are activated, they are exhibiting the expected inflammatory response to a foreign invader. They call it boosting. I call it the inflammatory response. What could be better than priming your immune system so that it is better able to respond to a pathogen? This preamble leads us to the meat of this post: Is it good to have the immune system activated? Is it good to have your immune system primed? Or boosted? Maybe not. It does explain why taking a probiotic helps increase the antibody response to influenza vaccine in the elderly and decreases the duration of respiratory infections. A short term inflammatory response may be of benefit, but it may not be an effect you want to have persist.
But here is some recent, interesting literature, about the effects of having an inflammatory response to acute and chronic infections. Chronic inflammation of all types is associated with atherosclerosis i.e. hardening of the arteries, nicely reviewed in Libby et al.’s Circulation article, “Inflammation and Atherosclerosis” from 2002. An inflammatory state can occur from many things, not just infections.
First up: the NEJM, “Treatment of periodontitis and endothelial function” from 2007.
Periodontitis is gum infection and endothelial cells are them what line the arteries of the body. So they took a 120 people in England with bad periodontal disease (insert your own English dentition joke here, I don’t stoop to those kind of cheap shots) to either aggressive treatment of their disease or standard treatment. Aggressive treatment consisted of scenes from the movie Marathon Man:
Patients in the intensive-treatment group underwent the adjunctive full-mouth intensive removal of subgingival dental plaque biofilms with the use of scaling and root planing after the administration of local anesthesia; teeth that could not be saved were extracted, and microspheres of minocycline were delivered locally into the periodontal pocket.
What they looked at in this study, however, were markers of inflammation and endothelial function. Initially, when they were really reefing and scraping the teeth, which is going to cause bacteremia and bleeding, the aggressively treated group had a big spike in signs of inflammation, but long term, as their gums healed, they had a decrease markers of inflammation and better measured arterial flow. Those in the standard group did not get the same long term response; they continued to have signs of inflammation and endothelial cell activation. And this means?
Chronic exposure to bacteria leads to an inflammatory state and has detrimental effects on arteries. Taking lots of probiotics, or other substances that cause an inflammatory response, or boosting the immune system in the parlance of the quacks, should act like chronic periodontitis with chronic sustained signs of inflammation.
Who cares?
Maybe you, if you are taking immune boosters that could really activate the immune system; that should lead to chronic inflammation, which is associated with hardening of the arteries.
Thrombosis, the boostering bonus prize
But wait. There’s more. The inflammatory state is a prothombotic state. Infected people make blood clots, and they can make these clots for a long time. Clots can manifest in several common ways: heart attacks, strokes, and pulmonary emboli (i.e. blood clot to the lung). There are now several studies out there demonstrate an epidemiological link between a recent infection and a thrombotic event. For example, from “Risk of deep vein thrombosis and pulmonary embolism after acute infection in a community setting,” Lancet, 2006:
7278 deep vein thrombosis patients and 3755 pulmonary embolism patients who were registered in a UK general practice database from 1987 to 2004. In the 2 weeks after a urinary tract infection, the risks of deep vein thrombosis and pulmonary embolism increased by 2.1-fold each, the report indicates. It took longer than 1 year for these elevated risks to return to baseline values.
Urinary tract infections increase your risk of blood clots and pulmonary embolism for up to a year.
How about heart attacks? Well, in Clinical Infectious Diseases 2007; 45:158-65 they looked at acute myocardial infarction and acute pneumococcal pneumonia and found an association, which had been noted since early last century. Acute pneumonia leads to heart attack.
Stroke? In European Heart Journal they looked at a database of strokes and heart attacks and found that:
There was strong evidence of an increased risk of both events in the seven days following infection — for MI, the adjusted odds ratio (OR) was 2.10, and for stroke, the OR was 1.92. The risk was highest in the three days following infection (OR 3.75 for MI and 4.07 for stroke). The risk of events was reduced over time, so there was little excess risk beyond one month after infection.
And a simple community-acquired pneumonia decreases 5 year life expectancy in a VA population from 84 months to 34 months:
Although the cause of the decreased long-term survival is not yet clear, it may be that the systemic inflammatory response produced by CAP accelerates the natural course of medical comorbidities such as atherosclerosis, Dr. Peyrani suggested. This hypothesis, she said, is bolstered by a recent study that showed reduced long-term survival in CAP+ patients who were clinically cured but had increased interleukin 6 and interleukin 10 levels at the time of hospital discharge.
So chronic inflammation and acute inflammation both increase your risk of thrombosis and vascular events. What would probiotics and immune boosters do if they really worked? They would cause acute and chronic inflammation. For those who may think I am talking about vaccines, not here. Vaccines cause the development of a specific antibody against whatever you are immunizing against, but it does not cause a generalized inflammatory response.
Correlation is not causation…but
Now I am well aware that association is not causality, and I am also well aware of the issues with epidemiological data to prove causality. But I submit for your consideration that if some product is really boosting your immune system, it is really activating your inflammatory response, and perhaps it may not be such a good idea.
Whenever I listen to skeptics talk about ID, they always complain how ID cannot make any predictions. Now I have been practicing ID for 23 years, and it is a science and I can make predictions. To suggest that ID is somehow inferior is. Huh? What? ID is intelligent design? Not infectious diseases? Oh. That’s different. Never mind.
But I will make a prediction: people who use probiotics or other substances that can measurably lead to an inflammatory response, or, have their immune system boosted, will have more strokes, heart attacks and pulmonary embolisms. So when you read that some product or other boosts the immune system, ask:
     1.  Says who?
     2.  What part of the immune system?
     3.  Are they calling an inflammatory response a boosting of the immune system?
If the answer to number three is a big yes, perhaps you should avoid the product. When it comes to your immune system, if you are normal, leaving good enough alone is probably the way to go.


More Boosting the Immune System
Can you boost your immune system? Sure, with a vaccine. That’s about it.
Mark Crislip on October 19, 2012
Link

Topics, as I noted a fortnight ago in my uniquely misspelled and ungrammatical way, never die.* Or even fade away. There are popular ideas that persist in the world that have little to do with reality. In the reality based world of medicine there are concepts that refuse to die. Atelectasis causing fever or the need to ‘double cover’ Pseudomonas. Neither are true, yet every year medical students tell me that is what they have been taught. It is said the only way new ideas take hold is for those that hold the old ideas to die off. So maybe 50 years from now those medical myths will be gone.
Popular culture also its myths. Take the immune system. Please. It is not a bicep that can be made stronger with a little exercise. It is a complex network of cells and proteins. There are antibodies (IgG with various subtypes, as well as IgM, IgA, IgE, etc.), the complement pathway, polymorphonuclear cells, monocytes, and lymphocytes in a profusion that rivals beetles. God, I think, has an inordinate fondness for lymphocytes. There is the Toll system, the cytokines and lymphokines, the non-specific defenses like cilia and mannose-binding lectin and on and on and on.
I have a journeyman’s understanding of the immune system, what is needed to understand why a given patient has an infection, although there is little I can do to reverse the immunologic defects: abnormal antibodies from Waldenström’s or low mannose binding lectin levels from liver disease are not amenable to clinical intervention. The most interesting discoveries concerning the immune system over the last few year has been the elucidation of the many polymorphisms in the immune system that can increase or decrease the risk of a variety of infections.
The fault, dear Brutus, is not in our stars, But in ourselves, that we are underlings.
Often what determines health or infection, life or death, is a single amino acid substitution, say, in a Toll-like receptor or the structure of our snot.
Of course these variations in the immune system are not absolute risks, they are relative risks. Health and illness are complex and a career medicine and infection control has continually emphasized that it is rarely one thing that leads to health or illness. It is the confluence of multiple factors, death by a thousand cuts.
The out-of-tune meat machine
There is no validity to the concept, the myth, of boosting your immune system. Metaphor time. Think of the body as a meat machine, like a car made out of steak. Mmmm. Steak. You can be properly tuned and maintained, the fluids and gas topped off, the air in the tires at the proper pressure. It will run optimally. You can’t over tune the car or fill tank past capacity. There is an optimum you can’t go beyond.
It is similar with the immune system. There are certainly habits that will have everything running suboptimally, and by altering those habits you will get the function close to its theoretical optimum. That is the things you learned in second grade: good diet, exercise, avoid tobacco, a good night’s sleep. All the things we know we should do but, the flesh being weak or the internet being interesting, we often avoid.
Also, in my world, we call the boosted immune system an inflammatory response: when, in response to assault from the microbial world, the body gets a bit of a turbocharge, kicking the Batmobile into high speed. For the short term, it is of benefit. The infection is removed or suppressed. But because the immune system is not a clean, beautiful system but the result of that ever sloppy process called evolution, kicking it into overdrive is not without its downsides. As I have mentioned ad nauseum in my infectious disease podcasts, inflammation is prothrombotic and the downside of many infections is an increased risk for stroke, heart attack and pulmonary embolism. If you really, truly, could boost your immune system, you would almost certainly increase your risk for thrombotic events.
So when someone says they can boost your immune system ask yourself, are they offering advice that takes what is probably a sub-optimally functioning human characteristic and nudging it towards some closer approximation of improved function or are they offering to make you better than an optimal baseline.
SCAM boosting
As I have spent the last five years in the world of Supplements, Complementary and Alternative Medicine (SCAM), I have also tried to come up some classification system, with little success.
There are two kinds of people in the world: those who divide the world into two kinds of people, and those who don’t. – Robert Benchley.
There are, broadly, two kinds of SCAMs. There are those that are based on total hooey: acupuncture, reiki, homeopathy, and Mitt’s health care plan.** And there are the SCAMs that take a wee bit of in vitro laboratory work or small clinical trials and conflate the results out of all proportion, usually translating into products sold by the proponent of the intervention. I am always amused by the accusation of being in the pocket of big pharma, when I do not get dime one for any antibiotic or vaccine I prescribe, but so often those that suggest various supplements for your illness somehow also sell them. Go figure.
If you are offering some SCAM advice it is important to mix and match with legitimate, effective therapies. It makes the SCAM look more reasonable, but if you mix cow pie with apple pie, it does not make the cow pie taste better; it makes the apple pie worse.
Natural News is good source for all the above: useless therapies, overblown therapies, and even, shock and horror, reasonable advice, all wrapped in a cocoon of really weird paranoia about government and big pharma. I am not conspiracy prone, preferring Hanlon’s razor: “Never attribute to malice that which is adequately explained by stupidity.”
Natural News wants to boost your immune system. Of course, part of the purpose of boosting your immune system, is to avoid vaccines:
…illogically claiming that your lack of a vaccine somehow causes other people who are already vaccinated to catch the flu. Yeah, I know, it makes no sense, but then again the entire vaccine industry is based on the same fantasy logic as unicorns, fairies, leprechauns and garden gnomes.
And, for the record, all the healthiest people walking around who don’t catch the flu are the ones who refuse flu shots while taking care of their immune system. It’s the vaccinated people who always seem to be sick for one reason or another, have you noticed?
In any case, it’s important to find ways to boost your immune system and shield yourself from colds and the flu without resorting to jabbing yourself in the arm with a cocktail of mercury, formaldehyde, aluminum and MSG.
OK. Hanlon’s razor? Or perhaps we should call it Pauli’s Razor: Not only is it not right, it’s not even wrong. But I and others have written extensively on this blog about the flu vaccine and my purpose is not to discuss the flu vaccine. Instead I want to take a look at:
The top 20 ways to boost your immunity to colds and flu without using a vaccine
There is no cold vaccine. I know. Picky. But I get the feeling the author doesn’t understand basic microbiology. At one point they suggest an air filter to remove bacteria and molds, neither of which cause flu or colds nor suppress the immune system. You can see the entire hodgepodge of the good, the bad and the ugly over at NN. I’ll hit some highlights.
1) Take a vitamin D supplement every day.
This is interesting and not yet completely worked out. Some groups who are vitamin D deficient have an increased risk of viral infection. However, those with normal levels get infections as well, but at lower rates. And it may not be the vitamin D level that is modifies your risk, but whether there are polymorphism in the vitamin D receptor.
It is safe to say that being replete in vitamin D will lower your risk of some infections. Unless, of course, you are a proponent of the Marshal Protocol. Newton’s law of Alternative Medicine: For every SCAM there is an equal and opposite SCAM. In the Marshall Protocol you avoid vitamin D as part of a complicated intervention where it is thought that bacteria and vitamin D act together to shut down the immune system and the bacteria take off to cause disease. Go figure.
But as a recent JAMA article demonstrated, taking vitamin D as a preventative for upper respiratory tract infection does nothing, although it may be of benefit in high doses to tuberculosis.
It is not as simple an idea as take vitamin D and not get infected. It is, as with all vitamins, important to be replete. Outside of TB it is unlikely to be of help as a pharmaceutical.
2) Get as much sunlight as you can for as late into the year as you can manage. Even getting sunlight on just your face helps produce more vitamin D in your body.
Always follow an overstatement with homey common sense advice. And he gives other good advice: wash your hands, get enough sleep, and avoid stress, as if anyone can do that after reading the rest of the advice. Trying to live up to all the other pieces of advice from Natural News would be time consuming, expensive, ineffective and as a result be very stressful:
Drink immune-boost beverages like organic Cocoa Mojo, which contains a blend of 4 medicinal mushrooms. Take Lomatium, Osha, Elderberry and more, avoid cleaners and cosmetics, eat more pungent spices, avoid cheese as it makes your nose stuffy (which is due to a lack of sinus circulation), Take zinc and selenium. Take immune-protective herbal tinctures such as goldenseal, garlic, echinacea, osha root and elderberry. Eat more live vegetables.
All of which, he says, is better than the flu vaccine, which works in 1 in 100 people. I read it on the Natural News: the flu shot works. He has the numbers wrong for efficacy, but he agrees it is effective. That is the take home message from Natural News, the one that should be spread, “Flu shots work…” since even at the mistaken number of 1 in 100, the vaccine is better than the nostrums and concoctions suggested, which have no proven utility.
Most of the products are offered by Natural News and most of which will do nothing. I didn’t see the essay as an infomercial, but isn’t that whole site?
15) At the same time, demand high levels of hygiene by those around you. Ask them to wash their hands, for example. Ask them to boost their immunity with herbs, nutrients and supplements that really work. In fact, when others fail to boost their immune systems, it’s actually highly irresponsible on their part.
To paraphrase the author from the beginning: “They’re even starting to lay a guilt trip on those who refuse to boost their immunity, illogically claiming that your lack of immunity boosting somehow causes other people who are already boosted to catch the flu.”
Then there is the dangerous advice such as:
8) Get off all medications that you can safely eliminate! Work with a naturopath to accomplish this, of course, as quitting medications cold turkey can also be dangerous. Most medications suppress your immune system, liver function, kidney function and even your reproductive function.
And:
16) Have an emergency supply of colloidal silver available. Not only do you want the liquid colloidal silver, you may also want to consider an inhalable form of silver like what you’ll find in the Silver Lungs product. At the Natural News Store, we currently carry GHC’s colloidal silver product called Silver Fuzion, and we’ll soon be carrying Sovereign Silver products.
And the just plain goofy:
12) Move your lymph! Rebounders (mini trampolines) are great for this purpose. Jumping rope also works, as does just hopping in place for a few minutes each day. You can also do arm rotations and other simple movements to keep your lymph circulating. Lymph movement is crucial for immunity.
It is not, although there is this belief that lymph can stagnate, build up toxins and degrade immunity. This concept has as much basis in reality as qi and meridians. Finally there is:
20) Laugh a little! Watch some comedy movies, or spend some fun time with family and friends. Laughter boosts immune function at many levels. It’s good for your body and your mental health. Find creative ways to expose yourself to comical situations and you’ll benefit as a result. 🙂
Well, after reading Natural News I should be immune to everything forever. Nothing incites laugher more than this odd collection of the good, the bad and the ugly.

* The Duck-Arizona football game is more interesting, so blame any errors today on my alma mater. Go Ducks.
** Ha. Just put that in there just to get your goat. An observation. I have given lectures for over 30 years. During the Clinton and Obama years I would make snide jokes about the powers that be and never had a complaint in the evaluations. Crack wise about a Republican and you will ALWAYS get a complaint. From that I conclude that Republicans are thin skinned whiney babies, although there may be other interpretations. Let’s see if the comments confirm my bias.

Tattoos Won’t Boost Your Immune System
Can getting a tattoo help reduce your risk of catching a cold? What about getting a bunch of ’em? Sadly, no amount of ink is going to boost your immune system.
Clay Jones on October 18, 2019
Link
Earlier this month I stumbled on an article in Mic, an online magazine aimed at millennials, that discussed the possible role of tattoos in “boosting the immune system” (which you can’t do) and reducing your risk of catching a cold. I am not a millennial, but thankfully I was still able to access and read the content. It was terrible in a well-meaning sort of way, and a great example of why dedicated science and medicine journalists are best suited for discussing these issues.
The author of this particular article is a yoga instructor. Not that there is anything wrong with that, of course. My wife is a certified yoga instructor. She just also happens to be quadruple boarded in pediatrics, pharmacology, pediatric oncology, and palliative medicine. Neither of us have any tattoos.
Speaking of tattoos, what do they have to do with the immune system or your risk of viral infections? Probably nothing at all. Well, almost certainly nothing at all. The whole concept, as I will discuss in absurd detail considering how silly it is, is absurdly silly. There is a tiny sliver of plausibility, and now two studies, but this is very unlikely to result in anything other than an Ig Nobel Prize.
But before I discuss the current article, we need to go all the way back to 2016. 2016, the year the Chicago Cubs broke the curse of a goat, or Babe Ruth, or something like that. Russia interfered with our elections. Oh, and Brexit. Also in 2016 there was a slurry of articles about tattoos preventing the common cold, like this one.
In March of that year, a study authored by Christopher Lynn and a team of anthropologists from the University of Alabama was published in the American Journal of Human Biology. It investigated a link between tattoos and immune function. Lynn was working from the personal observation that getting a tattoo seemed to make people feel tired and more likely to become ill. He further hypothesized that any negative effect on immune function would be reversed as more tattoos were accrued over time, and that there might actually be a beneficial response.
In the above linked Science Daily article, he is quoted likening this to the difference between someone who is out of shape going to the gym once, and someone partaking in regular exercise:
“After the stress response, your body returns to an equilibrium,” Lynn said. “However, if you continue to stress your body over and over again, instead of returning to the same set point, it adjusts its internal set points and moves higher.”
Though perhaps intuitively satisfying, this is nonsense from a medical standpoint. His use of the concept of stress is so nebulous that it renders this statement uninterpretable. He is trying to say that regular exercise, particularly of moderate intensity, is good for you and better than just occasionally hitting the gym. This is true in a variety of ways, including when it comes to immune function, but equating that to getting tattoos doesn’t make much sense.
Lynn recruited a convenience sample of 29 adult subjects, almost all women, with varying degrees of tattoo experience. He obtained saliva samples both before and after each subject got their planned tattoo in order to measure levels of cortisol and secretory immunoglobulin A (SIgA) as surrogate markers for stress and immune function respectively. Obviously the immune system and the human response to stress is extremely complex and involves many more factors than this, but cortisol and SIgA are easy to measure in saliva and these were anthropologists, after all, not medical researchers.
Before we get to the results, a quick and basic primer on IgA:
IgA is the most abundant antibody type in our bodies, and its secretory form is particularly prevalent in saliva and mucous secretions in the respiratory, GI, and genitourinary tract. This form is produced locally in mucous tissue rather than in the bone marrow where other immunoglobulins, including serum IgA, are made. Unique SIgA is produced in response to exposure of mucosal tissue to different microbial antigens, thus they provide protection from future infections largely by coating pathogens and preventing them from penetrating the mucosal surface.
There is much more to IgA, but for our purposes today that is about all you need to know. IgA clearly plays a role in preventing infections such as the common cold, among many others, but it isn’t quite that simple. A lot of people are deficient in the stuff, but because there are many redundant immune functions the vast majority, around 90% in fact, don’t have more infections. And in the 10% of IgA-deficient patients who do develop more infections, they don’t tend to be more severe. And this is over a lifetime of having no IgA. So the notion that transient changes in SIgA levels in response to acute stress might alter your risk of catching a cold is not well supported.
Now back to our study. I was unable to obtain the full paper, and the abstract linked to above was unfortunately not very helpful. But based on it and the numerous articles published at the time, it looks like they found that getting a tattoo was associated with a decrease in SIgA levels, but less so in subjects with more previous tattoo experience, and all results were within the normal range. Again, not that that really matters in this context.
This could have just been random fluctuation in an underpowered study. Noise, essentially. And who knows how long any changes in SIgA lasted after the tattoo session? Once again, not that it matters…at all. There is very little reason to expect a clinically meaningful difference in the risk of catching a cold when SIgA levels are a little lower. The authors attempted to link the drops in SIgA to stress, which is why they measured salivary cortisol levels, but I was unable to find any mention of those results. It was implied, however, that there was an inverse relationship with more experienced subjects having less of a stress response with repeated tattoo sessions.
It’s important to point out that cortisol levels vary significantly depending on the time of day. It does not appear that this was taken into account. The bottom line is that it was ridiculous in 2016, based on this study, to conclude that tattoos play any role whatsoever in the function of the human immune system regardless of how many you get.
Now lets fast forward to October of 2019 and see if there is reason to update this assessment based on new data. Here again is the Mic article that first got my attention. It starts by repeating the implausible and unfounded conclusions made in 2016:
Tattoos are wounds and when your body is hurt, your immune system swoops in like a cellular superhero that fights infections in not just the tattoo, but throughout the whole body.
This is wrong on many levels. Remember, the 2016 study found that SIgA levels decreased in all subjects, just less so in those with more tattoo experience. The implication was that more experienced subjects were less stressed and thus had lower cortisol levels, which had less of a negative effect on immune function. This does not mean that the overall function of their immune system was improved or that they would be less likely to get sick. Also, that study was garbage and didn’t tell us anything about cortisol levels in relation to getting a tattoo, and it isn’t even clear that cortisol spikes would change SIgA levels.
I’m going to move on from the Mic article now. More helpful in this discussion is the article in The Conversation which it was based on, and that was written by Christopher Lynn himself. In it, he discusses the details of his attempt to replicate the 2016 study in a population of American Samoans. The new study was published last month, again in the American Journal of Human Biology, which apparently is a respected publication.
I’m going to quote liberally here.
He starts off with a reference to his 2016 study:
This field season was the fourth of my research on the relationship between tattooing and immune response. My first study had focused on a small sample, mostly women, in Alabama. What I’d observed among that group suggested that tattooing could help beef up one’s immune response.
No, it didn’t. It suggested that randomly checking salivary SIgA levels yields random results.
He then demonstrates some admirable insight:
But one small study in the United States wasn’t proof of anything – despite headlines blaring that tattoos could cure the common cold. Good science means finding the same results multiple times and then interpreting them to understand something about the world.
Yes…sort of. Good science means attempts to replicate results after taking into account flaws in the design methodology of earlier studies and the prior plausibility of the hypothesis in question. In this case, replication with just another small study, particularly one that is needlessly complicated by aggressive statistical processing, just wouldn’t be enough.
He follows with an incredible leap in logic:
Tattooing creates a permanent image by inserting ink into tiny punctures under the topmost layer of skin. Your body interprets a new tattoo as a wound and responds accordingly, in two general ways.
Innate immune responses involve general reactions to foreign material. So getting a new tattoo triggers your immune system to send white blood cells called macrophages to eat invaders and sacrifice themselves to protect against infection.
Your body also launches what immunologists call adaptive responses. Proteins in the blood will try to fight and disable specific invaders that they recognize as problems. There are several classes of these proteins – called antibodies or immunoglobulins – and they continue to circulate in the bloodstream, on the lookout lest that same invader is encountered again. They’re at the ready to quickly launch an immune response the next time around.
This adaptive capacity of the immune system means that we could measure immunoglobulins in saliva as approximations of previous stress caused by tattooing.
Wait…what? There is no connection whatsoever between skin wounds and the production of salivary SIgA levels. As I discussed above, SIgA is only produced locally in the mucous membranes as a result of exposure to pathogens on those surfaces. And what does stress have to do with that process? Nothing. That last sentence is garbage.
He discusses the new study, which involved 25 subjects that were mostly tourists visiting American Samoa:
We collected saliva at the start and end of each tattoo session, controlling for the tattoo duration. We also measured recipients’ weight, height and fat density to account for health. From the saliva samples, we extracted the antibody immunoglobulin A, as well as the stress hormone cortisol and inflammatory marker C-reactive protein. Immunoglobulin A is considered a frontline immune defense and provides important protections against frequent pathogens like those of the common cold.
By comparing the levels of these biological markers, we determined that immunoglobulin A remains higher in the bloodstream even after tattoos heal. Furthermore, people with more time under the tattoo needle produced more salivary immunoglobulin A, suggesting an enhanced immune response to receiving a new tattoo compared to those with less or no tattoo experience. This effect appears to be dependent on receiving multiple tattoos, not just time passed since receiving one. This immune boost may be beneficial in the case of other skin injuries and for health in general.
So in this small study, they found that some of the subjects had higher levels of SIgA after getting a tattoo. Remember, in the previous study they all had decreased levels. This supports the notion that it’s all just random noise rather than that the immune system was somehow boosted. The claim that elevated SIgA levels, even if directly caused by the tattoo, would play a role in non-mucosal surface healing or general health goes against the basic scientific understanding of what these antibodies actually do in our bodies.
He goes on, quite a bit more in fact, but doesn’t say anything that is really different from what I’ve covered. He does at one point imply that getting tattoos is similar to being vaccinated. Yikes. And he does reveal that he is in the middle of another study, this time involving 50 subjects. He has collected more saliva samples which will be used to help him understand something about the world I suppose.
I have nothing against Lynn. And what a cool job, am I right? He gets to travel and hang out in tattoo parlors. He’s just way out of his element when it comes to the medical sciences. It’s hard to wrap my head around why there are anthropologists studying the immune system without any apparent input from a relevant expert. It’s like they just googled it one day.
Tattoos are fine, although not risk free. Make sure that you are going to a reputable establishment that follows proper safety protocols. And don’t expect that they will protect you from catching a cold no matter how many you get.

Tattoos Still Won’t Boost Your Immune System
Does the repeated stress on your immune system from getting tattoo after tattoo make you better able to fight off infections? No, no it does not.
Clay Jones on May 10, 2024
Link

One of the silliest topics that I’ve covered over the past 10+ years of writing for SBM, at least among the ones that I didn’t make up myself, was the claim that tattoos might boost the immune system and even make recipients healthier in general, but only if you get a bunch of ’em. Not that I have anything against tattoos, as long as appropriate safety measures are in place. Being tattooless, I have no skin in this game except for a desire for a better informed public.
In the innocent days of October of 2019, I first discussed the work of University of Alabama anthropologist Christopher Lynn on the potential relationship between getting some ink and “boosted” immune function that had been published in the American Journal of Biology in 2016 and again in 2019. This paper had resulted in some news articles that left a lot to be desired and I took them all to task. Lynn thanked me for the analysis on Twitter but accused me of sullying the good name of medical anthropology. In reality, I merely sullied the good name of Professor Lynn and called into question why an anthropologist was doing terrible medical research seemingly without any input from actual experts in immunology.
History, like Ka, is a wheel.
Lynn had initially set out to show that people who had received multiple tattoos over time have a more robust immune response to a new tattoo than people who are tattoo naive, a hypothesis based on pure conjecture that awkwardly compared getting a tattoo to going to the gym. The idea was that this repetitive stress could train the body to fight off infection more successfully. His initial 2016 study was small, with only 29 subjects, and involved measuring cortisol and secretory IgA (SIgA) in saliva both before and after participants got a tattoo. The decision to use these as surrogate markers of global immune function was based more on convenience rather than good science, however.
SIgA, as well as the small amount of serum IgA floating around in our bloodstream, is a component of our immune system’s response to microbial pathogens and does play a role in protecting us from some infections. SIgA coats the mucous membranes lining our respiratory, GI, and genitourinary tracts and works by attaching to antigens on the surface of microbial pathogens to help prevent penetration through these membranes where they could gain access to the bloodstream and other tissues. It’s also easy to measure because a blood draw isn’t necessary.
IgA isn’t that important, however, and it isn’t a helpful surrogate for general immune function. Millions of people have a selective IgA deficiency to varying degrees and it is by far the most common primary immunodeficiency. But most people who don’t have enough IgA are asymptomatic and diagnosed incidentally. Again, while some people do present with an unusual number of infections, most people with low or absent IgA do not get sick more often than people who are just lousy with the stuff.
As I explained back in 2019, relying on salivary SIgA levels isn’t helpful:
A lot of people are deficient in the stuff, but because there are many redundant immune functions the vast majority, around 90% in fact, don’t have more infections. And in the 10% of IgA-deficient patients who do develop more infections, they don’t tend to be more severe. And this is over a lifetime of having no IgA. So the notion that transient changes in SIgA levels in response to acute stress might alter your risk of catching a cold is not well supported.
https://sciencebasedmedicine.org/tattoos-wont-boost-your-immune-system/
Lynn’s initial study found that undergoing placement of a tattoo resulted in a decrease in salivary SIgA, but this response appeared to be more robust in subjects getting their first tattoo. Experienced subjects were still found to have lowered SIgA, just less so. But all the measured levels were within normal parameters for SIgA and, as I hope I’ve made clear, none of this matters anyway. There was, and still remains, no plausible scientific reason to think that these changes, even if the observed pattern wasn’t just random noise, would have any clinically relevance. These results don’t add anything to our understanding of the immune system or even the body’s response to tattoos.
The cortisol levels were obtained in order to show an association between stress and SIgA levels, with the assumption that acute stress (higher salivary cortisol) would be associated with decreased immune system function (lower SIgA). There is a nugget of plausibility to this as it is well recognized that stress, primarily chronic stress, absolutely does play a role in many negative health outcomes, decreased immune function definitely being one of them. Lynn’s overarching hypothesis, however, was that getting multiple tattoos, essentially brief stressors spread out over time rather than chronic constant stress, somehow trains the body to be more resistant to stress in general, which would result in a “primed” immune system better capable of responding to invasion by microbial pathogens.
And though they did appear to find an inverse relationship between cortisol and SIgA, it is almost certainly random noise, or lab error, because numerous studies in animals and human subjects have consistently found that acute stress transiently increases SIgA levels in saliva. Chronic stress is associated with lower levels, but chronic stress impairs immune function through mechanisms more varied and significant than specifically just a reduction in SIgA. Again, SIgA levels have never been accepted as a marker of overall immune function but have been used as a marker of stress.
The bottom line is that the results of Lynn’s study were almost certainly spurious and couldn’t have answered his question anyway. It was, to put it bluntly, garbage. His approach needed to change.
Narrator: “His approach would not change.”
That was 2016. In 2019, when I wrote my original post, Lynn had published a follow-up study in an attempt to replicate his meaningless findings. This time, 25 subjects were recruited and pre and post tattoo saliva samples were collected for measuring SIgA, cortisol, and an inflammatory marker. As I wrote in my previous post, the results did not shed much light on the situation:
So in this small study, they found that some of the subjects had higher levels of SIgA after getting a tattoo. Remember, in the previous study they all had decreased levels. This supports the notion that it’s all just random noise rather than that the immune system was somehow boosted. The claim that elevated SIgA levels, even if directly caused by the tattoo, would play a role in non-mucosal surface healing or general health goes against the basic scientific understanding of what these antibodies actually do in our bodies.
https://sciencebasedmedicine.org/tattoos-wont-boost-your-immune-system/
Lynn would claim that the new study bolstered his belief that tattoos have immune system benefits and even added improved wound healing and general health to the list. His language in an article he wrote at the time came very close to comparing tattoos to vaccinations:
Tattooing seems to exert a priming effect: That’s what biologists call it when naive immune cells are exposed to their specific antigen and differentiate into antibodies that remain in the bloodstream for many years. Each tattoo prepares the body to respond to the next.
https://theconversation.com/untangling-tattoos-influence-on-immune-response-121852
In that 2019 article, Lynn hinted at the future by mentioning an ongoing study involving 50 subjects. Nothing of much importance happened in the world for a while after that except for Taylor Swift becoming the embodiment of Satan. Fast forward to 2024 when, last week, I randomly had an unprovoked memory of this topic and decided to see what had become of Professor Lynn and his research into the health benefits of tattoos.
I found that in April of 2023, Parade Magazine had published an article on the subject for no apparent reason that I could find, as it only mentions the 2016 and 2019 studies I’ve already discussed. It is apparent, however, that Lynn had continued to expand on his belief system despite the lack of scientific plausibility or any new supporting research, and more clearly compared tattoos with vaccines:
The dermal injury of getting the tattoo and the pigment left in the skin—in both cases, we are purposefully injuring ourselves, but in a way that is analogous to exercise,” Dr. Lynn says. “We are tearing muscles to build muscles. We are stimulating the immune system to have a more robust reaction.”
Dr. Lynn says the research also draws comparisons between tattoos and vaccinations. “[With vaccines], we introduce a challenge, cause our immune system to turn on, and when the immune system turns back off, it remains somewhat vigilant,” Dr. Lynn says. “It creates new antibodies in circulation at a higher rate. Our immune system is adaptive. It interacts with our appraisal of stress.”
“What we see with novel or first tattoos is that cortisol, a stress hormone, goes up, while immunoglobulin A goes down,” says Dr. Lynn. “For people with relatively more tattoo experience [these reactions vary].”
(Clay here. Again, many studies have previously and since found that acute stress raises SIgA levels. The varied reactions that he found were likely due to lab error or random noise in the data and do not represent any actual trends in human physiology.)
In a way, you can think of tattoos as “training” the immune system. “One of the things that training the immune system is useful for is dealing with the topsy-turvy up and down of life,” says Dr. Lynn. “Even if the tattoo lasts a long time and is putting stress on the body, the immune response is happening immediately and throughout the experience. That suggests there is a priming effect [between tattoos and the immune system].”
https://parade.com/health/tattoos-immune-system
Thankfully Lynn doesn’t actually go so far as to claim that getting a tattoo is truly equivalent to a vaccine when it comes to preventing disease:
“I would never say anything like that,” Dr. Lynn says. “What we are saying is that there is an effect. Is it clinically significant? Not by itself. It is an extra influence on our health and well-being. What I usually say is, ‘If you want to be healthy, there are a hundred ways under the sun to be healthy. Tattooing is part of the lifestyle…here are additional benefits.'”
But even this milquetoast support of potential medical benefits from tattooing isn’t reasonable. Later in the article, and to his credit, Lynn clearly states that tattoos are not something he recommends to people with autoimmune disease to “strengthen the immune system” and mentions that his wife has lupus. We don’t generally think of these conditions as being caused by a weakened immune system, but rather one that is confused and causing damage from friendly fire, though treatment of these ailments often does consists of medications that do suppress the immune system. This adds to my concern that Lynn is way out of his depth here and should be relying on actual experts for help, which brings us to the unfortunate involvement of an actual expert. Sigh.
In the Parade Magazine article, there are several quotes from Dr. Sharon Nachman, who is the Chief of the Division of Pediatric Infectious Disease at Stony Brook Children’s Hospital, Vice Dean for Research at the Renaissance School of Medicine at Stony Brook, and she directs their Office of Clinical Trials. So she is an actual expert and should have no problem seeing just how bad these two studies are. She should be highly skeptical of the entire premise that tattoos improve immune function.
That isn’t what happened, and I am honestly baffled. She says the following in regards to the 2019 study:
“It’s a great paper,” said Dr. Sharon Nachman, MD, the chief of the division of pediatric infectious diseases at Stony Brook Children’s Hospital. “It looks at patients with a long history of tattoos. It looks at those who got tattoos versus those who didn’t. Did they have lower infections or rates of common illness? The answer is yes…as part of immune functioning, they were better able to handle infections.”
None of that happened. Neither the 2016 or 2019 study, and these two studies represented the totality of the literature on the subject of immune boosting tattoos at the time, did anything of the sort as I’ve explained in painful detail. So she either didn’t read the study, and perhaps regurgitated the take presented to her by the articles writer, or she was horribly misquoted. I truly hope that it was the latter, but frankly both are terrible.
In regards to people with autoimmune conditions getting tattoos in the hopes of seeing a benefit, she appropriately states that we don’t know if the risk outweighs the benefit, which seems to imply that there might be some benefit. She calls it an important scientific question and calls for more research. I disagree and I’m still confused as to how we got here. She does at least point out that tattoos should be done in a safe and hygienic fashion.
I was disappointed to learn that Lynn’s claims continues to be given an undeserved patina of academic legitimacy when I came across a September 2023 study. Sadly it is essentially just a rehash of the same flawed approach used in the first two experiments and used saliva samples left over from the 2019 study and a 2022 study that I believe is the one Lynn had referenced as ongoing back in 2019. 40 samples from subjects with with varying degrees of tattoo experience taken both before and after getting some fresh ink were included, only this time they focused on something called a bacteria killing activity (BKA) assay as a marker of overall immune function instead of SIgA.
Their results, as expected, were a mess. First off, the BKA assay is something that the 2nd author of the paper developed and is not a validated marker of general immune function. And there were problems with sample contamination that they just ignored. They also lost or didn’t have enough remaining saliva to perform the assay in a number of subjects. And what they found completely contradicted the earlier two (really 3 according to the discussion but I can’t access the 2022 study to see for myself) studies using SIgA, so they threw them under the bus and claimed that the BKA assay just works better. Convenient.
In fact, their failure to replicated the supposed immune suppression seen in tattoo naive subjects in this study completely undermines the entire hypothesis this was all based on. Acute stress is supposed to cause a transient insult that, with repeated exposures over time, teaches the body to be stronger like when Daniel-San learned karate by waxing Mr. Miyagi’s car. They also failed to find, using their unproven saliva assay, that subjects with more tattoo experience have a more robust immune system prior to getting the new tattoo. But they just forged ahead, cherry picking and nudging the goalposts a bit so that they could claim some degree of success:
We found that dermal stress of tattooing results in increased innate immune activity that is influenced by previous tattoo experience, supporting the model of tattooing as a phenotypic gambit. Tattooing may therefore enhance evolutionary fitness signals.
Garbage all the way down.
Of note, there was a March 2023 article in The Atlantic entitled “Tattoos Do Odd Things to the Immune System”. Unfortunately, I was unable to access it to see if this topic was covered with more appropriate skepticism, but I’m not hopeful considering the title. If anyone can get a hold of it, please let me know in the comments.

Nobel Prize in Medicine: Peripheral Immune Tolerance
Steven Novella on October 8, 2025
Link
Each year I like to write a post about the Nobel Prize in Physiology or Medicine. While advocating for higher standards of science in medicine we tend to spend much of our time criticizing pseudoscience, so I like to balance that by occasionally just celebrating great medical science, and the Nobel Prize is a great opportunity.
The 2025 award for physiology or medicine goes to three researchers, Mary E. Brunkow, Institute for Systems Biology, Seattle, USA, Fred Ramsdell, Sonoma Biotherapeutics, San Francisco, USA, Shimon Sakaguchi, Osaka University, Osaka, Japan, for their work on what is known as peripheral immune tolerance.
To understand the significance of this lets go back to my medical school days (I graduated in 1991). At the time one of the great mysteries we had yet to adequately resolve was why the immune system so vigorously attacked foreign invaders yet was able to avoid one’s own tissue. The immune system knows self from non-self. We make antibodies against pretty much everything, for example, except our own proteins.
One main hypothesis at the time had to do with the thymus, where T-cells develop and obtain their specificity against invaders. The thymus essentially contains self-cells and proteins which act as a template for what T-cells should not target – a process known as central immune tolerance. This works through negative selection – self-targeting T-cells are not allowed to develop and exit the thymus into the bloodstream. This is still essentially correct, and is the probable mechanism for some auto-immune diseases (a failure to exclude certain self-proteins). It was later discovered that the bone marrow also plays a role in central immune tolerance, by filtering out B-cells (the antibody producing cells) that make self-targeting antibodies.
But in 1995 Simon Sakaguchi made a discovery that was not in line with the central thymus theory. He discovered a new class of circulating peripheral T-cells which he called regulatory T-cells (Tregs). These T-cells suppress the activity of other T-cells through a variety of mechanisms. For example, they can secrete anti-inflammatory cytokines such as IL-10 and TGF-beta. They can also directly kill other T-cells. Tregs are able to identify self-reactive T-cells and suppress them, thereby reducing the chance of auto-immunity. This came to be known as peripheral immune tolerance.
Brunkow and Ramsdell came into the picture in 2001 – they discovered that a mouse strain that was very susceptible to auto-immune disease had a mutation in the Foxp3 gene. They then showed that a mutation in the human version of Foxp3 caused the autoimmune disease IPEX. This is a severe auto-immune disease that manifests in infancy, causing severe diarrhea, eczema, and early-onset type 1 diabetes among other problems. Treatment requires immunosuppressive drugs and can include bone marrow transplants.
As an aside – and a link to another Nobel Prize-winning discovery – early clinical trials are underway to use gene therapy, including CRISPR, to treat IPEX. This is a great target because it is a genetic auto-immune disease, due to a mutation in a single gene.
Back to this year’s prize, two years after Brunkow and Ramsdell’s work, Sakaguchi picked up the ball again and did research to demonstrate that the Foxp3 gene was involved in the development of Tregs, and therefore IPEX was a disease of peripheral immune tolerance.
In the last 30 years our understanding of the immune system has greatly expanded. It is much more complex than we thought back in the 1990s. The immune system is a complex web of central and peripheral mechanisms maintaining a dynamic homeostasis, that can both react to new threats while avoiding attacking one’s own tissue. Further, mechanisms that both increase and decrease inflammation exist in a delicate balance, striking a functional tradeoff to protect the body while minimizing damage.
As yet there are no approved therapies based on Tregs, but there are several in early clinical trials. These include treatments for autoimmune diseases, degenerative diseases, and organ transplantation rejection. This is yet another example of the typical 2-3 decade delay from basic science discovery to clinical application. That is how long it takes to fully understand the implications of a new discovery and translate it into an actual treatment.
It also demonstrates that basic scientists just following their curiosity can make discoveries with profound implications. And it further shows how modern science, including medical science, often progresses as a collaboration of different labs and scientists, and increasingly an international collaboration. This is why it is so tragic and short-sighted that the current administration has cancelled all NIH subgrants to international collaborators. This is already negatively impacting promising research.


You can’t beat the common cold, and that’s a fact
The common cold is very, very common, with a lot of treatments proposed to control its symptoms or shorten its course. Most don’t work.
John Snyder on December 20, 2013
Link
>> Disclaimer: nothing in this post is meant to be taken as medical advice. Always consult your own provider.
For those of us dedicated to supporting science-based medicine and fighting the ever-widening reach of sCAM, pseudoscience, and health fraud, finding a new woo-filled claim or a dangerous, evidence-lacking trend to write about is relatively easy. Many of us may not realize, however, that some of the most commonly used and recommended treatments, one of which at least is probably sitting in your medicine cabinet as you read this, is equally devoid of evidence to support its use.
Every drug store has row upon row of medicines designed to treat or prevent an acute upper respiratory tract infection, otherwise known as the common cold. Despite this, very few are able to live up to their promise. In most cases, particularly where children are concerned, the side effects of these medicines can be worse than the symptoms they are intended to treat. Because I am a pediatrician, and because the evidence for cough and cold medicines (I will refer to them here as CCMs) for children is particularly absent and because adverse events due to CCMs are most frequently seen in children, I will focus mainly on this population. 
The common cold – a (brief) overview
The term “cold” refers to a complex of signs and symptoms sharing similar characteristics but which may be caused by a variety of different viruses. Usually referred to by clinicians as viral upper respiratory tract infections (URIs), the very familiar features of the common cold include runny nose, nasal congestion, sneezing, cough, and sometimes sore throat and watery eyes. Colds may also be associated with systemic signs and symptoms, such as fever, chills, malaise, and body aches, though these are more typically seen in influenza, or “flu-like syndromes” caused by other viruses. At least 50% of colds are caused by rhinoviruses, of which there are approximately 100 serotypes. Other viruses that can cause colds include adenoviruses, enteroviruses, the respiratory syncytial virus (RSV), coronavirus, influenza and parainfluenza viruses, and human metapneumovirus (hMPV). Rhinoviruses survive best at the cooler temperatures found in the nose as opposed to the warm depths of the body, which is why the primary signs and symptoms of infection occur there. Other viruses can cause disease more systemically, and therefore are capable of producing more severe illness. The typical cold worsens for the first 3-4 days, plateaus for 1-2 days, and then improves over another 3-4 days. Most colds have resolved or significantly improved by day 7-10 of the illness.
An illness begging for a cure
Despite the relatively brief, self-limited, and generally benign nature of colds, they can be extremely uncomfortable nuisances, resulting in a staggering number of missed days from work and school. It is not surprising that many people are willing to try and pay for almost anything to relieve the annoying symptoms of the common cold, resulting in an estimated expenditure of close to $3 billion for over-the-counter CCMs in the US annually. Almost everyone has a favorite over-the-counter (OTC) or home remedy for the common cold. My mother always started me on 1,000mg daily of vitamin C at the onset of any cold symptoms (usually in the form of acerola with rose hips). Unfortunately, notwithstanding all of the marketing, hype and near universal belief in at least some form of cold remedy, there is little to no evidence supporting the efficacy of most CCMs.
The lack of efficacy of CCMs is not surprising when one considers the pathophysiology of common cold symptoms. Those familiar and annoying signs and symptoms are primarily a result of our body’s own inflammatory response to the viral destruction of infected cells in our upper airway. By the time this inflammation has begun, the progression of the illness and the resulting symptoms is inevitable. Our immune system (with the exception of those with congenital or acquired immunodeficiencies) is usually quite capable of rapidly countering the upper airway invasion by these viruses with this robust (though uncomfortable) inflammatory response. Most of the anecdotally reported benefits of CCMs are likely attributable to the self-limited nature of colds – a result our body’s own ability to clear the virus and repair the damage.
Not only is scientific evidence for the efficacy of CCMs lacking, their use in children is responsible for significant morbidity and even mortality. Every year in the US, over 7,000 children under the age of 12 are brought to emergency rooms as a result of an adverse event from a CCM. This is largely a result of incorrect dosing or frequency of administration. One study demonstrated that only 30% of parents were able to both accurately measure and correctly dose OTC CCMs for their child. Also contributing to the occurrence of adverse events is the fact that many children’s CCMs are “multi-symptom” products, containing several different drugs. When parents give more than one medication to their child simultaneously, they may be inadvertently overdosing at least one of these components. For example, many “multi-symptom” CCMs contain acetaminophen as a fever reducer. Unaware of this, parents often simultaneously give their children acetaminophen as a separate medication, resulting in potentially dangerous overdosing.
Common treatments for a common illness
By far, the most common diagnosis I make each day in my practice as a pediatrician is “viral URI”, otherwise known as the common cold. And every day, many times per day, I am asked by parents what they can give their suffering child to make them better faster. And every day, many times per day, my advice is far from modern or high-tech. That is because I am trying, as best as I can, to limit my advice to that which can be supported by the best science-based evidence. Too often, that leaves parents dissatisfied and sometimes even frustrated or angry. Some parents are thankful, however, for my honesty and for staying true to my oath to “first do no harm”. But the number of children who are prescribed or who are given OTC CCMs in the US is truly staggering. Every week approximately 10% of children (that’s over 82 million according to the 2012 US census) take these medicines without evidence of efficacy, and at significant risk.
In October of 2007, concerned about the lack of evidence supporting the efficacy of CCMs in children, and out of a growing concern about the safety of these products, the FDA’s Nonprescription Drugs Committee and Pediatric Advisory Committee unanimously recommended against the use of CCMs in children under 2 years of age. In response, US manufacturers voluntarily withdrew those products marketed for infants under age 2. In 2008, manufacturers revised their labeling to warn against use by children under age 4. Though a majority of the original FDA Advisory Committee members voted against the use of CCMs in children under age 6 years, the FDA has not yet officially ruled on that recommendation. The American Academy of Pediatrics, however, has officially recommended against their use in children under 6 years of age.
Even though the majority of randomized controlled trials show no difference in endpoints when CCMs are compared to placebo, and despite the potential for serious adverse events, these products remain ubiquitous on pharmacy shelves, and parents and many pediatric practitioners still turn to them for treating colds in children. Though the labeling changes noted above have resulted in a significant decline in reported adverse events from CCMs in children under 4, their use remains high.
The A-to-Z of OTC CCMs
Analgesics/antipyretics
In my practice, I find that parents frequently give acetaminophen or ibuprofen to their children with colds as if it were some sort of cure-all elixir. Although they may help with fever or muscle aches, they do not affect the upper respiratory signs and symptoms of a cold. Acetaminophen may actually suppress virus-neutralizing antibodies, potentially prolonging viral shedding and cold symptoms.
Antibiotics and antivirals
Being caused by viruses, it should be of no surprise that antibiotics do nothing for treatment of the common cold. There are upper respiratory tract infections for which antibiotics may be indicated, for example some ear and sinus infections, which are potential complications of colds. However, what we all know as the common cold is not treatable with antibiotics. Unfortunately, treatment of colds with antibiotics is not uncommon, and has contributed (along with the addition of antibiotics to livestock feed) to the very dangerous reality of antibiotic resistance. But that is a topic for another post.
There are major obstacles to the development of an effective antiviral agent for colds. These include the enormous number of viruses and virus serotypes that are known to cause colds, and the ease with which these viruses mutate and thus potentially evade any drug with which they may interact. For similar reasons, the development of a vaccine against the common cold remains elusive. One antiviral agent, pleconaril, has shown some promise in preliminary studies (mostly in adults), but was rejected by the FDA in 2002 due to its poor side effect profile.
Antihistamines
Some studies have demonstrated a modest decrease in sneezing and runny nose with the use of antihistamines in adults. While these drugs are helpful for the treatment of allergies, the signs and symptoms of which can resemble a cold, they have not been found to be effective when used to treat colds in children. Many OTC products marketed for use in children as “multi-symptom” cough and cold medicines contain first-generation antihistamines, which can have significant anticholinergic side effects. These can include gastrointestinal upset, dry mouth, increased heart rate, and even cardiac arrhythmias, central nervous system depression (or excitation), hallucinations, and respiratory depression.
Antitussives (cough medicines)
When I was training, I was taught never to treat a cough because coughing is a protective mechanism which clears the airway of mucus and pathogens. At that time, however, we weren’t aware that it probably didn’t matter, since no cough medicines have been shown to actually work better than placebo. But because they do contain drugs, however, they can have potentially serious side effects.
Dextromethorphan (think Robitussin-DM) is one of the most common “cough suppressants” on the market. It is a narcotic derivative which, when dosed correctly, has a low potential for side effects. At higher doses, however, it can have serious effects on the central nervous system, including hallucinations and dissociative states. Because of this, dextromethorphan has become a drug of abuse. Unfortunately, it doesn’t actually work. In a 2004 study, neither dextromethorphan nor the antihistamine diphenhydramine was found to outperform placebo at improving nighttime cough or sleep difficulty in children with colds. Other studies have shown that increasing the dose of dextromethorphan does not improve its efficacy, and can result in an increased risk of side effects. There is some evidence that dextromethorphan may even be responsible for some infant deaths.
Codeine has been used for a long time to treat cough in children despite no evidence that it is actually superior to placebo for this purpose. Codeine is an opioid compound that is converted in the liver to morphine, its active metabolite. Central nervous system effects of codeine are well described, as are serious, sometimes deadly events in infants and children. Individuals who are genetically predisposed to rapidly metabolize codeine into morphine are at particularly high risk of serious adverse events from the use of codeine-containing products. The American Academy of Pediatrics recently reaffirmed its prior policy statement that there are no well-controlled scientific studies to support the efficacy and safety of codeine for the treatment of cough in children, and that the use of codeine-containing products should therefore be avoided.
Aromatic vapor therapies
Vapor therapies containing some combination of menthol, camphor, and eucalyptus oil (such as Vicks VapoRub) are commonly used to treat cold symptoms in infants and children (though they are not recommended for use in children under the age of 2 years). These products are typically placed on the chest, neck, or under the nostrils (I have also encountered parents who swear by placing it on the soles of their infant’s feet). One study looking at inhalation of menthol vapor in school-age children showed no improvement over control in terms of cough or nasal airway flow or volume, though interestingly there was an improvement in the perception of nasal patency. Another study of colds in school-age children compared Vicks VapoRub, petrolatum, and no treatment. Parents gave Vicks the highest score in improving their child’s night time cough, congestion, and sleep difficulty. For obvious reasons this was not a blinded study, and the survey results should be interpreted in that light. After treating an 18 month old child with severe respiratory distress believed to be triggered by the application of Vicks VapoRub under her nostrils, a group from Wake Forest University School of Medicine studied the effect of this product on an experimental animal airway model. They found that Vicks increased mucin secretion and tracheal mucociliary transport velocity, and decreased ciliary beat frequency. Based on their findings, the authors hypothesized that Vicks may actually lead to mucus obstruction of small airways and increased nasal resistance to air flow.
CAM
There are so many so-called complementary and alternative therapies that are claimed to prevent and treat colds that I cannot possibly do justice to a discussion of them all here. I do discuss Echinacea below because this is the most commonly used and most studied CAM modality for treating colds. I will not even discuss homeopathy as there is no scientific plausibility for its efficacy.
Decongestants
These drugs (pseudoephedrine and phenylephrine) act on the sympathetic nervous system to cause constriction of capillaries, thereby decreasing swelling of the nasal and sinus mucosa. In adults, pseudoephedrine has been shown to decrease mucus production and runny nose. Similar evidence has not been demonstrated for phenylephrine, even though this drug has been steadily replacing pseudoephedrine in many products. This is because products containing pseudoephedrine can now only be sold at the pharmacy counter in an effort to prevent their use in the production of methamphetamine. There are no studies demonstrating the efficacy of decongestants in children, and dosing has been extrapolated from adult trials. One study by Hutten et al. and another by Clemens et al. found no difference between an oral antihistamine-decongestant combination containing phenylephrine and placebo. There are no studies on the use of pseudoephedrine in children. Unfortunately, the action of these drugs on the nervous system can produce serious side effects, including elevation of blood pressure, sleeplessness, headache, nausea, vomiting, and even cardiac arrhythmias and seizures. One drug once commonly used in OTC cough and cold medications, phenylpropanolamine, was taken off the market in 2000 because it could cause potentially fatal intracranial hemorrhages.
Echinacea
Echinacea is frequently touted as an effective, natural cold remedy. There are many published studies on the use of Echinacea for both treating and preventing colds. Most of these studies have significant methodological flaws. They also utilize different parts of the plant and at different doses, have produced conflicting results, and are difficult to interpret as a whole. The highest quality study to date, however, demonstrated no benefit over placebo in treating or preventing symptoms of the common cold in young adults.
Expectorants
Guaifenesin is the most common drug marketed as an expectorant. These agents purportedly work by drawing water into mucus, thinning it out and thus aiding clearance from the airway. It is found in products such as Mucinex, Robitussin DAC, Benalyin, and DayQuil mucus control. In one study, adults with colds reported subjective improvement in the thickness and quantity of sputum, but no decrease in cough. There are no studies demonstrating the efficacy of guaifenesin in children.
Honey
Perhaps the most promising treatment for cold related cough in children is turning out to be the golden sweet elixir, honey. In a well-designed, randomized, partially double-blind study, children receiving buckwheat honey showed significant improvement in cough symptom score compared to those receiving dextromethorphan or placebo. Another study demonstrates that honey given at bedtime was more effective than placebo in reducing the frequency and severity of nighttime cough. This was true whether the honey administered was eucalyptus, labiatae, or citrus honey. A criticism of other studies looking at the efficacy of honey has been the lack of a similarly sweet and viscous control group. In this study, the placebo compound was made from dates, and had similar sweetness, appearance, and texture.
>> Note: it is important to remember that honey should never be given to infants under 12 months of age due to the risk of botulism.
Probiotics
Probiotics have been in the news quite a bit lately for a variety of applications, including for the prevention of colds in children. A study of young children at a day care center in China found that those who received daily Lactobacillus acidophilus NCFM for 6 months had lower fever and less runny nose and cough during colds, as well as shorter colds and a reduced chance of being prescribed an antibiotic compared to those receiving placebo. Study children also missed fewer school days during colds. A recent Cochrane meta-analysis of randomized controlled trials exploring the use of probiotics in children found that they may significantly reduce the likelihood of developing a cold or requiring an antibiotic. One criticism of this analysis was the heterogeneity amongst the studies reviewed for the primary outcome of number of colds in children. It was also unclear which probiotic might be conferring the protection from colds. It was suggested that the heterogeneity of the study outcome findings might be due to the fact that the immune-modulating effects of probiotics are likely to be species- and strain-specific. The current consensus is that more data for specific probiotic species and strains is required before generalized recommendations can be made.
Saline nasal sprays and washes
Perhaps the most commonly used treatment for colds in infants is the application of saline drops and sprays to the nasal passages, often followed by bulb suction. Though this is not likely to result in anything more than transient improvement in nasal obstruction, one study looked at symptomatic relief during a cold as well as prevention of colds in children receiving instillation of nasal saline wash. Their result showed significant improvement in sore throat, cough, nasal obstruction, and secretions when given as treatment for a cold, as well as fewer illness days, school absences, and complications in children receiving the saline as a preventative.
Zinc
While zinc has the ability to inhibit rhinovirus replication in the test tube, clinical trials for the treatment of colds have been disappointing. While there was a very modest improvement in symptom score in one study of adults, the benefit was seen only when zinc was taken in large doses 5-6 times per day. At these doses, GI side effects were significant and patients complained of a bad taste in their mouth. Needless to say, 5-6 times per day dosing with these side effects would preclude this as a viable option in children. Additionally, a well-designed, randomized, double-masked, placebo-controlled study demonstrated no effectiveness of zinc on cold symptoms in children and adolescents.
Prevention is the best medicine
The common cold is caused by a large number of different viruses and virus serotypes, and these viruses mutate rapidly in the human host. This makes finding effective treatments and vaccines elusive. Since finding a cure for the common cold is unlikely, the best approach is to prevent infection. Spread of inflection occurs primarily via aerosol droplet (from sneezing and coughing) or by touching a contaminated object or person and then auto-inoculating oneself (by then touching the nose or eyes for example). There is scant evidence to support any dietary or medicinal prophylaxis for the common cold. If one existed, it would need to be taken chronically to be effective, and the risk-benefit ratio would have to be very low. The best way to prevent the common cold is to limit transmission. That means frequent hand washing, staying away from others as much as possible when sick, and avoidance of those with colds. The now-ubiquitous use of alcohol-based hand sanitizers does not prevent secondary transmission of colds due to rhinovirus (the most common cause of colds in children), and “antibacterial” soaps (usually containing triclosan or triclocarban) have no evidence of efficacy for preventing colds, and are now under close scrutiny by the FDA.
Modern medicine is sometimes quite limited in its capabilities. We need to be honest and humble when faced with these limitations. This, ultimately, is what distinguishes science-based medicine from pseudoscience and belief.

The (Cold) Drugs Don’t Work
The FDA continues to permit the inclusion of an ineffective ingredient in hundreds of cough and cold products.
Scott Gavura on March 30, 2023
Link

I’ve been blogging semi-regularly for almost 15 years and whenever I feel like I’m “blogged out” with nothing more to say, I inevitably find a topic that I’ve missed or forgotten to blog. When I read this post and then this paper about the dubious justification for the sale of a common cough and cold ingredient, I was frankly embarrassed that I hadn’t already written about it – years ago. Because the ineffectiveness of some cough and cold products is something everyone should be aware of.
We all suffer from coughs and colds. Surprisingly, while there are dozens of brands and formulations of cough and cold remedies on pharmacy shelves, they all use combinations of the same core handful of ingredients. And the evidence supporting some of these products is very, very weak. In the case of phenylephrine, included to treat “congestion”, it’s widely considered ineffective. Yet the FDA and regulators around the world continue to allow this ingredient to be included in cold products, as if it has medicinal benefits. Considering the evidence, this seems unwarranted.
What is phenylephrine?
In 1976, the FDA concluded that three medicines were safe and effective for the treatment of nasal congestion caused by colds, allergies, and sinusitis: phenylpropanolamine, pseudoephedrine, and phenylephrine. Almost 25 years later, phenylpropanolamine was withdrawn from the market after use was associated with strokes. Pseudoephedrine is an effective decongestant that is chemically very similar to methamphetamine, a addictive and controlled drug that subject to abuse. Pseudoephedrine does not share the same stimulant properties as methamphetamine, though it can cause jitteriness, mild tremors, and insomnia. However, because pseudoephedrine can be used to manufacture methamphetamine, the over-the-counter sale of cough and cold products that contain this ingredient are not permitted. Sales were moved “behind the counter” in the US, with the requirement for the customer to produce photo identification and the requirement for the pharmacy to maintain a log of all sales, tracked by customer name and address.
When pseudoephedrine was moved behind the counter, manufacturers of cough and cold products either had to accept a much smaller market for their (effective) product, or…pivot.

Some companies reformulated their products to contain phenylephrine instead, the last remaining non-prescription ingredient that the FDA had approved for congestion. Phenylephrine is from a category of drugs called alpha-1 agonists, that stimulate alpha-1 receptors that are present throughout the body, including the nasal passages. It is used as a nasal spray but more commonly as a oral product take to treat nasal congestion. There was a problem with FDA’s approval, however. There was little convincing evidence phenylephrine, when taken orally, was effective.
The evidence against phenylephrine
Phenylephrine is a poorly-absorbed drug (i.e., it has low bioavailability). Most of the drug is broken down during the absorption process and after passing through the liver. Only an estimated 38% of a dose actually reaches the bloodstream (compared with 90% for pseudoephedrine). In clinical trials, phenylephrine has been compared to other decongestants in a randomized controlled trial of 20 patients (way back in 1971) and found to be no more effective than placebo in reducing airway resistance. Another trial compared single doses of four different decongestants against placebo in 88 patients with congestion. It also found that phenylephrine was no more effective than placebo. In a review of the data that the FDA had considered, that review noted that for the 10mg dose, 4 studies showed efficacy and seven showed no difference from placebo. The authors concluded that a systematic review did not support the FDA’s decision. Other trials conducted since that time (like this one in 2009) are supportive of the conclusion that the 10mg dose is ineffective.
The fact that we are relying on trials conducted in the 1970’s pretty much tells us what we need to know about phenylephrine. Given how poorly it is absorbed, there is the question of whether simply giving bigger doses will work – and it turns out it may. However, the 10mg dose is what’s available in US cough and cold products – and the best evidence shows that this drug is effectively a placebo at that dose. I will point out that the manufacturers of the consumer products that contain this ingredient continue to write their own papers suggesting that there is evidence of efficacy.
The FDA is petitioned…and is finally acting
In 2015, pharmacy professors Randy Hatton and Leslie Hendeles of the University of Florida College of Pharmacy filed a citizen’s petition with the FDA, asking it to remove phenylephrine from the monograph of over-the-counter cold remedies, noting the absence of a decongestant effect at the approved dose of 10mg. They noted that since the FDA’s Nonprescription Drugs Advisory Committee had called for more research in 2007, four studies had been conducted, and none of those studies demonstrated that phenylephrine was more effective than a placebo. This petition is supported by the American Academy of Allergy, Asthma and Immunology:
The low bioavailability of pharmacologically active oral PE explains the lack of nasal therapeutic efficacy and cardiovascular effects. It is extensively metabolized in the gut mucosa causing insufficient systemic PE levels to produce vasoconstriction of nasal and other blood vessels. Available data do not support whether a dose greater than 40mg of oral PE would be effective or safe. Furthermore, the American Academy of Allergy, Asthma & immunology and the American College of Allergy, Asthma & Immunology in their role as patient advocates have concluded that keeping oral phenylephrine over‐the‐counter does a disservice to patients who might be prone to taking higher doses than recommended due to lack of effect and/or delay their visit to their primary care clinician or a specialist who could help resolve their symptoms.
Ineffective drugs don’t deserve stamps of approval
Professors Hatton and Hendeles reiterated their call for the FDA to take action in 2022, and finally the FDA may act this April:
The committee will discuss the adequacy of efficacy data available for oral phenylephrine as a nasal decongestant and whether oral nasal decongestants phenylephrine hydrochloride and phenylephrine bitartrate should be reclassified as not ‘Generally Recognized as Safe and Effective’ (GRASE) due to lack of efficacy.
Why the approval has persisted so long is puzzling from an evidence perspective, but perhaps it was sensible to the FDA. Phenylephrine is safe at the 10mg dose, and withdrawing the drug might raise more questions about why this drug was permitted in cough and cold products, for decades, without clear evidence of effectiveness. Until that time, remember that the only available non-prescription oral decongestant that has been shown to actually be effective is pseudoephedrine. Ask your pharmacist if pseudoephedrine is right for you.

The New Cough and Cold Products for Children: Evidence is Optional and Science is Marketing
Scott Gavura on January 16, 2014
Link

It’s the time of year where if you’re not sick, someone you know probably is. The influenza season in the Northern hemisphere started out slowly, but seems to be accelerating and hasn’t peaked yet. Add that to cold viruses circulating, and you get the peak purchasing period for cough and cold remedies. John Snyder gave a nice summary of the evidence base for the common treatments a few weeks ago. In short, despite all the advertising, there is little evidence to suggest that most of the “tried and true” products we’ve used for decades have any effect on our symptoms. One of the most sensible developments that’s occurred over the past few years has been the discontinuation or relabeling (depending on your country) of cough and cold products for children. The rationale to pull these products is compelling: Cough and cold remedies have a long history of use, and were sold without prescriptions before current regulatory standards were in place. They were effectively grandfathered onto the marketplace. When it comes to their use in children, the data are even more limited. There are few published trials and the results are complicated by different age groups, irregular dosing, lack of placebo control, and very small patient numbers. What’s even harder to believe was that doses were based mainly on expert opinion, not data, and generally didn’t consider that children don’t handle drugs the way adults do. So why withdraw them from pediatric use, but not adult use? Like most regulation, it comes down to risk and benefit. Both are troubling for pediatric use.
One of the earliest lessons you’ll gain from a pharmacokinetics course (which studies drug behavior in the body) is that children are not small adults. It’s not just their size, it’s their physiology. The stomach acidity can differ, changing how drugs are absorbed. Body-fat-proportion differences affect how drugs are distributed in the body. And the body’s pathways for metabolism are not fully mature, which means drugs can behave in different and often unpredictable ways. Given the lack of data showing how the major cough and cold ingredients behave in children, and a lack of evidence showing that they have any meaningful effects, it comes down to a question of safety. While these products had long histories of safe use, harms and deaths have been linked to cough and cold product use in children. Fatal side effects are exceptionally rare, but can occur. Risks are greater in the younger child, and particularly in infants. In light of the potential for harm and the lack of benefit, there is no justification to keep them in the market, and most regulators around the world eventually acted to reduce the risk that they will be used in children. Like many other health professionals, I was happy to see them go. Today’s treatment guidelines don’t recommend drug therapy.
The Cough Suppressant and Pharmacologic Protussive Therapy : ACCP Evidence-Based Clinical Practice Guidelines (2006) make the following recommendations about cough suppressants and expectorants:
    • In patients with acute cough due to the common cold, preparations containing zinc are not recommended. Level of evidence, good; benefit, none; grade of recommendation, D
    • In patients with acute cough due to the common cold, over the counter combination cold medications, with the exception of an older antihistamine-decongestant, are not recommended until randomized controlled trials prove that they are effective cough suppressants. Level of evidence, fair; benefit, none; grade of recommendation, D
    • In patients with cough due to URI [upper respiratory infection], central cough suppressants (i.e., codeine and dextromethorphan) have limited efficacy for symptomatic relief and are not recommended for this use. Level of evidence, good; benefit, none; grade of recommendation, D
The British Thoracic Society Cough Guideline Group in its recommendations for the assessment and management of cough in children (2007) notes the following:
    • Over-the-counter medications are as effective as placebo for acute cough with head colds in children. A systematic review of six RCTs and a further recent RCT found that over-the-counter antitussives, antihistamines and antihistamine-decongestant combinations were as effective as placebo with the potential for causing side effects.
Evidence is one thing. Reassuring parents that they don’t need to give any medication is another matter entirely – especially since many of us grew up taking cold remedies. Once these products disappeared from the shelves, their absence made my dialogue with patients easier. I could explain the rationale for no treatment, why the traditional treatments had been relabeled or removed from sale, and discuss the self-limiting nature of colds. I’d also suggest products that actually do work, like analgesics such as Tylenol, and sometimes saline (drug-free) nasal sprays for treating congestion. And that’s pretty much it. Once you break the habit of reaching for a bottle of syrup each time your kid gets sick, you adapt. Give fluids, lots of rest, and lots of TLC. And don’t worry about giving cold remedies.
The shelves didn’t stay bare for too long. As John Snyder pointed out, a stunning 10% of children are given a cough and cold remedy every week. The demand is huge. That’s an enormous market that manufacturers couldn’t ignore. There are several new remedies that you’ll see on the shelf – most of them marketed at infants and children, and they’re advertised as “natural” products that really work. The enabler is weak regulation. In the USA, it’s the Dietary Supplement Health and Education Act (DSHEA). In Canada, it’s the Natural Health Products Regulations. Different regulatory frameworks, but with the same intent – to allow “natural” products and supplements to be sold without actually requiring those products to be backed by good evidence of safety or effectiveness. It’s the easiest way for a new product to be approved – describe it as “natural” (if you’re in Canada) or a supplement (in the USA), and you bypass the strict regulatory requirements required if you called it a “drug” instead. It’s simply not possible to keep up with all of the new products appearing – here’s the evidence for some of the products that I’ve seen appear on pharmacy shelves:
Homeopathic remedies
The first products that appeared after the traditional cough and cold products disappeared were the homeopathic remedies. Even pharmacies that don’t tend to sell much homeopathy now seem to offer homeopathy for children, suggesting pharmacies are prioritizing sales ahead of scientific evidence – because as pseudoscience goes, there is no product so demonstrably useless as homeopathy. Based on the idea that “like cures like” (which is magical thinking) and the concept that water has a memory (also magical thinking), homeopathic remedies look like medicine – but don’t have any medicine in them. Various substances are taken and diluted – not just herbs but products like “Berlin Wall”, “Stonehenge” and even “Rabbit Anus” are considered potential “remedies”. The net effect is that while there are hundreds of homeopathic products sold, it’s effectively all the same thing – an inert placebo. The granddaddy of the homeopathic cold remedies is Oscillococcinum, a product of fermented duck’s heart and liver that has been diluted so dramatically (1 part in 100, 200 times in a row), that in order to consume even a single molecule of the original fermented duck, you would have to swallow a volume of tablets greater that the mass of the entire universe. The chance of effectiveness or side effects with this product is equally remote. Boiron, the manufacturer, has several other cough and cold products, including Stodal, a “toxin-free” homeopathic cough syrup without any demonstrated evidence of efficacy, either. There are other manufacturers on the market now, directly targeting the children’s market. Homeocan now has an entire line of “cough and cold” “remedies” that are marketed under the banner “Kids 0-9 All Natural Medicine” which were created by “a pharmacist and professional homeopath”. The cough and cold product is labelled “Helps relieve dry cough, congestion, mucus build-up and reduce pain and fever.” when the bottle actually contains no medicinal ingredients. There’s also NatraBio, which is advertised to be useful in children as young as 4 months, and it’s claimed:
Treating children with homeopathy utilizes nature’s medicines to gently relieve symptoms and promote healing. Homeopathic medicine is a safe treatment for most minor ailments. Precise levels of homeopathic ingredients work safely and without side effects.
    • All natural ingredients
    • No side effects
    • No sugar
    • No drowsiness
    • Made in accordance with the U.S. Homeopathic Pharmacopoeia.
If you didn’t know better, you could easily be fooled into thinking Natrabio is a product with medicine in it. The ingredient list, like all homeopathic remedies, is deliberately deceiving:
Active Ingredients: Aconitum Napellus (Monkshood) 3X, 6X, 12X, 30X (Aconite), Echinacea Angustifolia (Coneflower) 3x (Coneflower), Allium Cepa (Red Onion) 6X (Red Onion), Hydrastis Canadensis 6X (Golden Seal), Euphrasia Officinalis (Eyebright) 6X (Eyebright), Gelsemium Sempervirens 6X (Yellow Jessamine), Sanguinaria Canadensis (Blood Root) (Blood Root), Sticta Pulmonaria (Lungwort) 6X (Lungwort)
3X is a 1:1000 dilution. 6X is a 1:1,000,000 dilution. While there may be a few molecules of monkshood or red onion in the final dilution, it is all for intents and purposes inert, as these ingredients would not have any medicinal effects.
Zarbee’s
Not all the new cough and cold remedies are completely inert. Pediatrician Zack Zarbock created the honey-based cough syrup Zarbee’s, which is marketed as claiming it “maintains immune function” but actually contains:
Per teaspoon (5mL)
    • Honey 4.15 mL
    • Vitamin C 34 mg
    • Zinc 1.65 mg
Zarbee’s is effectively diluted honey, with a few vitamins added. Zarbee’s claims it is “clinically proven” but there are no trials in Pubmed using the product or its combination of ingredients. There are a few trials that show plain honey may be equivalent or superior to dextromethorphan (which is more than likely ineffective) and may be better than placebo or no treatment. So while it’s possible that pure honey may offer a modest effect on cough, the same can’t be said (with certainty) for Zarbee’s, as there are no studies with this particular product. Moreover, there is no evidence that vitamin C provides any meaningful effects in children with coughs and cold. And while there is some promising but conflicting evidence studying zinc lozenges for colds in adults, its use in children has not been established as effective. And there’s no evidence at all to suggest that zinc supplied as a syrup has any meaningful effects. The bottom line is that Zarbee’s doesn’t offer any demonstrable advantage over pure honey. Zarbee’s also markets a cough syrup for infants (aged 2-12 months) that contains agave nectar instead of honey. There is no published evidence to suggest that agave is effective for the treatment of cough in infants. And Zarbee’s also markets a “mucus relief” version which is honey and ivy (Hedera helix), the evidence for which is summarized below.
Helixia
Helixia is a new (to North America) line of cough and cold remedies that are marketed for children as young as 1-year old (and younger, “with consultation”). The active ingredient is English ivy leaf extract (Hedera helix). Leaves are purported to have expectorant and antispasmodic properties owing to irritation of the gastric mucosa, a mechanism of action which is unproven. The manufacturer claims the product is “clinically proven” but there’s no information on the website to support this claim. An enquiry to the manufacturer (Pendopharm) for evidence resulted in a link to Fazio S et al., “Tolerance, safety and efficacy of Hedera helix extract in inflammatory bronchial diseases under clinical practice conditions: a prospective, open, multicenter postmarketing study in 9657 patients“. The title tells you all you need to know about this study’s quality – it was an open label survey that asked about effectiveness and safety in children with inflammatory lung disease – not colds. When I pressed the manufacturer further, they provided me with the citation “Efficacy and tolerability of ivy-containing cough remedies, a study in children with recurrent obstructive airway disease”. It’s published in a German journal, dated 1996, and doesn’t appear to be in Pubmed or available online. It’s poorly written and missing most of the signs of a quality study. The researchers looks at airway function in children aged 6-15 with obstructive airway disease (not children with the common cold) and reported improvements in pulmonary function – not measures related to colds. Another irrelevant study. A search on my own was more instructive:
“Systematic Review of Clinical Trials Assessing the Effectiveness of Ivy Leaf (Hedera helix) for Acute Upper Respiratory Tract Infections” seems to provide the best overview, which is probably why the manufacturer was reluctant to provide it or mention it. Most of the relevant trials were published in Germany which makes reviewing the original trials difficult. Of the ten trials published, the authors noted that only one was considered high quality, and that trial excluded children from the study. The authors did not identify any trials that compared ivy leaf alone (the composition of Helixia Prospan) with placebo, which is the comparison we’re looking for. The authors concluded:
Although all studies report that ivy extracts are effective to reduce symptoms of URTI, there is no convincing evidence due to serious methodological flaws and lack of placebo controls. The combination of ivy and thyme might be more effective but needs confirmation.
That’s the conclusion that other groups have reached. The Natural Medicines Comprehensive Database says there is insufficient evidence to evaluate the effectiveness or safety of ivy. The Natural Standard, another publication, gives it a “C” (unclear or conflicting) rating for childhood asthma and obstructive lung disease, and no rating at all for coughs and colds. The manufacturer claims there are no drug interactions, but there is no evidence this has been systematically studied. In short, Helixa Cough Prospan is a poorly studied herbal remedy with no convincing evidence of effectiveness for the treatment of coughs or colds, in either adults or children.
Conclusion
It’s not possible to keep up with all of the new cough and cold products for children appearing on the market. But it is easy to understand the current state of the evidence, and the current treatment guidelines. There is little convincing evidence that the marketed cough and cold products for children have meaningful effects. Consequently, medicating children is generally unnecessary and sometimes inadvisable. It needs to be emphasized that coughs and colds are self-limiting illnesses – children will recover, with or without treatment. Manufacturers of cough and cold remedies are actively trying to convince consumers otherwise, and they’ve been aided by weak regulatory standards that are permitting products to be sold, often without any convincing evidence that they work. The result is a marketplace that’s reminiscent of where we were, with ineffective and unnecessary treatments crowding pharmacy shelves.

Decongestant doesn’t work, concludes FDA advisory committee
An FDA advisory committee has concluded that phenylephrine, a popular decongestant in cough and cold remedies, is ineffective.
Scott Gavura on September 28, 2023
Link


Earlier this year I noted that the FDA had committed to re-evaluating a popular but ineffective cold remedy ingredient, phenylephrine. The Non-prescription Drug Advisory Committee met in September 2023 to discuss the effectiveness of phenylephrine as an ingredient – both as a single agent (like the box above) and when combined with other ingredients. Not surprisingly, and consistent with the accumulated data, the committee concluded that the evidence does not support that phenylephrine is effective as a nasal decongestant. 
What is phenylephrine?
In 1976, the FDA concluded that three medicines were safe and effective for the treatment of nasal congestion caused by colds, allergies, and sinusitis: phenylpropanolamine, pseudoephedrine, and phenylephrine. Phenylpropanolamine was subsequently withdrawn from the market after use was associated with strokes. Pseudoephedrine is an effective decongestant. However it is chemically very similar to methamphetamine, an addictive and controlled drug that subject to abuse. Because pseudoephedrine can be used to manufacture methamphetamine, the over-the-counter sale of cough and cold products that contain this ingredient are not permitted in the USA. Sales were moved “behind the counter”, with the requirement for the customer to produce photo identification and the requirement for the pharmacy to maintain a log of all sales, tracked by customer name and address. (This restriction does not exist in other countries.)
When pseudoephedrine was moved behind the counter, manufacturers of cough and cold products either had to accept a much smaller market for their products, or find a substitute. Some companies reformulated their products to contain phenylephrine instead, the last remaining non-prescription ingredient that the FDA had approved for congestion. Phenylephrine is from a category of drugs called alpha-1 agonists, that stimulate alpha-1 receptors that are present throughout the body, including the nasal passages. It is used as a nasal spray, but more commonly as a oral product take to treat nasal congestion. There was a problem with FDA’s approval, however. There was little convincing evidence phenylephrine, when taken orally, was effective.
It may not be effective. But you cannot make methamphetamine from it.
The evidence against phenylephrine
Phenylephrine is a poorly-absorbed drug (i.e., it has low bioavailability). Most of the drug is broken down during the absorption process and after passing through the liver. Only an estimated 38% of a dose actually reaches the bloodstream (compared with 90% for pseudoephedrine). In clinical trials, phenylephrine has been compared to other decongestants and has not been shown to be effective. The fact that we are relying on trials conducted in the 1970’s pretty much tells us what we need to know about phenylephrine. Given how poorly it is absorbed, there is the question of whether simply giving bigger doses will work – and it turns out it may. However, the 10mg dose is what’s available in US cough and cold products – and the best evidence shows that this drug is effectively a placebo at that dose. In a review of the data that the FDA had considered, that review noted that for the 10mg dose, 4 studies showed efficacy and seven showed no difference from placebo. The authors concluded that a systematic review did not support the FDA’s decision. Other trials conducted since that time (like this one in 2009) are supportive of the conclusion that the 10mg dose is ineffective.
In September 2023, the FDA reviewed the evidence to support phenylephrine as a cough and cold ingredient. Here are a few of the key slides and conclusions:
Phenylephrine has action against alpha receptors – not its metabolites. Less than 1% of the drug is actually absorbed as the “active” drug. The maximum effective blood concentration (Cmax) is lower than the EC50, which is half maximal effective concentration. The drug is quickly eliminated from the body. And here is their bottom line on the clinical data, which won’t be surprising based on the pharmacology of the drug in the body:
The agency commented that the data available today refutes some of the assumptions made back in the 1970’s (pg. 55):
Finally, the science has changed in the interim, and a full understanding of the clinical pharmacology of PE [phenylephrine] when administered orally was not appreciated at the time that the Panel issued its recommendations. We now know that in addition to PE having less than 1% systemic bioavailability, the half-life is also significantly shorter than the original 4-hour dosing interval. These data were not available to the Panel, nor was the technology to fully assess oral bioavailability available until around the turn of this century. Therefore, is it not surprising that the Panel considered the equivocal findings in the original studies as sufficient to support a finding of efficacy (and safety) of PE 10 mg administered orally every 4 hours.
and, interestingly (pg. 60),
After careful review, we note that there were many methodological and statistical issues with these studies. We believe that these issues significantly limit any judgement of a statistical “win”, and more importantly a clinical “win”, for any of these studies. In fact, if these studies were submitted to the Agency today all would at most be considered Phase 1 studies at best. As a result, we believe that these studies do not stand up to the new data that are now available with regard to the efficacy of orally administered PE as a nasal decongestant.
Ultimately, the committee unanimously concluded that the evidence does not support that the recommended dosage of orally administered phenylephrine is effective as a nasal decongestant. No safety issues with use of oral phenylephrine at the recommended dose were identified.
Is this the end of phenylephrine?
The advisory committee’s conclusion was consistent with what many cold sufferers already knew: This drug doesn’t work.
The FDA’s briefing points out important benefits of changing the status of phenylephrine: reducing health care costs from taking a drug with no benefit, reducing the risk of allergic reactions or other side effects (when used in combination with other products), avoiding risk (especially with combination products) of taking an excessive amount in order to seek some benefit, minimizing risk to children, and importantly, it eliminates the missed opportunity to use a product that actually works.
This isn’t a final decision – yet. A advisory committee provides independent advice and recommendations to FDA. It will consider the input of this advisory committee before making a decision about the ongoing availability of oral phenylephrine. With this ingredient in which $1.8 billion of cough and cold products sold in the USA, it will be interesting to see how manufacturers (and consumers) of these products will react, given the advisory committee’s advice.

Medicine Must-Haves: A Pharmacist’s Guide to Your College Student’s First Aid Kit
A pharmacist recommends medications for a basic first-aid kit.
Scott Gavura on August 28, 2025
Link
Sending a child off to college or university is a milestone filled with excitement, anxiety, and – if you’re a pharmacist – a bit of overthinking about their medicine-related needs. (Just me?) Beyond the usual concerns, like roommates, buying a refrigerator, and moving across the country, there is less obvious but still important question – how do we set our kids up for independence, medicine-wise? While most young adults are generally healthy, the reality is that minor injuries, stomach upsets, headaches, and allergies don’t disappear at school, and they won’t have their parents around to help them. A well-selected first aid kit can help students effectively treat minor issues. It’s also worth noting which medicines are best avoided because they are ineffective, have side effects, or should be used only on the advice of a health care professional. Here is one pharmacist’s guide to medicines to consider for a basic/minimalist medicines kit for students. And it’s not just students – I have the same medicines on hand for when I travel (pictured above).
The Disclaimers
Before diving into my recommended medications, it’s worth noting a few key considerations and limitations. First, this list focuses on pharmaceuticals; items like bandages and thermometers are worth considering in a first aid kit, but they’re not part of this discussion – there are plenty of guides you can find on what to include. Second, each student’s health needs and medical history will be different. Allergies, chronic conditions, or sensitivity to certain medications should always guide what goes into a medicines kit. If unsure, check with a licensed health professional who knows their health history. I am not your pharmacist, so what I’m suggesting here is general information that does not reflect what might be most appropriate considering specific medical circumstances. With these points in mind, here are the medicines this pharmacist would generally recommend, and those best left at home. I’ll divide this into categories.
Pain and Inflammation
Most first aid kits should include acetaminophen, typically 325 mg or 500 mg tablets. These are effective pain relievers and are generally very safe when taken at recommended doses. They also have the advantage of not irritating the stomach. The main limitation of acetaminophen is that it does not treat inflammation. For other types of pain, or pain that doesn’t respond well to acetaminophen—such as minor injuries—an anti-inflammatory drug like ibuprofen 200 mg is my preferred choice. It’s widely available, easy to dose (1–2 tablets at a time), and effective for both pain and inflammation. An anti-inflammatory alternative to ibuprofen would be naproxen which has the advantage of less frequent dosing, but at the expense of more stomach and digestive complications, especially with prolonged use.
Digestive Issues
For common stomach problems, a few well-chosen medications can be very helpful and will be appreciated if they are accessible. Antacids like Tums (essentially calcium carbonate) provide quick relief for occasional heartburn or acid discomfort. For longer-lasting control, products that reduce stomach acid, such as famotidine (preferred over ranitidine because of safety concerns) can be useful for heartburn or stomach upset. There is also omeprazole, a proton pump inhibitor, but I don’t recommend it for first aid, because it takes days to reach peak effectiveness. If you need to take either product regularly, it should be on the advice of a physician.
For diarrhea, loperamide (Imodium) can be a lifesaver. It can help quickly get symptoms under control and allow your student to stay on schedule. While fine for occasional use, it should not be used if there’s a fever or blood in the stool, since loperamide treats the symptom rather than the underlying cause of the diarrhea. I recommend loperamide over any other antidiarrheal because of how quickly it works.
Allergies and Allergic Reactions
An antihistamine such as loratadine or cetirizine is a good choice for students who experience seasonal allergies, insect bites, hives, or other mild allergic reactions. These medications generally do not cause drowsiness (though cetirizine is more sedating than loratidine), making them convenient for busy active students. I do not recommend diphenhydramine – it causes drowsiness and is not more effective than the non-sedating antihistamines for common allergic reactions.
Topicals
Topical medications can help with minor skin issues. A mild non-prescription corticosteroid cream, such as 1% hydrocortisone, is useful for relieving irritation from insect bites, mild rashes, or other skin irritations. It’s generally safe for short-term use on small areas. However, avoid topical antihistamines – they are not effective.
For minor cuts, scrapes, or burns, a topical antibacterial ointment like bacitracin or a triple-antibiotic ointment can help prevent infection while the skin heals. Used sparingly, these products are typically well-tolerated.
What to Leave Out
Not every medication belongs in a student’s first aid kit. There are several I do not recommend.
Narcotic-containing products, such as codeine-based pain relievers or cough syrups, should be avoided entirely. These products carry risks of dependence, sedation, and are unnecessary for most minor pain.
Most over-the-counter cough and cold products offer limited benefit and can cause unwanted side effects, especially multi-ingredient formulations that combine decongestants, antihistamines, and pain relievers. These can be confusing to dose and often contain unnecessary or ineffective ingredients.
Drugs to promote sleeping (non-prescription) are not recommended. While it is popular, I do not recommend melatonin because of the lack of evidence and questionable manufacturing standards.
Herbal supplements. All of them. If you’ve read any of my posts for the past 15 years you’ll know why.
Conclusion
A thoughtfully stocked first aid kit won’t solve every health issue, but it can empower young students to manage common problems confidently and safely. The essentials I’ve suggested here reflect a minimalist, practical approach, one that I use myself when traveling. You can fit all these products into a small bag or box. Tip: When you pack the kit, note the earliest expiry date, write it on a label, and attach that label to the outside of the kit. A little preparation now can save stress and anxiety down the road, and gives students and their parents more peace of mind.
What did I miss?


HIV

More HIV Nonsense in Africa
Steven Novella on October 10, 2012
Link
It is estimated that 5% of people living in Sub-Saharan Africa are infected with HIV – that’s 22.5 million people. Infection rates vary wildly from country to country, with Swaziland having the highest rate at 25.9%. Gambia is below average, at 2% or 18 thousand people, but still has a serious HIV problem, and now finds themselves at the center of the HIV controversy in Africa.
This epidemic has been magnified by unfortunate realities on the ground. Africa has an insufficient public health and medical infrastructure to deal with the massive challenge such an epidemic presents. This has led the World Health Organization to contemplate partnering with local traditional healers, to make them into an extension of the effort to bring modern medical treatment to the HIV-infected in Africa. This desperate strategy is fraught with problems, not the least of which is that most traditional healers have had no prior contact with science-based medicine.
Former South African president Thabo Mbeki seriously set back his country’s HIV efforts by embracing crank HIV denial. Coupled with his denialism was efforts by Health Minister Manto Tshabalala-Msimang to use traditional medicines to treat HIV/AIDS. This combination resulted in restrictions on the distribution of anti-retoviral drugs in South Africa that is estimated to have cost hundreds of thousands of lives.
Tshabalala appealed to local tradition over science and evidence, and in fact resisted attempts to scientifically study her beet-root and other “natural” remedies. She argued that treatment with traditional methods should not get “bogged down in clinical trials” and criticized attempts to impose “Western science” on African methods.
Joining the ranks of leaders contributing to, rather than ameliorating, the HIV epidemic in Africa is Gambian President Yahya Jammeh. He is promoting the traditional medicine approach, adding his own cult of personality angle. He claims to have invented a secret formula of boiled herbs. In a state television address he said:
“Just as the Prophet Mohammed prevailed and established Islam (…)I also prevailed to cure HIV/AIDS to the point that 68 are being discharged today,”
“Who am I to expect that everybody would praise me.”
His herbal treatment also requires that patient stop their anti-retroviral therapy – which has garnered criticism from the WHO. Jammeh’s treatment is also more than just herbs. It has a healthy dollop of religion as well:
The treatment involves several herbal cream applied and consumed over a number of weeks and prayer from the Qur’an. His patients have to renounce alcohol, tea, coffee, theft and sex for the duration of their treatment.
He is also quoted as saying:
“Those who said that HIV/AIDS is not curable may be right because if you don’t know God and you believe that you descended from frog and you are not created by the Almighty Allah or you came to this world through evolution then you would not know that anything that happens in this world good or bad, Allah knows about it and has solutions about it. There is no disease that the Almighty Allah doesn’t know about and there is no disease without a cure.”
This all may seem strange and even primitive, but it is not fundamentally different from any form of faith healing in the West, or even most forms of co-called alternative medicine. The psychological elements are all the same. Treatments often involve avoiding alleged toxins or unhealthy foods or activities, and require a certain amount of faith – if not overtly religious, then in the human energy field, meridians, or magical homeopathic energies.
We also see the mislabeling of magical faith-based treatments as “traditional” in order to make them more palatable. Finally, despite frequent claims that alternative treatments are “complementary” to science-based medicine rather than a replacement for it, they are frequently a replacement for science-based therapies.
Once you reject rigorous science-based standards as the basis for modern medicine, then there is no practical or philosophical difference between whatever “alternative” treatment you offer in its place and the dangerous herbal witchcraft of Jammeh. The only difference between homeopathy, acupuncture, healing touch and Jammeh’s herbs is subjective and cultural.

Science vs HIV
Steven Novella on July 10, 2024
Link

The Human Immunodeficiency Virus (HIV) is a global pandemic, with 39 million cases worldwide, and over 1 million new infections each year. While it rose to epidemic and then pandemic levels in the 1980s, the first case goes back to 1959. HIV is a retrovirus that inserts its genetic material into the DNA of host cells, and targets the immune system as a “preemptive strike”, leaving those infected susceptible to opportunistic infections and cancers.
It has also been the target of a global effort to treat and prevent new infections, with fairly steady success over the last four decades. HIV is now manageable as a chronic illness, and effective treatments have lead the WHO to declare a goal to reduce new infections to zero by 2030. At the same time HIV has been the target of considerable pseudoscience, including denial that it exists and causes AIDS, that it was manufactured as a government conspiracy, and that there are numerous “alternative” treatments for HIV.
HIV has therefore been an interesting microcosm of the struggle between science and pseudoscience in tackling serious disease. It is helpful to look back over the history of this struggle – because there has been a clear victor. The proclamations and predictions of the deniers, alternative medicine gurus, conspiracy theorists, and pseudoscientists have all come to nothing. Meanwhile scientists have dissected HIV down to its core and devised numerous effective treatments.
We can now add one more victory for science against HIV – a preventive treatment that shows an astounding 100% efficacy in a phase III clinical trial. The treatment, lenacapavir, is a new PrEP strategy (pre-exposure prophylaxis) trialed in women in South Africa and Uganda. The treatment was compared to existing PrEP treatments, and was deemed so effective the trial was stopped early so that participants could choose to go on the new treatment.
Existing PrEP drugs include:
“Truvada® (emtricitabine/tenofovir disoproxil fumarate) is for all people at risk for HIV through sex or injection drug use. Generic versionsExit Disclaimer are also available.Descovy® (emtricitabine/tenofovir alafenamide) is for sexually active men and transgender women at risk of getting HIV. Descovy® is not for people assigned female at birth who are at risk for HIV through receptive vaginal sex.”
There is also Apretude® (cabotegravir), an every other month injection.
These treatments are about 99% effective in preventing infection, if used correctly. The tenofovir treatments are replication inhibitors. They are incorporated into HIV’s DNA where they stop replication. Cabotegravir binds to the enzyme integrase, which is necessary for the virus’s DNA to integrate into host DNA.
The “if used correctly” caveat is critical. The daily pills must be taken daily, and take between 7 and 21 days to achieve full efficacy. Taking a daily medication without exception can be challenging for many at-risk populations. Preventive strategies are best evaluated by “intention to treat” analyses. It is certainly necessary to demonstrate efficacy – that the treatment actually works. But it is also necessary to demonstrate effectiveness as a prevention strategy. If the drug works but few people take it for whatever reason, it’s not very effective.
The new treatment, lenacapavir, is given as an every six month injection. This is potentially a huge advantage, as one treatment provides six months of protection. The recent clinical trial, Purpose 1, compared lenacapavir to the two tenofovir treatments in a double-blind fashion. They found:
“During the randomised phase of the trial none of the 2,134 women who received lenacapavir contracted HIV. There was 100 percent efficiency.
By comparison, 16 of the 1,068 women (or 1.5%) who took Truvada (F/TDF) and 39 of 2,136 (1.8%) who received Descovy (F/TAF) contracted the HIV virus.”
Zero cases out of 2,134 women is impressive. I tried to find out how long a period this was, but the data is given per 100 person years. This is not helpful when the incidence is zero. But the methods indicates follow up for at least 52 weeks. Further, young women were studied because they are considered a very high risk population in these countries.
The fact that lenacapavir is 100% effective and is convenient, as a twice yearly injection, is significant. The pharmaceutical company, Gilead Science, says they will make the drug available to generic producers, which should keep the price down. This will hopefully make it affordable for countries to then provide the drug for free or at very low cost to their populations. It is certainly cost effective to prevent an HIV infection rather than treat HIV for decades.
In a way science has done its job, now it is up to the WHO and world governments to do their job. The goal of reducing new HIV infections to zero by 2030, while difficult, is not unachievable. It even raises the possibility of eventual elimination. It will be hard to eradicate as there are animal reservoirs, but cross-species infections are likely to be rare.
This is all great news. It is also important to step back and see the big picture. Science has steadily delivered and has given us the tools to fight this virus and possibly eliminate it. Pseudoscience has given us literally nothing, and has only served to delay and confound proper treatment.

PreP for HIV/AIDS
Two pills and an injection are FDA-approved to prevent HIV infection. Not enough patients and providers know about them.
Harriet Hall on August 30, 2022
Link

The Centers for Disease Control and Prevention (CDC) publishes guidelines and updates for preventing HIV infection. They call it Pre-Exposure Prophylaxis or PrEP. People at risk for HIV infection can be “PrEP-ared” to avoid infection.
FDA-approved medications for PrEP
The FDA has approved three medications for PrEP, two taken orally and one via injection:
     1.  Truvada
     2.  Descovy
Both of these are single tablets taken orally once a day. They are combinations of the two drugs emtricitabine and tenofovir. Both contain 200mg emtricitrabine; Truvada contains 300 mg. tenofovir disoproxil; Descovy contains 25 mg tenofoviralafenamide. Both forms of tenofovir have demonstrated similar efficacy in clinical trials. Truvada is recommended for all adults and adolescents weighing at least 77 pounds who are at risk through sex or injection drug use. Descovy is not recommended for people assigned female at birth who could get HIV through receptive vaginal sex; it has not yet been studied for HIV prevention in that population.
     1.  Apretude (cabotegravir) – an injection given in the buttocks every 2 months after 2 initial doses 1 month apart; recommended for all people at risk through sex.
They caution that these drugs do not cancel the need for other preventive measures. They “should be considered part of a comprehensive prevention plan that includes a discussion about adherence to PrEP, condom use to prevent getting other sexually transmitted infections (STIs), and other risk-reduction methods”.Their website estimates the effectiveness of PrEP as 99% for sexual transmission and 74-84% for injection drug users.The US Preventive Services Task Force did a systematic review of the evidence as of 2019. Their report was published in The Journal of the American Medical Association (JAMA). They found a relative risk of HIV infection of 46% in patients using PrEP compared to those using placebo, an absolute risk reduction of 2%. Efficacy was highly dependent on adherence, with good adherence decreasing the relative risk to 27%. There were more adverse renal and gastrointestinal adverse effects with PrEP than with placebo, but most adverse effects were mild and reversible.
Advantages of Injectable
Since the efficacy of oral PrEP is so dependent on adherence, an injection might improve efficacy by eliminating the need to remember to take a daily pill. But it would be rejected by those who hate needles. Cost is not an advantage. Truvada costs $2,000 a month; Apretude costs $3,700. But cost may not be an important consideration for patients, since several assistance plans are available that may reduce their cost to $0.It will be interesting to see how usage compares. It might be difficult to remember when the 2 months is up, but that can be addressed with automatic reminder systems.
Apretude efficacy vs Truvada
The pill and the injection have been compared in two randomized double-blind trials. Apretude was more effective, but the numbers varied. Adverse effects were more common with the injection. Apretude carries a boxed warning to the provider, who must verify that the patient is HIV negative before each injection. There are also warnings and precautions regarding hypersensitivity reactions, liver damage, and depression.
Conclusion: Many new HIV infections could be prevented
It’s encouraging that many (maybe most) new HIV infections could be prevented with PrEP. New HIV infections continue to be diagnosed, with racial inequities. The number declined the most among White gay and bisexual men. PrEP is not reaching everyone who could benefit. In 2017, 27% of Black and 31% of Hispanic/Latino gay and bisexual men were using pre-exposure prophylaxis (PrEP) to prevent HIV, compared with 42% of White gay and bisexual men. It’s important to make sure all those at risk know about PrEP and that everyone who requests it is given it. Science has made great strides, but we can do better.

There’s No Vaccine for HIV/AIDS, But There’s Truvada
Science has made great strides in understanding, treating, and preventing HIV/AIDS. We can hope for an AIDS vaccine, but meanwhile there is a pill that can markedly reduce the risk of becoming infected.
Harriet Hall on October 1, 2019
Link

The story of HIV/AIDS illustrates the value of science-based medicine. The first cases of AIDS were reported in 1981. By 1983, only two years later, two different research groups under Luc Montagnier and Robert Gallo had independently identified the cause of AIDS: a retrovirus that is now known as human immunodeficiency virus (HIV). Treatment with anti-retroviral drugs originally required multiple drugs given on a complicated schedule with many doses a day; they often caused unwanted side effects. Today patients can be treated with a once-a-day combination pill using lower doses that cause fewer side effects. AIDS was once considered a death sentence, but today it has become a chronic treatable disease with near-normal life expectancy. A 20-year-old with HIV can expect to live to 78.
Research is ongoing, but as yet there is no vaccine available. While we wait for a vaccine, there is a viable alternative that not everyone is aware of. People who are at high risk of becoming infected with HIV can take a daily pill that will markedly reduce their chances of infection. It’s expensive; it’s not perfect; but when we educate people about safe sex practices, shouldn’t we also educate them about the possibility of pre-exposure prophylaxis (PrEP)? I wonder if the average American even realizes there is such a thing.
What is Truvada?
Truvada is the most well-known of several brand names for a fixed-dose combination of two antiretroviral drugs: tenofovir disoproxil and emtricitabine. It is a pill taken once daily. It was approved in 2004 and is on the World Health Organization’s list of essential medicines. Wholesale cost in the developing world is US$6.06 to $7.44 a month; in the US it costs $1,415.00 per month. Why?
Is it effective?
A Cochrane systematic review estimated that PrEP could reduce the risk of infection by as much as 50%.
These four clinical trials are listed on the CDC website:
    • A 2010 study published in The New England Journal of Medicine found a 44% reduction in the rate of HIV infection with PrEP compared to placebo in men who have sex with men (MSM) . Detectable blood levels were strongly correlated with the prophylactic effect.
    • A placebo-controlled study in 2012 in Botswana found PrEP was 62.2% efficacious in preventing infection in heterosexual adults.
    • Another 2012 study in Kenya and Uganda looked at heterosexual couples where one partner was HIV-positive. The combination of tenofovir and emtricitabine reduced the risk of infection by 75% and tenofovir alone reduced the risk by 67%.
    • A 2013 randomized, double blind, placebo-controlled phase 3 study of HIV-negative adults in Bangkok, Thailand found a 9% reduction in infections in patients who used injection drugs.
Is it safe?
The most common side effects in HIV-negative patients are headache, abdominal pain and weight loss. The package insert carries numerous warnings. It can cause liver complications including severe hepatomegaly with steatosis. There is a risk of drug resistance if it is used in undiagnosed HIV infection; periodic verification of HIV-negative status is required. It should be used along with safe sex practices and it must be taken every day without fail. It can cause kidney problems, lactic acidosis, and bone problems. Its safety in pregnancy is not known.
Patients should weigh at least 77 pounds and be at risk of infection with HIV.
Who is a candidate for PrEP?
Truvada can be used to treat HIV/AIDS, but it has also been recommended for people who are HIV-negative if they:
    • Are men who engage in unprotected anal sex with other men
    • Are in a sexual relationship with an HIV-positive individual
    • Do not use condoms
    • Are transgender individuals who engage in high-risk sexual practices
    • Engage in transactional sex (for money, drugs, etc.)
    • Inject drugs and share equipment or are in high-risk groups
    • Use stimulants like methamphetamine that are associated with high-risk behaviors
    • Have been diagnosed with more than one anogenital sexually transmitted infection in the past year
What about circumcision?
An article in The BMJ explained:
there is now compelling epidemiological evidence from over 40 studies which shows that male circumcision provides significant protection against HIV infection; circumcised males are two to eight times less likely to become infected with HIV. Furthermore, circumcision also protects against other sexually transmitted infections, such as syphilis and gonorrhea…
It is recommended by the World Health Organization and has been adopted in Africa as a means of reducing HIV infection, but it has been criticized as inappropriate in developed countries with good hygiene, and many people are adamantly against circumcision for various reasons, some better than others. Most of the objections are ideological and philosophical rather than based on any scientific evidence of harm.
Superstition and science denial
Science has made considerable progress in understanding, treating, and preventing HIV/AIDS. But it has had to fight superstition and science denial every step of the way. There are still those who claim that poverty, not HIV, is the cause of AIDS, that anti-retroviral drugs are poisons, and that HIV tests are flawed. All kinds of untested, ineffective remedies have been proposed; the infamous Dana Ullman even recommends homeopathy for AIDS. These people ignore the evidence or try to explain it away, sometimes with fatal results, as in the case of Christine Maggiore, who refused anti-retroviral treatment for herself and her 3-year-old daughter. They both died of AIDS. Herbal remedies have been used in place of effective drugs. Hundreds of thousands of South Africans died unnecessarily because science denial influenced public policy: the health minister, Dr. Manto Tshabalala-Msimang was an AIDS denialist who promoted dietary measures like lemons, garlic, and olive oil and denied effective drugs to patients in South Africa. She was known as Dr. Beetroot for one of her dietary AIDS cures.
Conclusion: Science saves lives; superstition doesn’t
Science works. Scientific discoveries have identified the cause of HIV/AIDS, have saved lives, and have turned a deadly diagnosis into a manageable chronic disease that doesn’t even shorten life. Alternative medicine has nothing to offer but false hope; people who rely on diet, herbs, or homeopathy die. We can hope for an effective vaccine, but meanwhile we have effective treatments and effective preventive measures such as Truvada. In the 21st century, no one should become infected with HIV or die a preventable death because of ignorance or misinformation.

Second Patient Cured of HIV Still Clear
The second patient apparently cured of HIV had a good 30 month check up. What are the implications for HIV treatment?
Steven Novella on March 11, 2020
Link

Popular culture celebrates firsts. Everyone knows the first person on the Moon, the first person to fly across the Atlantic and the first African American major league baseball player, while few can name the second. But in some contexts, such as science, the second is arguably far more important. A one-time event can be a fluke, while a second is replication and confirmation.
Such is the case with the London patient, the second patient to have been apparently cured of HIV (the first being the Berlin patient). The Lancet HIV has just published a 30 month follow up of the London patient, finding that they are still free of intact HIV – apparently cured. What does this mean for the prospects of an HIV cure?
The two patients were treated in a similar way, with total bone marrow replacement. This is considered a high-risk treatment only suitable for desperate situations, and will not become a standard treatment. The Berlin patient was treated with total body irradiation followed by two rounds of bone-marrow transplant and then chemotherapy. The transplant came from a donor with the CCR5 variant that is resistant to HIV (they do not express CCR5, which is a T-cell receptor HIV uses to infect cells). The Berlin patient remains HIV free off anti-retroviral drugs.
The London patient was treated with one round of bone marrow transplantation and a milder form of chemotherapy, with no whole-body irradiation. So they represent not only a second case of apparent cure of HIV, but a demonstration that a less aggressive and risky treatment can be effective.
The current study sampled serum and multiple tissues to detect HIV. Specifically:
We used ultrasensitive viral load assays of plasma, semen, and cerebrospinal fluid (CSF) samples to detect HIV-1 RNA. In gut biopsy samples and lymph-node tissue, cell-copy number and total HIV-1 DNA levels were quantified in multiple replicates, using droplet digital PCR (ddPCR) and quantitative real-time PCR. We also analysed the presence of intact proviral DNA using multiplex ddPCR targeting the packaging signal (ψ) and envelope (env). We did intracellular cytokine staining to measure HIV-1-specific T-cell responses. We used low-sensitive and low-avidity antibody assays to measure the humoral response to HIV-1.
What they found was no intact HIV. They did find HIV remnants, which are essentially fragmentary “fossils” of HIV, but not intact HIV capable of infecting. Even though this is pretty thorough, it is still sampling, so they had to use a mathematical model to predict the probability of cure, which they estimate at greater than 99%. Whether or not this cure is permanent remains to be seen, as both patients will have to be followed, but these results are extremely encouraging.
What does this mean for HIV treatment going forward? Not much directly, as even the less aggressive treatment is still high risk and will only be used in extreme cases, such as life-threatening blood cancer. For most patients with HIV, standard anti-retroviral drug cocktail is still the standard of care. But these cases are an important proof of concept that has implications for future research.
One big lesson is that the CCR5 HIV resistant variant is an effective treatment for those already infected with HIV. So the next obvious question is – can we do gene therapy on HIV patients to give them the resistant variant? Will CRISPR come to the rescue?
If you recall, the two Chinese “CRISPR babies” were altered to have the CCR5 variant to make them resistant to HIV, because one of the donor parents was HIV positive. The researcher, He, is now in prison, and there is general consensus that this process was unethical and premature. But the concept is valid.
One of the early applications for CRISPR treatment involves autologous bone marrow transplants. The two HIV-cured patients were treatment with allogenic transplants, from another donor. But we could take the bone marrow out of a patient, use CRISPR to alter their genes, and then give them back to the patient. This would reduce the risk of graft failure due to rejection or graft-vs-host disease.
Even better, we could potentially use CRISPR inside patients, rather than on cells taken out of a patient. In fact, this was just reported for the first time one week ago. The treatment involved patients with a genetic form a blindness (Leber congenital amaurosis), and the CRISPR vector was injected just beneath the retina. Whether or not the treatment was successful remains to be seen.
To be clear, we are a long way away from routinely using CRISPR on HIV patients to give them the CCR5 resistant variant. But we do have some important proof-of-concept successes. The necessary clinical research will still take years, but there is a path forward. CRISPR is proving safe, so far, and the technology itself is still improving fairly rapidly.
In many ways the London patient HIV cure is a bit of a side show, but it does point the way to a potential cure for HIV in the future. It’s also another demonstration of how basic science research can pay off in unexpected ways, but that years of clinical research are necessary to translate these basic advances into practical treatments.

XMRV Chronic Fatigue Syndrome Update
Steven Novella on September 26, 2012
Link
Sometimes science works the way it’s supposed to. Scientists make hypotheses, test them by gathering preliminary evidence, and then argue about the inevitable conflicting results. Eventually better and better evidence is gathered until a consensus is achieved. Actually, I think that is how science usually works, it’s just that most questions in science are narrow and technical and don’t command media or public attention. Those that do tend to be the more enduring controversies or where a particular special interest (ideological, social, corporate, etc,) is involved.
In medicine scientific controversies may take on a life of their own, or become manufactured controversies (manufactroversies) that endure long past any genuine scientific debate. Such false controversies are often driven by patient groups who feel they are not being treated fairly or honestly, or by practitioners who do not want to give up on their favorite (lucrative) modality. This leads to a disconnect between the scientific controversy and the public controversy – a frequent theme on SBM.
I am happy to report that one such controversy has taken a turn for the good – a recent study has provided fairly definitive evidence that chronic fatigue syndrome (CFS) is not associated with either the XMRV or the pMLV viruses. The study was a consensus trial with both sides in the controversy collaborating to address all the criticisms of the earlier conflicting studies.
Background on XMRV
Chronic fatigue syndrome (CFS) is an enigmatic disorder. The primary symptom is debilitating fatigue that does not resolve with rest. Fatigue, however, is a very non-specific symptom, meaning that it can potentially result from many underlying causes. Anything that saps the energy our body uses to function will cause fatigue. In part CFS is a diagnosis of exclusion – it is based upon the presence of fatigue in the absence of any identifiable underlying cause. Therefore not everyone with chronic fatigue has CFS.
The non-specific nature of the clinical syndrome also frustrates our attempts to find the underlying cause or causes (it may, in fact, be many diseases all with a similar clinical presentation). So many things can potentially cause chronic fatigue – where do we begin. However, a chronic viral infection has long been suspected as a likely cause, at least in some cases.
An initial study (Lombardi et al published in Science in 2009) found a potential association between CFS and a retrovirus called XMRV (xenotropic murine leukemia virus-related virus). This has led some desperate patients with CFS to take anti-retroviral drugs (used mostly to treat HIV – another retrovirus) off label in order to treat their CFS. But this study, while intriguing, was considered preliminary. A second study of a related virus published in the Proceedings of the National Academy of Sciences (PNAS) in 2010 supported the association between CFS and retroviral infection.
Many patients with CFS were delighted by these findings. They seemed to confirm that their mysterious ailment was legitimate and also held out the promise of treatment.
Subsequent studies, however, failed to reproduce the findings. A larger, more rigorous and comprehensive study published in 2011 found no association at all between XMRV and CFS.
They report:
We collected blood samples from 100 CFS patients and 200 self-reported healthy volunteers from the same geographical area. We analyzed these in a blinded manner using molecular, serological and viral replication assays. We also analyzed samples from patients in the original study that reported XMRV in CFS. We did not find XMRV or related MLVs, either as viral sequences or infectious virus, nor did we find antibodies to these viruses in any of the patient samples, including those from the original study. We show that at least some of the discrepancy with previous studies is due to the presence of trace amounts of mouse DNA in the Taq polymerase enzymes used in these previous studies.
Other negative studies also were published. They further identified possible evidence of contamination that could have caused the prior study to be a false positive.
Proponents of the XMRV hypothesis, however, were not impressed. They essentially dismissed the findings of this later study by saying that the wrong technique was used to identify XMRV.
To complicate matters further, the lead researcher in the original study, Dr. Judy Mikovits, was briefly arrested in November 2011, after she was fired from her institute, on the charge that she stole computer data and lab notebooks. The charges were later dismissed, but the episode solidified Mikovits as a martyr in the eyes of hopeful patients who did not want to give up on XMRV.
Eventually the weight of negative replications reached a critical point and both Science and PNAS retracted the original two positive studies within a week of each other. In the PNAS retraction the authors wrote:
“It is our current view that the association of murine gamma retroviruses with C.F.S. has not withstood the test of time or of independent verification and that this association is now tenuous.”
Prior to the retraction, however, the current consensus trial was already underway. That study, as was suspected, provides the final nail in the XMRV CFS hypothesis. The researchers report:
Here we report blinded analysis of peripheral blood from a rigorously characterized, geographically diverse population of 147 patients with CFS/ME and 146 healthy subjects by the investigators describing the original association. This analysis reveals no evidence of either XMRV or pMLV infection.
The authors of this study include Mikovitz and Alter (an author on the PNAS study), as well as researchers who did not confirm the association. Mikovitz hoped to replicate her original findings, but like a good researcher she let the scientific chips fall where they may. The study found zero incidence of XMRV or pMLV in the CFS patients studied.
Conclusion
The XMRV hypothesis is now scientifically dead and buried, the latest study really serving as a memorial service for an already-dead hypothesis. Because researchers from both sides of the controversy were involved in designing a truly rigorous study that everyone could agree upon, there really is no wiggle room left for those who wish to support the XMRV hypothesis.
There are, of course, multiple lessons we can take from this episode. The first (and a very common theme on SBM) is that preliminary evidence is preliminary. Most of it will not pan out. This controversy resolved itself more quickly than most, but it still took several years. In medicine this means (as difficult as it may be) that patients and practitioners need to be cautious before they jump on preliminary findings.
Second – it is possible for scientists on opposite sides of a controversy to come together and resolve their differences with better evidence.
When this happens, then it is absolutely critical that the scientists on the “losing” side accept the results and make very clear and definitive statements to the public about their acceptance. Those who are invested in the failed hypothesis will be looking for any sign of dissent, any indication that there is a cover up or conspiracy. They will cling to any hint that there is something fishy going on, and they shouldn’t be encouraged by careless scientists.
Sometimes the scientists on the disproved side don’t give up, they allow proponents of their failed hypothesis to rally around them and choose to continue their career as a fringe crank championing a lost cause, rather than the honest author of a failed hypothesis.
I am glad to report that this does not appear to be the case with the XMRV story. It remains to be seen how the CFS community will respond.

IOM Recommends Replacing CFS with SEID
The Institute of Medicine has proposed replacing the terms chronic fatigue syndrome and myalgic encephalomyelitis with systemic exertion intolerance disease (SEID).
Harriet Hall on March 3, 2015
Link
Chronic fatigue syndrome (CFS) is a controversial diagnosis that has also been called myalgic encephalomyelitis (ME or ME/CFS), post-viral fatigue syndrome (PVS), chronic fatigue immune dysfunction syndrome (CFIDS), Iceland disease, “yuppie flu”, and many other names. A new report from the Institute of Medicine (IOM) says that none of those names really fit the disease and recommends it be re-named systemic exertion intolerance disease or SEID.
ME/CFS is thought to affect as many as 2.5 million Americans. The cause remains unknown, but in many cases it appears to have been “triggered by an infection or other prodromal event, such as immunization, anesthetics, physical trauma, exposure to environmental pollutants, chemicals and heavy meals, and rarely blood transfusions.” Some doctors question its very existence and interpret the symptoms as imaginary or psychological.
The IOM examines the evidence base
At the request of several government agencies including the NIH and the FDA, the IOM convened a committee of 15 experts to examine the evidence base for ME/CFS. They reviewed over 9,000 published studies and heard testimony from patients and advocates. Before publication, an additional 15 experts were asked to provide peer review. The full text of the report is available free online.
Few people will want to read the entire 304 pages, but dipping into it will give you a sense of the complexities of the issues, the rigor of their investigation, and the judgment that went into their recommendations. The section on history is particularly worthwhile.
They concluded that there was good evidence that ME/CFS is a real entity:
ME/CFS is a serious, chronic, complex, multisystem disease that frequently and dramatically limits the activities of affected patients.
They consolidated the published evidence to determine which symptoms were most representative of the disease, and they proposed new diagnostic criteria based on the best available evidence.
Problems with diagnosis
When CFS was first recognized as a new entity, it was thought to be associated with Epstein-Barr virus (EBV) and was called chronic EBV syndrome. When the relationship with the virus didn’t hold up, it was re-named chronic fatigue syndrome and a working definition was established for the purposes of research. That working definition was not originally intended for clinicians to use in diagnosing individual patients, but it was quickly adopted for that purpose without any formal validation.
Diagnosis has always been problematic: more than 70% of patients reported seeing four or more doctors before receiving a diagnosis. There have been at least 20 sets of diagnostic criteria or case definitions. One of the most commonly used is the Fukuda case definition, which requires prolonged fatigue that persists or relapses for 6 months or more, plus four or more of the following: impaired memory or concentration, sore throat, tender cervical or axillary lymph nodes, muscle pain, multi-joint pain, new headaches, unrefreshing sleep, and post-exertion malaise.
The problem with these definitions is readily apparent. Most of the criteria are subjective and not easily quantified. How much fatigue? How do you distinguish between physical fatigue and psychological fatigue? How much impairment of concentration? Everyone experiences fatigue and memory lapses; when does it become pathological? Even tenderness of lymph nodes relies on subjective patient reports and depends on how hard you press on them. Individuals with major depression, hypochondriacs, and the worried well might report enough of these symptoms to qualify. This is a very fuzzy area, and there is considerable overlap with other diagnoses like fibromyalgia, Gulf War syndrome, somatization disorder, etc. If we are going to study the condition, we want to make sure we aren’t studying a mixed bag of other conditions. In one study, 33.7% of healthy controls fulfilled the Fukuda definition.
New diagnostic criteria
The proposed diagnostic criteria for ME/CFS diagnosis requires that the patient have the following three symptoms:
     1.  A substantial reduction or impairment in the ability to engage in pre-illness levels of occupational, educational, social, or personal activities, that persists for more than 6 months and is accompanied by fatigue, which is often profound, is of new or definite onset (not lifelong), is not the result of ongoing excessive exertion, and is not substantially alleviated by rest, and
     2.  Post-exertional malaise,* and
     3.  Unrefreshing sleep*
At least one of the two following manifestations is also required:
     1.  Cognitive impairment* or
     2.  Orthostatic intolerance
* Frequency and severity of symptoms should be assessed. The diagnosis of ME/CFS should be questioned if patients do not have these symptoms at least half of the time with moderate, substantial, or severe intensity.
A new name
They say the name “chronic fatigue syndrome” has done a disservice to many patients, and the name “myalgic encephalomyelitis” fails to describe the major features of the disease. They propose renaming it “systemic exertion intolerance disease,” a name that they think more fully captures the full scope of the disorder.
Problems with diagnostic categories
Unexplained symptoms are common and frustrating. Doctors have always been puzzled by patients who complained of fatigue and a variety of associated symptoms without any identifiable pathological cause. Today’s CFS patients would once have been diagnosed with neurasthenia, a diagnosis that has been abandoned. “Fad” diagnoses wax and wane in popularity as both patients and doctors strive to give unexplained symptoms a satisfying name.
The same constellation of symptoms might be variously diagnosed by different mainstream and alternative medical providers as CFS, fibromyalgia, chronic Lyme disease, Gulf War syndrome, post-traumatic stress disorder (PTSD), multiple chemical sensitivity, environmental sensitivity, candidiasis, and any number of fake diseases. However the symptoms start, they quickly become complicated by deconditioning. As patients exercise less, they become less able to exercise. Muscles atrophy with disuse, endurance declines. Confirmation bias sets in. The sick role becomes a self-fulfilling prophecy. Whatever the underlying pathology, the degree of suffering is affected by psychological factors. It is devilishly difficult to sort out the physical from the psychological and to know how best to help these sufferers. Current treatments are not very effective.
When does a group of symptoms become a syndrome or a disease? We do our best to divide human suffering into categories and apply labels, but in the absence of valid diagnostic tests and pathophysiologic explanations, we are working in the dark. At this point, we don’t have conclusive evidence, we only have the best educated guesses of experts based on the limited evidence we do have.
Conclusion
Whatever we call it, I think it is inevitable that until we have a better understanding of this condition (or conditions?) it will be over-diagnosed by some doctors, some patients will self-diagnose inappropriately, and research will continue to be problematic. Anything we can do to make the diagnosis more precise will be welcome. The IOM proposals are a step in the right direction.

Rituximab for Chronic Fatigue Syndrome: Jumping the Gun
Harriet Hall on January 8, 2013
Link
Now that the XMRV myth has been put to rest, patients with Chronic Fatigue Syndrome (CFS) are no longer jumping the gun to demand anti-retroviral treatments. But they are jumping the gun in new ways, based on very preliminary data coming out of Norway.
A correspondent in Norway wrote to tell me patients from Norway with myalgic encephalitis/chronic fatigue syndrome (ME/CFS) are travelling to the US to have Dr. Andreas Kogelnik in San Francisco treat them with IV infusions of rituximab, apparently to no avail. A course of treatment costs over $6000, not to speak of travel and other expenses.
What is Rituximab?
It’s a chimeric monoclonal antibody against the protein CD20, and it destroys B cells. It is used to treat diseases with excessive, overactive, or dysfunctional B cells such as some lymphomas, leukemias, transplant rejection, and some autoimmune disorders, notably rheumatoid arthritis. It is expensive (several thousands of dollars per infusion), must be given IV, and can cause serious adverse effects including infusion reactions, reactivation of infections, and cardiac arrest.
Using it for CFS is not based on any clear scientific rationale, but only on a few observations of patient improvement and on speculation about a possible cause of CFS that might explain the observations. It has certainly not been established that CFS symptoms can be attributed to B cell abnormalities.
A Patient’s Story
A blogger in Canada has chronicled her experience at great length. She has been travelling to San Francisco for treatments, and she believes she is enrolled in a pilot study. A quote from her blog:
The treatments I would receive are not considered a clinical trial, but a pilot study because clinical trials are tightly regulated and operated. It needs a lot of work from investigators to establish guidelines and procedures, obtain approval from ethic boards, etc.
When questioned, she elaborated:
a pilot study is not a registered clinical trial. It’s a one person trial. It gives the opportunity for the physician and researcher to gain experience with the drug and to refine the protocol associated with its administration. The goal for this is to move forward with a very formal and well controlled clinical trial.
She is hopelessly confused about what constitutes a pilot study. I can’t tell whether she was misinformed or simply misunderstood what she was told, but it raises questions about informed consent. She had worked as a chemo nurse and had been involved in phase 1 studies of new drugs so she should know better.
She says Kogelnik told her he was in touch with the Norwegian researchers (see below) every two weeks; she got the impression that he was collaborating closely with them on pilot studies. But my Norwegian correspondent contacted those researchers and they told her that while they are in touch with Kogelnik now and then, they only have general discussions about ME and immunology. He has told them he is doing some kind of study; but they have never seen the protocol, don’t know how many patients are enrolled, and are concerned that he hasn’t officially registered his study.
The blogger has made multiple trips from Canada to San Francisco. The Genentech Foundation apparently pays for the drug under a patient assistance program if the patient can document 2 refusals by insurance, but the trips and special lab tests cost her around $6000 for the year. She vividly describes the difficulties of traveling with her symptoms, arranging for wheelchairs and oxygen, etc. She says travel makes her sicker.
She has come to hate the term CFS because of its associations. She prefers to call it ME. Now she says Kogelnik has changed her diagnosis to CVID (Common Variable Immune Dysfunction), but it seems to me neither her symptoms nor his treatment match very well with that diagnosis. Perhaps she means chronic fatigue immune dysfunction syndrome (CFIDS), which is essentially a synonym for CFS. She suggests that he is using a different diagnosis because it is more acceptable to insurance companies and regulators and helps to justify what he is doing.
Her B-cells were effectively eradicated by the drug, but she got worse instead of better. She says:
I have known to expect worsening of my symptoms. Dr K warned me about it….Dr K think that it takes about 3 months to start feeling durable effects of Ritux and they seem to taper the dose down as they go.
Here’s her protocol.
Rituximab induction: Day 1 and Day 15. Dose #3 at Week 8 (I got mine at Week 9). Dose #4 at Week 24. Dose #5 at Week 44 and Dose #6 at Week 60. Pretreatment for each infusion with Tylenol, IV Benadryl, and Phenergan (to reduce the risk or severity of infusion reactions).
Despite her initial enthusiasm, the drug has not helped her. In fact she has developed various new symptoms and abnormal liver function tests, but she refuses to attribute any of these to the treatment.
I am getting resigned that I may not respond from Rituximab- but then I guess if it happens, that’s totally fine too. I hope that this process can be of help to research, notably finding out who responds and why, and who doesn’t and why.
This is particularly sad, since she was not treated as part of a controlled study that might have actually accomplished those goals. She was merely a guinea pig in an irresponsible uncontrolled experiment.
What Is the Evidence?
An initial observation. Fluge and Mella observed that a patient with CFS had an unexpected, marked recovery of CFS symptoms lasting for 5 months during and after cytotoxic chemotherapy for Hodgkin’s disease. They reasoned that the improvement was probably related to her treatment with methotrexate, a drug known to induce immunomodulation in part through B-cell depletion.
A small case series. So they decided to try depleting B-cells with rituximab in the original patient plus two others. This was published as a case series in 2009. The treatment was 2 IV infusions given 2 weeks apart, with a maximum dose of 1000mg. 2 of the 3 patients were also given oral methotrexate for recurrent symptoms.
All three patients, with 7–10 years of CFS disease duration, had substantial relief of all symptoms related to CFS after rituximab intervention. Patients 1 and 2 had a marked symptom improvement after approximately 6 to 12–16 weeks, followed by slowly increasing symptoms (yet still a benefit 6 months after treatment). Patient 3 had slight symptom improvement from 6 to 26 weeks after treatment, thereafter a major recovery of all symptoms lasting until 40 weeks after treatment, followed by a gradual worsening the following month.
One randomized controlled trial. Their next step was to do a randomized, double-blind, placebo-controlled comparison of rituximab to IV saline. 2 infusions were given 2 weeks apart to 30 patients. All patients were pre-treated with cetirizine, paracetamol and dexamethasone to minimize the risk of reactions.
They are calling it a positive study; but for their primary end-point (effect on self-reported CFS symptoms three months after intervention) the results were actually negative. They continued to observe the patients for secondary endpoints, and other secondary endpoints were added to the protocol mid-stream. They found a significant difference between the groups at 6-10 months after treatment.
They characterized this as:
significant, though generally transient clinical responses, with CFS symptom improvement in two thirds of the included patients.
Of the patients on rituximab, 10 had a major or moderate response lasting from 8–44 weeks; the other third failed to respond. Two patients in the placebo group had a major or moderate response.
The study design could have been better. There were some significant differences between the patient characteristics in the two groups, and it doesn’t appear that they questioned patients to see if they could guess which group they were in (i.e., whether blinding was adequate).
More studies in progress. They announced:
Based on new pilot patient experiences [what does this mean? Are they, too, confusing pilot studies with anecdotal evidence?] we have now started two new open-label phase-II studies investigating Rituximab treatment with two infusions two weeks apart (as in the present study) followed by maintenance Rituximab infusions at 3, 6, 10 and 15 months, to further explore this treatment principle in CFS (ClinicalTrials.gov, NCT01156909 and NCT01156922).
Strangely, both of these studies are open-label, with no control group and no blinding. What were they thinking?
What Is Kogelnik Doing?
Kogelnik founded the Open Medicine Institute to facilitate electronic information sharing in a community-based process. It is crowd-sourcing private funds. It has great plans for research, but as yet no studies have been registered at ClinicalTrials.gov. As far as I have been able to determine, he is offering individual patients treatment outside of any legitimate study. I don’t know how he is representing this to his patients, but at least one medically trained patient believed she was participating in a pilot study Kogelnik was doing in collaboration with researchers in Norway. I have no way of knowing whether the misunderstanding was on her part or his.
Some of this reminds me of Burzynski’s deceptive tactics, but Kugelnik is no Burzynski. I’m willing to believe he is sincerely trying to help patients who have no other options. But I think he’s on the wrong track. The way to really help these patients is to insist on providing the drug only in the context of well-designed clinical studies to establish once and for all whether rituximab treatment is effective. Jumping the gun is not scientifically or ethically justified.
Don’t expect anyone to try to stop him. Rituximab is an FDA-approved drug for other indications, and it is not illegal to prescribe the drug off-label. Offering experimental treatments to patients is not illegal. Medical boards have disciplinary power: the infamous Dr. Mark Geier, chemical castrator of autistic children, lost his license for “almost total disregard of basic medical and ethical standards,” but that kind of medical board action is the exception to the rule. Similar malfeasance (Dr. William Rea, for example) has typically been ignored or punished only with a mild slap on the wrist. Even Burzynski has not lost his license. In the absence of regulatory action, the only remedy would be a lawsuit if a patient died or was seriously harmed by the treatments.
Conclusion
So basically, the evidence consists of one case report (involving a different drug!), a case series of 3, and one preliminary controlled study with 30 patients showing a 2/3 response that was delayed and transient. Preliminary studies serve to justify further studies but they are not sufficient to justify forging ahead with offering the treatments in clinical practice. All too often, attempts to replicate preliminary studies fail, and initially promising results are discredited by larger, better studies. XMRV was a prime example of that.
The protocol in the studies was 2 IV infusions 2 weeks apart. The protocol that Kogelnik is using (treatments 2 weeks apart, then at 8, 24, 44 and 60 weeks) doesn’t correspond to the published study or even to the Norwegian studies in progress.
In my opinion, what he is doing is not based on acceptable evidence and is not ethical. He is indulging in irresponsible, uncontrolled experimentation. He is knocking out a vital part of his patients’ immune systems (B cells produce antibodies to fight off infections) with little understanding of what he is accomplishing, of whether it addresses some basic underlying causal mechanism of CFS, or of what the possible long-term consequences might be. By jumping the gun he is putting patients at risk; exposing them to considerable cost, discomfort, and inconvenience; and by running around the track prematurely by himself, he is missing out on the real race to understand and treat patients diagnosed with CFS/ME/CFIDS.

Chronic Fatigue Syndrome: Rituximab Revisited
Harriet Hall on January 19, 2016
Link

Three years ago I wrote about an experimental treatment for chronic fatigue syndrome (CFS): rituximab (brand name Rituxan). I was concerned that doctors who offered it, like Andreas Kogelnik, were jumping the gun by offering it before the evidence was in, and that they might be putting patients at risk.
A correspondent who has been following the CFS forums asked me to revisit this issue. She sent me links to forum posts indicating that Dr. Kogelnik is treating CFS patients with the drug, that they are not being enrolled in clinical trials, that information about results is not available, and that at least one patient may have developed a life-threatening side effect. I want to stress that I don’t have any evidence that those statements are true. These are only posts on a forum, and I have no way to verify the information. I tried to get more information from Dr. Kogelnik’s clinic, but was unsuccessful. Nevertheless, even if everything in those forum posts is false, I think the issue is serious enough to bring it to the attention of the public again. My purpose is to provide accurate information about rituximab and to get people to think about the principles involved, not to make claims or accusations or cast any blame.
What is rituximab?
Rituximab is a monoclonal anti-CD20 antibody. It destroys B cells that have the CD20 antigen on their surface. B-cells are an important component of the immune system, and depleting B-cells makes patients more vulnerable to infections. Rituximab is licensed only for a few specific indications such as B-cell lymphomas and refractory rheumatoid arthritis, although it has been prescribed off-label for a number of other autoimmune diseases. If it works in CFS, that would support the hypothesis that CFS is an autoimmune disease (though this is far from a clearly-supported hypothesis, as the primary defining characteristic of CFS is exercise intolerance).
Side effects can be deadly
Rituximab is marketed with black box warnings about a number of serious side effects that can cause death and disability. It is given intravenously; infusion reactions are common, and severe infusion reactions have been fatal. Infusions require premedication and special safety precautions. Infusion reactions occur in up to 50% of patients, usually with the first dose; they typically develop within 30 minutes to 2 hours but can be delayed for up to 24 hours. Severe mucocutaneous reactions can also be fatal. Hepatitis B virus can be reactivated. Fatal bacterial, fungal, and viral infections can occur. It can cause cardiac arrhythmias, renal toxicity, bowel obstruction and perforation, and many other side effects.
One of the most serious side effects is progressive multifocal leukoencephalopathy (PML). It is a rare and usually fatal disease caused by the JC virus. Up to 58% of the general population has been infected with this virus, and a third of the adult population has a persistent asymptomatic infection. It only becomes a problem when the immune system has been severely damaged. PML is a demyelinating disease similar to multiple sclerosis but much worse. The symptoms vary with the location of lesions in the brain; they can include clumsiness, progressive weakness, and visual, speech, and sometimes personality changes. The prescribing information for Rituximab warns that if any new neurologic symptom develops during treatment, the drug should be stopped and the patient should be evaluated for PML. There is no treatment. It is usually fatal within a few months. Survivors are left with permanent neurologic disabilities. A recent study found 231 confirmed cases of PML with rituximab and suggested it occurs far more often than has been recognized.
The evidence to date
When I wrote about this before, the evidence for rituximab in CFS boiled down to a case series of three, and one small randomized controlled trial in 2008. That RCT was negative for the primary end-point of self-reported symptoms at 3 months but 2/3 of the subjects showed a delayed transient improvement after 6-10 months of followup. The protocol in that study was not the same as the protocol Dr. Kogelnik was using.
At the time I wrote, there were two more studies pending, both open label and without a control group. One of those is still ongoing. The other has been completed. It found an improvement in self-reported fatigue scores in 64% of patients. It took an average of 23 weeks to see improvement. 14 patients had a “major response” lasting an average of 105 weeks; 4 had a “moderate response” lasting 69 weeks. 18 of the 28 subjects were the same individuals who had participated in the 2008 randomized study. Adverse events included two allergic reactions, two episodes of neutropenia, and eight transient symptom flares. One major responder dropped out after 32 months when he experienced a full relapse. Since there was no control group, it’s hard to judge what these results mean.
By the time that study was published, July 2015, the researchers had embarked on a randomized, double-blind, placebo-controlled study, and they were also conducting a small open-label study on patients with very severe symptoms. Two out of their four severe patients had experienced “a slight beneficial effect” but they had classified all four as non-responders. They warned that the treatment is experimental and they said:
We do not encourage the use of rituximab for ME/CFS outside of approved clinical trials, and this is especially important for the group with very severe disease.
All the Rituximab/CFS research has been done by a single group of researchers in Norway. I find that a bit worrisome. Their results will be more convincing if they can be replicated elsewhere.
A totally disabled patient
Whitney Dafoe was a world-traveling photojournalist until 2009 when he started to develop crushing fatigue, dizziness, GI problems, joint pain, and weight loss (down to 115 pounds on a 6 foot 3 inch frame). According to a news article his disease has now progressed to where he can no longer talk, read, eat solid food, or use the Internet, and rarely gets out of bed. Dr. Kogelnik was the one who made the diagnosis of CFS. Whitney’s father, Ronald Davis, is a researcher affiliated with Kogelnik; the research seems to be mainly focused on identifying possible biomarkers for CFS and looking for an etiology.
Whitney is featured in a video that also features Dr. Kogelnik and his Open Medicine Institute. He posts as “Whit” on the Phoenix Rising forum. In December 2012 he was able to write an articulate, coherent post. He apparently was started on rituximab by Dr. Kogelnik in January 2013 and rapidly went downhill. By April he posted “Can’t read much now…”
In September he posted a disjointed message saying he was worse since starting rituximab, and complaining of throat swelling, apnea, and sleeplessness. He says “CFS also wrse[sic]. I can’t talk. Can’t type/text enough to communicate. Haven’t had a conversation with someone in 8 months…”
By November 2013 he was no longer able to post for himself. He had his caretaker post “I am now 99.99% bedridden and can’t go to a dentist. I have serious sleep apnea that wakes me up in the night unable to breathe, and seriously disturbing my sleep…” According to more recent posts, he can’t tolerate his sister being in the room or even his partner who used to lift him from bed to stretcher; the only people who can care for him are his parents.
I want to stress again that I don’t have all the facts, but I can’t help but wonder if this unfortunate young man might have developed cognitive and other neurologic problems due to PML triggered by the rituximab. If nothing else, I think we can assume that the rituximab didn’t help him. He thinks it made him worse, and he may be right.
Comments on Kogelnik from other patients
The following are quotations from posts on the Phoenix Rising forum and I want to stress that the information in them is unverified. On the other hand, I have no reason to doubt their veracity. Please take them with the grain of salt that they deserve. Note: ME stands for myalgic encephalomyelitis, an alternate name for CFS that some people feel is more appropriate.
    • I am surprised they haven’t published a retrospective chart review of all ME/CFS patients they’ve treated with rituximab at this clinic. I suspect this hasn’t happened because the outcomes with this treatment are abysmal in the real world outside of the Norwegian trials and no one would be prepared to hand over $40k once they saw the numbers.
    • I do not believe it is a research study and it is offered to anyone that they feel is a good candidate (who is then informed of all the potential risks.)… they are charging $40k for a treatment whose efficacy has not been adequately established in ME/CFS and they have not published their outcomes despite having treated an unknown number of patients with RTX. Even a small case series would be useful so people can have some peer-reviewed information before parting with 40 grand.
    • the reason I started this thread is because no where on PR or anywhere else I searched could I find one single person who went to OMI and got Ritux and had a significant recovery or remission. Everyone failed or only had a short response. It could be that most of these people don’t know of or aren’t active on any ME forums like PR, but it just seemed weird to me because 67% is an impressive efficacy rate and I would’ve expected to see more.
    • I am a health care professional, and he attempted to push me into studies I was not interested in after risks discussed. One of drugs carried risks of death with weird virus causing movement disorder. Side effect RARE – but no thanks! Clearly he had ego involved in wanting to publish this. Does not respect the importance of patient’s role in making decisions within the context of informed consent.
Conclusion: Rituximab for CFS is, at best, experimental
The evidence that rituximab may be an effective treatment for CFS is preliminary. It must be considered an experimental treatment at this point. I can only speculate about what Dr. Kogelnik is doing, because he has not been very forthcoming with information. In interviews he talks about organizing trials, but so far he mainly seems to be trying to collect better information on CFS patients rather than putting rituximab to a fair test. He has published nothing on rituximab; PubMed lists only two studies he did on valganciclovir. I searched for his name on clinicaltrials.gov and all I found was a study on vitamin D. If he is indeed treating patients outside of clinical trials, I think that’s a very bad idea. Rituximab is a very dangerous drug: its side effects can be fatal. I don’t know for sure if Whitney was harmed by the drug; but if he wasn’t, it’s only a matter of time until someone is harmed. I hope patients will carefully consider the risks and the preliminary state of the evidence before they spend a lot of money ($40,000?) on a therapeutic trial of rituximab. I understand the desperation and the wish to try “anything” that might relieve their suffering, but clinical trials are the only way to find out if this treatment really works. If patients are treated outside of clinical trials, their experience doesn’t help advance the scientific knowledge needed to help other patients.
I hope the advice of the Norwegian researchers will be heeded: not to use rituximab outside of approved clinical trials, especially on patients with very severe disease.

Hepatitis C Vaccine Fails Testing
A vaccine regimen intended to prevent chronic HCV infection was tested in a double-blind placebo-controlled trial. It failed. The incidence of chronic HCV infection was the same in the vaccinated group as in the placebo group.
Harriet Hall on March 2, 2021
Link
Hepatitis C is a virus that has infected millions of people worldwide. In 75-85% of cases, the infection becomes chronic and can lead to death from liver cancer or cirrhosis. There is a vaccine for hepatitis B that is given to most babies at birth, but there is no vaccine for hepatitis C. Hepatitis C is more common than B, and most chronically infected people don’t know they have it. If they know they have it, effective treatment is available but is very expensive. Studies have shown that people with hepatitis C who inject drugs rarely seek treatment. It would be great if high-risk people could be offered a vaccine to prevent chronic infection.
In January 2021, The New England Journal of Medicine published the results of a large (548 subjects) randomized, double blind, placebo controlled trial of a vaccine regimen designed to prevent chronic HCV infection in high-risk people who had recently injected drugs. It did not cause serious adverse effects. It was effective for producing antibodies and for lowering the peak HCV RNA level, but it failed to prevent chronic HCV infection. The rate of chronic infection was the same in the vaccine group as in the placebo group.
This negative vaccine trial serves as a reminder of just how remarkable the experience with Covid-19 vaccines has been. We now have several effective vaccines that are already available in the US or likely to be approved soon, and both China and Russia have developed their own effective vaccines. One might be fooled into thinking any vaccine based on valid scientific principles is likely to be effective, but this study shows that even when a vaccine “ought” to work, it may not. That’s why carefully controlled studies are always necessary.
Conclusion: There is still no vaccine to prevent chronic hepatitis C
This study got negative results, but there is good reason to hope future studies may come up with an effective way to prevent the chronic infections with HCV that lead to deaths or the need for liver transplants. Fingers crossed.

Ivermectin to Control Malaria — A Cluster-Randomized Trial
Another use for Ivermectin from last week’s NEJM
Tim Noonan on July 31, 2025
Link
Malaria causes about 1/4 billion new cases of disease and about 600,000 deaths every year. 3/4 of the deaths are children under 5 years old. The July 23, 2025, NEJM has a free full text article showing use of ivermectin to prevent malaria and potentially save a lot of lives. This should appeal to ivermectin proponents, since hundreds of thousands of lives could be saved by an effective intervention.
Malaria control and elimination is threatened by the spread of insecticide resistance and behavioral adaptation of vectors. Whether mass administration of ivermectin, a broad-spectrum antiparasitic drug that also kills mosquitoes feeding on treated persons, can reduce malaria transmission is unclear.
We conducted a cluster-randomized trial in Kwale, a county in coastal Kenya in which malaria is highly endemic and coverage and use of insecticide-treated nets are high. Clusters of household areas were randomly assigned in a 1:1 ratio to receive mass administration of ivermectin (400 μg per kilogram of body weight) or albendazole (400 mg, active control) once a month for 3 consecutive months at the beginning of the “short rains” season. Children 5 to 15 years of age were tested for malaria infection monthly for 6 months after the first round of treatment. The two primary outcomes were the cumulative incidence of malaria infection (assessed among children 5 to 15 years of age) and of adverse events (assessed among all eligible participants).
What about DDT?
Why can’t we just DDT the mosquitoes away? Surely, Dire Straits could have a Concert for DDT, singing that, I waaaant my DDT. The problem is resistance to DDT. Mosquitoes are not cooperating with plans to exterminate mosquitoes. Researchers have known about this DDT resistance for a while:
Insect resistance to dichlorodiphenyltrichloroethane (DDT) emerged in the 1940s, with the first conclusive study being conducted on the Culex molestus mosquitoes in 1947 in Italy. Insecticide resistance was also reported among Anopheles sacharovi mosquitoes in Greece in 1951 [23]. In 1955, it was reported in the An. gambiae species in Nigeria [24]. Thereafter, resistance has been reported in more than 500 insects, 50 of which transmit malaria parasites in humans [21, 25].
That simple solution is not an effective long-term solution, so the much more complex approach of medical intervention is currently needed. Genetically modified mosquitoes could be effective, but the technology is newish and opposition to this will be tremendous, even if there is abundant evidence of safety.
Take ivermectin
Ivermectin is an endectocide, a drug that is effective against endoparasites and ectoparasites, and is used in mass drug administration to treat onchocerciasis and lymphatic filariasis and to reduce their transmission. Through the Mectizan Donation Program established by Merck, more than 4.6 billion ivermectin treatments have been distributed safely since 1988 to populations in regions where malaria is endemic.6 Ivermectin can also kill malaria vectors that feed on treated persons.7 Thus, mass administration of ivermectin has been suggested as a potential strategy to reduce malaria transmission driven by mosquitoes that are either resistant to insecticides or evade them through behavioral changes.8 To address public health needs and guide the development of new malaria vector-control tools, the WHO produced the preferred product characteristics for endectocides in 2016 and updated it in 2022; one target characteristic that was considered to be of potential value to public health was a 20% reduction in the incidence of clinical malaria or infection.9,10
Our primary research question was whether mass administration of ivermectin, given in three monthly doses of 400 µg per kilogram of body weight at the start of the short rainy season (which typically spans from October through December), would result in a relevant reduction in malaria transmission in an eligible population and have an acceptable safety profile.11
From the Protocol supplementary material in PDF (page 125/266):
The study will be open label but outcome assessor-blinded. Participants in the ivermectin and control arms will receive products that differ in aspect and numbers. Participants will be informed that they are taking one of two antihelminthics. The sponsor and the study statistician will remain blinded to the assignment of each cluster group. All unblinded DSMB [Data and Safety Monitoring Board] reports will be prepared by an independent statistician.
Why?
From the Protocol supplementary material in PDF (page 110/266):
Given the use of albendazole in the control group, fully blinding the study would require a double-dummy approach with placebo-ivermectin and placebo-albendazole tablets. Ivermectin is only available in 3 mg tablets and it is dosed by body weight. This results in a relative high pill-burden with up to 13 tablets for heavier adults (see table 1). Adding placebo pills would further increase this burden. It is for this reason that the study is open-label but assessor blinded.
Screening
Pregnancy tests were required prior to dosing to minimize the possibility of embryonic/fetal harm from a drug with an uncertain pregnancy risk. Participants also had their skin checked for signs of other parasitic diseases. An added benefit is that other parasitic diseases are expected to be decreased by this public health intervention. Treatment for malaria was administered right away, when any of the children tested positive for malaria, regardless of whether the participants had symptoms.
Dosing
A finger stick blood test was used to detect malaria and to check drug levels. The dose of ivermectin was larger than currently given in Kenya, but within limits approved for use in the Netherlands and Germany. The repeated dosing of ivermectin and albendazole are more frequent than recommended anywhere, but calculations of elimination rates were expected to decrease the amount of drug remaining in the blood, at the time of the next dose, to less than 1% of the maximum blood level by the time the next dose would be given. Toxicity was not expected to be a significant risk, but was screened for. The safety results of the study did not show problems that any reviewers attributed to the increased doses of the study drugs.
From page 110/266 of the Protocol supplementary material in PDF. Table 1.
This dosing table seems as if it is encouraging a higher dose than is reasonable, but the displayed numbers are only the highest dose for that weight range. The doses are all multiples of 3 mg tablets. The highest per kg dose listed is for the 31-40 kg participants, the dose is 484 µg per kg for the lightest patients in that weight range. These are the only weight group receiving 5 tablets (15 mg ivermectin). 15 mg ranges from 375 µg per kg for the 40 kg participants up to 484 µg per kg for the 31 kg participants. Breaking up tablets to get more precise dosing was probably considered impractical.
This was during the rainy season. Transportation was by motorbike and bicycle, so the niceties of a hospital lab, or even the niceties of a watertight vehicle, were not available at the time of dosing. All of the participants were weighed, apparently using portable scales. The scales were cleaned and placed on a flat surface, at the time of dosing for an accurate weight.
Controlling Contamination
Contamination: a state of heterogeneous or impure roll out of the intervention in any given cluster or group of clusters. This implies a risk of over- or under estimating the effect size. Given that the maximum recorded dispersal of Anophelines in East Africa is 661 meters [42], contamination risk will be assessed by calculating the mean proportion of households with equal assignment in a 1 km radius around every core household. For control households only ivermectin-treated households within this 1 km radius may cause contamination. For ivermectin-treated households both control and non-participating households may cause contamination (Figure 7).
Why do the researchers worry about contamination? If the intervention affects the health of the mosquitoes that bite participants in the ivermectin group, the ivermectin is expected to harm those mosquitoes. Less healthy mosquitoes are less likely to spread malaria to participants in the control group (participants receiving albendazole) and less likely to spread malaria to the non-participants. Non-participants are part of the calculation of the efficacy of the intervention, if the possibility of contamination is not controlled for.
Having non-participants, who benefited from the intervention, but are not part of the intervention group, included in the calculations benefit from the intervention makes the intervention appear less effective. Since the rate of malaria among the non-participants is calculated using all of the people counted in the cluster, there would be contamination of the results. The clusters are arranged with a buffer area to prevent that beneficial effect to non-participants from affecting the statistical results from contamination by that bias. There is no actual contamination of non-participants by ivermectin. Each participant takes several tablets to get their monthly dose. This dose would be much more than a mosquito could carry to the next person they bite, even if the mosquito bit the study participant when the study participant’s blood concentration of ivermectin was at its highest.
From page 120/266 of the Protocol supplementary material in PDF. Figure 5.
What were the results?
A total of 84 clusters comprising 28,932 eligible participants underwent randomization. The baseline characteristics of the participants were similar in the trial groups. Six months after the first round of treatment, the incidence of malaria infection was 2.20 per child-year at risk in the ivermectin group and 2.66 per child-year at risk in the albendazole group; the adjusted incidence rate ratio (ivermectin vs. albendazole) was 0.74 (95% confidence interval [CI], 0.58 to 0.95, P=0.02). The incidence of serious adverse events per 100 treatments did not differ significantly between the trial groups (incidence rate ratio, 0.63; 95% CI, 0.21 to 1.91).
26% lower incidence of malaria infection is not a huge percentage, but malaria kills a lot of children. A small percentage of a lot of people is still a lot of people. Yet, even saving the lives of a hundred children would be great. This public health intervention could save tens of thousands of lives and prevent millions of cases of malaria. Malaria is not the only medical condition that could be made less harmful with this intervention.
Mass administration of ivermectin would be a drug-based approach to vector control that leverages a mechanism of action that is distinct from that of the currently used insecticides in public health programs. This innovative method not only enhances vector control but provides potential collateral benefits in areas in which neglected tropical diseases, such as scabies and diseases caused by soil-transmitted helminths and filariae, are also endemic,37-39 particularly if existing delivery systems are leveraged for the distribution of ivermectin.40,41
This trial provides evidence to support the use of ivermectin as a complementary strategy for malaria control and prevention in areas where malaria is mesoendemic and transmission is perennial.
Why should we care?
Kenya is on the equator, so they do not have the kinds of seasons we are used to outside of the tropics, yet. Maybe this intervention will help to avoid making malaria endemic in America again. Currently, almost all cases are due to travel to places where malaria is endemic, but there have been occasional cases transmitted within the United States. Both malaria and yellow fever (caused by a virus, not a parasite, but also transmitted by mosquitoes) used to be right at home in the United States. Since these diseases are not foreign to the United States, the environment may support their return. A wall won’t keep mosquitoes out. Screwworms are another problem a wall won’t solve. The plan to stop the spread of screwworms by dropping sterile flies from aircraft in the Darién Gap in Panama is no longer working.
Public health measures are becoming more important, so we should be investing more in research on public health.
The trial was conducted in accordance with the principles of the Declaration of Helsinki, . . .
That is the beginning of a paragraph describing the ethical requirements the researchers met. The concern some might raise is that the active control group is not receiving an inert placebo. They are receiving an effective intervention. Depriving research participants of effective treatment is prohibited by ethical standards, such as the Declaration of Helsinki. People who understand science and ethics recognize that depriving research participants of a safe and effective intervention is causing harm. Causing harm to one group of research participants, for no expected benefit, is no longer allowed.
Science improves by learning from the mistakes of scientists. This is why the United States Public Health Service Study of Untreated Syphilis in the Negro Male at Tuskegee and Macon County, Alabama, 1932 -1972 is notorious. Research participants were deprived of a safe and effective intervention for no benefit to the research participants.
Starvation is at its lowest level due to advances made by scientists, including Fritz Haber, whose discovery enabled the large-scale production of synthetic fertilizers, feeding billions and preventing global famine. Then again, Haber also came up with a method for poisoning soldiers on the battlefield and another method for poisoning prisoners in extermination camps. Haber was not exactly altruistic, but he did save many times more lives than he helped to kill – and Haber was one of the most harmful scientists ever.
The Declaration of Helsinki and its predecessor the Nuremburg Code, were implemented to prevent those types of abuse.
Science – and scientists – save lives
To paraphrase the fictional Dr. Ian Malcolm, “Your anti-science propagandists were so preoccupied with whether or not they could spread Fear, Uncertainty, and Dread, they didn’t stop to think if they should.” That is not what is meant by people using the original quote, but it highlights the problem of pretending that competent scientists do not already study the safety of interventions in many ways before these interventions even leave a laboratory. But the safety of every intervention is studied at every step along the way, beginning with animal studies all the way up to final approval, and it continues to be monitored after approval.
The people usually quoting the mathematician from Jurassic Park would have us believe that these forms of preventive medicine are going to kill us all, because scientists are the problem. But opposition to science is the real problem.
Opposition to science doesn’t stop scientists from saving lives, but this opposition can decrease the benefits of science. Regulation is what helps people to do science well, even when it seems as if everything and everyone is trying to coerce scientists toward irresponsible behavior. Public health interventions treat people who are healthy, or not as sick as they could be without public health interventions. These public health interventions are intended to prevent harm, but the irrational human brain does a horrible job of assessing the relative risks of a possibly severe medical condition and a probably very safe medical intervention.


Biohacking Backfires: When Self-Tracking Can Harm
Is your fitness tracker helping or hurting your health?
Scott Gavura on June 19, 2025
Link
Here’s my own smartwatch helping motivate me.
Last week my Garmin smartwatch gave me an update after a week of strength workouts, bike commutes, and two runs: “Training Status: Unproductive.” Subjectively I had been feeling pretty good, fitting in so much exercise despite a busy week. And yet, here was my watch, crunching thousands of data points into a single demoralizing status. I felt unfairly judged. Or was the watch onto something? Was I really training ineffectively? Or are these devices that promise optimized training plans and inevitable personal bests actually counterproductive, especially when their feedback starts to affect our mood, motivation, and mental health?
25 Years of Wearables
I am not a Luddite when it comes to wearable technology. I was marathon running with a Polar heart rate monitor back in the early 2000s, with an awkward chest strap and no way to export the very limited data. At the time, this type of measurement was mostly reserved for serious athletes. Eventually I upgraded myself to a Garmin GPS that was absolutely massive – but it could track so much running data! But these devices were strictly for workouts only.
The first mainstream consumer tracker, the Fitbit, launched in 2009. Since then, wearable fitness devices have exploded in popularity, promising to help us “optimize” our workouts and our lives with real-time feedback on everything from heart rate and sleep quality to training load and stress levels. Millions of people now wear devices like Garmin, Fitbit, Oura and Apple Watch not just to count steps, but to establish training schedules, monitor our sleep “quality”, and track our recovery. The appeal is obvious: objective data, personalized recommendations, and a sense of “control” over our health. But as these tools become more sophisticated and prescriptive, questions have been raised: How accurate are these devices? Is the advice they provide evidence-based? And to some, could all this tracking and data do more harm than good?
The Optimizer’s Curse
For some users, wearables have shifted from helpful tools to relentless performance auditors. Reddit is filled with posts from people who feel anxious when their heart rate spikes unexpectedly, guilty for missing step goals, or demoralized by poor “sleep scores” despite feeling well-rested. A recent article in Vox, entitled, I covered my body in health trackers for 6 months. It ruined my life. describe one person’s negative experience:
In the six months I spent hooked up to every health tracker I could find, feeding my morbid curiosity, I drove myself slightly crazy. Each hit of dopamine I enjoyed by getting good scores on a health-tracking app was offset by long periods of self-doubt that came from not fully understanding how to make sense of the torrent of data without my doctor’s help. I also became obsessive — checking the apps was the first thing I did in the morning and started occupying hours of my day.
That’s the contradiction embedded in this cutting-edge technology: It can often lead to panic rather than peace of mind.
In some cases, wearables encourage healthier behaviors, motivating people to move more, sleep better, or pay closer attention to how their body responds to training. But for others the constant stream of biometric data can lead to anxiety, self-doubt, and stress. When a device tells you your body is underperforming, even if you feel fine, who do you believe?
What the Evidence Says (So Far)
There is research that shows wearables can lead to modest improvements in health behaviors, at least in the short term. And the evidence base is growing. Most clinical trials and systematic reviews have focused on chronic disease management, cardiovascular health, physical activity, and psychological well-being.
Wearable smartwatches are associated with improvements in physical activity, self-management behaviors, and some surrogate health outcomes. A 2024 systematic review of smartwatch interventions found positive effects on outcomes such as foot ulcer recurrence, depression severity, healthcare utilization, lifestyle changes, medication adherence, unplanned hospital readmissions, atrial fibrillation diagnosis, and goal attainment for emotion regulation. The most used smartwatch was the Apple Watch. However, the review noted that the number of high-quality studies is actually quite limited, with only moderate quality: most studies were small and of short duration.
Other studies have found that using fitness trackers is associated with increased daily step counts and higher physical activity levels. A few randomized trials have shown small benefits for weight loss or cardiovascular risk factors. Direct impact on measurements like blood pressure or cholesterol are not as consistent. Effects are often modest, and long-term adherence tends to decline over time. While wearable technology shows promise for improving certain health behaviors and intermediate outcomes, persuasive evidence for long-term clinical benefit is still lacking. As “they” say, more research is required.
Effects on Mental Health
While wearables may support healthier behaviors, their psychological effects are more complex. For some, tracking activity, sleep, or recovery provides structure and motivation, potentially reducing stress and improving self-efficacy. Wearables are now being studied for monitoring and early detection of depression, anxiety, and stress. It’s hoped the devices can support self-management, and reduce psychological distress.
However, there is also evidence of wearables being associated with overuse or obsessive tracking. In some, wearable data may contribute to health anxiety, compulsive tracking behaviors, and even negative or maladaptive compensatory behaviors (e.g., disordered eating). Data overload, and the potential for misinterpretation of health data may negatively impact mental health, particularly in those that may be vulnerable. Obsessively checking heart rate, sleep scores, or recovery status may aggravate stress, especially when the reports provided seems at odds with subjective experience. While there are lots of anecdotes online, the negative consequence of wearable technology have been understudied.
Tools and Not Judges
While writing this post, a friend of mine went into atrial fibrillation, and it was his smartwatch that alerted him to it. He was assessed at the hospital and when he converted back to normal sinus rhythm, his watch notified him first. He even sent me the ECG his watch had recorded. Thinking back to my early 2000s Polar heart rate monitor with such limited functionality, I’m amazed how far this technology has progressed. Much of it s genuinely impressive, and in some cases, even possibly lifesaving. But as wearable devices become more advanced, we still need to think critically about what they tell us. These devices can be helpful tools when thoughtfully integrated into our broader health goals. They may be crunching our data, but they aren’t infallible. And if the feedback begins to affect our well-being or mental health, it’s worth stepping back and remembering who’s supposed to be in charge.

“Gain of Function” Research Is Misunderstood – And That Is A Problem
Misplaced concerns or opposition could lead to overregulation or even banning
Henry Miller on December 4, 2025
Link

“Gain of function” (GoF) research refers to genetic modification that deliberately enhances the abilities of an organism — often a virus or bacterium — to study how such changes affect its function, transmissibility, or virulence. In simple terms, it means imparting a new or stronger function that the organism didn’t previously have. Such modifications, which have been performed for decades, have been extraordinarily important, from inducing bacteria to synthesize pharmaceuticals to imparting pest-resistance to crop plants.
Despite the importance of GoF modifications, they have sometimes faced misplaced concerns or opposition that could lead to their being overregulated or even banned.
What Is Gain-of-Function Research?
In the simplest terms, “gain of function” is a broad category of research that involves genetically altering an organism to give it new abilities or characteristics. In biomedical or other sciences, GoF studies have many purposes:
    • Understand disease mechanisms — for example, modifying a virus to see how specific mutations affect its ability to infect cells or evade the immune system. For example, GoF experiments have been crucial for increasing our understanding of bacteria like Mycobacterium tuberculosis (which causes TB) in the pursuit of discovering new treatments.
    • Develop treatments — by altering the microorganism to synthesize a pharmaceutical. GoF-modified E. coli synthesize human insulin, and modified baker’s yeast (Saccharomyces cerevisiae) produces the antigen in Hepatitis B vaccine. GoF research has also been used to create CAR T-cells for cancer, and modified adenoviruses used in gene therapies for muscular dystrophy.
    • Other uses – GoF techniques have also been used to improve crop resiliency and animal health and other characteristics. An example of the latter was the addition of a Chinook salmon growth hormone gene to the Atlantic salmon to create a version of the fish – the AquAdvantage salmon — that grows to maturity in about half the time of the unmodified fish.
    • Model potential pandemics — by studying how animal viruses might mutate and adapt to infect humans.
Many such studies are completely benign — like most of those mentioned above or tweaking yeast or fruit-fly genes to study metabolism. Controversy arises with the modification of potential pandemic pathogens (PPPs), highly transmissible and/or virulent agents that could cause widespread illness if released accidentally.
Why It’s Controversial
1. Risk of Laboratory Escape
Critics worry that enhancing the pathogenicity or transmissibility of viruses — such as influenza, SARS, or other coronaviruses — creates the possibility of spread of a dangerous infectious agent if there is accidental release from the lab. The fear is that, depending on the enhanced or new function of the organism, a laboratory accident could spark an outbreak similar to naturally occurring ones.
This concern intensified after reports of safety breaches at U.S. labs (e.g., anthrax, influenza, and smallpox incidents at U.S. government labs in 2014) and debates about coronavirus research performed at the Wuhan Institute of Virology in Wuhan, China.
2. The Dual-Use Dilemma
GoF research is “dual use” – that is, it can advance science and medicine but also provide a roadmap for bioweapon development. The same mutations that help scientists anticipate viral evolution could, in the wrong hands, be exploited maliciously.
3. Ethical and Oversight Concerns
The question is not whether such research can be done but whether it should be done — and under what conditions. In 2014, the U.S. government imposed a moratorium on federally funded GoF research involving influenza, SARS, and MERS viruses. This pause was lifted in 2017, replaced by a stricter oversight system known as the Potential Pandemic Pathogen Care and Oversight (P3CO) framework. Critics argue that oversight remains opaque and inconsistent.
4. Scientific Divisions
Some virologists insist GoF experiments are indispensable for understanding how viruses mutate and for designing better vaccines and antiviral drugs. Others argue that computational models, pseudovirus systems, and field surveillance offer safer alternatives without creating potential new hazards.
The Broader Debate
The GoF controversy is as much philosophical as technical. It pits scientific freedom and preparedness against precaution and biosecurity. The key questions include:
How much risk is there in GoF research?
How much risk is society willing to tolerate in pursuit of knowledge that might avert future pandemics?
    • Who decides which experiments cross the line?
    • How can oversight keep pace with biotechnology’s accelerating power?
    • Should the knowledge that U.S. adversaries are working on bioweapons influence domestic policy?
Lack of Common Sense
When I was a Special Assistant to Dr. Frank Young, the Commissioner of the FDA, he used to counsel his minions that regulation needed to be tempered by common sense – which has been wanting in the GoF debates.
An example is NIH’s order to University of California, Berkely Professor Sarah Stanley to halt her research on Mycobacterium tuberculosis, the bacterium that causes tuberculosis, because the work was deemed “too dangerous.” What was the rationale?  The work often uses resistance to kanamycin, an antibiotic not used to treat humans because of severe side effects, in order to isolate mutated strains. The kanamycin kills all the bacteria except for those that are resistant. Thus, kanamycin resistance serves as a molecular marker that identifies and allows the isolation of the small percentage of mutants in a population that have been successfully modified, since only these bacteria survive when exposed to the kanamycin. That is the bacteria’s “new function.”
In any case, all the kanamycin-resistant strains are killed by clinically used antibiotics and cannot spread drug resistance to other strains, so they pose no incremental risk to the public. For decades, the selection of kanamycin-resistant mutants has not been considered dangerous by any reasonable definition. And yet, because kanamycin resistance is the acquisition, or gain, of a new function, it was (mistakenly) deemed to be dangerous by NIH. This is just one of many examples of the paucity of “gold standard” science currently at HHS agencies such as NIH, FDA, and CDC.
In Summary
“Gain of function” research is important in several ways. It can induce organisms to synthesize high-value pharmaceuticals or acquire other useful characteristics or to anticipate nature’s next move by creating them in the lab — but critics warn it could unleash what it seeks to prevent. The ongoing debate reflects a broader tension in modern science between balancing innovation with the imperative to protect the public from rare but catastrophic risks.
However, that balance must be governed by common sense. Precautions on genuinely dangerous GoF and other research – for example, on the influenza virus that caused the 1918-1920 Spanish Flu pandemic – are important. But effective, science-based oversight must distinguish between low-risk and actual, demonstrable threats so that we do not impede progress against deadly diseases for no real safety benefit. As Berkely Professor Sarah Stanley, whose tuberculosis research was halted, put it:
An overly broad approach, with the resulting ramifications for lifesaving research we’re already seeing, could be exacerbated by the recently proposed “Risky Research Review Act.” Without clear definitions, scientific expertise, and streamlined review processes, lifesaving research could be stopped. This would be an even bigger threat to public health than the broad, misinformed definition of “dangerous” that is being applied here.
Given the deficiencies of leadership in federal science agencies and the ignorance of scientific nuance that often emanates from Congress, it is difficult to be optimistic about the outcome for the foreseeable future.

